Citrus Sinensis ID: 014245
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 428 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LTC0 | 410 | Probable receptor-like pr | no | no | 0.829 | 0.865 | 0.489 | 7e-97 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.764 | 0.663 | 0.494 | 9e-94 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.780 | 0.681 | 0.487 | 2e-93 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.768 | 0.772 | 0.489 | 6e-88 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.768 | 0.772 | 0.485 | 9e-87 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.792 | 0.826 | 0.477 | 2e-86 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.785 | 0.819 | 0.460 | 4e-86 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.719 | 0.791 | 0.481 | 5e-86 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.691 | 0.718 | 0.495 | 1e-84 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.808 | 0.875 | 0.434 | 1e-79 |
| >sp|Q9LTC0|Y5707_ARATH Probable receptor-like protein kinase At5g47070 OS=Arabidopsis thaliana GN=At5g47070 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 354 bits (909), Expect = 7e-97, Method: Compositional matrix adjust.
Identities = 184/376 (48%), Positives = 250/376 (66%), Gaps = 21/376 (5%)
Query: 33 NDNEVGRIGSELTSQNVSAISVESEARP-------SYPS-------MSQRPSNLKEFTIA 78
++N+ R G EL + ++ SE S PS ++R NL+ F+
Sbjct: 18 DNNKNKRKGKELLQNSAPELTNRSETSSFNLQTPRSLPSPRSIKDLYTEREQNLRVFSYE 77
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKG-LIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTE 137
EL AT FSR +VIGEGGFG VYKG ++ N + + VA+K+L R+G+QGHK+W+ E
Sbjct: 78 ELSKATYVFSRKLVIGEGGFGIVYKGKILSNGDSSDPPLVVAIKKLNRQGLQGHKQWLAE 137
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 197
V FLG+V H N+VKL+GYC++D E GI+RLLVYEYM N S++ +L P+ L W RL+
Sbjct: 138 VQFLGVVNHPNVVKLIGYCSEDGETGIERLLVYEYMSNRSLEDHLFPRRSHTLPWKKRLE 197
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
I AA GL YLH D ++I RDFKSSN+LLD+Q+ KLSDFGLAR GP THV+TA
Sbjct: 198 IMLGAAEGLTYLH---DLKVIYRDFKSSNVLLDDQFCPKLSDFGLAREGPDGDNTHVTTA 254
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317
VGT GYAAPEYVQTG L +SDV+S+GV LYE+ITGRR I+RN+P +E++LL WVK Y
Sbjct: 255 RVGTHGYAAPEYVQTGHLRLKSDVYSFGVVLYEIITGRRTIERNKPVAERRLLDWVKEYP 314
Query: 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377
+D+++F IVDPRL Y L+ +A+LCL KN + RP M V+E + KI++ E
Sbjct: 315 ADSQRFSMIVDPRLRNNYPAAGARSLAKLADLCLKKNDKERPTMEIVVERLKKIIE---E 371
Query: 378 AGSPRRPLRSSTSRET 393
+ S P+ ++T++E+
Sbjct: 372 SDSEDYPMATTTTKES 387
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 344 bits (882), Expect = 9e-94, Method: Compositional matrix adjust.
Identities = 171/346 (49%), Positives = 241/346 (69%), Gaps = 19/346 (5%)
Query: 33 NDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQR---PSNLKEFTIAELKSATKNFSR 89
ND VG++ S T+ N +E+ S P +S+ S+L++FT +LK +T+NF
Sbjct: 92 NDQPVGQVSSTTTTSN-------AESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRP 144
Query: 90 SVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE 145
++GEGGFGCV+KG I+ + P + VAVK L G+QGHKEW+ E+NFLG +
Sbjct: 145 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLL 204
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
H NLVKLVGYC +DD QRLLVYE+MP GS++ +L +S L W++R+KIA AA+G
Sbjct: 205 HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 259
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L++LHE +I RDFK+SNILLD +NAKLSDFGLA+ P EG THVST V+GT GYA
Sbjct: 260 LSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYA 319
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325
APEYV TG L ++SDV+S+GV L E++TGRR +D+NRP E L++W +P+L D ++F +
Sbjct: 320 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYR 379
Query: 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
++DPRLEG +S++ K++ +A CL ++ + RPKMS+V+E + +
Sbjct: 380 LLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 172/353 (48%), Positives = 246/353 (69%), Gaps = 19/353 (5%)
Query: 26 RSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRP---SNLKEFTIAELKS 82
+S+ ND VG + S T+ N +E+ S P +S+ S+LK+F+ +LK
Sbjct: 79 QSAIVQSNDQPVGPVSSTTTTSN-------AESSLSTPIISEELNIYSHLKKFSFIDLKL 131
Query: 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGRRGVQGHKEWMTEV 138
AT+NF ++GEGGFGCV+KG ++ + P + VAVK L G+QGHKEW+ E+
Sbjct: 132 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEI 191
Query: 139 NFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKI 198
N+LG + H NLVKLVGYC +DD QRLLVYE+MP GS++ +L +S L W++R+KI
Sbjct: 192 NYLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKI 246
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A AA+GL++LHE +I RDFK+SNILLD ++NAKLSDFGLA+ P EG THVST V
Sbjct: 247 ALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRV 306
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318
+GT GYAAPEYV TG L ++SDV+S+GV L E++TGRR +D+NRP E L++W +P+L
Sbjct: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLL 366
Query: 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
D ++F +++DPRLEG +S++ K++ +A CL ++++ RPKMSEV+E++ +
Sbjct: 367 DKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 6e-88, Method: Compositional matrix adjust.
Identities = 170/347 (48%), Positives = 226/347 (65%), Gaps = 18/347 (5%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIK----NSEDPSQKVEVAVKQLGRR 126
NLK FT ELK+ATKNF + ++GEGGFGCV+KG I + P + VAVKQL
Sbjct: 70 NLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPE 129
Query: 127 GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 186
G QGHKEW+TEVN+LG + H NLV LVGYCA+ G RLLVYE+MP GS++ +L +
Sbjct: 130 GFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAE----GENRLLVYEFMPKGSLENHLFRRG 185
Query: 187 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246
LTWA+R+K+A AA+GL +LHE Q+I RDFK++NILLD +NAKLSDFGLA+ G
Sbjct: 186 AQPLTWAIRMKVAVGAAKGLTFLHEAKS-QVIYRDFKAANILLDADFNAKLSDFGLAKAG 244
Query: 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306
P+ THVST V+GT GYAAPEYV TGRL A+SDV+S+GV L ELI+GRR +D + +E
Sbjct: 245 PTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNE 304
Query: 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
L+ W PYL D ++ +I+D +L G+Y + +++A CL +A+ RPKMSEVL
Sbjct: 305 YSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLV 364
Query: 367 MVNKIVDASAEAGSPRRPLRSSTSRETP--DHTKTKHKRRIIESKTR 411
+ ++ + +P T E+P H+ K + S R
Sbjct: 365 TLEQLESVA-------KPGTKHTQMESPRFHHSSVMQKSPVRYSHDR 404
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 9e-87, Method: Compositional matrix adjust.
Identities = 164/338 (48%), Positives = 223/338 (65%), Gaps = 9/338 (2%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNS----EDPSQKVEVAVKQLGRR 126
NLK FT ELK+AT+NF ++GEGGFG V+KG I + P + VAVK+L
Sbjct: 67 NLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTE 126
Query: 127 GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 186
G QGHKEW+TEVN+LG + H NLVKLVGYC + G RLLVYE+MP GS++ +L +
Sbjct: 127 GYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVE----GENRLLVYEFMPKGSLENHLFRRG 182
Query: 187 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246
LTWA+R+K+A AA+GL +LH+ Q+I RDFK++NILLD ++N+KLSDFGLA+ G
Sbjct: 183 AQPLTWAIRMKVAIGAAKGLTFLHDAKS-QVIYRDFKAANILLDAEFNSKLSDFGLAKAG 241
Query: 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306
P+ THVST V+GT GYAAPEYV TGRL A+SDV+S+GV L EL++GRR +D+++ E
Sbjct: 242 PTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGME 301
Query: 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
Q L+ W PYL D ++ +I+D RL G+Y + + +A CL +A+ RPKMSEVL
Sbjct: 302 QSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLA 361
Query: 367 MVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRR 404
++++ G R + + R + K RR
Sbjct: 362 KLDQLESTKPGTGVGNRQAQIDSPRGSNGSIVQKSPRR 399
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (818), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 167/350 (47%), Positives = 230/350 (65%), Gaps = 11/350 (3%)
Query: 26 RSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRP---SNLKEFTIAELKS 82
R A F + + S++VS +S S P + S+ P + + FT+ EL++
Sbjct: 7 RDEAAVFTPQAQAQQLQKKHSRSVSDLSDPST--PRFRDDSRTPISYAQVIPFTLFELET 64
Query: 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQK-VEVAVKQLGRRGVQGHKEWMTEVNFL 141
TK+F ++GEGGFG VYKG I ++ K + VAVK L + G+QGH+EW+TEVNFL
Sbjct: 65 ITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 124
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
G + H NLVKL+GYC +DD RLLVYE+M GS++ +L K+ L+W+ R+ IA
Sbjct: 125 GQLRHPNLVKLIGYCCEDD----HRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALG 180
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
AA+GLA+LH + +I RDFK+SNILLD + AKLSDFGLA+ GP THVST V+GT
Sbjct: 181 AAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 239
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
GYAAPEYV TG L ARSDV+S+GV L E++TGR+ +D+ RP EQ L+ W +P L+D +
Sbjct: 240 YGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKR 299
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
+ QI+DPRLE +YS+R K +A CL +N + RP MS+V+E + +
Sbjct: 300 KLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (816), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 163/354 (46%), Positives = 237/354 (66%), Gaps = 18/354 (5%)
Query: 32 FNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSV 91
++ ++G +GS+ S++SV R + + Q P NLK F+ AELKSAT+NF
Sbjct: 20 YDAKDIGSLGSK-----ASSVSVRPSPR-TEGEILQSP-NLKSFSFAELKSATRNFRPDS 72
Query: 92 VIGEGGFGCVYKGLIK----NSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQ 147
V+GEGGFGCV+KG I + P + +AVK+L + G QGH+EW+ EVN+LG H+
Sbjct: 73 VLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHR 132
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI--LTWAMRLKIAQDAARG 205
+LVKL+GYC +D+ RLLVYE+MP GS++ +L + L+W +RLK+A AA+G
Sbjct: 133 HLVKLIGYCLEDE----HRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAKG 188
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
LA+LH + ++I RDFK+SNILLD ++NAKLSDFGLA+ GP +HVST V+GT GYA
Sbjct: 189 LAFLHSS-ETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYA 247
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325
APEY+ TG L +SDV+S+GV L EL++GRR +D+NRP E+ L++W KPYL + ++ +
Sbjct: 248 APEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFR 307
Query: 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAG 379
++D RL+ +YS+ K++ ++ CL + RP MSEV+ + I +A G
Sbjct: 308 VIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSLNAAIG 361
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 318 bits (815), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 155/322 (48%), Positives = 228/322 (70%), Gaps = 14/322 (4%)
Query: 70 SNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGR 125
+NLK F+++ELKSAT+NF V+GEGGFGCV+KG I S P + +AVK+L +
Sbjct: 51 ANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQ 110
Query: 126 RGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK 185
G QGH+EW+ E+N+LG ++H NLVKL+GYC +++ RLLVYE+M GS++ +L +
Sbjct: 111 EGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEE----HRLLVYEFMTRGSLENHLFRR 166
Query: 186 SETI--LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243
L+W R+++A AARGLA+LH Q+I RDFK+SNILLD +NAKLSDFGLA
Sbjct: 167 GTFYQPLSWNTRVRMALGAARGLAFLHNAQP-QVIYRDFKASNILLDSNYNAKLSDFGLA 225
Query: 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 303
R GP +HVST V+GT GYAAPEY+ TG L+ +SDV+S+GV L EL++GRR ID+N+P
Sbjct: 226 RDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQP 285
Query: 304 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363
E L+ W +PYL++ ++ +++DPRL+G+YSL K++ +A C+ +A++RP M+E
Sbjct: 286 VGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNE 345
Query: 364 VLEMVNKI---VDASAEAGSPR 382
+++ + ++ +AS E +P+
Sbjct: 346 IVKTMEELHIQKEASKEQQNPQ 367
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 313 bits (803), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 152/307 (49%), Positives = 214/307 (69%), Gaps = 11/307 (3%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIK----NSEDPSQKVEVAVKQLGRR 126
NLK FT AELK+AT+NF V+GEGGFG V+KG I + P V +AVK+L +
Sbjct: 53 NLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQD 112
Query: 127 GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 186
G QGH+EW+ EVN+LG H NLVKL+GYC +D+ RLLVYE+MP GS++ +L +
Sbjct: 113 GWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDE----HRLLVYEFMPRGSLENHLFRRG 168
Query: 187 ETI--LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244
L+W +RLK+A AA+GLA+LH + +I RDFK+SNILLD ++NAKLSDFGLA+
Sbjct: 169 SYFQPLSWTLRLKVALGAAKGLAFLHNA-ETSVIYRDFKTSNILLDSEYNAKLSDFGLAK 227
Query: 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 304
GP+ +HVST ++GT GYAAPEY+ TG L +SDV+SYGV L E+++GRR +D+NRP
Sbjct: 228 DGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPP 287
Query: 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 364
EQKL++W +P L++ ++ +++D RL+ +YS+ K++ +A CL + RP M+EV
Sbjct: 288 GEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEV 347
Query: 365 LEMVNKI 371
+ + I
Sbjct: 348 VSHLEHI 354
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (760), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 156/359 (43%), Positives = 225/359 (62%), Gaps = 13/359 (3%)
Query: 21 SLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAEL 80
S FS R F++ + + S S+ +V + + +S P +K FT EL
Sbjct: 3 SCFSSRVKADIFHNGKSSDLYGLSLSSRKSSSTVAAAQKTEGEILSSTP--VKSFTFNEL 60
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGRRGVQGHKEWMT 136
K AT+NF VIGEGGFGCV+KG + S P + +AVK+L + G QGH+EW+T
Sbjct: 61 KLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHREWLT 120
Query: 137 EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI--LTWAM 194
E+N+LG + H NLVKL+GYC +D+ RLLVYE+M GS++ +L + L W +
Sbjct: 121 EINYLGQLSHPNLVKLIGYCLEDE----HRLLVYEFMQKGSLENHLFRRGAYFKPLPWFL 176
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
R+ +A DAA+GLA+LH ++I RD K+SNILLD +NAKLSDFGLAR GP ++V
Sbjct: 177 RVNVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYV 235
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314
ST V+GT GYAAPEY+ +G L ARSDV+S+GV L E+++G+R +D NRP E+ L+ W +
Sbjct: 236 STRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWAR 295
Query: 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373
PYL+ ++ IVD RL+ +Y +++ VA CL ++RP M +V+ + ++ D
Sbjct: 296 PYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQD 354
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 428 | ||||||
| 255556958 | 422 | Protein kinase APK1A, chloroplast precur | 0.981 | 0.995 | 0.725 | 1e-179 | |
| 359481541 | 437 | PREDICTED: probable receptor-like protei | 0.995 | 0.974 | 0.681 | 1e-174 | |
| 297741627 | 460 | unnamed protein product [Vitis vinifera] | 0.985 | 0.917 | 0.698 | 1e-174 | |
| 224068749 | 424 | predicted protein [Populus trichocarpa] | 0.990 | 1.0 | 0.700 | 1e-173 | |
| 359486879 | 2201 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.192 | 0.669 | 1e-167 | |
| 356572460 | 428 | PREDICTED: probable receptor-like protei | 0.997 | 0.997 | 0.673 | 1e-165 | |
| 356505240 | 428 | PREDICTED: probable receptor-like protei | 0.997 | 0.997 | 0.673 | 1e-164 | |
| 357510763 | 434 | Protein kinase [Medicago truncatula] gi| | 0.990 | 0.976 | 0.666 | 1e-163 | |
| 357440361 | 427 | Protein kinase 2A [Medicago truncatula] | 0.992 | 0.995 | 0.651 | 1e-161 | |
| 297829514 | 418 | hypothetical protein ARALYDRAFT_478307 [ | 0.892 | 0.913 | 0.707 | 1e-161 |
| >gi|255556958|ref|XP_002519512.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223541375|gb|EEF42926.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1636), Expect = e-179, Method: Compositional matrix adjust.
Identities = 307/423 (72%), Positives = 357/423 (84%), Gaps = 3/423 (0%)
Query: 6 FTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSM 65
++ DKKDEP TT L S++S+ + F D EVGR SE +VS S+ES RPS+PSM
Sbjct: 3 LSHGDKKDEPKTT--KLVSVQSTNSAFTDREVGR-SSEFNYPDVSGTSIESIDRPSFPSM 59
Query: 66 SQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR 125
SQRPSNL+ FT+AELKSAT+NFSRSV++GEGGFGCVY+G IK+ EDP++K+EVAVKQLG+
Sbjct: 60 SQRPSNLRVFTVAELKSATRNFSRSVMLGEGGFGCVYRGSIKSLEDPTKKLEVAVKQLGK 119
Query: 126 RGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK 185
RG+QGHKEW+TEVN LG+VEH NLVKLVGYCADDDERGIQRLL+YE+MPNGSV+ +LS +
Sbjct: 120 RGMQGHKEWVTEVNVLGVVEHPNLVKLVGYCADDDERGIQRLLIYEFMPNGSVEDHLSAR 179
Query: 186 SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245
S+ + WAMRL+IAQDAARGL YLHE M FQII RDFKSSNILLDEQWNAKLSDFGLARL
Sbjct: 180 SDAPIPWAMRLRIAQDAARGLTYLHEEMGFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 239
Query: 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 305
GPSEG THVSTAVVGTMGYAAPEYVQTGRL ++SDVWSYGVFLYELITGRRP+DRNRPRS
Sbjct: 240 GPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFLYELITGRRPLDRNRPRS 299
Query: 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
EQKLL+WVKPYL+DAK+F QI+DPRLEGKY LR KL+ +AN CLV+N + RPKMSEVL
Sbjct: 300 EQKLLEWVKPYLADAKKFPQILDPRLEGKYPLRSAQKLATIANRCLVRNPKARPKMSEVL 359
Query: 366 EMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWKWRQKLI 425
EMVN+IVDAS+EA SP+ +SS + ET KTK+KRR ++ K RESG W KLI
Sbjct: 360 EMVNRIVDASSEASSPQLSFKSSITMETSRDHKTKNKRRKVDLKGRESGWFSRMWAPKLI 419
Query: 426 RTC 428
RTC
Sbjct: 420 RTC 422
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481541|ref|XP_002276673.2| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1592), Expect = e-174, Method: Compositional matrix adjust.
Identities = 299/439 (68%), Positives = 357/439 (81%), Gaps = 13/439 (2%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
MKCF F DKK+EP T+ + S++S+ +T + E+ R SEL+SQNVS +S ES ARP
Sbjct: 1 MKCFTFYYGDKKEEPKTSKWT--SVQSNNSTLTEQEMKRFASELSSQNVSNVSTESLARP 58
Query: 61 SYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
++PS+SQR SNL+ FT +ELKS TKNFSRS +IGEGGFGCVYKG+IK+S+DP K++VAV
Sbjct: 59 TFPSLSQRVSNLRVFTFSELKSVTKNFSRSAMIGEGGFGCVYKGMIKSSDDPPSKLDVAV 118
Query: 121 KQLGRRGVQ-----------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169
KQLG+RG+Q GHKEW+TEV LG+VEH NLVKLVGYCA+DDERGIQRLL+
Sbjct: 119 KQLGKRGMQARFLHDVFLVMGHKEWVTEVKVLGVVEHPNLVKLVGYCAEDDERGIQRLLI 178
Query: 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229
YEYMPNGSV+ +LS +S+T L+WAMRLKIAQDAA+GLAYLHE MDFQII RDFKSSNILL
Sbjct: 179 YEYMPNGSVESHLSSQSQTPLSWAMRLKIAQDAAQGLAYLHEEMDFQIIFRDFKSSNILL 238
Query: 230 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLY 289
DE+WNAKLSDFGLARLGPSEG THVSTAVVGTMGYAAPEYVQTGRL ++SDVWSYGVF+Y
Sbjct: 239 DEEWNAKLSDFGLARLGPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFIY 298
Query: 290 ELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL 349
ELITGRRP DRNRP+SEQKLL WVKP+LSD K+F I+DPRLEG Y L+ V +L+ VAN
Sbjct: 299 ELITGRRPFDRNRPKSEQKLLSWVKPFLSDIKKFNLILDPRLEGNYHLKSVQRLAIVANR 358
Query: 350 CLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESK 409
CLV+N ++RPKMSEVLEMVN+IVDA E GSP+ P++ S ET T+ K KR I + +
Sbjct: 359 CLVRNPKSRPKMSEVLEMVNRIVDAPRETGSPQPPVKRLLSIETSQITELKKKRNIKDLR 418
Query: 410 TRESGTLFWKWRQKLIRTC 428
E G L WKW +++RTC
Sbjct: 419 IGEGGWLPWKWTSRVVRTC 437
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741627|emb|CBI32759.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1591), Expect = e-174, Method: Compositional matrix adjust.
Identities = 296/424 (69%), Positives = 353/424 (83%), Gaps = 2/424 (0%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
MKCF F DKK+EP T+ + S++S+ +T + E+ R SEL+SQNVS +S ES ARP
Sbjct: 1 MKCFTFYYGDKKEEPKTSKWT--SVQSNNSTLTEQEMKRFASELSSQNVSNVSTESLARP 58
Query: 61 SYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
++PS+SQR SNL+ FT +ELKS TKNFSRS +IGEGGFGCVYKG+IK+S+DP K++VAV
Sbjct: 59 TFPSLSQRVSNLRVFTFSELKSVTKNFSRSAMIGEGGFGCVYKGMIKSSDDPPSKLDVAV 118
Query: 121 KQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ 180
KQLG+RG+QGHKEW+TEV LG+VEH NLVKLVGYCA+DDERGIQRLL+YEYMPNGSV+
Sbjct: 119 KQLGKRGMQGHKEWVTEVKVLGVVEHPNLVKLVGYCAEDDERGIQRLLIYEYMPNGSVES 178
Query: 181 YLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240
+LS +S+T L+WAMRLKIAQDAA+GLAYLHE MDFQII RDFKSSNILLDE+WNAKLSDF
Sbjct: 179 HLSSQSQTPLSWAMRLKIAQDAAQGLAYLHEEMDFQIIFRDFKSSNILLDEEWNAKLSDF 238
Query: 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDR 300
GLARLGPSEG THVSTAVVGTMGYAAPEYVQTGRL ++SDVWSYGVF+YELITGRRP DR
Sbjct: 239 GLARLGPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFIYELITGRRPFDR 298
Query: 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 360
NRP+SEQKLL WVKP+LSD K+F I+DPRLEG Y L+ V +L+ VAN CLV+N ++RPK
Sbjct: 299 NRPKSEQKLLSWVKPFLSDIKKFNLILDPRLEGNYHLKSVQRLAIVANRCLVRNPKSRPK 358
Query: 361 MSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWKW 420
MSEVLEMVN+IVDA E GSP+ P++ S ET T+ K KR I + + E G L WKW
Sbjct: 359 MSEVLEMVNRIVDAPRETGSPQPPVKRLLSIETSQITELKKKRNIKDLRIGEGGWLPWKW 418
Query: 421 RQKL 424
++
Sbjct: 419 TSRV 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224068749|ref|XP_002326190.1| predicted protein [Populus trichocarpa] gi|222833383|gb|EEE71860.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1579), Expect = e-173, Method: Compositional matrix adjust.
Identities = 300/428 (70%), Positives = 353/428 (82%), Gaps = 4/428 (0%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
MKCF F + DK DEP TPKS+ S++S + D E+GR GSEL SQNVS S ES RP
Sbjct: 1 MKCFSFHSGDKTDEP-KTPKSV-SVQSVNSPGADREIGRSGSELNSQNVSGTSTESMVRP 58
Query: 61 SYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
S PSMSQRPSNL+ FT++ELKSATKNFSRSV+IGEGGFGCVYKG IK++EDP+ K+E+AV
Sbjct: 59 SLPSMSQRPSNLRVFTVSELKSATKNFSRSVMIGEGGFGCVYKGSIKSTEDPTTKLEIAV 118
Query: 121 KQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ 180
KQLG+RG GHKEW+TEVN LG+VEH NLVKLVGYCAD+DERG+QRLL+YE+M GSV+
Sbjct: 119 KQLGKRG--GHKEWVTEVNVLGVVEHPNLVKLVGYCADEDERGMQRLLIYEFMSKGSVED 176
Query: 181 YLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240
+LS +S+ L WAMRL+IAQDAARGL YLHE MDFQII RDFKSSNILLDEQWNAKLSDF
Sbjct: 177 HLSIRSDKPLPWAMRLRIAQDAARGLKYLHEEMDFQIIFRDFKSSNILLDEQWNAKLSDF 236
Query: 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDR 300
GLARLGPSEG THVSTAVVGTMGYAAPEYVQTGRL ++SDVWSYGVFLYELITGRRP+DR
Sbjct: 237 GLARLGPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFLYELITGRRPLDR 296
Query: 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 360
NRP+SEQKLL+W++PYLSDAK+F+QIVDPRLE K L+ KL+++AN CLV+N + RPK
Sbjct: 297 NRPKSEQKLLEWIRPYLSDAKKFKQIVDPRLEQKDILKSAHKLANIANRCLVRNPKLRPK 356
Query: 361 MSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWKW 420
MSEVLE +N+IVDAS S ++ ++S +T T K+KRR ++ KT ESG W W
Sbjct: 357 MSEVLEKMNQIVDASTGTESAQQSSKNSAPIKTSHGTTAKNKRRNVDLKTGESGWFGWMW 416
Query: 421 RQKLIRTC 428
K +RTC
Sbjct: 417 NPKHVRTC 424
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486879|ref|XP_002273591.2| PREDICTED: uncharacterized protein LOC100254784 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1528), Expect = e-167, Method: Compositional matrix adjust.
Identities = 285/426 (66%), Positives = 351/426 (82%), Gaps = 3/426 (0%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
M CFPF +K DEP T + +S + D+EV R GSE SQN S IS ES A+
Sbjct: 1 MTCFPFHKGEKNDEPKATKSTSVRSSTSISMSTDHEVRRSGSEFNSQNASDISTESSAKT 60
Query: 61 SYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
S+ S+ QRPSNLK FT +ELKSATKNFSRS++IGEGGFG VY+G+I+++EDP +K+++AV
Sbjct: 61 SFTSLQQRPSNLKVFTFSELKSATKNFSRSLMIGEGGFGGVYRGVIRSTEDPHKKIDIAV 120
Query: 121 KQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ 180
KQL RRG+QGHKEW+TEVN LG+VEH+NLVKLVGYCA+DDERGIQRLL+YEYMPN SV
Sbjct: 121 KQLSRRGLQGHKEWVTEVNVLGVVEHENLVKLVGYCAEDDERGIQRLLIYEYMPNRSVQD 180
Query: 181 YLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240
+L+ + ET L+W+ RL+IAQDAARGLAYLHEGM+FQII RDFKSSNILLDEQWNAKLSDF
Sbjct: 181 HLTNRFETPLSWSTRLRIAQDAARGLAYLHEGMEFQIIFRDFKSSNILLDEQWNAKLSDF 240
Query: 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDR 300
GLARLGPS+G +HVSTAVVGT+GYAAPEY+QTGRL A+SDVWSYGVFLYELITGRRP+DR
Sbjct: 241 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTAKSDVWSYGVFLYELITGRRPLDR 300
Query: 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 360
NRP++EQKLL+W++P+LSD K+F+ I+DPRLEGKY+L+ KL+ VAN CLV+ +TRPK
Sbjct: 301 NRPKNEQKLLEWIRPHLSDVKKFQLILDPRLEGKYTLKSAQKLAAVANKCLVRQIKTRPK 360
Query: 361 MSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKH-KRRIIESKTRESGTLFW- 418
MSE+L+MVN+IV+A AE GSP+ P++SST R+ P+ +K K K ++ E+ L W
Sbjct: 361 MSEILDMVNRIVEA-AETGSPQPPIKSSTPRDAPEESKRKRLKTMFVDPIIGENRRLVWQ 419
Query: 419 KWRQKL 424
KWR KL
Sbjct: 420 KWRPKL 425
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572460|ref|XP_003554386.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1511), Expect = e-165, Method: Compositional matrix adjust.
Identities = 289/429 (67%), Positives = 343/429 (79%), Gaps = 2/429 (0%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAI-SVESEAR 59
MKCFPF+ +KKDEP S RS +T + EV R GS L SQ+VS S ES R
Sbjct: 1 MKCFPFSYGEKKDEPKGLQLQSTSGRSDNSTCVEAEVRRSGSALNSQDVSDNGSSESLRR 60
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
+ PS+SQRP NL+ FT++ELKSATKNFSRSV+IGEGGFGCVY GLI+++EDPS++ EVA
Sbjct: 61 NAIPSLSQRPCNLRVFTVSELKSATKNFSRSVMIGEGGFGCVYLGLIRSAEDPSRRTEVA 120
Query: 120 VKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 179
VKQL +RG+QGH+EW+TEVN LGIVEH NLVKLVGYCADDDERGIQRLL+YEYMPN SV+
Sbjct: 121 VKQLSKRGMQGHREWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLIYEYMPNRSVE 180
Query: 180 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239
+LS +SET L W+ RLKIA+DAA GL YLHE MDFQII RDFKSSNILLDEQWNAKLSD
Sbjct: 181 HHLSHRSETPLPWSRRLKIARDAASGLTYLHEEMDFQIIFRDFKSSNILLDEQWNAKLSD 240
Query: 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
FGLARLGPS+G THVSTAVVGTMGYAAPEYVQTGRL +++DVWSYGVFLYELITGRRP+D
Sbjct: 241 FGLARLGPSDGLTHVSTAVVGTMGYAAPEYVQTGRLTSKNDVWSYGVFLYELITGRRPLD 300
Query: 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359
RNRPR EQKLL+W++PYLSD K+F+ I+DPRL+ K + +L+ +AN CLVKN + RP
Sbjct: 301 RNRPRGEQKLLEWIRPYLSDGKKFQLILDPRLDKKQVFKSAQRLATIANRCLVKNPKNRP 360
Query: 360 KMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWK 419
KMSEVLEMVN +V+ S + SP+ PLRS + E T+T +K+R ++ K ES
Sbjct: 361 KMSEVLEMVNGMVE-SISSSSPQLPLRSVATLEASQDTETNNKKRTMDHKPGESNWFVRM 419
Query: 420 WRQKLIRTC 428
WR KL+RTC
Sbjct: 420 WRPKLVRTC 428
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505240|ref|XP_003521400.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1507), Expect = e-164, Method: Compositional matrix adjust.
Identities = 289/429 (67%), Positives = 346/429 (80%), Gaps = 2/429 (0%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAI-SVESEAR 59
MKCFPF+ +KKDEP S RS + + EV R GSEL SQ+VS S ES+ R
Sbjct: 1 MKCFPFSYGEKKDEPKGLQLQSTSGRSDNSMCVEAEVRRSGSELNSQDVSDNGSSESQRR 60
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
+ PS+SQRPSNL+ FT++ELKSATKNFSRSV+IGEGGFGCVY GLI+++ED S+++EVA
Sbjct: 61 NAIPSLSQRPSNLRVFTVSELKSATKNFSRSVMIGEGGFGCVYLGLIRSAEDSSRRIEVA 120
Query: 120 VKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 179
VKQL +RG+QGH+EW+TEVN LGIVEH NLVKLVGYCADDDERGIQRLL+YEYMPN SV+
Sbjct: 121 VKQLSKRGMQGHREWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLIYEYMPNRSVE 180
Query: 180 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239
+LS +SET L W RLKIA+DAARGL YLHE MDFQII RDFKSSNILLDEQWNAKLSD
Sbjct: 181 HHLSHRSETPLPWTRRLKIARDAARGLTYLHEEMDFQIIFRDFKSSNILLDEQWNAKLSD 240
Query: 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
FGLARLGPS+G THVSTAVVGTMGYAAPEYVQTGRL +++DVWSYGVFLYELITGRRP+D
Sbjct: 241 FGLARLGPSDGLTHVSTAVVGTMGYAAPEYVQTGRLTSKNDVWSYGVFLYELITGRRPLD 300
Query: 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359
RNRPR EQKLL+W++PYLSD K+F+ I+DPRL+ K + +L+ +AN CL KN + RP
Sbjct: 301 RNRPRREQKLLEWIRPYLSDGKKFQLILDPRLDKKQVFKSAQRLAMIANQCLAKNPKNRP 360
Query: 360 KMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWK 419
KMSEVLEMVN +V++S+ + SP+ PLRS + E T+T +K+R ++ K ES
Sbjct: 361 KMSEVLEMVNGMVESSSSS-SPQLPLRSVVTLEASQDTETNNKKRTMDQKLGESNWFVRM 419
Query: 420 WRQKLIRTC 428
WR KL+RTC
Sbjct: 420 WRPKLVRTC 428
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510763|ref|XP_003625670.1| Protein kinase [Medicago truncatula] gi|355500685|gb|AES81888.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1497), Expect = e-163, Method: Compositional matrix adjust.
Identities = 286/429 (66%), Positives = 350/429 (81%), Gaps = 5/429 (1%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVS-AISVESEAR 59
MKCFPF + DKKDEP + S RS +T+ D E R GSEL SQ++S + SVES R
Sbjct: 9 MKCFPFHSSDKKDEPKGLQSA--SGRSDSSTYVDVEGRRCGSELNSQDISDSGSVESLRR 66
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
+ P++SQRPSNL+ FT++ELKSATKNFSRSV++GEGGFGCVY+G+I++ +DPS+++EVA
Sbjct: 67 NAPPNLSQRPSNLRVFTVSELKSATKNFSRSVMLGEGGFGCVYQGVIRSVDDPSRRIEVA 126
Query: 120 VKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 179
VKQL +RGVQGH+EW+TEVN LGIVEH NLVKLVGYCADDDERGIQRLL+YEYMPN SV+
Sbjct: 127 VKQLSKRGVQGHREWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLIYEYMPNRSVE 186
Query: 180 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239
+LS ++ET L W RLKIA DAARGL YLHE MDFQII RDFKSSNILLD+QWNAKLSD
Sbjct: 187 HHLSHRAETPLPWNRRLKIAHDAARGLTYLHEEMDFQIIFRDFKSSNILLDDQWNAKLSD 246
Query: 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
FGLARLGPS+G THVSTAVVGTMGYAAPEY+QTGRL +++DVWSYGVFLYELITGRRP+D
Sbjct: 247 FGLARLGPSDGLTHVSTAVVGTMGYAAPEYLQTGRLTSKNDVWSYGVFLYELITGRRPLD 306
Query: 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359
RNRP+ EQKLL+W+KPYLSD K+F+ I+DPRL+ K +R +L+ +AN CLVKN + RP
Sbjct: 307 RNRPKGEQKLLEWIKPYLSDTKKFQLILDPRLDKKQVIRSAQRLATIANRCLVKNPKNRP 366
Query: 360 KMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKH-KRRIIESKTRESGTLFW 418
KMSEVLEMVN IV++S++ S + PL++ + E T+ ++ K+R ++ K RES
Sbjct: 367 KMSEVLEMVNGIVESSSDTNS-QLPLKNVSRIEVSHETEMRNTKKRTMDQKPRESNWFVR 425
Query: 419 KWRQKLIRT 427
WR KLIRT
Sbjct: 426 LWRPKLIRT 434
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357440361|ref|XP_003590458.1| Protein kinase 2A [Medicago truncatula] gi|355479506|gb|AES60709.1| Protein kinase 2A [Medicago truncatula] gi|388509014|gb|AFK42573.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 575 bits (1481), Expect = e-161, Method: Compositional matrix adjust.
Identities = 280/430 (65%), Positives = 343/430 (79%), Gaps = 5/430 (1%)
Query: 1 MKCFPFTNW--DKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEA 58
M CFPF + +KK + S S+ +T+ ++V R GSEL S + S S +S
Sbjct: 1 MNCFPFNIYYGEKKGDAKGLQMQSLSGLSNNSTYGGSDVRRTGSELNSLDASDNSSDSLR 60
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
R ++P++SQRPSNL+ FT++ELKSATKNF RSV++GEGGFGCVYKGLIK+ +DP++K+E+
Sbjct: 61 RNAFPNLSQRPSNLRVFTVSELKSATKNFGRSVMLGEGGFGCVYKGLIKSVDDPAKKIEI 120
Query: 119 AVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 178
AVKQLG+RG+QGHKEW+TEVN LGIVEH NLVKLVGYCADDDERGIQRLLVYEYMPN S+
Sbjct: 121 AVKQLGKRGIQGHKEWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLVYEYMPNRSL 180
Query: 179 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238
+ +LSP+SET L W+ RLKIAQDAARGL YLHE MDFQII RDFKSSNILLDEQWNAKLS
Sbjct: 181 EHHLSPRSETPLPWSRRLKIAQDAARGLTYLHEEMDFQIIFRDFKSSNILLDEQWNAKLS 240
Query: 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298
DFGLARLGPS+G THVSTAVVGTMGYAAPEY+QTGRL ++ DVWSYGVFLYELITGRRP+
Sbjct: 241 DFGLARLGPSDGLTHVSTAVVGTMGYAAPEYIQTGRLTSKIDVWSYGVFLYELITGRRPL 300
Query: 299 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 358
DRNRP+ EQ+LL+W++PYLSD K+F+ I+DPRLE K+ L+ KL+ VAN CLV+N + R
Sbjct: 301 DRNRPKGEQQLLEWIRPYLSDVKKFQIILDPRLERKHLLKSAQKLAIVANRCLVRNPKNR 360
Query: 359 PKMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFW 418
PKMSEVLEMV++IV++S + PL S S + T+ +K+RI++ K F
Sbjct: 361 PKMSEVLEMVDRIVESSVSTNQ-QPPLNSVASADDSQDTEINNKKRIMDPKP--DCNWFR 417
Query: 419 KWRQKLIRTC 428
WR KL+RTC
Sbjct: 418 LWRPKLLRTC 427
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297829514|ref|XP_002882639.1| hypothetical protein ARALYDRAFT_478307 [Arabidopsis lyrata subsp. lyrata] gi|297328479|gb|EFH58898.1| hypothetical protein ARALYDRAFT_478307 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1478), Expect = e-161, Method: Compositional matrix adjust.
Identities = 276/390 (70%), Positives = 328/390 (84%), Gaps = 8/390 (2%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEA-- 58
MKCF F+ DKK E TP S+ S + F+D E+ R GSE S++VS S ES
Sbjct: 1 MKCFLFSGGDKKGEQ-KTPISV----SLTSNFSDREINRSGSEFNSRDVSGTSTESSMGR 55
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
+ SYP+MS R SN++EF+I +LKSATKNFSRSV+IGEGGFGCV++G ++N EDPS K+EV
Sbjct: 56 KNSYPTMSTRASNIREFSITDLKSATKNFSRSVMIGEGGFGCVFRGTVRNLEDPSNKIEV 115
Query: 119 AVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 178
AVKQLG+RG+QGHKEW+TEVNFLGIVEH+NLVKL+GYCA+DDERGIQRLLVYEYMPN SV
Sbjct: 116 AVKQLGKRGLQGHKEWVTEVNFLGIVEHKNLVKLLGYCAEDDERGIQRLLVYEYMPNRSV 175
Query: 179 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238
+ +LSP+S T+LTW +RL+IAQDAARGL YLHE M+FQII RDFKSSNILLDE W AKLS
Sbjct: 176 EFHLSPRSLTVLTWDLRLRIAQDAARGLTYLHEEMEFQIIFRDFKSSNILLDEDWKAKLS 235
Query: 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298
DFGLARLGPSEG THVST VVGTMGYAAPEY+QTGRL ++SDVW YGVFLYELITGRRP+
Sbjct: 236 DFGLARLGPSEGLTHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFLYELITGRRPV 295
Query: 299 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 358
DRNRP+ EQKLL+WV+PYLSD ++F+ I+DPRLEGKY ++ V KL+ VAN CLV+N++ R
Sbjct: 296 DRNRPKGEQKLLEWVRPYLSDTRKFKLILDPRLEGKYPIKSVQKLAVVANRCLVRNSKAR 355
Query: 359 PKMSEVLEMVNKIVDASAEAGSPRR-PLRS 387
PKMSEVLEMV KIV+AS+ GSP+ PL S
Sbjct: 356 PKMSEVLEMVTKIVEASSGNGSPQLVPLNS 385
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 428 | ||||||
| TAIR|locus:2085069 | 418 | AT3G09830 [Arabidopsis thalian | 0.873 | 0.894 | 0.708 | 7.5e-144 | |
| TAIR|locus:2142639 | 420 | AT5G03320 [Arabidopsis thalian | 0.978 | 0.997 | 0.636 | 1.6e-141 | |
| TAIR|locus:2064920 | 435 | AT2G39110 [Arabidopsis thalian | 0.962 | 0.947 | 0.569 | 5.8e-121 | |
| TAIR|locus:2053250 | 462 | AT2G28940 [Arabidopsis thalian | 0.752 | 0.696 | 0.643 | 1.1e-110 | |
| TAIR|locus:2151992 | 410 | AT5G47070 [Arabidopsis thalian | 0.771 | 0.804 | 0.520 | 4.1e-88 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.808 | 0.706 | 0.479 | 1.8e-85 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.771 | 0.669 | 0.492 | 3e-85 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.726 | 0.686 | 0.513 | 6.4e-83 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.792 | 0.826 | 0.477 | 6.6e-81 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.707 | 0.711 | 0.523 | 4.7e-80 |
| TAIR|locus:2085069 AT3G09830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1406 (500.0 bits), Expect = 7.5e-144, P = 7.5e-144
Identities = 270/381 (70%), Positives = 320/381 (83%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEA-- 58
MKCF F+ DK+ E T P S+ S + F+D E+ R GSE S++VS S ES
Sbjct: 1 MKCFLFSGGDKRGEQKT-PISV----SLTSIFSDREINRSGSEFNSRDVSGTSTESSMGR 55
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
+ SYP +S R SNL+EF+I +LKSATKNFSRSV+IGEGGFGCV++G ++N ED S K+EV
Sbjct: 56 KNSYPPVSTRASNLREFSITDLKSATKNFSRSVMIGEGGFGCVFRGTVRNLEDSSVKIEV 115
Query: 119 AVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 178
AVKQLG+RG+QGHKEW+TEVNFLGIVEH NLVKL+GYCA+DDERGIQRLLVYEYMPN SV
Sbjct: 116 AVKQLGKRGLQGHKEWVTEVNFLGIVEHTNLVKLLGYCAEDDERGIQRLLVYEYMPNRSV 175
Query: 179 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238
+ +LSP+S T+LTW +RL+IAQDAARGL YLHE M+FQII RDFKSSNILLDE W AKLS
Sbjct: 176 EFHLSPRSLTVLTWDLRLRIAQDAARGLTYLHEEMEFQIIFRDFKSSNILLDEDWKAKLS 235
Query: 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298
DFGLARLGPSEG THVST VVGTMGYAAPEY+QTGRL ++SDVW YGVFLYELITGRRP+
Sbjct: 236 DFGLARLGPSEGLTHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFLYELITGRRPV 295
Query: 299 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 358
DRNRP+ EQKLL+WV+PYLSD ++F+ I+DPRLEGKY ++ V KL+ VAN CLV+N++ R
Sbjct: 296 DRNRPKGEQKLLEWVRPYLSDTRKFKLILDPRLEGKYPIKSVQKLAVVANRCLVRNSKAR 355
Query: 359 PKMSEVLEMVNKIVDASAEAG 379
PKMSEVLEMVNKIV+AS+ G
Sbjct: 356 PKMSEVLEMVNKIVEASSGNG 376
|
|
| TAIR|locus:2142639 AT5G03320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1384 (492.3 bits), Expect = 1.6e-141, P = 1.6e-141
Identities = 273/429 (63%), Positives = 329/429 (76%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAIS-VESEAR 59
MKCF F DKKDE +PK + S + F+D V + GS+ + ++VS S V S R
Sbjct: 1 MKCFLFPLGDKKDEQ-RSPKPV----SPTSNFSD--VNKSGSDFSPRDVSGTSTVSSTGR 53
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
S SMS R +NL+EFTI +LKSAT+NFSRS +IGEGGFGCV+ G IKN EDPS+K+EVA
Sbjct: 54 NSNTSMSARENNLREFTIGDLKSATRNFSRSGMIGEGGFGCVFWGTIKNLEDPSKKIEVA 113
Query: 120 VKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 179
VKQLG+RG+QGHKEW+TEVNFLG+VEH NLVKL+G+CA+DDERGIQRLLVYEYMPN SV+
Sbjct: 114 VKQLGKRGLQGHKEWVTEVNFLGVVEHSNLVKLLGHCAEDDERGIQRLLVYEYMPNQSVE 173
Query: 180 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239
+LSP+S T+LTW +RL+IAQDAARGL YLHE MDFQII RDFKSSNILLDE W AKLSD
Sbjct: 174 FHLSPRSPTVLTWDLRLRIAQDAARGLTYLHEEMDFQIIFRDFKSSNILLDENWTAKLSD 233
Query: 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
FGLARLGPS G +HVST VVGTMGYAAPEY+QTGRL ++SDVW YGVF+YELITGRRP+D
Sbjct: 234 FGLARLGPSPGSSHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFIYELITGRRPLD 293
Query: 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359
RN+P+ EQKLL+WV+PYLSD ++FR IVDPRLEGKY ++ V KL+ VANLCL +NA+ RP
Sbjct: 294 RNKPKGEQKLLEWVRPYLSDTRRFRLIVDPRLEGKYMIKSVQKLAVVANLCLTRNAKARP 353
Query: 360 KMSEVLEMVNKIVDASAEAGXXXXXXXXXXXXXXXDHTKTKHKRRIIESKTRESGTLFWK 419
KMSEVLEMV KIV+AS+ + +++++ E G L
Sbjct: 354 KMSEVLEMVTKIVEASSPGNGGKKPQLVPLKSQETSRVEEGKNKKVLDGA--EGGWLEKL 411
Query: 420 WRQKLIRTC 428
W K +R C
Sbjct: 412 WNPKNVRAC 420
|
|
| TAIR|locus:2064920 AT2G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1190 (424.0 bits), Expect = 5.8e-121, P = 5.8e-121
Identities = 245/430 (56%), Positives = 309/430 (71%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
MKCF F+ +D+ T K F AT G GSE S +A S+ S
Sbjct: 16 MKCFYFSKDKTQDDEAKTRK--FG----SATMAR---GGSGSEFNSDTSTATSITS---- 62
Query: 61 SYPSMSQRPSN-LKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
S +S+ SN LK F + +LK+ATKNFSRS++IGEGGFG V++G+I+N +D +K+++A
Sbjct: 63 SLHVLSETHSNNLKVFVLDDLKTATKNFSRSLMIGEGGFGGVFRGVIQNPQDSRKKIDIA 122
Query: 120 VKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 179
VKQL RRG+QGHKEW+TEVN LG+VEH NLVKL+GYCA+DDERGIQRLLVYEY+ N SV
Sbjct: 123 VKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLVYEYVQNRSVQ 182
Query: 180 QYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238
+LS + T L W+ RLKIAQD ARGLAYLH+GM+FQII RDFKSSNILLDE WNAKLS
Sbjct: 183 DHLSNRFIVTPLPWSTRLKIAQDTARGLAYLHQGMEFQIIFRDFKSSNILLDENWNAKLS 242
Query: 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298
DFGLAR+GPS+G THVSTAVVGT+GYAAPEY+QTG L A+SDVWSYG+FLYELITGRRP
Sbjct: 243 DFGLARMGPSDGITHVSTAVVGTIGYAAPEYIQTGHLTAKSDVWSYGIFLYELITGRRPF 302
Query: 299 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 358
DRNRPR+EQ +L+W++P+LSD K+F+ I+DPRLEG Y L+ KL+ VAN CL+ A+ R
Sbjct: 303 DRNRPRNEQNILEWIRPHLSDIKKFKMIIDPRLEGNYYLKSALKLAAVANRCLMVKAKAR 362
Query: 359 PKMSEVLEMVNKIVDASAE-AGXXXXXXXXXXXXXXXDHTKTKH-KRRIIESKTRESGTL 416
P MS+V EM+ +IV+ S++ A + ++ + KRR +E E+G
Sbjct: 363 PTMSQVSEMLERIVETSSDGAPSGLPLMKSLTPKDAFEASRRERVKRRFVELLIGENGCP 422
Query: 417 -FWKWRQKLI 425
W KL+
Sbjct: 423 NLPTWSHKLV 432
|
|
| TAIR|locus:2053250 AT2G28940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
Identities = 215/334 (64%), Positives = 266/334 (79%)
Query: 56 SEARPSYPS-MSQR------PSN-LKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIK 107
S R ++P +SQR P N LK FT ELK ATK F+R ++IGEGGFGCVY+G++
Sbjct: 63 SPERLTFPKPLSQRWIGGLVPENDLKVFTFKELKIATKGFNRGLLIGEGGFGCVYRGVVD 122
Query: 108 NSEDPS--QKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165
S+ K+ VAVKQL R+G+QGHKEW+ EVNFLG+V H NLVKLVGYCADDDERG+Q
Sbjct: 123 VSDSNGFDSKINVAVKQLNRQGLQGHKEWINEVNFLGVVNHPNLVKLVGYCADDDERGMQ 182
Query: 166 RLLVYEYMPNGSVDQYLSPKSETI-LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 224
RLLVYE M N S++ +L + ++ L W MRLKIAQDAA+GLAYLHE MDFQ+I RDFKS
Sbjct: 183 RLLVYELMCNKSLEDHLVGRVVSVSLPWMMRLKIAQDAAQGLAYLHEEMDFQLIFRDFKS 242
Query: 225 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSY 284
SNILLDE++ AKLSDFGLAR GP EG HVST+VVGT+GYAAPEYVQTG+L A+SDVWS+
Sbjct: 243 SNILLDERFGAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGKLTAKSDVWSF 302
Query: 285 GVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY-SLRLVSKL 343
GV LYELITGRR +DRNRPR EQKLL+WVKPY+SD+K+F IVDPRLEG+Y ++ V ++
Sbjct: 303 GVVLYELITGRRAVDRNRPRGEQKLLEWVKPYVSDSKKFHLIVDPRLEGQYYCMKSVQRV 362
Query: 344 SHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377
+ +AN CL+K ++RPKMSEV+ ++ +I+D AE
Sbjct: 363 AALANKCLMKQPKSRPKMSEVVSLLGRIIDEEAE 396
|
|
| TAIR|locus:2151992 AT5G47070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
Identities = 177/340 (52%), Positives = 240/340 (70%)
Query: 43 ELTSQN-VSAISVES-EARPSYPSM----SQRPSNLKEFTIAELKSATKNFSRSVVIGEG 96
ELT+++ S+ ++++ + PS S+ ++R NL+ F+ EL AT FSR +VIGEG
Sbjct: 36 ELTNRSETSSFNLQTPRSLPSPRSIKDLYTEREQNLRVFSYEELSKATYVFSRKLVIGEG 95
Query: 97 GFGCVYKG-LIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGY 155
GFG VYKG ++ N + + VA+K+L R+G+QGHK+W+ EV FLG+V H N+VKL+GY
Sbjct: 96 GFGIVYKGKILSNGDSSDPPLVVAIKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVKLIGY 155
Query: 156 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDF 215
C++D E GI+RLLVYEYM N S++ +L P+ L W RL+I AA GL YLH D
Sbjct: 156 CSEDGETGIERLLVYEYMSNRSLEDHLFPRRSHTLPWKKRLEIMLGAAEGLTYLH---DL 212
Query: 216 QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL 275
++I RDFKSSN+LLD+Q+ KLSDFGLAR GP THV+TA VGT GYAAPEYVQTG L
Sbjct: 213 KVIYRDFKSSNVLLDDQFCPKLSDFGLAREGPDGDNTHVTTARVGTHGYAAPEYVQTGHL 272
Query: 276 AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY 335
+SDV+S+GV LYE+ITGRR I+RN+P +E++LL WVK Y +D+++F IVDPRL Y
Sbjct: 273 RLKSDVYSFGVVLYEIITGRRTIERNKPVAERRLLDWVKEYPADSQRFSMIVDPRLRNNY 332
Query: 336 SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375
L+ +A+LCL KN + RP M V+E + KI++ S
Sbjct: 333 PAAGARSLAKLADLCLKKNDKERPTMEIVVERLKKIIEES 372
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 855 (306.0 bits), Expect = 1.8e-85, P = 1.8e-85
Identities = 172/359 (47%), Positives = 244/359 (67%)
Query: 17 TTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFT 76
T S +S+ ND VG + S T+ N + S + P S+LK+F+
Sbjct: 70 TLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAES----SLSTPIISEELNIYSHLKKFS 125
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSED----PSQKVEVAVKQLGRRGVQGHK 132
+LK AT+NF ++GEGGFGCV+KG ++ + P + VAVK L G+QGHK
Sbjct: 126 FIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHK 185
Query: 133 EWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTW 192
EW+ E+N+LG + H NLVKLVGYC +DD QRLLVYE+MP GS++ +L +S L W
Sbjct: 186 EWLAEINYLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPW 240
Query: 193 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 252
++R+KIA AA+GL++LHE +I RDFK+SNILLD ++NAKLSDFGLA+ P EG T
Sbjct: 241 SIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKT 300
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312
HVST V+GT GYAAPEYV TG L ++SDV+S+GV L E++TGRR +D+NRP E L++W
Sbjct: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
Query: 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
+P+L D ++F +++DPRLEG +S++ K++ +A CL ++++ RPKMSEV+E++ +
Sbjct: 361 ARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 853 (305.3 bits), Expect = 3.0e-85, P = 3.0e-85
Identities = 169/343 (49%), Positives = 237/343 (69%)
Query: 33 NDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVV 92
ND VG++ S T+ N + S + P S+L++FT +LK +T+NF +
Sbjct: 92 NDQPVGQVSSTTTTSNAES----SSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESL 147
Query: 93 IGEGGFGCVYKGLIKNSED----PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN 148
+GEGGFGCV+KG I+ + P + VAVK L G+QGHKEW+ E+NFLG + H N
Sbjct: 148 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPN 207
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
LVKLVGYC +DD QRLLVYE+MP GS++ +L +S L W++R+KIA AA+GL++
Sbjct: 208 LVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLSF 262
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268
LHE +I RDFK+SNILLD +NAKLSDFGLA+ P EG THVST V+GT GYAAPE
Sbjct: 263 LHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPE 322
Query: 269 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328
YV TG L ++SDV+S+GV L E++TGRR +D+NRP E L++W +P+L D ++F +++D
Sbjct: 323 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLD 382
Query: 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
PRLEG +S++ K++ +A CL ++ + RPKMS+V+E + +
Sbjct: 383 PRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
Identities = 166/323 (51%), Positives = 230/323 (71%)
Query: 56 SEARPSYPSMS---QRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSED- 111
+E+ S P MS + S L+ F +LK AT+NF ++GEGGFGCV+KG I+ +
Sbjct: 69 AESGSSTPLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 128
Query: 112 ---PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 168
P + VAVK L G+QGHKEW+ E+NFLG + H +LVKLVGYC ++D QRLL
Sbjct: 129 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEED----QRLL 184
Query: 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 228
VYE+MP GS++ +L ++ L W++R+KIA AA+GLA+LHE + +I RDFK+SNIL
Sbjct: 185 VYEFMPRGSLENHLFRRTLP-LPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL 243
Query: 229 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFL 288
LD ++NAKLSDFGLA+ P E +HVST V+GT GYAAPEYV TG L +SDV+S+GV L
Sbjct: 244 LDGEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVL 303
Query: 289 YELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVAN 348
E++TGRR +D++RP EQ L++WV+P+L D K+F +++DPRLEG YS++ K + VA
Sbjct: 304 LEILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAA 363
Query: 349 LCLVKNARTRPKMSEVLEMVNKI 371
CL ++++ RPKMSEV+E + +
Sbjct: 364 QCLNRDSKARPKMSEVVEALKPL 386
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 6.6e-81, P = 6.6e-81
Identities = 167/350 (47%), Positives = 230/350 (65%)
Query: 26 RSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKE---FTIAELKS 82
R A F + + S++VS +S S P + S+ P + + FT+ EL++
Sbjct: 7 RDEAAVFTPQAQAQQLQKKHSRSVSDLSDPST--PRFRDDSRTPISYAQVIPFTLFELET 64
Query: 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQK-VEVAVKQLGRRGVQGHKEWMTEVNFL 141
TK+F ++GEGGFG VYKG I ++ K + VAVK L + G+QGH+EW+TEVNFL
Sbjct: 65 ITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 124
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
G + H NLVKL+GYC +DD R LLVYE+M GS++ +L K+ L+W+ R+ IA
Sbjct: 125 GQLRHPNLVKLIGYCCEDDHR----LLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALG 180
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
AA+GLA+LH + +I RDFK+SNILLD + AKLSDFGLA+ GP THVST V+GT
Sbjct: 181 AAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 239
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
GYAAPEYV TG L ARSDV+S+GV L E++TGR+ +D+ RP EQ L+ W +P L+D +
Sbjct: 240 YGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKR 299
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
+ QI+DPRLE +YS+R K +A CL +N + RP MS+V+E + +
Sbjct: 300 KLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 4.7e-80, P = 4.7e-80
Identities = 164/313 (52%), Positives = 218/313 (69%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGRR 126
NLK FT ELK+ATKNF + ++GEGGFGCV+KG I + P + VAVKQL
Sbjct: 70 NLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPE 129
Query: 127 GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 186
G QGHKEW+TEVN+LG + H NLV LVGYCA+ G RLLVYE+MP GS++ +L +
Sbjct: 130 GFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAE----GENRLLVYEFMPKGSLENHLFRRG 185
Query: 187 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246
LTWA+R+K+A AA+GL +LHE Q+I RDFK++NILLD +NAKLSDFGLA+ G
Sbjct: 186 AQPLTWAIRMKVAVGAAKGLTFLHEAKS-QVIYRDFKAANILLDADFNAKLSDFGLAKAG 244
Query: 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306
P+ THVST V+GT GYAAPEYV TGRL A+SDV+S+GV L ELI+GRR +D + +E
Sbjct: 245 PTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNE 304
Query: 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
L+ W PYL D ++ +I+D +L G+Y + +++A CL +A+ RPKMSEVL
Sbjct: 305 YSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLV 364
Query: 367 MVNKIVDASAEAG 379
+ ++ ++ A+ G
Sbjct: 365 TLEQL-ESVAKPG 376
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00280194 | hypothetical protein (424 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 428 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-35 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-24 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-23 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-18 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 1e-48
Identities = 79/278 (28%), Positives = 115/278 (41%), Gaps = 34/278 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVEHQNLV 150
+GEG FG VY K + VA+K + ++ ++ +E + E+ L ++H N+V
Sbjct: 6 KLGEGSFGKVYLARDKKT-----GKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
+L D+D+ LV EY G + L K L+ + L YLH
Sbjct: 61 RLYDVFEDEDKL----YLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH 114
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 270
I+ RD K NILLDE + KL+DFGLAR VGT Y APE +
Sbjct: 115 ---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVL 168
Query: 271 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPR 330
D+WS GV LYEL+TG+ P + + F++I P+
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGD---------------DQLLELFKKIGKPK 213
Query: 331 LEGKYSLRLVSK-LSHVANLCLVKNARTRPKMSEVLEM 367
+S + LVK+ R E L+
Sbjct: 214 PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-47
Identities = 74/210 (35%), Positives = 110/210 (52%), Gaps = 15/210 (7%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
+GEG FG VYKG +K ++VEVAVK L Q +E++ E + ++H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGK-GDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
KL+G C +++ ++V EYMP G + YL L+ + L A ARG+ YL
Sbjct: 65 KLLGVCTEEE----PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA--APE 268
I RD + N L+ E K+SDFGL+R + + V G + APE
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG---GKLPIRWMAPE 174
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
++ G+ ++SDVWS+GV L+E+ T G P
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 4e-47
Identities = 73/202 (36%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVEHQNLVK 151
+GEGGFG VY K + +VA+K + + E + E+ L + H N+VK
Sbjct: 1 LGEGGFGTVYLARDKKT-----GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVK 55
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L G D++ + V EY GS+ L ++E L+ L+I GL YLH
Sbjct: 56 LYGVFEDENHLYL----VMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS 110
Query: 212 GMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE-Y 269
II RD K NILLD KL+DFGL++L S+ +VGT Y APE
Sbjct: 111 ---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL 165
Query: 270 VQTGRLAARSDVWSYGVFLYEL 291
+ G + +SD+WS GV LYEL
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 72/211 (34%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
+GEG FG VYKG +K +KVEVAVK L Q +E++ E + ++H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGK-GGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
KL+G C +++ +V EYM G + YL + + + L A ARG+ YL
Sbjct: 65 KLLGVCTEEEPL----YIVMEYMEGGDLLSYLRKNRPKL-SLSDLLSFALQIARGMEYLE 119
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG---YAAP 267
I RD + N L+ E K+SDFGL+R G + AP
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD----DDYYRKRGGKLPIRWMAP 172
Query: 268 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
E ++ G+ ++SDVWS+GV L+E+ T G +P
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 7e-46
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 18/215 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLV 150
+GEG FG VYKG +K + EVAVK L + K+++ E + + H N+V
Sbjct: 2 KLGEGAFGEVYKGKLKGK--DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-------SPKSETILTWAMRLKIAQDAA 203
+L+G C +++ LV EYM G + YL ++ L+ L A A
Sbjct: 60 RLLGVCTEEEPL----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
+G+ YL + + RD + N L+ E K+SDFGL+R + + T +
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ APE ++ G ++SDVWS+GV L+E+ T G P
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-45
Identities = 92/285 (32%), Positives = 122/285 (42%), Gaps = 34/285 (11%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIV 144
+ +G G FG VYK K + VAVK L +R + + E+ L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGK-----IVAVKILKKRSEKSKKDQTARREIRILRRL 55
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
H N+V+L+ D D LV EY G + YLS L+ KIA R
Sbjct: 56 SHPNIVRLIDAFEDKDHL----YLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILR 109
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
GL YLH II RD K NILLDE K++DFGLA+ + T VGT Y
Sbjct: 110 GLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWY 164
Query: 265 AAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323
APE + G + DVWS GV LYEL+TG+ P + +L
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL-------------I 211
Query: 324 RQIVDPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
R+I+ P LE + + CL K+ RP E+L+
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 4e-45
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 17/211 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFLGIVEHQNLV 150
+GEG FG VYKG +K + + +VAVK L + +E++ E + + + H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGE-GTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
+L+G C + +V EYMP G + +L K LT L++A A+G+ YL
Sbjct: 65 RLLGVCTQGE----PLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG---YAAP 267
+ RD + N L+ E K+SDFGL+R + + G + AP
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAP 173
Query: 268 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
E ++ G+ ++SDVWS+GV L+E+ T G +P
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-35
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 29/283 (10%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGVQGHKEWMTEVNFLGI 143
++R ++G G FG VY L K++ + +AVK L + + E+ L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGE-----LMAVKSVELSGDSEEELEALEREIRILSS 55
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 203
++H N+V+ G D+++ + + EY+ GS+ L K L + K +
Sbjct: 56 LQHPNIVRYYGSERDEEKNTL--NIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQIL 111
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
GLAYLH I+ RD K +NIL+D KL+DFG A+ + +V GT
Sbjct: 112 EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323
+ APE ++ +D+WS G + E+ TG+ P SE + + +
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW------SELGNPMAALYKIGSSGEP 222
Query: 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+I + L + CL ++ + RP E+L+
Sbjct: 223 PEIPE---------HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 9/207 (4%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLGIVEHQNLVK 151
+GEG FG V D + +VAVK L G + H ++ E+ L ++H+N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGD-NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
G C R ++ L+ EY+P+GS+ YL + I L + +G+ YL
Sbjct: 71 YKGVCEKPGGRSLR--LIMEYLPSGSLRDYLQRHRDQINL-KRLLLFSSQICKGMDYLG- 126
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP-SEGFTHVSTAVVGTMGYAAPEYV 270
+ I RD + NIL++ + K+SDFGLA++ P + + +V + + APE +
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 271 QTGRLAARSDVWSYGVFLYELITGRRP 297
+T + ++ SDVWS+GV LYEL T P
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 9e-35
Identities = 91/286 (31%), Positives = 130/286 (45%), Gaps = 46/286 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
+G G G V K L + P+ K+ +AVK + R + K+ + E++ L +
Sbjct: 8 ELGAGNSGVVSKVLHR----PTGKI-MAVKTI-RLEINEAIQKQILRELDILHKCNSPYI 61
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS----PKSETILTWAMRLKIAQDAARG 205
V G ++ + I EYM GS+D+ L E IL KIA +G
Sbjct: 62 VGFYGAFYNNGDISI----CMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKG 112
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L YLHE +II RD K SNIL++ + KL DFG++ + ++ VGT Y
Sbjct: 113 LTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYM 166
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325
APE +Q + +SD+WS G+ L EL TGR P P + +
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFPYP-----------PENDPPDGIFELLQY 215
Query: 326 IVD---PRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367
IV+ PRL GK+S NLCL+K+ R RP E+LE
Sbjct: 216 IVNEPPPRLPSGKFS----PDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 74/218 (33%), Positives = 110/218 (50%), Gaps = 26/218 (11%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGI 143
N+ +IG G FG VYKGL + D VA+KQ+ + + K M E++ L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGD-----FVAIKQISLEKIKEEALKSIMQEIDLLKN 55
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMRLKIAQ 200
++H N+VK +G D I + EY NGS+ Q + P E+++ + + Q
Sbjct: 56 LKHPNIVKYIGSIETSDSLYI----ILEYAENGSLRQIIKKFGPFPESLVA----VYVYQ 107
Query: 201 DAARGLAYLHEGMDFQ-IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 259
+GLAYLHE Q +I RD K++NIL + KL+DFG+A +VV
Sbjct: 108 -VLQGLAYLHE----QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVV 160
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
GT + APE ++ + SD+WS G + EL+TG P
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 82/282 (29%), Positives = 119/282 (42%), Gaps = 35/282 (12%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH 146
F IG+GGFG VYK K + EVA+K + + ++ + E+ L +H
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRT-----GKEVAIKVIKLESKEKKEKIINEIQILKKCKH 56
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
N+VK G DE I V E+ GS+ L ++T LT + + ++ +GL
Sbjct: 57 PNIVKYYGSYLKKDELWI----VMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGL 111
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
YLH II RD K++NILL KL DFGL+ + +VGT + A
Sbjct: 112 EYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMA 165
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326
PE + ++D+WS G+ EL G+ P P K L +
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIA----------TN 212
Query: 327 VDPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
P L K+S L CL KN RP ++L+
Sbjct: 213 GPPGLRNPEKWSDEFKDFLKK----CLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 21/209 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
IG+G FG V G + QKV AVK L + + ++ E + + + H NLV+L
Sbjct: 14 IGKGEFGDVMLGDYRG-----QKV--AVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQL 65
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
+G + + +V EYM GS+ YL + ++T A +L A D G+ YL E
Sbjct: 66 LGVVLQGN--PL--YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
+ RD + N+L+ E AK+SDFGLA+ S + + + APE ++
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALRE 173
Query: 273 GRLAARSDVWSYGVFLYELIT-GRRPIDR 300
+ + +SDVWS+G+ L+E+ + GR P R
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 86/288 (29%), Positives = 116/288 (40%), Gaps = 33/288 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIV-EHQ 147
+GEG FG VY + VA+K L ++ KE + E+ L +
Sbjct: 7 KLGEGSFGEVYLAR--------DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQDAARGL 206
N+VKL + D+ LV EY+ GS++ L + L+ + L I L
Sbjct: 59 NIVKLYDFFQDEG----SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGLARLGPSEGFT----HVSTAVVGT 261
YLH II RD K NILLD KL DFGLA+L P G T + + VGT
Sbjct: 115 EYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 262 MGYAAPEYVQTGRLA---ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318
GY APE + LA + SD+WS G+ LYEL+TG P + + S
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKIILEL 230
Query: 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ P S L L K+ + R S L
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 67/216 (31%), Positives = 113/216 (52%), Gaps = 28/216 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVE-VAVKQLGRRGVQGHKEW--MTEVNFLGIVEHQN 148
VIG G FG V +G +K P +K VA+K L + G + +TE + +G +H N
Sbjct: 11 VIGGGEFGEVCRGRLK---LPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
+++L G + +++ EYM NGS+D++L +++ T + + + A G+ Y
Sbjct: 67 IIRLEGVVT----KSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKY 121
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG----- 263
L E M++ + RD + NIL++ K+SDFGL+R S A T G
Sbjct: 122 LSE-MNY--VHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIPI 172
Query: 264 -YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ APE + + + SDVWS+G+ ++E+++ G RP
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 79/226 (34%), Positives = 108/226 (47%), Gaps = 24/226 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQNL 149
+G+G FG V K++ K+ A+K L ++ + KE +TE N L + H +
Sbjct: 1 LGKGSFGKVLLVRKKDTG----KL-YAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 150 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
VKL + A E +L LV EY P G + +LS K R A+ L Y
Sbjct: 56 VKL--HYAFQTEE---KLYLVLEYAPGGELFSHLS-KEGRFSEERARFYAAE-IVLALEY 108
Query: 209 LHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
LH G II RD K NILLD + KL+DFGLA+ SEG + GT Y AP
Sbjct: 109 LHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAP 162
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQW 312
E + D WS GV LYE++TG+ P +R +K+L+
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 67/216 (31%), Positives = 111/216 (51%), Gaps = 24/216 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFLGIVEHQNLV 150
V+G G FG VYKG+ E K+ VA+K L + +KE + E + V+H ++V
Sbjct: 14 VLGSGAFGTVYKGVWI-PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSP-----KSETILTWAMRLKIAQDAARG 205
+L+G C Q L+ + MP G + Y+ S+ +L W +++ A+G
Sbjct: 73 RLLGICL-----SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGY 264
++YL E +++ RD + N+L+ + K++DFGLA+ L E H V + +
Sbjct: 122 MSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-PIKW 177
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 299
A E + +SDVWSYGV ++EL+T G +P +
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 57/291 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGVQGHKEWMTEVNFLGIVEHQNL 149
IG+G FG VY L++ D +K+ L + ++ + EV L + H N+
Sbjct: 7 QIGKGSFGKVY--LVRRKSDGKL---YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 150 VKLVGYCADDDERGIQRLL-VYEYMPNGSVDQYL--------SPKSETILTWAMRLKIAQ 200
+K + +L V EY G + Q + E IL W ++L +A
Sbjct: 62 IKYYESFEEKG-----KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA- 115
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVV 259
L YLH +I+ RD K NI L KL DFG+++ L + VV
Sbjct: 116 -----LKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVV 164
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319
GT Y +PE Q +SD+WS G LYEL T + P + + +L
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLEL---------- 211
Query: 320 AKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367
+I+ P + +YS S+L ++ + L K+ RP ++++L+
Sbjct: 212 ---ALKILKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 79/283 (27%), Positives = 126/283 (44%), Gaps = 35/283 (12%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGI 143
+F IG+G FG V+K + K + K A+KQ+ + +E + E L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRK-----ADKRVYAMKQIDLSKMNRREREEAIDEARVLAK 55
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 203
++ +++ D + I V EY NG + + L + L +
Sbjct: 56 LDSSYIIRYYESFLDKGKLNI----VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTM 262
GLA+LH +I+ RD KS N+ LD N K+ D G+A+ L + F + +VGT
Sbjct: 112 LGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF---ANTIVGTP 165
Query: 263 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322
Y +PE + +SDVW+ GV LYE TG+ P D N ++ L+ K
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALIL---------KI 213
Query: 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
R + P + YS +L+ + + CL K+ R RP ++L
Sbjct: 214 IRGVFPP-VSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 7e-28
Identities = 83/254 (32%), Positives = 122/254 (48%), Gaps = 29/254 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVEHQNLV 150
V+GEG FG V + D + ++ VAVK L R Q + W E+N L + H+N+V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEM-VAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
K G C++ +G+Q L+ EY+P GS+ YL PK + L A L AQ G+AYLH
Sbjct: 70 KYKGCCSEQGGKGLQ--LIMEYVPLGSLRDYL-PKHK--LNLAQLLLFAQQICEGMAYLH 124
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS-EGFTHVSTAVVGTMGYAAPEY 269
I RD + N+LLD K+ DFGLA+ P + V + + A E
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 270 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329
++ + + SDVWS+GV LYEL+T S K+F +++ P
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTH------------------CDSKQSPPKKFEEMIGP 223
Query: 330 RLEGKYSLRLVSKL 343
+ +RL+ L
Sbjct: 224 KQGQMTVVRLIELL 237
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V+ G + +VAVK L + G + ++ E + + H LV+L
Sbjct: 14 LGAGQFGEVWMGTWNGT------TKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
C++++ I V EYM GS+ +L L + +A A G+AYL E
Sbjct: 67 YAVCSEEEPIYI----VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ES 121
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPEY 269
++ I RD + NIL+ E K++DFGLARL + +T A G + + APE
Sbjct: 122 RNY--IHRDLAARNILVGENLVCKIADFGLARLIEDDEYT----AREGAKFPIKWTAPEA 175
Query: 270 VQTGRLAARSDVWSYGVFLYELIT-GRRP 297
GR +SDVWS+G+ L E++T GR P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 21/220 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLV 150
+GEG FG V+ G + E + K VAVK L K++ E L +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-----------SPKSETI-LTWAMRLKI 198
K G C + D ++V+EYM +G ++++L SP S LT + L+I
Sbjct: 72 KFYGVCTEGD----PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A A G+ YL F + RD + N L+ K+ DFG++R + + V
Sbjct: 128 AVQIASGMVYL-ASQHF--VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + + PE + + SDVWS+GV L+E+ T G++P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 65/201 (32%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V++GL KN V VA+K L + +++ EV L + H++L+ L
Sbjct: 14 LGSGYFGEVWEGLWKNR------VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
C+ + I + E M GS+ +L +L A + +A A G+AYL E
Sbjct: 68 FAVCSVGEPVYI----ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
I RD + NIL+ E K++DFGLARL + + + + APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASH 178
Query: 273 GRLAARSDVWSYGVFLYELIT 293
G + +SDVWS+G+ LYE+ T
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 80/284 (28%), Positives = 126/284 (44%), Gaps = 45/284 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK--QLGRRGVQGHKEWMTEVNFLGIVEHQNL 149
V+G+G G VYK K P+ K+ A+K + K+ + E+ L E +
Sbjct: 8 VLGQGSSGVVYKVRHK----PTGKI-YALKKIHVDGDEEFR-KQLLRELKTLRSCESPYV 61
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAARGL 206
VK Y A E I +V EYM GS+ L E +L IA+ +GL
Sbjct: 62 VKC--YGAFYKEGEIS--IVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGL 112
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
YLH II RD K SN+L++ + K++DFG++++ + + VGT+ Y +
Sbjct: 113 DYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMS 168
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326
PE +Q + +D+WS G+ L E G+ P S +L+Q I
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-------------AI 215
Query: 327 VD---PRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
D P L ++S + + CL K+ + RP +E+L+
Sbjct: 216 CDGPPPSLPAEEFS----PEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 72/212 (33%), Positives = 112/212 (52%), Gaps = 23/212 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G FG V KG+ VEVAVK L + G KE++ E + + ++H +V+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKE--VEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET----ILTWAMRLKIAQDAARGLA 207
L+G C +G +LV E P G + +YL + E + A ++ A G+A
Sbjct: 61 LIGVC-----KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMA 109
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAA 266
YL E F + RD + N+LL + AK+SDFG++R LG + +TA + + A
Sbjct: 110 YL-ESKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
PE + G+ +++SDVWSYGV L+E + G +P
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 18/220 (8%)
Query: 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQ 147
+ IG G FG V+ G K +VA+K + R G ++++ E + + H
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLE------KRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
LV+L G C + LV+E+M +G + YL + + L + D G+A
Sbjct: 60 KLVQLYGVCTERSPI----CLVFEFMEHGCLSDYLRAQRGKFSQETL-LGMCLDVCEGMA 114
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
YL +I RD + N L+ E K+SDFG+ R + +T ST + +++P
Sbjct: 115 YLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSP 170
Query: 268 EYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSE 306
E + +++SDVWS+GV ++E+ + G+ P + NR SE
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 82/292 (28%), Positives = 121/292 (41%), Gaps = 33/292 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFLGIVEHQNLVK 151
+GEG G V K +KN+ + A+K + K+ + E+ + +VK
Sbjct: 9 LGEGAGGSVTKCRLKNT-----GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQ-YLSPKSETILTWAMRL-KIAQDAARGLAYL 209
G D+ I + EY GS+D Y K L KIA+ +GL+YL
Sbjct: 64 YYGAFLDESSSSIG--IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
H +II RD K SNILL + KL DFG++ E ++ GT Y APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPER 174
Query: 270 VQTGRLAARSDVWSYGVFLYELITGRRPI--DRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327
+Q + SDVWS G+ L E+ R P + P +LL Y+ +
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----YIVNMPNPELKD 230
Query: 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE------MVNKIVD 373
+P K+S + CL K+ RP ++LE + K V+
Sbjct: 231 EPGNGIKWS----EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVN 278
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V+ G + D VA+K + R G +++ E + + H NLV+L
Sbjct: 12 LGSGQFGVVHLGKWRGKID------VAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
G C +R I +V EYM NG + YL + L L + D + YL
Sbjct: 65 YGVCTK--QRPI--FIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN 119
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPEY 269
I RD + N L+ E K+SDFGLAR + +T + GT + +A PE
Sbjct: 120 ---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT----SSQGTKFPVKWAPPEV 172
Query: 270 VQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 300
R +++SDVWS+GV ++E+ + G+ P +R
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V++GL N+ VAVK L + G K+++ E + + H L++L
Sbjct: 14 LGAGQFGEVWEGLWNNT------TPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQL 66
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
C ++ I V E M GS+ +YL + L + +A A G+AYL E
Sbjct: 67 YAVCTLEEPIYI----VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EA 121
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPEY 269
++ I RD + N+L+ E K++DFGLAR+ + + A G + + APE
Sbjct: 122 QNY--IHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIKWTAPEA 175
Query: 270 VQTGRLAARSDVWSYGVFLYELIT-GRRP 297
R + +SDVWS+G+ L E++T GR P
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 80/293 (27%), Positives = 120/293 (40%), Gaps = 51/293 (17%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI 143
+ + IGEG G VYK + + EVA+K++ R Q + + E+ +
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRAT-----GKEVAIKKMRLRK-QNKELIINEILIMKD 71
Query: 144 VEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGS----VDQYLSPKSETILTWAMRLKI 198
+H N+V DE L +V EYM GS + Q +E + + +
Sbjct: 72 CKHPNIVDYYDSYLVGDE-----LWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----V 121
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
++ +GL YLH +I RD KS NILL + + KL+DFG A E S V
Sbjct: 122 CREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--V 176
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318
VGT + APE ++ + D+WS G+ E+ G PYL
Sbjct: 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG------------------EPPYLR 218
Query: 319 D--AKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ + I P L K + + N CLVK+ RP E+L+
Sbjct: 219 EPPLRALFLITTKGIPPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 70/207 (33%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVEHQNLVK 151
IG+G FG VYKG++K EVAVK K ++ E L +H N+VK
Sbjct: 3 IGKGNFGDVYKGVLKG------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+G C +V E +P GS+ +L K + LT L+++ DAA G+ YL
Sbjct: 57 LIGVCVQKQPI----YIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT----MGYAAP 267
I RD + N L+ E K+SDFG++R E + T G + + AP
Sbjct: 112 K---NCIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAP 164
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITG 294
E + GR + SDVWSYG+ L+E +
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 96/309 (31%), Positives = 126/309 (40%), Gaps = 87/309 (28%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTE------------- 137
IG G FG V K L K S +AVK++ R V K + +
Sbjct: 12 IGRGAFGTVNKMLHKPS-----GTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ-----YLSPKS---ETI 189
V F G + + G C + E M + S+D+ Y KS E I
Sbjct: 66 VKFYGALFRE------GDC----------WICMELM-DISLDKFYKYVYEVLKSVIPEEI 108
Query: 190 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPS 248
L KIA + L YL E + +II RD K SNILLD N KL DFG++ +L S
Sbjct: 109 LG-----KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 249 EGFTHVSTAVVGTMGYAAPEYVQTGRLAA---RSDVWSYGVFLYELITGRRPIDRNRPRS 305
T G Y APE + RSDVWS G+ LYE+ TG+ P
Sbjct: 162 IAKTR----DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP------ 211
Query: 306 EQKLLQWVKPYLSDAKQFRQIVD---PRL----EGKYSLRLVSKLSHVANLCLVKNARTR 358
+W + Q Q+V P L E ++S V+ NLCL+K+ R
Sbjct: 212 -----KWNSVF----DQLTQVVKGDPPILSNSEEREFSPSFVN----FINLCLIKDESKR 258
Query: 359 PKMSEVLEM 367
PK E+LE
Sbjct: 259 PKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 9e-24
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V+ G +VA+K L ++G + ++ E N + ++H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNGHT------KVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRL 66
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
+ ++ EYM NGS+ +L LT + +A A G+A++ E
Sbjct: 67 YAVVTQE-----PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ER 120
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
++ I RD +++NIL+ E K++DFGLARL +T A + + APE +
Sbjct: 121 KNY--IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINY 177
Query: 273 GRLAARSDVWSYGVFLYELIT-GRRP 297
G +SDVWS+G+ L E++T GR P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM--TEVNFLGIVEHQNL 149
IG+G FG V K ++ D K+ + K++ + ++ +EVN L ++H N+
Sbjct: 7 TIGKGSFGTVRK--VRRKSD--GKI-LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 150 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLS--PKSETILTWAMRLKIAQDAARGL 206
V+ Y +R Q L +V EY G + Q + K + +I L
Sbjct: 62 VR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 207 AYLHEGMDF--QIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMG 263
H D ++ RD K +NI LD N KL DFGLA+ LG F VGT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK---TYVGTPY 175
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAK 321
Y +PE + +SD+WS G +YEL P R++ +L +K +
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF---TARNQLQLASKIKEGKF----- 227
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367
R+ +YS S+L+ V L + RP E+L++
Sbjct: 228 -------RRIPYRYS----SELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-23
Identities = 65/210 (30%), Positives = 116/210 (55%), Gaps = 15/210 (7%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFLGIVEHQNL 149
V +G G FGCV KG+ K ++++VA+K L + E M E + +++ +
Sbjct: 1 VELGSGNFGCVKKGVYKMR---KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
V+++G C + +LV E G ++++LS K + I T + +++ + G+ YL
Sbjct: 58 VRMIGVCEAEA-----LMLVMEMASGGPLNKFLSGKKDEI-TVSNVVELMHQVSMGMKYL 111
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPE 268
EG +F + RD + N+LL Q AK+SDFGL++ LG + + +A + + APE
Sbjct: 112 -EGKNF--VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + ++RSDVWSYG+ ++E + G++P
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 93 IGEGGFGCVYKGLI--KNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNL 149
+GEG FG VYKG + N + V A+K L + +E+ E + ++H N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSV--AIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETILTWAMRLKIAQDAARGL 206
V L+G C + +++EY+ +G + ++L SP S+ + + + +
Sbjct: 71 VCLLGVCTKEQPT----CMLFEYLAHGDLHEFLVRNSPHSD--VGAESGDETVKSSLDCS 124
Query: 207 AYLH------EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST 256
+LH GM++ + RD + N L+ E K+SDFGL+R S + V +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 257 AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYEL 291
+ + + PE + G+ SD+WS+GV L+E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 75/268 (27%), Positives = 108/268 (40%), Gaps = 29/268 (10%)
Query: 92 VIGEGGFGCVYK-GLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV 150
VIG+G FG V + + K K + + V+ + E L + H LV
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR---NVLNERRILQELNHPFLV 63
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS----ETILTWAMRLKIAQDAARGL 206
L Y D+E LV + + G + +LS K E + W + +A L
Sbjct: 64 NLW-YSFQDEE---NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA------L 113
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
YLH II RD K NILLDEQ + ++DF +A + T T+ GT GY A
Sbjct: 114 EYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMA 167
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRP--IDRNRPRSEQKLLQWVKPYLS---DAK 321
PE + + D WS GV YE + G+RP R + + Q L +
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST 227
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANL 349
+ ++ LE RL L + N
Sbjct: 228 EAIDAINKLLERDPQKRLGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-23
Identities = 77/236 (32%), Positives = 118/236 (50%), Gaps = 25/236 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDP-SQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNL 149
+G G FG VY+G + P S + VAVK L R+G Q KE++ E + + H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL-RKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSET----ILTWAMRLKIAQDAAR 204
VKL+G C ++ + ++ E M G + YL + E +LT L I D A+
Sbjct: 62 VKLLGVCLLNEPQ----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-----KLSDFGLARLGPSEGFTHVSTAVV 259
G YL E M F I RD + N L+ E+ K+ DFGLAR + +
Sbjct: 118 GCVYL-EQMHF--IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 314
+ + APE + G+ +SDVWS+GV ++E++T G++P + Q++LQ V
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP---ALNNQEVLQHVT 227
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-23
Identities = 79/234 (33%), Positives = 121/234 (51%), Gaps = 26/234 (11%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFLGIVE 145
R V+G G FG VYKG I E + K+ VA+K L G + + E+M E + ++
Sbjct: 9 LKRVKVLGSGAFGTVYKG-IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK-----SETILTWAMRLKIAQ 200
H +LV+L+G C IQ LV + MP+G + Y+ S+ +L W +++
Sbjct: 68 HPHLVRLLGVCLSPT---IQ--LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI---- 118
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 260
A+G+ YL E +++ RD + N+L+ + K++DFGLARL EG A G
Sbjct: 119 --AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL--LEGDEKEYNADGG 171
Query: 261 TM--GYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQ 311
M + A E + + +SDVWSYGV ++EL+T G +P D R LL+
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 61/214 (28%), Positives = 117/214 (54%), Gaps = 15/214 (7%)
Query: 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK-EWMTEVNFLGIVEH 146
++ VIG G FG V++G++K ++V VA+K L + + ++++E + +G H
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPG--RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
N+++L G + +++ EYM NG++D+YL ++ + + + + A G+
Sbjct: 66 HNIIRLEGVVT----KFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGM 120
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGY 264
YL D + RD + NIL++ K+SDFGL+R+ EG T+ ++ + +
Sbjct: 121 KYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGGKIPIRW 176
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
APE + + + SDVWS+G+ ++E+++ G RP
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+GEG FG V+ N K+ VAVK L K++ E L ++H+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYL-------------SPKSETILTWAMRLKIA 199
G C + D ++V+EYM +G ++++L + +E LT + L IA
Sbjct: 73 YGVCVEGDPL----IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQMLHIA 126
Query: 200 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 259
Q A G+ YL + RD + N L+ E K+ DFG++R S + V +
Sbjct: 127 QQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + PE + + SDVWS GV L+E+ T G++P
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 22/210 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RGVQGHKEWMTEVNFLGIVEHQNLV 150
VIG+G FGCVY G + +S+ QK+ AVK L R ++ ++++ E + H N++
Sbjct: 2 VIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQDAARG 205
L+G C + G L+V YM +G + ++ +P + ++ + ++ A+G
Sbjct: 60 SLLGICLPSE--GSP-LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ------VAKG 110
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFT-HVSTAVVGTMG 263
+ YL + + RD + N +LDE + K++DFGLAR + E ++ H T +
Sbjct: 111 MEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ A E +QT + +SDVWS+GV L+EL+T
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 6e-22
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+GEG FG V+ N K+ VAVK L +++ E L +++HQ++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETI----------LTWAMRLKIA 199
G C + G L+V+EYM +G ++++L P ++ + LT L IA
Sbjct: 73 YGVCTE----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 200 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 259
A G+ YL + F + RD + N L+ + K+ DFG++R S + V +
Sbjct: 129 SQIASGMVYL-ASLHF--VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + PE + + SD+WS+GV L+E+ T G++P
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-22
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V+ G NS +VAVK L + G + ++ E N + ++H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNNS------TKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRL 66
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
Y E I ++ EYM GS+ +L + + + A G+AY+
Sbjct: 67 --YAVVTKEEPI--YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
I RD +++N+L+ E K++DFGLAR+ +T A + + APE +
Sbjct: 123 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINF 178
Query: 273 GRLAARSDVWSYGVFLYELIT-GRRP 297
G +SDVWS+G+ LYE++T G+ P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 8e-22
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 19/208 (9%)
Query: 93 IGEGGFG----CVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFLGIVEH 146
+GEG FG C Y + E + +VAVK L G E+ L + H
Sbjct: 12 LGEGHFGKVELCRY-----DPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLYH 65
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
+N+VK G C +D GI+ L+ E++P+GS+ +YL P+++ + +LK A +G+
Sbjct: 66 ENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGM 122
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYA 265
YL Q + RD + N+L++ + K+ DFGL + + + + V + + +
Sbjct: 123 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT 293
APE + + SDVWS+GV LYEL+T
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 70/203 (34%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK-EWMTEVNFLGIVEHQNLV 150
++G+G FG V+KG +K+ K VAVK Q K ++++E L +H N+V
Sbjct: 2 LLGKGNFGEVFKGTLKD------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIV 55
Query: 151 KLVGYCADDDERGIQRLLVY---EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
KL+G C QR +Y E +P G +L K + + T + +K A DAA G+A
Sbjct: 56 KLIGVCT-------QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-VKFALDAAAGMA 107
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
YL I RD + N L+ E K+SDFG++R +G S + + AP
Sbjct: 108 YLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAP 163
Query: 268 EYVQTGRLAARSDVWSYGVFLYE 290
E + GR ++ SDVWSYG+ L+E
Sbjct: 164 EALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-21
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G +G VY+G+ K + VAVK L + +E++ E + ++H NLV+L
Sbjct: 14 LGGGQYGEVYEGVWKK-----YSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
+G C R ++ E+M G++ YL + + + L +A + + YL E
Sbjct: 68 LGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EK 122
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
+F I RD + N L+ E K++DFGL+RL + +T + A + + APE +
Sbjct: 123 KNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 179
Query: 273 GRLAARSDVWSYGVFLYELIT 293
+ + +SDVW++GV L+E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+GEG FG V+ N K+ VAVK L + K++ E L ++H+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSP--------------KSETILTWAMRLKI 198
G C D D ++V+EYM +G ++++L +++ L + L I
Sbjct: 73 YGVCGDGDPL----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A A G+ YL + RD + N L+ K+ DFG++R S + V
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + + PE + + SDVWS+GV L+E+ T G++P
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK-EWMTEVNFLGIVEHQNLVK 151
+G+G FG VY+GL K + VA+K + + E++ E + + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAMRLK 197
L+G + G L+V E M G + YL P + + A +
Sbjct: 74 LLGVVS----TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI- 128
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
A G+AYL + + RD + N ++ E K+ DFG+ R +
Sbjct: 129 -----ADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ + + APE ++ G +SDVWS+GV L+E+ T
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 86/289 (29%), Positives = 126/289 (43%), Gaps = 42/289 (14%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMT---EVNF 140
N+ R ++G+G FG VY D E+AVKQ+ + KE E+
Sbjct: 3 NWRRGKLLGQGAFGRVYL-----CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQL 57
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVY-EYMPNGSVDQYLSPKSETILTWAMRLKIA 199
L ++H+ +V+ G C DDE L ++ EYMP GSV L K+ LT + K
Sbjct: 58 LKNLQHERIVQYYG-CLRDDET----LSIFMEYMPGGSVKDQL--KAYGALTETVTRKYT 110
Query: 200 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAV 258
+ G+ YLH M I+ RD K +NIL D N KL DFG + RL +V
Sbjct: 111 RQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW--VKPY 316
GT + +PE + ++DVWS G + E++T + P W +
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP--------------WAEFEAM 213
Query: 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
+ K Q +P+L S + L V+NA+ RP E+L
Sbjct: 214 AAIFKIATQPTNPQLPSHVSPDARNFLR----RTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 4e-21
Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 23/207 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+IGEG FG V +G E QKV AVK + + V + ++ E + + H+NLV+
Sbjct: 13 IIGEGEFGAVLQG-----EYTGQKV--AVKNI-KCDVTA-QAFLEETAVMTKLHHKNLVR 63
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+G G+ +V E M G++ +L + +++ L+ + D A G+ YL
Sbjct: 64 LLGVIL---HNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 271
+++ RD + NIL+ E AK+SDFGLAR+G V + + + + APE ++
Sbjct: 119 K---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKL-PVKWTAPEALK 170
Query: 272 TGRLAARSDVWSYGVFLYELIT-GRRP 297
+ +++SDVWSYGV L+E+ + GR P
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 76/286 (26%), Positives = 130/286 (45%), Gaps = 37/286 (12%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKV--EVAVKQLGRRGVQGHKEWMTEVNFLGI 143
++ V+G+G FG L + +ED S V EV + +L + ++ + E+ L +
Sbjct: 1 HYIPIRVLGKGAFGEAT--LYRRTEDDSLVVWKEVNLTRLSEKE---RRDALNEIVILSL 55
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLV-YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA 202
++H N++ + DD LL+ EY G++ + + + M L
Sbjct: 56 LQHPNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
++Y+H+ I+ RD K+ NI L + KL DFG++++ SE ++ T VVGT
Sbjct: 111 VSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAET-VVGTP 165
Query: 263 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID-RNRPRSEQKLLQWVKPYLSDAK 321
Y +PE Q + +SD+W+ G LYEL+T +R D N K++Q
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ---------G 216
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367
+ +V YS L+S + L ++ RP EVL+
Sbjct: 217 NYTPVVSV-----YSSELISLVHS----LLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 22/227 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
++G G FG V+KG I E S K+ VA+K + R G Q +E + +G ++H +V
Sbjct: 14 LLGSGVFGTVHKG-IWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI-----LTWAMRLKIAQDAARG 205
+L+G C G LV + P GS+ ++ +++ L W +++ A+G
Sbjct: 73 RLLGICP-----GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKG 121
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
+ YL E +++ R+ + NILL +++DFG+A L + + + + +
Sbjct: 122 MYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQ 311
A E + GR +SDVWSYGV ++E+++ G P RP LL+
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 36/277 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+GEG +G VYK + K + VA+K + +E + E++ L + +VK
Sbjct: 10 KLGEGSYGSVYKAIHKET-----GQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 152 LVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
G Y + D +V EY GSV + ++T LT I +GL YLH
Sbjct: 63 YYGSYFKNTD-----LWIVMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLH 116
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 270
+ I RD K+ NILL+E+ AKL+DFG++ G V+GT + APE +
Sbjct: 117 ---SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 271 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSDAKQFRQIVDP 329
Q ++D+WS G+ E+ G+ P P R+ + P LSD +++ +
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFN- 230
Query: 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
V K CLVK+ RP ++L+
Sbjct: 231 --------DFVKK-------CLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 6e-21
Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 23/212 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V G + D VA+K + + G E++ E + + H+ LV+L
Sbjct: 12 LGTGQFGVVKYGKWRGQYD------VAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
G C +R I +V EYM NG + YL + + L++ +D G+AYL
Sbjct: 65 YGVCTK--QRPI--YIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLESK 119
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPEY 269
Q I RD + N L+D+Q K+SDFGL+R + +T + VG+ + ++ PE
Sbjct: 120 ---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEV 172
Query: 270 VQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 300
+ + +++SDVW++GV ++E+ + G+ P +R
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 6e-21
Identities = 70/222 (31%), Positives = 114/222 (51%), Gaps = 26/222 (11%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIV 144
F + V+G G FG VYKGL E K+ VA+K+L R + +KE + E + V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLW-IPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASV 66
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI-----LTWAMRLKIA 199
++ ++ +L+G C +Q L+ + MP G + Y+ + I L W +++
Sbjct: 67 DNPHVCRLLGICLTS---TVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--- 118
Query: 200 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAV 258
A+G+ YL E +++ RD + N+L+ + K++DFGLA+L G E H
Sbjct: 119 ---AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 299
V + + A E + +SDVWSYGV ++EL+T G +P D
Sbjct: 173 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 93 IGEGGFGCVYK----GLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQ 147
IG+G FG V++ GL+ VAVK L ++ E + +H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPF----TMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETI--------------- 189
N+VKL+G CA G L++EYM G ++++L SP+++
Sbjct: 69 NIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 190 --LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247
L+ +L IA+ A G+AYL E + + RD + N L+ E K++DFGL+R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
S + S + + PE + R SDVW+YGV L+E+ +
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-21
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGVQGHKEWM--------TEVNFL 141
+IG+G +G VY L + + +AVKQ L H +E+ L
Sbjct: 8 LIGKGTYGRVYLALNVTTGE-----MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVY-EYMPNGSVDQYLSP--KSETILTWAMRLKI 198
++H N+V+ +G+ E + L ++ EY+P GS+ L + E L ++
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV 117
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
+ GLAYLH I+ RD K+ N+L+D K+SDFG+++ + ++
Sbjct: 118 LE----GLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 259 VGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRP 297
G++ + APE + + +A+ D+WS G + E+ GRRP
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 8e-21
Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 46/293 (15%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG---RRGVQGHKEW---MTEVNF 140
+++ V+G+G +G VY GL +Q +AVKQ+ + KE+ EV+
Sbjct: 2 WTKGEVLGKGAYGTVYCGLT------NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDL 55
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMRLK 197
L ++H N+V+ +G C DD+ I E++P GS+ L+ P E + K
Sbjct: 56 LKSLKHVNIVQYLGTCLDDNTISI----FMEFVPGGSISSILNRFGPLPEPVFC-----K 106
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR----LGPSEGFTH 253
+ G+AYLH ++ RD K +N++L KL DFG AR +G ++
Sbjct: 107 YTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313
+ ++ GT + APE + +SD+WS G ++E+ TG+ P+ + R
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRLAAMF---- 218
Query: 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
Y+ + PRL +S + CL ++ RP ++L
Sbjct: 219 --YIGAHRGLM----PRLPDSFSAAAID----FVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 68/219 (31%), Positives = 86/219 (39%), Gaps = 42/219 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT------EVNFLGIVEH 146
+G GGFG V L+K S+ A+K + +R + E E L H
Sbjct: 1 LGVGGFGRVE--LVKVK---SKNRTFALKCVKKRHIV---ETGQQEHIFSEKEILEECNH 52
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR-- 204
+VKL Y D++ I L+ EY G + L R + AR
Sbjct: 53 PFIVKL--YRTFKDKKYIYMLM--EYCLGGELWTILR----------DRGLFDEYTARFY 98
Query: 205 ------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
YLH II RD K N+LLD KL DFG A+ S T
Sbjct: 99 IACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TF 152
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
GT Y APE + D WS G+ LYEL+TGR P
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG+G FG V G + +VAVK + + ++ E + + + H NLV+
Sbjct: 13 TIGKGEFGDVMLG-------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+G ++ +V EYM GS+ YL + ++L LK + D + YL E
Sbjct: 64 LLGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-E 119
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 271
+F + RD + N+L+ E AK+SDFGL + E + T + + + APE ++
Sbjct: 120 ANNF--VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALR 172
Query: 272 TGRLAARSDVWSYGVFLYELIT-GRRPIDR 300
+ + +SDVWS+G+ L+E+ + GR P R
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 81/307 (26%), Positives = 124/307 (40%), Gaps = 65/307 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW----MTEVNFLGIVEHQN 148
IGEG +G VYK K + + VA+K++ R + + + E+ L + H N
Sbjct: 7 IGEGTYGQVYKARNKKTGEL-----VALKKI--RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMP---NGSVDQYLSPKSETILTWAMRLK-IAQDAAR 204
+V+L + I +V+EYM G +D +E+ ++K +
Sbjct: 60 IVRLKEIVTSKGKGSI--YMVFEYMDHDLTGLLDSPEVKFTES------QIKCYMKQLLE 111
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
GL YLH I+ RD K SNIL++ KL+DFGLAR + V+ T+ Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 265 AAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPIDRNRPRSEQ-----KLL---- 310
PE + L A D+WS G L EL G +PI + EQ +L
Sbjct: 168 RPPELL----LGATRYGPEVDMWSVGCILAELFLG-KPIFQGSTELEQLEKIFELCGSPT 222
Query: 311 --QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVAN----------LCLVKNARTR 358
W P +S F + + + Y RL H+ + L L + + R
Sbjct: 223 DENW--PGVSKLPWFENL---KPKKPYKRRLREFFKHLIDPSALDLLDKLLTL--DPKKR 275
Query: 359 PKMSEVL 365
+ L
Sbjct: 276 ISADQAL 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV 150
V +G+G FG V+ G + VA+K L + G + ++ E + + H+ LV
Sbjct: 12 VKLGQGCFGEVWMGTWNGT------TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
+L +++ +V EYM GS+ +L + L + +A A G+AY+
Sbjct: 65 QLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV- 118
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 270
E M++ + RD +++NIL+ E K++DFGLARL +T A + + APE
Sbjct: 119 ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 175
Query: 271 QTGRLAARSDVWSYGVFLYELIT-GRRP 297
GR +SDVWS+G+ L EL T GR P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 93 IGEGGFG----CVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN 148
+G+G FG C Y L N+ + VAVK+L + +++ E+ L ++H N
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEV-----VAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
+VK G C R ++ LV EY+P GS+ YL E + + L A +G+ Y
Sbjct: 67 IVKYKGVCYSAGRRNLR--LVMEYLPYGSLRDYLQKHRERLDHRKL-LLYASQICKGMEY 123
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG-FTHVSTAVVGTMGYAAP 267
L + + RD + NIL++ + K+ DFGL ++ P + + V + + AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 268 EYVQTGRLAARSDVWSYGVFLYELIT 293
E + + + SDVWS+GV LYEL T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 70/239 (29%), Positives = 101/239 (42%), Gaps = 58/239 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH---------KEWMTEVNFLG 142
+IGEG F V K + ++ E A+K L +R + KE +T +N
Sbjct: 8 IIGEGSFSTVVLAKEK---ETNK--EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--- 59
Query: 143 IVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYL---SPKSETILTWAMRLKI 198
H ++KL Y D+E L V EY PNG + QY+ E R
Sbjct: 60 --GHPGIIKLY-YTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCT----RFYA 108
Query: 199 AQ--DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL----GPSEGFT 252
A+ A L YLH II RD K NILLD+ + K++DFG A++ E
Sbjct: 109 AEILLA---LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
Query: 253 HVSTA--------------VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
+T VGT Y +PE + SD+W+ G +Y+++TG+ P
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 72/276 (26%), Positives = 120/276 (43%), Gaps = 35/276 (12%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G+G +G VYK +K D +Q + LG + ++ + E+ L V H N++
Sbjct: 8 LGKGSYGSVYK--VKRLSD-NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII-- 62
Query: 153 VGYCADDDERGIQRL-LVYEYMPNGSVDQYLS--PKSETILTWAMRLKIAQDAARGLAYL 209
+ +L +V EY P G + + +S K ++ +I RGL L
Sbjct: 63 ---SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
HE +I+ RD KS+NILL K+ D G++++ +++ +GT Y APE
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEV 172
Query: 270 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329
+ + +SD+WS G LYE+ T P + RS Q L V+ ++ P
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFE---ARSMQDLRYKVQ-----RGKY-----P 219
Query: 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
+ YS L + L + RP ++L
Sbjct: 220 PIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 78/303 (25%), Positives = 118/303 (38%), Gaps = 80/303 (26%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT-EVNFLGIVE 145
F+ IG+G FG VYK + K + VA+K + + E + E+ FL
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRT-----NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETILTWAMRLKIAQDAA 203
+ K G + I + EY GS L ET + + +R +
Sbjct: 58 SPYITKYYGSFLKGSKLWI----IMEYCGGGSCLDLLKPGKLDETYIAFILR-----EVL 108
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV----- 258
GL YLHE I RD K++NILL E+ + KL+DFG++ +++ +
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNT 157
Query: 259 -VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP------------IDRNRPRS 305
VGT + APE ++ ++D+WS G+ EL G P I +N P
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-- 215
Query: 306 EQKLLQWVKPYLSD---AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 362
P L +K F+ V LCL K+ + RP
Sbjct: 216 ---------PSLEGNKFSKPFKDFVS--------------------LCLNKDPKERPSAK 246
Query: 363 EVL 365
E+L
Sbjct: 247 ELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 71/294 (24%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 87 FSRS-----VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNF 140
F RS +G G FG V+ K E+ + V VK L + + E+ E++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETI----LTWA 193
+ H+N+V+L+G C + + ++ EY G + Q+L K E + L+
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPH----YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117
Query: 194 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 253
++ + A G+ +L + + RD + N L+ Q K+S L++ + +
Sbjct: 118 QKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313
+ A++ + + APE VQ + +SDVWS+GV ++E+ T Q
Sbjct: 175 LRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-----------------QGE 216
Query: 314 KPY--LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
P+ LSD + ++ +LE S+L + C N + RP SE++
Sbjct: 217 LPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 21/213 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQK-VEVAVKQL--GRRGVQGHKEWMTEVNFLGIVEHQN 148
VIG G FG V G +K P ++ + VA+K L G Q +++++E + +G +H N
Sbjct: 11 VIGAGEFGEVCSGRLKL---PGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPN 66
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
++ L G + ++V EYM NGS+D +L K + T + + + A G+ Y
Sbjct: 67 IIHLEGVVT----KSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKY 121
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL---GPSEGFTHVSTAVVGTMGYA 265
L D + RD + NIL++ K+SDFGL+R+ P +T + + +
Sbjct: 122 LS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWT 176
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
APE + + + SDVWSYG+ ++E+++ G RP
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 77/238 (32%), Positives = 110/238 (46%), Gaps = 53/238 (22%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ----LGRRGVQGHKEWMT---EVNFLGIVE 145
IGEG +G VYK D + VA+K+ L G+ ++ E+ L +E
Sbjct: 7 IGEGAYGTVYKA-----RDLNTGRFVALKKVRVPLSEEGIP-----LSTLREIALLKQLE 56
Query: 146 ---HQNLVKLVGYCAD-DDERGIQRLLVYEYMPNGSVDQ----YLS--PKS----ETI-- 189
H N+V+L+ C +R ++ LV+E+ VDQ YLS PK ETI
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKD 111
Query: 190 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249
L + RG+ +LH +I+ RD K NIL+ K++DFGLAR+
Sbjct: 112 LMRQL--------LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI---Y 157
Query: 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307
F T+VV T+ Y APE + A D+WS G EL RRP+ R ++Q
Sbjct: 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVEHQNLV 150
IGEG FG VY+G+ + E+ K+ VAVK +E ++ E + +H ++V
Sbjct: 13 CIGEGQFGDVYQGVYMSPENE--KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQDAARG 205
KL+G ++ +V E P G + YL S +++ ++ +L A
Sbjct: 71 KLIGVITEN-----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA------ 119
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
LAYL E F + RD + N+L+ KL DFGL+R E + S + + +
Sbjct: 120 LAYL-ESKRF--VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWM 175
Query: 266 APEYVQTGRLAARSDVWSYGVFLYE-LITGRRP 297
APE + R + SDVW +GV ++E L+ G +P
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-20
Identities = 61/212 (28%), Positives = 115/212 (54%), Gaps = 17/212 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQK-VEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNL 149
VIG G FG V +G +K P ++ + VA+K L + +++++E + +G +H N+
Sbjct: 11 VIGAGEFGEVCRGRLKL---PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
+ L G + +++ E+M NG++D +L +++ T + + + A G+ YL
Sbjct: 68 IHLEGVVT----KSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG---TMGYAA 266
E M++ + RD + NIL++ K+SDFGL+R + T+ +G + + A
Sbjct: 123 SE-MNY--VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
PE + + + SDVWSYG+ ++E+++ G RP
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 6e-20
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 25/230 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFLGIVEHQNLVK 151
+G+G FG V +G S + + VAVK L + +++ E + ++H+NL++
Sbjct: 3 LGDGSFGVVRRGEWSTSG--GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L G ++V E P GS+ L + + A A G+ YL
Sbjct: 61 LYGVVLTH-----PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT-MGYAAPEYV 270
+ I RD + NILL K+ DFGL R P +V + + APE +
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 271 QTGRLAARSDVWSYGVFLYELIT-GRRP------------IDRNRPRSEQ 307
+T + SDVW +GV L+E+ T G P ID+ R E+
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER 222
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 7e-20
Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 40/224 (17%)
Query: 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN 148
VV+G+G +G VY D S +V +A+K++ R + + E+ ++H+N
Sbjct: 12 ERVVLGKGTYGIVYAA-----RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK-------SETILTWAMRLKIAQD 201
+V+ +G +++ I E +P GS+ L K +TI+ + ++
Sbjct: 67 IVQYLGSDSENGFFKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI----- 117
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFG----LARLGP-SEGFTHVS 255
GL YLH+ QI+ RD K N+L++ K+SDFG LA + P +E FT
Sbjct: 118 -LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--- 170
Query: 256 TAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRP 297
GT+ Y APE + G A +D+WS G + E+ TG+ P
Sbjct: 171 ----GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH---KEWMTEVNFLGIVEHQNL 149
I +G +G V+ K++ D A+K + + + + +TE + L + +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDI-----YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV 55
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETIL--------TWAMRLKIAQD 201
VKL Y + ++ + LV EY+P G D ++L A R+ IA+
Sbjct: 56 VKL--YYSFQGKKNL--YLVMEYLPGG--DLA------SLLENVGSLDEDVA-RIYIAEI 102
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA---- 257
L YLH II RD K NIL+D + KL+DFGL+++G +++
Sbjct: 103 VL-ALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 258 --VVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPR 304
+VGT Y APE V G+ +++ D WS G LYE + G P P
Sbjct: 159 KRIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-20
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 171 EYMPNGSVD---QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227
E+M GS+D + P IL KIA GL YL+ +I+ RD K SNI
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMHRDIKPSNI 135
Query: 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 287
L++ + KL DFG++ E ++ VGT Y +PE +Q G+ +SDVWS G+
Sbjct: 136 LVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 288 LYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRL-EGKYSLRLVSKL 343
+ EL G+ P + + + + +QIV PRL + L
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDP-----MGILDLLQQIVQEPPPRLPSSDFPEDLRD-- 244
Query: 344 SHVANLCLVKNARTRP 359
+ CL+K+ RP
Sbjct: 245 --FVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 9e-20
Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 33/254 (12%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW--MTEVNFLGI 143
+ + V+G G FG V+ K + V +KQ+ + + E L +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQK-----LVIIKQIPVEQMTKDERLAAQNECQVLKL 55
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLK 197
+ H N+++ +D I V EY P G++ +Y+ + +TIL + +++
Sbjct: 56 LSHPNIIEYYENFLEDKALMI----VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLARLGPSEGFTHVST 256
+A L ++H I+ RD K+ NILLD+ K+ DFG++++ S+ +
Sbjct: 112 LA------LHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAY 159
Query: 257 AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID-RNRPRSEQKLLQWVKP 315
VVGT Y +PE + +SD+W+ G LYEL + +R + N P K++
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA 219
Query: 316 YLSD--AKQFRQIV 327
+SD + RQ++
Sbjct: 220 PISDRYSPDLRQLI 233
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 76/279 (27%), Positives = 126/279 (45%), Gaps = 37/279 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG VY+GL + D EV++ G+ G + K+ E+ L ++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 153 VGYCADDDERGIQRLLVY-EYMPNGSVDQYLS---PKSETILTWAMRLKIAQDAARGLAY 208
+G ++D L ++ E +P GS+ + L E ++ R + GL Y
Sbjct: 68 LGTEREED-----NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEY 117
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268
LH D + RD K +NIL+D KL+DFG+A+ F + G+ + APE
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWMAPE 171
Query: 269 YV-QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327
+ Q G +D+WS G + E+ TG+ P S+ + + V + +K+ I
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVF-KIGRSKELPPIP 224
Query: 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
D L + CL ++ RP +E+LE
Sbjct: 225 D---------HLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 17/225 (7%)
Query: 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFL 141
+ + +G G FG VY+GL + + + +++VAVK L Q +++ E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMR--L 196
HQN+V+L+G + + R ++ E M G + +L P+ E + M+ L
Sbjct: 64 SKFNHQNIVRLIGVSFER----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 197 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLSDFGLARLGPSEGFTH 253
A+D A+G YL E I RD + N LL AK++DFG+AR +
Sbjct: 120 FCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + + PE G +++DVWS+GV L+E+ + G P
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 73/218 (33%), Positives = 107/218 (49%), Gaps = 19/218 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V+ G + +VAVK L + G + ++ E + + H LV+L
Sbjct: 14 LGNGQFGEVWMGTWNGN------TKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL 66
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
+ E I +V EYM GS+ +L L + +A A G+AY+ E
Sbjct: 67 YAVVS---EEPI--YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ER 120
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
M++ I RD +S+NIL+ + K++DFGLARL +T A + + APE
Sbjct: 121 MNY--IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALY 177
Query: 273 GRLAARSDVWSYGVFLYELIT-GRRPID--RNRPRSEQ 307
GR +SDVWS+G+ L EL+T GR P NR EQ
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 93 IGEGGFG----CVYKGLIKNSEDPS-----QKVEVAVKQLGRRGV--QGHKEWMTEVNFL 141
+GEG FG C +GL + + + Q V VAVK L R V +++ E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDFLKEIKIM 71
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--------PKSETI--LT 191
+++ N+++L+G C DD ++ EYM NG ++Q+LS + I ++
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPL----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 192 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 251
A L +A A G+ YL + RD + N L+ + K++DFG++R S +
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 252 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ V + + A E + G+ SDVW++GV L+E+ T
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 44/219 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQG-HKEWMTEVNFLGIVEHQNLV 150
IGEG G V+K + + + VA+K++ RR G + + E+ L +H +V
Sbjct: 8 IGEGAHGIVFKAKDRETGET-----VALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNG------SVDQYLSPKSETILTWAMRLKIAQDAAR 204
KL+ D G +LV EYMP+ ++ L P+++ M LK
Sbjct: 63 KLL----DVFPHGSGFVLVMEYMPSDLSEVLRDEERPL-PEAQVKSYMRMLLK------- 110
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL---GPSEGFTHVSTAVVGT 261
G+AY+H I+ RD K +N+L+ K++DFGLARL ++H V T
Sbjct: 111 GVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH----QVAT 163
Query: 262 MGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
Y APE + AR D+W+ G EL+ G
Sbjct: 164 RWYRAPELL----YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 58/181 (32%), Positives = 80/181 (44%), Gaps = 34/181 (18%)
Query: 197 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVS 255
KIA + L YLH + +I RD K SN+L++ KL DFG++ L S
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAK 160
Query: 256 TAVVGTMGYAAPEYVQTGRLAA----RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311
T G Y APE + +SDVWS G+ + EL TGR P D
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS----------- 209
Query: 312 WVKPYLSDAKQFRQIVD---PRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367
W P+ +Q +Q+V+ P+L K+S N CL KN + RP E+L+
Sbjct: 210 WKTPF----QQLKQVVEEPSPQLPAEKFSPEFQD----FVNKCLKKNYKERPNYPELLQH 261
Query: 368 V 368
Sbjct: 262 P 262
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 39/223 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFL-GIVEHQNL 149
VIGEG FG V K IK +++ A+K++ + H+++ E+ L + H N+
Sbjct: 14 VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAMR 195
+ L+G C + RG L + EY P+G++ +L + + + L+
Sbjct: 71 INLLGAC---EHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
L A D ARG+ YL + Q I RD + NIL+ E + AK++DFGL+R
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 175
Query: 256 TAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
V TMG + A E + SDVWSYGV L+E+++
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 16/216 (7%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
++GEG FG V +G + + KV V +L +E+++E + +H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 152 LVGYC--ADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETI---LTWAMRLKIAQDAARG 205
L+G C A ++ + +++ +M +G + +L + + L LK D A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF---THVSTAVVGTM 262
+ YL + I RD + N +L E ++DFGL++ S + ++ V +
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 263 GYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
A E + ++SDVW++GV ++E+ T G+ P
Sbjct: 183 ---AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V+ G + +++VA+K + G ++++ E + + H LV+L
Sbjct: 12 LGSGQFGVVHLGKWRA------QIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 153 VGYCADDDERGIQRLLVY---EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
G C Q+ +Y E+M NG + YL + + L+ M L + QD G+ YL
Sbjct: 65 YGVC-------TQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYL 116
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
I RD + N L+ K+SDFG+ R + +T S A + ++ PE
Sbjct: 117 ERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEV 172
Query: 270 VQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 300
+ +++SDVWS+GV ++E+ T G+ P ++
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 92 VIGEGGFGCVYK----GLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLG-IVE 145
+G G FG V + GL K D KV AVK L +E M+E+ + +
Sbjct: 42 TLGAGAFGKVVEATAYGLSK--SDAVMKV--AVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
H+N+V L+G C G L++ EY G + +L K E+ LT L + A+G
Sbjct: 98 HENIVNLLGACT----IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG----- 260
+A+L I RD + N+LL K+ DFGLAR + S VV
Sbjct: 154 MAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARL 205
Query: 261 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ + APE + SDVWSYG+ L+E+ +
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (211), Expect = 2e-18
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 35/214 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMTEVNFLGIVEHQN 148
+GEG +G VYK K + VA+K++ G+ + E++ L ++H N
Sbjct: 7 LGEGTYGVVYKARDKKT-----GEIVALKKIRLDNEEEGIP--STALREISLLKELKHPN 59
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
+VKL+ + + LV+EY + +YL K L+ + I RGLAY
Sbjct: 60 IVKLLDVIHTER----KLYLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGYAA 266
H +I+ RD K NIL++ KL+DFGLAR P +TH VV T+ Y A
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---VV-TLWYRA 166
Query: 267 PEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
PE + L ++ D+WS G E+ITG+
Sbjct: 167 PEIL----LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 59/177 (33%), Positives = 79/177 (44%), Gaps = 29/177 (16%)
Query: 197 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVS 255
K+ + L YL E +I RD K SNILLD N KL DFG++ RL S+
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KTR 173
Query: 256 TAVVGTMGYAAPEYV----QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE--QKL 309
+A G Y APE + + R+DVWS G+ L EL TG+ P + E K+
Sbjct: 174 SA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
Query: 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
LQ P L + F ++ LCL K+ R RPK E+L+
Sbjct: 232 LQEEPPSLPPNEGFSPDFCSFVD----------------LCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 67/229 (29%), Positives = 112/229 (48%), Gaps = 31/229 (13%)
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPS-QKVEVAVKQLGRRGVQGHKE--WM 135
EL + + R +G G FG + +G +K PS +++ VA+ L R G + ++
Sbjct: 1 ELDNKSIKIERI--LGTGRFGELCRGCLKL---PSKRELPVAIHTL-RAGCSDKQRRGFL 54
Query: 136 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 195
E LG +H N+V+L G RG ++V EYM NG++D +L K E L
Sbjct: 55 AEALTLGQFDHSNIVRLEGVIT----RGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQL 109
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
+ + A G+ YL E M + + + + +L++ K+S F + SE
Sbjct: 110 MGMLPGLASGMKYLSE-MGY--VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE------ 160
Query: 256 TAVVGTMG------YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
A+ TM +AAPE +Q ++ SDVWS+G+ ++E+++ G RP
Sbjct: 161 -AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGVQGHKEWMTEVNFLGIVEHQNLV 150
IG G FG VY + ++ + +AVK+ + + KE E+ L +++H NLV
Sbjct: 8 IGGGTFGKVYTAVNLDTGEL-----MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 151 KLVGYCADDDERGIQRLLVY-EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
K G ++ + ++ EY G++++ L + IL + GLAYL
Sbjct: 63 KYYGVEVHREK-----VYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPS-----EGFTHVSTAVVGTMG 263
H I+ RD K +NI LD KL DFG A +L + E + GT
Sbjct: 116 HSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPA 168
Query: 264 YAAPEYVQTGRLAAR---SDVWSYGVFLYELITGRRP 297
Y APE + G+ +D+WS G + E+ TG+RP
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 91/303 (30%), Positives = 127/303 (41%), Gaps = 48/303 (15%)
Query: 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVN 139
L T F VIGEG +G VYK K + Q V A+K + + +E E N
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKT---GQLV--AIKIMDIIEDE-EEEIKEEYN 54
Query: 140 FL-GIVEHQNLVKLVG--YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRL 196
L H N+ G + Q LV E GSV + + + RL
Sbjct: 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV----KGLRKKGKRL 110
Query: 197 K------IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSE 249
K I ++ RGLAYLHE ++I RD K NILL + KL DFG++ L +
Sbjct: 111 KEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167
Query: 250 GFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRP- 303
G + +GT + APE + ARSDVWS G+ EL G+ P+ P
Sbjct: 168 GRRNTF---IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224
Query: 304 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363
R+ K+ + P L + + + K + + CL+KN RP M E
Sbjct: 225 RALFKIPRNPPPTLKSPENWSK----------------KFNDFISECLIKNYEQRPFMEE 268
Query: 364 VLE 366
+LE
Sbjct: 269 LLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 3e-18
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV 150
V +G+G FG V+ G + +VA+K L + G + ++ E + + H LV
Sbjct: 12 VKLGQGCFGEVWMGTWNGT------TKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
L +++ +V E+M GS+ +L L + +A A G+AY+
Sbjct: 65 PLYAVVSEE-----PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI- 118
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 270
E M++ I RD +++NIL+ + K++DFGLARL +T A + + APE
Sbjct: 119 ERMNY--IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 175
Query: 271 QTGRLAARSDVWSYGVFLYELIT-GRRP 297
GR +SDVWS+G+ L EL+T GR P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFL-GIVEHQNL 149
VIGEG FG V + +IK K+ A+K L + H+++ E+ L + H N+
Sbjct: 9 VIGEGNFGQVIRAMIKKD---GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMR 195
+ L+G C + RG + + EY P G++ +L + + LT
Sbjct: 66 INLLGAC---ENRGYLYIAI-EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
L+ A D A G+ YL E Q I RD + N+L+ E +K++DFGL+R
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--------GEE 170
Query: 256 TAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
V TMG + A E + +SDVWS+GV L+E+++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGVQGHKEWMT---EVNFLGIVEHQ 147
+GEG + VYK K + VA+K+ LG R T E+ L ++H
Sbjct: 8 LGEGTYAVVYKARDKET-----GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 148 NLVKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
N++ L+ + + I LV+E+M +++ + KS +LT A RGL
Sbjct: 63 NIIGLLDVFGHKSN---IN--LVFEFME-TDLEKVIKDKS-IVLTPADIKSYMLMTLRGL 115
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGY 264
YLH I+ RD K +N+L+ KL+DFGLAR P+ TH VV T Y
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH---QVV-TRWY 168
Query: 265 AAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 298
APE + AR D+WS G EL+ R P
Sbjct: 169 RAPELL----FGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 72/239 (30%), Positives = 111/239 (46%), Gaps = 45/239 (18%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM- 135
I +L+ ++F VIG G FG V L+++ S++V A+K L K M
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKS--SKQV-YAMKLLS-------KFEMI 82
Query: 136 --TEVNFL----GIVEHQN---LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 186
++ F I+ H N +V+L + A D++ + +V EYMP G + +S
Sbjct: 83 KRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYL--YMVMEYMPGGDLVNLMS-NY 137
Query: 187 ETILTWA----MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242
+ WA + +A DA + ++H RD K N+LLD+ + KL+DFG
Sbjct: 138 DIPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGT 188
Query: 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRP 297
+ G TA VGT Y +PE +++ G D WS GVFLYE++ G P
Sbjct: 189 CMKMDANGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLGIVEHQNLV 150
+GEG FG V K + + VAVK L ++ ++E N L V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPK--------------------SET 188
KL G C+ D LL+ EY GS+ +L S K E
Sbjct: 67 KLYGACSQDGPL----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 189 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGP 247
LT + A +RG+ YL E +++ RD + N+L+ E K+SDFGL+R +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ + S + + + A E + +SDVWS+GV L+E++T
Sbjct: 180 EDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-18
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 14/220 (6%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G+GGFG V +K + ++ K+L +R +G + + E L V + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR--KGEQMALNEKKILEKVSSRFIVSL 58
Query: 153 V-GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
+ DD LV M G + ++ E A + A GL +LH+
Sbjct: 59 AYAFETKDD-----LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 271
+I+ RD K N+LLD+ N ++SD GLA GT GY APE +Q
Sbjct: 114 ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEVLQ 167
Query: 272 TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311
D ++ G LYE+I GR P + + + E++ L+
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 8e-18
Identities = 102/334 (30%), Positives = 149/334 (44%), Gaps = 51/334 (15%)
Query: 63 PSMSQRPSNLKEFTIAEL---KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
PS S R +LK+ IAEL + K F+ IG G FG VY + D VA
Sbjct: 1 PSTS-RAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY-----FARDVRTNEVVA 54
Query: 120 VKQLGRRGVQGHKEW---MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNG 176
+K++ G Q +++W + EV FL ++H N ++ G C R LV EY
Sbjct: 55 IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG-CY---LREHTAWLVMEYCLGS 110
Query: 177 SVDQ---YLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233
+ D + P E + I A +GLAYLH +I RD K+ NILL E
Sbjct: 111 ASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPG 162
Query: 234 NAKLSDFGLARL-GPSEGFTHVSTAVVGTMGYAAPEYV---QTGRLAARSDVWSYGVFLY 289
KL+DFG A + P+ F VGT + APE + G+ + DVWS G+
Sbjct: 163 QVKLADFGSASIASPANSF-------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 215
Query: 290 ELITGRRPI-DRNRPRSEQKLLQWVKPYLSD---AKQFRQIVDPRLEGKYSLRLVSK--L 343
EL + P+ + N + + Q P L + FR VD L+ R S+ L
Sbjct: 216 ELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275
Query: 344 SHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377
H+ L R RP+ + +++++ + DA E
Sbjct: 276 KHMFVL------RERPE-TVLIDLIQRTKDAVRE 302
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 8e-18
Identities = 72/229 (31%), Positives = 115/229 (50%), Gaps = 26/229 (11%)
Query: 92 VIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFLGIVEHQNL 149
V+G G FG VYKG+ I + E+ K+ VA+K L + +KE + E + V +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK-----SETILTWAMRLKIAQDAAR 204
+L+G C + LV + MP G + Y+ S+ +L W +++ A+
Sbjct: 72 CRLLGICLTSTVQ-----LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AK 120
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAVVGTMG 263
G++YL E +++ RD + N+L+ + K++DFGLARL E H V +
Sbjct: 121 GMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIK 176
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQ 311
+ A E + R +SDVWSYGV ++EL+T G +P D R LL+
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 52/133 (39%), Positives = 68/133 (51%), Gaps = 18/133 (13%)
Query: 171 EYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227
E+M GS+DQ L E IL KI+ RGL YL E +I+ RD K SNI
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVKPSNI 131
Query: 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTA--VVGTMGYAAPEYVQTGRLAARSDVWSYG 285
L++ + KL DFG++ G S A VGT Y +PE +Q +SD+WS G
Sbjct: 132 LVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
Query: 286 VFLYELITGRRPI 298
+ L E+ GR PI
Sbjct: 186 LSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 21/224 (9%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM 135
TI + K ++R IG+G G VY + D + EVA+KQ+ + Q KE +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAI-----DVATGQEVAIKQMNLQQ-QPKKELI 63
Query: 136 -TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAM 194
E+ + +H N+V + D G + +V EY+ GS+ ++ ET +
Sbjct: 64 INEILVMRENKHPNIVNYL----DSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQ 116
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTH 253
+ ++ + L +LH Q+I RD KS NILL + KL+DFG A++ P +
Sbjct: 117 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---S 170
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
+ +VGT + APE V + D+WS G+ E++ G P
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 2e-17
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 39/223 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFL-GIVEHQNL 149
VIGEG FG V K IK +++ A+K++ + H+++ E+ L + H N+
Sbjct: 2 VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMR 195
+ L+G C + RG L + EY P+G++ +L + + L+
Sbjct: 59 INLLGAC---EHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
L A D ARG+ YL + Q I RD + NIL+ E + AK++DFGL+R
Sbjct: 115 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 163
Query: 256 TAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
V TMG + A E + SDVWSYGV L+E+++
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG----HKEWMTEVNFLGIVEHQ 147
V+GEG +G V K K + + VA+K+ + + K + EV L + H+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEI-----VAIKKF--KESEDDEDVKKTALREVKVLRQLRHE 60
Query: 148 NLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
N+V L RL LV+EY+ ++ + L + A+R I Q + +
Sbjct: 61 NIVNLKEAFRRKG-----RLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQ-LLQAI 113
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
AY H II RD K NIL+ E KL DFG AR + + + T V T Y A
Sbjct: 114 AYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRA 169
Query: 267 PE----YVQTGRLAARSDVWSYGVFLYELITGR 295
PE G+ DVW+ G + EL+ G
Sbjct: 170 PELLVGDTNYGKPV---DVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT--EVNFLGIVEHQNLV 150
IGEG +G VYK ++ VA+K++ R E+ L + H N++
Sbjct: 7 IGEGTYGVVYKA--RDKLT---GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 151 KLVGYCADDDERGIQRL-LVYEYMPNG---SVDQYLSPKSETILTWAMRLKIAQDAARGL 206
KL+ D R L LV+E+M + E+++ + +GL
Sbjct: 62 KLL-----DVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-----YQLLQGL 111
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGY 264
A+ H I+ RD K N+L++ + KL+DFGLAR P +TH V T Y
Sbjct: 112 AFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH----YVVTRWY 164
Query: 265 AAPEYVQTGRLAARS-DVWSYGVFLYELITGR 295
APE + + + D+WS G EL++ R
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM 135
TI + K ++R IG+G G V+ + D + EVA+KQ+ + + +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVF-----TAIDVATGQEVAIKQINLQKQPKKELII 64
Query: 136 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 195
E+ + +++ N+V + D G + +V EY+ GS+ ++ ET + A
Sbjct: 65 NEILVMKELKNPNIVNFL----DSFLVGDELFVVMEYLAGGSLTDVVT---ETCMDEAQI 117
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHV 254
+ ++ + L +LH Q+I RD KS N+LL + KL+DFG A++ P +
Sbjct: 118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---K 171
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 303
+ +VGT + APE V + D+WS G+ E++ G P P
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 4e-17
Identities = 79/296 (26%), Positives = 119/296 (40%), Gaps = 51/296 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG G FG V G K V VK+L ++ EV + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRG---MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWA---MRLKIAQDAARGLAY 208
+G C + I LLV E+ P G + YL + A + ++A + A GL +
Sbjct: 60 CLGQCIE----SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268
LH+ DF I D N L + K+ D+GLA E + + + APE
Sbjct: 116 LHQ-ADF--IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172
Query: 269 YVQ-------TGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 320
V+ +S++WS GV ++EL T +P P LSD
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY----------------PDLSDE 216
Query: 321 KQFRQIV--------DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368
+ +Q+V P+L+ KYS R V C + + TRP EV E++
Sbjct: 217 QVLKQVVREQDIKLPKPQLDLKYSDRWY----EVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 41/282 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G+G FG VYK K + A K + + +++M E++ L +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKE-----TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 153 V-GYCADDDERGIQRLLVY-EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
Y ++ L + E+ G++D + + E LT + + L +LH
Sbjct: 68 YEAYFYENK------LWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 270
++I RD K+ NILL + KL+DFG++ S + +GT + APE V
Sbjct: 121 SH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVV 175
Query: 271 --QTGRLAA---RSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWVKPYLSDAKQFR 324
+T + ++D+WS G+ L EL P + N R K+L+ P L ++
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS 235
Query: 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
S + CLVK+ RP +E+L+
Sbjct: 236 ----------------SSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 80/289 (27%), Positives = 120/289 (41%), Gaps = 47/289 (16%)
Query: 92 VIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLGIVEHQNL 149
VIG G VY + + N+E +VA+K++ Q E EV + H N+
Sbjct: 8 VIGVGATAVVYAAICLPNNE------KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK-SETILTWAMRLKIAQDAARGLAY 208
VK DE + V Y+ GS+ + L A+ + ++ +GL Y
Sbjct: 62 VKYYTSFVVGDELWL----VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTH-VSTAVVGTMGYAA 266
LH I RD K+ NILL E + K++DFG+ A L T V VGT + A
Sbjct: 118 LH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 267 PEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSD----- 319
PE ++ ++D+WS+G+ EL TG P + P + LQ P L
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 320 --AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+K FR+++ LCL K+ RP E+L+
Sbjct: 235 KYSKSFRKMIS--------------------LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 35/281 (12%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVE 145
F++ IG+G FG VYKG+ ++ +++V VA+K + + E E+ L +
Sbjct: 6 FTKLERIGKGSFGEVYKGI----DNRTKEV-VAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
+ + G +G + ++ EY+ GS L P L I ++ +G
Sbjct: 61 SPYITRYYGSYL----KGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKG 113
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L YLH + I RD K++N+LL EQ + KL+DFG+A G VGT +
Sbjct: 114 LDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWM 168
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325
APE ++ ++D+WS G+ EL G P P L+ P
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---------- 218
Query: 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
P LEG+YS CL K+ R RP E+L+
Sbjct: 219 ---PTLEGQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-17
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 14/216 (6%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT---EVNFLG 142
N+ R ++G+G FG VY + D +++ Q + KE E+ L
Sbjct: 3 NWRRGKLLGQGAFGRVY---LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLK 59
Query: 143 IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA 202
++H+ +V+ G D E+ + + EYMP GSV L K+ LT ++ K +
Sbjct: 60 NLQHERIVQYYGCLRDRAEKTLT--IFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQI 115
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST-AVVGT 261
G++YLH M I+ RD K +NIL D N KL DFG ++ + + +V GT
Sbjct: 116 LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
+ +PE + ++DVWS G + E++T + P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 8e-17
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IGEG FG +Y L K D V + L + V+ + EV L ++H N+V
Sbjct: 7 KIGEGSFGKIY--LAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLKIAQDAARG 205
+ A E G + +V EY G + + ++ + + IL+W +++ + G
Sbjct: 64 ---FFASFQENG-RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------G 113
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWN-AKLSDFGLAR-LGPSEGFTHVSTAVVGTMG 263
L ++H D +I+ RD KS NI L + AKL DFG+AR L S ++ VGT
Sbjct: 114 LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---MELAYTCVGTPY 167
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRN 301
Y +PE Q ++D+WS G LYEL T + P + N
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 9e-17
Identities = 65/220 (29%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE---WMTEVNFL 141
+F +G G FG V K S A+K L + + K+ + E L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKY-----YALKILSKAKIVKLKQVEHVLNEKRIL 55
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 200
+ H LV L G DD L LV EY+P G + +L A R AQ
Sbjct: 56 QSIRHPFLVNLYGSFQDDS-----NLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAAQ 109
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 260
L YLH I+ RD K N+LLD K++DFG A+ +T + G
Sbjct: 110 VVL-ALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCG 160
Query: 261 TMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRP 297
T Y APE + + G+ D W+ G+ +YE++ G P
Sbjct: 161 TPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 29/224 (12%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RGVQGHKEW-----MTEVN 139
+ + +G G F Y+ + D +AVKQ+ R +E E+
Sbjct: 1 EWLKGQQLGTGAFSSCYQ-----ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIR 55
Query: 140 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMRL 196
+ + H ++++++G +D + E+M GSV LS E ++ +
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNL----FVEWMAGGSVSHLLSKYGAFKEAVI-----I 106
Query: 197 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGLA-RLGPS-EGFTH 253
+ RGL+YLHE QII RD K +N+L+D +++DFG A RL G
Sbjct: 107 NYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
++GT+ + APE ++ + DVWS G + E+ T + P
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 79/267 (29%), Positives = 114/267 (42%), Gaps = 69/267 (25%)
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFS---RSVVIGEGGFGCVYKGLIKNSEDP-SQK 115
P P S S+ SA K+ S R IG G G VYK + + + + K
Sbjct: 46 PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK 105
Query: 116 V-----EVAVK-QLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG--IQRL 167
V E V+ Q+ R E+ L V H N+VK C D + IQ L
Sbjct: 106 VIYGNHEDTVRRQICR-----------EIEILRDVNHPNVVK----CHDMFDHNGEIQVL 150
Query: 168 LVYEYMPNGSVD-------QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 220
L E+M GS++ Q+L+ + IL+ G+AYLH I+ R
Sbjct: 151 L--EFMDGGSLEGTHIADEQFLADVARQILS-------------GIAYLHRR---HIVHR 192
Query: 221 DFKSSNILLDEQWNAKLSDFGLAR-----LGPSEGFTHVSTAVVGTMGYAAPEYVQT--- 272
D K SN+L++ N K++DFG++R + P + VGT+ Y +PE + T
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRILAQTMDP-------CNSSVGTIAYMSPERINTDLN 245
Query: 273 -GRLAARS-DVWSYGVFLYELITGRRP 297
G + D+WS GV + E GR P
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 68/265 (25%), Positives = 122/265 (46%), Gaps = 42/265 (15%)
Query: 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRGVQGHKEWMT----EVN 139
+ +IG G FG VY G+ + S +AVKQ+ + + E+
Sbjct: 4 KGALIGSGSFGSVYLGM-----NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIA 58
Query: 140 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV----DQYLSPKSETILTWAMR 195
L ++H+N+V+ +G D D I EY+P GSV + Y + + + + +
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNI----FLEYVPGGSVAALLNNYGAFEETLVRNFVRQ 114
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL----GPSEGF 251
+ +GL YLH + II RD K +NIL+D + K+SDFG+++ S
Sbjct: 115 I------LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
Query: 252 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLL 310
++ G++ + APE V+ ++D+WS G + E++TG+ P D + ++ K+
Sbjct: 166 NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG 225
Query: 311 QWVKPYL-----SDAKQF-RQIVDP 329
+ P + S+A F + +
Sbjct: 226 ENASPEIPSNISSEAIDFLEKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 81/283 (28%), Positives = 121/283 (42%), Gaps = 39/283 (13%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLGIVE 145
F++ IG+G FG V+KG+ ++ +QKV VA+K + + ++ E+ L +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI----DNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAA 203
+ K G D + I + EY+ GS L P ET + +R +
Sbjct: 61 SPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILR-----EIL 111
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
+GL YLH + I RD K++N+LL E KL+DFG+A G VGT
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 166
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323
+ APE ++ +++D+WS G+ EL G P P L+ P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------- 218
Query: 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
P LEG YS L CL K RP E+L+
Sbjct: 219 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 35/230 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVE--------------VAVKQLGRRG-VQGHKEWMTE 137
+GEG FG V+ + ++ E VAVK L ++++ E
Sbjct: 13 LGEGQFGEVH---LCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETI----- 189
V L + N+ +L+G C D + + EYM NG ++Q+L ++ +
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCM----IMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 190 -LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248
L+++ L +A A G+ YL E ++F + RD + N L+ + + K++DFG++R S
Sbjct: 126 SLSFSTLLYMATQIASGMRYL-ESLNF--VHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 249 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ V + + A E V G+ +SDVW++GV L+E++T R
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 80/291 (27%), Positives = 131/291 (45%), Gaps = 46/291 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ-------LGRRGVQGHKEWMTEVNFLGIVE 145
+G G FGCVYK KN+ Q + +A+K+ G+ + K V+ + I++
Sbjct: 8 LGSGAFGCVYKVRKKNN---GQNL-LALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63
Query: 146 ----HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETIL---TWAMRLKI 198
H N+V+ ++D I L+ E P G L K + W + +++
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLI-EGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
L YLH+ + +I+ RD +NI+L E ++DFGLA+ E T+V
Sbjct: 123 VL----ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSV 173
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318
VGT+ Y+ PE V+ ++DVW++G LY++ T + P LS
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------------MLS 220
Query: 319 DAKQFRQIV-DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368
A + + V +P EG YS ++ V CL +A RP + +V M+
Sbjct: 221 LATKIVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKE---WMTEVNF 140
N+ ++G+G FG VY D E+AVKQ+ + KE E+
Sbjct: 3 NWRLGKLLGQGAFGRVYL-----CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQL 57
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 200
L + H+ +V+ G D ER + + E+MP GS+ L KS LT + K +
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLS--IFMEHMPGGSIKDQL--KSYGALTENVTRKYTR 113
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS-TAVV 259
G++YLH M I+ RD K +NIL D N KL DFG ++ + + +V
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
GT + +PE + ++D+WS G + E++T + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 57/165 (34%), Positives = 84/165 (50%), Gaps = 20/165 (12%)
Query: 171 EYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227
E+M GS+DQ L E IL K++ RGLAYL E QI+ RD K SNI
Sbjct: 83 EHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLRE--KHQIMHRDVKPSNI 135
Query: 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 287
L++ + KL DFG++ + ++ + VGT Y +PE +Q + +SD+WS G+
Sbjct: 136 LVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 288 LYELITGRRPIDRNRPRSEQKLLQWV--KPYLSDAKQFRQIVDPR 330
L EL GR PI P + K L+ + +P + + + PR
Sbjct: 192 LVELAIGRYPI----PPPDAKELEAIFGRPVVDGEEGEPHSISPR 232
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 45/246 (18%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVN----- 139
K+F +G+GG+G V+ K++ + VA+K++ + + + EV
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEI-----VALKRMKKSLLF----KLNEVRHVLTE 51
Query: 140 --FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSP----KSETILTWA 193
L + + LVKL+ Y DDE L EY+P G L+ + +
Sbjct: 52 RDILTTTKSEWLVKLL-YAFQDDE---YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM 107
Query: 194 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 253
+ A DA L Y+H RD K N L+D + KL+DFGL S+G
Sbjct: 108 AEMFEAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGL-----SKGIVT 153
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP-------RSE 306
+ +VVG+ Y APE ++ D WS G LYE + G P + P +
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
Query: 307 QKLLQW 312
++ LQ
Sbjct: 214 KETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 19/229 (8%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM 135
+I + K ++R IG+G G VY + D + EVA+KQ+ + Q KE +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAI-----DIATGQEVAIKQMNLQQ-QPKKELI 63
Query: 136 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 195
+N + ++ +V Y D G + +V EY+ GS+ ++ ET +
Sbjct: 64 --INEILVMRENKNPNIVNYL-DSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQI 117
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHV 254
+ ++ + L +LH Q+I RD KS NILL + KL+DFG A++ P +
Sbjct: 118 AAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---K 171
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 303
+ +VGT + APE V + D+WS G+ E++ G P P
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 87/289 (30%), Positives = 123/289 (42%), Gaps = 62/289 (21%)
Query: 93 IGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQN 148
IG G FG VY ++ +E VA+K++ G Q +++W + EV FL + H N
Sbjct: 23 IGHGSFGAVYFARDVRTNE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGS----VDQYLSPKSETILTWAMRLKIAQDAAR 204
++ G C + LV EY GS ++ + P E + I A +
Sbjct: 77 TIEYKG-CYLREHTA---WLVMEYCL-GSASDILEVHKKPLQEVEIA-----AICHGALQ 126
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAVVGTMG 263
GLAYLH + I RD K+ NILL E KL+DFG A L P+ F VGT
Sbjct: 127 GLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-------VGTPY 176
Query: 264 YAAPEYV---QTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVKPYLSD 319
+ APE + G+ + DVWS G+ EL + P+ + N + + Q P LS
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSS 236
Query: 320 ---AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
+ FR VD CL K + RP E+L
Sbjct: 237 NDWSDYFRNFVD--------------------SCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 51/291 (17%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG--RRGVQGHKEWMTEVNFLGIV 144
+ + IGEG FG L+K+ ED Q V +K++ + + +E EV L +
Sbjct: 2 YVKVKKIGEGSFGKAI--LVKSKEDGKQYV---IKEINISKMSPKEREESRKEVAVLSNM 56
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLKI 198
+H N+V+ Y +E G +V +Y G + + ++ + + IL W +++ +
Sbjct: 57 KHPNIVQ---YQESFEENG-NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL 112
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A L ++H D +I+ RD KS NI L + KL DFG+AR+ S ++
Sbjct: 113 A------LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VELARTC 161
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318
+GT Y +PE + +SD+W+ G LYE+ T +
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-------------------- 201
Query: 319 DAKQFRQIVDPRLEGKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+A + +V + G Y S L ++ + +N R RP ++ +LE
Sbjct: 202 EAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 34/297 (11%)
Query: 73 KEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK 132
K TI ++ S+ K + VI G G YKG + ++ VK++ V
Sbjct: 681 KSITINDILSSLKEEN---VISRGKKGASYKGKSIKNG-----MQFVVKEIND--VNSIP 730
Query: 133 EWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTW 192
+E+ +G ++H N+VKL+G C + L++EY+ ++ + L L+W
Sbjct: 731 S--SEIADMGKLQHPNIVKLIGLCRSEKGA----YLIHEYIEGKNLSEVLRN-----LSW 779
Query: 193 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 252
R KIA A+ L +LH ++V + I++D + L RL
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLC 833
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312
+ + + Y APE +T + +SD++ +G+ L EL+TG+ P D +++W
Sbjct: 834 TDTKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVEW 891
Query: 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL---CLVKNARTRPKMSEVLE 366
+ SD +DP + G S+ +++ V NL C + RP ++VL+
Sbjct: 892 ARYCYSDC-HLDMWIDPSIRGDVSVN-QNEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM---TEVNFLG 142
+ R +G G FG V+ D + A+K + V K+ E L
Sbjct: 2 DLERIKTVGTGTFGRVHL-----VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK 56
Query: 143 IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA 202
V H +++L + + D+R + L+ EY+P G + YL ++ + + L A +
Sbjct: 57 EVSHPFIIRL--FWTEHDQRFLYMLM--EYVPGGELFSYL--RNSGRFSNSTGLFYASEI 110
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
L YLH +I+ RD K NILLD++ + KL+DFG A+ +T + GT
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTP 162
Query: 263 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
Y APE +Q+ D W+ G+ +YE++ G P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 76/308 (24%), Positives = 142/308 (46%), Gaps = 58/308 (18%)
Query: 93 IGEGGFGCVYKGLIKNSED-PS----------QKVEVAVKQLGRRGVQGHK-EWMTEVNF 140
+GEG FG V+ + N +D P+ + + VAVK L + + +++ EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---------------PK 185
L ++ N+++L+G C D+D ++ EYM NG ++Q+LS P
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPL----CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 186 SETILT--WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243
+ + ++ L +A A G+ YL ++F + RD + N L+ E K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL-SSLNF--VHRDLATRNCLVGENLTIKIADFGMS 185
Query: 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 303
R + + + V + + A E + G+ SDVW++GV L+E++ + + +P
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQP 241
Query: 304 RSE---QKLLQWVKPYLSDAKQ----FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNAR 356
E +++++ + D + FR P +G Y L L C ++ R
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCP--QGLYELMLQ---------CWSRDCR 290
Query: 357 TRPKMSEV 364
RP S++
Sbjct: 291 ERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 40/280 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFLGIVEHQNLV 150
++G G G VYK ++++ +AVK + V+ K+ M+E+ L + ++
Sbjct: 8 ILGHGNGGTVYKAYHL----LTRRI-LAVKVIPLDITVELQKQIMSELEILYKCDSPYII 62
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
Y A E I + E+M GS+D Y E +L +IA +GL YL
Sbjct: 63 GF--YGAFFVENRIS--ICTEFMDGGSLDVYRK-IPEHVLG-----RIAVAVVKGLTYL- 111
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 270
+I+ RD K SN+L++ + KL DFG++ + ++ VGT Y APE +
Sbjct: 112 --WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERI 165
Query: 271 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD-- 328
+ SDVWS G+ EL GR P + +Q + L + + IVD
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQ---------IQKNQGSLMPLQLLQCIVDED 216
Query: 329 -PRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
P L G++S + V H C+ K + RP +++
Sbjct: 217 PPVLPVGQFSEKFV----HFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 19/229 (8%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM 135
+I + K ++R IG+G G VY + D + EVA++Q+ + Q KE +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAM-----DVATGQEVAIRQMNLQQ-QPKKELI 64
Query: 136 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 195
+N + ++ +V Y D G + +V EY+ GS+ ++ ET +
Sbjct: 65 --INEILVMRENKNPNIVNYL-DSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQI 118
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHV 254
+ ++ + L +LH Q+I RD KS NILL + KL+DFG A++ P +
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---K 172
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 303
+ +VGT + APE V + D+WS G+ E+I G P P
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 89/302 (29%), Positives = 133/302 (44%), Gaps = 49/302 (16%)
Query: 93 IGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQN 148
IG G FG VY ++NSE VA+K++ G Q +++W + EV FL + H N
Sbjct: 23 IGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ---YLSPKSETILTWAMRLKIAQDAARG 205
++ G C + LV EY + D + P E + + A +G
Sbjct: 77 TIQYRG-CYLREHTA---WLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQG 127
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAVVGTMGY 264
LAYLH +I RD K+ NILL E KL DFG A + P+ F VGT +
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-------VGTPYW 177
Query: 265 AAPEYV---QTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVKPYLSD- 319
APE + G+ + DVWS G+ EL + P+ + N + + Q P L
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
Query: 320 --AKQFRQIVDPRLEGKYSLRLVSK--LSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375
++ FR VD L+ R S+ L H + R RP + +++++ + DA
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH-RFVL-----RERP-PTVIMDLIQRTKDAV 290
Query: 376 AE 377
E
Sbjct: 291 RE 292
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMTEVNFLGIVEHQN 148
IGEG +G VYK K + + VA+K++ GV + E++ L + H N
Sbjct: 7 IGEGTYGVVYKARDKLTGE-----IVALKKIRLETEDEGVPSTA--IREISLLKELNHPN 59
Query: 149 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
+V+L+ + +L LV+E++ + + +Y+ T L + +G+A
Sbjct: 60 IVRLLDVVHSE-----NKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHVSTAVVGTMGYA 265
Y H +++ RD K N+L+D + KL+DFGLAR G P +TH VV T+ Y
Sbjct: 114 YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYR 166
Query: 266 APEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 298
APE + R + D+WS G E++ RRP+
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 73/300 (24%), Positives = 143/300 (47%), Gaps = 50/300 (16%)
Query: 93 IGEGGFG----CVYKGLIKNSED-------PSQKVEVAVKQLGRRGVQGHK-EWMTEVNF 140
+GEG FG C +G+ K + +Q V VAVK L + + +++ E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSE------TILT 191
+ ++ N+++L+ C D ++ EYM NG ++Q+LS P+ ++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPL----CMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 192 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 251
++ + +A A G+ YL ++F + RD + N L+ + + K++DFG++R S +
Sbjct: 129 YSTLIFMATQIASGMKYL-SSLNF--VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 252 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE---QK 308
+ V + + + E + G+ SDVW++GV L+E++T + + +P S+ ++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQPYSQLSDEQ 241
Query: 309 LLQWVKPYLSDAKQFRQIVDPR----LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 364
+++ + D Q RQ+ P+ + Y L L C +NA+ RP E+
Sbjct: 242 VIENTGEFFRD--QGRQVYLPKPALCPDSLYKLMLS---------CWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 87/287 (30%), Positives = 121/287 (42%), Gaps = 58/287 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQNL 149
IG G FG VY NS + +V VAVK++ G Q +++W + EV FL ++H N
Sbjct: 29 IGHGSFGAVY--FATNSH--TNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT 83
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQ---YLSPKSETILTWAMRLKIAQDAARGL 206
++ G C + LV EY + D + P E + I A +GL
Sbjct: 84 IEYKG-CYLKEHTA---WLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGL 134
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAVVGTMGYA 265
AYLH +I RD K+ NILL E KL+DFG A P+ F VGT +
Sbjct: 135 AYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-------VGTPYWM 184
Query: 266 APEYV---QTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVKPYLSD-- 319
APE + G+ + DVWS G+ EL + P+ + N + + Q P L
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244
Query: 320 -AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
FR VD CL K + RP +E+L
Sbjct: 245 WTDSFRGFVD--------------------YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 67/290 (23%), Positives = 133/290 (45%), Gaps = 42/290 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVK 151
+G+G FG VY+G ++ + VAVK + ++ E++ E + + ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSET-----ILTWAMRLKIAQDAA 203
L+G + +G L+V E M +G + YL P++E T +++A + A
Sbjct: 74 LLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
G+AYL+ + + RD + N ++ + K+ DFG+ R + + +
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY--LSDAK 321
+ APE ++ G SD+WS+GV L+E+ + +EQ PY LS+ +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQ 229
Query: 322 QFRQIVDPRLEGKYSLR---LVSKLSHVANLCLVKNARTRPKMSEVLEMV 368
+ ++D G Y + +++ + +C N + RP E++ ++
Sbjct: 230 VLKFVMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 22/220 (10%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVN------ 139
N+ ++G G FG VY D E+AVKQ+ +E EVN
Sbjct: 3 NWRLGKLLGRGAFGEVYL-----CYDADTGRELAVKQVPFD--PDSQETSKEVNALECEI 55
Query: 140 -FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKI 198
L + H +V+ G D +E+ + + EYMP GS+ L K+ LT + +
Sbjct: 56 QLLKNLRHDRIVQYYGCLRDPEEKKLS--IFVEYMPGGSIKDQL--KAYGALTENVTRRY 111
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS-TA 257
+ +G++YLH M I+ RD K +NIL D N KL DFG ++ + + +
Sbjct: 112 TRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
V GT + +PE + ++DVWS + E++T + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 75/293 (25%), Positives = 117/293 (39%), Gaps = 56/293 (19%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE 145
V IGEG G V + D S +VAVK++ R Q + EV + +
Sbjct: 20 YLDNFVKIGEGSTGIV-----CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ 74
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA-- 203
H N+V++ DE +V E++ G++ T + R+ Q A
Sbjct: 75 HPNIVEMYSSYLVGDEL----WVVMEFLEGGAL---------TDIVTHTRMNEEQIATVC 121
Query: 204 ----RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV- 258
+ L++LH +I RD KS +ILL KLSDFG VS V
Sbjct: 122 LAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC--------AQVSKEVP 170
Query: 259 -----VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313
VGT + APE + D+WS G+ + E++ G P +
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY-------------FN 217
Query: 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+P L K+ R + P+L K ++ +L + LV++ R +E+L
Sbjct: 218 EPPLQAMKRIRDNLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 71/259 (27%), Positives = 102/259 (39%), Gaps = 59/259 (22%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----RRGVQGHKEWMTEVNFLGIVEH 146
VIG G FG V+ L+++ + +V A+K L +R H E + L +
Sbjct: 8 VIGRGAFGEVW--LVRDKDT--GQV-YAMKVLRKSDMIKRNQIAH--VRAERDILADADS 60
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----D 201
+VKL Y + DE + LV EYMP G + L K A R IA+ D
Sbjct: 61 PWIVKL--YYSFQDEEHL--YLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVLALD 115
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA------------------ 243
+ L ++H RD K NIL+D + KL+DFGL
Sbjct: 116 SVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 244 ---------RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG 294
R + + + VGT Y APE ++ D WS GV LYE++ G
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
Query: 295 RRPI-DRNRPRSEQKLLQW 312
P + K++ W
Sbjct: 227 FPPFYSDTLQETYNKIINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 28/287 (9%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+GEG FG V +G + N +D KV V ++ +++++E + +H N+++L
Sbjct: 7 LGEGEFGSVMEGQL-NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 153 VGYCADDDERG--IQRLLVYEYMPNGSVDQYL--SPKSET--ILTWAMRLKIAQDAARGL 206
+G C E +++ +M +G + +L S + L M +K D A G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
YL I RD + N +L+E N ++DFGL++ + + + + A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325
E + +SDVWS+GV ++E+ T G+ P P E + YL + +Q
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPY----PGVEN---SEIYDYLRQGNRLKQ 235
Query: 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372
D L+G YSL + C + N + RP + + K +
Sbjct: 236 PPDC-LDGLYSL---------MSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 92/310 (29%), Positives = 131/310 (42%), Gaps = 41/310 (13%)
Query: 69 PSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RG 127
P N + L T + IG+G +G VYK + N +D S AVK L
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYK--VTNKKDGSL---AAVKILDPISD 60
Query: 128 VQGHKEWMTEVNFL-GIVEHQNLVKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSP- 184
V +E E N L + H N+VK G + D G Q LV E GSV + +
Sbjct: 61 VD--EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL 118
Query: 185 -KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL- 242
L AM I A GL +LH +II RD K +NILL + KL DFG+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175
Query: 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-----LAARSDVWSYGVFLYELITGRRP 297
A+L + + S VGT + APE + + AR DVWS G+ EL G P
Sbjct: 176 AQLTSTRLRRNTS---VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
Query: 298 IDRNRP-RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNAR 356
+ P ++ K+ + P L +++ +H + CL+K+
Sbjct: 233 LFDMHPVKTLFKIPRNPPPTLLHPEKW----------------CRSFNHFISQCLIKDFE 276
Query: 357 TRPKMSEVLE 366
RP ++ +LE
Sbjct: 277 ARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 46/155 (29%), Positives = 66/155 (42%), Gaps = 22/155 (14%)
Query: 168 LVYEYMPNG---SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 224
LV EY+ G S+ + L E WA + + G+ LH II RD K
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPED---WAK--QYIAEVVLGVEDLH---QRGIIHRDIKP 125
Query: 225 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSY 284
N+L+D+ + KL+DFGL+R G + VGT Y APE + SD WS
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 285 GVFLYELITGRRPIDRNRP-----RSEQKLLQWVK 314
G ++E + G P P + + W +
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGIVEHQNLV 150
+G G FG V KG+ K + S+K VAVK L E + E N + +++ +V
Sbjct: 3 LGSGNFGTVKKGMYKMKK--SEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIV 59
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
+++G C +LV E G ++++L +T ++ + G+ YL
Sbjct: 60 RMIGIC-----EAESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLE 112
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEY 269
E + RD + N+LL Q AK+SDFGL++ LG E + T + + APE
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 270 VQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + +++SDVWS+GV ++E + G++P
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 69/224 (30%), Positives = 104/224 (46%), Gaps = 49/224 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFL-GIVEHQNL 149
+G+G +G V+K + + + ++V VA+K++ R + E+ FL + +H N+
Sbjct: 15 LGKGAYGIVWKAIDRRT----KEV-VALKKIFDAFRNATDAQRTFREIMFLQELGDHPNI 69
Query: 150 VKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA------ 202
VKL+ A++D + I LV+EYM ET L +R I +D
Sbjct: 70 VKLLNVIKAEND-KDI--YLVFEYM-------------ETDLHAVIRANILEDVHKRYIM 113
Query: 203 ---ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL---GPSEGFTHVST 256
+ L Y+H G +I RD K SNILL+ KL+DFGLAR V T
Sbjct: 114 YQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 257 AVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
V T Y APE + L + D+WS G L E++ G+
Sbjct: 171 DYVATRWYRAPEIL----LGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 73/241 (30%), Positives = 117/241 (48%), Gaps = 22/241 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGVQGHKEWMTEVNFLGIVEHQ 147
V+G+GG+G V++ + K + + K+ A+K L + R + E N L V+H
Sbjct: 3 VLGKGGYGKVFQ-VRKVTGADTGKI-FAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
+V L+ Y + G + L+ EY+ G + +L + E I + + L
Sbjct: 61 FIVDLI-YAF---QTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALE 114
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
+LH+ II RD K NILLD Q + KL+DFGL + EG V+ GT+ Y AP
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAP 169
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRPID-RNRPRSEQKLLQW---VKPYLS-DAKQ 322
E + D WS G +Y+++TG P NR ++ K+L+ + PYL+ +A+
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 323 F 323
Sbjct: 230 L 230
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 93 IGEGGFGCVYKG-LIKNSEDPSQKVEVAVKQLGR-RGVQGHKEWMTEVNFLGIVEHQNLV 150
+GE FG +YKG L D +Q V A+K L Q E+ E + + + H N+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLV--AIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSE------------TILTWAMR 195
L+G + +++EY+ G + ++L SP S+ + L
Sbjct: 71 CLLGVVTQEQPV----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
L IA A G+ YL + +D + NIL+ EQ + K+SD GL+R S + V
Sbjct: 127 LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + + PE + G+ ++ SD+WS+GV L+E+ + G +P
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 40/227 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT--------EVNFLGIV 144
IG G +G VYK KN E A+K+ +G KE T E+ L +
Sbjct: 8 IGRGTYGRVYKAKRKN---GKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLREL 59
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPN--GSVDQYLSPKSETILTWAMRLKIAQDA 202
+H+N+V LV + ++ + L+++Y + + ++ + +M +
Sbjct: 60 KHENVVSLVEVFLEHADKSVY--LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLARL--GPSEGFTHVST 256
G+ YLH ++ RD K +NIL+ E+ K+ D GLARL P + +
Sbjct: 118 LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 257 AVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 298
VV T+ Y APE + L AR D+W+ G EL+T PI
Sbjct: 175 VVV-TIWYRAPELL----LGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 77/302 (25%), Positives = 118/302 (39%), Gaps = 70/302 (23%)
Query: 87 FSRSVVIGEGGFGCVYKGL-----------IKNSEDPSQKVEVAVKQLGRRGVQGHKEWM 135
+ R +IG G +G VY+G I N + P V +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS---------------DIQ 47
Query: 136 TEVNFLGIVEH---QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETIL 190
EV L + N+ K G I + EY GSV + P +E +
Sbjct: 48 REVALLSQLRQSQPPNITKYYGSYLKGPRLWI----IMEYAEGGSVRTLMKAGPIAEKYI 103
Query: 191 TWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 250
+ +R + L Y+H+ +I RD K++NIL+ N KL DFG+A L
Sbjct: 104 SVIIR-----EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAAL----- 150
Query: 251 FTHVS---TAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSE 306
S + VGT + APE + G+ ++D+WS G+ +YE+ TG N P S+
Sbjct: 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG------NPPYSD 204
Query: 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGK-YSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
+ + + +K PRLE YS L CL + + R E+L
Sbjct: 205 VDAFRAMM-LIPKSKP------PRLEDNGYS----KLLREFVAACLDEEPKERLSAEELL 253
Query: 366 EM 367
+
Sbjct: 254 KS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIV-EHQNLV 150
+GEG FG V K ++P++ VAVK L + + ++E+ + ++ +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL------SPKSETILTWAMRLKIAQDAAR 204
L+G C + +V EY +G++ +L + + Q
Sbjct: 80 NLLGVCTQEGPL----YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 205 GLAY-LHEGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 259
AY + GM+F + I RD + N+L+ E K++DFGLAR + +T
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ + APE + +SDVWS+GV L+E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 82/286 (28%), Positives = 133/286 (46%), Gaps = 26/286 (9%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVE 145
F++ IG+G FG V+KG+ ++ +Q+V VA+K + + E E+ L +
Sbjct: 6 FTKLERIGKGSFGEVFKGI----DNRTQQV-VAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
+ K G +G + ++ EY+ GS L A LK + +G
Sbjct: 61 SPYVTKYYGSYL----KGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKG 113
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L YLH + I RD K++N+LL EQ + KL+DFG+A G VGT +
Sbjct: 114 LDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWM 168
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSD--AKQ 322
APE +Q +++D+WS G+ EL G P P R + + P L+ +K
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKP 228
Query: 323 FRQIVDPRLEGKYSLRLVSK--LSHVANLCLVKNARTRPKMSEVLE 366
F++ +D L S R +K L H +VKNA+ ++E+++
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKF---IVKNAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 70/221 (31%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNL 149
V+G+G FG V+ L++ P A+K L + V+ E + L V H +
Sbjct: 3 VLGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
VKL + A E + L+ +++ G + LS E + T +D LA L
Sbjct: 61 VKL--HYAFQTEGKL--YLILDFLRGGDLFTRLS--KEVMFT-------EEDVKFYLAEL 107
Query: 210 HEGMD----FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA--VVGTMG 263
+D II RD K NILLDE+ + KL+DFGL++ E H A GT+
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVE 163
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI---DRN 301
Y APE V +D WS+GV ++E++TG P DR
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 69/219 (31%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT-----EVNFLGIVE-- 145
IG G +G VYK + DP VA+K + VQ +++ + EV L +E
Sbjct: 8 IGVGAYGTVYK-----ARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAF 59
Query: 146 -HQNLVKLVGYCADD-DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 203
H N+V+L+ CA +R + LV+E+ VDQ L + + + + +D
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLM 114
Query: 204 R----GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 259
R GL +LH I+ RD K NIL+ KL+DFGLAR+ T VV
Sbjct: 115 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVV 168
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298
T+ Y APE + A D+WS G E+ R+P+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 51/210 (24%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVK 151
+G+G FG VY+G+ K + VA+K + ++ E++ E + + ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------SPKSETILTWAMRLKIAQDAA 203
L+G + +G L++ E M G + YL + + + +++A + A
Sbjct: 74 LLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
G+AYL+ + + RD + N ++ E + K+ DFG+ R + + +
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ +PE ++ G SDVWS+GV L+E+ T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G FG V+ ++ +VAVK + + G + ++ E N + ++H LVKL
Sbjct: 14 LGAGQFGEVWMATY------NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
+ ++ E+M GS+ +L + + + A G+A++ +
Sbjct: 67 HAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
I RD +++NIL+ K++DFGLAR+ +T A + + APE +
Sbjct: 122 ---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINF 177
Query: 273 GRLAARSDVWSYGVFLYELIT-GRRP 297
G +SDVWS+G+ L E++T GR P
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 70/254 (27%), Positives = 102/254 (40%), Gaps = 69/254 (27%)
Query: 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW-----MT 136
S +++ +GEG FG VYK + VA+K++ + K+ +
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKT-----GRVVALKKIL---MHNEKDGFPITALR 56
Query: 137 EVNFLGIVEHQNLVKLVGYCAD-DDERGIQRLLVYEYMP-----------NGSVDQYLSP 184
E+ L ++H N+V L+ + D+ +R VY P N SV
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV------ 110
Query: 185 KSETILTWAMRLKIAQ------DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238
+L +Q G+ YLHE I+ RD K++NIL+D Q K++
Sbjct: 111 ----------KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIA 157
Query: 239 DFGLARL---------GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSY 284
DFGLAR G G T T +V T Y PE + L R D+W
Sbjct: 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL----LGERRYTTAVDIWGI 213
Query: 285 GVFLYELITGRRPI 298
G E+ T RRPI
Sbjct: 214 GCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 31/232 (13%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE--- 133
I +L+ +++ VIG G FG V L+++ SQKV A+K L + + +
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQ--LVRHKS--SQKV-YAMKLLSKFEMIKRSDSAF 89
Query: 134 WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWA 193
+ E + + +V+L +CA D++ + +V EYMP G + +S + WA
Sbjct: 90 FWEERDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMPGGDLVNLMS-NYDVPEKWA 144
Query: 194 ----MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249
+ +A DA + +H RD K N+LLD+ + KL+DFG
Sbjct: 145 KFYTAEVVLALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDET 195
Query: 250 GFTHVSTAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRP 297
G TA VGT Y +PE +++ G D WS GVFL+E++ G P
Sbjct: 196 GMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMTEVNFL 141
NF + IGEG +G VYK +N + +V VA+K++ GV + E++ L
Sbjct: 1 NFQKVEKIGEGTYGVVYKA--RNKL--TGEV-VALKKIRLDTETEGVPSTA--IREISLL 53
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
+ H N+VKL+ ++ + LV+E++ + + +++ + + +
Sbjct: 54 KELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ 108
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHVSTAVV 259
+GLA+ H +++ RD K N+L++ + KL+DFGLAR G P +TH VV
Sbjct: 109 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV 162
Query: 260 GTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 295
T+ Y APE + + + + D+WS G E++T R
Sbjct: 163 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 93 IGEGGFGCVY--KGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQN 148
+GEG FG V + + + + P++ V VAVK L + + ++E+ + ++ +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAM 194
++ L+G C D G +LV EY G++ +YL + E LT+
Sbjct: 80 IINLLGACTQD---GPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
+ A ARG+ YL + I RD + N+L+ E K++DFGLAR + +
Sbjct: 136 LVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+T + + APE + +SDVWS+GV L+E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 35/207 (16%)
Query: 171 EYMPNGSVDQYLSPKSET-ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229
EYM GS+D+ + T + + +I +GL +L E + II RD K +N+L+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLV 136
Query: 230 DEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAAR------SDVW 282
+ KL DFG++ L S ++ +G Y APE +++G SDVW
Sbjct: 137 NGNGQVKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVW 191
Query: 283 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRLEGKYSLRL 339
S G+ + E+ GR P P + Y + Q IVD P L YS
Sbjct: 192 SLGLSILEMALGRYPYP---PET----------YANIFAQLSAIVDGDPPTLPSGYS--- 235
Query: 340 VSKLSHVANLCLVKNARTRPKMSEVLE 366
CL K RP +++LE
Sbjct: 236 -DDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A + GL +LHE II RD K N+LLD + + K++DFG+ + G G T ++
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
GT Y APE + D W+ GV LYE++ G+ P +
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK-EWMTEVNFLGIVEHQNLVK 151
IG G FG V+ G ++ P VAVK K +++ E L H N+V+
Sbjct: 3 IGRGNFGEVFSGRLRADNTP-----VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+G C I V E + G +L + + + +++ ++AA G+ YL
Sbjct: 58 LIGVCTQKQPIYI----VMELVQGGDFLTFLRTEGPRLKVKEL-IQMVENAAAGMEYLES 112
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM--GYAAPEY 269
I RD + N L+ E+ K+SDFG++R E + ST + + + APE
Sbjct: 113 K---HCIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 270 VQTGRLAARSDVWSYGVFLYE 290
+ GR ++ SDVWS+G+ L+E
Sbjct: 168 LNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 67/302 (22%), Positives = 125/302 (41%), Gaps = 51/302 (16%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG---RRGVQGHKEWMTEVNF 140
NF IG+G F VYK + VA+K++ + ++ + E++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRV-----VALKKVQIFEMMDAKARQDCLKEIDL 55
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE--------TILTW 192
L ++H N++K + +++E I V E G + + + + TI +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNI----VLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 193 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 252
++L L ++H +I+ RD K +N+ + KL D GL R S+ T
Sbjct: 112 FVQL------CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--T 160
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI---DRNRPRSEQKL 309
+ ++VGT Y +PE + +SD+WS G LYE+ + P N +K+
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 220
Query: 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369
+ P L A + + +L + + C+ + RP +S VL++
Sbjct: 221 EKCDYPPLP-ADHYSE----------------ELRDLVSRCINPDPEKRPDISYVLQVAK 263
Query: 370 KI 371
++
Sbjct: 264 EM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 12/218 (5%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH 146
F + V+G+GGFG V ++ + A K+L ++ ++ K +N I+E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGESMALNEKQILEK 56
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
N + V A E LV M G + ++ E + A + GL
Sbjct: 57 VN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGL 115
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
LH+ +I+ RD K NILLD+ + ++SD GLA P EG T VGT+GY A
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQT--IKGRVGTVGYMA 169
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 304
PE V+ R D W+ G LYE+I G+ P + + +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 74/291 (25%), Positives = 114/291 (39%), Gaps = 61/291 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL------GRRGVQGHKEWMTEVNFLGIVEH 146
IG G +G VYK + + VA+K + +Q E++ L H
Sbjct: 11 IGSGTYGDVYKARDIATGE-----LVAIKVIKLEPGDDFEIIQQ------EISMLKECRH 59
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS----PKSETILTWAMRLKIAQDA 202
N+V G D+ I V EY GS+ P SE + + + ++
Sbjct: 60 PNIVAYFGSYLRRDKLWI----VMEYCGGGSLQDIYQVTRGPLSELQIAY-----VCRET 110
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS---TAVV 259
+GLAYLHE I RD K +NILL E + KL+DFG++ T + +
Sbjct: 111 LKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ-----LTATIAKRKSFI 162
Query: 260 GTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316
GT + APE G + D+W+ G+ EL + P+ P + L K
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALFLISK-- 218
Query: 317 LSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
P+L+ K+S CL K+ + RP +++L
Sbjct: 219 -------SNFPPPKLKDKEKWSP----VFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLGIVEHQNL 149
++GEG +G V K K+ E + ++ VA+K+ K M E+ L + H+NL
Sbjct: 8 LVGEGSYGMVMK--CKHKE--TGQI-VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 150 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
V L+ R +RL LV+E++ + +D K L + K RG+ +
Sbjct: 63 VNLIEVF-----RRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGIEF 115
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGYAA 266
H II RD K NIL+ + KL DFG AR P E V T V T Y A
Sbjct: 116 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE----VYTDYVATRWYRA 168
Query: 267 PEY-VQTGRLAARSDVWSYGVFLYELITG 294
PE V + D+W+ G + E++TG
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 66/230 (28%), Positives = 115/230 (50%), Gaps = 23/230 (10%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW-MTEVNFLGIV 144
NF + +GEG + VYKG + + VA+K++ +G + E++ + +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTT-----GEIVALKEIHLDAEEGTPSTAIREISLMKEL 55
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK-IAQDAA 203
+H+N+V+L ++ + +LV+EYM + + +Y+ +K
Sbjct: 56 KHENIVRLHDVIHTEN----KLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHVSTAVVGT 261
+G+A+ HE +++ RD K N+L++++ KL+DFGLAR G P F S VV T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVV-T 163
Query: 262 MGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310
+ Y AP+ + R + S D+WS G + E+ITG RP+ +Q L
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 54/167 (32%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 171 EYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227
E+M GS+DQ L E IL K++ +GL YL E +I+ RD K SNI
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNI 135
Query: 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 287
L++ + KL DFG++ + ++ + VGT Y +PE +Q + +SD+WS G+
Sbjct: 136 LVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 288 LYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGK 334
L E+ GR PI P +++ L + P D + PR G+
Sbjct: 192 LVEMAIGRYPIP--PPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 93 IGEGGFGCVY--KGLIKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLGIV-EHQN 148
+GEG FG V + L + + P + V VAVK L + + ++E+ + ++ +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAM 194
++ L+G C D ++ EY G++ +YL + + +T+
Sbjct: 83 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
+ ARG+ YL + I RD + N+L+ E K++DFGLAR + +
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+T + + APE + +SDVWS+GV ++E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 71/229 (31%), Positives = 104/229 (45%), Gaps = 34/229 (14%)
Query: 93 IGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGVQGHKEWM--------TEVNFLGI 143
IGEG +G V+K +KN VA+K R VQ +E M + L
Sbjct: 9 IGEGAYGKVFKARDLKNGGR-----FVALK---RVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 144 VEHQNLVKLVGYCA-DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA 202
EH N+V+L C +R + LV+E+ VDQ L+ + + + + +D
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDM 115
Query: 203 A----RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
RGL +LH +++ RD K NIL+ KL+DFGLAR+ F T+V
Sbjct: 116 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSV 169
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307
V T+ Y APE + A D+WS G E+ R+P+ R +Q
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK-EWMTEVNFLGIVEHQNLVK 151
+GEG + VYKG K +++ VA+K++ +G + EV+ L ++H N+V
Sbjct: 14 LGEGTYATVYKGRSKLTDN-----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L + E+ + LV+EY+ + + QYL +I ++L + Q RGL Y H
Sbjct: 69 L--HDIIHTEKSLT--LVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ-LLRGLNYCHR 122
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE-YV 270
+++ RD K N+L++E+ KL+DFGLAR T+ + V T+ Y P+ +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILL 177
Query: 271 QTGRLAARSDVWSYGVFLYELITGR 295
+ + + D+W G YE+ TGR
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 93 IGEGGFGCVYK--GLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQN 148
+GEG FG V + + P Q V VAVK L + + ++E+ + ++ +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAM 194
++ L+G C + G ++V EY G++ ++L + E L++
Sbjct: 80 IINLLGVCTQE---GPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
+ A ARG+ YL + I RD + N+L+ E K++DFGLAR G +
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDI 187
Query: 255 STAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ G + APE + +SDVWS+G+ ++E+ T
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 66/230 (28%), Positives = 98/230 (42%), Gaps = 39/230 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE---WMTEVNFLGIVEHQNL 149
+G G FG V K + + A+K L +R + K+ E + L + H +
Sbjct: 26 LGTGSFGRVRIAKHKGTGE-----YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 204
V + C+ DE + LL E++ G + +L + D A+
Sbjct: 81 VNM--MCSFQDENRVYFLL--EFVVGGELFTHLRKAG----------RFPNDVAKFYHAE 126
Query: 205 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
YLH II RD K N+LLD + + K++DFG A+ P FT + GT
Sbjct: 127 LVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGT 178
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLL 310
Y APE +Q+ D W+ GV LYE I G P + P R +K+L
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228
|
Length = 329 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 79/302 (26%), Positives = 127/302 (42%), Gaps = 47/302 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G+G FG VYK KN E A K + + + +++M E+ L H +VKL
Sbjct: 20 LGDGAFGKVYKA--KNKE---TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKL 74
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
+G D + I + E+ P G+VD + + +++ I + L YLH
Sbjct: 75 LGAFYWDGKLWI----MIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHS- 128
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
+II RD K+ N+LL + KL+DFG++ + + +GT + APE V
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 273 GRLAA-----RSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSDAKQFRQI 326
+ ++D+WS G+ L E+ P P R K+ + P LS
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS----- 239
Query: 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE--MVNKIVDASAEAGSPRRP 384
K+S+ L L K+ TRP +++LE V+ + RP
Sbjct: 240 -------KWSMEFRDFL----KTALDKHPETRPSAAQLLEHPFVSSVTS--------NRP 280
Query: 385 LR 386
LR
Sbjct: 281 LR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLGIVEHQNL 149
V+GEG FG + L+ + QK A+K++ R ++ E L ++H N+
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKY--AMKEI-RLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLKIAQDAA 203
V + E +V EY G + Q + + +TIL W +++ +
Sbjct: 61 VAF----KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL----- 111
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
G+ ++HE +++ RD KS NI L + KL DFG ARL S G + VGT
Sbjct: 112 -GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYVGTPY 165
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRN 301
Y PE + +SD+WS G LYEL T + P N
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 67/235 (28%), Positives = 98/235 (41%), Gaps = 59/235 (25%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-------WMTE 137
F + IGEG +G VY+ D + VA+K+ V+ E + E
Sbjct: 7 TEFEKLNRIGEGTYGIVYRA-----RDTTSGEIVALKK-----VRMDNERDGIPISSLRE 56
Query: 138 VNFLGIVEHQNLVKL---------------VGYCADDDERGIQRLLVYEYMPNGSVDQYL 182
+ L + H N+V+L + YC D + LL + MP
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQD----LASLL--DNMPT------- 103
Query: 183 SPKSETILTWAMRLK-IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241
P SE+ ++K + RGL YLHE II RD K SN+LL ++ K++DFG
Sbjct: 104 -PFSES------QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFG 153
Query: 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 295
LAR T V T+ Y APE + + D+W+ G L EL+ +
Sbjct: 154 LAR--TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVK 151
+GE FG VYKG + + Q VA+K L + +E+ E ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSE-----------TILTWAMRLK 197
L+G + +++ Y + + ++L SP S+ + L A +
Sbjct: 73 LLGVVTKEQPLS----MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
I A G+ +L ++ +D + N+L+ ++ N K+SD GL R + + +
Sbjct: 129 IVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + + +PE + G+ + SD+WSYGV L+E+ + G +P
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM-TEVNFLGIVEHQNLV 150
++ EG FG ++ G I E P ++ EV VK + + + E L + HQN++
Sbjct: 13 LLQEGTFGRIFYG-ILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL------SPKSETILTWAMRLKIAQDAAR 204
++ C +D E ++Y YM G++ +L + L+ + +A A
Sbjct: 72 PILHVCIEDGEP---PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR---------LGPSEGFTHVS 255
G++YLH+ +I +D + N ++DE+ K++D L+R LG +E
Sbjct: 129 GMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN----- 180
Query: 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ + A E + ++ SDVWS+GV L+EL+T
Sbjct: 181 ----RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE---WMTEVNFLGIV-EHQ 147
V+G+G FG V +K S AVK L + + + MTE L + H
Sbjct: 2 VLGKGSFGKVMLARLKESGRL-----YAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 56
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
L +L C +R V E++ NG + KS R A + L
Sbjct: 57 FLTQLY-CCFQTPDR---LFFVMEFV-NGGDLMFHIQKSRRFDEARARF-YAAEITSALM 110
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
+LH D II RD K N+LLD + + KL+DFG+ + G G T ++ GT Y AP
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAP 165
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
E +Q D W+ GV LYE++ G P +
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 82/306 (26%), Positives = 123/306 (40%), Gaps = 39/306 (12%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGVQ 129
+L + ++ L+ F V+G G +G VYKG +K + + KV +
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED------- 54
Query: 130 GHKEWMTEVNFLG-IVEHQNLVKLVGYCADDDERGI--QRLLVYEYMPNGSVDQYLSPKS 186
+E E+N L H+N+ G G Q LV E+ GSV +
Sbjct: 55 EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK 114
Query: 187 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARL 245
L I ++ RGLA+LH ++I RD K N+LL E KL DFG+ A+L
Sbjct: 115 GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171
Query: 246 GPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDR 300
+ G +GT + APE + RSD+WS G+ E+ G P+
Sbjct: 172 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
Query: 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 360
P L+ P P+L+ K + K CLVKN +RP
Sbjct: 229 MHPMRALFLIPRNPP-------------PKLKSK---KWSKKFIDFIEGCLVKNYLSRPS 272
Query: 361 MSEVLE 366
++L+
Sbjct: 273 TEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK-EWMTEVNFLGIVEHQNLVK 151
+GEG + V+KG K +E+ VA+K++ +G + EV+ L ++H N+V
Sbjct: 13 LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L + ER + LV+EY+ + + QYL + +++ + Q RGL+Y H+
Sbjct: 68 L--HDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQ-LLRGLSYCHK 121
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE-YV 270
+I+ RD K N+L++E+ KL+DFGLAR T+ + V T+ Y P+ +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLL 176
Query: 271 QTGRLAARSDVWSYGVFLYELITGR 295
+ + D+W G LYE+ TGR
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 25/219 (11%)
Query: 93 IGEGGFGCVY--KGLIKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLGIV-EHQN 148
+GEG FG V + + + E P++ +VAVK L + + ++E+ + ++ +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAM 194
++ L+G C D ++ EY G++ +YL + E L++
Sbjct: 86 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
+ A ARG+ YL + I RD + N+L+ E K++DFGLAR +
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+T + + APE + +SDVWS+GV L+E+ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 77/276 (27%), Positives = 113/276 (40%), Gaps = 34/276 (12%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH 146
F + V+G+GGFG V ++ + + K++ +R +G + E L V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR--KGESMALNEKQILEKVNS 59
Query: 147 QNLVKLV-GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
Q +V L Y D LV M G + ++ L A + G
Sbjct: 60 QFVVNLAYAYETKD-----ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L LH + RD K NILLD+ + ++SD GLA P EG VGT+GY
Sbjct: 115 LEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP-EG--ESIRGRVGTVGYM 168
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325
APE + R D W G +YE+I G+ P R R E+ VK R+
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKEK-----VK---------RE 211
Query: 326 IVDPRL---EGKYSLRLVSKLSHVANLCLVKNARTR 358
VD R+ E YS + + + + L K+ + R
Sbjct: 212 EVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 47/220 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW-----MTEVNFL-GIVEH 146
+G+G FG VY K + + V A+K++ ++ W + EV L + EH
Sbjct: 7 LGDGTFGSVYLARNK---ETGELV--AIKKMKKK----FYSWEECMNLREVKSLRKLNEH 57
Query: 147 QNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
N+VKL ++DE L V+EYM G++ Q + + + ++ I +G
Sbjct: 58 PNIVKLKEVFRENDE-----LYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS-----TAVVG 260
LA++H+ F RD K N+L+ K++DFGLAR + T V
Sbjct: 112 LAHIHKHGFFH---RDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVS 160
Query: 261 TMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
T Y APE + L + S D+W+ G + EL T R
Sbjct: 161 TRWYRAPEIL----LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH 146
F+ ++G+G FG V + +K+ + QKV V + + +E++ E + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 147 QNLVKLVGYCADDDERGIQRL----LVYEYMPNGSVDQYL--SPKSETILTWAMR--LKI 198
N++KL+G R RL ++ +M +G + +L S E T ++ ++
Sbjct: 61 PNVIKLIGVSLR--SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
D A G+ YL I RD + N +L+E ++DFGL++ S + A
Sbjct: 119 MIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + A E + SDVW++GV ++E++T G+ P
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 71/212 (33%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVN-FLGIVEHQ 147
VIG+G FG V L K+ D AVK L ++ + KE M E N L V+H
Sbjct: 2 VIGKGSFGKVL--LAKHKAD---GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP 56
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
LV L Y ++ V +Y+ G + +L + + R A + A L
Sbjct: 57 FLVGL-HYSFQTADK---LYFVLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALG 110
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV--GTMGYA 265
YLH II RD K NILLD Q + L+DFGL + EG H T GT Y
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYL 163
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
APE ++ D W G LYE++ G P
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 63/220 (28%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFLGIVEHQNLV 150
+G G +G V + +VA+K+L R + K E+ L ++H+N++
Sbjct: 23 VGSGAYGQVCSAFDTKT-----GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 151 KLVG-YCADDDERGIQRLLVYEYMPNGSVD-------QYLSPKSETILTWAMRLKIAQDA 202
L+ + Q VY D Q LS L + +
Sbjct: 78 GLLDVFTPASSLEDFQD--VYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQI-------- 127
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
RGL Y+H II RD K SNI ++E K+ DFGLAR E T V T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATR 179
Query: 263 GYAAPE-------YVQTGRLAARSDVWSYGVFLYELITGR 295
Y APE Y QT D+WS G + EL+TG+
Sbjct: 180 WYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 13/220 (5%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G+GGFG V +KN+ ++ K+L ++ G K + E L V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS--GEKMALLEKEILEKVNSPFIVNL 58
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
A E LV M G + ++ E L + + G+ +LH
Sbjct: 59 ----AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS- 113
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
I+ RD K N+LLD+Q N +LSD GLA +G T T GT GY APE ++
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMAPEILKE 168
Query: 273 GRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQ 311
+ D ++ G +YE++ GR P D ++++L +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 72/222 (32%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW-----MTEVNFLGIVEH 146
IGEG +G VYK K++ + VA+K++ + KE + E+ L + H
Sbjct: 14 QIGEGTYGQVYKARDKDTGE-----LVALKKVR---LDNEKEGFPITAIREIKILRQLNH 65
Query: 147 QNLVKLVGYCADD----DERGIQR--LLVYEYMPN---GSVDQYLSPKSETILTWAMRLK 197
+N+V L D D + + LV+EYM + G ++ L SE + M+
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK-- 123
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
GL Y H + RD K SNILL+ + KL+DFGLARL SE +
Sbjct: 124 ---QLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 258 VVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYELITGRRPI 298
V+ T+ Y PE + R DVWS G L EL T ++PI
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 41/107 (38%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L LH+ F +I RD K NILLD Q + L DFGL +L + + GT Y
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYL 160
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQ 311
APE + D W+ GV LYE++TG P D N +K+LQ
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFLGIVEHQNL 149
IG G +G V + D +VA+K++ + K + E+ L + H+N+
Sbjct: 7 PIGSGAYGVVCSAV-----DKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 150 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWA-MRLKIAQDAARGLA 207
+ L+ + +V E M D + KS LT ++ + Q RGL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME---TDLHKVIKSPQPLTDDHIQYFLYQ-ILRGLK 117
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAA 266
YLH +I RD K SNIL++ + K+ DFGLAR + P E T V T Y A
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 267 PEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 298
PE + L++ D+WS G EL+T R+P+
Sbjct: 175 PELL----LSSSRYTKAIDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 78/284 (27%), Positives = 125/284 (44%), Gaps = 35/284 (12%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG G FG V G + + P+Q V VK+L VQ +++ E ++H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQ---VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRL--KIAQDAARGLAY 208
+G C + LLV E+ P G + YL S + ++T ++A + A GL +
Sbjct: 60 CLGQCTEV----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268
LH+ I D N LL K+ D+GL+ E + + + + APE
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
Query: 269 YVQT--GRL-----AARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 320
V G L S+VWS GV ++EL G +P R S++++L +
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY---RHLSDEQVLTYTV-----R 224
Query: 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 364
+Q ++ PRL+ L L + V C ++ + RP EV
Sbjct: 225 EQQLKLPKPRLK----LPLSDRWYEVMQFCWLQPEQ-RPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 31/232 (13%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE--- 133
I +L+ +++ VIG G FG V L+++ ++KV A+K L + + +
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKS--TRKV-YAMKLLSKFEMIKRSDSAF 89
Query: 134 WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWA 193
+ E + + +V+L + A D+R + +V EYMP G + +S + WA
Sbjct: 90 FWEERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVNLMS-NYDVPEKWA 144
Query: 194 ----MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249
+ +A DA + ++H RD K N+LLD+ + KL+DFG E
Sbjct: 145 RFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195
Query: 250 GFTHVSTAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRP 297
G TA VGT Y +PE +++ G D WS GVFLYE++ G P
Sbjct: 196 GMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227
L+ +Y+ G + +L + E +R+ IA+ L +LH+ II RD K NI
Sbjct: 82 LILDYVNGGELFTHLY-QREHFTESEVRVYIAE-IVLALDHLHQ---LGIIYRDIKLENI 136
Query: 228 LLDEQWNAKLSDFGLAR--LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS--DVWS 283
LLD + + L+DFGL++ L E + + GT+ Y APE ++ G D WS
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193
Query: 284 YGVFLYELITGRRPIDRNRPRSEQK 308
GV +EL+TG P + ++ Q
Sbjct: 194 LGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G+G FG VYK +++ V A K + + + +++M E++ L +H N+VKL
Sbjct: 13 LGDGAFGKVYK-----AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
+ ++ I + E+ G+VD + + E LT + + L YLHE
Sbjct: 68 LDAFYYENNLWI----LIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
+II RD K+ NIL + KL+DFG++ + + +GT + APE V
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 273 GRLAAR-----SDVWSYGVFLYEL 291
R +DVWS G+ L E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A + A GL +LH II RD K N++LD + + K++DFG+ + G T +
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTF 161
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
GT Y APE + D W++GV LYE++ G+ P D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK-EWMTEVNFLGIVEHQNLVK 151
+GEG + V+KG K +E+ VA+K++ +G + EV+ L ++H N+V
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L D LV+EY+ + + QY+ + +++ + Q RGLAY H
Sbjct: 69 LHDIVHTDK----SLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ-ILRGLAYCHR 122
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE-YV 270
+++ RD K N+L++E+ KL+DFGLAR T+ + V T+ Y P+ +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLL 177
Query: 271 QTGRLAARSDVWSYGVFLYELITGR 295
+ + + D+W G +E+ +GR
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 83/291 (28%), Positives = 122/291 (41%), Gaps = 51/291 (17%)
Query: 93 IGEGGFGCVYKGLIK-NSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFL-GIVEHQNLV 150
IG+G +G V+K L K N + K+ + + +E E N L + +H N+V
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVV 78
Query: 151 KLVG-YCADDDERGIQRLLVYEYMPNGSVDQYL-------SPKSETILTWAMRLKIAQDA 202
K G Y D + G Q LV E GSV + E I+ + I +A
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEA 133
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGT 261
GL +LH + I RD K +NILL + KL DFG+ A+L + VGT
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGT 187
Query: 262 MGYAAPEYVQTGR-----LAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKP 315
+ APE + + AR DVWS G+ EL G P+ P R+ K+ + P
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247
Query: 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
L P L ++ + CL K+ RP +S++L+
Sbjct: 248 TLH---------QPELWS-------NEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 37/216 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMTEVNFLGIVEHQN 148
IGEG +G VYK D +A+K++ GV + E++ L ++H N
Sbjct: 10 IGEGTYGVVYKA-----RDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGN 62
Query: 149 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ----DAA 203
+V+L + +RL LV+EY+ D L ++ +A ++ +
Sbjct: 63 IVRLQDVVHSE-----KRLYLVFEYL-----DLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLAR-LG-PSEGFTHVSTAVVG 260
RG+AY H +++ RD K N+L+D + NA KL+DFGLAR G P FTH V
Sbjct: 113 RGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH----EVV 165
Query: 261 TMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGR 295
T+ Y APE + R + D+WS G E++ +
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A + + GL +LH II RD K N++LD + + K++DFG+ + +G T +
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTF 161
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
GT Y APE + D W+YGV LYE++ G+ P D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A + L +LH +I RD K NILLD + + KL+DFG+ + G G T +T
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTF 156
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
GT Y APE +Q D W+ GV +YE++ G+ P +
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 73/274 (26%), Positives = 115/274 (41%), Gaps = 32/274 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
IGEG G V K++ +VAVK++ R Q + EV + H+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGK-----QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDM 84
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
DE + V E++ G++ ++ T + + R L+YLH
Sbjct: 85 YNSYLVGDELWV----VMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQ 137
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272
+I RD KS +ILL KLSDFG E ++VGT + APE +
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISR 192
Query: 273 GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLE 332
D+WS G+ + E+I G P + +P L ++ R + PR+
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRV- 238
Query: 333 GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
K S ++ S L +L LV+ R E+L+
Sbjct: 239 -KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 76/285 (26%), Positives = 119/285 (41%), Gaps = 39/285 (13%)
Query: 92 VIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNL 149
++G G +G VYKG +K + A+K + G + +E E+N L H+N+
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQ------LAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNI 65
Query: 150 VKLVGYCADDDERGI--QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
G + G+ Q LV E+ GSV + L I ++ RGL+
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYAA 266
+LH+ ++I RD K N+LL E KL DFG+ A+L + G +GT + A
Sbjct: 126 HLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMA 179
Query: 267 PEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
PE + +SD+WS G+ E+ G P+ P L+
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---------- 229
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ PRL+ K + K CLVKN RP ++++
Sbjct: 230 ---RNPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 70/225 (31%), Positives = 112/225 (49%), Gaps = 50/225 (22%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMTEVNFLGIVEHQN 148
IGEG +G VYKG K + ++ VA+K++ GV + E++ L ++H N
Sbjct: 8 IGEGTYGVVYKGRNKKT----GQI-VAMKKIRLESEEEGVPSTA--IREISLLKELQHPN 60
Query: 149 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLS--PKSETILTWAMRLKIAQDAA 203
+V L + RL L++E++ S+D +YL PK + + DA
Sbjct: 61 IVCLQDVLMQES-----RLYLIFEFL---SMDLKKYLDSLPKGQYM-----------DAE 101
Query: 204 RGLAYLH---EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHV 254
+YL+ +G+ F +++ RD K N+L+D + KL+DFGLAR G P +TH
Sbjct: 102 LVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH- 160
Query: 255 STAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPI 298
VV T+ Y APE + R + D+WS G E+ T ++P+
Sbjct: 161 --EVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG-PSEGFTHVSTAVVGTM 262
RGL Y+H ++ RD K SN+LL+ + K+ DFGLAR+ P T T V T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 263 GYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 298
Y APE + + ++ D+WS G L E+++ RP+
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 33/291 (11%)
Query: 86 NFSRSVVIGEGGFGCVYKG--LIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI 143
NF IG G F VY+ L+ +KV++ + ++ + E++ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI----FEMMDAKARQDCVKEIDLLKQ 58
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--PKSETILTWAMRLKIAQD 201
+ H N++K + +D+E I V E G + Q + K + ++ K
Sbjct: 59 LNHPNVIKYLDSFIEDNELNI----VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
+ ++H +++ RD K +N+ + KL D GL R S+ T + ++VGT
Sbjct: 115 LCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGT 169
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
Y +PE + +SD+WS G LYE+ + P ++ S +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LFSLCQ 218
Query: 322 QFRQIVDPRLEGK-YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
+ Q P L + YS KL + ++C+ + RP + V ++ ++
Sbjct: 219 KIEQCDYPPLPTEHYS----EKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 53/157 (33%), Positives = 73/157 (46%), Gaps = 26/157 (16%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
GL LH +I+ RD K NILLD+ + ++SD GLA P EG T VGT+GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP-EGET--IRGRVGTVGY 167
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324
APE V+ R D W G +YE+I G+ P R R E+ VK R
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF---RQRKEK-----VK---------R 210
Query: 325 QIVDPRL---EGKYSLRLVSKLSHVANLCLVKNARTR 358
+ V+ R+ + +YS + + L K+ R
Sbjct: 211 EEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 71/268 (26%), Positives = 115/268 (42%), Gaps = 32/268 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQN 148
+IG GGFG VY G K D + A+K L ++ + QG + E L +V +
Sbjct: 1 IIGRGGFGEVY-GCRK--ADTGKMY--AMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55
Query: 149 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
+V C +L + + M G + +LS + + A A + GL
Sbjct: 56 CPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGLE 111
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
++H ++ RD K +NILLDE + ++SD GLA S+ H S VGT GY AP
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAP 164
Query: 268 EYVQTGRLAARSDVW-SYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326
E +Q G S W S G L++L+ G P +++ + + ++ +
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------DRMTLT 213
Query: 327 VDPRLEGKYSLRLVSKLSHVANLCLVKN 354
+ L +S L S L + + +
Sbjct: 214 MAVELPDSFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
GL +LH+ II RD K N+LLD+ + K++DFG+ + + G ST GT Y
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN-GEGKAST-FCGTPDY 162
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
APE ++ + D WS+GV LYE++ G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 75/294 (25%), Positives = 135/294 (45%), Gaps = 42/294 (14%)
Query: 111 DPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170
DP +KV L + +E++ L +H +VK DD + + LL+
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYAR--SELHCLAACDHFGIVKHF----DDFKSDDKLLLIM 144
Query: 171 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY------LHEGMDFQIIVRDFKS 224
EY G +++ + + + L + Q+ GL + L E +++ RD KS
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPF-------QEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 225 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSY 284
+NI L KL DFG ++ V+++ GT Y APE + R + ++D+WS
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257
Query: 285 GVFLYELITGRRPIDRNRPRSEQKLLQWV-----KPY---LSDAKQFRQIVDPRLEGKYS 336
GV LYEL+T RP + S+++++Q V P+ +S + ++DP L +
Sbjct: 258 GVILYELLTLHRPF---KGPSQREIMQQVLYGKYDPFPCPVSSGMK--ALLDPLLSKNPA 312
Query: 337 LRLVSK-------LSHVANLC--LVKNARTRPKMSEVLEMVNKIVDASAEAGSP 381
LR ++ L +VANL +V+++ T + E++ ++ ++ A P
Sbjct: 313 LRPTTQQLLHTEFLKYVANLFQDIVRHSETISP-HDREEILRQLQESGERAPPP 365
|
Length = 478 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L +LHE II RD K N+LLD + + KL+D+G+ + G G T ++ GT Y
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYI 163
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPID--RNRPRSEQKLLQWVKPYLSDAKQF 323
APE ++ D W+ GV ++E++ GR P D +Q + YL
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN----TEDYLFQVILE 219
Query: 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 358
+QI PR L K S V L K+ + R
Sbjct: 220 KQIRIPR-------SLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 68/210 (32%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVN-FLGIVEHQ 147
VIG+G FG V L K D S AVK L ++ + KE M E N L ++H
Sbjct: 2 VIGKGSFGKVL--LAKRKSDGSF---YAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP 56
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
LV L Y E+ V +Y+ G + + + E A + A +
Sbjct: 57 FLVGL-HYSFQTAEK---LYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIG 110
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
YLH II RD K NILLD Q + L+DFGL + G T ++ GT Y AP
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAP 165
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRP 297
E ++ D W G LYE++ G P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 35/89 (39%), Positives = 50/89 (56%), Gaps = 3/89 (3%)
Query: 216 QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL 275
+I+ RD K NILLD++ + ++SD GLA P EG T VGT+GY APE + +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGET--VRGRVGTVGYMAPEVINNEKY 178
Query: 276 AARSDVWSYGVFLYELITGRRPIDRNRPR 304
D W G +YE+I G+ P + + R
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 19/222 (8%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV 150
+ IGEG G V K+S +VAVK + R Q + EV + +HQN+V
Sbjct: 27 IKIGEGSTGIVCIAREKHSGR-----QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVV 81
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
++ +E + + E++ G++ +S +T L + + + L YLH
Sbjct: 82 EMYKSYLVGEELWV----LMEFLQGGALTDIVS---QTRLNEEQIATVCESVLQALCYLH 134
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYAAPEY 269
+I RD KS +ILL KLSDFG A++ ++VGT + APE
Sbjct: 135 SQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEV 188
Query: 270 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311
+ D+WS G+ + E++ G P + P K L+
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 70/210 (33%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVN-FLGIVEHQ 147
VIG+G FG V L K D AVK L ++ V KE M E N L V+H
Sbjct: 2 VIGKGSFGKVL--LAKRKLDGKC---YAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP 56
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
LV L Y E+ V +++ G + +L + + R A+ A L
Sbjct: 57 FLVGL-HYSFQTTEK---LYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAAE-IASALG 110
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
YLH I+ RD K NILLD Q + L+DFGL + G ++ T +T GT Y AP
Sbjct: 111 YLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAP 165
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRP 297
E ++ D W G LYE++ G P
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 77/261 (29%), Positives = 113/261 (43%), Gaps = 30/261 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE---WMTEVN-FLGIVEHQ 147
VIG+G FG V + +++ AVK L ++ + KE M+E N L V+H
Sbjct: 2 VIGKGSFGKVLL-----ARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 56
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
LV L D + V +Y+ G + +L + L R A + A L
Sbjct: 57 FLVGLHFSFQTAD----KLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALG 110
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST--AVVGTMGYA 265
YLH I+ RD K NILLD Q + L+DFGL + E H T GT Y
Sbjct: 111 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYL 163
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQ---WVKPYLSDAK 321
APE + D W G LYE++ G P RN +L +KP ++++
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA 223
Query: 322 QFRQIVDPRLEGKYSLRLVSK 342
R +++ L+ + RL +K
Sbjct: 224 --RHLLEGLLQKDRTKRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 33/233 (14%)
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---M 135
++K NF R+ +G G FG V KN + P VA+K+ + + K+
Sbjct: 26 KMKYEDFNFIRT--LGTGSFGRVILATYKNEDFPP----VAIKRFEKSKIIKQKQVDHVF 79
Query: 136 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 195
+E L + H V L G D+ LV E++ G +L
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDES----YLYLVLEFVIGGEFFTFLRRNK--------- 126
Query: 196 LKIAQD-----AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 250
+ D AA+ + I+ RD K N+LLD+ K++DFG A++ +
Sbjct: 127 -RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185
Query: 251 FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 303
+T + GT Y APE + +D W+ G+F+YE++ G P N P
Sbjct: 186 YT-----LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
L YLHE II RD K N+LLD + + KL+D+G+ + G G T ++ GT Y
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
APE ++ D W+ GV ++E++ GR P D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L YLH ++ RD K N++LD+ + K++DFGL + G S+G T GT Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
APE ++ D W GV +YE++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A + A GL +LH II RD K N++LD + + K++DFG+ + +G T +
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTF 161
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
GT Y APE + D W++GV LYE++ G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
L +LHE II RD K N+LLD + KL+D+G+ + G G T ++ GT Y
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
APE ++ D W+ GV ++E++ GR P D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 22/244 (9%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV 150
+ IGEG G V +K+S VAVK++ R Q + EV + +H+N+V
Sbjct: 26 IKIGEGSTGIVCIATVKSSGK-----LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 80
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
++ DE + V E++ G++ ++ T + + + L+ LH
Sbjct: 81 EMYNSYLVGDELWV----VMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLH 133
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 270
+I RD KS +ILL KLSDFG E ++VGT + APE +
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELI 188
Query: 271 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ-WVKPYLSDAKQFRQIVDP 329
D+WS G+ + E++ G P P K+++ + P L + + V P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHK----VSP 244
Query: 330 RLEG 333
L+G
Sbjct: 245 SLKG 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 64/288 (22%), Positives = 116/288 (40%), Gaps = 27/288 (9%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE 145
NF IG G F VY+ P +V + L + + + E++ L +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLN 60
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--PKSETILTWAMRLKIAQDAA 203
H N++K +D+E I V E G + + + K + ++ K
Sbjct: 61 HPNVIKYYASFIEDNELNI----VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
L ++H +++ RD K +N+ + KL D GL R S+ T + ++VGT
Sbjct: 117 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPY 171
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323
Y +PE + +SD+WS G LYE+ + P ++ S K+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LYSLCKKI 220
Query: 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
Q P L + +L + N+C+ + RP ++ V ++ ++
Sbjct: 221 EQCDYPPLPSDH---YSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQN 148
+IG GGFG VY A+K L ++ + QG + E L +V +
Sbjct: 1 IIGRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55
Query: 149 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
+V C +L + + M G + +LS + MR A + GL
Sbjct: 56 CPFIV--CMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRF-YATEIILGLE 111
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
++H ++ RD K +NILLDE + ++SD GLA S+ H S VGT GY AP
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAP 164
Query: 268 EYVQTGRLAARSDVW-SYGVFLYELITGRRPIDRNRPRSEQKL 309
E +Q G S W S G L++L+ G P +++ + + ++
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 11/132 (8%)
Query: 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227
V EY+ G + +LS E + + + L YLH G +I+ RD K N+
Sbjct: 72 FVMEYVNGGELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENL 126
Query: 228 LLDEQWNAKLSDFGLARLGPSEGFTHVST--AVVGTMGYAAPEYVQTGRLAARSDVWSYG 285
+LD+ + K++DFGL + EG T +T GT Y APE ++ D W G
Sbjct: 127 MLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 286 VFLYELITGRRP 297
V +YE++ GR P
Sbjct: 183 VVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 36/215 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW-----MTEVNFLGIVEH 146
+GEG + VYKG K + VA+K++ H+E + E + L ++H
Sbjct: 12 KLGEGSYATVYKGRSKLTGQ-----LVALKEIRLE----HEEGAPFTAIREASLLKDLKH 62
Query: 147 QNLVKLVGYCADDDERGIQRLL--VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
N+V L D ++ L V+EY+ + + QY+ + +RL + Q R
Sbjct: 63 ANIVTL------HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ-LLR 114
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG--PSEGFTHVSTAVVGTM 262
GLAY H +++ RD K N+L+ E+ KL+DFGLAR PS+ +++ VV T+
Sbjct: 115 GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---EVV-TL 167
Query: 263 GYAAPEYVQTGRLAARS--DVWSYGVFLYELITGR 295
Y P+ V G + D+W G YE+ TGR
Sbjct: 168 WYRPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 65/229 (28%), Positives = 93/229 (40%), Gaps = 52/229 (22%)
Query: 92 VIGEGGFGCV-----------YKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVN 139
VIG G FG V Y I N + ++ E A + R V G + W+T ++
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 140 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 199
+ A DE + LV +Y G + LS + + R +A
Sbjct: 68 Y----------------AFQDENNL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA 109
Query: 200 Q-----DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG-LARLGPSEGFTH 253
+ D+ L Y+H RD K N+LLD+ + +L+DFG RL T
Sbjct: 110 EMVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TV 158
Query: 254 VSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRP 297
S VGT Y +PE +Q GR D WS GV +YE++ G P
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 34/235 (14%)
Query: 93 IGEGGFGCVYKGLIKNSED-----PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQ 147
+G+G F +YKG+++ D P Q+V V +K LG + + + + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS-LAFFETASLMSQLSHK 61
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
+LVKL G C D + ++V EY+ G +D +L + + ++ +L +A+ A L
Sbjct: 62 HLVKLYGVCVRD-----ENIMVEEYVKFGPLDVFLH-REKNNVSLHWKLDVAKQLASALH 115
Query: 208 YLHEGMDFQIIVRDFKSSNILLDE-------QWNAKLSDFGLAR-LGPSEGFTHVSTAVV 259
YL + +++ + NIL+ KLSD G+ + E V
Sbjct: 116 YLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-------ERV 165
Query: 260 GTMGYAAPEYVQTGRLAARS--DVWSYGVFLYELITGRRPIDRN-RPRSEQKLLQ 311
+ + APE ++ G+ + D WS+G L E I + SE++
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKERFY 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 47/219 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
IGEG +G V+K +N E + ++ VA+K+ K + E+ L ++H NLV
Sbjct: 9 IGEGSYGVVFK--CRNRE--TGQI-VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 151 KLVGYCADDDERGIQRL-LVYEYM-----------PNGSVDQYLSPKSETILTWAMRLKI 198
L+ + R ++L LV+EY P G V ++L K + W
Sbjct: 64 NLI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKK----IIWQT---- 109
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVST 256
+ + + H+ I RD K NIL+ +Q KL DFG AR+ GP + +T
Sbjct: 110 ----LQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--- 159
Query: 257 AVVGTMGYAAPEY-VQTGRLAARSDVWSYGVFLYELITG 294
V T Y APE V + DVW+ G EL+TG
Sbjct: 160 -YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 47/223 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMTEVNFLGIVEHQN 148
IGEG +G V+K KN E VA+K++ GV + E+ L ++H+N
Sbjct: 8 IGEGTYGTVFKA--KNRETHEI---VALKRVRLDDDDEGVPSSA--LREICLLKELKHKN 60
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMP----------NGSVDQYLSPKSETILTWAMRLKI 198
+V+L D + LV+EY NG +D E + ++ +L
Sbjct: 61 IVRLYDVLHSDKKL----TLVFEYCDQDLKKYFDSCNGDIDP------EIVKSFMFQL-- 108
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHVST 256
+GLA+ H ++ RD K N+L+++ KL+DFGLAR G P + +
Sbjct: 109 ----LKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY----S 157
Query: 257 AVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 298
A V T+ Y P+ + +L + S D+WS G EL RP+
Sbjct: 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 53/224 (23%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW----MT---EVNFLGIVE 145
I EG +G VY+ K + + VA+K+L + KE +T E+N L ++
Sbjct: 13 IEEGTYGVVYRARDKKTGEI-----VALKKL-----KMEKEKEGFPITSLREINILLKLQ 62
Query: 146 HQNLVKL----VGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAM 194
H N+V + VG ++ D + +V EY+ + +L + + ++
Sbjct: 63 HPNIVTVKEVVVG--SNLD----KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM---- 112
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFT 252
G+A+LH D I+ RD K+SN+LL+ + K+ DFGLAR P + +T
Sbjct: 113 -----LQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT 164
Query: 253 HVSTAVVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYELITGR 295
+ VV T+ Y APE + + D+WS G EL+T +
Sbjct: 165 QL---VV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 30/237 (12%)
Query: 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--------Q 129
A K K + S V+G G G V + +P AVK + G+ Q
Sbjct: 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEP-----FAVKVVDMEGMSEADKNRAQ 79
Query: 130 GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET 188
+ +F IV+ H++ K + E + LV +Y G + Q + +++T
Sbjct: 80 AEVCCLLNCDFFSIVKCHEDFAK---KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT 136
Query: 189 ILTWAMRLKIAQDAARGLAYL------HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242
T+ + GL ++ H +I RD KS+NILL KL DFG
Sbjct: 137 NRTFR-------EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189
Query: 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
+++ + V GT Y APE + + ++D++S GV LYEL+T +RP D
Sbjct: 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
RGL Y+H ++ RD K SNIL++E + K+ DFGLAR+ + T V T
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRY 170
Query: 264 YAAPEYVQT-GRLAARSDVWSYGVFLYELITGR 295
Y APE + T + D+WS G E++ G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 84/298 (28%), Positives = 120/298 (40%), Gaps = 55/298 (18%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKE 133
TI E+ +N S +G G +G V D + VAVK+L R + + K
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAF-----DTKTGLRVAVKKLSRPFQSIIHAKR 62
Query: 134 WMTEVNFLGIVEHQNLVKL--VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILT 191
E+ L ++H+N++ L V A E LV M D K + +
Sbjct: 63 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTD 119
Query: 192 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 251
++ I Q RGL Y+H II RD K SN+ ++E K+ DFGLAR E
Sbjct: 120 DHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 173
Query: 252 THVSTAVVGTMGYAAPE-------YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 304
T V T Y APE Y QT D+WS G + EL+TGR
Sbjct: 174 ---MTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGRT-------- 216
Query: 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 362
+ P Q + I+ RL G L+ K+S + +++ PKM+
Sbjct: 217 --------LFPGTDHIDQLKLIL--RLVGTPGAELLKKISSESARNYIQSLTQMPKMN 264
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR---LGPSEGFTHVSTAVVGT 261
GL +LH II RD K N++LD + K++DFG+ + G + ++ GT
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-----ASTFCGT 159
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
Y APE +Q + D WS+GV LYE++ G+ P
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 57/195 (29%), Positives = 81/195 (41%), Gaps = 29/195 (14%)
Query: 111 DPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170
Q+ +V VK V G K E++ L + H+ ++ L+ R + V
Sbjct: 115 GDEQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLI-----HAYR--WKSTVC 162
Query: 171 EYMPNGSVDQY-----LSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 224
MP D + P E +T RL A LAYLH II RD K+
Sbjct: 163 MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEA------LAYLHGR---GIIHRDVKT 213
Query: 225 SNILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWS 283
NI LDE NA L DFG A +L T GT+ +PE + A++D+WS
Sbjct: 214 ENIFLDEPENAVLGDFGAACKLDAHP-DTPQCYGWSGTLETNSPELLALDPYCAKTDIWS 272
Query: 284 YGVFLYELITGRRPI 298
G+ L+E+ +
Sbjct: 273 AGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 54/252 (21%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW-----MTEVN 139
+ + IG+G FG V+K K ++ VA+K++ ++ KE + E+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQ-----IVALKKVL---MENEKEGFPITALREIK 63
Query: 140 FLGIVEHQNLVKLVGYC-----ADDDERGIQRLLVYEY--------MPNGSVDQYLSPKS 186
L +++H+N+V L+ C + +G LV+E+ + N +V LS
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKG-SFYLVFEFCEHDLAGLLSNKNVKFTLSEIK 122
Query: 187 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-- 244
+ + + GL Y+H +I+ RD K++NIL+ + KL+DFGLAR
Sbjct: 123 KVM----------KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF 169
Query: 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPID 299
+ T V T+ Y PE + L R D+W G + E+ T R PI
Sbjct: 170 SLSKNSKPNRYTNRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWT-RSPIM 224
Query: 300 RNRPRSEQKLLQ 311
+ +EQ L
Sbjct: 225 QG--NTEQHQLT 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
GL +LH+ +II RD K N+LLD N ++SD GLA + +G + + GT G+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSK-TKGYAGTPGF 163
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311
APE +Q D ++ GV LYE+I R P + E K L+
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 38/94 (40%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
GL YLHE +I+ RD K N+LLD + K++DFGL + G GF ++ GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG--MGFGDRTSTFCGTPEF 167
Query: 265 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 297
APE V T R+ D W GV +YE++ G P
Sbjct: 168 LAPE-VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 14/113 (12%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR---LGPSEGFTHVSTAVVGT 261
GL +LH I+ RD K NILLD + K++DFG+ + LG ++ + GT
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-----TCTFCGT 159
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314
Y APE + + D WS+GV LYE++ G+ P E++L Q ++
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 72/269 (26%), Positives = 109/269 (40%), Gaps = 70/269 (26%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----RRGVQGHKEWMTEVNFLGIVEH 146
VIG G FG V L++ + + + A+K+L + H E + L ++
Sbjct: 8 VIGRGAFGEVR--LVQKKD--TGHI-YAMKKLRKSEMLEKEQVAHVR--AERDILAEADN 60
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----D 201
+VKL Y + DE + L+ EY+P G + L K +T R IA+ D
Sbjct: 61 PWVVKL--YYSFQDENYL--YLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAID 115
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-------------RLGPS 248
+ L Y+H RD K N+LLD + + KLSDFGL L +
Sbjct: 116 SIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 249 EGFTHVST-----------------------AVVGTMGYAAPE-YVQTGRLAARSDVWSY 284
+ + VGT Y APE ++QTG D WS
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSL 225
Query: 285 GVFLYELITGRRPIDRNRPRSE-QKLLQW 312
GV +YE++ G P + P+ +K++ W
Sbjct: 226 GVIMYEMLVGYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 46/142 (32%), Positives = 60/142 (42%), Gaps = 23/142 (16%)
Query: 168 LVYEYMPNGSVDQYLSPKSETILTWAM------RLKIAQDAARGLAYLHEGMDFQIIVRD 221
LV EY P G + L+ + E M L +A + + Y+H RD
Sbjct: 78 LVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH---------RD 127
Query: 222 FKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT------GRL 275
K N+L+D + KL+DFG A + S VGT Y APE + T G
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 276 AARSDVWSYGVFLYELITGRRP 297
D WS GV YE+I GR P
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFLGIVEHQNLV 150
IG G +G V KNSE +VA+K++ K + E+ L ++H+N++
Sbjct: 13 IGRGAYGIVCSA--KNSE---TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVI 67
Query: 151 KLVGYCADDDERGIQR------LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
+ D R +VYE M D + +S L+ R
Sbjct: 68 AI-----KDIMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
GL Y+H ++ RD K SN+LL+ + K+ DFGLAR +G T V T Y
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWY 174
Query: 265 AAPEYV-QTGRLAARSDVWSYGVFLYELITGRRPI 298
APE + DVWS G EL+ GR+P+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 17/212 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFLGIVEHQNL 149
IG G +G V + S +KV A+K++ K + E+ L +H N+
Sbjct: 12 NIGSGAYGVVCSAIDTRS---GKKV--AIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
+ + +V + M S ++ + + +R + Q RGL Y+
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLM--ESDLHHIIHSDQPLTEEHIRYFLYQ-LLRGLKYI 123
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH--VSTAVVGTMGYAAP 267
H +I RD K SN+L++E ++ DFG+AR S H T V T Y AP
Sbjct: 124 HSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 268 EYVQT-GRLAARSDVWSYGVFLYELITGRRPI 298
E + + D+WS G E++ GRR +
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 67/236 (28%), Positives = 98/236 (41%), Gaps = 52/236 (22%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSE-----------DPSQKVEVAVKQLGRRG-VQGHK 132
++F VIG G FG V +KN++ + ++ E A + R V G
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 133 EWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTW 192
+W+T ++ Y D+ LV +Y G + LS K E L
Sbjct: 61 QWITTLH---------------YAFQDEN---NLYLVMDYYVGGDLLTLLS-KFEDRLPE 101
Query: 193 AM------RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246
M + IA D+ L Y+H RD K NIL+D + +L+DFG + L
Sbjct: 102 DMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLK 151
Query: 247 PSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRP 297
E T S+ VGT Y +PE +Q G+ D WS GV +YE++ G P
Sbjct: 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVN 139
+S K++ +IG G FG VY+ + I SE +VA+K++ + ++E + N
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSE------KVAIKKVLQDPQYKNRELLIMKN 115
Query: 140 FLGIVEHQNLVKLVGY----CADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETILTW 192
+ H N++ L Y C +E+ I +V E++P +V +Y+ + + + +
Sbjct: 116 ----LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLF 170
Query: 193 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLAR--LGPSE 249
++L Q R LAY+H I RD K N+L+D + KL DFG A+ L
Sbjct: 171 LVKLYSYQ-LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226
Query: 250 GFTHVSTAVVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYELITG 294
+++ + Y APE + D+WS G + E+I G
Sbjct: 227 SVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
L YLH + ++ RD K N++LD+ + K++DFGL + G +G T GT Y
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 162
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
APE ++ D W GV +YE++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 7/130 (5%)
Query: 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227
V EY G + +LS E + T + L YLH ++ RD K N+
Sbjct: 72 FVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENL 126
Query: 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 287
+LD+ + K++DFGL + G S+G T GT Y APE ++ D W GV
Sbjct: 127 MLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 184
Query: 288 LYELITGRRP 297
+YE++ GR P
Sbjct: 185 MYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 66/231 (28%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH---K 132
TI E+ ++ + +G G +G V L D +VA+K+L R Q K
Sbjct: 9 TIWEVPDRYRDLKQ---VGSGAYGTVCSAL-----DRRTGAKVAIKKL-YRPFQSELFAK 59
Query: 133 EWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILT 191
E+ L ++H+N++ L+ + D Y MP D K E +
Sbjct: 60 RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF--YLVMPFMGTDLGKLMKHEKLSE 117
Query: 192 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 251
++ + Q +GL Y+H II RD K N+ ++E K+ DFGLAR SE
Sbjct: 118 DRIQFLVYQ-MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-- 171
Query: 252 THVSTAVVGTMGYAAPE-------YVQTGRLAARSDVWSYGVFLYELITGR 295
T V T Y APE Y QT D+WS G + E++TG+
Sbjct: 172 ---MTGYVVTRWYRAPEVILNWMHYTQT------VDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 46/140 (32%), Positives = 63/140 (45%), Gaps = 18/140 (12%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
L +LH+ II RD K NILLD + L+DFGL++ E + + GT+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEY 172
Query: 265 AAPEYVQTGRLAARS--DVWSYGVFLYELITGRRP------------IDRNRPRSEQKLL 310
AP+ V+ G D WS GV +YEL+TG P I R +SE
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 232
Query: 311 QWVKPYLSDAKQFRQIVDPR 330
Q + D Q + DP+
Sbjct: 233 QEMSALAKDIIQRLLMKDPK 252
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 99 GCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL---VGY 155
GC GL+ ++ D VAVK++ Q K + E+ + ++H N+VK+ +G
Sbjct: 14 GCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGP 73
Query: 156 CADDDERGIQRL-------LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
D + L +V EYM D + + RL + Q RGL Y
Sbjct: 74 SGSDLTEDVGSLTELNSVYIVQEYM---ETDLANVLEQGPLSEEHARLFMYQ-LLRGLKY 129
Query: 209 LHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTH---VSTAVVGTMGY 264
+H ++ RD K +N+ ++ E K+ DFGLAR+ ++H +S +V T Y
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH-YSHKGYLSEGLV-TKWY 184
Query: 265 AAPEYVQTGRLAARS-DVWSYGVFLYELITGR 295
+P + + ++ D+W+ G E++TG+
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 146 HQNLVKLVGYCADDDERGIQRLL-VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
H N+V L+ D E L V+EY+P ++ + L+ ++ L ++
Sbjct: 37 HPNIVALL----DSGEAPPGLLFAVFEYVPGRTLREVLA--ADGALPAGETGRLMLQVLD 90
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHVSTA---- 257
LA H + I+ RD K NI++ + +AK+ DFG+ L P V+T
Sbjct: 91 ALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 258 -VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 296
V+GT Y APE ++ + SD++++G+ E +TG+R
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS---TAVVG 260
GL Y+H ++ RD K N+L++ K+ DFGLAR G SE + T V
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVA 171
Query: 261 TMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 298
T Y APE + + + ++ DVWS G L EL+ GR+P+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 63/287 (21%), Positives = 121/287 (42%), Gaps = 49/287 (17%)
Query: 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM----TEVNFLGIVE 145
SV+I E +YKG+ N E V ++ + +GHK + E+ L ++
Sbjct: 25 SVLIKENDQNSIYKGIFNNKE-------VIIRTFKKFH-KGHKVLIDITENEIKNLRRID 76
Query: 146 HQNLVKLVGY---CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA 202
N++K+ G+ DD R L+ EY G + + L E L++ +L +A D
Sbjct: 77 SNNILKIYGFIIDIVDDLPRLS---LILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDC 131
Query: 203 ARGLAYLHE--GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 260
+GL L++ ++ + S + L+ E + K+ GL ++ S F +V+
Sbjct: 132 CKGLYNLYKYTNKPYKNL----TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF---- 183
Query: 261 TMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318
M Y + + + + D++S GV L+E+ TG+ P + L+
Sbjct: 184 -MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN----------------LT 226
Query: 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
+ + I++ K L ++ + C ++ RP + E+L
Sbjct: 227 TKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH---KEWMTEVNFL 141
+ ++ +G G +G V + K + + +VA+K+L R Q K E+ L
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGE-----KVAIKKL-SRPFQSEIFAKRAYRELTLL 68
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQ 200
++H+N++ G+ + + D YL P +T L M +++
Sbjct: 69 KHMQHENVI------------GLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSE 116
Query: 201 DAAR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 252
D + GL Y+H II RD K N+ ++E K+ DFGLAR +E
Sbjct: 117 DKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 170
Query: 253 HVSTAVVGTMGYAAPE-------YVQTGRLAARSDVWSYGVFLYELITGR 295
T V T Y APE Y QT D+WS G + E++TG+
Sbjct: 171 --MTGYVVTRWYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 65/236 (27%), Positives = 101/236 (42%), Gaps = 34/236 (14%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHK---EWMTEVNFL 141
NF V+G G +G V+ L++ A+K L + VQ K TE N L
Sbjct: 1 NFELLKVLGTGAYGKVF--LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
V + + Y + + L+ +Y+ G + +L R ++D
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAK---LHLILDYVSGGEMFTHLY----------QRDNFSED 105
Query: 202 AAR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 253
R L +LH+ I+ RD K NILLD + + L+DFGL++ SE
Sbjct: 106 EVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KE 161
Query: 254 VSTAVVGTMGYAAPEYV--QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307
+ + GT+ Y APE + + G A D WS G+ ++EL+TG P R+ Q
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQ 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 93 IGEGGFGCVYKGLIKNS---EDPSQKV--EVAVKQLG-RRGVQGHKEWMTEVNFLGIVEH 146
+G+G FG VY L+K+ + KV E+ V +L VQ ++E L ++H
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDH 61
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET--------ILTWAMRLKI 198
+VK + D I + EY +D L T + W ++L +
Sbjct: 62 PAIVKFHASFLERDAFCI----ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
G+ Y+H+ +I+ RD K+ NI L K+ DFG++RL G ++T
Sbjct: 118 ------GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTF 165
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYEL 291
GT Y +PE ++ ++SD+WS G LYE+
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQ--KVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV 150
+G+G F ++KG+ + D + K EV +K L + + + + + + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI-LTWAMRLKIAQDAARGLAYL 209
G C DE ++V EY+ GS+D YL I ++W +L++A+ A L +L
Sbjct: 63 LNYGVCVCGDES----IMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFL 116
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG-PSEGFTHVSTAV-VGTMGYAAP 267
D + + + N+LL + + K + +L P T + + + + + P
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPP 173
Query: 268 EYVQTGR-LAARSDVWSYGVFLYELITG 294
E ++ + L+ +D WS+G L+E+ +G
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 35/94 (37%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
RGL YLH I+ RD K N+L++ K+ DFGLAR+ + H++ VV T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 264 YAAPEYVQTG--RLAARSDVWSYGVFLYELITGR 295
Y APE + G + D+WS G EL+ R
Sbjct: 170 YRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 97/384 (25%), Positives = 155/384 (40%), Gaps = 71/384 (18%)
Query: 64 SMSQRPSNLKEFTIAELK-SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ 122
S S+R +N I + + K + IG G +G++ + D + VA+K+
Sbjct: 2 SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGA-----QGIVCAAYDAILERNVAIKK 56
Query: 123 LGRR-GVQGH-KEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRLLVYEYMPNGSVD 179
L R Q H K E+ + V H+N++ L+ + Q + + + + ++
Sbjct: 57 LSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116
Query: 180 QY----LSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 235
Q L + + L + M G+ +LH II RD K SNI++
Sbjct: 117 QVIQMELDHERMSYLLYQMLC--------GIKHLHSA---GIIHRDLKPSNIVVKSDCTL 165
Query: 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-- 293
K+ DFGLAR + G + + T V T Y APE + D+WS G + E+I
Sbjct: 166 KILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
Query: 294 ----GRRPIDRNRPRSEQ----------KLLQWVKPYLSD---------AKQFRQIVDP- 329
G ID+ EQ KL V+ Y+ + K F ++ P
Sbjct: 223 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA 282
Query: 330 -----RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE--MVNKIVDAS-AEAGSP 381
+L+ + L+SK+ LV +A R + E L+ +N D S AEA P
Sbjct: 283 DSEHNKLKASQARDLLSKM-------LVIDASKRISVDEALQHPYINVWYDPSEAEAPPP 335
Query: 382 RRPLRSSTSRETPDHTKTKHKRRI 405
+ P + RE HT + K I
Sbjct: 336 KIPDKQLDERE---HTIEEWKELI 356
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 62/228 (27%), Positives = 93/228 (40%), Gaps = 50/228 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSE-----------DPSQKVEVAVKQLGRRG-VQGHKEWMTEVN 139
VIG G FG V +K++E + ++ E A + R V G +W+T ++
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 140 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 199
+ A DE + LV +Y G + LS + + R IA
Sbjct: 68 Y----------------AFQDENYL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA 109
Query: 200 Q-----DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
+ + L Y+H RD K N+LLD + +L+DFG +G
Sbjct: 110 EMVLAIHSIHQLHYVH---------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160
Query: 255 STAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRP 297
S A VGT Y +PE +Q G+ D WS GV +YE++ G P
Sbjct: 161 SVA-VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG G FG V I D V VK+L + E++ + + I++H N+++
Sbjct: 3 IGNGWFGKVLLSEIYT--DTG-VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLKIAQDAARG 205
+G C + I LLV+EY G + YLS + S+ +L M +IA G
Sbjct: 60 CLGQCVE----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA----G 111
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
+ ++H+ + D N L K+ D+G+ E + + +
Sbjct: 112 VTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 266 APEYV---QTGRLAAR----SDVWSYGVFLYEL 291
APE V G + A S+VW+ GV L+EL
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 32/203 (15%)
Query: 112 PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYE 171
P Q V +K +G++G + E L V H +++++ D G +V
Sbjct: 88 PGQPDPVVLK-IGQKGTT-----LIEAMLLQNVNHPSVIRM----KDTLVSGAITCMV-- 135
Query: 172 YMPNGSVDQYLSPKSETILTWAMR-------LKIAQDAARGLAYLHEGMDFQIIVRDFKS 224
+P+ S D Y T LT R L I + GL YLH +II RD K+
Sbjct: 136 -LPHYSSDLY------TYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKT 185
Query: 225 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSY 284
NI +++ + D G A+ + GT+ APE + + +++D+WS
Sbjct: 186 ENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSA 242
Query: 285 GVFLYELITGRRPIDRNRPRSEQ 307
G+ L+E++ I + P + +
Sbjct: 243 GIVLFEMLAYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+GEG + VYKG+ S Q V + V + GV + E + L ++H N+V
Sbjct: 13 LGEGSYATVYKGI---SRINGQLVALKVISMKTEEGVPFTA--IREASLLKGLKHANIVL 67
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L D V+EYM + + QY+ + + +RL + Q RGLAY+H
Sbjct: 68 L----HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIHG 121
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG--PSEGFTHVSTAVVGTMGYAAPEY 269
I+ RD K N+L+ KL+DFGLAR PS+ + S+ VV T+ Y P+
Sbjct: 122 Q---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY---SSEVV-TLWYRPPDV 174
Query: 270 VQ-TGRLAARSDVWSYGVFLYELITGR 295
+ ++ D+W G E++ G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 53/185 (28%), Positives = 79/185 (42%), Gaps = 51/185 (27%)
Query: 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----DAARGLAYLHEGMDFQIIVRDF 222
L+ E++P G + L K +T+ A + IA+ DA L ++H RD
Sbjct: 78 LIMEFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLGFIH---------RDI 127
Query: 223 KSSNILLDEQWNAKLSDFGLA-------RLGPSEGFTH---------------------- 253
K N+LLD + + KLSDFGL R TH
Sbjct: 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187
Query: 254 ----VSTAVVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR-SEQ 307
++ + VGT Y APE ++QTG D WS GV +YE++ G P P+ + +
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR 246
Query: 308 KLLQW 312
K++ W
Sbjct: 247 KVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----QGHKEWMTEVNFLGIVEHQ 147
+I G +G VY L+++ E + A+K++ ++ + Q + ++ E + L E+
Sbjct: 8 LISNGAYGAVY--LVRHKE---TRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENP 61
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAM-RLKIAQDAARGL 206
+V + +C+ + +R + +V EY+ G L K+ L M R+ A+ L
Sbjct: 62 FVVSM--FCSFETKRHL--CMVMEYVEGGDCATLL--KNIGALPVDMARMYFAE-TVLAL 114
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG-------PSEGFTHVST--- 256
YLH ++ I+ RD K N+L+ + KL+DFGL+++G EG T
Sbjct: 115 EYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 257 ---AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
V GT Y APE + D W+ G+ LYE + G P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 42/218 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFLGIVEHQNLV 150
+G G +G V ++ D + +VAVK+L R + + + E+ L ++H+N++
Sbjct: 23 VGSGAYGSV-----CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI 77
Query: 151 KL--VGYCADDDERGIQRLLVYEYMP---NGSVD-QYLSPKSETILTWAMRLKIAQDAAR 204
L V A E + LV M N V Q LS + L + + R
Sbjct: 78 GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL--------LR 129
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
GL Y+H II RD K SN+ ++E ++ DFGLAR E T V T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWY 181
Query: 265 AAPE-------YVQTGRLAARSDVWSYGVFLYELITGR 295
APE Y QT D+WS G + EL+ G+
Sbjct: 182 RAPEIMLNWMHYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 44/231 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMTEV--NFLGI--- 143
+GEG +G V K + D VA+K++ V ++ + +F +
Sbjct: 17 LGEGTYGKVEK-----AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 144 -----VEHQNLVKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 197
++H+N++ LV Y D I LV + M + + + K LT +
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGD---FIN--LVMDIM-ASDLKKVVDRK--IRLTESQVKC 123
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVS- 255
I GL LH+ + + RD +NI ++ + K++DFGLAR G +S
Sbjct: 124 ILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 256 ----------TAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGR 295
T+ V T+ Y APE + + D+WS G EL+TG+
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
V+G+G +G V L+++ D Q V +K+L R + K E L ++H N+
Sbjct: 7 VVGKGSYGEV--SLVRHRTDGKQYV---IKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
V +D +V + G + L + +L ++ A L YL
Sbjct: 62 VAYRESWEGEDG---LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
HE I+ RD K+ N+ L K+ D G+AR+ E +++ ++GT Y +PE
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPEL 173
Query: 270 VQTGRLAARSDVWSYGVFLYELIT 293
+SDVW+ G +YE+ T
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS-TAVVGTM 262
R L Y+H F RD K NIL + K+ DFGLAR+ ++ T + T V T
Sbjct: 114 RALKYIHTANVFH---RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 263 GYAAPEYVQT--GRLAARSDVWSYGVFLYELITGR 295
Y APE + + D+WS G E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 46/153 (30%), Positives = 67/153 (43%), Gaps = 24/153 (15%)
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGS----VDQYLSPKSETILTWAMRLKIAQDAA 203
N+V L Y +D LV ++ G + ++L+ E + WA + +A DA
Sbjct: 46 NMVCLHKYIVSED----SVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA- 100
Query: 204 RGLAYLH-EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
LH EG I+ RD +NILLD++ + +L+ F SE V M
Sbjct: 101 -----LHREG----IVCRDLNPNNILLDDRGHIQLTYFSRW----SEVEDSCDGEAVENM 147
Query: 263 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 295
Y APE D WS G L+EL+TG+
Sbjct: 148 -YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 48/285 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
IG G +G VYK N+ + + A+K + + E+ + +H N+V
Sbjct: 17 IGSGTYGDVYKARNVNTGELA-----AIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSV-DQY--LSPKSETILTWAMRLKIAQDAARGLAYL 209
G D+ I E+ GS+ D Y P SE+ + + ++++ +GL YL
Sbjct: 72 FGSYLRRDKLWIC----MEFCGGGSLQDIYHVTGPLSESQIAY-----VSRETLQGLYYL 122
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-----ARLGPSEGFTHVSTAVVGTMGY 264
H RD K +NILL + + KL+DFG+ A + + F +GT +
Sbjct: 123 HSKGKMH---RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF-------IGTPYW 172
Query: 265 AAPEYVQTGRLAARS---DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
APE R + D+W+ G+ EL + P+ P +L
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLMTKS 224
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
F+ P+L+ K ++ + H + L KN + RP ++L+
Sbjct: 225 NFQP---PKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 53/186 (28%)
Query: 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----DAARGLAYLHEGMDFQIIVRDF 222
L+ E++P G + L K +T+ + IA+ D+ L ++H RD
Sbjct: 78 LIMEFLPGGDMMTLLM-KKDTLTEEETQFYIAETVLAIDSIHQLGFIH---------RDI 127
Query: 223 KSSNILLDEQWNAKLSDFGLA----------------RLGPSEGFT-------------- 252
K N+LLD + + KLSDFGL PS+ FT
Sbjct: 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD-FTFQNMNSKRKAETWK 186
Query: 253 ----HVSTAVVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR-SE 306
++ + VGT Y APE ++QTG D WS GV +YE++ G P P+ +
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 307 QKLLQW 312
+K++ W
Sbjct: 246 KKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGH-KEWMTEVNFLG 142
K + + IG G +G++ + D + VAVK+L R Q H K E+ L
Sbjct: 21 KRYQQLKPIGSGA-----QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 75
Query: 143 IVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNG---SVDQYLSPKSETILTWAMRLK 197
V H+N++ L+ + Q + LV E M + L + + L + M
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC- 134
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
G+ +LH II RD K SNI++ K+ DFGLAR + + T
Sbjct: 135 -------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTP 181
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG 294
V T Y APE + D+WS G + EL+ G
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 36/121 (29%), Positives = 47/121 (38%), Gaps = 32/121 (26%)
Query: 205 GLAYLH-EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV--------- 254
L YLH G I+ RD K NILL E + LSDF L++ E
Sbjct: 115 ALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 255 ------------------STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 296
S + VGT Y APE + + D W+ G+ LYE++ G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 297 P 297
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 39/219 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDP-------SQKVEVAVKQLGRRGVQGHKE----WMTEVNFL 141
+G G +Y G++ +D ++++V +K L H++ + + +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLD----PSHRDISLAFFETASMM 58
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
V H+++V L G C R ++ ++V E++ G +D ++ KS+ +LT + K+A+
Sbjct: 59 RQVSHKHIVLLYGVCV----RDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQ 113
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILL-----DEQWNA--KLSDFGLARLGPSEGFTHV 254
A L+YL D ++ + + NILL D + KLSD G+ T +
Sbjct: 114 LASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-------ITVL 163
Query: 255 S-TAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYEL 291
S V + + APE V+ + L+ +D WS+G L+E+
Sbjct: 164 SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L +LH+ + I+ RD K NILLD + L DFGL++ ++ T + GT Y
Sbjct: 109 LEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 266 APE-YVQTGRLAARSDVWSYGVFLYELITGRRP 297
APE + D WS GV ++E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT------EVNFLGIVEH 146
+GEG + VYKG K +V K + + ++ +E T E + L ++H
Sbjct: 13 LGEGSYATVYKG----------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
N+V L D LV+EY+ + + QY+ + ++L + Q RGL
Sbjct: 63 ANIVLL----HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ-LLRGL 116
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
+Y+H+ I+ RD K N+L+ + KL+DFGLAR T+ + V T+ Y
Sbjct: 117 SYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRP 171
Query: 267 PE-YVQTGRLAARSDVWSYGVFLYELITG 294
P+ + + + D+W G E+I G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 50/195 (25%), Positives = 77/195 (39%), Gaps = 65/195 (33%)
Query: 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKI-AQDAAR--------GLAYLHEGMDFQIIV 219
V +Y+P G +++ +RL I +D AR + +H+ M F I
Sbjct: 79 VMDYIPGGD-----------MMSLLIRLGIFEEDLARFYIAELTCAIESVHK-MGF--IH 124
Query: 220 RDFKSSNILLDEQWNAKLSDFGLA---------------------RLGPSEGFTHVSTA- 257
RD K NIL+D + KL+DFGL + PSE ++ +
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 258 -------------------VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298
+VGT Y APE + D WS GV LYE++ G+ P
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
Query: 299 DRNRP-RSEQKLLQW 312
+ P ++ K++ W
Sbjct: 245 LADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE----WMTEVNFLGIVEHQ 147
V+GEG +G V K K +++ VA+K+ + + ++E + E+ L ++ +
Sbjct: 8 VVGEGAYGVVLKCRHKETKEI-----VAIKKF--KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
N+V+L + R + LV+EY V++ + E + K+ + +
Sbjct: 61 NIVEL----KEAFRRRGKLYLVFEY-----VEKNMLELLEEMPNGVPPEKVRSYIYQLIK 111
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
+H I+ RD K N+L+ KL DFG AR SEG T V T Y +P
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANYTEYVATRWYRSP 170
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGR 295
E + D+WS G L EL G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 7/126 (5%)
Query: 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229
Y+ + V LS LT L ARG+ +L + RD + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270
Query: 230 DEQWNAKLSDFGLAR--LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 287
+ K+ DFGLAR + S + ST + + + APE + SDVWSYG+
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 288 LYELIT 293
L+E+ +
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G +G VYK K+ +D E A+KQ+ G+ E+ L ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEK---EYALKQIEGTGIS--MSACREIALLRELKHPNVIAL 63
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQY----LSPKSETILTWAMRLKIAQDAARGLAY 208
+R + L Y + ++ + K L +M + G+ Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 209 LHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTM 262
LH ++ RD K +NIL+ E+ K++D G ARL P + + VV T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179
Query: 263 GYAAPEYVQTGRLAARS-DVWSYGVFLYELIT 293
Y APE + R ++ D+W+ G EL+T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 4/100 (4%)
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
L I + R + YLHE +II RD K+ NI ++ + L DFG A P + +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKY 240
Query: 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 295
GT+ APE + D+WS G+ L+E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 69/262 (26%), Positives = 108/262 (41%), Gaps = 42/262 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGH-KEWMTEVNFLGIVEHQNLV 150
IG G +G++ + D VA+K+L R Q H K E+ + V H+N++
Sbjct: 25 IGSGA-----QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 151 KLVGYCADDD--ERGIQRLLVYEYMPNG---SVDQYLSPKSETILTWAMRLKIAQDAARG 205
L+ E LV E M + L + + L + M G
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC--------G 131
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
+ +LH II RD K SNI++ K+ DFGLAR + G + + T V T Y
Sbjct: 132 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELI------TGRRPIDR-NR---------PRSEQKL 309
APE + D+WS G + E++ GR ID+ N+ P +KL
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 310 LQWVKPYLSDAKQFRQIVDPRL 331
V+ Y+ + ++ + P+L
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 33/91 (36%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
G+ +LH II RD K SNI++ K+ DFGLAR + G + + T V T Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 183
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGR 295
APE + D+WS G + E+I G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 25/238 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G +G VYK K+ +D + A+KQ+ G+ E+ L ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDR---DYALKQIEGTGIS--MSACREIALLRELKHPNVISL 63
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQY----LSPKSETILTWAMRLKIAQDAARGLAY 208
+R + L Y + ++ + K L M + G+ Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 209 LHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTM 262
LH ++ RD K +NIL+ E+ K++D G ARL P + + VV T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179
Query: 263 GYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319
Y APE + R ++ D+W+ G EL+T PI R Q+ ++ PY D
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR----QEDIKTSNPYHHD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 52/223 (23%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVK----QLGRRGVQGHKEWMTEVNFL 141
+ + IGEG +G VYK + D + VA+K ++ G+ + E++ L
Sbjct: 2 AYEKLEKIGEGTYGKVYK-----ARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLL 54
Query: 142 GIVEHQN-LVKLVGYCADDDERG-IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 199
++ +V+L+ +++ G LV+EY+ + + +++ + K
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGR-PLPAKTI 112
Query: 200 QD----AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLARLG--PSEGFT 252
+ +G+A+ H+ ++ RD K N+L+D+Q K++D GL R P + +T
Sbjct: 113 KSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITG 294
H +V T+ Y APE + + D+WS G E+
Sbjct: 170 H---EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 34/97 (35%), Positives = 45/97 (46%), Gaps = 15/97 (15%)
Query: 211 EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG-----T 261
+GM F I RD + NILL K+ DFGLAR + S VV
Sbjct: 225 KGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNARLP 279
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + APE + SDVWSYG+ L+E+ + G P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 13/140 (9%)
Query: 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ------DAARGLAYLHEGMD 214
E G +L + P+ S +P ET W L + ARG+ +L
Sbjct: 138 EAGQASVLFSRFQPSTS--GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---AS 192
Query: 215 FQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTG 273
+ I RD + NILL E K+ DFGLAR + + +A + + + APE +
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-PLKWMAPESIFDK 251
Query: 274 RLAARSDVWSYGVFLYELIT 293
+SDVWS+GV L+E+ +
Sbjct: 252 VYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 15/97 (15%)
Query: 211 EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG-----T 261
+GMDF I RD + N+LL + AK+ DFGLAR + S VV
Sbjct: 223 QGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKGNARLP 277
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + APE + +SDVWSYG+ L+E+ + G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 5/116 (4%)
Query: 179 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238
D+ + LT + + ARG+ +L + I RD + NILL E K+
Sbjct: 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKIC 215
Query: 239 DFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
DFGLAR + + A + + + APE + +SDVWS+GV L+E+ +
Sbjct: 216 DFGLARDIYKDPDYVRKGDARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 29/201 (14%)
Query: 171 EYMPNGSV-DQY--LSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227
EY GS+ D Y P SE + + R + +GLAYLH RD K +NI
Sbjct: 86 EYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGKMH---RDIKGANI 137
Query: 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV---QTGRLAARSDVWSY 284
LL + + KL+DFG+A + +GT + APE + G D+W+
Sbjct: 138 LLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195
Query: 285 GVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLS 344
G+ EL + P+ P +L F+ P+L+ K + S
Sbjct: 196 GITAIELAELQPPMFDLHPMRAL--------FLMSKSNFQP---PKLKDK--TKWSSTFH 242
Query: 345 HVANLCLVKNARTRPKMSEVL 365
+ + L KN + RP +L
Sbjct: 243 NFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 3e-06
Identities = 42/139 (30%), Positives = 63/139 (45%), Gaps = 18/139 (12%)
Query: 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226
+L+ +Y+ +G + L K E L+ A KI + L LH+ II D K N
Sbjct: 85 VLIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLEN 139
Query: 227 ILLDE-QWNAKLSDFGLARLGPSEGFTHVSTAVV--GTMGYAAPEYVQTGRLAARS-DVW 282
+L D + L D+GL + + T GT+ Y +PE + G S D W
Sbjct: 140 VLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYFSPEKI-KGHNYDVSFDWW 190
Query: 283 SYGVFLYELITGRRPIDRN 301
+ GV YEL+TG+ P +
Sbjct: 191 AVGVLTYELLTGKHPFKED 209
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 41/146 (28%), Positives = 56/146 (38%), Gaps = 48/146 (32%)
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLA----------------------------- 243
M F I RD K NIL+D + KL+DFGL
Sbjct: 120 MGF--IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 244 ----------RLGPSE---GFTH---VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 287
RL P E H ++ ++VGT Y APE + D WS GV
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 288 LYELITGRRPIDRNRP-RSEQKLLQW 312
LYE++ G+ P P ++ K++ W
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 33/126 (26%), Positives = 54/126 (42%), Gaps = 18/126 (14%)
Query: 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 228
+YE + + L K + ++ +L + L ++H F RD K NIL
Sbjct: 86 LYELIKGRK--RPLPEK--RVKSYMYQL------LKSLDHMHRNGIFH---RDIKPENIL 132
Query: 229 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVF 287
+ KL+DFG R S T + T Y APE + T G + D+W+ G
Sbjct: 133 IK-DDILKLADFGSCRGIYS---KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCV 188
Query: 288 LYELIT 293
+E+++
Sbjct: 189 FFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 64/249 (25%), Positives = 110/249 (44%), Gaps = 65/249 (26%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK--EWMTEVNFLGIVEHQNLV 150
IG G FG V+ L+K+ +Q+ K + RG++ + + + EVN + ++H+N+V
Sbjct: 21 IGNGRFGEVF--LVKHKR--TQEF-FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 151 K---------------LVGYC-ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAM 194
+ L+ +C A D R IQ+ Y G ++++
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC----YKMFGKIEEHAI----------- 120
Query: 195 RLKIAQDAARGLAYLHEGMDF----QIIVRDFKSSNILLDE----------QWN------ 234
+ I + LAY H D +++ RD K NI L Q N
Sbjct: 121 -VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 235 -AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV--QTGRLAARSDVWSYGVFLYEL 291
AK+ DFGL++ + G ++ + VGT Y +PE + +T +SD+W+ G +YEL
Sbjct: 180 IAKIGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 292 ITGRRPIDR 300
+G+ P +
Sbjct: 237 CSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 45/176 (25%), Positives = 76/176 (43%), Gaps = 33/176 (18%)
Query: 211 EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYA 265
+GM+F + I RD + NILL E K+ DFGLAR + + A + + +
Sbjct: 190 KGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWM 248
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP-----IDRNRPRSEQKLLQWVKPYLSD 319
APE + +SDVWS+GV L+E+ + G P ID R ++ + P +
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 308
Query: 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375
+ ++ ++D C RP SE++E + ++ A+
Sbjct: 309 PEMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 205 GLAY-LHEGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLAR--LGPSEGFTHVSTA 257
G +Y + GM+F + RD + N+L+ E K+ DFGLAR + S + ST
Sbjct: 243 GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
+ + + APE + SDVWS+G+ L+E+ T
Sbjct: 303 L--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 61/247 (24%), Positives = 93/247 (37%), Gaps = 54/247 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG----HKEWMTEVNFLGIVEHQN 148
IG+GG G VY DP VA+K++ R + K ++ E + H
Sbjct: 10 IGKGGMGEVYLA-----YDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMP--NG--------SVDQYLSPKSE-----TILTWA 193
+V + C+D D VY MP G SV Q S E ++ +
Sbjct: 64 IVPVYSICSDGD-------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF- 115
Query: 194 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-------QWNAKLS-----DFG 241
L I + Y+H ++ RD K NILL W A + +
Sbjct: 116 --LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 242 LARLGPSEGFTHVSTA----VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
L + S +VGT Y APE + + +D+++ GV LY+++T P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
Query: 298 IDRNRPR 304
R + R
Sbjct: 231 YRRKKGR 237
|
Length = 932 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 40/163 (24%), Positives = 61/163 (37%), Gaps = 55/163 (33%)
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA------------ 243
L +A ++ + ++H RD K NIL+D + KL+DFGL
Sbjct: 110 LTLAIESVHKMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160
Query: 244 ---------RLGPSEGFTHVST------------------------AVVGTMGYAAPEYV 270
+ PS+ + VS ++VGT Y APE +
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220
Query: 271 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQW 312
D WS GV L+E++ G+ P P Q K++ W
Sbjct: 221 LRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 49/231 (21%), Positives = 77/231 (33%), Gaps = 46/231 (19%)
Query: 168 LVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 222
+V M GS + L E + + ++ D L Y+H F I R
Sbjct: 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHS-KGF--IHRSV 127
Query: 223 KSSNILLDEQWNAKLSDFGLARLGPSEGFTH-------VSTAVVGTMGYAAPEYVQTGRL 275
K+S+ILL LS + G S+ + + +PE +Q
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN--LPWLSPEVLQQNLQ 185
Query: 276 A--ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------------PYLSDA 320
+SD++S G+ EL G P Q LL+ V+ Y
Sbjct: 186 GYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPLYEDSM 243
Query: 321 KQFRQ------IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
Q R D + Y+ LCL ++ +RP S++L
Sbjct: 244 SQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 15/149 (10%)
Query: 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 228
+Y +M + + D P L R I + + Y+H D ++I RD K NI
Sbjct: 249 LYSFMYDEAFDWKDRP-----LLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIF 299
Query: 229 LDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGV 286
L+ L DFG A E F + VGT+ +PE + +D+WS G+
Sbjct: 300 LNCDGKIVLGDFGTAMPFEKEREAFDY---GWVGTVATNSPEILAGDGYCEITDIWSCGL 356
Query: 287 FLYELITGRR-PIDRNRPRSEQKLLQWVK 314
L ++++ PI + ++LL+ +
Sbjct: 357 ILLDMLSHDFCPIGDGGGKPGKQLLKIID 385
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 11/81 (13%)
Query: 168 LVYEYMPNGSVDQYLSPKSETILTW---AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 224
LV EY+ G V L I + M +K + A L YLH II RD K
Sbjct: 81 LVMEYLIGGDVKSLLH-----IYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKP 132
Query: 225 SNILLDEQWNAKLSDFGLARL 245
N+L+ + + KL+DFGL+++
Sbjct: 133 DNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 33/158 (20%), Positives = 58/158 (36%), Gaps = 26/158 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+ G VY L+ ++ +K R +E EV L ++ + L
Sbjct: 6 LKGGLTNRVY--LLGTKDED-----YVLKINPSREKGADRE--REVAILQLLARKGLPVP 56
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
+ + + L+ E++ + L SE + IA+ A LA LH+
Sbjct: 57 KVLASGESDGWS--YLLMEWIE----GETLDEVSE-----EEKEDIAEQLAELLAKLHQ- 104
Query: 213 MDFQIIV---RDFKSSNILLDEQWNAKLSDFGLARLGP 247
++V D NIL+D+ + D+ A GP
Sbjct: 105 --LPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 50/202 (24%), Positives = 72/202 (35%), Gaps = 73/202 (36%)
Query: 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----DAARGLAYLHEGMDFQIIVRDF 222
L+ E++P G + L K +T R +A+ +A L ++H RD
Sbjct: 78 LIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLGFIH---------RDI 127
Query: 223 KSSNILLDEQWNAKLSDFGLARLGPSEGF--THVST------------------------ 256
K NIL+D + KLSDFGL S GF H S
Sbjct: 128 KPDNILIDRGGHIKLSDFGL-----STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 257 ------------------------AVVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYEL 291
+ VGT Y APE ++Q G D WS G ++E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFEC 241
Query: 292 ITGRRPI-DRNRPRSEQKLLQW 312
+ G P N + +K++ W
Sbjct: 242 LIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 62/235 (26%), Positives = 93/235 (39%), Gaps = 49/235 (20%)
Query: 172 YMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231
+M GS + L ++ A+ I A RGL YLH+ I R+ K+S+IL+
Sbjct: 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISG 136
Query: 232 QWNAKLSD----FGLARLGPSE----GFTHVSTAVVGTMGYAAPEYVQTGRLA--ARSDV 281
LS + L R G F ST+V + + +PE ++ +SD+
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGYNVKSDI 193
Query: 282 WSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYL-----------SDAKQFRQIVD 328
+S G+ EL TGR P ++ R+ Q LLQ +K PY S K + VD
Sbjct: 194 YSVGITACELATGRVPF-QDMLRT-QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVD 251
Query: 329 P------------------RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
RL S ++ LCL ++ RP S +L
Sbjct: 252 SGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 27/84 (32%), Positives = 40/84 (47%), Gaps = 5/84 (5%)
Query: 208 YLH-EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
Y+H EG II RD K+ N+L++ + L DFG A T + GT+ A
Sbjct: 275 YIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330
Query: 267 PEYVQTGRLAARSDVWSYGVFLYE 290
PE + D+WS G+ ++E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 428 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.9 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.72 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.65 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.51 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.41 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.4 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.26 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.14 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.07 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.05 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.93 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.92 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.64 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.64 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.47 | |
| PLN02236 | 344 | choline kinase | 97.36 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.15 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.1 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.03 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.7 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.68 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.65 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.54 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.53 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.51 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.43 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.28 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.22 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.99 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.64 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.55 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.27 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.23 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.09 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.26 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-56 Score=428.20 Aligned_cols=291 Identities=55% Similarity=0.918 Sum_probs=252.9
Q ss_pred CCcccCHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcc
Q 014245 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV 150 (428)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 150 (428)
....|++.++..+|++|+..++||+|+||.||+|...++. .||||++.........+|.+|+.++.+++|||||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~------~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv 134 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGT------VVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLV 134 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCC------EEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcc
Confidence 5678999999999999999999999999999999988753 7999988765443145699999999999999999
Q ss_pred cEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC
Q 014245 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 151 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~ 230 (428)
+++|||.+... +.+||+|||++|+|.+++.......++|..+++|+.++|+||+|||..+.+.||||||||+|||||
T Consensus 135 ~LlGyC~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 135 KLLGYCLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred cEEEEEecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 99999998774 359999999999999999865433799999999999999999999998777899999999999999
Q ss_pred CCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 231 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 231 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
+++++||+|||+|+..+.. .........||.+|+|||++..+..+.++||||||++|+||+||+.|.+...+.....+.
T Consensus 212 ~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999999999766541 111111117999999999999999999999999999999999999999877666666789
Q ss_pred HhHhhhhhhhhhhhhhcCCcCC-CCccH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLE-GKYSL-RLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
.|+++.+.+. .+.+++|+.+. ..+.. .....+..++.+|++.+|.+||+|.+|++.|+.+.
T Consensus 291 ~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 291 EWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9998877766 78899999987 56554 67788999999999999999999999999986554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-54 Score=393.17 Aligned_cols=253 Identities=29% Similarity=0.426 Sum_probs=210.8
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
.+.+..||+|..|+||++.++.++ +.+|+|.+.... ....+++.+|+++++..+|||||.+||.|..+.. +
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~-----~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~---~ 152 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTG-----KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE---E 152 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCC-----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc---e
Confidence 445668999999999999988765 489999995443 3446789999999999999999999999998774 3
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
+.|+||||++|+|++++... +.+++...-.|+.+|++||.|||+. .+||||||||+|||++..|.|||||||.++.
T Consensus 153 isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 59999999999999999654 4599999999999999999999962 3999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (428)
.... ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||....+.. ..-...+..
T Consensus 229 lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-----------~~~~~Ll~~ 293 (364)
T KOG0581|consen 229 LVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-----------LDIFELLCA 293 (364)
T ss_pred hhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-----------CCHHHHHHH
Confidence 5432 4567899999999999999999999999999999999999999997642111 111122334
Q ss_pred hcCCcCCCCccH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 326 IVDPRLEGKYSL-RLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 326 ~~~~~l~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+++...+ ..+. .+++++++++..||++||.+||+++|+++|
T Consensus 294 Iv~~ppP-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 294 IVDEPPP-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HhcCCCC-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 4443222 2233 488999999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=394.72 Aligned_cols=258 Identities=33% Similarity=0.544 Sum_probs=213.8
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 167 (428)
...||+|+||+||+|.+++.. .||+|.+...... ..+.|.+|+.+|.+++|||||+++|+|.+... .++
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~------~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---~~~ 116 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTD------VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---SLC 116 (362)
T ss_pred hhhcccCCceeEEEEEeCCce------eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---ceE
Confidence 345999999999999998763 4999999765322 25689999999999999999999999998763 248
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCC-eeeccCCCCceEECCCC-CeEEeeeccccc
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ-IIVRDFKSSNILLDEQW-NAKLSDFGLARL 245 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~DFGla~~ 245 (428)
+||||+++|+|.+++.......+++..++.|+.||+.||.|||++ + ||||||||+||||+.++ ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 999999999999999864456799999999999999999999998 7 99999999999999998 999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCcchhc--cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQ--TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
..... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+... .
T Consensus 194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~----------------~ 255 (362)
T KOG0192|consen 194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV----------------A 255 (362)
T ss_pred ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH----------------H
Confidence 54321 2233468999999999999 56899999999999999999999999987654111 1
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
..++....+...+..+++.+..++.+||..||..||++.+++..|+.+......
T Consensus 256 ~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 256 SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 122222233334444778999999999999999999999999999988765543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=398.84 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=212.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
..|...++||+|||+.||.+....+++ .||+|++.+.. ....+.+.+|++|.+.|+|||||+++++|.+.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge-----~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGE-----VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCc-----EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence 579999999999999999999755444 89999998753 2345778899999999999999999999999885
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
. |||+|+|+.++|..++. .++.+++.+++.+++||+.||.|||+. +|+|||||..|+||+++.+|||+|||
T Consensus 93 V----YivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 93 V----YIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred e----EEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 4 99999999999999986 446799999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
||.....++. ...+.||||.|+|||++....++..+||||+||+||-||.|++||+...-.+...
T Consensus 164 LAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~------------- 228 (592)
T KOG0575|consen 164 LATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN------------- 228 (592)
T ss_pred eeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH-------------
Confidence 9987764432 3456899999999999999999999999999999999999999998653222211
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.... -..+..++.+..+||..+|+.||.+|||+++|+.+
T Consensus 229 ---~Ik~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 229 ---KIKLNE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---HHHhcC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111111 11233577889999999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=386.10 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=207.7
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-------HHHHHHHHHHHhcCCCCCcccEeeE
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-------HKEWMTEVNFLGIVEHQNLVKLVGY 155 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~~~~~ 155 (428)
..+.|.+.+.||+|+||.|-+|..+.+ ++.||||++.++.... .....+|++||++|+|||||+++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~t-----gk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKT-----GKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEccc-----CcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 345788899999999999999986554 4589999998763322 2235699999999999999999999
Q ss_pred EecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC---
Q 014245 156 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ--- 232 (428)
Q Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~--- 232 (428)
|...+.. ||||||++||+|.+++..+ +.+.+.....++.|++.||.|||++ ||+||||||+|||+..+
T Consensus 245 f~~~ds~----YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 245 FEVPDSS----YMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred eecCCce----EEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence 9988854 9999999999999998654 3478888899999999999999998 99999999999999665
Q ss_pred CCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCC---CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014245 233 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL---AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309 (428)
Q Consensus 233 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 309 (428)
..+||+|||+|+.... .....+.||||.|.|||++.++.+ ..++|+||+||+||-+++|.+||.......
T Consensus 316 ~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---- 388 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---- 388 (475)
T ss_pred eEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----
Confidence 7799999999997652 344567999999999999987653 348899999999999999999998654322
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCC--CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 310 LQWVKPYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....++...++. ......++++..+||.+||..||++|||+.|++++
T Consensus 389 -----------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 -----------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -----------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111222222222 23455788999999999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=378.71 Aligned_cols=251 Identities=30% Similarity=0.491 Sum_probs=204.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
..+|...+.||+|+||+||+|.++... ..||||.+.+.. ....+.+..|+.||+.++|||||.+++++...+.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~-----~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSG-----TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCC-----ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 457888889999999999999988764 389999998773 3455678899999999999999999999998874
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC------CCe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ------WNA 235 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~------~~~ 235 (428)
+|||||||+||+|.++|+.++ .+++..+..++.|++.||++||++ +||||||||.||||+.. -.+
T Consensus 84 ----i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 84 ----IYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred ----EEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence 599999999999999997654 599999999999999999999999 99999999999999765 458
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
||+|||+|+...... .....+|+|.|||||++....|+.|+|+||+|++||+|++|+.||+.....+....++
T Consensus 155 KIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~---- 227 (429)
T KOG0595|consen 155 KIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK---- 227 (429)
T ss_pred EecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh----
Confidence 999999999876432 3456899999999999999999999999999999999999999998765443222111
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 366 (428)
.+..+....+......+.+++...+..+|.+|-+..+-+.
T Consensus 228 -----------k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 228 -----------KGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred -----------ccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 1122222333344455667777777788777776665544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-52 Score=365.40 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=208.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeE-EecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGY-CADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~-~~~~~~ 161 (428)
.+|.++++||+|.||+||++....+ ++.+|.|.+.-.. .........|+.+|++|+|||||+++++ |.++..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~-----g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLD-----GKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccC-----cchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 4678888999999999999986544 4589999886432 2345678899999999999999999984 444333
Q ss_pred CCceEEEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeccCCCCceEECCCCCeEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDF-QIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.++||||||++|+|...|+. ...+.+++..+|+++.|++.||.++|.+... -|+||||||.||+|+.+|.+||+
T Consensus 94 ---vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 94 ---VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred ---hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 25899999999999999863 2346799999999999999999999984221 39999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
||||++.+... .....+.+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+..-.. +
T Consensus 171 DfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~---L--------- 236 (375)
T KOG0591|consen 171 DFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS---L--------- 236 (375)
T ss_pred cchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH---H---------
Confidence 99999986543 233457899999999999999999999999999999999999999998763211 1
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
.. .+-......-....++.++..|+..|+..||+.||+.-.+++.+..
T Consensus 237 -~~---KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 237 -CK---KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -HH---HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 1112222222336788999999999999999999997666665554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=368.40 Aligned_cols=249 Identities=28% Similarity=0.399 Sum_probs=206.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.++||+|+||+||.++.++++ +.+|+|++.+...- ..+....|..||..++||+||+++-.|++...
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~-----kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTG-----KIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccC-----ceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 57999999999999999999977554 48999999876442 34567899999999999999999988888774
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
+|||+||+.||.|..+|++. +.|++..+..++.+|+.||.|||++ +||||||||+|||||++|+++|+|||
T Consensus 100 ----LylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 100 ----LYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ----EEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccc
Confidence 59999999999999999754 4599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
|++..-..+ ..+..++||+.|||||++.+..|+.++|.||||+++|||++|.+||.........
T Consensus 171 L~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~-------------- 234 (357)
T KOG0598|consen 171 LCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY-------------- 234 (357)
T ss_pred cchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH--------------
Confidence 998543332 2345689999999999999999999999999999999999999999876533221
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP----KMSEVLE 366 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~ell~ 366 (428)
+.+...+ ....+..++.+.++++.+.|..||++|. ++.+|.+
T Consensus 235 --~~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 235 --DKILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred --HHHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1222222 1122334667899999999999999995 5666544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=375.89 Aligned_cols=254 Identities=30% Similarity=0.516 Sum_probs=214.8
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEE
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
.++.||+|.||.||.|.+++.. .||+|.+... ....+.|.+|+.+|++|+|+|||+++|+|..+.. ++|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~------~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p----iyI 278 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGST------KVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP----IYI 278 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCC------cccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc----eEE
Confidence 4557999999999999999875 5899998765 3445788999999999999999999999998764 499
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCC
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 248 (428)
|||||+.|+|.++|+...+..+.....+.++.|||+||+||+++ ++|||||-+.||||++++.+||+|||||+...+
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999999976667799999999999999999999998 999999999999999999999999999995544
Q ss_pred CCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014245 249 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327 (428)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (428)
+.+.. .....-..-|.|||.+..+.++.|+|||||||+||||+| |+.||.+....+.. +.+
T Consensus 356 ~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-----------------~~l 417 (468)
T KOG0197|consen 356 DEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-----------------ELL 417 (468)
T ss_pred Cceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-----------------HHH
Confidence 43322 223334567999999999999999999999999999999 99999876543222 223
Q ss_pred CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 328 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
+...+-..+..+++++.++|..||+.+|++|||++.+...|+.+...
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 33333344556889999999999999999999999999999887654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=374.12 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=212.7
Q ss_pred HHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcC-CCCCcccEeeEE
Q 014245 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIV-EHQNLVKLVGYC 156 (428)
Q Consensus 81 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 156 (428)
....++|..++.||.|+|++|++|....+ ++.||||++.+...- ..+.+..|-.+|.+| .||.|+++|..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t-----~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKAT-----GKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCC-----CceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 33456899999999999999999986554 558999999876432 234567899999999 999999999999
Q ss_pred ecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeE
Q 014245 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
+|+.. +|+|+||+++|+|.++|.+. +.|++..++.++.+|+.||+|||++ |||||||||+|||||++|++|
T Consensus 144 QD~~s----LYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 144 QDEES----LYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred ecccc----eEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence 98875 49999999999999999765 4599999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCce---------ee--eeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh
Q 014245 237 LSDFGLARLGPSEGFT---------HV--STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 305 (428)
Q Consensus 237 l~DFGla~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 305 (428)
|+|||.|+.+...... .. ...++||..|.+||++..+..+..+|||+||||||+|+.|.+||-...+-
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney- 293 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY- 293 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-
Confidence 9999999876532211 11 25699999999999999999999999999999999999999999765432
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..++.+++-. -.++..+++.+.+|+.+.|..||.+|+++++|.+|
T Consensus 294 ---------------liFqkI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 ---------------LIFQKIQALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------------HHHHHHHHhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1222333221 13445566889999999999999999999999886
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=362.12 Aligned_cols=260 Identities=28% Similarity=0.418 Sum_probs=207.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.+|...+.||+|+||.||++....+. ...|||..........+.+.+|+.+|.+|+|||||+++|....... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g-----~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~ 89 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTG-----ELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN--D 89 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCC-----cceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC--e
Confidence 35777889999999999999977642 3799999876643335678999999999999999999997544333 2
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-CCCeEEeeeccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLA 243 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla 243 (428)
.+++.|||+++|+|.+++...+. .+++..+..+..||++||+|||++ +|||+||||+||||+. ++.+||+|||++
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccc
Confidence 46899999999999999987655 699999999999999999999998 9999999999999999 799999999999
Q ss_pred ccCCC-CCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 244 RLGPS-EGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+.... .........+.||+.|||||++..+. .+.++|||||||++.||+||+.||.... .....+
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-~~~~~~------------ 232 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-EEAEAL------------ 232 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-chHHHH------------
Confidence 86543 11112234578999999999998643 3459999999999999999999997631 000100
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
..+......+.++..++.+..+++.+|+..||++|||+.+++++...
T Consensus 233 --~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 233 --LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred --HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 01111112224556688899999999999999999999999998543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=371.30 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=214.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
..|....+||+|+.|.||.|....++ ..||||++........+-+++|+.+|+.++|+|||++++.|...++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~-----~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de--- 344 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTK-----QEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE--- 344 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCC-----ceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce---
Confidence 46888889999999999999866554 3799999988877767778899999999999999999988877654
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
++.|||||+||+|.|.+... .+++.++..|+.+++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++.
T Consensus 345 -LWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 345 -LWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred -eEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 59999999999999999754 389999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... ....++|||.|||||++....|++++||||||++++||+-|.+||-...+.....++.
T Consensus 418 qi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------------- 482 (550)
T KOG0578|consen 418 QISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------- 482 (550)
T ss_pred ccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------------
Confidence 7654432 3456899999999999999999999999999999999999999997655433332221
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+....-.....++..+.+++.+||+.|+++|+++.|||+|
T Consensus 483 --~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 483 --TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 12222333455678899999999999999999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=343.56 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=209.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-cc-HHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QG-HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+.|+.+.++|+|+||.||+++++++++ .||||++..... .. .+-.++|+++|++|+|+|+|.++.+|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~Tgq-----IVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-- 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQ-----IVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-- 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCccc-----EEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc--
Confidence 357888899999999999999877654 899999976543 22 345689999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++||+|||+..-|.+ +....+ .++...+.+++.|++.|+.|+|++ ++|||||||+||||+.+|.+||||||.
T Consensus 75 --klhLVFE~~dhTvL~e-Le~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 75 --KLHLVFEYCDHTVLHE-LERYPN-GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred --eeEEEeeecchHHHHH-HHhccC-CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 4599999998855544 443433 388899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-------
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK------- 314 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~------- 314 (428)
|+..... ....+..+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+....+...++....
T Consensus 148 AR~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 148 ARTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred hHhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence 9976533 233456889999999999887 679999999999999999999999999887766655554321
Q ss_pred -hhhhhhhhhhhhcCCcCCCC-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 -PYLSDAKQFRQIVDPRLEGK-----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 -~~~~~~~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+....-+..+.-|..... -.+..+..+.+++..||+.||.+|++.++++.+
T Consensus 226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111222211211111 112455688999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=367.47 Aligned_cols=268 Identities=26% Similarity=0.413 Sum_probs=208.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.++||+|+||.||+|.+........+..||+|.+..... .....+.+|+.++..+ +||||++++++|.....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 357899999999999999999865443444556799999875432 2345788999999999 89999999999876543
Q ss_pred CCceEEEEEeecCCCCcccccCCCC-------------------------------------------------------
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKS------------------------------------------------------- 186 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 186 (428)
.+++||||+++|+|.+++....
T Consensus 86 ---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 86 ---PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred ---ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 3589999999999998886421
Q ss_pred -----cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecC
Q 014245 187 -----ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261 (428)
Q Consensus 187 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 261 (428)
...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...............++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 12477888999999999999999998 9999999999999999999999999999764322211112234567
Q ss_pred cccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHH
Q 014245 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLV 340 (428)
Q Consensus 262 ~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 340 (428)
+.|+|||++.+..++.++|||||||++|||++ |..||........ +... +.+. .....+..++
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~-------------~~~~-~~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQR-------------LKDG-TRMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHH-------------HhcC-CCCCCCCCCC
Confidence 88999999999999999999999999999997 9999976432211 1110 0000 0011122345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 341 SKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 341 ~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
+.+.+++.+||+.||++||++.+|++.|+.++.
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 689999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=337.41 Aligned_cols=237 Identities=30% Similarity=0.450 Sum_probs=204.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||.|+||.|.+++.+.++ ..+|+|++.+...- ..+...+|..+|+.+.||+++++++.|.+.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g-----~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSG-----NYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCC-----ceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 47888999999999999999977654 48999999876543 33456799999999999999999999988774
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
+||||||.+||.|..++++.+ .|++..++.++.||+.||+|||+. +|++|||||+|||||.+|.+||+|||
T Consensus 119 ----lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 ----LYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred ----EEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEecc
Confidence 599999999999999997544 499999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
.|+..... +-..||||.|+|||+++...|+.++|.|||||++|||+.|.+||....+..
T Consensus 190 FAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---------------- 248 (355)
T KOG0616|consen 190 FAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---------------- 248 (355)
T ss_pred ceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----------------
Confidence 99865432 456899999999999999999999999999999999999999998765522
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCC
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 358 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 358 (428)
....++...+ .++..++.++.+|+...|+.|-.+|
T Consensus 249 iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 249 IYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2233333333 3566778899999999999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=359.11 Aligned_cols=269 Identities=25% Similarity=0.317 Sum_probs=209.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
..|+.+++||+|+||.||+|+...+ ++.||+|++..... .......+|+.||++|+||||+++.+...+....
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~t-----gkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLET-----GKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeeccc-----CcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 4588888999999999999986554 45899999976542 2345567999999999999999999999887333
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.+|||+|||++ +|..++.. ..-.|++.++..+++|++.||+|||.+ +|+|||||.+|||||.+|.+||+||||
T Consensus 192 --siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 192 --SIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred --eEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence 46999999977 88888864 334599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-----hh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-----PY 316 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-----~~ 316 (428)
|+++....... .+..+-|..|.|||.+.|. .|+.++|+||.||||.||++|++.|.+.........+-.+- .+
T Consensus 265 Ar~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 265 ARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred eeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 99876554332 4567889999999998875 59999999999999999999999999887655544433211 00
Q ss_pred hhhhhhhhhhcCCcCCCCc-------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKY-------SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
|. ...+...........+ ...++....+|+..+|..||.+|.|+.++++.
T Consensus 344 W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 344 WP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 0000000000001111 12345678899999999999999999998874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=362.99 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=207.0
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC----Cc-ccHHHHHHHHHHHhcCC-CCCcccEeeEE
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GV-QGHKEWMTEVNFLGIVE-HQNLVKLVGYC 156 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 156 (428)
..++|.+.+.||+|+||.|+.|.+..++ ..||+|.+.+. .. ...+.+.+|+.+++.++ ||||++++.++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~-----~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTG-----EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCC-----CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 4578999999999999999999876654 38999977664 11 23456678999999998 99999999999
Q ss_pred ecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC-CCe
Q 014245 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNA 235 (428)
Q Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~~ 235 (428)
..... +++||||+.||+|.+++.. .+.+.+..+..++.|++.|++|||++ +|+||||||+|||++.+ +++
T Consensus 90 ~t~~~----~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 90 ATPTK----IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred ecCCe----EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCE
Confidence 98774 5999999999999999976 34589999999999999999999998 99999999999999999 999
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccCC-CC-CchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (428)
||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+........
T Consensus 161 Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~------ 232 (370)
T KOG0583|consen 161 KLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY------ 232 (370)
T ss_pred EEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH------
Confidence 999999998763 1223455689999999999999877 86 6899999999999999999999874322111
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRL-VSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+..... .++..+ +.++..|+.+||..||.+|+++.+++++
T Consensus 233 ----------~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 233 ----------RKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ----------HHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 11111111 122223 7899999999999999999999999954
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=382.86 Aligned_cols=268 Identities=26% Similarity=0.450 Sum_probs=227.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.+....+.||+|+||+||+|...+-........||||.++..... ...+|.+|+++|..|+|||||+++|+|...+..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~- 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL- 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee-
Confidence 344556689999999999999877665667789999999887665 678999999999999999999999999988865
Q ss_pred ceEEEEEeecCCCCcccccCCCC------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKS------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
+||+|||..|||.+||..+. ..+++..+.+.||.|||.||+||-++ .+|||||-..|+||.+
T Consensus 565 ---~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 565 ---CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred ---EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999996432 12388999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~ 310 (428)
+..|||+||||++.....++........-..+|||||.+..++|+.++|||||||+|||+++ |+.||.+....+..+.+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 99999999999998776666554434455689999999999999999999999999999999 99999876554333222
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
.+..+ -..+..++.++.+||..||+.+|.+||++.||...|........
T Consensus 719 ----------------~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 719 ----------------RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ----------------HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 22222 34556788899999999999999999999999999988765543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=348.83 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=212.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-HHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+.|++..+||.|..++||+|.....++ .||||++.-..... .+.+.+|+..|+.++||||++++..|..+..
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e-----~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-- 98 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNE-----VVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-- 98 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCC-----EEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce--
Confidence 578999999999999999999876654 89999998765543 4788999999999999999999999988774
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
+++||.||.+|++.+++...-...+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+
T Consensus 99 --LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 99 --LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred --eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceee
Confidence 59999999999999999765555699999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceee-e-eeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 244 RLGPSEGFTHV-S-TAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 244 ~~~~~~~~~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
-.+...+.... . ..++||+.|||||++.. ..|+.|+||||||++.+||.+|..||....+....- ..++. .
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLqn---~ 248 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQN---D 248 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhcC---C
Confidence 65544432221 1 56799999999999653 569999999999999999999999998876643321 11110 0
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ...-..+..+....+...+.+++..||+.||++|||+.+++++
T Consensus 249 pp---~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 249 PP---TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CC---CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00 0000011222233456789999999999999999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=348.61 Aligned_cols=267 Identities=27% Similarity=0.344 Sum_probs=215.6
Q ss_pred HHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--------------ccHHHHHHHHHHHhc
Q 014245 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--------------QGHKEWMTEVNFLGI 143 (428)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~ 143 (428)
.+-....++|++++.||+|.||.|-+|+... .++.||||++.+... ...+...+|+.||++
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~-----~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk 164 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEV-----DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK 164 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecC-----CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh
Confidence 3344557899999999999999999998544 345899999976422 123578899999999
Q ss_pred CCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 014245 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 223 (428)
Q Consensus 144 l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 223 (428)
|+|||||+++.+..+.... .+|||+|||..|.+...=.... .+++.++++|+.+++.||+|||.+ +|||||||
T Consensus 165 l~H~nVV~LiEvLDDP~s~--~~YlVley~s~G~v~w~p~d~~--els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIK 237 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDPESD--KLYLVLEYCSKGEVKWCPPDKP--ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIK 237 (576)
T ss_pred cCCcCeeEEEEeecCcccC--ceEEEEEeccCCccccCCCCcc--cccHHHHHHHHHHHHHHHHHHHhc---Ceeccccc
Confidence 9999999999999887655 6799999999888765433222 289999999999999999999999 99999999
Q ss_pred CCceEECCCCCeEEeeecccccCCCC---CceeeeeeeecCcccCCcchhccCC---C-CCchhhhhHHHHHHHHHhCCC
Q 014245 224 SSNILLDEQWNAKLSDFGLARLGPSE---GFTHVSTAVVGTMGYAAPEYVQTGR---L-AARSDVWSYGVFLYELITGRR 296 (428)
Q Consensus 224 p~NILl~~~~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DvwslG~il~elltg~~ 296 (428)
|+|+||+++|++||+|||.+...... +........+|||.|||||...++. + +.+.||||+||+||.|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 99999999999999999999765322 2222233478999999999887743 3 568999999999999999999
Q ss_pred CCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 297 PIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 297 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
||..... .+.+..+++..+.-...+++.+++.+||.++|.+||+.|.++.+|..|..-..
T Consensus 318 PF~~~~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 318 PFFDDFE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred CcccchH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 9976432 12345666666665555677889999999999999999999999988865443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=355.55 Aligned_cols=268 Identities=24% Similarity=0.322 Sum_probs=213.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHH-HHHHHHHHHhcCC-CCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK-EWMTEVNFLGIVE-HQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~ 161 (428)
.++|..++.||.|+||.||+|+.....+ .||||++++.-....+ .-.+|+..|++|+ |||||++.+++.+.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~-----~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGE-----LVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCc-----eeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 3578899999999999999999766544 7999999876433222 2358999999998 9999999999998774
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+|+|||||+ .+|.+++..+ +..|++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||
T Consensus 84 ---~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 84 ---ILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred ---eEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence 4699999995 4999999877 67899999999999999999999998 99999999999999988899999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhc-cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-----hh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-----KP 315 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-----~~ 315 (428)
+|+...... ..+..+.|..|.|||++. .+.|+.+.||||+|||++|+.+-++-|.+....+...-+.-+ +.
T Consensus 156 LARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 156 LAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD 232 (538)
T ss_pred cccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence 999765432 235678999999999875 567899999999999999999999999887655443222211 11
Q ss_pred hhhhhhhhhhhcCCcCCCC-------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGK-------YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.....+...++-.+... .-...+.++.++|.+|+.+||.+|||+++++++
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1222223333333222221 122367899999999999999999999999987
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=357.49 Aligned_cols=248 Identities=32% Similarity=0.440 Sum_probs=210.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|.||.||+|+.+.+. ..||+|.+.+... +..+.+.+|++|++.|+|||||.++++|....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~-----~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~- 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTI-----QVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH- 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccce-----eEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce-
Confidence 47888889999999999999866554 4899999987643 345678999999999999999999999988774
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
+++|.||+.| +|..++.+.. .+++..+..|+.+++.||.|||+. +|+|||+||.|||++.+|.+|+||||+
T Consensus 76 ---~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 76 ---LWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred ---EEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 4999999966 9999997644 499999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
|+.+... ....+...|||.|||||.+.+..|+..+|+|||||++|||++|++||.... +.+.+
T Consensus 147 Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv--------- 209 (808)
T KOG0597|consen 147 ARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLV--------- 209 (808)
T ss_pred hhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHH---------
Confidence 9976543 455677899999999999999999999999999999999999999996432 11111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..++... ..++...+..+..++...|.+||..|.+..+++.|
T Consensus 210 -~~I~~d~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 210 -KSILKDP--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -HHHhcCC--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1222111 12344677899999999999999999999999886
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=323.92 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=212.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++++.||+|-||.||.|..+.+. ..||+|++.+... ....++.+|++|-+.|+||||+++|+||.++..
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~-----~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSL-----FIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred hhccccccccCCccccEeEeeeccCC-----cEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 47899999999999999999977654 3899999976543 335678999999999999999999999999875
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
. ||++||...|+|...+.......+++.....++.|++.||.|+|.+ +|+||||||+|+|++..+.+||+|||
T Consensus 97 i----yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 97 I----YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred e----EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCC
Confidence 4 9999999999999999866667799999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
.+...+.. .....+||..|.+||+..+..++..+|+|++|++.||++.|.+||..........
T Consensus 170 wsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk------------- 232 (281)
T KOG0580|consen 170 WSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK------------- 232 (281)
T ss_pred ceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH-------------
Confidence 99765422 2346899999999999999999999999999999999999999998654222211
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..- .-.++..++....++|.+|+..+|.+|....|++++
T Consensus 233 ---rI~k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 233 ---RIRKV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---HHHHc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11111 112335567889999999999999999999999886
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=358.83 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=210.1
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcC-CCCCcccEeeEEec
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIV-EHQNLVKLVGYCAD 158 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 158 (428)
..++|..+++||+|.||+|+++..+++++ .+|||.+++... ...+..+.|..|+... +||.+++++..|+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e-----~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNE-----YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCc-----EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 35689999999999999999999988765 899999998754 3456778999998887 59999999999998
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
... +|+||||+.||++..+++ ...|++..+..++..|+.||.|||++ +||+||||.+|||||.+|.+||+
T Consensus 441 ~~~----l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 441 KEH----LFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred CCe----EEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence 874 599999999999555443 24599999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||+++..... ...+.+++|||.|||||++.+..|+.++|.|||||+|||||.|..||.+.+.++.
T Consensus 511 DFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------ 576 (694)
T KOG0694|consen 511 DFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------ 576 (694)
T ss_pred ccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------
Confidence 99999864422 3356789999999999999999999999999999999999999999987654332
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLE 366 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~ell~ 366 (428)
+..++.. ...|+..++.+...++.++|..+|++|.-+ .+|.+
T Consensus 577 ----FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 577 ----FDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK 623 (694)
T ss_pred ----HHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence 2233322 224566788899999999999999999754 55554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.78 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=206.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|+.+.+||+|+||.||+|+-+++++ .+|+|++++.... ..+.+..|-.+|...++|+||++|-.|++..
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~-----iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGE-----IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCc-----EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 4689999999999999999999777654 8999999876543 3456778999999999999999999999877
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
. +||||||++||++..+|... ..|++..+..++.+++.||+.||+. |+|||||||+|+|||..|++||+||
T Consensus 215 ~----LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 215 Y----LYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred e----eEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccc
Confidence 4 59999999999999999654 4599999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCC----------------------CCce------e-----------------eeeeeecCcccCCcchhccCCC
Q 014245 241 GLARLGPS----------------------EGFT------H-----------------VSTAVVGTMGYAAPEYVQTGRL 275 (428)
Q Consensus 241 Gla~~~~~----------------------~~~~------~-----------------~~~~~~gt~~y~aPE~~~~~~~ 275 (428)
||+.-... .... . .....+|||.|||||++.+..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99842110 0000 0 0124689999999999999999
Q ss_pred CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccC
Q 014245 276 AARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKN 354 (428)
Q Consensus 276 ~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~d 354 (428)
+..+|.||||||+||||.|.+||....+..... +..|-.. +.......++++..+||.+||. |
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPEEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCCcCcccHHHHHHHHHHhc-C
Confidence 999999999999999999999999887665432 2222111 1111122344789999999999 9
Q ss_pred CCCCC---CHHHHHHH
Q 014245 355 ARTRP---KMSEVLEM 367 (428)
Q Consensus 355 p~~RP---s~~ell~~ 367 (428)
|++|. .++||.+|
T Consensus 430 ~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHhcCcccHHHHhcC
Confidence 99996 47777654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=359.73 Aligned_cols=265 Identities=25% Similarity=0.409 Sum_probs=207.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||.||+|.............||+|.+..... .....+.+|+.+++.+ +|+||++++++|.....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~- 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP- 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC-
Confidence 46889999999999999999876544444556799999975432 3345688999999999 89999999999987764
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------------------------------------------------
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS-------------------------------------------------------- 186 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 186 (428)
.++||||+++|+|.+++....
T Consensus 117 ---~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 117 ---VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred ---eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 499999999999998874321
Q ss_pred ------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceee
Q 014245 187 ------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254 (428)
Q Consensus 187 ------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 254 (428)
...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 12478888999999999999999998 999999999999999999999999999976543222222
Q ss_pred eeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCC
Q 014245 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEG 333 (428)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 333 (428)
.....+++.|||||++.+..++.++|||||||++|+|++ |..||........ ... ........
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~--------------~~~~~~~~ 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYK--------------MVKRGYQM 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHH--------------HHHcccCc
Confidence 223345678999999998899999999999999999997 9999975432211 111 11111111
Q ss_pred CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 334 KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 334 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
..+...+.++.+++.+||+.||++||++.+|++.|++++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111223578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=320.19 Aligned_cols=266 Identities=24% Similarity=0.358 Sum_probs=209.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.+|...++||+|.||.||+|....+ ++.||||++...... ......+|++.|+.++|+||+.++++|...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t-----~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTET-----GKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCC-----CcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCce
Confidence 3678888999999999999996554 448999999765433 234678999999999999999999999887754
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.||+|||+. +|+..|+.+. ..++...+..++.++++||+|||.+ .|+||||||.|+|++.+|.+||+|||+
T Consensus 77 ----~lVfEfm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 77 ----SLVFEFMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred ----EEEEEeccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 899999954 9999887553 5699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH--------
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-------- 313 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-------- 313 (428)
|+.+....... +..+-|..|.|||.+.|. .|+..+|+||.|||+.||+-|.+-|.+....+....+-.+
T Consensus 148 Ar~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 148 ARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred hhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence 99887654332 234789999999988875 5999999999999999999998888776554433222111
Q ss_pred hhhhhhhhhhhhhc---CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIV---DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
++.+.......++. .+.+ .......++++.+|+..++..||.+|+++.|++++
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CccccccccHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111111111 1111 12334556778999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=352.26 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=208.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+.+.+...||+|.||+||+|.+.+ .||||++..... ...+.|.+|+.++++-+|.||+-+.|||.....
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred HHhhccceeccccccceeeccccc--------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 345567789999999999999886 499999987644 346789999999999999999999999987653
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.||+.+|+|.+|+.+|+... ..|.....+.|+.||++|+.|||.+ +|||||||..||+|.+++.|||+||||
T Consensus 463 ----AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 ----AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ----eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 79999999999999998654 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhcc---CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
+................|...|||||+++. .+|+..+|||||||++|||+||..||..... ++.+...-+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifmVGr----- 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFMVGR----- 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEEecc-----
Confidence 976443322223334568889999999874 4689999999999999999999999983221 111100000
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
..+.++ ......+++.++.+|+..||..++++||.+.+|+..|+.++..
T Consensus 608 -----G~l~pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 608 -----GYLMPD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -----cccCcc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 000000 0112235667999999999999999999999999998888754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=358.56 Aligned_cols=264 Identities=26% Similarity=0.391 Sum_probs=205.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|+||.||+|.............||+|.+..... ...+.+.+|+.+|..+ +||||++++++|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 46888999999999999999864433344556899999875432 3345788999999999 899999999999887644
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------------------------------------------------
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS-------------------------------------------------------- 186 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 186 (428)
++||||+++|+|.+++....
T Consensus 115 ----~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 115 ----LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred ----eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 99999999999988885321
Q ss_pred -----------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 187 -----------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 187 -----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 12478888999999999999999998 9999999999999999999999999999765433
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (428)
..........++..|+|||++.+..++.++|||||||++|||++ |..||....... .......
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~-------------- 331 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK-------------- 331 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH--------------
Confidence 22111222345678999999999999999999999999999998 899987543221 1111111
Q ss_pred CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 329 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
.......+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0001111112346899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=349.50 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=208.3
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.|+....||+|.||.||+|....+ ++.||+|++.-.... ..+.+.+|+.+|.+++++||.++||.+......
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t-----~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L-- 86 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKT-----KKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL-- 86 (467)
T ss_pred ccccchhccccccceeeeeeeccc-----cceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH--
Confidence 567778999999999999985544 458999999866443 457788999999999999999999999887654
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
+++||||.||++.+.+... ..+.+..+.-|+++++.||.|||.+ +.+|||||++|||+..+|.+||+|||++.
T Consensus 87 --wiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 87 --WIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred --HHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceee
Confidence 8999999999999999644 3357888888999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
........ ...++|||.|||||++....|+.++||||||++.+||++|.+|+....+.....+
T Consensus 160 ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl--------------- 222 (467)
T KOG0201|consen 160 QLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL--------------- 222 (467)
T ss_pred eeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe---------------
Confidence 76544332 3678999999999999988999999999999999999999999987665322111
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+...-++.+...+++.+++++..||+.||+.||++.+++++
T Consensus 223 --Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 223 --IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11112223333677889999999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=341.02 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=200.3
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc---HHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
...||+|++|.||+|.+.+ ..||+|.+....... .+.+.+|+.+|.+++||||++++|++.+........
T Consensus 25 ~~~i~~g~~~~v~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFNN-------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred CeEEeeCCceEEEEEEECC-------EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence 3579999999999998743 379999997653332 466789999999999999999999997722222246
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++...+.++.|++.||.|||.. .+++||||||+|||+++++.+||+|||+++..
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred EEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 8999999999999999754 3588999999999999999999973 27889999999999999999999999999764
Q ss_pred CCCCceeeeeeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
.... ....|++.|+|||++.+ ..++.++|||||||++|||++|..||..........
T Consensus 174 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~---------------- 232 (283)
T PHA02988 174 SSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD---------------- 232 (283)
T ss_pred cccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----------------
Confidence 3321 23468999999999976 679999999999999999999999998654322111
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
.+.........+...++.+.+++.+||+.||++|||++++++.|+.+.
T Consensus 233 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111111111222245678999999999999999999999999998764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=359.11 Aligned_cols=249 Identities=28% Similarity=0.412 Sum_probs=208.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
+-|+.++.||.|+.|.|-+|++..+++ ..|||++.+... .....+.+|+-||+.+.||||+++|+++.+..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGq-----laaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~- 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQ-----LAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ- 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccc-----eeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-
Confidence 568889999999999999998766544 899999977621 23456789999999999999999999998876
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
++|+|.||++||.|.+++..+ +.+++.++.++++||+.|+.|+|.. +|+||||||+|+|||..+++||+|||
T Consensus 86 ---~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 86 ---HLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred ---eEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence 459999999999999999755 4599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCC-CchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
+|.+.... ..-.+.||+|.|.|||++.|.+|+ .++||||.|||||.||||+.||++.. ...+...++.
T Consensus 158 MAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~----- 226 (786)
T KOG0588|consen 158 MASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQR----- 226 (786)
T ss_pred eeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHc-----
Confidence 99865433 234567999999999999999995 69999999999999999999998543 2222222221
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.. -+.+..++.+..+|+.+||..||++|.|+++|++|-
T Consensus 227 --------G~--f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 227 --------GV--FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --------Cc--ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 00 123345778999999999999999999999999973
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=342.03 Aligned_cols=248 Identities=24% Similarity=0.414 Sum_probs=208.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccH---HHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH---KEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.+|++.+.||+|+||.|-+|.. ...++.||||.+.+...... -.+.+|++||+.|+||||+.+|.+|...+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e-----~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYE-----HKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhh-----ccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 4788888999999999999874 33456899999988766544 356799999999999999999999988774
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
++|||||..+|.|.|++..++ .+++.++..+++||+.|+.|+|.+ +++|||||.+|||||.++++||+|||
T Consensus 128 ----IvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 128 ----IVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred ----EEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence 599999999999999997654 499999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|+..+.... ..+.+||+|.|.+||++.+.+| ++.+|.|||||+||-|+.|..||++.+...
T Consensus 199 LSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--------------- 260 (668)
T KOG0611|consen 199 LSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--------------- 260 (668)
T ss_pred hhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---------------
Confidence 998765433 3467999999999999999998 579999999999999999999999864321
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.++++-...... +..+.+..-||++||..||++|.|+.+|..+-
T Consensus 261 -lvrQIs~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 261 -LVRQISRGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -HHHHhhcccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 122332222221 12334677899999999999999999998763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.61 Aligned_cols=268 Identities=25% Similarity=0.448 Sum_probs=204.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCC-----------CCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccE
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSED-----------PSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKL 152 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----------~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~ 152 (428)
++|.+.+.||+|+||.||+|.+....+ ......||+|.+..... .....+.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999998754321 12345799999876532 234578999999999999999999
Q ss_pred eeEEecCCCCCceEEEEEeecCCCCcccccCCCC-----------------cccccHHHHHHHHHHHHHHHHHhhcCCCC
Q 014245 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS-----------------ETILTWAMRLKIAQDAARGLAYLHEGMDF 215 (428)
Q Consensus 153 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 215 (428)
++++.+.+. .++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.
T Consensus 85 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--- 157 (304)
T cd05096 85 LGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--- 157 (304)
T ss_pred EEEEecCCc----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence 999987664 499999999999998875321 12467888999999999999999998
Q ss_pred CeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh--
Q 014245 216 QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-- 293 (428)
Q Consensus 216 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-- 293 (428)
+|+||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999999976543332222334456889999999998899999999999999999987
Q ss_pred CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 294 GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 294 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
+..||...... .............. .......+..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 238 ~~~p~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDE---QVIENAGEFFRDQG-------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCCcCCHH---HHHHHHHHHhhhcc-------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 56777654322 11111111110000 00000111234568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=340.13 Aligned_cols=262 Identities=25% Similarity=0.454 Sum_probs=211.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|+||.||+|.............|++|.+..... .....+.+|+.++..++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~-- 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP-- 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc--
Confidence 36888889999999999999987655445566899999875433 234568899999999999999999999987653
Q ss_pred ceEEEEEeecCCCCcccccCCCCc--------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSE--------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl 229 (428)
.+++|||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +++|+||||+|||+
T Consensus 83 --~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~ 157 (283)
T cd05048 83 --TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLV 157 (283)
T ss_pred --eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEE
Confidence 4899999999999998864321 4578899999999999999999998 99999999999999
Q ss_pred CCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014245 230 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQK 308 (428)
Q Consensus 230 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 308 (428)
++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~-- 235 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV-- 235 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999976543332223334567889999999998899999999999999999998 9999976543221
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
... +........+..++.++.+|+.+||+.||.+||++++|+++|+.
T Consensus 236 -~~~--------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 -IEM--------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHH--------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 11111112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=330.34 Aligned_cols=255 Identities=27% Similarity=0.387 Sum_probs=213.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc---HHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
+.|+.++.||+|.-|+||++..++++ ..+|+|++.+..... ..+...|-+||+.++||.++.+|+.|..+..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~-----~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTN-----CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCC-----ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 45777889999999999999988765 389999998765433 3466789999999999999999999988774
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.|||||||+||+|..+.++...+.|++..++.++.+|+.||+|||.. |||+|||||+||||-++|++.|+||.
T Consensus 152 ----~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 152 ----SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred ----eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence 49999999999999999988888999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCC---------------------------------CCc---------------------eeeeeeeecCcccCCc
Q 014245 242 LARLGPS---------------------------------EGF---------------------THVSTAVVGTMGYAAP 267 (428)
Q Consensus 242 la~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aP 267 (428)
|+..... ... ...+..++||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8743210 000 0123467899999999
Q ss_pred chhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHH
Q 014245 268 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA 347 (428)
Q Consensus 268 E~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li 347 (428)
|++.+...+.++|.|+|||++|||+.|..||.+.... ..+..++-..+.-......+..+.+||
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKDLI 368 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHHHH
Confidence 9999999999999999999999999999999876543 233344443333333336778999999
Q ss_pred HHhcccCCCCCCC----HHHHHHH
Q 014245 348 NLCLVKNARTRPK----MSEVLEM 367 (428)
Q Consensus 348 ~~cl~~dp~~RPs----~~ell~~ 367 (428)
++.|.+||++|.. +.||-+|
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHhccChhhhhccccchHHhhcC
Confidence 9999999999998 8888765
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=352.77 Aligned_cols=265 Identities=30% Similarity=0.478 Sum_probs=213.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.+....++||+|+||.||+|.+....... ...||+|...... .....+|++|+++|++++|||||++||++.....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~-~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFK-VVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCce-eeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 44556689999999999999987653211 1228999987532 3456789999999999999999999999998876
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
. ++|||+|+||+|.++|.+... .++..+.+.++.+.+.||+|||++ ++|||||-.+|+|++.++.+||+|||
T Consensus 236 l----~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 236 L----MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred c----EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence 5 999999999999999987654 589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
+++.... +........-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.......
T Consensus 308 Ls~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------------- 372 (474)
T KOG0194|consen 308 LSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------------- 372 (474)
T ss_pred cccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH-------------
Confidence 9986541 1111112234578999999999999999999999999999999 89999876533211
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
..++....+...+...+.++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus 373 ---~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 373 ---AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11112222233334566789999999999999999999999999998876654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=341.17 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=202.0
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.|+..+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.++..++|+||+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCC-----ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 3778889999999999999876543 3899999865432 22345789999999999999999999988765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++|+|.+++.......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 74 --~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 74 --ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred --eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 359999999999998887654444689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .
T Consensus 149 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~------- 215 (285)
T cd05631 149 AVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---R------- 215 (285)
T ss_pred cEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---H-------
Confidence 97643221 1234579999999999999999999999999999999999999998654322111110 0
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
.+.. ....+...++.++.+|+.+||+.||.+||+ +++++++
T Consensus 216 --~~~~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 216 --RVKE--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --Hhhc--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0000 111233345678999999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=374.12 Aligned_cols=268 Identities=28% Similarity=0.471 Sum_probs=220.7
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+-+..+.||+|.||.||.|.+.+.........||+|.+.+... +...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~-- 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP-- 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc--
Confidence 3456678999999999999998765544477899999987643 4567899999999999999999999999986543
Q ss_pred eEEEEEeecCCCCcccccCCCC-----cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKS-----ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
++++|||+||+|..||+... ...++....+.++.|||+|+.||+++ ++|||||...|+||++...+||+|
T Consensus 771 --~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 771 --LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred --EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 89999999999999998541 34588899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
||+|+......+........-...|||||.+..+.++.|+|||||||+|||++| |..||......+...
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~---------- 915 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL---------- 915 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH----------
Confidence 999995554444433333233468999999999999999999999999999999 999998765432221
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
..+... +-..+..+++.+.++|..||+.+|++||++..|++.+..+......
T Consensus 916 ------~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 916 ------DVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ------HHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 111111 2234556888999999999999999999999999998888765543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=347.69 Aligned_cols=267 Identities=27% Similarity=0.395 Sum_probs=209.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.++||+|+||.||+|...+......++.||+|++..... ...+.+..|+.++.++ +|+||++++++|...+.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~- 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG- 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC-
Confidence 47889999999999999999876655555667899999875432 2345678899999999 89999999998876543
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------------------------------------------------
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS-------------------------------------------------------- 186 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 186 (428)
.++++|||+++++|.+++....
T Consensus 86 --~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 86 --PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred --CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 3589999999999998875321
Q ss_pred ---cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcc
Q 014245 187 ---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263 (428)
Q Consensus 187 ---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 263 (428)
...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++................++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12588999999999999999999998 999999999999999999999999999986543222122223456778
Q ss_pred cCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHH
Q 014245 264 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSK 342 (428)
Q Consensus 264 y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 342 (428)
|+|||++.+..++.++|||||||++|||++ |..||........ +... +........+.....+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~--------------~~~~~~~~~~~~~~~~ 304 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRR--------------LKEGTRMRAPEYATPE 304 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHH--------------HhccCCCCCCccCCHH
Confidence 999999999999999999999999999998 9999975432211 1110 0000111112234568
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 343 LSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 343 l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
+.+++.+||+.+|++||++.+|+++|+.++.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=345.56 Aligned_cols=266 Identities=27% Similarity=0.373 Sum_probs=205.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+.||+|+||.||++....++ ..+|+|.+..... .....+.+|+.+|+.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSG-----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence 368999999999999999999876543 3789998875432 23467889999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 77 --EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred --EEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 459999999999999998643 3488999999999999999999975 2699999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh----
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS---- 318 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 318 (428)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. .+...
T Consensus 151 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~ 224 (331)
T cd06649 151 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEG 224 (331)
T ss_pred ccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccC
Confidence 8754322 1234579999999999999899999999999999999999999997554322211110 00000
Q ss_pred ----------------------------hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 319 ----------------------------DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 319 ----------------------------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.......+............++.++.+|+.+||+.||++|||+.+|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000111111111111223567899999999999999999999999873
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=341.57 Aligned_cols=264 Identities=26% Similarity=0.436 Sum_probs=208.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.+|+..+.||+|+||.||+|.+..... .....||+|.+..... ....++.+|+.+++.++||||++++|+|....
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~--- 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCC-ccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC---
Confidence 468999999999999999998765432 2344699999875432 34567889999999999999999999997643
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 83 --~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 83 --VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred --ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence 379999999999999987543 3488899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~---~----------- 222 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---S----------- 222 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---H-----------
Confidence 86643332222223345678999999999999999999999999999998 99999764322111 1
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
++........+..++.++.+++.+||..+|++||++.+++..|..+....
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 223 ---ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 11001111111223457899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=349.79 Aligned_cols=240 Identities=25% Similarity=0.431 Sum_probs=200.1
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
++-||+|+.|.||+|.+.+. .||||+.... -..+++-|++|+|+||+.+.|+|.... .+|||
T Consensus 129 LeWlGSGaQGAVF~Grl~ne-------tVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP----cyCIi 190 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNE-------TVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP----CYCII 190 (904)
T ss_pred hhhhccCcccceeeeeccCc-------eehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc----eeEEe
Confidence 44699999999999998864 6999987532 236788999999999999999998766 45999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
||||..|-|...|+.. ..+.......+..+||.|+.|||.+ .|||||||.-||||..+..|||+|||.++.....
T Consensus 191 MEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999999643 4588888899999999999999998 9999999999999999999999999999865432
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
.....++||..|||||++.+.+.++|+|||||||+|||||||..||..-... ..+..+-..
T Consensus 266 ---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----------------AIIwGVGsN 326 (904)
T KOG4721|consen 266 ---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----------------AIIWGVGSN 326 (904)
T ss_pred ---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----------------eeEEeccCC
Confidence 2344689999999999999999999999999999999999999999653221 011111122
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
.+.-..+..+++.+.-|+++||+..|..||++.+++.||+-.
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 233345556778899999999999999999999999998753
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.76 Aligned_cols=265 Identities=25% Similarity=0.455 Sum_probs=213.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.+|.+.+.||+|+||.||+|.............+++|.+........+.+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP--- 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc---
Confidence 35788889999999999999876554445566799999876655556778999999999999999999999987654
Q ss_pred eEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~ 230 (428)
.++||||+++++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~ 157 (291)
T cd05094 82 -LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG 157 (291)
T ss_pred -eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 499999999999999986432 23488999999999999999999998 999999999999999
Q ss_pred CCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHH
Q 014245 231 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKL 309 (428)
Q Consensus 231 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~ 309 (428)
.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-- 235 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-- 235 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 999999999999976544332222334557889999999998899999999999999999999 99998765432211
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
.. +..... ......++..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 236 -~~-------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 -EC-------------ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HH-------------HhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11 111111 11122345689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=351.73 Aligned_cols=267 Identities=23% Similarity=0.366 Sum_probs=209.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCC-CCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.++||+|+||.||+|.+...........||+|.+...... ..+.+.+|+.+|..+. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4578899999999999999998765544445567999999754332 3457889999999996 9999999999987654
Q ss_pred CCceEEEEEeecCCCCcccccCCCC-------------------------------------------------------
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKS------------------------------------------------------- 186 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 186 (428)
.+||||||++|+|.+++....
T Consensus 116 ----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 116 ----IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred ----eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 499999999999988774321
Q ss_pred ---------------------------------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCce
Q 014245 187 ---------------------------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227 (428)
Q Consensus 187 ---------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NI 227 (428)
...+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 12477888899999999999999998 999999999999
Q ss_pred EECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhh
Q 014245 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSE 306 (428)
Q Consensus 228 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~ 306 (428)
|++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999976543222222233457788999999998899999999999999999997 9999975432111
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
+... +...........++.++.+++.+||+.||++||++.+|.+.|+.+..
T Consensus 349 --~~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 --FYNK--------------IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHH--------------HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1000 00001111223456789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=343.60 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=193.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.+|+..+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++|+||+++++++.+..
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 145 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTG-----RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG--- 145 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCC-----CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC---
Confidence 35667788999999999999876543 3799999865433 23467889999999999999999999997765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.+++||||+++|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 146 -~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 146 -EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred -eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence 359999999999997643 245677889999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhcc-----CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
+...... .......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+....
T Consensus 216 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----- 288 (353)
T PLN00034 216 RILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----- 288 (353)
T ss_pred eeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----
Confidence 7653221 11234579999999998743 23456899999999999999999999743322211111100
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ..........++.++.+|+.+||+.||++||++.|++++
T Consensus 289 --------~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 --------C-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --------h-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000111223456789999999999999999999999986
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=362.28 Aligned_cols=264 Identities=24% Similarity=0.336 Sum_probs=216.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEee-EEecC-CC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVG-YCADD-DE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~-~~~~~-~~ 161 (428)
.++++.++|.+|||+.||+|...... ..||+|++-..+....+.+.+|+.+|++|. |+|||.+++ ..... ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~-----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGG-----KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCC-----ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 46788899999999999999976652 479999987777777788999999999995 999999999 33322 22
Q ss_pred C-CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 162 R-GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 162 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
. ..+.+|+||||.||.|-|++..+....|++.++++|+.|+++|+++||.. .++|||||||-+||||+.+|..|||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 2 24678999999999999999877666699999999999999999999986 668999999999999999999999999
Q ss_pred cccccCCCCCcee-------eeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 241 GLARLGPSEGFTH-------VSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 241 Gla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
|.|.......... ..-...-|+.|.|||++. +...++|+|||||||+||-|+....||+....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------- 263 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------- 263 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence 9986432211000 011235689999999874 66789999999999999999999999986522
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
..+++....-.....++..|.+||..||+.||++||++-+++.++.++...
T Consensus 264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 244454444444567889999999999999999999999999999887643
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=341.41 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=200.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISE-----HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 36889999999999999999876543 3799999865322 23456789999999999999999999887765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 75 ---FLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred ---eEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 459999999999999998654 3488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 147 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~------------- 208 (291)
T cd05612 147 FAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE------------- 208 (291)
T ss_pred cchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence 99765322 223579999999999999889999999999999999999999997654321111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
.+.... ..++..++..+.+++.+||+.||.+||+ +++++++
T Consensus 209 ---~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 209 ---KILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---HHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111111 1122234568899999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=346.83 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=204.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||+|....++ ..||+|++..... .....+..|+.++..++||||+++++++.+.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTG-----EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 46899999999999999999976543 3799999875422 23456789999999999999999999998766
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 75 ---YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred ---EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 459999999999999999643 3488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..
T Consensus 147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~--------- 212 (333)
T cd05600 147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY--------- 212 (333)
T ss_pred CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh---------
Confidence 9975432 23346799999999999999999999999999999999999999986543322111110
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+...........++.++.+++.+||..+|.+||++.+++++
T Consensus 213 -~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 -WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 001111111111112456789999999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=325.31 Aligned_cols=269 Identities=24% Similarity=0.310 Sum_probs=209.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc--HHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|+.++.|++|+||.||+|..+.+++ .||+|+++...... .-.-++|+++|.+++|||||.+-.+....+..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~e-----IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDE-----IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcce-----eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 457888899999999999998666544 89999997654221 12457999999999999999999888766544
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.+|||||||++ +|..++.... .+|...++..++.|++.||+|||.+ .|+||||||+|+|++..|.+||+|||+
T Consensus 151 --~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 151 --KIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred --eeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccch
Confidence 46999999976 8998887654 5699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH--------
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-------- 313 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-------- 313 (428)
|+.+...- ...+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+....+..+.+-..
T Consensus 224 AR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 224 AREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred hhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 99876542 234567889999999998875 5999999999999999999999999887665544333211
Q ss_pred hhhhhhhhhhhhh-----cCCcCCCCccHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQI-----VDPRLEGKYSLR-LVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~-----~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
++.+........+ ....++..+... +++.-.+|+..+|..||.+|.|+.+.+++
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111111111000 001111222221 55778899999999999999999999886
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=335.01 Aligned_cols=266 Identities=27% Similarity=0.453 Sum_probs=211.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||.||++.............+|+|.+..........+.+|+.++.+++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP--- 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc---
Confidence 46888999999999999999865543344556799999876655556678999999999999999999999987654
Q ss_pred eEEEEEeecCCCCcccccCCCC-----------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKS-----------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||+++++
T Consensus 82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 82 -LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred -cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 499999999999999885322 13489999999999999999999998 999999999999999999
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHh
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 312 (428)
.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......... ..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~---~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---EC 234 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH
Confidence 999999999975543322222233446788999999998889999999999999999998 99999765432211 10
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
+..... ......++.++.+++.+||+.||.+||++.++++.|+.+...
T Consensus 235 -------------i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 -------------ITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -------------HHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000000 001112446799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=334.84 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=208.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|.............||+|.+...... ..+.+.+|++++..++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP-- 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC--
Confidence 468888899999999999998765543445568999998765443 45688999999999999999999999987653
Q ss_pred ceEEEEEeecCCCCcccccCCCC------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKS------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
.++||||+++++|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+|||++.
T Consensus 83 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~ 157 (280)
T cd05049 83 --PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY 157 (280)
T ss_pred --eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence 599999999999999986432 24578899999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~ 310 (428)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...........+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999999975433222222233456789999999999999999999999999999998 99999765432211111
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.... ....+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 238 ----------------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ----------------TQGR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----------------HcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0100 11112235578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=335.98 Aligned_cols=268 Identities=23% Similarity=0.283 Sum_probs=202.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETK-----EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCC-----cEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC--
Confidence 47899999999999999999976543 3799999865422 23456789999999999999999999997765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||++++.|..+... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 74 --~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 74 --KLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred --EEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 45999999998877655432 23588999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-hhh----
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-PYL---- 317 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~---- 317 (428)
+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... +..
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 147 ARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 986533221 11234578999999999998899999999999999999999999998654332221111110 000
Q ss_pred ---hhhhhhhhhcCCcC------CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 ---SDAKQFRQIVDPRL------EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ---~~~~~~~~~~~~~l------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...........+.. ...+...++.++.+++.+||+.||++|||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 011112356789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=344.82 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 167 (428)
++||+|+||.||+|....++ ..||+|++..... .....+.+|+.++..++||||+++++++...+ ..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKATG-----KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD----RLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC----EEE
Confidence 36999999999999876543 3899999875422 23356778999999999999999999998766 459
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 72 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999999888643 3589999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014245 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327 (428)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (428)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......... . .+.
T Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~-------------~~~ 208 (323)
T cd05571 147 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---E-------------LIL 208 (323)
T ss_pred cCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---H-------------HHH
Confidence 221 1233467999999999999999999999999999999999999999754322111 1 011
Q ss_pred CCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 328 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
... ..++..++.++.+++.+||+.||++|| ++.+++++
T Consensus 209 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 209 MEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 111 112234567899999999999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=347.09 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=214.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|..++++|+|+||.++++.++... ..+++|.+..... .......+|+.+++++.|||||.+++.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~-----~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~- 77 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDD-----KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ- 77 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCC-----ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc-
Confidence 57889999999999999998876543 3799999876543 234467899999999999999999999988774
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..+|||+||+||+|.+.|.......|+++.+..++.|++.|+.|||++ .|+|||||+.|||++.++.|||+|||+
T Consensus 78 --~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 78 --LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred --eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence 259999999999999999877667899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
|+...... ....+.+|||.||+||++.+.+|+.|+|||||||++|||++-+++|...+.. .++.
T Consensus 153 aK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~----------- 216 (426)
T KOG0589|consen 153 AKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELIL----------- 216 (426)
T ss_pred hhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHH-----------
Confidence 99876553 2345689999999999999999999999999999999999999999875432 1111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
++. +..-...+..++.++..++..|+..+|+.||++.+++.+
T Consensus 217 --ki~-~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 217 --KIN-RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --HHh-hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111 111234455677899999999999999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=345.97 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=201.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 91 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTG-----EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN- 91 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-
Confidence 57889999999999999999976654 3799999865422 23456889999999999999999999998766
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 92 ---~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 92 ---RVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred ---EEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence 359999999999999988654 3488899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 164 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------------- 224 (329)
T PTZ00263 164 FAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-------------- 224 (329)
T ss_pred CceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH--------------
Confidence 997654321 2357999999999999999999999999999999999999999765432111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
..+....+ .++..++..+.+++.+||+.||.+||+ +++++.+
T Consensus 225 --~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 225 --EKILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --HHHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111111 112224567899999999999999996 6888865
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=330.60 Aligned_cols=259 Identities=24% Similarity=0.419 Sum_probs=204.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|+||.||+|.+.... .....||+|.+..... .....+.+|+.++.+++||||+++++++...+.
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPS--KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT-- 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCC--CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC--
Confidence 46889999999999999999865322 2345899999876533 234578899999999999999999999987654
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.++++|||.+
T Consensus 81 --~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 81 --MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred --cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence 499999999999999987543 3589999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
........ .......++..|+|||++.+..++.++|||||||++||+++ |..||........ ....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~--------- 221 (266)
T cd05064 155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAV--------- 221 (266)
T ss_pred ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH---------
Confidence 64322111 11112345678999999999999999999999999999875 9999976543221 1110
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
.+ ......+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 222 ----~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 ----ED-GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----HC-CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 011112334567899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=326.09 Aligned_cols=272 Identities=24% Similarity=0.323 Sum_probs=212.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC--CcccHHHHHHHHHHHhcCCCCCcccEeeEEec-CC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCAD-DD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~ 160 (428)
...|...+.||+|+||.|+.+....++ ..||||++... .....++..+|+++|+.++|+||+.+++++.. ..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~-----~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTG-----EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCC-----CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 456777889999999999999977654 48999999743 33456788899999999999999999999876 22
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
......|+|+|+| +.+|...|+.. ..++..++..++.|++.||.|+|+. +|+||||||+|+|++.++.+||+||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 2334579999999 67999999643 4499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhc-cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|+|+...........+..+.|..|.|||++. ...|+.+.||||.|||+.||++|++-|.+.+......++........
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~- 248 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS- 248 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC-
Confidence 9999775432233346788999999999775 46799999999999999999999999998876655555443221110
Q ss_pred hhhhhhhc----------CCcCCC-Cc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIV----------DPRLEG-KY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~----------~~~l~~-~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+..+- .+.... .+ .+...+...+|+.+||..||.+|+|++|.+++
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 01111111 011111 11 12445788999999999999999999999986
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=331.76 Aligned_cols=262 Identities=23% Similarity=0.444 Sum_probs=204.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+.||+|+||.||+|.+.+.........||+|.+..... ....++.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~- 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP- 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-
Confidence 467999999999999999999876543333456799999864332 234568899999999999999999999876653
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
.++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+|||+++++.
T Consensus 84 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 84 ---TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred ---eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 499999999999999886422 12367888999999999999999998 9999999999999999999
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 313 (428)
++|+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||............
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~--- 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV--- 234 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---
Confidence 99999999875433222222223356788999999998899999999999999999999 78898765432211111
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
..... ...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 235 -------------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 -------------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -------------HcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00000 0112234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=332.44 Aligned_cols=255 Identities=33% Similarity=0.549 Sum_probs=198.5
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEE
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 167 (428)
..+.||.|.||.||+|.+.. ........|+||.+..... ...+.+.+|++++++++||||++++|++..... .+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~----~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP----LF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS----EE
T ss_pred EeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc----cc
Confidence 45689999999999999884 2344567899999965433 346789999999999999999999999995553 49
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
+||||+++|+|.+++.......+++..++.|+.||+.||+|||++ +++|+||+++|||++.++.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999999999876455699999999999999999999998 99999999999999999999999999998763
Q ss_pred CCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
............+...|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~~------------ 219 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKLK------------ 219 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHHH------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccc------------
Confidence 3333333344567789999999999889999999999999999999 789987653221 111110
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
+. .....+..++..+.+++..||..+|++||++.+|++.|
T Consensus 220 -~~-~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 -QG-QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TT-EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cc-ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 01112223456899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=334.16 Aligned_cols=264 Identities=25% Similarity=0.408 Sum_probs=209.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||.||+|.............||+|.+..... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~- 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP- 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc-
Confidence 46889999999999999999865444444566899999875532 2345788999999999 89999999999987664
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++||||+++|+|.+++.......+++..+..++.|++.||+|||++ +|+|+||||+|||++.++.++|+|||+
T Consensus 114 ---~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ---ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ---eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 49999999999999998754444589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+................++..|+|||++.+..++.++|||||||++|+|++ |..||......... ..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~---------- 255 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YK---------- 255 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HH----------
Confidence 975543322112223456788999999999999999999999999999998 99999765432111 11
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
..............+.++.+++.+||..+|++||++.++++.|.++
T Consensus 256 ----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 ----LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0111111111123456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=344.22 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=201.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||.||+|.+.... ...||+|.+.... ......+.+|+.++..++||||+++++++.+..
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~- 104 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNED----FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES- 104 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCC----CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC-
Confidence 47899999999999999999865432 2379999986432 223456789999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 105 ---~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 105 ---YLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred ---EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCC
Confidence 459999999999999998654 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------------- 238 (340)
T PTZ00426 177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------------- 238 (340)
T ss_pred CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH-------------
Confidence 99765322 234679999999999998889999999999999999999999998654321111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.+..... .++..++..+.+++.+||+.||++|+ ++++++++
T Consensus 239 ---~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 239 ---KILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---HHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111111 12223456789999999999999995 89998876
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=330.65 Aligned_cols=264 Identities=27% Similarity=0.425 Sum_probs=207.1
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+|.+.+.||+|+||.||+|.............+++|.+..... .....+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL-- 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc--
Confidence 4778889999999999999875433333445789998875433 2345788999999999999999999999876643
Q ss_pred eEEEEEeecCCCCcccccCCC----------------------CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC
Q 014245 165 QRLLVYEYMPNGSVDQYLSPK----------------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 222 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~----------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl 222 (428)
++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +++||||
T Consensus 79 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~di 153 (290)
T cd05045 79 --LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDL 153 (290)
T ss_pred --EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhh
Confidence 8999999999999887532 123578999999999999999999998 9999999
Q ss_pred CCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCC
Q 014245 223 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRN 301 (428)
Q Consensus 223 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~ 301 (428)
||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++++|++ |..||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999975433221111223346778999999988889999999999999999998 99999765
Q ss_pred CchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 302 RPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
.+.. +.... ........+...+.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 234 ~~~~---~~~~~--------------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 234 APER---LFNLL--------------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CHHH---HHHHH--------------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 4322 11111 1111111222345689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=331.51 Aligned_cols=267 Identities=26% Similarity=0.399 Sum_probs=200.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 76 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER--- 76 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCC-----CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC---
Confidence 57999999999999999999876543 3799999865432 23456789999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 77 -~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 77 -CLTLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred -eEEEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence 35999999975 8888876433 3478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh--------
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------- 314 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------- 314 (428)
+...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 151 RAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 7543221 11233578999999998865 568999999999999999999999998765443322221110
Q ss_pred hhhhhhhhhhhhcCCcCCCCc----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDAKQFRQIVDPRLEGKY----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.......+.....+...... ....+.++.+++.+||+.||.+|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000011111111111111000 11235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=339.14 Aligned_cols=267 Identities=26% Similarity=0.357 Sum_probs=202.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+.||+|+||.||+|....++ ..+|+|.+..... .....+.+|+++++.++|+||++++++|.+.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSG-----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--
Confidence 368999999999999999999876543 3788888765422 23457889999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 77 --EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred --EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 459999999999999998643 3488899999999999999999974 2799999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh--------
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------- 314 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------- 314 (428)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 151 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (333)
T cd06650 151 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226 (333)
T ss_pred chhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence 8754322 1234579999999999998889999999999999999999999997554322211110000
Q ss_pred --------------------hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 --------------------PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 --------------------~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..........+............++.++.+|+.+||+.||++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000000001000000111245678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.81 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=203.1
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
.|.+.+.||+|+||.||+|...... +..||+|.+..........+.+|+.+|+.++|||||++++++...+ .
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~----~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDP----KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD----K 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCC----CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC----E
Confidence 4888999999999999999865431 2368888776554444556788999999999999999999998765 4
Q ss_pred EEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.||||||+++|+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 59999999999999877532 234588999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
+..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~------------ 281 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ------------ 281 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH------------
Confidence 86543322223345679999999999999999999999999999999999999997543221 111
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..... ...+..++.++.+++.+||..||++||++.+++.+
T Consensus 282 -~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 282 -QVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -HHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1111111 11222355789999999999999999999999753
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=326.23 Aligned_cols=255 Identities=25% Similarity=0.455 Sum_probs=205.0
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
+|.+.+.||+|+||.||+|.....+ ..|++|.+... ......+.+|+.+++.++|+||+++++++.....
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 76 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP---- 76 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCC-----ceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC----
Confidence 5778889999999999999976543 37999988654 2345678899999999999999999999987664
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.++||||+++++|.+++.......+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 48999999999999998765555689999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||........ ....
T Consensus 154 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~----------- 218 (263)
T cd05052 154 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELL----------- 218 (263)
T ss_pred cccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH-----------
Confidence 5432211 1112234678999999998899999999999999999998 9999976432211 1110
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 219 ---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 ---EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111122233557899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=333.54 Aligned_cols=265 Identities=26% Similarity=0.453 Sum_probs=209.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
.++|+..+.||+|+||.||+|.............+|+|.+..... .....+.+|+.++..+ +|+||+++++++.....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 357888999999999999999876554334456899999875432 3345688999999999 89999999999987654
Q ss_pred CCceEEEEEeecCCCCcccccCCC--------------CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCce
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NI 227 (428)
.++||||+++|+|.+++..+ ....+++..++.++.|++.||.|||+. +|+||||||+||
T Consensus 91 ----~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 91 ----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred ----eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 49999999999999988532 234689999999999999999999998 999999999999
Q ss_pred EECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhh
Q 014245 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSE 306 (428)
Q Consensus 228 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~ 306 (428)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999986543332222223345678999999988899999999999999999998 9999975433221
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
... +........+...+..+.+++.+||..||++|||+.++++.|+.++
T Consensus 244 ~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKL-----------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH-----------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 0011111122234568999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.18 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=204.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|.+...+. .....+++|.+..... ....++..|+.++..++||||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~--- 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGD-SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS--- 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCC-ceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCc---
Confidence 467888899999999999998765432 2234588888764432 23356778888999999999999999875432
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+|||+++++.+||+|||++
T Consensus 83 --~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 83 --LQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred --cEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence 378999999999999996533 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...............++..|+|||++.++.++.++|||||||++|||++ |..||..........+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~- 228 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGE- 228 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCC-
Confidence 86543322222234557789999999998899999999999999999998 999997654322211111 000
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
.. ..+..+...+.+++.+||..||++||++.++++.|..+.+
T Consensus 229 --~~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 --RL-------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --cC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 00 0011133567889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=331.54 Aligned_cols=270 Identities=25% Similarity=0.341 Sum_probs=198.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcC---CCCCcccEeeEEecC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIV---EHQNLVKLVGYCADD 159 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~ 159 (428)
++|.+.+.||+|+||.||+|.....+ +..||+|.+..... .....+.+|+.+++.+ +||||++++++|...
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNG----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCC----CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 47899999999999999999864321 24789998865432 2234566777777665 799999999998642
Q ss_pred C-CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 160 D-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 160 ~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
. .....+++||||++ ++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 2 11234699999996 6898888765555689999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVKPYL 317 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~ 317 (428)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|..||...........+ .... .
T Consensus 153 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~--~ 227 (290)
T cd07862 153 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG--L 227 (290)
T ss_pred cccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC--C
Confidence 99999765332 1233467899999999999889999999999999999999999999876543221111 1100 0
Q ss_pred hhhhhhh-------hhcCCcCCC---CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFR-------QIVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~-------~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+. ......... .....++..+.+++.+||+.||++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000000 000000000 0112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=325.02 Aligned_cols=260 Identities=27% Similarity=0.468 Sum_probs=206.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|+||.||+|.+.... .....||+|.+...... ....|..|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPG--KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP-- 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCC--CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc--
Confidence 57889999999999999999876432 22447999998754332 34578899999999999999999999877654
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+|+||||+|||+++++.++|+|||++
T Consensus 80 --~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 80 --VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred --eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchh
Confidence 499999999999999986543 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~--------- 221 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAV--------- 221 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHH---------
Confidence 87642222222223345678999999998899999999999999999998 9999965432211 1111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
... .....+..++..+.+++.+||+.+|++||++.+|+++|+++
T Consensus 222 ----~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 ----EDG-YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----HcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00011223457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=339.18 Aligned_cols=271 Identities=22% Similarity=0.329 Sum_probs=199.5
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC-C
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE-R 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~ 162 (428)
+|++.++||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++||||+++++++..... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCC-----CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence 4888999999999999999876543 389999986432 2334568899999999999999999998865432 1
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
....|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred CceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence 224699999994 6888888643 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc-eeeeeeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh----
Q 014245 243 ARLGPSEGF-THVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP---- 315 (428)
Q Consensus 243 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~---- 315 (428)
++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 975432211 112234679999999999876 6789999999999999999999999976543222111110000
Q ss_pred ----hhhh--hhhhhhhcCCcCCCCcc---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 ----YLSD--AKQFRQIVDPRLEGKYS---LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ----~~~~--~~~~~~~~~~~l~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.. .......+......... ...+..+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 00000001111110111 1234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=339.55 Aligned_cols=243 Identities=26% Similarity=0.378 Sum_probs=195.6
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 167 (428)
+.||+|+||.||++....++ ..||+|.+.+... .....+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKASG-----KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD----RLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----EEE
Confidence 36999999999999876543 3899999875422 23456789999999999999999999998766 359
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999999998888543 3589999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014245 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327 (428)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (428)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........... +.
T Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~----------------~~ 208 (328)
T cd05593 147 TDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------------IL 208 (328)
T ss_pred Ccc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH----------------hc
Confidence 211 112346799999999999998999999999999999999999999975432211110 10
Q ss_pred CCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 328 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
... ..++..++.++.+++.+||+.||++|| ++.+++++
T Consensus 209 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 209 MED--IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cCC--ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 000 112233567889999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=329.37 Aligned_cols=261 Identities=25% Similarity=0.430 Sum_probs=204.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.+|++.+.||+|+||.||+|.....+ ......+++|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPG-MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP-- 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCC-CCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc--
Confidence 46788899999999999999864322 22345799999875432 334678899999999999999999999887664
Q ss_pred ceEEEEEeecCCCCcccccCCCC---------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKS---------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 228 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NIL 228 (428)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||
T Consensus 82 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 82 --VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred --eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 499999999999999884221 23478889999999999999999998 9999999999999
Q ss_pred ECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhH
Q 014245 229 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQ 307 (428)
Q Consensus 229 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~ 307 (428)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-- 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-- 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999976543332222334556778999999988889999999999999999998 999997643221
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
...... .......+..++..+.+++.+||+.||++||++.+|+++|..
T Consensus 235 -~~~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 -VIEMVR--------------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHH--------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111110 000011222345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=339.08 Aligned_cols=268 Identities=25% Similarity=0.388 Sum_probs=207.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||.||+|...+......++.||||.+..... .....+.+|+.++..+ +|+||+++++++.....
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG- 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC-
Confidence 47999999999999999999876555555677899999975432 2345688999999999 78999999998876543
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------------------------------------------------
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS-------------------------------------------------------- 186 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 186 (428)
..++||||+++|+|.+++....
T Consensus 86 --~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 86 --PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred --ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 3489999999999998875321
Q ss_pred ---------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeee
Q 014245 187 ---------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257 (428)
Q Consensus 187 ---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 257 (428)
...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367888899999999999999998 999999999999999999999999999976432221111222
Q ss_pred eecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCcc
Q 014245 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYS 336 (428)
Q Consensus 258 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 336 (428)
..+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ..... .. ......+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~----~~----------~~~~~~~ 304 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRL----KE----------GTRMRAP 304 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHH----hc----------cCCCCCC
Confidence 345678999999998899999999999999999997 9999975432111 11100 00 0000111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 337 LRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 337 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
...++++.+++.+||+.+|++||++.+|+++|+.+++.
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 12345789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=339.35 Aligned_cols=243 Identities=26% Similarity=0.370 Sum_probs=195.2
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 167 (428)
+.||+|+||.||++....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----RLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----EEE
Confidence 36999999999999876543 3899999875421 23456778999999999999999999998765 459
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
+||||+++|+|..++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 72 lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 72 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999999998888543 3589999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014245 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327 (428)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (428)
... .......||+.|+|||++.+..++.++|||||||++|||++|..||.......... .+.
T Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----------------~~~ 208 (323)
T cd05595 147 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------------LIL 208 (323)
T ss_pred CCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH----------------HHh
Confidence 221 11234679999999999999999999999999999999999999997654321111 111
Q ss_pred CCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 328 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.... .++..+++++.+++.+||+.||++|| ++.+++++
T Consensus 209 ~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 209 MEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred cCCC--CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1111 12233567889999999999999998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=325.66 Aligned_cols=254 Identities=25% Similarity=0.459 Sum_probs=204.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.++||+|+||.||+|...++. .||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 75 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNST------KVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP--- 75 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCc------eEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---
Confidence 47888999999999999999865432 68999886543 235678899999999999999999999877654
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 76 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 76 -IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred -cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccce
Confidence 49999999999999998765455688999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......++..|+|||++.++.++.++|||||||++|+|++ |..||......... ....
T Consensus 152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~--------- 218 (261)
T cd05072 152 VIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SALQ--------- 218 (261)
T ss_pred ecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HHHH---------
Confidence 6543221 11223346778999999998889999999999999999998 99999764332211 1110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
... .......++.++.+++.+||..+|++||+++++++.|++
T Consensus 219 -~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 219 -RGY----RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -cCC----CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 001112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.27 Aligned_cols=261 Identities=25% Similarity=0.442 Sum_probs=206.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.+|....+||+|+||.||+|.............+++|.+..........+.+|+++++.++|+||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP--- 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc---
Confidence 36777889999999999999765443444566899999876655556789999999999999999999999987654
Q ss_pred eEEEEEeecCCCCcccccCCCCc-------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSE-------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
.++||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||+++
T Consensus 82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 82 -LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred -eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 4999999999999998864321 3488999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~ 310 (428)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~- 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC- 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-
Confidence 99999999999975543322222233445788999999998899999999999999999998 9999865433211110
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.... .....+..++..+.+++.+||+.||++||++++|++.|+
T Consensus 237 ---------------~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ---------------ITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---------------HHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1010 001111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=329.95 Aligned_cols=261 Identities=21% Similarity=0.378 Sum_probs=205.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+|.+.+.||+|+||.||+|...++........||+|.+...... ....+..|+.++..++||||+++++++.....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~--- 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP--- 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc---
Confidence 46667789999999999998776544445668999999755332 23568899999999999999999999987664
Q ss_pred eEEEEEeecCCCCcccccCCC--------------CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC
Q 014245 165 QRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~ 230 (428)
.++++||+++++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 83 -~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~ 158 (283)
T cd05091 83 -LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF 158 (283)
T ss_pred -eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence 48999999999999887421 123478888999999999999999998 999999999999999
Q ss_pred CCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHH
Q 014245 231 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKL 309 (428)
Q Consensus 231 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~ 309 (428)
+++.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||....... .
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V 235 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 999999999999876543332222334456789999999988899999999999999999998 888887643321 1
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
.. .+.+.. ....+..++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 236 ~~-------------~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IE-------------MIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-------------HHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 111111 111233456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.96 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=195.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|++.+.||+|+||.||+|....+. ..||+|.... ..+.+|+.+++.|+||||+++++++.....
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~-----~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-- 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTC-----EHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKF-- 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCC-----CEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe--
Confidence 357999999999999999999876543 3799997532 356799999999999999999999987653
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++|||++. ++|..++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 158 --~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 158 --TCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred --eEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 499999994 6888887544 3488999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh-----hHHHHHhHhhhh-
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS-----EQKLLQWVKPYL- 317 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~- 317 (428)
....... ........||+.|+|||++.+..++.++|||||||++|||++|..||....... ...+.......-
T Consensus 230 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred ccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 7532211 112234679999999999999999999999999999999999998875432110 000100000000
Q ss_pred -------hhhhhhhhhc---------CCcCCCC--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 -------SDAKQFRQIV---------DPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 -------~~~~~~~~~~---------~~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+.... .+..... .....+.++.+|+.+||+.||++|||+.|++++
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 0000000 011356789999999999999999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=337.05 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=193.2
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
||+|+||.||+|....++ ..||+|.+.... ......+..|+.++..++||||+++++++.+.. ..++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQ-----RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE----KLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC----eEEEE
Confidence 699999999999976543 379999986532 223456789999999999999999999998765 35999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 72 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 72 LAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred EcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999999988653 3489999999999999999999998 9999999999999999999999999999753222
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+...
T Consensus 147 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~-------------~~~~~~ 208 (312)
T cd05585 147 D--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MY-------------RKILQE 208 (312)
T ss_pred C--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HH-------------HHHHcC
Confidence 1 12334679999999999999999999999999999999999999997643211 11 111111
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPK---MSEVLEM 367 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~ell~~ 367 (428)
. ..++..+++++.+++.+||..||++||+ +.+++.+
T Consensus 209 ~--~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 209 P--LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred C--CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1 1122345678999999999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=326.08 Aligned_cols=255 Identities=28% Similarity=0.475 Sum_probs=208.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
..+|++.++||.|+||.||+|...+.. .+++|.+..........+..|+.+++.++|+||+++++++.+...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~------~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRV------RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP-- 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCC------cEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC--
Confidence 346888999999999999999876632 799999887665556788999999999999999999999987664
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++ +++|+||||+|||+++++.+||+|||++
T Consensus 77 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 77 --VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred --eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccch
Confidence 49999999999999999865556689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||........ ....
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~--------- 217 (261)
T cd05148 152 RLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQI--------- 217 (261)
T ss_pred hhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHH---------
Confidence 765432211 123446778999999988889999999999999999998 8999976542211 1111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
. .......+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 218 ----~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 218 ----T-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----H-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0 011111223455789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=343.44 Aligned_cols=265 Identities=22% Similarity=0.397 Sum_probs=206.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||.||+|.+.+.........||+|++...... ....+.+|+.+|.++. ||||++++++|.....
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~- 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP- 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC-
Confidence 357788899999999999999765434445568999999765322 2356889999999997 9999999999987664
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------------------------------------------------
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS-------------------------------------------------------- 186 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 186 (428)
.++||||+++|+|.+++....
T Consensus 116 ---~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 116 ---IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred ---cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 499999999999998885321
Q ss_pred ----------------------------------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 187 ----------------------------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 187 ----------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
...+++..++.|+.|++.||+|||+. +++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 12367778889999999999999998 99999999999
Q ss_pred eEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchh
Q 014245 227 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 305 (428)
Q Consensus 227 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 305 (428)
||+++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999975432211111223457889999999998889999999999999999998 899987543221
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
. +. ..+........+..++.++.+++.+||..+|.+||++++|++.|+.++
T Consensus 350 ~--~~--------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q--FY--------------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--HH--------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 00 001111111122234578999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=327.04 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=204.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+++|.+.+.||+|+||.||+|.+...........|++|.+..... .....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 457899999999999999999987533233456899998865432 2345688999999999999999999998876543
Q ss_pred CceEEEEEeecCCCCcccccCCCCc-----ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC---C
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSE-----TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---N 234 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~ 234 (428)
++||||+++++|.+++..... ..+++..++.++.||+.||+|||++ +++||||||+|||++.++ .
T Consensus 85 ----~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 85 ----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred ----EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence 899999999999998864321 3589999999999999999999998 999999999999998765 5
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 313 (428)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~---- 233 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF---- 233 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 99999999986533222111222334568999999998899999999999999999997 9999976543221111
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
+........+..++..+.+++.+||+.+|++||++.+|+++|.
T Consensus 234 -------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 -------------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0001111222334578999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=354.05 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=207.5
Q ss_pred HHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEe
Q 014245 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
.....++|.+.+.||+|+||+||+|....++ ..||+|.+..... .....+.+|+.++..++|+||+++++.+.
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDG-----EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 3444579999999999999999999865543 3899999865432 23456789999999999999999988775
Q ss_pred cCCCC----CceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 158 DDDER----GIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 158 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
..+.. ...+++||||+++|+|.+++..+ ....+++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCS 178 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeC
Confidence 43321 12358999999999999988643 234689999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 311 (428)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~~ 255 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VMH 255 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence 99999999999986543322223345689999999999999999999999999999999999999997643221 111
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... ....+..+++++.+++.+||+.||.+||++.+++++
T Consensus 256 -------------~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 -------------KTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------------HHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 111233456789999999999999999999999875
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=326.97 Aligned_cols=275 Identities=28% Similarity=0.431 Sum_probs=207.1
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
|...+.||+|+||+||++.+... ....+..||+|.+..... .....+.+|+.+++.++||||+++++++...... .
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK--G 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccc-cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc--e
Confidence 48889999999999999876432 223455799999876532 3456788999999999999999999998765432 4
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.++||||+++++|.+++... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 58999999999999998643 389999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 246 GPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 246 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... .......++..|+|||++.+..++.++||||||+++++|++|..||........ .......... ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~ 234 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRLI 234 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhhh
Confidence 5432211 111223456779999999888899999999999999999999999865432111 1111000000 001111
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
+..+.......+..++..+.+++.+||+.+|++||+++++++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 112222222223345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=323.69 Aligned_cols=262 Identities=23% Similarity=0.420 Sum_probs=200.8
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC--C
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--R 162 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--~ 162 (428)
|.+.++||+|+||.||+|...... ....+|+|.+.... ....+.+..|+.+++.++|+||+++++++..... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD---SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCC---CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 356778999999999999876543 22368999886542 2335678899999999999999999998754321 1
Q ss_pred CceEEEEEeecCCCCcccccCC----CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSP----KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
....++||||+++|+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEEC
Confidence 1245899999999999887632 1224588999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|||+++...............+++.|++||++.+..++.++||||||+++|||++ |..||....... ......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~--- 228 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYLR--- 228 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH---
Confidence 9999986543322222223346778999999998889999999999999999999 889997543221 111110
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
... . ......++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 229 -~~~--------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 -QGN--------R--LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -cCC--------C--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 0 011223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=344.13 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=197.6
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.|..++.||+|+||+||+|....++ ..||+|++..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTH-----ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 5888999999999999999876543 4899999975432 23456889999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||.. +|+||||||+||||+.++.+||+|||+
T Consensus 75 --~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 75 --NLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred --EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 459999999999999998643 3488999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc---------------------------------------------eeeeeeeecCcccCCcchhccCCCCC
Q 014245 243 ARLGPSEGF---------------------------------------------THVSTAVVGTMGYAAPEYVQTGRLAA 277 (428)
Q Consensus 243 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 277 (428)
+........ .......+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 753210000 00112357999999999999889999
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHH--hcccCC
Q 014245 278 RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL--CLVKNA 355 (428)
Q Consensus 278 ~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~~dp 355 (428)
++|||||||++|||++|..||...........+. . ....+.......++.++.+++.+ |+..++
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~-------------~-~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI-------------N-WENTLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHH-------------c-cccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 9999999999999999999997654332211100 0 00011111112345678888887 556677
Q ss_pred CCCCCHHHHHHH
Q 014245 356 RTRPKMSEVLEM 367 (428)
Q Consensus 356 ~~RPs~~ell~~ 367 (428)
..||++.+++++
T Consensus 294 ~~R~~~~~~l~h 305 (381)
T cd05626 294 LGRNGADDIKAH 305 (381)
T ss_pred cCCCCHHHHhcC
Confidence 779999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=322.60 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=204.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|++.+.||+|+||.||+|...++ ..||+|.+.... ...+++.+|+.++++++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~------~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNT------TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP-- 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCC------eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC--
Confidence 35688999999999999999986543 269999987543 345678899999999999999999999887664
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 76 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 76 --IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred --eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence 49999999999999999765545689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
......... ......++..|+|||++.+..++.++||||||+++++|++ |+.||........... .
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~--------- 217 (261)
T cd05068 151 RVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ---V--------- 217 (261)
T ss_pred EEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---H---------
Confidence 865432211 1111223457999999998899999999999999999999 9999976532211110 0
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
............+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 -----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 218 -----DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0001111222355789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.23 Aligned_cols=262 Identities=24% Similarity=0.435 Sum_probs=207.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|.............||+|.+..... .....+.+|+.++..++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~- 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP- 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC-
Confidence 357889999999999999999987655445567899999865432 334568899999999999999999999987654
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.
T Consensus 84 ---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 84 ---TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred ---cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCC
Confidence 499999999999999886432 12368889999999999999999998 9999999999999999999
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 313 (428)
+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||......... ...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~ 234 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFV 234 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---HHH
Confidence 99999999876543322222233457889999999988889999999999999999998 99999754432211 111
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
. .. .....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~-------------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 I-------------DG-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred h-------------cC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 00 001112224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=308.77 Aligned_cols=269 Identities=23% Similarity=0.307 Sum_probs=212.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC-C
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE-R 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~ 162 (428)
.++|.+.+.||+|||+-||++..-. +...+|+|++.-...++.+..++|++..++++||||++++++...+.. .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s-----~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLS-----TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccC-----cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 4689999999999999999997443 345899999988777788899999999999999999999988755432 2
Q ss_pred CceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
....||+++|...|+|.+.+... ....+++..++.|+.+|++||++||+. .++++||||||+|||+.+.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 33569999999999999988643 234699999999999999999999997 335999999999999999999999999
Q ss_pred cccccCCCCCceee-------eeeeecCcccCCcchhcc---CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 241 GLARLGPSEGFTHV-------STAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 241 Gla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
|.++...-.-.... -.....|..|.|||.+.- ...+.++|||||||+||+|+.|..||+.....
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------ 247 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------ 247 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc------
Confidence 99976542211100 012357899999998863 45688999999999999999999999743211
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
.....-.+.++.+.-.....+++.+.+++..||+.||.+||++.+++..++.+.
T Consensus 248 --------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 --------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 011111222323332333347889999999999999999999999999988764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=341.07 Aligned_cols=255 Identities=24% Similarity=0.305 Sum_probs=195.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||+||+|....++ ..||+|++.+... .....+..|+.++..++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTG-----HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 47889999999999999999876543 3899999865422 22356778999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.++|||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 75 ---NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred ---eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 359999999999999998654 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc---------------------------------eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHH
Q 014245 242 LARLGPSEGF---------------------------------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFL 288 (428)
Q Consensus 242 la~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 288 (428)
+++....... .......+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 9875422100 0011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHH
Q 014245 289 YELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLV--KNARTRPKMSEVLE 366 (428)
Q Consensus 289 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~--~dp~~RPs~~ell~ 366 (428)
|||++|..||...........+. . . .. ...... ...+++++.+++.+++. .++..||++++|++
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~---~----~---~~--~~~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVM---N----W---KE--TLIFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHH---c----C---cC--cccCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 99999999997654322111100 0 0 00 000111 11244677788877543 33445689999998
Q ss_pred H
Q 014245 367 M 367 (428)
Q Consensus 367 ~ 367 (428)
+
T Consensus 293 h 293 (363)
T cd05628 293 N 293 (363)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=335.63 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=194.3
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHH---hcCCCCCcccEeeEEecCC
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFL---GIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~~ 160 (428)
|.+.+.||+|+||.||+|....++ ..||+|.+.+.. ....+.+.+|+.++ +.++||||+++++++.+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTG-----ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 677889999999999999876543 379999987542 12234566666554 5678999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..|+||||+++|+|..++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 76 ----~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 ----HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred ----EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 45999999999999888753 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 146 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------------ 211 (324)
T cd05589 146 GLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------------ 211 (324)
T ss_pred cCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 9987532221 12334679999999999999899999999999999999999999997654321111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.+.... ..++..++..+.+++.+||+.||.+|| ++.+++++
T Consensus 212 ----~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 212 ----SIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111110 112223557889999999999999999 57777764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=324.34 Aligned_cols=263 Identities=26% Similarity=0.429 Sum_probs=206.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|+..++||+|+||+||+|.+...+.. ..+.||+|.+..... .....+.+|+.++..++|+||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGEN-VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST--- 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCc-cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC---
Confidence 4688889999999999999987654322 244689999865433 33567889999999999999999999997543
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++++||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 83 --~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 83 --VQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred --cEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 379999999999999986532 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...............+++.|+|||++.+..++.++|||||||++|||++ |..||........... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~-------- 225 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL---LE-------- 225 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH--------
Confidence 86543322211222345678999999998899999999999999999998 9999975433221111 10
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
...........+..+.+++.+||+.||++||++.++++.|..+...
T Consensus 226 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 226 ------KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ------CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0001111223456889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=327.41 Aligned_cols=265 Identities=22% Similarity=0.423 Sum_probs=206.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+.||+|+||.||+|...+.........||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP- 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-
Confidence 467999999999999999999876533333456799998865432 233467899999999999999999999887654
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
.++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++.
T Consensus 84 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 84 ---TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred ---cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 499999999999999986422 12356678889999999999999998 9999999999999999999
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 313 (428)
++|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......... ..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~~- 233 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---KF- 233 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH-
Confidence 99999999875433222222223345778999999998899999999999999999999 78898754332111 10
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
+.+... ...+...+..+.+++.+||+.+|++||++.++++.|.+.+
T Consensus 234 ------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 ------------VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ------------HHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 011100 0111233568999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=344.11 Aligned_cols=254 Identities=26% Similarity=0.325 Sum_probs=199.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||+||+|....++ ..||+|++.... ......+.+|+.+|..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTG-----HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 47899999999999999999976543 379999987532 123355778999999999999999999998766
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 75 ---YLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred ---eEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 459999999999999998653 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce------------------------------------eeeeeeecCcccCCcchhccCCCCCchhhhhHH
Q 014245 242 LARLGPSEGFT------------------------------------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYG 285 (428)
Q Consensus 242 la~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 285 (428)
++......... ......+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 98753221100 001134699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC---HH
Q 014245 286 VFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK---MS 362 (428)
Q Consensus 286 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~ 362 (428)
|++|||++|..||...........+ .. . ...+.......+++++.+++.+|+. +|.+|++ +.
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i---~~----~-------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKI---IN----W-------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHH---Hc----C-------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 9999999999999865432211100 00 0 0000001111345688899999996 9999998 99
Q ss_pred HHHHH
Q 014245 363 EVLEM 367 (428)
Q Consensus 363 ell~~ 367 (428)
+++++
T Consensus 292 ~ll~h 296 (364)
T cd05599 292 EIKSH 296 (364)
T ss_pred HHhcC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=343.51 Aligned_cols=252 Identities=26% Similarity=0.337 Sum_probs=202.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||+||+|....++ ..||+|++..... .....+..|+.++..++|+||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTG-----QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCC-----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 47899999999999999999876543 3899999875421 33456889999999999999999999988765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 75 ---HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred ---eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 359999999999999998754 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCC---------------------------ceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhC
Q 014245 242 LARLGPSEG---------------------------FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG 294 (428)
Q Consensus 242 la~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 294 (428)
++....... .........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 997654322 00112345799999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC--CcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 014245 295 RRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD--PRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLEM 367 (428)
Q Consensus 295 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~ell~~ 367 (428)
+.||.......... .+.. ..+.......+++++.+++.+||. ||.+||+ +.+++++
T Consensus 227 ~~Pf~~~~~~~~~~----------------~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 227 FPPFYSDTLQETYN----------------KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCHHHHHH----------------HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99998654322111 0111 001111111256789999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=328.45 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=196.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNG-----KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-- 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCC-----CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--
Confidence 357999999999999999999876443 3799999875432 22346779999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||++ ++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 77 --TLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred --eEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 3599999995 5777777543 24488899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh-
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA- 320 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 320 (428)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... .......+...
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~ 225 (303)
T cd07869 150 ARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPN 225 (303)
T ss_pred ceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCC
Confidence 87543221 11234568999999998865 45789999999999999999999999865432111 11100000000
Q ss_pred -h------hhhhhcCCcCC----CCcc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 -K------QFRQIVDPRLE----GKYS-----LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 -~------~~~~~~~~~l~----~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ........... .... ...+..+.+++.+||+.||++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 00000000000 0000 0123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=329.03 Aligned_cols=267 Identities=25% Similarity=0.437 Sum_probs=209.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCC--CCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNS--EDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
..+|.+.+.||+|+||.||+|..... ........||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 35788889999999999999986431 222344579999986542 23456788999999999 899999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCC
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 225 (428)
.. .++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +++||||||+
T Consensus 94 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 166 (304)
T cd05101 94 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166 (304)
T ss_pred Cc----eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence 53 489999999999999986432 23578888999999999999999998 9999999999
Q ss_pred ceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCch
Q 014245 226 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 304 (428)
Q Consensus 226 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~ 304 (428)
|||++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999986543332222233456778999999998889999999999999999998 88888654322
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
. +.... ........+..++..+.+++.+||+.+|++||++.++++.|.+++.-
T Consensus 247 ~---~~~~~--------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 E---LFKLL--------------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred H---HHHHH--------------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 11110 00001111223557899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=337.87 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=194.5
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 167 (428)
+.||+|+||.||++....++ ..||+|.+..... .....+..|+.++..++||||+++++++...+ ..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~----~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATG-----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----RLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC----EEE
Confidence 36999999999999865543 4899999875422 23456778999999999999999999988766 459
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 72 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999999999888643 358999999999999999999996 6 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---------------- 208 (325)
T cd05594 147 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------------- 208 (325)
T ss_pred CCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH----------------
Confidence 2221 1123457999999999999999999999999999999999999999765432111111
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.... ..++..+++++.+++.+||+.||++|+ ++.+++++
T Consensus 209 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 209 LMEE--IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0000 012223456889999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.11 Aligned_cols=267 Identities=26% Similarity=0.431 Sum_probs=207.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCC--CCcceEEEEEEccCCC-cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
++|.+.+.||+|+||.||+|...+... ......+|+|.+.... .....++..|+.++..+ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468999999999999999998654221 1223469999987543 23345688899999999 8999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
. .++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 98 ~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 98 P----LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred c----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 4 499999999999999986532 13488999999999999999999988 99999999999
Q ss_pred eEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchh
Q 014245 227 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 305 (428)
Q Consensus 227 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 305 (428)
||++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999999875532221111222334578999999998889999999999999999998 888986543221
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
..... ........+...+.++.+++.+||..+|++||++.++++.|+.++...
T Consensus 251 ~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 LFKLL-----------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHH-----------------HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 11110 001111122335578999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=347.00 Aligned_cols=269 Identities=20% Similarity=0.269 Sum_probs=195.0
Q ss_pred HHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC------CCCcccE
Q 014245 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE------HQNLVKL 152 (428)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~~ 152 (428)
++...+++|.+.++||+|+||+||+|.....+ ..||||++.... .....+..|+.++..++ |.+|+++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~-----~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRK-----EYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCC-----eEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 33445688999999999999999999876543 479999986432 22334556777666664 4568899
Q ss_pred eeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECC
Q 014245 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 153 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~ 231 (428)
++++..... .+++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ . +||||||||+|||++.
T Consensus 197 ~~~~~~~~~---~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~ 267 (467)
T PTZ00284 197 QRYFQNETG---HMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMET 267 (467)
T ss_pred EEEEEcCCc---eEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEec
Confidence 998876543 468999998 77888887643 358999999999999999999996 5 9999999999999987
Q ss_pred CC----------------CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCC
Q 014245 232 QW----------------NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 295 (428)
Q Consensus 232 ~~----------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 295 (428)
++ .+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence 65 499999998764321 123568999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhHHHHHhHhhhhh----h---hhhhhhhcCC--cCCCCc---------------cHHHHHHHHHHHHHhc
Q 014245 296 RPIDRNRPRSEQKLLQWVKPYLS----D---AKQFRQIVDP--RLEGKY---------------SLRLVSKLSHVANLCL 351 (428)
Q Consensus 296 ~p~~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~~~--~l~~~~---------------~~~~~~~l~~li~~cl 351 (428)
.||..........++......+. . ......+.+. .+.... .....+.+.+||.+||
T Consensus 343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 422 (467)
T PTZ00284 343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422 (467)
T ss_pred CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence 99987654433322221100000 0 0000000000 000000 0012356789999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 014245 352 VKNARTRPKMSEVLEM 367 (428)
Q Consensus 352 ~~dp~~RPs~~ell~~ 367 (428)
+.||++|||+.|+++|
T Consensus 423 ~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 423 HYDRQKRLNARQMTTH 438 (467)
T ss_pred CcChhhCCCHHHHhcC
Confidence 9999999999999985
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=327.32 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=201.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+|++.++||+|+||.||++....++ ..||+|.+...... ....+.+|+.+++.++||||+++++.+.+.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCC-----ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 4788899999999999999865433 38999998654322 2345778999999999999999999987765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.+++||||+++|+|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 74 --ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred --eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 359999999999999888654445689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~------------ 213 (285)
T cd05605 149 AVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV------------ 213 (285)
T ss_pred ceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH------------
Confidence 97643221 122357899999999999888999999999999999999999999764332111100
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
...+.. ....++..++..+.+++.+||+.||.+|| ++.+++++
T Consensus 214 -~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 214 -ERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -HHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011110 11123344667899999999999999999 88888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.44 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=196.3
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCC-CcccEeeEEecCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQ-NLVKLVGYCADDDE 161 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~ 161 (428)
+|++.+.||+|+||.||+|....++ ..||+|.+.+.. ....+.+..|..++..+.|+ +|+++++++.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 4788999999999999999876553 379999987532 23345678899999999765 5888888887765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 75 ---RLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred ---EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 359999999999999888644 3488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..
T Consensus 147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~---------- 211 (324)
T cd05587 147 MCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQ---------- 211 (324)
T ss_pred cceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH----------
Confidence 987432221 123346799999999999999999999999999999999999999976542211 11
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~ell~~ 367 (428)
.+... ...++..++.++.+++.+||..||.+|++. ++++++
T Consensus 212 ---~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 212 ---SIMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111 111223355688999999999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=321.74 Aligned_cols=263 Identities=23% Similarity=0.423 Sum_probs=203.6
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC--C
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--R 162 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--~ 162 (428)
|.+.+.||+|+||.||+|...... .....||+|.+..... .....+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD--GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC--CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 567889999999999999875422 2345799999875432 234578899999999999999999998866443 1
Q ss_pred CceEEEEEeecCCCCcccccCCC----CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPK----SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
....++||||+++|+|..++... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 12358999999999998887432 224589999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~--- 229 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLR--- 229 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---
Confidence 9999986543322222222345678999999988889999999999999999999 889987543221 111110
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
.. .....+..++..+.+++.+||+.||++||++.++++.|..+
T Consensus 230 ----------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 ----------HG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----------cC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.81 Aligned_cols=256 Identities=26% Similarity=0.327 Sum_probs=198.3
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC----cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
+|++.+.||+|+||.||++..... ...+..||+|.+.+.. ....+.+..|+.++..+ +|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc--CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 488899999999999999876432 2245589999986432 12345678899999999 5999999999887765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.+++||||+++|+|.+++..+ ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 79 ----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 79 ----KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred ----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeC
Confidence 359999999999999988643 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.............
T Consensus 150 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-------- 220 (332)
T cd05614 150 GLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS-------- 220 (332)
T ss_pred cCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--------
Confidence 99975432221 122346799999999998865 47889999999999999999999997543221111100
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
..+.. .....+..++..+.+++.+||+.||++|| ++++++++
T Consensus 221 ----~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 ----RRILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----HHHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00110 01112233557889999999999999999 77788775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=342.84 Aligned_cols=254 Identities=23% Similarity=0.280 Sum_probs=196.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+.+.. ......+.+|+.++..++||||+++++++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTG-----KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 47889999999999999999876543 379999986532 1234567889999999999999999999987663
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 76 ----~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 76 ----LYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred ----eEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 59999999999999988643 3588999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce---------------------------------------------eeeeeeecCcccCCcchhccCCCC
Q 014245 242 LARLGPSEGFT---------------------------------------------HVSTAVVGTMGYAAPEYVQTGRLA 276 (428)
Q Consensus 242 la~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 276 (428)
+++........ ......+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 98632110000 000125799999999999998999
Q ss_pred CchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCC
Q 014245 277 ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNAR 356 (428)
Q Consensus 277 ~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~ 356 (428)
.++|||||||++|||++|..||...........+. . . ...+.-.....++.++.+++.+||. +|.
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~---~-------~----~~~~~~p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKII---N-------W----RETLYFPDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHH---c-------c----CCccCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence 99999999999999999999997654322111000 0 0 0001000111245678999999997 677
Q ss_pred CC---CCHHHHHHH
Q 014245 357 TR---PKMSEVLEM 367 (428)
Q Consensus 357 ~R---Ps~~ell~~ 367 (428)
+| +++.+++++
T Consensus 292 ~r~~r~~~~~~l~h 305 (377)
T cd05629 292 NRLGRGGAHEIKSH 305 (377)
T ss_pred hcCCCCCHHHHhcC
Confidence 65 599999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.57 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
+.||+|+||.||++....+. ..+..||+|.+..... .....+..|+.+|+.++||||+++++++...+ ..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~----~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGA--DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG----KL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccC--CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC----eE
Confidence 57999999999999864322 2345899999865321 22345778999999999999999999998765 35
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 9999999999999988643 3478888899999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+
T Consensus 151 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~----------------~~~ 212 (323)
T cd05584 151 IHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI----------------DKI 212 (323)
T ss_pred ccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH----------------HHH
Confidence 2221 1223457999999999999888999999999999999999999999765432111 111
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
..... ..+..+++.+.+++.+||+.+|++|| ++++++++
T Consensus 213 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 213 LKGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11111 12223456889999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=319.60 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=203.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||.||+|...++. .||+|.+..... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~------~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----- 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE----- 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc------eEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCC-----
Confidence 56899999999999999999865432 589999875432 346789999999999999999999987542
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++|+|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCcee
Confidence 238999999999999999754445588999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~-------------- 215 (262)
T cd05071 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------------- 215 (262)
T ss_pred eccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH--------------
Confidence 65432211 1123346778999999988899999999999999999999 8889875532211110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
+.. .........++..+.+++.+|++.+|++||++.++++.|+...
T Consensus 216 --~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 216 --VER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --Hhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 000 0111123345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.74 Aligned_cols=271 Identities=23% Similarity=0.341 Sum_probs=206.5
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC-Cc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER-GI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~-~~ 164 (428)
.|...+++|+|+||.||+|....+. ..||||+.-.+.. .-.+|+.+|+.++|||||++.-+|....+. ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~-----~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETE-----EEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCC-----ceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 5777889999999999999987663 3899998754421 224899999999999999999888765544 34
Q ss_pred eEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC-CCeEEeeec
Q 014245 165 QRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFG 241 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG 241 (428)
...||||||+. +|.++++.. .+..++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence 55789999976 898888632 234477778888999999999999997 99999999999999976 899999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
.|+....... ..+...|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+....+...++..+....+.
T Consensus 172 SAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~- 247 (364)
T KOG0658|consen 172 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR- 247 (364)
T ss_pred cceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH-
Confidence 9987654322 3456789999999988875 5999999999999999999999999987665554444332211111
Q ss_pred hhhhh-------hcCCcCC-----CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhh
Q 014245 321 KQFRQ-------IVDPRLE-----GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM--VNKIVD 373 (428)
Q Consensus 321 ~~~~~-------~~~~~l~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~--L~~~~~ 373 (428)
+.+.. ...+.+. .-+....+++..+|+.++|..+|.+|.++.|++.+ ++.+.+
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11111 1111121 12334567899999999999999999999999875 444443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.79 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=196.3
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.|..+++||+|+||.||+|....++ ..||+|.+.+... .....+.+|+.+++.++|+||+++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTK-----ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCC-----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 5889999999999999999876543 3799999875422 23456789999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 75 --~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 75 --NLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred --EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 459999999999999988643 3588999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCC---------------------------------------------ceeeeeeeecCcccCCcchhccCCCCC
Q 014245 243 ARLGPSEG---------------------------------------------FTHVSTAVVGTMGYAAPEYVQTGRLAA 277 (428)
Q Consensus 243 a~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ 277 (428)
+....... ........+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 75321000 000012357999999999999999999
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCC
Q 014245 278 RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNART 357 (428)
Q Consensus 278 ~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~ 357 (428)
++|||||||++|||++|..||....+......+. . ....+.......+++++.+++.+++ .+|.+
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------~-~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI-------------N-WQTSLHIPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH-------------c-cCCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence 9999999999999999999998654322111100 0 0011111111234567888888876 59999
Q ss_pred CCC---HHHHHHH
Q 014245 358 RPK---MSEVLEM 367 (428)
Q Consensus 358 RPs---~~ell~~ 367 (428)
|++ +.+++++
T Consensus 293 R~~~~~~~ei~~h 305 (382)
T cd05625 293 RLGKNGADEIKAH 305 (382)
T ss_pred cCCCCCHHHHhcC
Confidence 987 8888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.51 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=190.2
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhc-CCCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGI-VEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++||+|+||.||+|....++ ..||+|.+.... ....+.+..|..++.. .+||||+++++++.... ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTN-----EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----HL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EE
Confidence 36999999999999976554 379999987532 1233455667777765 48999999999988765 45
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999999888643 3489999999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......... . .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~---~-------------~i 208 (316)
T cd05592 147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF---D-------------SI 208 (316)
T ss_pred CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH---H-------------HH
Confidence 3221 2233467999999999999989999999999999999999999999765432111 1 01
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS-EVLE 366 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ell~ 366 (428)
... ...++..++.++.+++.+||+.||++||++. ++++
T Consensus 209 ~~~--~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 209 LND--RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 100 1112233556789999999999999999875 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=319.32 Aligned_cols=251 Identities=25% Similarity=0.473 Sum_probs=198.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||.||+|.+.... .+|+|.+.... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~------~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 73 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQI------KVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP--- 73 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCc------eEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC---
Confidence 35788889999999999999876432 68999876443 334678899999999999999999999977654
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 74 -~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 74 -LYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred -EEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence 499999999999999886433 3588999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |+.||........ ...... ..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~~----~~-- 218 (256)
T cd05114 149 YVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMISR----GF-- 218 (256)
T ss_pred ccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHC----CC--
Confidence 54322211 1122345678999999988889999999999999999999 9999976543211 111110 00
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.. ..+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 219 -~~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 -RL-------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CC-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00 01112346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=342.27 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=200.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+.+.. ......+.+|+.+++.++||||+++++++.+..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSK-----QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 467999999999999999999876543 379999986432 123345778999999999999999999988765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 117 ----~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 117 ----YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred ----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEec
Confidence 459999999999999988643 378888999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccC----CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
|++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||.........
T Consensus 187 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--------- 256 (370)
T cd05596 187 GTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY--------- 256 (370)
T ss_pred cceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH---------
Confidence 99976543221 112346799999999998653 4788999999999999999999999865432111
Q ss_pred hhhhhhhhhhcCCc--CCCCccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDPR--LEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~--l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ell~~ 367 (428)
..+.... +.-.....++.++.+++.+||..+|.+ |+++.+++++
T Consensus 257 -------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 -------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111110 111111235678999999999999988 9999999886
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=325.72 Aligned_cols=269 Identities=24% Similarity=0.427 Sum_probs=207.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCC-----------CCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCccc
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSED-----------PSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVK 151 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----------~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~ 151 (428)
.++|.+.+.||+|+||.||+|.....+. ......||+|.+..... ...+.+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999998765332 12345799999876543 34567889999999999999999
Q ss_pred EeeEEecCCCCCceEEEEEeecCCCCcccccCCCC---------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC
Q 014245 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS---------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 222 (428)
Q Consensus 152 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl 222 (428)
+++++..... .++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||
T Consensus 84 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dl 156 (296)
T cd05051 84 LLGVCTVDPP----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDL 156 (296)
T ss_pred EEEEEecCCC----cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccccc
Confidence 9999987654 499999999999999986433 12589999999999999999999998 9999999
Q ss_pred CCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh--CCCCCCC
Q 014245 223 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT--GRRPIDR 300 (428)
Q Consensus 223 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~ 300 (428)
||+||+++.++.++|+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999976543332233334567789999999988889999999999999999998 7778865
Q ss_pred CCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
..... ............ ...........++.++.+++.+||+.||++||++.+|++.|+
T Consensus 237 ~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 237 LTDQQ---VIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cChHH---HHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 43221 111111100000 000111112234568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=318.48 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=194.7
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~ 170 (428)
.||+|+||.||+|....++ ..+|+|.+..... .....+.+|+++++.++||||+++++++..... .++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~ 72 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADN-----TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP----IYIVM 72 (252)
T ss_pred ccCcccCccEEEEEEecCC-----ceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC----eEEEE
Confidence 6999999999999875443 3799998765432 334678899999999999999999999987654 49999
Q ss_pred eecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCC
Q 014245 171 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 250 (428)
Q Consensus 171 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 250 (428)
||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 73 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 73 ELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred eeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccc
Confidence 9999999999986432 3588999999999999999999998 99999999999999999999999999987543211
Q ss_pred ceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 251 FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
.........++..|+|||.+.++.++.++||||||+++|+|++ |..||........... +..
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-----------------~~~ 211 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-----------------IEQ 211 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-----------------HHc
Confidence 1111111123457999999998899999999999999999998 8899865432211111 111
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1111222344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=323.28 Aligned_cols=276 Identities=25% Similarity=0.373 Sum_probs=205.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||.||+|.+... +...+..|++|.+........+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-- 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPL-QDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR-- 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCC-cCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC--
Confidence 4788899999999999999986432 1223457999998766555567889999999999999999999988654432
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 3589999999999999986432 3489999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCcee-eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh---hh
Q 014245 245 LGPSEGFTH-VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS---DA 320 (428)
Q Consensus 245 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~ 320 (428)
......... ......++..|+|||++.+..++.++||||||++++||++|..|+....... ......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 232 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF----MRMMGNDKQGQMIV 232 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh----hhhcccccccccch
Confidence 654322111 1112234456999999998899999999999999999999887764332110 000000000 00
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
..+.+.+...........++.++.+++.+||..+|++|||+.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 001111111111112233557899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=325.13 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=203.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC-CcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.++||+|+||.||+|.....+. ...+++|.+... .....+.+.+|+.++.++ +||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~- 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGL---KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY- 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCC---cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc-
Confidence 478899999999999999998765432 234788877643 223446788999999999 79999999999987654
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 228 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NIL 228 (428)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 78 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil 151 (297)
T cd05089 78 ---LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVL 151 (297)
T ss_pred ---ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEE
Confidence 499999999999999885422 13488899999999999999999998 9999999999999
Q ss_pred ECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhH
Q 014245 229 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQ 307 (428)
Q Consensus 229 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~ 307 (428)
+++++.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~- 227 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL- 227 (297)
T ss_pred ECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 999999999999998632211 01111223557999999998889999999999999999998 9999976543211
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
.. . +........+..++..+.+++.+||+.+|.+||++.++++.|..+....
T Consensus 228 --~~-------------~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 228 --YE-------------K-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred --HH-------------H-HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 0 0111111122235578999999999999999999999999999888655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=333.29 Aligned_cols=243 Identities=28% Similarity=0.409 Sum_probs=193.1
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++||+|+||.||+|....++ ..||+|.+.+.. ......+..|..++..+ +||||+++++++.+.+ ..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESG-----RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----RL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCC-----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC----EE
Confidence 36999999999999876543 379999986532 22345677888888876 7999999999998765 45
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred EEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999999999999888644 3489999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... . .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---~-------------~i 208 (320)
T cd05590 147 IFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF---E-------------AI 208 (320)
T ss_pred CcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---H-------------HH
Confidence 2221 1233467999999999999989999999999999999999999999765432111 1 11
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~ell~~ 367 (428)
..... ..+..++.++.+++.+||+.||++||++ ++++++
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 209 LNDEV--VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred hcCCC--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11111 1122345688999999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.84 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=199.0
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
..++|++.+.||+|+||.||+|....++ ..+|+|.+.+.. ......+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQ-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 3468999999999999999999976654 379999986432 12334577899999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 116 ~----~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 116 K----YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred C----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEe
Confidence 5 459999999999999998643 378899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccC----CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
||++........ ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 186 FG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~-------- 256 (370)
T cd05621 186 FGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY-------- 256 (370)
T ss_pred cccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH--------
Confidence 999986543221 122356799999999998754 3788999999999999999999999765432111
Q ss_pred hhhhhhhhhhhcCCc--CCCCccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014245 316 YLSDAKQFRQIVDPR--LEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~--l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ell~~ 367 (428)
..+++.. +.......++..+.+++..||..++.+ |+++.+++++
T Consensus 257 --------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 --------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111 111111235677889999999755543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=318.99 Aligned_cols=251 Identities=27% Similarity=0.475 Sum_probs=199.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||.||+|.+.+.. .+|+|.+.... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~------~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 73 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQY------DVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP--- 73 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCC------cEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC---
Confidence 35788889999999999999875532 59999887543 335678999999999999999999999977654
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++|+|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+|||++.++.+||+|||+++
T Consensus 74 -~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 74 -IYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred -cEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence 3999999999999999865432 589999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-------------- 213 (256)
T cd05113 149 YVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK-------------- 213 (256)
T ss_pred ecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH--------------
Confidence 6533221 11122345678999999998889999999999999999999 9999975443211110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
+... .........+..+.+++.+||+.+|.+||++.+|++.|
T Consensus 214 --~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 214 --VSQG-LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred --HhcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 0000 00011112357899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=343.60 Aligned_cols=254 Identities=25% Similarity=0.303 Sum_probs=197.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+|+.++|+||+++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTN-----ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCC-----CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 36899999999999999999876543 4899999865322 23456789999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 75 ---NLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred ---EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 459999999999999998654 3488899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCC-----------------------------------------ceeeeeeeecCcccCCcchhccCCCCCchh
Q 014245 242 LARLGPSEG-----------------------------------------FTHVSTAVVGTMGYAAPEYVQTGRLAARSD 280 (428)
Q Consensus 242 la~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 280 (428)
++....... ........+||+.|||||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 975321000 000012357999999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-
Q 014245 281 VWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP- 359 (428)
Q Consensus 281 vwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP- 359 (428)
||||||++|||++|+.||...........+.. . ...+.......++.++.+++.+|+ .+|.+|+
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-------~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVIN-------W-------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhc-------c-------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 99999999999999999987654322211100 0 000000111234567888888876 5999999
Q ss_pred --CHHHHHHH
Q 014245 360 --KMSEVLEM 367 (428)
Q Consensus 360 --s~~ell~~ 367 (428)
++.+++++
T Consensus 292 ~~t~~ell~h 301 (376)
T cd05598 292 KNGADEIKAH 301 (376)
T ss_pred CCCHHHHhCC
Confidence 89999886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=333.10 Aligned_cols=250 Identities=27% Similarity=0.359 Sum_probs=212.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc---HHHHHHHHHHHhcCC-CCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG---HKEWMTEVNFLGIVE-HQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~ 159 (428)
...|++.+.||+|.||.||++..+.++ ..+|+|.+.+..... ...+.+|+.||+++. |||||.++++|.+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg-----~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTG-----KEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCC-----ceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 457888899999999999999977653 489999998775533 457899999999998 99999999999988
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC----CCCe
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE----QWNA 235 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~----~~~~ 235 (428)
.. +++|||++.||.|.+.|... .+++..+..++.|++.++.|||+. ||+||||||+|+|+.. ++.+
T Consensus 109 ~~----~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 109 DS----VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred Ce----EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcE
Confidence 74 49999999999999999766 299999999999999999999998 9999999999999953 3579
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..........
T Consensus 179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------- 248 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------- 248 (382)
T ss_pred EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------
Confidence 9999999987655 234556899999999999999999999999999999999999999998765432221
Q ss_pred hhhhhhhhhhhc--CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQIV--DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~--~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+. +..........++..+.+++..|+..||.+|+++.++++|
T Consensus 249 ---------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ---------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111 1133445556778899999999999999999999999995
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=332.94 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=196.5
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
+|.+.+.||+|+||.||+|....++ ..||+|.+.+... .....+..|..++..+ +|++|+++++++.+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 4788999999999999999876553 3799999875422 2234567788888777 6899999999988765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 75 ---RLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred ---EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 359999999999999888643 3488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~---------- 211 (323)
T cd05616 147 MCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---Q---------- 211 (323)
T ss_pred CceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---H----------
Confidence 987533221 1223467999999999999999999999999999999999999999765432111 1
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~ell~~ 367 (428)
.+.... ..++...+.++.+++.+||+.||++|++. .+++++
T Consensus 212 ---~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 212 ---SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ---HHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111111 11223456788999999999999999985 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=333.05 Aligned_cols=243 Identities=26% Similarity=0.411 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++||+|+||.||+|....++ ..||+|.+.... ......+..|..++..+ +||||+++++++.+.. ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTD-----EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----RL 71 (321)
T ss_pred CccccCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----eE
Confidence 36999999999999876543 379999987542 22335577888888866 8999999999998766 35
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999999888643 3488999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .. .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~-------------~i 208 (321)
T cd05591 147 ILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FE-------------SI 208 (321)
T ss_pred ccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HH-------------HH
Confidence 3222 122346799999999999998999999999999999999999999986543211 11 11
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-------KMSEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-------s~~ell~~ 367 (428)
..... ..+..++.++.+++.+||+.||++|| ++++++++
T Consensus 209 ~~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 209 LHDDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11110 11222456889999999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=324.60 Aligned_cols=268 Identities=24% Similarity=0.417 Sum_probs=202.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCC---------CCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEee
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSED---------PSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVG 154 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~---------~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~ 154 (428)
++|.+.+.||+|+||.||++.....+. ......||+|.+..... .....+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478899999999999999987654321 12234689999876432 23457889999999999999999999
Q ss_pred EEecCCCCCceEEEEEeecCCCCcccccCCCC----------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCC
Q 014245 155 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKS----------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 224 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp 224 (428)
++..... .++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||
T Consensus 85 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp 157 (295)
T cd05097 85 VCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT 157 (295)
T ss_pred EEcCCCc----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence 9987654 499999999999999885431 12368889999999999999999998 999999999
Q ss_pred CceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh--CCCCCCCCC
Q 014245 225 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT--GRRPIDRNR 302 (428)
Q Consensus 225 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~ 302 (428)
+|||++.++.+||+|||++................++..|+|||++.++.++.++|||||||++++|++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999976543322222233455778999999998899999999999999999998 667876543
Q ss_pred chhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 303 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.... +......... .........+...+..+.+++.+||+.||++||++.+|++.|.
T Consensus 238 ~~~~---~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQV---IENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHH---HHHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 3221 1111100000 0000000111124568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=335.08 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=199.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
..+|.+.+.||+|+||.||++...+. .....|++|.+... ....+|+.+|+.++||||+++++++....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~---~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~--- 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGD---EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS--- 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCC---ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC---
Confidence 45799999999999999999976532 23457899987643 24568999999999999999999988765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++|||++. ++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 160 -~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 160 -TVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred -EEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccc
Confidence 3599999995 688888843 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh----
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD---- 319 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 319 (428)
................||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...+..
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 7654333222233567999999999999999999999999999999999999999765432211111100000000
Q ss_pred ---------hhhhhhhcCCcCCCCcc-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 ---------AKQFRQIVDPRLEGKYS-------LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ---------~~~~~~~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+.+. .......+. ..+..++.+++.+||..||++||++.+++.+
T Consensus 313 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 313 FPQNGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCCccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 000111000 1234578899999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=328.75 Aligned_cols=264 Identities=25% Similarity=0.433 Sum_probs=215.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-HHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+...+.++||+|.||+|.++...+ ...||+|.++...... ..+|..|+++|.+|+|||||+++|+|..++..
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi- 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL- 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch-
Confidence 345677899999999999998765 3489999998775543 47899999999999999999999999988765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
++|+|||++|+|.+|+..+....+.-.....|+.||+.||+||.+. ++|||||.+.|+|+|+++++||+|||++
T Consensus 611 ---cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 611 ---CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred ---HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 8999999999999999866433345556778999999999999987 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh--CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT--GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+......+.+.....+-..+|||||.+..++++.++|||+||+++||+++ ...||.....+.. ++....++....
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~ 761 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQG 761 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCC
Confidence 98777777776667778899999999999999999999999999999876 7889876543322 221111111111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
. ..-...+.-++..+.+++.+||..+-++||++++|..+|.+.
T Consensus 762 ~-------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 R-------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred c-------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 111122334678899999999999999999999999998764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=336.55 Aligned_cols=254 Identities=24% Similarity=0.300 Sum_probs=200.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATG-----DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 46889999999999999999876543 3799999875422 23456789999999999999999999988765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 75 ---NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred ---eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 3599999999999999987542 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhc------cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
++......... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...........+
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i----- 221 (330)
T cd05601 148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI----- 221 (330)
T ss_pred CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH-----
Confidence 99865433221 233457999999999986 456789999999999999999999999765432211100
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.. ...+.-.....++..+.+++..||. +|.+||++.+++++
T Consensus 222 -~~~--------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 222 -MNF--------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -HcC--------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 0000001112355788999999998 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=317.87 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=201.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||.||+|....+. .+|+|.+..... ....+.+|+.+++.++|+||+++++++....
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~------~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---- 74 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNT------KVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEP---- 74 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCc------eeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCC----
Confidence 46888999999999999999866443 689998875433 3467899999999999999999999875432
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||++++++.++|+|||++.
T Consensus 75 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 75 -IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred -cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeee
Confidence 38999999999999998755445589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||......... ...
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~---------- 216 (260)
T cd05070 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---EQV---------- 216 (260)
T ss_pred eccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----------
Confidence 65432211 1122345678999999988889999999999999999999 89999754322111 110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
........+...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 217 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ----ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011111223455789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=329.74 Aligned_cols=242 Identities=25% Similarity=0.411 Sum_probs=191.1
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhc-CCCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGI-VEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
+.||+|+||.||+|....++ ..||+|.+.... ......+..|..++.. ++||||+++++++.+.+ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----NL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC----EE
Confidence 36999999999999976543 379999987542 1233456677888876 49999999999998766 35
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999999988643 3488899999999999999999998 9999999999999999999999999998743
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... +...+. .
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~-----------~ 210 (316)
T cd05619 147 MLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR-----------M 210 (316)
T ss_pred CCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-----------h
Confidence 2211 12234679999999999999899999999999999999999999997654321 111110 0
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS-EVLE 366 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ell~ 366 (428)
..+ .++..++.++.+++.+||+.||++||++. ++++
T Consensus 211 ~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 211 DNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 011 11223456789999999999999999997 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=344.36 Aligned_cols=268 Identities=24% Similarity=0.340 Sum_probs=194.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCC---
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD--- 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--- 160 (428)
.++|.+.++||+|+||.||+|....++ ..||||++.... ....+|+.+|+.++||||+++++++....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTS-----EKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCC-----CEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 467999999999999999999976543 379999885432 23457999999999999999998875432
Q ss_pred -CCCceEEEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-CeE
Q 014245 161 -ERGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAK 236 (428)
Q Consensus 161 -~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~~k 236 (428)
.....+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+||||+.++ .+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCcee
Confidence 222346799999975 67666542 2234589999999999999999999998 999999999999998665 699
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVK 314 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~ 314 (428)
|+|||+++...... ......||+.|+|||++.+. .|+.++|||||||++|||++|.+||...........+ +...
T Consensus 212 L~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 212 LCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred eeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999998653221 12345789999999988764 6899999999999999999999999865433221111 1000
Q ss_pred -hhhhhh----hhhhhhcCC-----cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 -PYLSDA----KQFRQIVDP-----RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 -~~~~~~----~~~~~~~~~-----~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..... ..+..+.-+ .+...++...+.++.+|+.+||+.||.+|||+.+++++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000 000000000 01111122245689999999999999999999999976
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=319.79 Aligned_cols=266 Identities=24% Similarity=0.409 Sum_probs=209.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.++||+|+||.||+|.+.... ......|++|.+..... .....+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~- 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE- 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-
Confidence 457889999999999999999977532 22345799998865432 334668899999999999999999999876432
Q ss_pred CceEEEEEeecCCCCcccccCCCCc------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSE------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
..++++||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 83 --~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 83 --PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred --CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 24899999999999999864321 4589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 315 (428)
|+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||....+.. +..+...
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~ 234 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKD 234 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHc
Confidence 999999986543332222233456778999999998889999999999999999999 999997654322 1111110
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
.........+++++.+++.+||..+|++||++.++++.|+.+..
T Consensus 235 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 --------------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --------------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00111122345689999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.38 Aligned_cols=267 Identities=25% Similarity=0.450 Sum_probs=206.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCC--CCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSE--DPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
.+|.+.+.||+|+||.||+|...+.. .......+|+|.+..... .....+..|+.++..+ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 47888999999999999999864321 122345789998875432 3345688999999999 6999999999997765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
. .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+|
T Consensus 92 ~----~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 92 P----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred c----eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 3 499999999999999986432 23588999999999999999999998 99999999999
Q ss_pred eEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchh
Q 014245 227 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 305 (428)
Q Consensus 227 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 305 (428)
||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999976543221111122234568999999998899999999999999999999 899997653322
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
...... . ......+..++.++.+++.+||..+|++||++.++++.|.++....
T Consensus 245 ~~~~~~----------------~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 LFKLLR----------------E-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHH----------------c-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 111110 0 0001112234568889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=330.45 Aligned_cols=242 Identities=24% Similarity=0.386 Sum_probs=190.7
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++||+|+||.||+|....++ ..||+|.+.... ......+..|..++..+ +||||+++++++.+.+ ..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG-----EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----HL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC----EE
Confidence 36999999999999976543 379999987542 12334566788887754 9999999999998765 45
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999999888643 3488999999999999999999998 9999999999999999999999999998743
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||....... +......
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~~----------- 210 (316)
T cd05620 147 VFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIRV----------- 210 (316)
T ss_pred ccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh-----------
Confidence 2111 12345679999999999999999999999999999999999999997654221 1111100
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS-EVLE 366 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ell~ 366 (428)
..+ .++..++.++.+++.+||+.||++||++. ++++
T Consensus 211 ~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 211 DTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 011 11222456889999999999999999984 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.39 Aligned_cols=259 Identities=22% Similarity=0.369 Sum_probs=205.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDR-----KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN- 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCC-----CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-
Confidence 57899999999999999999876543 379999875432 233456889999999999999999999988765
Q ss_pred CCceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
..++||||+++|+|.+++... ....+++..++.++.|++.||.|||++ +++|+||||+|||++.++.++|+|
T Consensus 76 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 76 ---ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ---eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECc
Confidence 348999999999999887532 234578899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ......
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~------- 219 (267)
T cd08228 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQK------- 219 (267)
T ss_pred cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHH-------
Confidence 999876543221 1123568899999999988889999999999999999999999986543211 111111
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
+.............+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 220 ------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 220 ------IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0011111112234567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.11 Aligned_cols=249 Identities=28% Similarity=0.473 Sum_probs=200.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.+|.+.+.||+|+||.||+|...+. .+++|.+.... ..+.+.+|+.+++.++|+||+++++++.....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 73 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGN-------KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG--- 73 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCC-------cEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC---
Confidence 4688899999999999999976532 68999886432 34678899999999999999999998755432
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence 358999999999999998765555689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
..... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... +....
T Consensus 151 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~---------- 212 (256)
T cd05082 151 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV---------- 212 (256)
T ss_pred ecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----------
Confidence 54321 122345678999999998889999999999999999998 999987543211 11110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
...........++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 213 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 213 ----EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ----hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0011111223356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=315.66 Aligned_cols=250 Identities=25% Similarity=0.425 Sum_probs=196.4
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
.||+|+||.||+|.+.... ....+|+|.+..... ...+.+..|+.+++.++||||+++++++.... .++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK---SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES-----WMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecCC---CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----cEEE
Confidence 5899999999999764322 234799999865432 23467889999999999999999999885432 4899
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 74 MELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999999999998643 3589999999999999999999998 9999999999999999999999999999765433
Q ss_pred Cceee-eeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014245 250 GFTHV-STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327 (428)
Q Consensus 250 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (428)
..... .....+++.|+|||++....++.++|||||||++|||++ |..||........ ....
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~i-------------- 211 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQMI-------------- 211 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH--------------
Confidence 22111 122234678999999988889999999999999999998 9999976543211 1111
Q ss_pred CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 328 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
........+..++.++.+++.+||+.||++||++++|.+.|+..
T Consensus 212 ~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 212 ESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11111122234567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=314.44 Aligned_cols=270 Identities=23% Similarity=0.311 Sum_probs=204.0
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCC-cccEeeEEecCCC-
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDE- 161 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~- 161 (428)
.|..+++||+|+||+||+|....++ ..||+|++.-.... ......+|+.+|+.|+|+| ||.+++++.....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g-----~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTG-----KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCC-----CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 4566667999999999999977654 48999999765332 2345689999999999999 9999999987662
Q ss_pred -CCceEEEEEeecCCCCcccccCCCCc--ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 162 -RGIQRLLVYEYMPNGSVDQYLSPKSE--TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 162 -~~~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
....++||+||+ ..+|.+++..... ..++...+..++.||+.||+|||++ +|+||||||.||||+++|.+||+
T Consensus 87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeee
Confidence 223568999999 4599999976553 3477788999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|||+|+....... ..+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|.+.........+--... .
T Consensus 163 DFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG-t 239 (323)
T KOG0594|consen 163 DFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG-T 239 (323)
T ss_pred ccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC-C
Confidence 9999986543322 23456899999999999887 699999999999999999999999988765333222211100 0
Q ss_pred hhhhhhhhh---cCCc--C-----CCCccH---HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQI---VDPR--L-----EGKYSL---RLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~---~~~~--l-----~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+... .+-. . ...... .......+++.+||+.+|.+|.|+..++.+
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000111111 0100 0 001111 112478899999999999999999999987
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=325.45 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=202.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|+||.||+|.+..++ ....+++|.+.... ......+.+|+.++.++ +|+||+++++++.....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~- 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY- 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCC---ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC-
Confidence 57888999999999999999875432 22356888776432 23345788999999999 89999999999987654
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 228 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NIL 228 (428)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||
T Consensus 83 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nil 156 (303)
T cd05088 83 ---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 156 (303)
T ss_pred ---ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEE
Confidence 499999999999999886432 13578999999999999999999998 9999999999999
Q ss_pred ECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhH
Q 014245 229 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQ 307 (428)
Q Consensus 229 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~ 307 (428)
++.++.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||.........
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred ecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 999999999999998632111 01111234668999999988889999999999999999998 99999754332111
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
... ........+...+..+.+++.+||+.+|++||+++++++.|..++...
T Consensus 234 ---~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 234 ---EKL--------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred ---HHH--------------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 100 000011111224567899999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=307.91 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=206.7
Q ss_pred HHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----c----cHHHHHHHHHHHhcC-CCCCccc
Q 014245 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----Q----GHKEWMTEVNFLGIV-EHQNLVK 151 (428)
Q Consensus 81 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~E~~~l~~l-~h~nIv~ 151 (428)
....+.|...+.||.|..+.|-++.++.++. .+|+|++..... + ..+.-.+|+.||+++ .||+|++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~-----e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~ 87 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGK-----EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID 87 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhccccc-----ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence 3445678888899999999999998776543 788888854321 1 123456899999998 8999999
Q ss_pred EeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 152 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
+.+++..+... |+|+|.|+.|.|.|++... ..++++....|++|+.+|++|||.+ .||||||||+|||+|+
T Consensus 88 l~D~yes~sF~----FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd 158 (411)
T KOG0599|consen 88 LQDVYESDAFV----FLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD 158 (411)
T ss_pred eeeeccCcchh----hhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence 99999887754 9999999999999999754 4599999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc------CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 305 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 305 (428)
+.++||+|||.++...... .....||||+|+|||.+.. ..|+..+|+|++|||+|.|+.|.+||.......
T Consensus 159 n~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml 235 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML 235 (411)
T ss_pred ccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence 9999999999998765432 2345799999999998864 357889999999999999999999997653322
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCc--CCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPR--LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+ ++... ....-..+.+.+..+||.+||+.||.+|.|++|+++|
T Consensus 236 MLR~----------------ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 MLRM----------------IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHH----------------HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 2211 11111 1222344677889999999999999999999999986
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=332.41 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=193.8
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++||+|+||.||+|....++ ..||+|.+.+... .....+..|..++..+ +||||+++++++.+.. ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTR-----RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----RL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC----EE
Confidence 36999999999999876543 3799999975422 2335577899999888 7999999999998765 45
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999999998888543 3589999999999999999999998 9999999999999999999999999998743
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh--hHHHHHhHhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS--EQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 324 (428)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+. ..
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~ 215 (329)
T cd05588 147 IRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL---------FQ 215 (329)
T ss_pred ccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH---------HH
Confidence 2211 12234679999999999999999999999999999999999999996432111 00000110 01
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK------MSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~ell~~ 367 (428)
.+..... ..+..++.++.+++.+||+.||.+||+ +.+++++
T Consensus 216 ~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 216 VILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111111 122234567899999999999999997 6777764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=310.53 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=203.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC--CcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
+++|++.++||+|.|+.||++.+..++. .+|+|.+... ...+.+++.+|+.|-+.|+||||+++.+.+.....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~-----~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGL-----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchH-----HHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 4578888899999999999998766543 6777776533 22356788999999999999999999988877664
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC---CCCCeEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~ 238 (428)
.|||+|+|+|++|..-|-.+ ..+++..+-..+.||++||.|+|.+ +|||||+||+|+||. ...-+||+
T Consensus 85 ----~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 85 ----HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred ----eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence 49999999999997766443 4588888999999999999999998 999999999999994 34459999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||+|..... ...-..++|||+|||||++...+|+..+|||+.||+||-|+.|.+||.+.......
T Consensus 156 ~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly----------- 221 (355)
T KOG0033|consen 156 DFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY----------- 221 (355)
T ss_pred ccceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH-----------
Confidence 9999987662 22345689999999999999999999999999999999999999999874322111
Q ss_pred hhhhhhhhcC--CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVD--PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~--~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.++.. -...+.....++++..+|+++||..||.+|.|+.|.+.+
T Consensus 222 -----e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 222 -----EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -----HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11211 123344555678899999999999999999999999864
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=317.33 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=198.0
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
+|++.+.||+|+||.||+|.+.... .+|+|.+.... .....+.+|+.+++.++|+||+++++++...+.
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~------~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 73 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKI------DVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP---- 73 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCc------cEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc----
Confidence 5778889999999999999875432 68999886443 234578899999999999999999999876653
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.++||||+++++|.+++..+. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCccccee
Confidence 499999999999999986543 3589999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ... .
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~----------~ 215 (256)
T cd05059 150 VLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ESV----------S 215 (256)
T ss_pred cccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HHH----------H
Confidence 432211 11112234467999999998899999999999999999999 89999754332111 100 0
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
. ......+...+.++.+++.+||..+|++||++.++++.|
T Consensus 216 ~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 216 A----GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred c----CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 001111223567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=329.75 Aligned_cols=243 Identities=28% Similarity=0.426 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
+.||+|+||.||+|....++ ..||+|.+.+.. ......+..|..++..+ +||||+++++++.+.+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTD-----ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----RL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EE
Confidence 36999999999999876543 379999987542 22345677888999887 7999999999998765 45
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999999999999888644 3489999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .+
T Consensus 147 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~-------------~i 208 (318)
T cd05570 147 ILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQ-------------SI 208 (318)
T ss_pred CcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HH-------------HH
Confidence 2221 112345799999999999999999999999999999999999999975542211 11 11
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~ell~~ 367 (428)
..... .++..++..+.+++.+||+.||.+||++ .+++++
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 209 LEDEV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HcCCC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11111 1222355789999999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=323.06 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=193.8
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
||+|+||+||++....++ ..||+|.+...... ..+.+..|+.+++.++|+||+++++++.... ..++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRATG-----KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT----DLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEccCC-----cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC----eEEEE
Confidence 699999999999876543 37999998654322 2356778999999999999999999887765 35999
Q ss_pred EeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 170 YEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
|||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 9999999998776432 234589999999999999999999998 99999999999999999999999999997543
Q ss_pred CCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014245 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327 (428)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (428)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ......
T Consensus 149 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~------------~~~~~~ 214 (280)
T cd05608 149 DGQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE------------LKQRIL 214 (280)
T ss_pred CCC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH------------HHHhhc
Confidence 322 112345799999999999999999999999999999999999999975432211100 001111
Q ss_pred CCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 328 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
... ..++..++..+.+++.+||+.||++|| ++++++++
T Consensus 215 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 NDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 111 122334667899999999999999999 67778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=316.61 Aligned_cols=253 Identities=26% Similarity=0.468 Sum_probs=203.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.++||+|+||.||+|...++ ..||+|.+..... ....+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~------~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 73 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGH------TKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQE----- 73 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCC------ceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccC-----
Confidence 5788999999999999999986543 3799999875443 346788999999999999999999987543
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCccee
Confidence 248999999999999998765556689999999999999999999988 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......++..|+|||++....++.++||||||+++|+|++ |..||............
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------------- 216 (260)
T cd05067 151 LIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL------------- 216 (260)
T ss_pred ecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------------
Confidence 6542221 11223446778999999998889999999999999999999 99999755432111110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
............+.++.+++.+||..+|++||++++++..|+.
T Consensus 217 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 217 ----ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001111122345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=315.30 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=201.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+...||+|+||.||+|....+. .+|+|.+.... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~------~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT------KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE----- 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc------eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----
Confidence 46888899999999999999876543 58999876543 2346788999999999999999999987532
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence 238999999999999999765445588999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||........ ...
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----------- 215 (260)
T cd05069 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ----------- 215 (260)
T ss_pred EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-----------
Confidence 65332211 1122346778999999988899999999999999999999 9999976432211 111
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
+.. ......+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus 216 --~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 216 --VER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --HHc-CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 01111223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=321.91 Aligned_cols=268 Identities=24% Similarity=0.421 Sum_probs=202.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCC-----------CCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccE
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSE-----------DPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKL 152 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----------~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~ 152 (428)
++|++.+.||+|+||.||++...... .......+|+|.+..... .....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999998654321 112345799999875432 334678999999999999999999
Q ss_pred eeEEecCCCCCceEEEEEeecCCCCcccccCCCCc---------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 014245 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE---------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 223 (428)
Q Consensus 153 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 223 (428)
++++...+.. ++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++|+|||
T Consensus 85 ~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk 157 (296)
T cd05095 85 LAVCITSDPL----CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA 157 (296)
T ss_pred EEEEecCCcc----EEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence 9999877643 999999999999998864321 2477888999999999999999998 99999999
Q ss_pred CCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh--CCCCCCCC
Q 014245 224 SSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT--GRRPIDRN 301 (428)
Q Consensus 224 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~ 301 (428)
|+|||++.++.++|+|||++................+++.|++||+..++.++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999976533322222223345678999999888899999999999999999998 77888654
Q ss_pred CchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 302 RPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
..... ......... .. ........+..++..+.+++.+||+.||++||++.+|++.|.
T Consensus 238 ~~~~~---~~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 238 SDEQV---IENTGEFFR------DQ-GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ChHHH---HHHHHHHHh------hc-cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 33211 111110000 00 000000111234578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=315.10 Aligned_cols=249 Identities=29% Similarity=0.489 Sum_probs=203.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||.|+||.||+|...+ ..||+|.+..... ..+++.+|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 74 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRG-------QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP--- 74 (256)
T ss_pred hhccceeeeecCCCceEEEEEecC-------cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC---
Confidence 478889999999999999998653 2699999976543 46788999999999999999999999987543
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 75 -~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 75 -LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccc
Confidence 49999999999999999765545689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
...... ....++..|+|||++.++.++.++||||||+++++|++ |..||........ .....
T Consensus 151 ~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~--------- 213 (256)
T cd05039 151 EASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHVE--------- 213 (256)
T ss_pred cccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHh---------
Confidence 653211 12334667999999988889999999999999999998 9999975532211 11100
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
.......+..+++.+.+++.+||..+|++||++.++++.|+.
T Consensus 214 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 214 -----KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -----cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 011111122345789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=327.45 Aligned_cols=268 Identities=26% Similarity=0.440 Sum_probs=207.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCC--CCcceEEEEEEccCCC-cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
.+|.+.+.||+|+||.||+|....... ......||+|.+.... ......+.+|+.++.++ +||||++++++|....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468899999999999999998654321 1233468999887543 23456788999999999 8999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
. .++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|
T Consensus 92 ~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 92 P----LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred c----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 3 499999999999999886432 23478889999999999999999998 99999999999
Q ss_pred eEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchh
Q 014245 227 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 305 (428)
Q Consensus 227 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 305 (428)
||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976533221111222344578999999999999999999999999999998 889987643221
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
.... . .. ......+...+..+.+++.+||+.+|++||++.++++.|.++.....
T Consensus 245 ~~~~---~-------------~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 LFKL---L-------------KE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHH---H-------------Hc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1110 0 00 01111122345689999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.63 Aligned_cols=251 Identities=29% Similarity=0.434 Sum_probs=203.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|+..+.||+|+||.||+|....++ ..|++|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADK-----RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG--- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCC-----cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC---
Confidence 4778889999999999999876543 379999886432 234567889999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 73 -KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred -EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 459999999999999999765445689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
........ ......|++.|+|||++.+..++.++||||||+++++|++|..||....... ...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~------------ 211 (256)
T cd08529 149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL------------ 211 (256)
T ss_pred eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH------------
Confidence 76543221 1234568899999999999899999999999999999999999997654211 111
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.... .......++..+.+++.+||+.+|++||++.+++++
T Consensus 212 -~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 -KIIRGV-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -HHHcCC-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111111 111222456789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.88 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=204.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+.||+|+||.||+|...+.........||+|.+..... ....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~- 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP- 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc-
Confidence 357889999999999999999875432233456899999875533 334678899999999999999999999987664
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS--------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 222 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl 222 (428)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||
T Consensus 83 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl 156 (288)
T cd05050 83 ---MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDL 156 (288)
T ss_pred ---cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence 499999999999999885321 12478888999999999999999998 9999999
Q ss_pred CCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCC
Q 014245 223 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRN 301 (428)
Q Consensus 223 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~ 301 (428)
||+|||++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999875433221111222345678999999998899999999999999999998 88898654
Q ss_pred CchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 302 RPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.... .... +.+.... ..+..++.++.+++.+||+.+|++||++.|+++.|+
T Consensus 237 ~~~~---~~~~-------------~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 237 AHEE---VIYY-------------VRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CHHH---HHHH-------------HhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3221 1111 1111110 112234578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.25 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=193.1
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
||+|+||.||++....++ ..||+|.+...... ....+..|+++++.++||||+++++++.+.. ..++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~----~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTG-----KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT----HLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEccCC-----cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC----eEEEE
Confidence 699999999999876543 37999998653221 2344567999999999999999999987655 45999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999999999888655555689999999999999999999998 9999999999999999999999999998765332
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......... .. .......
T Consensus 149 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~----------~~~~~~~ 213 (277)
T cd05607 149 K---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--EL----------KRRTLED 213 (277)
T ss_pred c---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HH----------HHHhhcc
Confidence 1 1234578999999999998889999999999999999999999997543211110 00 0111111
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+. .....++.++.+++.+||+.||++||++.|+++.
T Consensus 214 ~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 214 EVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 111 0112356789999999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=316.31 Aligned_cols=260 Identities=25% Similarity=0.495 Sum_probs=204.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|+..+.||+|+||.||+|...... .....+++|.+.... ......+..|+.++..++|+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPG--RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP-- 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCC--CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC--
Confidence 46788899999999999999876432 223478999987553 2335678899999999999999999999987664
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 81 --~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 81 --AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred --cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccc
Confidence 499999999999999986433 4589999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceee-eeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 244 RLGPSEGFTHV-STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
........... ......++.|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~--------- 222 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKA--------- 222 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH---------
Confidence 75533221111 111223457999999998889999999999999999998 999997543321 1111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
+.. ..........+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 223 ----i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 ----IND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----Hhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 011111223457889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=332.48 Aligned_cols=269 Identities=23% Similarity=0.300 Sum_probs=199.2
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|.+.+.||+|+||.||+|..... +..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVL-----DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCC-----CceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 457899999999999999999986543 34799999875432 23456789999999999999999999987543
Q ss_pred C--CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 161 E--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 161 ~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
. .....++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 2 12246999999965 66666542 378888999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh-h-
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK-P- 315 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~- 315 (428)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+.... +
T Consensus 162 Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 162 DFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred eCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999754322 12234578999999999999899999999999999999999999997654322111 000000 0
Q ss_pred --hhhh-hhhhhhhcCC----------c-----C---CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 --YLSD-AKQFRQIVDP----------R-----L---EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 --~~~~-~~~~~~~~~~----------~-----l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... .......++. . + ...........+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000 0 0 001111234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=319.88 Aligned_cols=258 Identities=27% Similarity=0.389 Sum_probs=202.4
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
.++.|+..+.||+|+||.||+|.....+ ..||+|.+.... .....+..|+.++..+ +|+||+++++++.....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCC-----cEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 4567888899999999999999876543 389999986543 3446788999999998 79999999999876432
Q ss_pred C--CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ....++||||+++++|.+++.......+++..+..++.|++.||+|||++ +|+|+||||+||++++++.++|+|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 1 13568999999999999998765445689999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
||++....... .......|++.|+|||++. +..++.++|||||||++|||++|..||............
T Consensus 155 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---- 228 (272)
T cd06637 155 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---- 228 (272)
T ss_pred CCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----
Confidence 99987543221 1223467899999999986 345888999999999999999999999754322111100
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............++.++.+++.+||..+|.+||++.+++++
T Consensus 229 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 ------------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ------------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000111112345688999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=316.89 Aligned_cols=260 Identities=25% Similarity=0.467 Sum_probs=203.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+.|++.+.||+|+||.||+|....... ....||+|.+.... .....+|..|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-- 79 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK--REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP-- 79 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC--CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc--
Confidence 357888999999999999998765432 23479999987543 2345678999999999999999999999876654
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 80 --~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 80 --VMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred --eEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccc
Confidence 499999999999999987543 4589999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeee-eee--cCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 244 RLGPSEGFTHVST-AVV--GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 244 ~~~~~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
............. ... .+..|+|||++.+..++.++|||||||++|||++ |..||....... ...++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~---- 226 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQ---- 226 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHc----
Confidence 7543322111111 111 2457999999998899999999999999999987 999997654321 1111110
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
......+..++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 227 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 ----------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001111223456789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=318.39 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=207.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++...||+|+||.||+|..+...+......+++|.+...... ....+.+|+.++++++|+||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP-- 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc--
Confidence 478889999999999999999876655556668999998765433 35678999999999999999999999977654
Q ss_pred ceEEEEEeecCCCCcccccCCCCc-------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeE
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSE-------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
.++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++
T Consensus 83 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 83 --HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred --ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEE
Confidence 3999999999999999865441 1589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 315 (428)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 158 l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~-- 231 (275)
T cd05046 158 VSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL-- 231 (275)
T ss_pred EcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH--
Confidence 999999864322211 11223456778999999988889999999999999999999 888986543211 11111
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
....+.......++..+.+++.+||+.+|++||++.++++.|.
T Consensus 232 -----------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 -----------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111112234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=331.17 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
+.||+|+||.||+|....++ ..||+|.+.+... .....+..|+.++.++ +||||+++++++...+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTE-----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC----EE
Confidence 36999999999999876554 3799999876422 2334577888888776 8999999999998765 45
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|..++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999999998887543 3589999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh--hHHHHHhHhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS--EQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 324 (428)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......+.. .
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------~ 215 (329)
T cd05618 147 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---------Q 215 (329)
T ss_pred cCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH---------H
Confidence 2221 12234679999999999999999999999999999999999999996321110 000001100 0
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK------MSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~ell~~ 367 (428)
.+..... ..+...+..+.+++.+||+.||++||+ +.+++++
T Consensus 216 ~i~~~~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 216 VILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHhcCCC--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111111 122345567899999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=334.87 Aligned_cols=263 Identities=21% Similarity=0.295 Sum_probs=194.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.+|.+.+.||+|+||.||+|.+.... ..||+|... ...+.+|+.+|++|+|+|||++++++....
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~-----~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~---- 233 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYP-----QRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG---- 233 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCC-----CEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC----
Confidence 46999999999999999999876543 379999632 234568999999999999999999988765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++|||++. ++|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 234 ~~~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 234 LTCLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 3489999994 68888775432 3589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCch-----hhHHHHHhHhh---h
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR-----SEQKLLQWVKP---Y 316 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~---~ 316 (428)
...............||+.|+|||++.+..++.++|||||||+||||++|..|+...... ....+...+.. .
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 653322222223467999999999999999999999999999999999988765332111 01111111111 0
Q ss_pred hhhh---------hhhhhh----cCCcCCCCcc---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 LSDA---------KQFRQI----VDPRLEGKYS---LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~---------~~~~~~----~~~~l~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ..+... ..+....... ......+.+|+.+||+.||++|||+.|++++
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 000000 0000000000 1234578899999999999999999999986
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.64 Aligned_cols=253 Identities=28% Similarity=0.411 Sum_probs=201.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-----ccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-----QGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
++|.+.+.||+|++|.||+|....++ ..+++|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTG-----RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCC-----cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence 47899999999999999999865443 3799998864322 1234678899999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|
T Consensus 77 ~----~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 77 E----TLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred C----eEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 6 459999999999999988643 3488899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceee-eeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 240 FGLARLGPSEGFTHV-STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
||++........... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------- 216 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----------- 216 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-----------
Confidence 999875432211110 12356888999999999888999999999999999999999999754322111
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............+..++..+.+++.+||..+|++||++.+++++
T Consensus 217 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 217 -----FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111111122333456789999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=319.37 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=197.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.++||+|+||.||+|....+. ..||+|.+.... ......+.+|+.++.+++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTR-----RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR-- 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCC-----cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE--
Confidence 36788899999999999999865443 379999986542 2334678899999999999999999999987653
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++
T Consensus 74 --~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 74 --ISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred --EEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 48999999999997543 267888899999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
...... ......||..|+|||++.+..++.++||||||+++|+|++|..||............. ...
T Consensus 143 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~---------~~~ 209 (279)
T cd06619 143 TQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL---------QLL 209 (279)
T ss_pred eecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH---------HHH
Confidence 754322 1234579999999999998899999999999999999999999996533211110000 000
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+...........+.++.+++.+||+.+|++||++++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111111111112245678999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=316.72 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=205.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.+|++.+.||+|+||.||+|....++ ..+++|.+..... .....+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDG-----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN- 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCC-----ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-
Confidence 46888889999999999999865443 3799998765322 23457889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
..++||||+++++|.+++.. .....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 76 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 76 ---ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ---eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECc
Confidence 34899999999999998853 2234589999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .....
T Consensus 150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-------- 218 (267)
T cd08229 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK-------- 218 (267)
T ss_pred chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhh--------
Confidence 999875533221 1223568999999999988889999999999999999999999996543211 11110
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
.+... .........++..+.+++.+||+.+|++|||+.+|++.+.++.
T Consensus 219 --~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 219 --KIEQC---DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --hhhcC---CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01111 1111122346678999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=334.18 Aligned_cols=246 Identities=32% Similarity=0.452 Sum_probs=203.6
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
-|+-++.||.|+||.||.|....+.+ .||||++.-.+.+ ...+++.|+..|++|+|||+|.+.|+|..+...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~e-----vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSE-----VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccc-----eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 47777889999999999998766554 8999998755443 345788999999999999999999999887765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
+|||||| -|+-.|++.-. .+++-+-.+..|..+.+.||+|||+. +.||||||..||||++.|.|||+|||.
T Consensus 102 ----WLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 102 ----WLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred ----HHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence 8999999 66888888643 35688999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|..... ..+++|||.|||||++. .+.|+-++|||||||+..||.-.++|+..........
T Consensus 173 Asi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY----------- 235 (948)
T KOG0577|consen 173 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----------- 235 (948)
T ss_pred hhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH-----------
Confidence 876543 35689999999999885 5789999999999999999999999987654322111
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.+.-.|.+. ..+.+..++.++..||++-|.+|||..+++.+
T Consensus 236 --HIAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 236 --HIAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --HHHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11111122222 45678899999999999999999999998764
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=331.51 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=192.0
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
+.||+|+||.||++..... ...+..||+|++..... .....+..|+.++++++||||+++++++.+.. ..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITG--PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG----KLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEecc--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----EEEE
Confidence 5799999999999875322 12345899999875432 23345678999999999999999999998765 4599
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCC
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 248 (428)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 99999999999988543 3589999999999999999999998 999999999999999999999999999875433
Q ss_pred CCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014245 249 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328 (428)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (428)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... . .+..
T Consensus 151 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~-------------~i~~ 212 (318)
T cd05582 151 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---T-------------MILK 212 (318)
T ss_pred CC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---H-------------HHHc
Confidence 21 1223467999999999999888999999999999999999999999765322111 1 1111
Q ss_pred CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 014245 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363 (428)
Q Consensus 329 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 363 (428)
... ..+..++..+.+++.+||+.||++||++.+
T Consensus 213 ~~~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 AKL--GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111 122235578899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=330.67 Aligned_cols=267 Identities=25% Similarity=0.300 Sum_probs=198.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLG-----INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCC-----ceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 3578999999999999999999865543 489999986542 233457789999999999999999999987554
Q ss_pred CC--CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 161 ER--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 161 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.. ....++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 21 1246999999965 56555532 378888999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ........
T Consensus 166 Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~--~~~~~~~~ 240 (359)
T cd07876 166 DFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN--KVIEQLGT 240 (359)
T ss_pred cCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCC
Confidence 99999754321 11234578999999999999999999999999999999999999998654321110 00000000
Q ss_pred hh--------hhhhhhc--CCcCCC----------------CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DA--------KQFRQIV--DPRLEG----------------KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~--------~~~~~~~--~~~l~~----------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ....... .+.... .........+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000000 000000 0111234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.88 Aligned_cols=266 Identities=26% Similarity=0.345 Sum_probs=201.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|+||.||++....++ ..+|+|.+..... ....++.+|++++..++||||+++++++.+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSG-----LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCC-----eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC---
Confidence 36899999999999999999876543 3788888865422 23456889999999999999999999998766
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||++
T Consensus 73 -~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 73 -EISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred -EEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCc
Confidence 459999999999999998654 4588999999999999999999972 28999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh----
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD---- 319 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 319 (428)
...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.....................
T Consensus 148 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 148 GQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred cccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 754322 123457899999999998888999999999999999999999999754422221111100000000
Q ss_pred ----------------hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 ----------------AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ----------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...................++.++.+++.+||..+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000010000000111255679999999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=334.76 Aligned_cols=257 Identities=25% Similarity=0.329 Sum_probs=199.9
Q ss_pred HHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEE
Q 014245 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYC 156 (428)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 156 (428)
+....++|++.+.||+|+||.||+|....+. ..+|+|.+.+.. ......+.+|+.+++.++||||+++++.+
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCC-----cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3334578999999999999999999877654 379999986432 12234577899999999999999999999
Q ss_pred ecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeE
Q 014245 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
.+.. ..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 113 ~~~~----~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 113 QDDR----YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred EcCC----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEE
Confidence 8765 459999999999999988643 378888999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccC----CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
|+|||++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.........
T Consensus 183 L~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----- 256 (371)
T cd05622 183 LADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----- 256 (371)
T ss_pred EEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-----
Confidence 999999986543221 122356799999999998753 3788999999999999999999999865432111
Q ss_pred HhhhhhhhhhhhhhcCC--cCCCCccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 014245 313 VKPYLSDAKQFRQIVDP--RLEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEMV 368 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ell~~L 368 (428)
..+... .+.......++..+.+++..||..++.+ |+++.+++++.
T Consensus 257 -----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 257 -----------SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----------HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111110 1111112245678899999999844433 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.33 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=192.0
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDE 161 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~ 161 (428)
+|...++||+|+||.||+|....++ ..||+|.+.+.. ....+.+..|..++..+. |++|+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 4778899999999999999876543 379999987542 223456778899988885 577888988887765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 75 ---RLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred ---EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 359999999999999988643 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~---------- 211 (323)
T cd05615 147 MCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQ---------- 211 (323)
T ss_pred cccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH----------
Confidence 987533221 122345799999999999998999999999999999999999999976543211 11
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM 361 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 361 (428)
.+.... ..++...+.++.+++.+||+.+|.+|++.
T Consensus 212 ---~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 212 ---SIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---HHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111 11223355688999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=325.57 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=191.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
..+|.+.+.||+|+||.||+|...... ..||+|..... ....|+.+++.++|+||+++++++.....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQP-----DPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI-- 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCC-----ceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCe--
Confidence 457999999999999999999976553 37899975432 23579999999999999999999987653
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+. ++|.+++... ...+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 132 --~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 132 --TCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred --eEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccc
Confidence 489999994 5888877543 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCC-CCCCchhhH-------HHHHhHhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQ-------KLLQWVKP 315 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~-~~~~~~~~~-------~~~~~~~~ 315 (428)
+..... .......||+.|+|||++.+..++.++|||||||++|||+++..|+ ......... .+......
T Consensus 205 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~ 281 (357)
T PHA03209 205 QFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281 (357)
T ss_pred cccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHH
Confidence 743221 1123457999999999999999999999999999999999955554 332211111 11111100
Q ss_pred hhhhhh---------hhhhhcCC--cCCCCc-------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAK---------QFRQIVDP--RLEGKY-------SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~---------~~~~~~~~--~l~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... ....+++. .....+ ...++.++.++|.+||+.||++|||+.|++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 282 LKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000000 00000000 000000 01234566789999999999999999999986
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=314.65 Aligned_cols=260 Identities=25% Similarity=0.463 Sum_probs=204.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|....++ .....+|+|.+..... ...+.+..|+.++..++||||+++++++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPG--KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP-- 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCC--CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc--
Confidence 47888999999999999999865332 1234789999865432 234678899999999999999999999977654
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.++|+|||++
T Consensus 80 --~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 80 --VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred --cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 499999999999999987543 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceee-eeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 244 RLGPSEGFTHV-STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
........... .....++..|+|||++.+..++.++||||||+++|++++ |..||......... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~~~~------- 223 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAIE------- 223 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---HHHh-------
Confidence 86543221111 112234568999999998889999999999999999887 99999765432211 1110
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
+. ........++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 224 ------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 ------EG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 01111223456889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=322.56 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=199.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+...... ....+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 78 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS-- 78 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCC-----CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe--
Confidence 57899999999999999999866543 37999998754322 33467789999999999999999999987653
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 79 --~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 79 --LTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred --EEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 5999999975 7877775432 3478899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh--------
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------- 314 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------- 314 (428)
....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 152 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 152 RAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred eecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 7543221 11223568999999998865 458899999999999999999999998765443322221110
Q ss_pred hhhhhhhhhhhhcCCcCCC----CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDAKQFRQIVDPRLEG----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.+.....+.....+.... .....++.++.+++.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000000011000 0112345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=312.97 Aligned_cols=251 Identities=25% Similarity=0.479 Sum_probs=196.2
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~ 170 (428)
.||+|+||.||+|.+.... .+..||+|.+...... ..+.+.+|+.+++.++|+||+++++++... ..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~---~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-----~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK---KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecCC---CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-----CeEEEE
Confidence 3899999999999875332 2336999998765332 345688999999999999999999988543 248999
Q ss_pred eecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCC
Q 014245 171 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 250 (428)
Q Consensus 171 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 250 (428)
||+++++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 74 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 74 EMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred EeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 999999999988643 24589999999999999999999998 99999999999999999999999999997543322
Q ss_pred cee-eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014245 251 FTH-VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328 (428)
Q Consensus 251 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (428)
... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+ .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----------------~ 212 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-----------------E 212 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-----------------H
Confidence 111 1112234578999999988889999999999999999996 99999765432211111 0
Q ss_pred CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 329 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
.......+...++++.+++.+||..+|++||++.+|.+.|+..
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 213 QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0011112233567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=331.79 Aligned_cols=270 Identities=23% Similarity=0.281 Sum_probs=199.6
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC-C
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE-R 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~ 162 (428)
+|++.+.||+|+||.||+|....+ +..||+|.+.... ....+++.+|+.+++.++|+||+++++++..... .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRD-----GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCC-----CCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence 478889999999999999986543 3379999986532 2234678899999999999999999999976552 1
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
....++||||+. ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence 124699999996 5787777533 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh--hhh-
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP--YLS- 318 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~- 318 (428)
++....... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..... ...
T Consensus 150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 976433221 112334689999999998874 478999999999999999999999987654433222211000 000
Q ss_pred ---hhhhhhhhc-CCcCCC-------CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 ---DAKQFRQIV-DPRLEG-------KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ---~~~~~~~~~-~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
........+ ...... ......++++.+++.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 000000 0111235688999999999999999999999886
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=313.50 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=202.2
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+|++.+.||+|+||.||++....++ ..+++|.+.... ....+.+..|+.+++.++|+||+++++.+.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSD-----QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG---- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCC-----ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----
Confidence 4788899999999999999876543 379999886432 334567889999999999999999999998765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.+++||||+++|+|.+++.......+++..++.++.|++.||.|||++ +|+|+||||+||++++++.++|+|||++.
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 459999999999999988654455689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~---------------- 210 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL---------------- 210 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH----------------
Confidence 6543221 2234678999999999998889999999999999999999999997643221110
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... ....+..++..+.+++.+||+.||++||++.+++..
T Consensus 211 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 KVCQGS-YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhcCC-CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000000 111223355678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=328.35 Aligned_cols=238 Identities=29% Similarity=0.393 Sum_probs=187.0
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHH-HHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVN-FLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++||+|+||+||+|....++ ..||+|.+..... .....+..|.. +++.++||||+++++++.+.. ..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG-----KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----KL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC----EE
Confidence 36999999999999976543 3899999865422 22344555554 567899999999999988765 45
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred EEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999999888643 3588999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ . ..+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~-------------~~i 208 (323)
T cd05575 147 IEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM---Y-------------DNI 208 (323)
T ss_pred ccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH---H-------------HHH
Confidence 2211 123346799999999999999999999999999999999999999976432211 1 111
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 362 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 362 (428)
..... ......+..+.+++.+||+.||.+||++.
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 209 LNKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11111 11223467899999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=315.83 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=206.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.+|.+.+.||+|+||.||+|.....+ ......+|+|.+..... .....+.+|+.++..++||||+++++++.. .
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--- 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEG-EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S--- 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCC-CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C---
Confidence 46788899999999999999876543 22345799998876543 234678899999999999999999999986 2
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++
T Consensus 82 -~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 82 -QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred -ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence 3489999999999999987543 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...............++..|+|||.+....++.++||||||++++|+++ |..||........ .+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~-------- 225 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PDLLE-------- 225 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHh--------
Confidence 86543222111122234578999999988889999999999999999999 9999976543221 11110
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
.......+...+..+.+++.+||..+|++||++.++++.|..+..
T Consensus 226 ------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 226 ------KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000011111234578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.61 Aligned_cols=252 Identities=28% Similarity=0.456 Sum_probs=200.1
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
|+..++||+|+||.||++....++ +.||+|.+...... ....+..|+.+++.++|+||+++++.+.+.+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--- 73 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD--- 73 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCC-----ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC---
Confidence 677889999999999999876553 48999998654322 2345778999999999999999999988765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 74 -~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 -ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred -EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 459999999999999988654445689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 150 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~------------ 214 (285)
T cd05630 150 VHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------ 214 (285)
T ss_pred eecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH------------
Confidence 7543221 1123479999999999999999999999999999999999999997643221111110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
.... .....+...++.++.+++.+||+.||++||+ +.+++++
T Consensus 215 -~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 215 -RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -hhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0000 0011122234567899999999999999999 8898875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=321.27 Aligned_cols=263 Identities=29% Similarity=0.490 Sum_probs=205.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|+..+.||+|+||.||+|....++. .....+|+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--- 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGE-TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT--- 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCC-cceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC---
Confidence 467888899999999999998765433 23456899988754332 2346889999999999999999999987543
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++
T Consensus 83 --~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 83 --IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred --ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence 278999999999999986543 3488899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...............++..|+|||++.+..++.++||||||+++|||++ |..||..........+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~-- 227 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KG-- 227 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CC--
Confidence 86543222112223445778999999998899999999999999999997 999997643222211111 00
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
... ......+..+.+++..||..+|++||++.++++.|..+...
T Consensus 228 ------~~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 ------ERL--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000 01112345788999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=319.69 Aligned_cols=268 Identities=25% Similarity=0.343 Sum_probs=197.4
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcC---CCCCcccEeeEEecCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIV---EHQNLVKLVGYCADDD 160 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~ 160 (428)
+|++.+.||+|+||.||+|....++ ..||+|.+...... ....+.+|+.+++.+ +||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSG-----HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence 4888999999999999999876543 37999988654221 223456777776655 7999999999886532
Q ss_pred C-CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 161 E-RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 161 ~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. .....++||||+++ +|.+++.......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 76 TDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred CCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 1 22356899999974 888888655445589999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~ 318 (428)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.......... ....... .
T Consensus 152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~--~ 226 (288)
T cd07863 152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL--P 226 (288)
T ss_pred cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC--C
Confidence 99997653221 1233568999999999998899999999999999999999999997654332211 1111000 0
Q ss_pred hhhhhhh-------hcCCcCC---CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQ-------IVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~-------~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+.. ...+... ......++..+.+++.+||+.||++||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 0000000 01112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=313.44 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=201.5
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
++||+|++|.||+|.+... ......||+|.+..... ...+.+.+|+.++++++||||+++++++.+ . ..++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS--GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H----PLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecC--CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C----eEEEE
Confidence 3689999999999987653 22334699999987765 556788999999999999999999999877 3 35999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++++|.+++.......+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccc
Confidence 9999999999998765434689999999999999999999998 9999999999999999999999999999865432
Q ss_pred Cce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014245 250 GFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327 (428)
Q Consensus 250 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (428)
... .......++..|+|||++.+..++.++|||||||++++|++ |..||............ . .
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~----------~-- 215 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---D----------K-- 215 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----------h--
Confidence 211 11223467889999999998899999999999999999999 99999754332211110 0 0
Q ss_pred CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 328 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 -EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00001112234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=335.44 Aligned_cols=254 Identities=24% Similarity=0.302 Sum_probs=196.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|+..+.||+|+||.||+|....++ ..||+|.+.... ......+..|+.++..++|+||+++++.+.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTG-----HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 36888999999999999999876543 379999986432 223456788999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 75 ---NLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred ---EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 459999999999999998644 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc---------------------------------eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHH
Q 014245 242 LARLGPSEGF---------------------------------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFL 288 (428)
Q Consensus 242 la~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 288 (428)
++........ .......+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 9864321100 0011235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 014245 289 YELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK---MSEVL 365 (428)
Q Consensus 289 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~ell 365 (428)
|||++|..||....+......+. . . ...+.-.....++.++.+++.+++ .||.+|++ +.+++
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~------~-~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVM------N-W-------KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHH------c-C-------CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 99999999997654432211110 0 0 000000001124567888888876 49999985 67777
Q ss_pred HH
Q 014245 366 EM 367 (428)
Q Consensus 366 ~~ 367 (428)
++
T Consensus 292 ~h 293 (360)
T cd05627 292 SH 293 (360)
T ss_pred cC
Confidence 65
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=320.61 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=203.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.+|++.+.||+|+||.||+|....++ ..|++|.+..........+.+|+.+++.++|+||+++++++....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~---- 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD---- 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCC-----cEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC----
Confidence 57899999999999999999865443 379999987765555677889999999999999999999988755
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|.+++... .+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred EEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence 459999999999999988532 478899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
...... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.... ....
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~----------- 229 (296)
T cd06654 165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIA----------- 229 (296)
T ss_pred hccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHh-----------
Confidence 543221 1122357899999999999888999999999999999999999999765432111 1000
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.........+..++..+.+++.+||..+|++||++.+++++
T Consensus 230 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 --TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 01100111223455789999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=314.24 Aligned_cols=245 Identities=24% Similarity=0.442 Sum_probs=190.7
Q ss_pred eecccCceEEEEEEEcCCCC-------CCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 92 VIGEGGFGCVYKGLIKNSED-------PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.||+|+||.||+|....... ......|++|.+..........+.+|+.++..++||||+++++++......
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~-- 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN-- 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC--
Confidence 68999999999998653221 123446899988765544556788999999999999999999999876643
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC-------eEE
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-------AKL 237 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~-------~kl 237 (428)
++||||+++|+|..++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +++
T Consensus 80 --~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 --IMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred --EEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 89999999999998876432 4589999999999999999999998 9999999999999987664 899
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhc-cCCCCCchhhhhHHHHHHHHH-hCCCCCCCCCchhhHHHHHhHhh
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELI-TGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
+|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|..||..........+.
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~----- 222 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY----- 222 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-----
Confidence 999998654321 2346888999999886 466899999999999999998 588888654322111100
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
..... ........+.+|+.+||+.||++||++.+|+++++
T Consensus 223 ------------~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 ------------EGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ------------hcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 01112457899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=317.15 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=200.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+..........+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~--- 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTG-----ELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--- 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCC-----eEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC---
Confidence 357999999999999999999865443 379999987554444566789999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 80 -~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 80 -KLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred -EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence 459999999999999988643 3588999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
........ ......|++.|+|||.+. ...++.++|||||||++|||++|..||....+....... ..
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~------ 223 (267)
T cd06646 154 AKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SK------ 223 (267)
T ss_pred eeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ec------
Confidence 75532211 122356889999999874 345788999999999999999999998644322111000 00
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.....+... ....++..+.+++.+||..+|++||++++++++|
T Consensus 224 ---~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 ---SNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---CCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000001110 1123457899999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=343.02 Aligned_cols=266 Identities=25% Similarity=0.477 Sum_probs=222.1
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
...+.++||.|.||+||+|.++..+ .....||||.++.... ....+|+.|+.||.+++||||+++.|+.......
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pg--kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv-- 705 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPG--KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV-- 705 (996)
T ss_pred heEEEEEEecccccceecccccCCC--CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee--
Confidence 4567789999999999999987654 2355899999987644 3456899999999999999999999999887754
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.||+|||++|+|+.||+.+. +.|++.+...++++|+.|+.||-+. ++|||||...|||++.+...|++||||++
T Consensus 706 --MIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 706 --MIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred --EEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccccee
Confidence 88999999999999999766 4599999999999999999999986 99999999999999999999999999999
Q ss_pred cCCCCCceeeeeeeec--CcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVG--TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
...++. ....+..-| ..+|.|||.+...+++.++|||||||+|||.++ |..||......+..
T Consensus 780 vledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-------------- 844 (996)
T KOG0196|consen 780 VLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-------------- 844 (996)
T ss_pred ecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH--------------
Confidence 765443 111222222 368999999999999999999999999999998 99999865432211
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcCC
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAG 379 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~~ 379 (428)
..++...+-..+.+++..|.+||..||++|-.+||.+.+|+..|++++++.....
T Consensus 845 ---kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 845 ---KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred ---HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 1223334445667889999999999999999999999999999999998765433
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=312.18 Aligned_cols=253 Identities=30% Similarity=0.525 Sum_probs=203.6
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-HHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
+.||+|+||.||+|...... .....+++|.+....... ...+.+|+.++..++|+||+++++++.+.. ..++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----PLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC----ceEEE
Confidence 36999999999999876531 224479999997664433 578889999999999999999999998744 35999
Q ss_pred EeecCCCCcccccCCCC-------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 170 YEYMPNGSVDQYLSPKS-------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
|||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence 99999999999997642 25689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+................+++.|+|||.+....++.++||||||+++|+|++ |..||....... +....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~-------- 220 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYL-------- 220 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH--------
Confidence 987654332222344567899999999988889999999999999999999 699997653221 11111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.+ ......+..++.++.+++.+||..+|++||++.+++++|+
T Consensus 221 -----~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 -----RK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----Hc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 1111223344678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=314.41 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=191.4
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~ 170 (428)
.||+|+||.||+|...+.. ....+++|.+..... .....+.+|+.+++.++||||+++++++.+... .++||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~ 74 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGY---TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP----YLLVM 74 (269)
T ss_pred cccccCCceEEEEEEcCCC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC----cEEEE
Confidence 5899999999999865422 234689998865432 234578899999999999999999999987654 38999
Q ss_pred eecCCCCcccccCCCC---cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 171 EYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 171 e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
||+++|+|.+++.... ....++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999999986432 22456778889999999999999998 99999999999999999999999999997544
Q ss_pred CCCceeeeeeeecCcccCCcchhccC-------CCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 248 SEGFTHVSTAVVGTMGYAAPEYVQTG-------RLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
............|+..|+|||++.+. .++.++||||||+++|||++ |..||............ .
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~--~------ 223 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT--V------ 223 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--h------
Confidence 33222222345678899999988642 35789999999999999997 99999765432211110 0
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.........+.+ ....++.+.+++..|+ .+|++||++++|++.|.
T Consensus 224 ~~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 REQQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hcccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000001111111 1124457888999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=313.03 Aligned_cols=255 Identities=28% Similarity=0.489 Sum_probs=203.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|...++ ..+++|.+..... ..+++.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~------~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGT------TKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP-- 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCC------ceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc--
Confidence 45789999999999999999986543 2689999875433 45678999999999999999999999876553
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 76 --~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 76 --IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred --eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence 49999999999999999765555689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
......... ......++..|+|||.+.+..++.++||||||+++++|++ |+.||....... ......
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~-------- 218 (261)
T cd05034 151 RLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVE-------- 218 (261)
T ss_pred eeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH--------
Confidence 765432111 1112335678999999998889999999999999999999 999996543221 111110
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
. ......+...+.++.+++.+||..+|++||+++++++.|+.
T Consensus 219 -----~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 -----R-GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----c-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 00111112235689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=312.51 Aligned_cols=253 Identities=28% Similarity=0.482 Sum_probs=198.7
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
++||+|+||.||+|.+...+. ....+|+|.+...... ..+.+.+|+.+++.++|+||+++++++... ..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCC--CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-----ceEEE
Confidence 369999999999998755431 2347999998765442 456788999999999999999999987643 24899
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++|+|.+++.... .+++..++.++.|++.||+|||.. +++|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 74 MELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999999999997544 589999999999999999999998 9999999999999999999999999999765332
Q ss_pred Ccee-eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014245 250 GFTH-VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327 (428)
Q Consensus 250 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (428)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .+..+... .
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~----~------- 214 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES----G------- 214 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc----C-------
Confidence 2111 1112224567999999998899999999999999999998 99999765432 12211111 0
Q ss_pred CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 328 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
.....+..++..+.+++.+||..+|++||++.++++.|..+.
T Consensus 215 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 215 ---ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 000112234568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.34 Aligned_cols=241 Identities=29% Similarity=0.386 Sum_probs=187.9
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHH-HHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVN-FLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
+.||+|+||.||+|....++ ..||+|.+..... .....+..|.. +++.++||||+++++++...+ ..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEE-----KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----KL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC----eE
Confidence 36999999999999876543 3799999865321 22234444544 567889999999999998766 35
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 72 YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999999999999988643 3478888899999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~-------------~i 208 (325)
T cd05602 147 IEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD-------------NI 208 (325)
T ss_pred ccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH-------------HH
Confidence 2211 123346799999999999999999999999999999999999999976443211 11 11
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell 365 (428)
..... .....++..+.+++.+||+.||.+||++.+.+
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 209 LNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HhCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11111 11223556889999999999999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.79 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=206.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||+|....++ ..|++|.+.... ....+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDG-----RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCC-----CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 57999999999999999999976433 379999886432 223567889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|
T Consensus 76 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 76 ---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ---eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEec
Confidence 349999999999999888532 234588999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...+..
T Consensus 150 ~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~-------- 218 (267)
T cd08224 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK-------- 218 (267)
T ss_pred cceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh--------
Confidence 999875433211 123356899999999999888999999999999999999999999644311 111111
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
.+............++..+.+++.+||..+|++||++.+|++.|..+.
T Consensus 219 -----~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 219 -----KIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----hhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000111111112245678999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.21 Aligned_cols=256 Identities=28% Similarity=0.479 Sum_probs=195.3
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
+.||+|+||.||+|...... .....+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+. ..++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCC--CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcEEE
Confidence 36899999999999875432 234579999986432 2345678899999999999999999998765432 24899
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999986543 2367778889999999999999998 9999999999999999999999999999754332
Q ss_pred Ccee--eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhC-CCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 250 GFTH--VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 250 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... ......++..|+|||++.+..++.++|||||||++|||++| .+||...... ......
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~------------- 215 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL------------- 215 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-------------
Confidence 2111 11233467789999999888899999999999999999995 5566543221 111111
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
... .....+...+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 216 ~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 216 LQG-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred hcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 000 000111224567999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=316.87 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=199.1
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
|+..++||+|+||+||+|....++ ..+|+|.+...... ....+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--- 73 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATG-----KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD--- 73 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCC-----cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC---
Confidence 667789999999999999876543 37999998654322 2345778999999999999999999887765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 74 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 74 -ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred -EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 359999999999999888654445699999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 150 ~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~------------ 214 (285)
T cd05632 150 VKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD------------ 214 (285)
T ss_pred eecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------
Confidence 7543221 1223578999999999998899999999999999999999999997653321111110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
...... ...+...++..+.+|+..||+.||++||+ +.+++.+
T Consensus 215 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 215 RRVLET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred Hhhhcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 000000 11122335567899999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=317.23 Aligned_cols=244 Identities=24% Similarity=0.426 Sum_probs=189.7
Q ss_pred eecccCceEEEEEEEcCCC-------------------CCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccE
Q 014245 92 VIGEGGFGCVYKGLIKNSE-------------------DPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~-------------------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 152 (428)
.||+|+||.||+|.+.... +......|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999864211 122345789999876554445678899999999999999999
Q ss_pred eeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC
Q 014245 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 232 (428)
Q Consensus 153 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~ 232 (428)
++++.+... .++||||+++|+|..++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++..
T Consensus 82 ~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSE----NIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCc----eEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999987664 38999999999999888643 34588999999999999999999998 99999999999999765
Q ss_pred C-------CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHH-hCCCCCCCCCc
Q 014245 233 W-------NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELI-TGRRPIDRNRP 303 (428)
Q Consensus 233 ~-------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~p~~~~~~ 303 (428)
+ .+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 4 3799999988643221 12357888999998875 56899999999999999995 69999976543
Q ss_pred hhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 304 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
........ . ...... .....+.+++.+||+.+|++||++.+|++.|
T Consensus 228 ~~~~~~~~-------------~--~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKERFYE-------------K--KHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHH-------------h--ccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 22211110 0 001111 1234789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=350.83 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=203.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.++||+|+||.||+|....++ ..||+|++..... ...+++.+|+.+++.++||||+++++++.+.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg-----~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~- 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCS-----RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD- 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCC-----cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-
Confidence 57999999999999999999876543 3799999875422 23457889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCC---------CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPK---------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 232 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~ 232 (428)
..++||||++||+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 76 ---~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~d 149 (932)
T PRK13184 76 ---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLF 149 (932)
T ss_pred ---EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCC
Confidence 359999999999999887531 112356677889999999999999998 99999999999999999
Q ss_pred CCeEEeeecccccCCCCCc----------------eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCC
Q 014245 233 WNAKLSDFGLARLGPSEGF----------------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 296 (428)
Q Consensus 233 ~~~kl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 296 (428)
+.+||+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 9999999999976521100 001123579999999999999999999999999999999999999
Q ss_pred CCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhh
Q 014245 297 PIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-KMSEVLEMVNKIVDA 374 (428)
Q Consensus 297 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ell~~L~~~~~~ 374 (428)
||........... .....+. .......+++.+.+++.+||+.||++|| +++++++.|+..+..
T Consensus 230 PF~~~~~~ki~~~--------------~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 230 PYRRKKGRKISYR--------------DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCCcchhhhhhh--------------hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9976332111000 0000000 0001123556789999999999999995 677788888877654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=328.80 Aligned_cols=268 Identities=25% Similarity=0.299 Sum_probs=198.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|.....+ ..||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCC-----cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 468999999999999999999865443 379999987542 2334567899999999999999999998865432
Q ss_pred --CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 --RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.....|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 12246999999965 67666642 378888999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh-------
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW------- 312 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~------- 312 (428)
||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 170 fG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 170 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred CCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99997643221 22345789999999999999999999999999999999999999976543322111100
Q ss_pred -----Hhh----hhhhhhh-----hhhhcCCcC---CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 313 -----VKP----YLSDAKQ-----FRQIVDPRL---EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 313 -----~~~----~~~~~~~-----~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+ +..+... +.......+ ...........+.+++.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0000000 000000000 000111234578999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.96 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=193.2
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++||+|+||.||+|....++ ..||+|.+.+... .....+..|+.++.++ +||||+++++++.+.. .+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKND-----QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----RL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC----EE
Confidence 36999999999999876553 3799999976432 2345577899999888 7999999999988765 45
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999999998887543 3489999999999999999999998 9999999999999999999999999998743
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.............+.. ..+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~---------~~~ 215 (327)
T cd05617 147 LGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF---------QVI 215 (327)
T ss_pred cCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH---------HHH
Confidence 2211 12234679999999999999999999999999999999999999996432221111111110 011
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~ell~~ 367 (428)
..... ..+...+..+.+++.+||+.||.+|+++ .+++++
T Consensus 216 ~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 216 LEKPI--RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11111 1222345678999999999999999985 466554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=317.08 Aligned_cols=278 Identities=23% Similarity=0.353 Sum_probs=204.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
..|++.+.||+|+||.||++.+... ....+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~- 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN- 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccC-CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC-
Confidence 3578889999999999999986532 22335589999987543 23346788999999999999999999998775332
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.++|+|||++
T Consensus 82 -~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 -GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred -ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 3589999999999999986432 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
......... .......|+..|+|||++.+..++.++||||||+++|+|+++..|+.............. ..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~-~~~~~-~~~ 234 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT-HGQMT-VTR 234 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc-ccccc-HHH
Confidence 765432211 112235577789999999888899999999999999999998776533211000000000 00000 000
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
....+...........++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000110111111223567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=333.17 Aligned_cols=246 Identities=24% Similarity=0.433 Sum_probs=203.8
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEe
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYE 171 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e 171 (428)
+||+|+||+||.|+...+ .+.+|||.+..+.......+..|+.+.+.|+|.|||+++|.+..++. +-+.||
T Consensus 582 VLGKGTYG~VYA~RD~~t-----qvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf----~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDT-----QVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF----FKIFME 652 (1226)
T ss_pred EeecCceeEEEeeccccc-----eeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe----EEEEee
Confidence 799999999999985554 46899999998887777889999999999999999999999876653 467899
Q ss_pred ecCCCCcccccCCCCcccc--cHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC-CCCCeEEeeecccccCCC
Q 014245 172 YMPNGSVDQYLSPKSETIL--TWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 172 ~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~ 248 (428)
-++||+|.++++.+= +++ .+...-.+.+||++||.|||++ .|||||||-+||||+ -.|.+||+|||-++...
T Consensus 653 qVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA- 727 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA- 727 (1226)
T ss_pred cCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc-
Confidence 999999999997542 334 7788889999999999999998 999999999999995 57889999999998643
Q ss_pred CCceeeeeeeecCcccCCcchhccCC--CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 249 EGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
+....+..+.||..|||||++..+. |+.++|||||||++.||.||++||-........ +-++
T Consensus 728 -ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------------MFkV 791 (1226)
T KOG4279|consen 728 -GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------------MFKV 791 (1226)
T ss_pred -cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------------hhhh
Confidence 3344566789999999999998764 899999999999999999999999654321110 0011
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
---+..+..+..++.+...+|.+|+..||.+||+++++++.
T Consensus 792 GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 792 GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 11123455677889999999999999999999999999874
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=313.04 Aligned_cols=260 Identities=25% Similarity=0.443 Sum_probs=205.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.++||+|+||.||+|.+.... .....|++|...... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--- 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP--- 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCC---
Confidence 46888899999999999999875432 233468999887654 334567899999999999999999999987543
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||++
T Consensus 81 --~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 81 --VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred --cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCcee
Confidence 389999999999999996543 3489999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... .......++..|+|||.+....++.++||||||++++||++ |..||......... .... ..
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~----~~-- 224 (270)
T cd05056 155 RYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIE----NG-- 224 (270)
T ss_pred eecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH----cC--
Confidence 76543321 11122334568999999988889999999999999999996 99999765432111 1000 00
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
.. ...+..++..+.+++.+|+..+|++||++.++++.|+.+..
T Consensus 225 ------~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 ------ER--LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ------Cc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 01122345789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=326.15 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=202.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC--CcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
..|+++++||+||.+.||++...+.. .+|+|++... +.+...-|.+|+..|.+| .|.+||++|+|-..++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~------iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~- 433 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQ------IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG- 433 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCc------chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc-
Confidence 56999999999999999999865543 5777766433 334456789999999999 6999999999988765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+||||||- ..+|..+|.++......| .++.+..|++.|+.++|+. ||||-||||+|+|+-. |.+||+|||
T Consensus 434 ---~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFG 504 (677)
T KOG0596|consen 434 ---YLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFG 504 (677)
T ss_pred ---eEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeec
Confidence 469999986 559999998776554445 7788999999999999998 9999999999999975 589999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCC-----------CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-----------LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
+|.....+.........+||+.||+||.+.... .+.++||||||||||+|+.|++||....
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------- 576 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------- 576 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--------
Confidence 999887777666777899999999999886432 4578999999999999999999997432
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCccHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLR-LVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+..+.++...-.++.. ...++.++++.||+.||.+||++.+||++
T Consensus 577 -------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 -------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122344555666443233221 11239999999999999999999999986
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=331.60 Aligned_cols=263 Identities=23% Similarity=0.299 Sum_probs=206.2
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-C-----CCcccEeeEEecC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-H-----QNLVKLVGYCADD 159 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~~~~~~ 159 (428)
+|.+.++||+|+||.|.+|....+++ .||||+++... ....+...|+.+|..|+ | -|+|+++++|...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e-----~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGE-----IVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCc-----EEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 57889999999999999999766554 89999997543 33456678999999996 4 3899999999987
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC--CeEE
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW--NAKL 237 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~--~~kl 237 (428)
+. .|||+|.+ ..+|.++|..+....|+...++.|+.||+.||.+||+. +|||+||||+||||.+.+ .+||
T Consensus 261 ~H----lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 261 NH----LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cc----eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 75 49999999 66999999988878899999999999999999999998 999999999999996544 5999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh--
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-- 315 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-- 315 (428)
+|||.|......- ...+.+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+....+....+.-+.-
T Consensus 333 IDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 333 IDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred EecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 9999998765432 256788999999999999999999999999999999999988988776655444432210
Q ss_pred ---hhhhhhhhhhhcCC---------------------------------cCC-------CCccHHHHHHHHHHHHHhcc
Q 014245 316 ---YLSDAKQFRQIVDP---------------------------------RLE-------GKYSLRLVSKLSHVANLCLV 352 (428)
Q Consensus 316 ---~~~~~~~~~~~~~~---------------------------------~l~-------~~~~~~~~~~l~~li~~cl~ 352 (428)
++.........++. ... ..........+.+++.+||.
T Consensus 408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 00000000001100 000 00111233578999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 014245 353 KNARTRPKMSEVLEM 367 (428)
Q Consensus 353 ~dp~~RPs~~ell~~ 367 (428)
.||.+|+|..+.++|
T Consensus 488 ~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 488 WDPAERITPAQALNH 502 (586)
T ss_pred cCchhcCCHHHHhcC
Confidence 999999999999986
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=313.21 Aligned_cols=251 Identities=29% Similarity=0.488 Sum_probs=195.0
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCceEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
+||+|+||.||+|....++ ....+++|.+.... ......+.+|+.++.++ +||||+++++++..... .++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----~~lv 74 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----LYLA 74 (270)
T ss_pred cCCCCCCceEEEEEEcCCC---CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC----ceEE
Confidence 6899999999999876542 22357888886533 23446788999999999 89999999999987664 4999
Q ss_pred EeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCe
Q 014245 170 YEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 235 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 235 (428)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeE
Confidence 99999999999886432 12478899999999999999999998 99999999999999999999
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHh
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 314 (428)
||+|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||....... .....
T Consensus 152 kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~- 224 (270)
T cd05047 152 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL- 224 (270)
T ss_pred EECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH-
Confidence 99999998532211 01111234567999999988889999999999999999997 999996543221 11100
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
............+.++.+++.+||..+|.+||++.++++.|+.++
T Consensus 225 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 -------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111112234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=310.51 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=202.2
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|++.+.||+|++|.||++....++ ..|++|.+..... ...+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDG-----KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG-- 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCC-----cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC--
Confidence 4888999999999999999876543 3799999865432 334568899999999999999999988754332
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 74 -LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred -EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 358999999999999998765445689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......|++.|+|||++.+..++.++||||||+++++|++|..||......... .
T Consensus 150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~------~--------- 212 (257)
T cd08223 150 RVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV------Y--------- 212 (257)
T ss_pred EEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------H---------
Confidence 7653321 1223457899999999999999999999999999999999999999754321110 0
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
......+ ...+...+..+.+++.+||+.+|++||++.+++++
T Consensus 213 -~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 213 -RIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -HHHhcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0001111 11233466789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.43 Aligned_cols=202 Identities=26% Similarity=0.401 Sum_probs=161.4
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
.++||+|+||.||+|...+.. ..+.||+|.+..... ...+.+|+.+|+.++||||+++++++...... ..++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~---~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK---DDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADR--KVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCC---CCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCc--EEEEE
Confidence 357999999999999875432 234799999865432 34577999999999999999999998765433 56899
Q ss_pred EeecCCCCcccccCCC-------CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE----CCCCCeEEe
Q 014245 170 YEYMPNGSVDQYLSPK-------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLS 238 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~ 238 (428)
|||+. ++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 99995 5777766421 123588999999999999999999998 99999999999999 466789999
Q ss_pred eecccccCCCCCce-eeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCC
Q 014245 239 DFGLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNR 302 (428)
Q Consensus 239 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~ 302 (428)
|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99999865432211 112346789999999998764 58999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.47 Aligned_cols=238 Identities=28% Similarity=0.367 Sum_probs=185.9
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHH-HHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVN-FLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++||+|+||.||+|....++ ..||+|.+.+... .....+..|.. +++.++||||+++++++.+.+ ..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDG-----SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----KL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----EE
Confidence 36999999999999976543 3799999865422 22334555554 678899999999999988765 35
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|...+... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999999998887543 3488889999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||....... +.. .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~-------------~i 208 (321)
T cd05603 147 VEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD-------------NI 208 (321)
T ss_pred CCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH-------------HH
Confidence 2211 12334679999999999998899999999999999999999999997653211 111 11
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 362 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 362 (428)
....+ ..+...+..+.+++.+||+.||.+||++.
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 LHKPL--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hcCCC--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11111 11223456789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=312.73 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=189.1
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~ 170 (428)
.||+|+||.||+|..... .....+++|.+..... .....+.+|+.+++.++|+||+++++++..... .++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~----~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG---MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP----YLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecC---CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc----eEEEE
Confidence 589999999999975433 2234688898764432 234568899999999999999999999987654 49999
Q ss_pred eecCCCCcccccCCCCc---ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 171 EYMPNGSVDQYLSPKSE---TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 171 e~~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
||+++|+|.+++..... ..+++...+.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 99999999999865322 3356778889999999999999998 99999999999999999999999999987543
Q ss_pred CCCceeeeeeeecCcccCCcchhcc-------CCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 248 SEGFTHVSTAVVGTMGYAAPEYVQT-------GRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
............+++.|+|||++.. ..++.++|||||||++|||++ |..||......... ..... .
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--~~~~~----~ 225 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL--KQVVR----E 225 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH--HHHhh----c
Confidence 3222222233456778999998753 356789999999999999999 78888754322111 10000 0
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
....... ......++..+.+++..|+ .||++||++++|++.|
T Consensus 226 --~~~~~~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 --QDIKLPK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred --cCccCCC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0000111 1122345567788889998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=321.65 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=210.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc--HHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+-|...+.||+|.|+.|-+|.+--++ ..||||++.+..... ...+++|++.|+.++|||||++|.+.....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTG-----ekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-- 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTG-----EKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-- 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhccc-----ceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc--
Confidence 34777789999999999998865443 489999998875543 356889999999999999999999987765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE-CCCCCeEEeeec
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL-DEQWNAKLSDFG 241 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFG 241 (428)
.+|||+|+-++|+|.|||.++. ..+.+..+.+++.||+.|+.|+|+. ++|||||||+||.+ ..-|-|||+|||
T Consensus 91 --KlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 91 --KLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred --eEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence 4699999999999999998654 4599999999999999999999998 99999999999987 556889999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCC-chhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA-RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
++..+... ...+..||+..|-|||++.+..|+. ++||||||||||-|++|+.||+.... .
T Consensus 165 FSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------S 225 (864)
T KOG4717|consen 165 FSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------S 225 (864)
T ss_pred ccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------h
Confidence 99766443 2345689999999999999999975 89999999999999999999986543 3
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.+-.++|... ..+..++.++++||..||..||.+|.+.++|...
T Consensus 226 ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 226 ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 34445566554 3567889999999999999999999999998764
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=314.48 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=198.2
Q ss_pred eecccCceEEEEEEEcCCCC-CCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSED-PSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
.||+|+||.||+|....... ......+++|.+..... .....+.+|+.+++.++||||+++++++..... .++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~v 77 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP----QYII 77 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC----eEEE
Confidence 68999999999998764321 22335789998865432 345678899999999999999999999987654 4999
Q ss_pred EeecCCCCcccccCCC-----CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-----CeEEee
Q 014245 170 YEYMPNGSVDQYLSPK-----SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-----NAKLSD 239 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~D 239 (428)
|||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+|||++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999998642 223478899999999999999999998 999999999999999887 899999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
||++................++..|+|||++.++.++.++|||||||++|+|++ |..||....... .....
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----- 226 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----- 226 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH-----
Confidence 999875433222222223456788999999999999999999999999999998 999997543221 11110
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
............+..+.+++.+||..+|.+||++.+|++.|+
T Consensus 227 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 ---------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000111122345678999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=324.23 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=195.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||++....++ ..||+|.+.+.. ....+.+.+|+.++..++|+||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTG-----QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 47899999999999999999876543 379999986422 123456788999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 75 ---NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred ---eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 459999999999999998643 23488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc-----CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 148 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i------ 220 (331)
T cd05597 148 SCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------ 220 (331)
T ss_pred ceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH------
Confidence 9875433221 11223569999999999863 45788999999999999999999999764322111100
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNA--RTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp--~~RPs~~ell~~ 367 (428)
..... .. .+. .....++..+.+++.+||..++ ..|+++.+++++
T Consensus 221 ~~~~~----~~--~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 221 MNHKE----HF--QFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HcCCC----cc--cCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00000 00 000 1111256678889988775433 347899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=313.73 Aligned_cols=254 Identities=32% Similarity=0.515 Sum_probs=200.2
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHH--HHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK--EWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
|++.+.||+|+||+||++.....+ ..+|+|.+......... ....|+.+++.++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---- 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNG-----QKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN---- 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTT-----EEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS----
T ss_pred CEEeEEEEeCCCEEEEEEEECCCC-----eEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc----
Confidence 567889999999999999977654 37999999877544322 3456999999999999999999998855
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|.+++. ....+++..++.++.|++.||.+||+. +++|+||||+|||++.++.++|+|||.+.
T Consensus 72 ~~~~v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred ccccccccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 4589999999999999987 234589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhc-cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
..... ........++..|+|||++. +..++.++||||||+++++|++|..||................... .
T Consensus 147 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-----~ 219 (260)
T PF00069_consen 147 KLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-----L 219 (260)
T ss_dssp ESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-----H
T ss_pred ccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc-----c
Confidence 53111 12334567899999999998 7889999999999999999999999998763222222222111000 0
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..... ........+.+++.+||+.||++||++.+++++
T Consensus 220 ~~~~~------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 220 PSSSQ------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHTT------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccc------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000012689999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=314.12 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=207.4
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
|.++.+||+|+||.||+|.++.++. .+|||+.... .+..+++.|+.||++++.|+||++||.+..... +
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~-----v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD----L 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGH-----VLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD----L 103 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCc-----EEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc----e
Confidence 5566789999999999999876654 8999997654 456789999999999999999999998776654 4
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++|||||..|++.+.++.+ ++++++.++..++...++||+|||.. .-||||||..||||+.+|.+||+|||+|...
T Consensus 104 WIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred EeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh
Confidence 9999999999999999754 46799999999999999999999987 8899999999999999999999999999766
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.+... ......|||.|||||++..-.|+.++||||||++..||..|++||....+.... +.-.
T Consensus 180 TDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------------FMIP 242 (502)
T KOG0574|consen 180 TDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------------FMIP 242 (502)
T ss_pred hhhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------------Eecc
Confidence 54322 234578999999999999999999999999999999999999999865442111 0001
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+...-.-+...+.++-++++.||..+|++|-|+-+++++
T Consensus 243 T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 243 TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12222223345678899999999999999999999999875
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.71 Aligned_cols=248 Identities=28% Similarity=0.462 Sum_probs=195.0
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~ 164 (428)
.+.+..||.|+.|.|+++.++.++ ..+|||.+.+... +..++++..+.++.+. ++|+||+.+|||..+...
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~-----~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV-- 166 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTG-----HIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV-- 166 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccc-----eEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH--
Confidence 344557999999999999988754 4899999987644 3456777888877766 499999999999988765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
++.||.| ..-++.++. +...++++..+-++...++.||.||.++ ++|+|||+||+|||+|+.|++||||||++.
T Consensus 167 --~IcMelM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 167 --FICMELM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred --HHHHHHH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccc
Confidence 7789988 334444443 3345689998889999999999999986 599999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhcc---CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
...+.. ..+...|.+.|||||.+.- ..|+.++||||||++++||.||+.||.+...+ .+
T Consensus 241 rlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe------------- 302 (391)
T KOG0983|consen 241 RLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FE------------- 302 (391)
T ss_pred eeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HH-------------
Confidence 554322 2345679999999999864 46899999999999999999999999874321 11
Q ss_pred hhhhhcC---CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+-.+++ +.+... ..+++.+.+++..||..|+.+||.+.+++++
T Consensus 303 ~ltkvln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 303 VLTKVLNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1112222 222222 2378899999999999999999999999885
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.36 Aligned_cols=254 Identities=22% Similarity=0.420 Sum_probs=202.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|...... .+++|.+.... .....+.+|+.+++.++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~------~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~--- 73 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHT------KVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E--- 73 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCc------cEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C---
Confidence 357889999999999999999865433 58999876542 234678899999999999999999999876 3
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..+++|||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 74 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 74 -PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred -CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence 248999999999999999765555688899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
........ .......++..|+|||++..+.++.++|||||||++|+|++ |..||......... ....
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~-------- 217 (260)
T cd05073 150 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALE-------- 217 (260)
T ss_pred eeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHh--------
Confidence 75433221 11222345678999999998889999999999999999999 99999764322111 1100
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
...........+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 ------RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000011122345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.13 Aligned_cols=239 Identities=29% Similarity=0.352 Sum_probs=186.9
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHH-HHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVN-FLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++||+|+||+||+|....++ ..||+|++.+... .....+..|.. +++.++||||+++++++...+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDG-----KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----KL 71 (325)
T ss_pred CceeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC----EE
Confidence 36999999999999876543 3799999865421 22345556654 467799999999999998765 35
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999998888543 3589999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~----------------~~~ 208 (325)
T cd05604 147 IAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY----------------DNI 208 (325)
T ss_pred CCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH----------------HHH
Confidence 2211 1223467999999999999999999999999999999999999999765322111 111
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 363 (428)
....+ ......+..+.+++.+||+.+|.+||++.+
T Consensus 209 ~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 209 LHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 11111 111224567889999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.65 Aligned_cols=246 Identities=30% Similarity=0.479 Sum_probs=194.6
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~ 170 (428)
+||+|+||.||+|...++ ..+|+|.+...... ....+.+|+.+++.++||||+++++++..... .++||
T Consensus 2 ~ig~g~~g~vy~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~ 71 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDK------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP----IYIVM 71 (250)
T ss_pred ccCCCCCceEEEEEecCC------cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc----cEEEE
Confidence 689999999999986543 27999998765432 23468899999999999999999999987664 49999
Q ss_pred eecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCC
Q 014245 171 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 250 (428)
Q Consensus 171 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 250 (428)
||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 72 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 72 ELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred ECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 9999999999886433 3478999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 251 FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
. .......+++.|+|||++.++.++.++||||||+++|+|++ |..||...........+ . .
T Consensus 148 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---~--------------~ 209 (250)
T cd05085 148 Y-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---E--------------K 209 (250)
T ss_pred c-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---H--------------c
Confidence 1 11112244678999999998889999999999999999998 99999755332111100 0 0
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
......+..++..+.+++.+|+..+|++||++.++++.|.
T Consensus 210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 210 GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0111122235578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=315.34 Aligned_cols=245 Identities=23% Similarity=0.451 Sum_probs=191.3
Q ss_pred eecccCceEEEEEEEcCCCC--CCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
.||+|+||.||+|....... ......+++|.+........+.+.+|+.+++.++||||+++++++...... ++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~----~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES----IMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc----EEE
Confidence 69999999999998754332 123446888888655544556788999999999999999999999876543 899
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC--------eEEeeec
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--------AKLSDFG 241 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFG 241 (428)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. ++++|||
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999987543 3588999999999999999999998 9999999999999987765 6999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCC-CCCCCCCchhhHHHHHhHhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGR-RPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
++..... .....+++.|+|||++.+. .++.++||||||+++|+|++|. .||............
T Consensus 154 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~--------- 218 (258)
T cd05078 154 ISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--------- 218 (258)
T ss_pred cccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---------
Confidence 8864332 1235688999999998864 5799999999999999999985 565543322111100
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.. ....+.....++.+++.+||+.||++||+++++++.|+
T Consensus 219 --------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 --------ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00111223467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=314.95 Aligned_cols=278 Identities=25% Similarity=0.413 Sum_probs=208.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
..|...+.||+|+||.||+|.+...+ ...+..+|+|.+...... ....+.+|+.+++.++|+||+++++++......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~- 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR- 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC-
Confidence 35777889999999999999876432 234568999999765443 456899999999999999999999998774432
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 82 -~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 -SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred -ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 3589999999999999997543 2489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
......... .......++..|++||.+.+..++.++||||||++++||++|..|+............. ... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~-~~~~~~ 234 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQG-QMIVTR 234 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccc-cccHHH
Confidence 865422111 11122345567999999988889999999999999999999999986532211000000 000 000001
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
+...+........+..++.++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111122233457899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.89 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=195.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.++||+|+||.||++....++ ..+|+|.+.+... .....+..|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNAD-----KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCC-----CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 36889999999999999999977654 3799999864321 22345778999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+++||||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 75 ---NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred ---EEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 359999999999999999643 23589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
++........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~-------- 218 (332)
T cd05623 148 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-------- 218 (332)
T ss_pred hheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH--------
Confidence 9875432221 1223457999999999986 3468899999999999999999999997653221111
Q ss_pred hhhhhhhhhhcCCcCC---CCccHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNAR--TRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~--~RPs~~ell~~ 367 (428)
.+...... ......++.++.+++.+|+..++. .|+++.+++++
T Consensus 219 --------~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 --------KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --------HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111000 011123567889999998865444 46899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=325.43 Aligned_cols=267 Identities=24% Similarity=0.314 Sum_probs=198.1
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|.+.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCC-----CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 4578999999999999999999865543 3799999875422 23456778999999999999999999886432
Q ss_pred C--CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 161 E--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 161 ~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
. .....++++|++ +++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 1 123468999998 7899887753 3489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVKPY 316 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~ 316 (428)
|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+ ......
T Consensus 161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred CCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999764322 234578999999999876 56899999999999999999999999765432211111 000000
Q ss_pred ----hhh--hhhhhhhcCCcCCCCc-------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 ----LSD--AKQFRQIVDPRLEGKY-------SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ----~~~--~~~~~~~~~~~l~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.. ......... .+.... .....+.+.+++.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000000 000000 00123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.95 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=203.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.+|+..+.||.|+||.||+|....++ ..|++|.+........+.+.+|+.+++.++||||+++++++....
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATG-----QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD---- 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCC-----cEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc----
Confidence 46999999999999999999865443 379999987665555677889999999999999999999998765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++|+||+++++|.+++... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence 459999999999999988643 489999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.............
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~------------- 228 (296)
T cd06655 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------- 228 (296)
T ss_pred hcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------
Confidence 5433221 1233568999999999998889999999999999999999999997654322211100
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ........+..++..+.+++.+||..||++||++.+++++
T Consensus 229 ~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 229 T--NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred h--cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 0000001122355678999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=308.35 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=204.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||.|+||.||+|....++ ..+++|.+........+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~---- 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATG-----ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD---- 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCC-----CEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC----
Confidence 57889999999999999999876543 379999987665556678899999999999999999999987765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 4599999999999999886542 3589999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccC---CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTG---RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.............
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~---------- 217 (262)
T cd06613 150 QLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS---------- 217 (262)
T ss_pred hhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 543321 112345788999999998776 78999999999999999999999997654322111100
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..... ..........+.++.+++.+||..+|.+||++.+|+.+
T Consensus 218 --~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 218 --KSNFP-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --hccCC-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00111233456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=314.17 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=199.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~---- 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTG-----ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD---- 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCC-----cEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Confidence 46888889999999999999866543 379999987654444566789999999999999999999988765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|.+++... +.+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence 359999999999999988644 3589999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
...... .......|++.|+|||++. ...++.++|||||||++|+|++|..||....+........ .
T Consensus 155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~------- 223 (267)
T cd06645 155 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--K------- 223 (267)
T ss_pred EccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--c-------
Confidence 543221 1123457999999999874 4568899999999999999999999986543321111000 0
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+... ....++..+.+++.+||+.+|++||++++|+++
T Consensus 224 --~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 224 --SNFQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --cCCCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000001110 011244678999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=315.61 Aligned_cols=266 Identities=27% Similarity=0.373 Sum_probs=205.7
Q ss_pred cCHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEe
Q 014245 75 FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLV 153 (428)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~ 153 (428)
.++.++....+.|++.+.||+|+||.||+|...... ..+|+|.+.... .....+..|+.++..+ +|+||++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~ 79 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYY 79 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCC-----cEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence 345555556788999999999999999999976543 379999886543 2345678899999988 799999999
Q ss_pred eEEecCC--CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 154 GYCADDD--ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 154 ~~~~~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
+++.... ......++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||++++
T Consensus 80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~ 156 (282)
T cd06636 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTE 156 (282)
T ss_pred eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence 9986432 1123569999999999999998765555688888999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 306 (428)
++.++|+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|..||....+...
T Consensus 157 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred CCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 9999999999987543211 1123457899999999875 34678899999999999999999999965432211
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ..............++..+.+++.+||..||.+||++.+|+++
T Consensus 235 ~~----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 235 LF----------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hh----------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 10 0001111111122356789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=310.36 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=198.8
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---------cHHHHHHHHHHHhcCCCCCcccEeeEE
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---------GHKEWMTEVNFLGIVEHQNLVKLVGYC 156 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~~~~~~ 156 (428)
+|.+...||+|+||.||+|.....+ ..+|+|.+...... ..+.+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSG-----ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCC-----cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 4778889999999999999865433 37999988654322 124578899999999999999999999
Q ss_pred ecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeE
Q 014245 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
..... .++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++
T Consensus 76 ~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 76 LDADH----LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred EeCCc----cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 87664 48999999999999999654 3588899999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCce----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 237 LSDFGLARLGPSEGFT----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 237 l~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
|+|||+++........ .......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ...
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~-- 222 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIF-- 222 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HHH--
Confidence 9999998765422111 11123468899999999998889999999999999999999999997543211 100
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ......+...+..+.+++.+||+.||.+||++.+++++
T Consensus 223 ------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 ------------KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ------------HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0000 11112223456789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=315.05 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=198.1
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
|++.+.||+|+||.||+|....+. ..+++|.+........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETG-----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----NL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCC-----eEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC----EE
Confidence 567778999999999999876543 478999987665555677889999999999999999999998765 35
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++++|..++... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 78 ~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 78 WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 9999999999998877532 24589999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
.... .......|++.|+|||++. +..++.++|||||||++|+|++|..||........ .....
T Consensus 154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~-------- 221 (282)
T cd06643 154 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIA-------- 221 (282)
T ss_pred cccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHh--------
Confidence 3221 1223457899999999874 34578899999999999999999999975432111 11100
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+.+ ..+..++.++.+++.+||+.||++||++.+++++
T Consensus 222 ---~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 222 ---KSEPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---hcCCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011 1122355789999999999999999999998875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=321.57 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=196.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||.||++....++ ..||+|.+.+.. ......+.+|..++..++|+||+++++++.+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTE-----RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 47899999999999999999876543 379999986532 122345778999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..|+||||++||+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 75 ---YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred ---EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 3599999999999999996532 3588999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc-----CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
++........ .......||+.|+|||++.+ +.++.++|||||||++|+|++|+.||..........
T Consensus 148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-------- 218 (331)
T cd05624 148 SCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-------- 218 (331)
T ss_pred ceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH--------
Confidence 9976543321 12234579999999999875 567889999999999999999999997644321111
Q ss_pred hhhhhhhhhhcCCc--CC-CCccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDPR--LE-GKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~--l~-~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ell~~ 367 (428)
.+.... +. ......+++++.+++.+||..++++ |+++++++++
T Consensus 219 --------~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 219 --------KIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --------HHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111100 00 0111234678999999999865544 4688888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=306.98 Aligned_cols=248 Identities=30% Similarity=0.487 Sum_probs=196.9
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
++||+|+||.||+|...++ ..|++|.+...... ....+.+|++++++++|+||+++++++.+... .++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~------~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGN------TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP----IYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeCC------CcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC----eEEE
Confidence 3699999999999987652 27999988765443 45678999999999999999999999987764 4999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++++|.+++.... ..+++..++.++.+++.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 71 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 71 MELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999999986543 3478899999999999999999998 9999999999999999999999999999754322
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (428)
..........++..|+|||++.++.++.++||||||+++|+|++ |..||...........+ .
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-----------------~ 209 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-----------------E 209 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-----------------h
Confidence 21111122334667999999988899999999999999999999 88898765432211111 0
Q ss_pred CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 329 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.......+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 210 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 210 SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01111122345568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=312.19 Aligned_cols=267 Identities=22% Similarity=0.339 Sum_probs=197.5
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|++.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTG-----QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES--- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCC-----cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC---
Confidence 4788899999999999999876543 3799999865422 23457889999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCC-cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||++ ++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+
T Consensus 73 -~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 73 -RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred -eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccc
Confidence 4599999997 58888775433 25689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh------
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK------ 314 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~------ 314 (428)
+....... .......+++.|+|||++.+. .++.++|||||||++++|++|+.||.......... ......
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 87543221 112234678999999988654 47889999999999999999999997654322111 000000
Q ss_pred -hhhhhhhhhhhhcCCcCC---CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 -PYLSDAKQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 -~~~~~~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+................. ......++.++.+++.+||+.||++|||+.+|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000001111100000 00111245788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.91 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=203.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|.....+ ..||+|.+........+.+.+|+.+++.++|+||+++++++....
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--- 89 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATG-----QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--- 89 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCC-----CEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 368999999999999999999865443 379999987665555667889999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 90 -ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred -EEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence 45999999999999998854 2378889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+..... .
T Consensus 163 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~------------ 226 (297)
T cd06656 163 AQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L------------ 226 (297)
T ss_pred eEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--e------------
Confidence 7543322 11233568899999999998889999999999999999999999997543211100 0
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...........+..++..+.+++.+||..+|++||++.+++++
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 227 -IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000111223455678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.20 Aligned_cols=258 Identities=25% Similarity=0.435 Sum_probs=218.2
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
+.....+||-|.||.||.|+|+.-. ..||||.++.+. ...++|+.|+.+|+.++|||+|+++|+|..+...
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkys-----lTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF--- 338 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF--- 338 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccc-----eeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe---
Confidence 4555678999999999999998654 379999997654 4568999999999999999999999999988765
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
|||+|||..|+|-++|+...+..++.-..+.++.||..|++||..+ ++|||||...|.|+.++..||++||||+++
T Consensus 339 -YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 -YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred -EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999987777788888999999999999999998 999999999999999999999999999998
Q ss_pred CCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
+..+.+.... ...-.+-|.|||-+.-..++.|+|||+|||+|||+.| |-.||.+.+......+
T Consensus 415 MtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L--------------- 478 (1157)
T KOG4278|consen 415 MTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL--------------- 478 (1157)
T ss_pred hcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH---------------
Confidence 8655443221 1223567999999998999999999999999999999 9999987654333322
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
+....+-+-+..+++.+.+||+.||+++|.+||++.|+.+.++.+...
T Consensus 479 --LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 479 --LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred --HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 233333344556778999999999999999999999999999988754
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.96 Aligned_cols=247 Identities=27% Similarity=0.498 Sum_probs=198.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||.||+|...+ ..||+|.+.... ....+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 72 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTG-------QKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG---- 72 (254)
T ss_pred HHceeeeeeccCCCCceEecccCC-------CceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC----
Confidence 468889999999999999986432 268999886432 3457889999999999999999999986543
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++++|.+++.......+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.
T Consensus 73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence 38999999999999999765555689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
..... ......+..|+|||++.++.++.++||||||+++|+|++ |..||............
T Consensus 149 ~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~------------- 210 (254)
T cd05083 149 VGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV------------- 210 (254)
T ss_pred ecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------------
Confidence 54321 112234568999999998899999999999999999998 99999765432211110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
...........++..+.+++.+||+.+|++||+++++++.|++
T Consensus 211 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 211 ----EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0011111222355788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=308.41 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=197.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-----ccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-----QGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
.+|...++||+|+||.||+|....++ ..|++|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTG-----RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCC-----cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 47889999999999999999865443 3799998764321 2234678899999999999999999988764
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
... ..+++|||+++++|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 77 ~~~--~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 77 AEK--TLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CCC--EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 322 458999999999999988643 3488899999999999999999988 999999999999999999999999
Q ss_pred ecccccCCCCCc-eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 240 FGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
||++........ ........++..|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~----------- 218 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI----------- 218 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-----------
Confidence 999875432111 11112356889999999999888999999999999999999999999754321110
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............+....+.+.+++ +||..+|++||++++|+.+
T Consensus 219 -----~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 219 -----FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -----HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 111111111223334556777777 6888999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=318.07 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=203.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|+..+.||+|+||.||+|....++ ..+|+|.+...... ..+.+..|++++..++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTG-----KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCC-----cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 36888999999999999999876543 38999999765432 3456889999999999999999999987755
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+.+++|.+++.......+++..+..++.|++.||+|||.. +++|+||||+||+++.++.++|+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 75 ---YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred ---EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 459999999999999998765556689999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce---------------------------eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhC
Q 014245 242 LARLGPSEGFT---------------------------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG 294 (428)
Q Consensus 242 la~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 294 (428)
++......... .......||..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98654321100 011234689999999999988899999999999999999999
Q ss_pred CCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 014245 295 RRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK----MSEVLEM 367 (428)
Q Consensus 295 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~ell~~ 367 (428)
..||........ +..+.............+..+.+++.+||+.||++||+ +.+++++
T Consensus 229 ~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 229 TTPFKGSNRDET----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCCchHHH----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 999976543211 11111111111111225678999999999999999999 7777774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=307.64 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=203.5
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|+..++||.|+||.||.+.....+ ..+++|.+.... .....++.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDD-----SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCC-----cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC---
Confidence 5888999999999999998865443 378999876542 334567889999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 73 -~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 73 -TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred -eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 459999999999999999765445689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
........ ......|++.|+|||++.+..++.++||||||+++++|++|..||.........
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---------------- 210 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV---------------- 210 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH----------------
Confidence 76543321 223457899999999998888899999999999999999999999754322111
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
..+...... .....++.++.+++.+||..+|.+||++.++++++
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 211 VKIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011111111 11234567899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.15 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=199.4
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|.+++.||+|+||+||+|....+. ..+|+|.+..... .....+..|+.+|..|+|||||+++++|.+..
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg-----~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQ-----EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCC-----eEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 3568999999999999999999976543 4789998865432 23467889999999999999999999987654
Q ss_pred CCCceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCC----CCCeeeccCCCCceEECC---
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGM----DFQIIVRDFKSSNILLDE--- 231 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~ivHrDlkp~NILl~~--- 231 (428)
.. .+||||||+++|+|.++|... ....+++..++.|+.||+.||+|||... ..+||||||||+||||+.
T Consensus 86 ~~--~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 NQ--KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 33 469999999999999988642 1245899999999999999999999842 125999999999999964
Q ss_pred --------------CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHHHhCC
Q 014245 232 --------------QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGR 295 (428)
Q Consensus 232 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~ 295 (428)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 3358999999997653322 2234579999999999864 45889999999999999999999
Q ss_pred CCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 296 RPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 296 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.||....... .+...+. . .+.+. ....+.++.+||..||..+|.+||++.+++.+
T Consensus 241 ~PF~~~~~~~--qli~~lk----------~--~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 241 TPFHKANNFS--QLISELK----------R--GPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCcCCcHH--HHHHHHh----------c--CCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9997543211 1111000 0 01110 11235689999999999999999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.39 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=194.3
Q ss_pred Cceeeccc--CceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 89 RSVVIGEG--GFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 89 ~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++.+||+| +||+||++....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~--- 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTG-----EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--- 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccC-----cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE---
Confidence 45689999 78999999876554 3899999875432 233457789999999999999999999987763
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++|+|.+++..+....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++|||.+.
T Consensus 74 -~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 -LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred -EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 59999999999999998755445589999999999999999999998 99999999999999999999999998654
Q ss_pred cCCCCCce-----eeeeeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 245 LGPSEGFT-----HVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 245 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
.....+.. .......++..|+|||++.+ ..++.++|||||||++|||++|..||........ .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence 32211110 01122356788999999876 4589999999999999999999999975432211 111000000
Q ss_pred h---h-----hhhhh----------------------hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 S---D-----AKQFR----------------------QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~---~-----~~~~~----------------------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. + ..... ..............+++.+.+++.+||+.||++|||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 0 00000 0000000011222456789999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=307.70 Aligned_cols=243 Identities=28% Similarity=0.510 Sum_probs=191.6
Q ss_pred eeecccCceEEEEEEEcCCCC-----CCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 91 VVIGEGGFGCVYKGLIKNSED-----PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
+.||+|+||.||+|....... ......+++|.+...... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~---- 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DE---- 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CC----
Confidence 368999999999999876541 223346888887654433 6788999999999999999999999987 43
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-------CeEEe
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-------NAKLS 238 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~ 238 (428)
.++||||+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 3899999999999999875432 588999999999999999999998 999999999999999888 79999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccC--CCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 315 (428)
|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.............
T Consensus 151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 9999875432 1234577889999998876 78999999999999999999 577876553221111100
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
. ....... ....+.+++.+||..+|.+||++.++++.|
T Consensus 221 ---~--------~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ---D--------QHRLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---c--------CCCCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0000000 116889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.92 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=202.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|+..+.||.|+||.||+|....++ ..|++|.+.... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTN-----QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS--- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCC-----eEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC---
Confidence 36888889999999999999876543 379999987553 233457889999999999999999999988764
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++|+||+++++|.+++... .+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 73 -KLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred -eEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 459999999999999998754 589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
+...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....+...... +
T Consensus 146 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-------------~ 210 (274)
T cd06609 146 GQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-------------I 210 (274)
T ss_pred eeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-------------h
Confidence 7654321 122345788999999999988899999999999999999999999976542211100 0
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+.+.. ..++.++.+++.+||..+|++||++++++++
T Consensus 211 ~~~~~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 211 PKNNPPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hhcCCCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0001111111 1156689999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=310.66 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=200.2
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
..++++.....||+|+||.||+|....++ ..|++|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 78 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQ-----VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG- 78 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCC-----cEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-
Confidence 34566777789999999999999865543 379999987766556678899999999999999999999988765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccc--cHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-CCCeEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETIL--TWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~ 238 (428)
..++|+||+++++|.+++.... ..+ ++..+..++.||+.||+|||++ +|+||||||+||+++. ++.++|+
T Consensus 79 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~ 151 (268)
T cd06624 79 ---FFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKIS 151 (268)
T ss_pred ---EEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEe
Confidence 4599999999999999986432 224 7888889999999999999998 9999999999999976 6789999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCC--CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
|||++....... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||........... .
T Consensus 152 dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~---~--- 223 (268)
T cd06624 152 DFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF---K--- 223 (268)
T ss_pred cchhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh---h---
Confidence 999987543211 1122346899999999987644 78899999999999999999999965432111100 0
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..........+..+.+++.+++.+||+.+|.+||++.+++++
T Consensus 224 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 ---------VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---------hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000001112233456789999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=313.34 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=200.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+.|++.+.||.|+||.||+|....++ ..+++|.+........+.+.+|+.+++.++|+||+++++++....
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETG-----ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG---- 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCC-----ceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC----
Confidence 56889999999999999999876543 379999987765556677889999999999999999999987765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|..++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 4599999999999988775432 3589999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
...... .......+++.|+|||++. ...++.++|||||||++|+|++|..||....... ......
T Consensus 159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~------ 228 (292)
T cd06644 159 KNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA------ 228 (292)
T ss_pred eccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHh------
Confidence 532211 1123456889999999885 3446889999999999999999999997543211 111100
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+.. ..+..++.++.+++.+||..+|++||++.+++++
T Consensus 229 -----~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 -----KSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----cCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 1122345678999999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=306.52 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=202.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|+..+.||+|+||.||+|....++ ..+++|.+..... ...+.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---- 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETG-----QVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT---- 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCC-----cEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC----
Confidence 57889999999999999999977543 3799999865432 578899999999999999999999998765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++++||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence 3599999999999999986433 4589999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... ......|+..|+|||++.+..++.++||||||+++++|++|+.||............ .
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------------~ 212 (256)
T cd06612 148 QLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------------P 212 (256)
T ss_pred hcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------c
Confidence 6543221 123356889999999999889999999999999999999999999764332111000 0
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ........+..+...+.+++.+||+.||++||++.+++++
T Consensus 213 ~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 213 N--KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred c--CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0 0000111223455789999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=307.09 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=198.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-----cccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
.+|++.++||+|+||.||+|....++ ..|++|.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTG-----RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCC-----cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 47889999999999999999866543 389999875321 12235678899999999999999999988765
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
... .+++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +++|+||||+|||++.++.++|+|
T Consensus 77 ~~~--~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 77 MER--TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred CCc--eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 432 458999999999999988643 3478888999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 240 FGLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
||++......... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------------ 217 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------------ 217 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------------
Confidence 9998754321111 112235689999999999888899999999999999999999999975422111
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.............+......+.+++.+|+. +|++||++++|+++
T Consensus 218 ----~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 218 ----IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011111111222344566788899999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=314.43 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=188.7
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~ 170 (428)
.+||+|+||.||+|...++. ....||+|.+..... ...+.+|+.+++.++||||+++++++...... ..++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~---~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv~ 79 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK---DEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDR--KVWLLF 79 (317)
T ss_pred eEeccCCCeeEEEEEecCCC---ccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC--eEEEEE
Confidence 57999999999999875432 345799999865432 34678999999999999999999998765433 469999
Q ss_pred eecCCCCcccccCCC-------CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE----CCCCCeEEee
Q 014245 171 EYMPNGSVDQYLSPK-------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSD 239 (428)
Q Consensus 171 e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~D 239 (428)
||+++ +|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99964 776665321 123588999999999999999999998 99999999999999 5667899999
Q ss_pred ecccccCCCCCce-eeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh-------HHHH
Q 014245 240 FGLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-------QKLL 310 (428)
Q Consensus 240 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-------~~~~ 310 (428)
||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||..||........ ..+.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 9999865432211 112345789999999998764 579999999999999999999999975432111 0011
Q ss_pred HhHhhhh----hhhhhh---------hhhc-CCcCC--------CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 311 QWVKPYL----SDAKQF---------RQIV-DPRLE--------GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 311 ~~~~~~~----~~~~~~---------~~~~-~~~l~--------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
......- ...... .... ..... ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000 000000 0000 00000 00001123468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=308.47 Aligned_cols=263 Identities=23% Similarity=0.412 Sum_probs=201.2
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC-
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG- 163 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~- 163 (428)
|.+.++||+|+||.||+|..... ...+..||+|.+.... ....+++.+|+.+++.++||||+++++++......+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSE--DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeecc--CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 56778999999999999986542 1234589999986543 234567889999999999999999999887643221
Q ss_pred -ceEEEEEeecCCCCcccccCCC----CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 164 -IQRLLVYEYMPNGSVDQYLSPK----SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 164 -~~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
...++++||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 1247889999999998776421 123478889999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |..||....... +..+..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~--- 229 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI--- 229 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---
Confidence 9999986543222222223446678999999998889999999999999999999 889987543321 111110
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
... .+ ......+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 230 -~~~--------~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 -KGN--------RL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -cCC--------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 00 01123456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=305.56 Aligned_cols=256 Identities=30% Similarity=0.542 Sum_probs=202.1
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
|++.+.||.|+||.||++....... .....||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+ .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE----P 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC----e
Confidence 3567789999999999999865431 23358999999765443 4668889999999999999999999998765 3
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.+++|||+++++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCcee
Confidence 49999999999999998754433389999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
......... ....+++.|+|||.+.+..++.++||||||+++++|++ |..||........ .....
T Consensus 153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~---------- 218 (258)
T smart00219 153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYLK---------- 218 (258)
T ss_pred ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh----------
Confidence 543322111 12337789999999988889999999999999999998 8888875432211 11110
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.. .........+.++.+++.+||..+|++|||+.++++.|
T Consensus 219 ---~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 ---KG-YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---cC-CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 00111222567899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=312.91 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=201.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||.|+||.||+|....+. ..+|+|.+........+.+..|+.+++.++|+||+++++++....
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETG-----LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN---- 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCC-----cEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC----
Confidence 46888889999999999999876432 379999987665555678899999999999999999999998765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccch
Confidence 3599999999999999886432 3589999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
...... .......|++.|+|||++. ...++.++||||||+++|+|++|..||........ ....
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~------- 220 (280)
T cd06611 152 KNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI------- 220 (280)
T ss_pred hhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH-------
Confidence 543221 1223457899999999875 34467899999999999999999999976532211 1110
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+.+ ..+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 221 ----~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 221 ----LKSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----hcCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000001 1122345688999999999999999999999885
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=306.83 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=202.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|++.+.||.|+||.||+|....++ ..+++|.+..... ...+.+..|+.+++.++|+||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~- 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDG-----KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ- 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC-
Confidence 4788899999999999999866543 3789998865432 2345688999999999999999999988764433
Q ss_pred ceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhh-----cCCCCCeeeccCCCCceEECCCCCeE
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLH-----EGMDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
..+++|||+++++|.+++... ....+++..++.++.|++.||.||| +. +++|+||||+||+++.++.+|
T Consensus 75 -~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 75 -TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred -EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEE
Confidence 468999999999999988642 2346899999999999999999999 65 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
|+|||++........ ......|++.|+|||++.+..++.++||||||+++++|++|..||...... .+....
T Consensus 151 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~--- 222 (265)
T cd08217 151 LGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI--- 222 (265)
T ss_pred EecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH---
Confidence 999999986543321 123457899999999999888999999999999999999999999865421 111111
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
........+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 223 -----------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 -----------KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----------hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111122334566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.44 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=198.3
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.|+..+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 76 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK--- 76 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCC-----eEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc---
Confidence 3556678999999999999865433 4799999875432 334578899999999999999999999987653
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++.
T Consensus 77 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 77 -LWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred -eEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence 5999999999999998864 3488999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
...... .......|+..|+|||++.+..++.++|||||||+++||++|..||....+.... .
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~------------- 211 (277)
T cd06642 150 QLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---F------------- 211 (277)
T ss_pred cccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---h-------------
Confidence 543321 1122356889999999999888999999999999999999999998654322111 0
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+...........++..+.+++.+||+.+|++||++.+++++
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 -LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000011111222355689999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=314.50 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=198.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~--- 77 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTD-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--- 77 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCC-----cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC---
Confidence 57899999999999999999876543 3799999865432 23346778999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++
T Consensus 78 -~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 78 -SLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred -eEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcch
Confidence 3599999996 58888776432 3488899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
....... .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....... ....
T Consensus 152 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~-~~~~ 228 (301)
T cd07873 152 RAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP-TEET 228 (301)
T ss_pred hccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-Chhh
Confidence 7543221 112234678999999988654 47889999999999999999999997654332211111000000 0000
Q ss_pred hhhhc---------CCcCCC----CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIV---------DPRLEG----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~---------~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..++ .+.... .....++..+.+|+.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00100 010000 0112345678999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=312.28 Aligned_cols=267 Identities=30% Similarity=0.399 Sum_probs=203.0
Q ss_pred CHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEee
Q 014245 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVG 154 (428)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 154 (428)
.++.+....++|++.+.||+|+||.||+|...... ..+|+|.+.... .....+..|+.+++.+ +||||+++++
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNG-----SKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCC-----ceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 34555666789999999999999999999876543 378999876432 2235678899999999 7999999999
Q ss_pred EEecCC-CCCceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 155 YCADDD-ERGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 155 ~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
++.... ..+...++||||+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~ 159 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT 159 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence 885422 1223569999999999999887521 234588899999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc-----CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 306 (428)
++.+||+|||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|..||........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred CCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 99999999999876533221 1223568999999998753 4578899999999999999999999975432111
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
+... .....+.+ ..+..++..+.+++.+||+.||++||++.++++++
T Consensus 238 --~~~~-----------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 --LFKI-----------PRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --Hhhc-----------cccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1000 00000000 01112345799999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=306.99 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=188.7
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~ 170 (428)
.||+|+||.||+|...... ....+++|.+.... ....+.+.+|+.+++.++||||+++++.|.+... .++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~----~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT---GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP----YLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCC---CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc----cEEEE
Confidence 5999999999999754432 23356777766543 2345688999999999999999999999987654 49999
Q ss_pred eecCCCCcccccCCCC--cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCC
Q 014245 171 EYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 171 e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 248 (428)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc
Confidence 9999999999986532 23466777889999999999999998 999999999999999999999999999864322
Q ss_pred CCceeeeeeeecCcccCCcchhcc-------CCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 249 EGFTHVSTAVVGTMGYAAPEYVQT-------GRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
...........|+..|+|||++.. ..++.++||||||+++|||++ |..||........... . +.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~----~~-- 223 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH--V----IK-- 223 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--H----Hh--
Confidence 211122234578899999998753 235789999999999999997 5778865433211110 0 00
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.......++.+.. .+.+.+.+++..|| .+|++||++++|++.|.
T Consensus 224 ~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 DQQVKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hcccccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0011112222222 24567888999999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=325.10 Aligned_cols=242 Identities=26% Similarity=0.329 Sum_probs=186.0
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcC---CCCCcccEeeEEecCCCCCceE
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIV---EHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
||+|+||+||+|....++ ..||+|.+...... ....+..|..++..+ +||||+++++++.+... .
T Consensus 1 lG~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~----~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTR-----RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD----L 71 (330)
T ss_pred CCCCCceEEEEEEECCCC-----CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe----E
Confidence 799999999999876543 38999998653221 223455677777655 79999999999987664 4
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred EEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999999888643 3589999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (428)
.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+. .
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~------~------- 211 (330)
T cd05586 147 LTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA------F------- 211 (330)
T ss_pred CCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH------c-------
Confidence 2221 123346799999999998764 47999999999999999999999997643221111000 0
Q ss_pred hcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 014245 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP----KMSEVLEM 367 (428)
Q Consensus 326 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~ell~~ 367 (428)
....+. ...++.++.+++.+||+.||.+|| ++.+++++
T Consensus 212 -~~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 212 -GKVRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred -CCCCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 000111 112456889999999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=308.56 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=202.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
..|+..+.||.|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--- 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCC-----EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC---
Confidence 35777889999999999999876543 379999887543 234567889999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 76 -KLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred -EEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 459999999999999988643 488899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......++..|+|||++.+..++.++|||||||++|||++|..||....+......
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------------- 212 (277)
T cd06640 149 GQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------------- 212 (277)
T ss_pred eeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh--------------
Confidence 7654322 122335688899999999888899999999999999999999999976543211110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............++..+.+++.+||+.+|++||++.+++++
T Consensus 213 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 213 ---IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11111223344567889999999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=307.68 Aligned_cols=252 Identities=27% Similarity=0.452 Sum_probs=198.0
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc------ccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV------QGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
+|.+.+.||+|+||.||+|....+ ..+|+|.+..... .....+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~------~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQG------QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCC------CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence 478889999999999999975432 3799998864321 1234578999999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|
T Consensus 75 ~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 75 N----TISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred C----eEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 5 459999999999999998643 3478999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCC----ceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 240 FGLARLGPSEG----FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 240 FGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
||++....... .........|+..|+|||++.+..++.++||||||+++++|++|..||............
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----- 220 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI----- 220 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-----
Confidence 99987542211 111123456899999999999888999999999999999999999999754322111000
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ........+..++.++.+++.+||..+|++||++.+++++
T Consensus 221 --------~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 221 --------GA--HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --------hh--ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0000111222356788999999999999999999998863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.04 Aligned_cols=259 Identities=33% Similarity=0.422 Sum_probs=202.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
.+++|++.+.||+|+||.||+|....++ ..+++|.+..... ....+.+|+.+++++ +|+||+++++++.+...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTG-----QLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCC-----cEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 4578999999999999999999876543 3799998865533 346788999999999 79999999999977552
Q ss_pred --CCceEEEEEeecCCCCcccccCCCC--cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEE
Q 014245 162 --RGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 237 (428)
Q Consensus 162 --~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 237 (428)
.....++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence 2345699999999999999886432 35689999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhcc-----CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
+|||++....... .......|++.|+|||++.. ..++.++||||||+++++|++|..||....... .+.+.
T Consensus 155 ~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~ 230 (275)
T cd06608 155 VDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFKI 230 (275)
T ss_pred CCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHHh
Confidence 9999987543221 11234568999999998754 346789999999999999999999997543211 11110
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. . ............+.++.+++.+||..||++|||+.+++++
T Consensus 231 ~-----------~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 P-----------R--NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred h-----------c--cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0 0000111122356789999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=304.55 Aligned_cols=251 Identities=24% Similarity=0.481 Sum_probs=197.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.+|++.+.||+|+||.||+|....+. .+|+|.+.... .....+.+|+++++.++||||+++++++.....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 73 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKR------KVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP--- 73 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCC------eEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCc---
Confidence 36778889999999999999875332 68999886543 234678899999999999999999999877653
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 74 -~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 74 -ICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred -eEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence 499999999999999886433 3478999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......++..|+|||++.++.++.++||||||+++|||++ |..||....... .....
T Consensus 149 ~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~---------- 214 (256)
T cd05112 149 FVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI---------- 214 (256)
T ss_pred ecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH----------
Confidence 5432211 11122345678999999998889999999999999999998 999997543221 11100
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.. ......+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 215 ~~----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 215 NA----GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred hC----CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00 000001111346899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=311.16 Aligned_cols=267 Identities=32% Similarity=0.406 Sum_probs=205.0
Q ss_pred cCHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEe
Q 014245 75 FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLV 153 (428)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~ 153 (428)
+.+.++...+++|.+.+.||+|+||.||+|....+. ..+|+|.+.... .....+..|+.++..+ +||||++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~-----~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~ 85 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDG-----SLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFY 85 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCC-----CEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 445566667889999999999999999999875443 379999886532 2345677899999998 899999999
Q ss_pred eEEecCCC-CCceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC
Q 014245 154 GYCADDDE-RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 154 ~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~ 230 (428)
+++...+. .+...++||||+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++
T Consensus 86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~ 162 (291)
T cd06639 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLT 162 (291)
T ss_pred EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEc
Confidence 99876432 123569999999999999887531 234589999999999999999999998 999999999999999
Q ss_pred CCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccC-----CCCCchhhhhHHHHHHHHHhCCCCCCCCCchh
Q 014245 231 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-----RLAARSDVWSYGVFLYELITGRRPIDRNRPRS 305 (428)
Q Consensus 231 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 305 (428)
.++.+||+|||++........ ......|+..|+|||++... .++.++|||||||++|+|++|+.||.......
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 999999999999875433221 12235688999999987643 36889999999999999999999997543211
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..... ...+.+ .........+.+++.+||+.+|++||++.+++++
T Consensus 241 --~~~~~~~-----------~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 --TLFKIPR-----------NPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHHHHhc-----------CCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111000 000001 1112344679999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=311.38 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=202.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|+||+||+|....++ ..||+|.+.... ....+.+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 76 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTG-----TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN--- 76 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCC-----cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC---
Confidence 46788889999999999999876433 378999876543 234567889999999999999999999998875
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.+++||||+++++|.+++... +.+++..+..++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++
T Consensus 77 -~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 77 -NICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred -EEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 459999999999999988643 3589999999999999999999963 28999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh-----HHHHHhHhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-----QKLLQWVKPYLS 318 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~ 318 (428)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..+...
T Consensus 152 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------ 221 (284)
T cd06620 152 GELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL------ 221 (284)
T ss_pred cchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH------
Confidence 643221 12235789999999999888899999999999999999999999976543211 111111
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
+..+............++..+.+++.+||+.||++||++.|++++.
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 222 ----LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ----HHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111111111111123567899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=307.29 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=197.7
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----------ccHHHHHHHHHHHhcCCCCCcccEeeE
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----------QGHKEWMTEVNFLGIVEHQNLVKLVGY 155 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~~~~~ 155 (428)
+|...+.||+|+||.||+|....++ ..+|+|.+..... ...+.+..|+.+++.++|+||++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTG-----EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCC-----ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 4777889999999999999865433 3799998753211 012457789999999999999999999
Q ss_pred EecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCe
Q 014245 156 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 235 (428)
Q Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 235 (428)
+..... .++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||+|+||+++.++.+
T Consensus 77 ~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 77 ETTEEY----LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred eccCCc----eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 877653 49999999999999998654 4588999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccCC--CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (428)
+|+|||++................|+..|+|||++.... ++.++||||||+++++|++|..||....... .+...
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~- 224 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKL- 224 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHh-
Confidence 999999997543221111223456889999999987654 7899999999999999999999996432211 11100
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
................++..+.+++.+||..+|++||++.+++++
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 ---------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---------hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000011111122223456789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=328.75 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=202.8
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
-|.++..||-|+||.||+|..+.+ +..-|.|+|........+.++-|++||..++||+||++++.|..++.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket-----~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk---- 103 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKET-----KLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK---- 103 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccc-----hhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc----
Confidence 356677899999999999986644 34667788877777778899999999999999999999998877664
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
++|+.|||.||-.+..+-.-. ..+.+.++..+++|++.||.|||++ .|||||||..|||++-+|.++|+|||++-.
T Consensus 104 LwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence 499999999999988775433 4599999999999999999999998 999999999999999999999999999853
Q ss_pred CCCCCceeeeeeeecCcccCCcchhcc-----CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
... .......+.|||+|||||+... .+|+.++||||||++|.||..+.+|.....+... ++...+
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaK------ 249 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK------ 249 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhh------
Confidence 221 1223456899999999998764 5799999999999999999999999865543221 111111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
--.+.+ -.+...+..+.+++.+||..||..||++.+|++|
T Consensus 250 -----SePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 -----SEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -----cCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 001111 1234567789999999999999999999999864
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=310.15 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=198.6
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+|++.+.||+|+||.||+|.....+ ..||+|.+.... ......+.+|+.++.+++|+||+++++.+....
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 72 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTG-----VTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG---- 72 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC----
Confidence 6788899999999999999876443 379999886542 233467889999999999999999999888765
Q ss_pred eEEEEEeecCCCCcccccCCCC-cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|..++.... ...+++..+..++.|++.||.|||++ .+|+|+||||+||+++.++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 4599999999999998886431 23589999999999999999999963 28999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccC------CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG------RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
...... ......|++.|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 151 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--------- 217 (286)
T cd06622 151 GNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA--------- 217 (286)
T ss_pred ccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---------
Confidence 754322 12234688899999988544 35789999999999999999999997543221111
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..+.... ....+..++.++.+++.+||+.+|++||++.+++++
T Consensus 218 ----~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 218 ----QLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----HHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111111111 112333467889999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=305.81 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=203.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||.|+||+||+|....++ ..+++|++..... .....+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNN-----EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCC-----cEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC---
Confidence 47899999999999999999876543 3799999865432 34567889999999999999999999887755
Q ss_pred ceEEEEEeecCCCCcccccCCCCc-ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+
T Consensus 73 -~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 73 -ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccch
Confidence 45999999999999999865432 4589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce--eeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 243 ARLGPSEGFT--HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 243 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
+......... .......|+..|+|||++... .++.++||||||+++++|++|+.||........ +......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---- 222 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---- 222 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC----
Confidence 8765433222 122345789999999998877 788999999999999999999999975533211 1111000
Q ss_pred hhhhhhhcCCcCCCCc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+.+.... ...++..+.+++.+||..||++||++.+|+++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 011111111 12456789999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=310.44 Aligned_cols=268 Identities=26% Similarity=0.343 Sum_probs=201.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|+||.||+|....++ ..|++|.+.... ....+.+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATG-----EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCC-----cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC--
Confidence 36889999999999999999876543 379999886542 223467889999999999999999999998755
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||++++.|..++... ..+++..+..++.||+.||.|||++ +++|+||+|+||++++++.+||+|||+
T Consensus 74 --~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 74 --RLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred --EEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 459999999987777665432 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh-
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA- 320 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 320 (428)
+........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||..................+...
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 147 ARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH 225 (288)
T ss_pred ccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 876543321 122346788999999999887 78999999999999999999999997654322111111100000000
Q ss_pred -------hhhhh--hcCCc----CCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 -------KQFRQ--IVDPR----LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 -------~~~~~--~~~~~----l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..... ..+.. +...++..++.++.+++.+||..+|++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00000 0001122246789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=301.30 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=206.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHH---HHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK---EWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|..+++||+|.||.|.++.-+ ++++.+|+|++++...-... .-..|-++|+..+||.+..+.-.|+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEK-----at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREK-----ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeec-----ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 367889999999999999999844 44569999999887543333 3467899999999999999877777766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.+|+||||..||.|.-++.. ...|++...+.+...|+.||.|||++ +||.||||.+|+|||.+|++||+||
T Consensus 242 ----rlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 ----RLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred ----eEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence 45999999999999988864 45699999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|+++..-.. ......+||||.|+|||++....|+.++|.|.+||++|||++|+.||..........++-
T Consensus 313 GLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--------- 381 (516)
T KOG0690|consen 313 GLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--------- 381 (516)
T ss_pred ccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---------
Confidence 999864333 344567999999999999999999999999999999999999999998655443333322
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
-..+ .++..++++...|+...|..||.+|. ++.||.++
T Consensus 382 -------~ed~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 382 -------MEDL--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -------hhhc--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1111 34556778899999999999999995 56666654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=317.95 Aligned_cols=258 Identities=24% Similarity=0.466 Sum_probs=214.3
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
...+.||.|.||.||+|.+.+-. ...+..||||.-+.+. ....+.|+.|+.+|++++|||||+++|+|.+.. .
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~-kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-----~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPE-KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-----M 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccc-cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----e
Confidence 34568999999999999987652 3456679999987743 345678999999999999999999999998765 3
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
+||||.++.|.|..+++.+. ..++......++.||+.||+|||+. .+|||||...|||+...--+||+|||+++..
T Consensus 466 WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 89999999999999998654 4588899999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (428)
....+...+ ...-..-|||||-+.-..++.++|||.|||.+||++. |..||.+-...+. + .
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------I-~ 603 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------I-G 603 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------E-E
Confidence 766554332 2334567999999988899999999999999999998 9999976433211 1 1
Q ss_pred hcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 326 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
.+...-+...++.+++.|..|+.+||+.+|.+||.+.++...|..+..
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 112222334567788999999999999999999999999999888765
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=304.50 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=200.4
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|+..+.||+|+||.||+|....++ ..+++|.+..... .....+.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQ-----KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK--- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCC-----cEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC---
Confidence 5788899999999999999876543 3799999865432 33567889999999999999999999887655
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-CeEEeeecc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGL 242 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGl 242 (428)
..++||||+++++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .+||+|||+
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 73 -ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred -EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 459999999999999999765555689999999999999999999998 999999999999998654 579999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... ......|+..|+|||.+.+..++.++||||||+++++|++|..||........ ...
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~---------- 212 (256)
T cd08220 149 SKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLK---------- 212 (256)
T ss_pred ceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHH----------
Confidence 97654321 12235689999999999988889999999999999999999999976533211 110
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ........++..+.+++.+||..+|++|||+.+++++
T Consensus 213 ---~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 213 ---IMSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---HHhc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000 0011122355689999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.72 Aligned_cols=267 Identities=25% Similarity=0.343 Sum_probs=199.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|+....||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETG-----QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCC-----cEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--
Confidence 46888999999999999999876543 3799998864422 23356789999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++++|..++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 74 --~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 74 --KLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred --EEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 459999999999888876533 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH-hHhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ-WVKPYLSDA 320 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~ 320 (428)
+........ ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+. .........
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 986543221 1223567889999999876 457899999999999999999999998655432221111 000000000
Q ss_pred hh-------hhhhcCCcCCCC-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQ-------FRQIVDPRLEGK-----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~-------~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ......+..... ....++..+.+++.+||+.+|++||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 000000000000 011345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=304.36 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=201.5
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|++.+.||+|+||.||++....++ ..|++|.+.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDG-----KQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG--- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCC-----CEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC---
Confidence 5888999999999999999865443 379999886432 233457889999999999999999999987765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.......+++..++.++.|++.||.|||++ +++|+||+|+|||++.++.++|+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 73 -NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred -eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 459999999999999988654444578999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
........ ......|++.|+|||++.+..++.++|||||||++++|++|..||.........
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---------------- 210 (256)
T cd08218 149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV---------------- 210 (256)
T ss_pred eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH----------------
Confidence 76533221 122356889999999999888999999999999999999999999754321110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+.... ....+..++.++.+++.+||+.+|++||++.+|+++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 211 LKIIRGS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHhcCC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111111 111223456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.15 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=200.7
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc------ccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV------QGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
+|+..+.||+|+||.||+|....++ ..||+|.+..... ...+.+..|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTG-----TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCC-----cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence 4788899999999999999864443 3799999864331 1245788999999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-CeEEe
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLS 238 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~ 238 (428)
+. .++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .+||+
T Consensus 76 ~~----~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 76 SH----FNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred Ce----EEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 63 49999999999999998643 3588999999999999999999998 999999999999998776 59999
Q ss_pred eecccccCCCCCce--eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 239 DFGLARLGPSEGFT--HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 239 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
|||++......... .......|+..|+|||++.+..++.++||||||+++++|++|..||............
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~------ 220 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI------ 220 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH------
Confidence 99998765432111 1122356889999999998888999999999999999999999999654322111111
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............+..++.++.+++.+||..+|.+||++.+++++
T Consensus 221 -------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 221 -------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 01111111223344567789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=310.43 Aligned_cols=267 Identities=26% Similarity=0.370 Sum_probs=199.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|+..+.||+|+||.||+|....++ ..||+|.+...... ..+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETG-----QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCC-----CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--
Confidence 36888999999999999999976543 37999988654322 3456889999999999999999999997655
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++++|..+.... ..+++..++.++.||+.||+|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 74 --RLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred --eEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 459999999999998876533 3389999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH-HHhHhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL-LQWVKPYLSDA 320 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~ 320 (428)
+....... .......++..|+|||++.+ ..++.++||||||+++++|++|..||..........- ...........
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07846 147 ARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224 (286)
T ss_pred eeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence 87643322 12233568899999998875 4478899999999999999999999975543221111 11100000000
Q ss_pred -------hhhhhhcCCcCCC-----CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 -------KQFRQIVDPRLEG-----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 -------~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
........+.... .....++..+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000 0012346789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=312.48 Aligned_cols=249 Identities=28% Similarity=0.415 Sum_probs=198.2
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
|.....||+|+||.||++....++ ..||+|.+........+.+.+|+.+++.++|+||+++++.+...+ ..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~ 94 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTG-----KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD----EL 94 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCC-----CEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC----eE
Confidence 344457999999999999865443 379999987655555667889999999999999999999988765 35
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.++|+|||++...
T Consensus 95 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 999999999999998753 2488999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......|++.|+|||++.+..++.++||||||+++|||++|..||........... +...
T Consensus 169 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------------~~~~ 233 (292)
T cd06658 169 SKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------------IRDN 233 (292)
T ss_pred cccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhc
Confidence 3221 112345789999999999888899999999999999999999999975433211110 1111
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+.+. .....+..+.+++.+||..||.+|||+++++++
T Consensus 234 ~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 234 LPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111 112345678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=309.74 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=200.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||++.....+ ..+|+|.+..... .....+.+|+++++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSG-----KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 46889999999999999999876543 3799999865322 23456889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+|||++.++.+||+|||
T Consensus 75 ---~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 75 ---NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred ---eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 359999999999999998654 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||......... .
T Consensus 147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---------- 208 (290)
T cd05580 147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY---E---------- 208 (290)
T ss_pred CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----------
Confidence 99765432 23456899999999998888899999999999999999999999765421111 0
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.+.... ...+..++..+.+++.+||..||.+|+ ++++++++
T Consensus 209 ---~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 209 ---KILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---HHhcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111111 112223457889999999999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.24 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=207.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.+.|..-++||+||||.||-++.+.++ +.+|.|.+.+.... +..-.++|-.||.+++.+.||.+--.|...+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTG-----KMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATG-----KMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecch-----hhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 356888999999999999999877654 47888888665332 3345679999999999999999976666666
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
. +||||..|+||+|.-+|...+...|++..++.++.+|+.||++||+. +||.|||||+|||||+.|+++|+|+
T Consensus 259 ~----LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 259 A----LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred c----eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence 4 59999999999999999888777899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|||....... .....+||.+|||||++.++.|+...|.|||||+||||+.|+.||.........
T Consensus 332 GLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~------------- 395 (591)
T KOG0986|consen 332 GLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR------------- 395 (591)
T ss_pred ceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------
Confidence 9998765432 233458999999999999999999999999999999999999999754322111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
+.+...+. .....++..++++..+|....|..||.+|.- ++++.+|
T Consensus 396 eEvdrr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 396 EEVDRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred HHHHHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 01111111 1123466778899999999999999999974 4455543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=325.52 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=194.1
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC----CcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
..+||+|+|-+||+|... ..++.||.-.+... .....++|..|+.+|+.|+|||||++|.++.+.... .
T Consensus 45 ~evLGrGafKtVYka~De-----~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~--~ 117 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDE-----EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK--T 117 (632)
T ss_pred hhhcccccceeeeecccc-----ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc--e
Confidence 347999999999999853 34556776554322 223457899999999999999999999999887764 4
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-CCCeEEeeecccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLAR 244 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~ 244 (428)
+.+|+|.+..|+|..|+.+.+ .++...+..|++||++||.|||++ .++|||||||-+||+|+. .|.|||+|+|||.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence 589999999999999997654 378889999999999999999997 779999999999999975 5889999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
..... .....+|||.|||||+.. ..|+..+||||||++++||+|+..||..=... .... +
T Consensus 195 l~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIY-------------K 254 (632)
T KOG0584|consen 195 LLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIY-------------K 254 (632)
T ss_pred Hhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHH-------------H
Confidence 76432 234479999999999877 78999999999999999999999999642211 1111 1
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.....+..+..--.++++++|.+||.. .++|||+.|||++
T Consensus 255 KV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 255 KVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11111111111111235899999999999 9999999999985
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=311.78 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=198.0
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
|.....||+|+||.||+|.....+ ..||+|.+........+.+.+|+.++..++||||+++++++...+ ..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSG-----RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE----EL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCC-----CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC----eE
Confidence 444557999999999999865433 379999987655555667889999999999999999999988765 45
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++++|..++.. ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 94 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred EEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999999987753 3488999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......|+..|+|||++.+..++.++|||||||+++||++|..||........... ... .
T Consensus 168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~----------~ 232 (297)
T cd06659 168 SKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRD----------S 232 (297)
T ss_pred cccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hhc----------c
Confidence 3321 112346789999999999988899999999999999999999999975433211111 000 0
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... .......+..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 233 PPPK--LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCC--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 01112245678999999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.73 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=198.4
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-----ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-----QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
+|+..+.||+|+||.||+|.....+ ..|++|.+..... ...+.+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDG-----DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCC-----cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence 4777889999999999999876433 3799998865432 23467889999999999999999999988765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 ----NLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred ----eEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 359999999999999998654 3488999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|++....... ......|++.|++||.+.... ++.++|+||||+++|+|++|..||....... ......
T Consensus 147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~------ 215 (258)
T cd06632 147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIG------ 215 (258)
T ss_pred ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHH------
Confidence 9987643322 123456899999999987766 8999999999999999999999997643211 111100
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
........+..+.+.+.+++.+||..+|++||++.+++.+
T Consensus 216 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 216 --------RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --------hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0000111223355788999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=305.74 Aligned_cols=254 Identities=31% Similarity=0.437 Sum_probs=201.4
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+|+..+.||+|+||.||+|.....+ ..+++|.+..... ....++.+|+++++.++||||+++++++....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTG-----KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG---- 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCC-----cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC----
Confidence 5777889999999999999876543 3799999876543 34467889999999999999999999998765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 4599999999999999987543 458899999999999999999998 7 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .....++..|+|||++.+..++.++||||||+++++|++|..||........ ......
T Consensus 149 ~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~---------- 213 (265)
T cd06605 149 GQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELL---------- 213 (265)
T ss_pred hhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHH----------
Confidence 6543221 1126788999999999988999999999999999999999999975421111 111111
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...............++.++.++|.+||..+|++||++.+++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 214 QYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111111111111266789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=305.32 Aligned_cols=259 Identities=28% Similarity=0.393 Sum_probs=202.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|...+.||.|++|.||+|....+ +..+|+|.+..... .....+.+|+++++.++||||++++++|.+....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNT-----GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS- 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCC-----CeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC-
Confidence 3678889999999999999997654 34799999875433 3456789999999999999999999998765433
Q ss_pred ceEEEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+++||||+++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 75 -SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred -eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecc
Confidence 46999999999999887643 1234588899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCc--hhhHHHHHhHhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP--RSEQKLLQWVKPYLSD 319 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~ 319 (428)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... .....+..+...
T Consensus 151 ~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 222 (287)
T cd06621 151 VSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---- 222 (287)
T ss_pred ccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----
Confidence 986543221 1234678899999999988999999999999999999999999976532 111122222111
Q ss_pred hhhhhhhcCCcCCCCc--cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKY--SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+.+.... ....++.+.+++.+||..+|++|||+.|++++
T Consensus 223 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 223 ------MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ------CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0000111111 12346789999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=306.14 Aligned_cols=266 Identities=17% Similarity=0.202 Sum_probs=188.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-----------HHHHHHHHHHHhcCCCCCcccEe
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-----------HKEWMTEVNFLGIVEHQNLVKLV 153 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~~~ 153 (428)
++|.+.++||+|+||.||+|...++. .....+++|......... ......+...+..+.|+||++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDH--CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCc--ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 58999999999999999999876542 112346666543222111 01123344556778999999999
Q ss_pred eEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC
Q 014245 154 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
+.+..........++++|++. .++.+.+... ..+++..++.|+.|++.||+|||++ +|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 877655443334578888873 3565555432 2357788899999999999999998 999999999999999999
Q ss_pred CeEEeeecccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH
Q 014245 234 NAKLSDFGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 308 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 308 (428)
.++|+|||+|+........ .......||+.|+|||++.+..++.++|||||||+++||++|..||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~- 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL- 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH-
Confidence 9999999999765322111 1122357999999999999999999999999999999999999999765322211
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
...... .-+..+....+. ....+..+.+++..|+..+|++||++++|++.|
T Consensus 243 -~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 -IHAAKC-----DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred -HHHhHH-----HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 110000 000111111111 112356899999999999999999999999875
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=304.53 Aligned_cols=267 Identities=24% Similarity=0.332 Sum_probs=199.8
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|++.+.||+|+||.||+|....++ ..|++|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETG-----ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS--- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCC-----ceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC---
Confidence 4788899999999999999876543 3799999876542 23467889999999999999999999998755
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 73 -~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 73 -GFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred -eeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 459999999 999999886433 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh-H-------h
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW-V-------K 314 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-~-------~ 314 (428)
........ .......|+..|+|||++.+. .++.++||||||+++++|++|.+||.............. . +
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW 225 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHH
Confidence 86543321 112235689999999988654 468899999999999999999888865443221111100 0 0
Q ss_pred hhhhhhhhhhhhcCCcCCC----CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDAKQFRQIVDPRLEG----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..........+..+.... .........+.+++.+||..+|++||++++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000000000 0111345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=304.08 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=198.3
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC----------cccHHHHHHHHHHHhc-CCCCCcccEee
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------VQGHKEWMTEVNFLGI-VEHQNLVKLVG 154 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~nIv~~~~ 154 (428)
+|++.+.||+|+||.||+|...... ...+|+|.+.... .....++..|+.++.. ++||||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~----~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNG----QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCC----CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 4778889999999999999976522 2378999875321 1223457788888865 79999999999
Q ss_pred EEecCCCCCceEEEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECC
Q 014245 155 YCADDDERGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~ 231 (428)
++...+ ..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ . +++|+||+|+|||++.
T Consensus 77 ~~~~~~----~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~ 149 (269)
T cd08528 77 TFLEND----RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGE 149 (269)
T ss_pred eEccCC----eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECC
Confidence 998765 35999999999999988743 123458899999999999999999996 4 8999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 311 (428)
++.+||+|||++....... ......|+..|++||++.+..++.++||||||+++|+|++|..||..........
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~--- 223 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT--- 223 (269)
T ss_pred CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH---
Confidence 9999999999997654332 2334678999999999998889999999999999999999999996543221111
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
.+.+..........++..+.+++.+||+.||++||++.|+.+++.
T Consensus 224 -------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 -------------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -------------HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 011111111111134568999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=321.64 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=209.7
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
...++||+|.||.|++|.|... ..+.+.||||.+...... ....|++|+.+|.+|+|+|++++||+..+.. .
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~p--sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp-----~ 185 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQP--SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP-----A 185 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCC--CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----h
Confidence 3456899999999999999863 345678999999876554 5678999999999999999999999998743 2
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
.||||+++.|+|.+.|++.....|-....-.++.||+.||.||..+ ++|||||-..|+||-....|||+||||.+..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 6999999999999999875666788888889999999999999998 9999999999999998889999999999866
Q ss_pred CCCC-ceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 247 PSEG-FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 247 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
.... ...+.....-...|+|||.+....++.++|||+|||+||||+| |..||-+-.... +.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------IL 325 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------IL 325 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------HH
Confidence 4332 2222223344568999999999999999999999999999999 899997764322 22
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
+.+|..-.-.-+..+++++.+++..||..+|++||++..|.+.+
T Consensus 326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 33333223334556889999999999999999999999998654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=307.92 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=202.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||.||+|....++ ..|++|.+........+.+.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~--- 90 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATG-----QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE--- 90 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCC-----CEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc---
Confidence 58899999999999999999865433 3799999865544555678899999999999999999999987654
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++|+||+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 91 -~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 91 -LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred -EEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 49999999999999998643 378889999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||............
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------------- 227 (293)
T cd06647 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------- 227 (293)
T ss_pred ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--------------
Confidence 5443221 123356889999999998888999999999999999999999999765332110000
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.............++..+.+++.+||+.+|++||++.+++.+
T Consensus 228 -~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 228 -ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111111222355679999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=300.25 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=205.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|++|.||+|....++ ..|++|.+..... .....+..|+.++..++|+||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTG-----KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG--- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCC-----cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC---
Confidence 36888999999999999999877543 3799999876544 34567899999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+ . +++|+||+|+||+++.++.++|+|||+
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 73 -EISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred -eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 459999999999999999654 458999999999999999999999 8 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..........+..
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~----------- 213 (264)
T cd06623 147 SKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ----------- 213 (264)
T ss_pred ceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH-----------
Confidence 8765432211 124568899999999998889999999999999999999999997654211111111
Q ss_pred hhhhcCCcCCCCccHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLR-LVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..... ...... ++..+.+++.+||..+|++||++.+++++
T Consensus 214 --~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 --AICDGPP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --HHhcCCC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111 112223 56789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=307.33 Aligned_cols=264 Identities=24% Similarity=0.336 Sum_probs=194.2
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|+..+.||+|+||.||+|....++ ..+++|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g-----~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~-- 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK-- 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCC-----cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc--
Confidence 4788899999999999999876543 3799998865322 223567789999999999999999999987653
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++|+||++ ++|.+++... ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 74 --~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 74 --LTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred --eEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 599999996 4777766533 24589999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh--h
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD--A 320 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 320 (428)
....... .......+++.|+|||++.+.. ++.++|||||||++|+|++|..|+......... .......+.. .
T Consensus 147 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~ 222 (284)
T cd07839 147 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTE 222 (284)
T ss_pred hccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCCh
Confidence 7543221 1122346789999999887644 789999999999999999999886443322111 1100000000 0
Q ss_pred ---hhhhhhcCC----cCC-----CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 ---KQFRQIVDP----RLE-----GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ---~~~~~~~~~----~l~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.......+. ... ......++.++.+++.+||+.||.+|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000 000 01112356788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.04 Aligned_cols=275 Identities=19% Similarity=0.288 Sum_probs=188.7
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcc----------eE----EEEEEccCCCcccHHHHHHHHHHHhcCCCCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQK----------VE----VAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN 148 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~----------~~----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 148 (428)
..++|.+++.||+|+||+||++..+........ .. ++.|.+. ........+.+|+.+|+.++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 457899999999999999999876543211100 00 1111111 11123456789999999999999
Q ss_pred cccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCC---cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCC
Q 014245 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225 (428)
Q Consensus 149 Iv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 225 (428)
|+++++++.+.+. .|+|+|++. ++|.+++.... ........+..|+.||+.||.|||++ +||||||||+
T Consensus 225 Iv~l~~~~~~~~~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~ 296 (501)
T PHA03210 225 ILKIEEILRSEAN----TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE 296 (501)
T ss_pred cCcEeEEEEECCe----eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 9999999987764 489999984 56666653221 11233556778999999999999998 9999999999
Q ss_pred ceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCC-CCCCCCch
Q 014245 226 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR-PIDRNRPR 304 (428)
Q Consensus 226 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~ 304 (428)
|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|.. |+......
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 9999999999999999998654322 112234679999999999999999999999999999999999875 44433322
Q ss_pred hhHHHHHhHhhhhhhh-------hhhhhhcCC-cC---CCCcc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 305 SEQKLLQWVKPYLSDA-------KQFRQIVDP-RL---EGKYS-----LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~-------~~~~~~~~~-~l---~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+........... ..+...++. .+ ..... ..++.++.+++.+||+.||.+||++.|++++
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2222222111100000 000111100 00 00000 0133567888999999999999999999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=308.74 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=198.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||++...... ..|++|.+..... .....+.+|+++++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETR-----QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCC-----cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 36889999999999999999876543 3799999875532 23456789999999999999999999988765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||++|++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 75 ---HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred ---EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 459999999999999999644 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc-------------eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH
Q 014245 242 LARLGPSEGF-------------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 308 (428)
Q Consensus 242 la~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 308 (428)
+++....... ........|+..|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--- 223 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--- 223 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 9864211100 001112467889999999988889999999999999999999999997543221
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
+..... ......+. ....++.++.+++.+||+.+|++||+..++.+.|+.
T Consensus 224 ~~~~~~--------~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 LFGQVI--------SDDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHH--------hcccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111000 00000011 111355678999999999999999996555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=306.32 Aligned_cols=266 Identities=24% Similarity=0.287 Sum_probs=198.4
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-----cHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
+|++.+.||+|+||.||+|....++ ..|++|.+...... ....+..|+.+++.++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETG-----RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCC-----cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence 4788889999999999999876543 38999998765332 2345678999999999999999999998854
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+|||++.++.++|+||
T Consensus 76 ----~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 ----NINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred ----EEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 459999999 899999987543 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHhhh--
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVKPY-- 316 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~-- 316 (428)
|++........ ......+++.|+|||++.+ ..++.++|||||||++++|++|..||............ ......
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (298)
T cd07841 147 GLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224 (298)
T ss_pred eeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence 99976543221 1223456888999998865 45788999999999999999998888755432221111 000000
Q ss_pred --hhhhhhhhhhcCCcCCC-----CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 --LSDAKQFRQIVDPRLEG-----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 --~~~~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+................ ......+..+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000000 0112346789999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=302.76 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=198.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
-|+..+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.++..++||||+++++++.....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 76 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--- 76 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCC-----cEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe---
Confidence 4677889999999999999865443 3899998765432 234578899999999999999999999987653
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 77 -~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 77 -LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred -EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 59999999999999988642 488999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... ......|+..|+|||++.+..++.++|||||||++++|++|..||...........
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------- 212 (277)
T cd06641 150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL--------------- 212 (277)
T ss_pred ecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH---------------
Confidence 5533211 12235688999999999888889999999999999999999999975432211110
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+...........++.++.+++.+||+.+|.+||++.+++++
T Consensus 213 --~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 --IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --HhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00001111223355788999999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=305.77 Aligned_cols=267 Identities=22% Similarity=0.331 Sum_probs=197.1
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|+..+.||.|+||.||+|....++ ..|++|.+..... .....+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-- 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-- 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCC-----CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc--
Confidence 4888999999999999999876543 3799998865432 233578899999999999999999999876653
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+. ++|..++.......+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 74 --~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 74 --LYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred --EEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 499999995 5888888655555689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH-HHHHhHhh------
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQWVKP------ 315 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~------ 315 (428)
....... .......+++.|+|||++.+.. ++.++||||||+++|+|+||+.||......... ........
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 148 RAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 7543221 1122345788999999887644 588999999999999999999999765432211 11111000
Q ss_pred -hhhhhhhhhhhcCCcCCC---CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 -YLSDAKQFRQIVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 -~~~~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.................. .....++.++.+++.+||+.||.+||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000000000 0011245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=319.51 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=208.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
....|.+...||+|.|+.|.+|.+..+. ..||||.+++.... ....+.+|+++|..|+|||||+++.+.....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~-----~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTG-----TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCC-----ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 3568999999999999999999977653 48999999876443 3345889999999999999999999998877
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
. +|+||||+.+|.+.+++..+++ ..+..+..++.|++.|++|||++ .|||||||++||||+.+.++||+||
T Consensus 129 ~----lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 129 T----LYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred e----eEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence 5 4999999999999999976654 56688899999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|++..+.. .......+|++.|.|||++.+..| ++.+|+||+|++||.|+.|..||++..-.
T Consensus 200 gfS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------------- 261 (596)
T KOG0586|consen 200 GFSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------------- 261 (596)
T ss_pred ccceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---------------
Confidence 99987653 344567899999999999999887 56999999999999999999999865321
Q ss_pred hhhhhhhcCCcCCCCc--cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKY--SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..-.+.+.+.+ +...+.++.++|+++|.++|.+|++++++..+
T Consensus 262 -----~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 262 -----ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -----cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11112222222 22355688999999999999999999999875
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=305.22 Aligned_cols=266 Identities=24% Similarity=0.343 Sum_probs=194.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|+||.||+|....++ ..||+|.+...... ....+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 76 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTG-----QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK--- 76 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCC-----cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC---
Confidence 57899999999999999999865443 37999998654322 2345678999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 -~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 77 -TLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred -eEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence 35999999974 8988876443 3588999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH-HHHHhHhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 321 (428)
+....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||........+ ......... ....
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 227 (291)
T cd07844 151 RAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT-PTEE 227 (291)
T ss_pred cccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC-CChh
Confidence 75322111 1122356889999998875 45889999999999999999999999755422111 111000000 0000
Q ss_pred hhhhh------cCCcCCC---C----ccHHH--HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQI------VDPRLEG---K----YSLRL--VSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~------~~~~l~~---~----~~~~~--~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+... ....... . ..... ...+.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 0000000 0 00011 2678899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.26 Aligned_cols=257 Identities=28% Similarity=0.385 Sum_probs=205.9
Q ss_pred HHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEec
Q 014245 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCAD 158 (428)
Q Consensus 81 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 158 (428)
...+-++.....||.|.||.||-|...++++ ..|+|.+.-... ...+.+.+|..++..|+|||+|++||+-.+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGe-----llAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGE-----LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccc-----hhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence 3345678888999999999999999766554 788888765432 344678899999999999999999999988
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.+.. +|.||||++|+|.+++... ...++.....+..|++.||+|||+. |||||||||+||||+.+|.+|++
T Consensus 1306 Rekv----~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1306 REKV----YIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred HHHH----HHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEee
Confidence 7755 8899999999999999643 3477777788899999999999998 99999999999999999999999
Q ss_pred eecccccCCCCC--ceeeeeeeecCcccCCcchhccCC---CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014245 239 DFGLARLGPSEG--FTHVSTAVVGTMGYAAPEYVQTGR---LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 239 DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (428)
|||.|....... .........||+.|||||++.+.. ...++|||||||+++||+||+.||...+..-
T Consensus 1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-------- 1448 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-------- 1448 (1509)
T ss_pred cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--------
Confidence 999998654321 111123678999999999998643 5678999999999999999999997654321
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+.. +...-.+..+..++.+-.+++.+||+.||++|.++.||+++
T Consensus 1449 -------aIMy~-V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1449 -------AIMYH-VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------HHHhH-HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 01111 11122334555688899999999999999999999988886
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=304.99 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=192.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHH-HhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNF-LGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|+||.||+|....++ ..||+|.+..... ....++..|+.+ ++.++||||+++++++.....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~- 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTG-----TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD- 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCC-----cEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc-
Confidence 36889999999999999999876543 4899999875432 234456667665 566799999999999987654
Q ss_pred CceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.++||||++ |+|.+++... ....+++..++.++.||+.||+|||++ .+++||||||+|||++.++.+||+||
T Consensus 75 ---~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 75 ---VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred ---EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeec
Confidence 499999996 6887776432 224689999999999999999999974 27999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhcc----CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
|++....... ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||....... ..+
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~------- 217 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQL------- 217 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHH-------
Confidence 9987543221 1223568899999998865 446889999999999999999999996432110 111
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...............++.++.+++.+||..+|++||++.+++++
T Consensus 218 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 218 -------KQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -------HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111111112356789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=312.45 Aligned_cols=269 Identities=24% Similarity=0.303 Sum_probs=199.7
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|+..+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTG-----QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCC-----CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 3478999999999999999999876543 379999986532 233456778999999999999999999986543
Q ss_pred C--CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 161 E--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 161 ~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
. .....++||||+. ++|.+.+... +++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 2 1124599999995 5887777432 78889999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH-HhH----
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWV---- 313 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~---- 313 (428)
|||+++...... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+ ...
T Consensus 161 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 161 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred cCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999998654321 123356889999999999999999999999999999999999999765432111100 000
Q ss_pred -----------hhhhhhh-----hhhhhhcCCcC----CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 -----------KPYLSDA-----KQFRQIVDPRL----EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 -----------~~~~~~~-----~~~~~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+.... ..+.+.....+ ........+..+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00001110000 000112346678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=294.89 Aligned_cols=258 Identities=24% Similarity=0.299 Sum_probs=207.9
Q ss_pred HHhcCCCCc-eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 82 SATKNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 82 ~~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
..+++|++. ++||-|-.|.|-.+.++.+++ .+|+|++... ....+|+++.-.. .|||||.++++|...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~e-----kfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQE-----KFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchh-----hhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 346677765 589999999999999887765 7999998533 4556888876555 799999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC---CCCeE
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAK 236 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~~k 236 (428)
...-..+.+|||.|+||.|...|+.++...|++.++..|++||+.|+.|||+. +|.||||||+|+|... +..+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceE
Confidence 65555778999999999999999999889999999999999999999999997 9999999999999954 55699
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
|+|||+|+..... ....+.+-||.|.|||++....|+...|+||+||++|-|++|.+||........ .+
T Consensus 205 LtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-------sp- 273 (400)
T KOG0604|consen 205 LTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------SP- 273 (400)
T ss_pred ecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------Ch-
Confidence 9999999864432 123457889999999999999999999999999999999999999976543211 00
Q ss_pred hhhhhhhhhhcCC--cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 LSDAKQFRQIVDP--RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..-..+... .....-...++++..++|+.+|..+|.+|.|+.+++++
T Consensus 274 ----gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 274 ----GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ----hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 111111111 11223345678899999999999999999999999886
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=300.32 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=199.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|+..+.||+|+||.||+|.....+ ..+|+|.+..... ...+.+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~--- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDS-----EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG--- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCC-----ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC---
Confidence 5788899999999999999976543 3689999865422 23457789999999999999999999987765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC-eEEeeecc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-AKLSDFGL 242 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGl 242 (428)
..++|+||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||++++++. +||+|||.
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 73 -RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred -eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 359999999999999998765545689999999999999999999998 9999999999999998864 69999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... .......|++.|+|||++.+..++.++||||||+++++|++|..||......... .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~-------- 212 (257)
T cd08225 149 ARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV------L-------- 212 (257)
T ss_pred chhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------H--------
Confidence 87654322 1122356899999999998888999999999999999999999999754321110 0
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....... .......+.++.+++.+||..+|++||++.+++++
T Consensus 213 --~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 213 --KICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --HHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111111 11122345689999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=302.60 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=198.6
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
.|...+.||+|++|.||+|.....+ ..+++|.+........+.+.+|+.+++.++||||+++++++...+ .
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~----~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTG-----RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD----E 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCC-----CEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC----e
Confidence 4555679999999999999865443 379999886554445567889999999999999999999988765 3
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.++|+||+++++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 5999999999999998865 3488999999999999999999998 999999999999999999999999998865
Q ss_pred CCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (428)
...... ......|++.|+|||.+.+..++.++||||||+++++|++|..||....+....... ..
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~-------------~~ 229 (285)
T cd06648 165 VSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-------------RD 229 (285)
T ss_pred hccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-------------Hh
Confidence 432211 122356899999999998888999999999999999999999999754332111100 00
Q ss_pred hcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 326 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+.+. ....++..+.+++.+||..+|++||++.+++++
T Consensus 230 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 230 NLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0001111 111245689999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.02 Aligned_cols=266 Identities=25% Similarity=0.459 Sum_probs=208.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
...|...++||+|+||.||+|.....+ ..||+|.+..... ....|+.++++++|||||+++|+|.+....
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~- 758 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNG-----MQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGA- 758 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCC-----cEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCC-
Confidence 356788889999999999999875433 3799999864332 123568899999999999999999887644
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
++||||+++|+|.+++.. ++|..+..|+.|++.||+|||..+..+|+||||||+||+++.++.+++. ||..
T Consensus 759 ---~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 759 ---YLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred ---EEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 999999999999999952 8899999999999999999996555699999999999999999988875 6665
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
..... .....||+.|||||++.+..++.++|||||||++|||+||+.||+..... ......|++..... ...
T Consensus 830 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~ 901 (968)
T PLN00113 830 GLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSD-CHL 901 (968)
T ss_pred ccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCc-cch
Confidence 43221 12246899999999999999999999999999999999999999643221 22344444432222 223
Q ss_pred hhhcCCcCCCC--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 324 RQIVDPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 324 ~~~~~~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
...+++.+... .......++.+++.+||+.||++||++.++++.|+++.....
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 34455555332 334566678899999999999999999999999998876543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=298.43 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=199.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-----cccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
.+|.+.+.||+|+||.||+|....++ ..|++|.+.... ......+.+|+.++++++|+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTG-----RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCC-----CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 47889999999999999999865433 379999875321 12345788999999999999999999998765
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
... .+++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 77 ~~~--~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 77 EEK--KLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CCC--EEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 432 458999999999999988643 3478899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCc-eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 240 FGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
||+++....... ........|+..|+|||++.+..++.++|||||||++++|++|..||....... .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~---------- 217 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--A---------- 217 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--H----------
Confidence 999975432111 011123568999999999988889999999999999999999999997542211 1
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.+..........+..+.+.+.+++.+||. +|..||++.+++.+
T Consensus 218 ----~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 218 ----IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111111112223445567889999999999 57999999988864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=298.74 Aligned_cols=254 Identities=30% Similarity=0.437 Sum_probs=199.6
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|.+.+.||+|+||.||+|....++ ..|++|.+...... ....+..|+.+++.++|+||+++++++...+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTG-----ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE--- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCC-----cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC---
Confidence 5888899999999999999865443 37999998765443 5677899999999999999999999987655
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 73 -KVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred -EEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 459999999999999998654 3478899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceee--eeeeecCcccCCcchhccCC---CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 244 RLGPSEGFTHV--STAVVGTMGYAAPEYVQTGR---LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 244 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
........... .....+++.|+|||++.+.. ++.++||||||+++++|++|..||............
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~-------- 218 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-------- 218 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--------
Confidence 76543322111 12356889999999998766 889999999999999999999999754321111000
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
......+.+. ....++..+.+++.+||+.+|.+||++.+++.+
T Consensus 219 ----~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 219 ----VGAGHKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ----HhcCCCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000011111 111236678899999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=302.00 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=197.1
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCC---CCCcccEeeEEecCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDDE 161 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~ 161 (428)
.|+..+.||+|+||.||+|....++ ..+++|.+..... .....+.+|+.+++.++ ||||+++++++....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~- 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTG-----RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP- 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCC-----cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-
Confidence 4778889999999999999975443 3799999865432 34467889999999986 999999999987655
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 76 ---~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 76 ---RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred ---EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 459999999999999988643 589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
++....... .......|+..|+|||++.++ .++.++||||||+++|+|++|..||............
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---------- 214 (277)
T cd06917 147 VAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---------- 214 (277)
T ss_pred ceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----------
Confidence 997654332 112345789999999988754 4688999999999999999999999764322111000
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+.+.. ..++.++.+++.+||+.||++||++.+++.+
T Consensus 215 ---~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 215 ---PKSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---ccCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000111111 1145689999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.52 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=201.1
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+|++.+.||.|+||.||+|....++ ..|++|.+..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTK-----KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCC-----cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 5888999999999999999876443 3799999875432 33567889999999999999999999887655
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 74 --NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred --eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 459999999999999998654 3588999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||..........+..
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------- 212 (258)
T cd05578 147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----------- 212 (258)
T ss_pred ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH-----------
Confidence 87654322 1234568899999999988889999999999999999999999998665421111111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM--SEVLE 366 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~ell~ 366 (428)
.... .....+...+..+.+++.+||..||.+||++ +++++
T Consensus 213 ---~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 213 ---KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0000 1112233455789999999999999999999 66554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=311.53 Aligned_cols=275 Identities=24% Similarity=0.323 Sum_probs=201.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC-
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE- 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~- 161 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTG-----VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCC-----CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 468999999999999999999876543 379999986432 2234567889999999999999999998865442
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.....++|+||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 79 SFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred ccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence 1234699999996 478777753 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce-eeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 242 LARLGPSEGFT-HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 242 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
++......... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||............. ..+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~---~~~~~ 228 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL---GVLGT 228 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCC
Confidence 98764332111 11233578999999998754 568899999999999999999999997654322111110 00000
Q ss_pred --hhhhhhhcCCc-------C--CCC-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhh
Q 014245 320 --AKQFRQIVDPR-------L--EGK-----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM--VNKIVD 373 (428)
Q Consensus 320 --~~~~~~~~~~~-------l--~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~--L~~~~~ 373 (428)
.+.+..+.+.. . ... .....+.++.+++.+||+.+|++||++.+++++ ++...+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 01111111000 0 000 011235679999999999999999999999997 554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=305.14 Aligned_cols=269 Identities=24% Similarity=0.310 Sum_probs=198.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||.|+||.||+|....+. ..+++|.+...... ....+.+|+.++++++||||+++++++......
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTG-----EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCC-----cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 47888899999999999999876443 37999998654322 234567899999999999999999998776322
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||++ ++|.+++.... ..+++..++.++.||+.||+|||++ +++|+||||+|||++.++.+||+|||+
T Consensus 80 --~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 80 --KIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred --cEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence 4699999996 48888876543 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHh------
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVK------ 314 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~------ 314 (428)
+....... .......+++.|+|||++.+. .++.++||||||+++++|++|..||...........+ ....
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 153 AREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred eeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 87654321 112334678899999988754 4688999999999999999999999765433221111 1000
Q ss_pred -hhhhhh-----hhhhhhcCCcCCCCccHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 -PYLSDA-----KQFRQIVDPRLEGKYSLR-LVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 -~~~~~~-----~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.+... ..........+...+... +++.+.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000 000000001111112222 46778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.00 Aligned_cols=276 Identities=28% Similarity=0.390 Sum_probs=206.0
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC--CCC
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD--ERG 163 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~ 163 (428)
+...+.||+||||.||+|+++.++ ..||||.+.... ....+.+.+|+++|++|+|+|||+++++-.+.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG-----~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETG-----RLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred eeehhhhcCCccceeeeecccccc-----cchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 444557999999999999866554 489999998753 334577899999999999999999988765433 012
Q ss_pred ceEEEEEeecCCCCcccccCCCC-cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE--CCCCC--eEEe
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL--DEQWN--AKLS 238 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl--~~~~~--~kl~ 238 (428)
...++|||||.||||...+..-. ...+++...+.++.+++.||.|||++ +||||||||.||++ .++|+ .||+
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence 24589999999999999997532 35699999999999999999999998 99999999999998 33343 7999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|||.|+...+.. ...+++||..|++||++.. +.|+..+|.|||||++|+++||..||.......-..-+.|..- .
T Consensus 167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~-t 242 (732)
T KOG4250|consen 167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII-T 242 (732)
T ss_pred cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh-c
Confidence 999999765543 5678999999999999984 8899999999999999999999999976543321111111100 0
Q ss_pred hhhhhhhhhcCCcC------------CCCccHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHhhhh
Q 014245 318 SDAKQFRQIVDPRL------------EGKYSLRLVSKLSHVANLCLVKNARTRP--KMSEVLEMVNKIVDA 374 (428)
Q Consensus 318 ~~~~~~~~~~~~~l------------~~~~~~~~~~~l~~li~~cl~~dp~~RP--s~~ell~~L~~~~~~ 374 (428)
..+........+.. .-.........+-.++..+|..+|++|- ...+....+..++..
T Consensus 243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 00111000011111 1223344556777888889999999998 777777777776643
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=306.58 Aligned_cols=273 Identities=22% Similarity=0.302 Sum_probs=197.1
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+|.+.+.||+|+||.||+|..... ..+..||+|.+.... ......+.+|+.++..++||||+++++++.+....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 478889999999999999997652 123489999997643 23346678999999999999999999999876322
Q ss_pred CceEEEEEeecCCCCcccccCCC---CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC----CCCe
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE----QWNA 235 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~----~~~~ 235 (428)
..++||||+++ +|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+
T Consensus 78 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 78 --SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred --eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence 46999999965 666655322 123688999999999999999999998 9999999999999999 9999
Q ss_pred EEeeecccccCCCCCc-eeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh-------
Q 014245 236 KLSDFGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSE------- 306 (428)
Q Consensus 236 kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~------- 306 (428)
||+|||++........ ........+++.|+|||++.+. .++.++|||||||++++|++|..||........
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 9999999986543221 1112345688999999988764 578999999999999999999999976543320
Q ss_pred HHHHHhHhhh----------hhhhhhhhhhcCCcCCCCcc---------H--HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 014245 307 QKLLQWVKPY----------LSDAKQFRQIVDPRLEGKYS---------L--RLVSKLSHVANLCLVKNARTRPKMSEVL 365 (428)
Q Consensus 307 ~~~~~~~~~~----------~~~~~~~~~~~~~~l~~~~~---------~--~~~~~l~~li~~cl~~dp~~RPs~~ell 365 (428)
..+...+... ...........+......+. . ....++.+++.+||+.||++|||+.+++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 0010000000 00000000000000000000 0 2345789999999999999999999998
Q ss_pred HH
Q 014245 366 EM 367 (428)
Q Consensus 366 ~~ 367 (428)
++
T Consensus 312 ~~ 313 (316)
T cd07842 312 EH 313 (316)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=310.79 Aligned_cols=272 Identities=22% Similarity=0.283 Sum_probs=202.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.+|++.+.||+|+||.||+|....++ ..|++|.+..... .....+.+|+.+|+.++||||+++++++......
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSG-----KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCC
Confidence 68999999999999999999876543 3799999875422 3346678899999999999999999988765544
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
...+++||||+. ++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 80 FKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred CceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 456799999995 6898888644 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce--eeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh---
Q 014245 243 ARLGPSEGFT--HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY--- 316 (428)
Q Consensus 243 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--- 316 (428)
+......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 8754332211 11234578999999998865 45889999999999999999999999765433221111110000
Q ss_pred --hh--hhhhhhhh---cCCcCCC---CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 --LS--DAKQFRQI---VDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 --~~--~~~~~~~~---~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+. ....+... ....... ......+.++.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 00000000 0000000 0112346789999999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=294.85 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=205.2
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|...+.||+|++|.||+|....++ ..|++|.+..... ...+.+.+|+.++++++|+||+++++.+.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTG-----ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK-- 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC--
Confidence 4778899999999999999876433 3799999876543 345678899999999999999999999987631
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
...++|+||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 24599999999999999987544 689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
................++..|+|||.+.+..++.++||||||+++++|++|..||......... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------------~ 213 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA---------------L 213 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---------------H
Confidence 8665433211123457889999999998888999999999999999999999999765411100 0
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............+...+..+.+++.+|+..+|++||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 214 YKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 01111111222333456789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=292.85 Aligned_cols=251 Identities=29% Similarity=0.454 Sum_probs=202.7
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
.|...+.||+|++|.||++....++ ..+++|.+..........+.+|+.+++.++|+||+++++++.... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTG-----KEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD----E 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCC-----cEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----e
Confidence 4778889999999999999976433 379999987765545678899999999999999999999998765 3
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.++++||+++++|.+++.... ..+++..+..++.|++.||.|||.. +++|+||+|+||++++++.++|+|||.+..
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 499999999999999987543 4589999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (428)
...... .....|+..|++||++.+..++.++||||||+++++|++|..||............. .
T Consensus 148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~ 211 (253)
T cd05122 148 LSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-------------T 211 (253)
T ss_pred cccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-------------h
Confidence 543321 234678999999999988889999999999999999999999997653221111100 0
Q ss_pred hcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 326 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+.+ .....++..+.+++.+||+.||++|||+.+++++
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 212 NGPPGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCCCCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000001 0111135689999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.13 Aligned_cols=266 Identities=24% Similarity=0.315 Sum_probs=194.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+++|.+.+.||+|+||.||+|.....+ ..|++|.+...... ....+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-- 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRING-----QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-- 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCC-----cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--
Confidence 468999999999999999999876543 37999998654332 2346779999999999999999999998755
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 77 --TLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred --eEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccc
Confidence 3599999995 67766654332 3477888889999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh--
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD-- 319 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 319 (428)
++...... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||......... +... ...+..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~-~~~~~~~~ 225 (291)
T cd07870 150 ARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-LEKI-WTVLGVPT 225 (291)
T ss_pred ccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-HHHH-HHHcCCCC
Confidence 87543221 112234578999999988754 5788999999999999999999999765432211 1110 000000
Q ss_pred hh------hh----hhhcCCcCCCCcc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AK------QF----RQIVDPRLEGKYS-----LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~------~~----~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. .. ............. ......+.+++.+|++.||++|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 00 0000000000000 0124578899999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.57 Aligned_cols=248 Identities=31% Similarity=0.419 Sum_probs=195.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
+.|...+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTN-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCC-----cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence 46888999999999999999876543 3799998864322 233568899999999999999999999987664
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 90 ----~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 90 ----AWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred ----EEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence 499999996 56766664322 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
++...... ....|++.|+|||++. ...++.++||||||+++|||++|..||............
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~-------- 226 (307)
T cd06607 161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------- 226 (307)
T ss_pred cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH--------
Confidence 98754322 2356889999999874 456889999999999999999999999754322111000
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
............++..+.+++.+||..+|++||++.+|+.+.
T Consensus 227 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 227 --------AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --------hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000001111223567899999999999999999999998863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=301.92 Aligned_cols=254 Identities=29% Similarity=0.435 Sum_probs=204.4
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
...+.|+....||+|+||.||+|.....+ ..+++|.+..... ....+..|+.+++.++|+||+++++++....
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 88 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATG-----KEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD- 88 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCC-----cEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-
Confidence 34567888899999999999999876432 3799999876543 4567889999999999999999999998775
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 89 ---~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 89 ---ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred ---EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence 4599999999999999997643 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... .......+++.|++||++.+..++.++||||||+++|+|++|..||...........
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~------------ 227 (286)
T cd06614 162 FAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL------------ 227 (286)
T ss_pred hhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------
Confidence 986543221 112334688999999999888899999999999999999999999975433211110
Q ss_pred hhhhhcCCcCC-CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLE-GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+...... ......++..+.+++.+||+.+|.+||++.+++++
T Consensus 228 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 228 ----ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0000011 11112255789999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.48 Aligned_cols=269 Identities=26% Similarity=0.313 Sum_probs=198.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+...... ....+.+|+.++++++|+||+++++++.+...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSG-----EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCC-----cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 457999999999999999999876543 37999998644221 22356789999999999999999999876542
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
. ..++||||+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 81 ~--~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 81 D--SIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred C--eEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 2 45999999964 7887776432 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
++....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....... ..
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~-~~ 230 (309)
T cd07845 154 LARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP-NE 230 (309)
T ss_pred eeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC-Ch
Confidence 998654322 11222346788999998865 457899999999999999999999998655433222111100000 00
Q ss_pred hhhhhhcC------CcCCCC-------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVD------PRLEGK-------YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~------~~l~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+..... ..+... .....++.+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 000000 001235678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=309.96 Aligned_cols=271 Identities=26% Similarity=0.365 Sum_probs=199.8
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC--CcccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
..++|++.+.||+|+||.||+|....++ ..+|+|.+... .......+..|+.++.++ +||||+++++++...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTK-----EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCC-----eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 3467889999999999999999876443 37999988543 223345677899999999 999999999998765
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
+.. ..++||||++ ++|..++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 80 ~~~--~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 80 NDK--DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred CCc--eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 432 4599999996 5898888643 588899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCce---eeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 240 FGLARLGPSEGFT---HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 240 FGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
||++......... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 230 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999765432211 12234578999999998765 4578899999999999999999999976543322111111000
Q ss_pred hhhh-------hhhhhhhcC----CcCC--CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSD-------AKQFRQIVD----PRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~-------~~~~~~~~~----~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ......+++ .... .......+.++.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 000000010 0000 00111246789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=301.14 Aligned_cols=274 Identities=23% Similarity=0.306 Sum_probs=198.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|++.+.||+|+||.||+|....+. ..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTK-----QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCC-----cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 357999999999999999999866543 4899998864322 223456789999999999999999999876532
Q ss_pred C----CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEE
Q 014245 162 R----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 237 (428)
Q Consensus 162 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 237 (428)
. ....++||||+. ++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL 160 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence 1 235699999995 47877775432 3589999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCce--eeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 238 SDFGLARLGPSEGFT--HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 238 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999755332211 112235678899999988664 37889999999999999999999997665433332222211
Q ss_pred hhhh-----hhhhhhhhcCCcCCCCccH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLS-----DAKQFRQIVDPRLEGKYSL---------RLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~-----~~~~~~~~~~~~l~~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ....+.............. .....+.+++.+||..||.+||++++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 0000000000000000000 123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.55 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=195.6
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
||.|+||.||+|....++ ..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+... .++|
T Consensus 1 lg~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKSKN-----RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY----IYML 71 (262)
T ss_pred CCCCCceEEEEEEECCCC-----cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc----cEEE
Confidence 699999999999976533 3799999875432 234678899999999999999999999887654 4999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 72 MEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred EecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9999999999999654 3488999999999999999999998 9999999999999999999999999999865432
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
. ......|++.|++||++.+..++.++|+||||+++|+|++|..||......... . ...+...
T Consensus 147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~-------------~~~~~~~ 209 (262)
T cd05572 147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-I-------------YNDILKG 209 (262)
T ss_pred c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-H-------------HHHHhcc
Confidence 2 123357899999999998888999999999999999999999999765421111 1 1111111
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
.....++...+..+.+++.+||..+|++||+ +.|++++
T Consensus 210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 1122233334678999999999999999999 7887773
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=300.66 Aligned_cols=243 Identities=25% Similarity=0.366 Sum_probs=186.5
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHH---hcCCCCCcccEeeEEecCCCCCce
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFL---GIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
+||+|+||.||++....++ ..+|+|.+...... ....+.+|..++ ...+||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK---- 71 (279)
T ss_pred CcccCCCeEEEEEEECCCC-----cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe----
Confidence 4899999999999875443 38999988654322 122344554443 34479999999999987653
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++..
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 49999999999999888643 3489999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
..... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..........+....
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------- 211 (279)
T cd05633 147 FSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------- 211 (279)
T ss_pred ccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-----------
Confidence 43221 123468999999998864 55899999999999999999999999754332211111100
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.......+..++.++.+++.+||+.||++|| ++++++++
T Consensus 212 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 212 ----LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0111123334567899999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=301.17 Aligned_cols=246 Identities=28% Similarity=0.404 Sum_probs=192.9
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
||+|+||+||+|.....+ ..|++|.+..... .....+..|+++++.++||||+++++++...+ ..++|
T Consensus 1 lg~g~~g~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKATG-----KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD----DLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcCCC-----cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC----eEEEE
Confidence 699999999999866543 3799999865322 23445678999999999999999999987765 35999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++++|.+++.......+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 9999999999998765545689999999999999999999998 9999999999999999999999999998754321
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
.......++..|+|||++.+..++.++||||||+++++|++|+.||...........+. .....
T Consensus 149 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~- 212 (277)
T cd05577 149 ---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK------------RRTLE- 212 (277)
T ss_pred ---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH------------hcccc-
Confidence 11233567889999999988889999999999999999999999997654321111000 00000
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.....+..+++.+.+++.+||+.||++|| ++.+++++
T Consensus 213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 01112233467899999999999999999 66667653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=294.99 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=203.7
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|.+.+.||.|+||.||++....++ ..+++|.+..... .....+..|+++++.++|+|++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDG-----KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG--- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCC-----cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC---
Confidence 5788899999999999999976433 3799999876543 34567889999999999999999999988764
Q ss_pred ceEEEEEeecCCCCcccccCCCC--cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++|+||+++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 73 -KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred -EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcc
Confidence 4599999999999999886542 35689999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... .......|++.|+|||.+.+..++.++||||||+++++|++|..||....... ...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---------- 213 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---------- 213 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH----------
Confidence 997654432 12334578999999999988889999999999999999999999997653211 111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... ....+..++..+.+++.+||..+|++||++.+++++
T Consensus 214 ---~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 214 ---KILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---HHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011110 111222455789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.71 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=196.6
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
|++.+.||.|++|.||+|....++ ..|++|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~---- 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTG-----EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN---- 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCC-----CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC----
Confidence 677889999999999999876433 3799998865432 23356889999999999999999999998765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||++ ++|.+++.......+++..++.++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 4599999995 6899888655444689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh------
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL------ 317 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 317 (428)
...... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||........ +........
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 223 (283)
T cd07835 148 AFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDV 223 (283)
T ss_pred ccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHH
Confidence 543221 111233568899999987654 578999999999999999999999976543221 111111000
Q ss_pred ----hhhhhhhhhcCC---cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 ----SDAKQFRQIVDP---RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ----~~~~~~~~~~~~---~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+...+.. .........++..+.+++.+||+.+|.+||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000 00001112344688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=298.21 Aligned_cols=267 Identities=24% Similarity=0.370 Sum_probs=197.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+|+..+.||.|++|.||+|....++ ..||+|.+...... ....+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTG-----EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK--- 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCC-----eEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc---
Confidence 5888999999999999999976543 47999998755332 34567789999999999999999999988664
Q ss_pred eEEEEEeecCCCCcccccCCCC-cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++
T Consensus 73 -~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 73 -LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred -EEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 4999999975 8888775433 24589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh-hhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK-PYLSDA 320 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~~ 320 (428)
....... .......+++.|++||++.+. .++.++||||||+++|+|++|..||.......... ...... +.....
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 7543221 112234678899999988654 57889999999999999999999997654332211 111100 000000
Q ss_pred hhhhhh--cCCcCC-------CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQI--VDPRLE-------GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~--~~~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+... ...... .......+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 000000 00112345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=304.26 Aligned_cols=255 Identities=30% Similarity=0.424 Sum_probs=192.3
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~ 163 (428)
+|...+.||+|+||.||++....++ ..+|+|.+..... .....+..|+.++.++. |+||+++++++.....
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~-- 77 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSG-----TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD-- 77 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCC-----CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc--
Confidence 4555668999999999999876543 3899999875432 34457889999999995 9999999999887654
Q ss_pred ceEEEEEeecCCCCccccc---CCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 164 IQRLLVYEYMPNGSVDQYL---SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.+++|||+.. +|.++. .......+++..+..++.|++.||+|||+. .+++||||||+|||++.++.+||+||
T Consensus 78 --~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 78 --CWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred --EEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeec
Confidence 4899999854 554432 222335689999999999999999999963 28999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccC---CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG---RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|++....... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||...... ........
T Consensus 153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~ 224 (288)
T cd06616 153 GISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQVV 224 (288)
T ss_pred chhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHhhhc
Confidence 9987543221 11234689999999998876 6899999999999999999999999754310 00000000
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+.+.......++.++.+++.+||+.+|++||++++|+++
T Consensus 225 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 -------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001122222223466789999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=300.99 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=195.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|++|.||+|....++ ..|++|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTN-----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-- 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCC-----cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--
Confidence 57899999999999999999876543 3799998865432 23356889999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-CCCeEEeeec
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFG 241 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG 241 (428)
..++||||++ ++|.+++.......+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||
T Consensus 75 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 75 --RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred --eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 4599999995 5787777554444568888899999999999999998 9999999999999985 5579999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHh-h---
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVK-P--- 315 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~-~--- 315 (428)
++....... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||............ .... +
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 149 LARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred cccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 997543221 112234678999999988764 5789999999999999999999999765433221111 0000 0
Q ss_pred hhhhhhhhhhhc--CCcCCC----CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQIV--DPRLEG----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~--~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.......... .+.... ......++.+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 000000 0112345678999999999999999999999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=296.32 Aligned_cols=262 Identities=20% Similarity=0.233 Sum_probs=192.4
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~ 164 (428)
|++.+.||+|+||.||+|.....+ ..||+|.+..... ........|+.++.++ +|+||+++++++.+....
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~-- 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTG-----KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG-- 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCC-----cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC--
Confidence 667889999999999999876543 3799999865422 2223455788889888 499999999999876322
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||++ |+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 4599999996 57777775432 3589999999999999999999998 9999999999999999 999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh-hhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD-AKQ 322 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 322 (428)
....... .....++..|+|||++.. +.++.++|||||||++|||++|..||............ ...... ...
T Consensus 148 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~ 221 (282)
T cd07831 148 GIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI---HDVLGTPDAE 221 (282)
T ss_pred ccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH---HHHcCCCCHH
Confidence 6532211 123468899999997654 55788999999999999999999999765433221111 100000 000
Q ss_pred hhhhc------CCcCCC-------CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIV------DPRLEG-------KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~------~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.... +..... .....++..+.+++.+||+.+|++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 000000 0112456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=296.81 Aligned_cols=276 Identities=27% Similarity=0.401 Sum_probs=203.3
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhc--CCCCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI--VEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.....+||+|.||.||+|.+.+. .||||++... ....|.+|-+|.+. ++|+||++++++-........
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~-------~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNR-------LVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred hhhHHHhhcCccceeehhhccCc-------eeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 34455799999999999998763 7999999753 44678888888775 489999999988766654456
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcC------CCCCeeeccCCCCceEECCCCCeEEe
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG------MDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.++||+||.+.|+|.++|..+ .++|....+|+..+++||+|||+. .+++|+|||||..||||..|++..|+
T Consensus 282 eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 789999999999999999754 499999999999999999999964 46789999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCC-CC-----CchhhhhHHHHHHHHHhCCCCCC-CCCchhhHHHHH
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LA-----ARSDVWSYGVFLYELITGRRPID-RNRPRSEQKLLQ 311 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~elltg~~p~~-~~~~~~~~~~~~ 311 (428)
|||+|..+.........-..+||.+|||||++.+.. +. .+.||||+|.+||||++...-+. +..+.-..-+..
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999998776443333344589999999999998643 22 36899999999999999765442 111110000000
Q ss_pred hHhhhhhhhhhhhh-hcCCcCCCCccH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 312 WVKPYLSDAKQFRQ-IVDPRLEGKYSL-----RLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 312 ~~~~~~~~~~~~~~-~~~~~l~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
.+...-. .+.++. ++..+.++.++. .-..-+++.+..||..||+-|.|+.=+.+.+.++.....
T Consensus 439 evG~hPt-~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 439 EVGNHPT-LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HhcCCCC-HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0000000 011111 112222222222 223568899999999999999999999999888775544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.55 Aligned_cols=275 Identities=22% Similarity=0.320 Sum_probs=202.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSET-----NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCC-----CCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 35799999999999999999986543 3489999986532 2234567789999999999999999998865432
Q ss_pred -CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 162 -RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 162 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.....++||||+. ++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence 1124699999995 6888888643 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh----
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP---- 315 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~---- 315 (428)
|++....... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9997654321 12234568899999998865 4688999999999999999999999976543222211111000
Q ss_pred ----hhhhhhhhhhhc---CCcCCC---CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhh
Q 014245 316 ----YLSDAKQFRQIV---DPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM--VNKIV 372 (428)
Q Consensus 316 ----~~~~~~~~~~~~---~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~--L~~~~ 372 (428)
..... .....+ ...... .....++.++.+++.+||+.+|++||++.+++++ +..+.
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 231 EDLGFIRNE-KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHhhhcCch-hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000 000000 000000 0112356788999999999999999999999987 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=299.72 Aligned_cols=270 Identities=20% Similarity=0.268 Sum_probs=196.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.+ +|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCC-----cEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence 46889999999999999999876543 3799998765422 2335688899999999 56999999998876553
Q ss_pred -CCceEEEEEeecCCCCcccccCCCC---cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-CCCeE
Q 014245 162 -RGIQRLLVYEYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAK 236 (428)
Q Consensus 162 -~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~~k 236 (428)
.....|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+||+++. ++.+|
T Consensus 76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 76 NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 22236999999975 7888775432 24589999999999999999999998 9999999999999998 88999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK 314 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~ 314 (428)
|+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ......
T Consensus 152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999875432211 1122357889999998865 457899999999999999999999997654322111 111000
Q ss_pred hhhhhhhhhhhhcC-------CcCC----CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDAKQFRQIVD-------PRLE----GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~~~~~-------~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. .....+..... +... ......++.++.++|.+||..||.+||++.+++.+
T Consensus 230 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 T--PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred C--CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00000000000 0000 00112356789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=302.59 Aligned_cols=250 Identities=30% Similarity=0.428 Sum_probs=195.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.|...+.||+|+||.||+|....++ ..+|+|.+..... .....+..|+.+++.++|||++++++++.+...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 99 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTN-----EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT- 99 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCC-----cEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe-
Confidence 4777889999999999999876543 3799999864422 234568899999999999999999999987664
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++||||+++ +|.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||+
T Consensus 100 ---~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 100 ---AWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred ---EEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 4999999964 777766432 34589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
+..... .....|++.|+|||++. .+.++.++|||||||++|+|++|..||..........
T Consensus 172 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~----------- 234 (317)
T cd06635 172 ASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----------- 234 (317)
T ss_pred ccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-----------
Confidence 865432 12356889999999874 4568899999999999999999999987543211110
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
.+.............+..+.+++.+||+.+|.+||++.++++++...
T Consensus 235 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 235 -----HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -----HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 11111111111223556799999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=304.81 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=192.1
Q ss_pred eeccc--CceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEE
Q 014245 92 VIGEG--GFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 92 ~lG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 167 (428)
.||+| +||+||+|.....+ ..||+|.+..... ...+.+.+|+.+++.++||||++++++|...+. .+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~----~~ 75 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTG-----TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW----LW 75 (328)
T ss_pred HhCCcccCceeEEEEEEcCCC-----cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc----eE
Confidence 46666 99999999865443 3899999865432 234678899999999999999999999988664 49
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
+||||+.+++|.+++.......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++++|||.+....
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 999999999999998765445589999999999999999999998 99999999999999999999999998654321
Q ss_pred CCCcee-----eeeeeecCcccCCcchhccC--CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-h---
Q 014245 248 SEGFTH-----VSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-Y--- 316 (428)
Q Consensus 248 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~--- 316 (428)
...... ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ....... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 230 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSP 230 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCC
Confidence 111100 01112356679999998764 478999999999999999999999976543211 1110000 0
Q ss_pred -----hhhhh-h-------h--------------hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 -----LSDAK-Q-------F--------------RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 -----~~~~~-~-------~--------------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..... . . .......+.......++..+.+|+.+||..||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 0 0 00111112222234567889999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=294.14 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=201.7
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|++.+.||+|+||.||++....++ ..+++|.+..... .....+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDN-----QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN--- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCC-----CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC---
Confidence 4788899999999999999865443 3799999865432 23456789999999999999999999987764
Q ss_pred ceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 73 -KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred -EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeecc
Confidence 459999999999999988642 124589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++...... ......|++.|++||.+.+..++.++|+||||+++++|++|+.||......... .
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~---------- 211 (256)
T cd08530 149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---Y---------- 211 (256)
T ss_pred chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----------
Confidence 99765443 122356889999999999888999999999999999999999999765432111 0
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.............++.++.+++.+||..+|++||++.+++++
T Consensus 212 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 212 ----KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001111122333567789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=299.93 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=195.6
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
..+||+|+||.||+|....++ ..||+|.+..........+.+|+.+++.++|+||+++++++...+ ..++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 95 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELWVV 95 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCC-----eEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC----EEEEE
Confidence 357999999999999876543 389999986554445567889999999999999999999998765 45999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++++|.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 96 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 9999999999887532 378899999999999999999998 9999999999999999999999999998654322
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
. .......|++.|+|||++.+..++.++||||||+++|+|++|..||............ ......
T Consensus 170 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-------------~~~~~~ 234 (292)
T cd06657 170 V--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLPP 234 (292)
T ss_pred c--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------HhhCCc
Confidence 1 1123356899999999998888999999999999999999999999754332111110 011111
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+. ....++..+.+++.+||..+|.+||++.+++++
T Consensus 235 ~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 235 KLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111 011245678899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=288.92 Aligned_cols=277 Identities=23% Similarity=0.289 Sum_probs=201.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
...|+.+..||+|+||.||+|.-.++++.. .+.+|+|+++.... .......+|+.+++.|+||||+.+..+|...+.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKR-TKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCccc-chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 457999999999999999999877665432 34799999976522 122456799999999999999999999887532
Q ss_pred CCceEEEEEeecCCCCcccccCCCC---cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC----CC
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ----WN 234 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~----~~ 234 (428)
..+|++||.+. +|...|..+. ...++...+..|++||+.|+.|||++ =|+||||||+|||+..+ |.
T Consensus 102 ---~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 102 ---KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred ---eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence 46999999977 8887775332 24688999999999999999999998 89999999999999877 89
Q ss_pred eEEeeecccccCCCCCcee-eeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH-----
Q 014245 235 AKLSDFGLARLGPSEGFTH-VSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ----- 307 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~----- 307 (428)
|||+|||+++.+...-..- .....+.|..|.|||.+.+. .|+.+.||||.|||+.||+|-.+-|.+.......
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999875432221 23456889999999998875 4899999999999999999998888654322111
Q ss_pred --HHHHh----------Hhhhhhhhhhhh-hhcCCcCCCCccH---H-------HHHHHHHHHHHhcccCCCCCCCHHHH
Q 014245 308 --KLLQW----------VKPYLSDAKQFR-QIVDPRLEGKYSL---R-------LVSKLSHVANLCLVKNARTRPKMSEV 364 (428)
Q Consensus 308 --~~~~~----------~~~~~~~~~~~~-~~~~~~l~~~~~~---~-------~~~~l~~li~~cl~~dp~~RPs~~el 364 (428)
.+... .++.+....... .+.+-......+. . -++...+|+.++|..||-+|.|+.+.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 11100 011111111110 0000000000000 0 11337789999999999999999999
Q ss_pred HHHH
Q 014245 365 LEMV 368 (428)
Q Consensus 365 l~~L 368 (428)
+++.
T Consensus 335 leh~ 338 (438)
T KOG0666|consen 335 LEHP 338 (438)
T ss_pred hccc
Confidence 9863
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=293.46 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=193.0
Q ss_pred HHHHHHHhcCCCCceee--cccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEe
Q 014245 77 IAELKSATKNFSRSVVI--GEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLV 153 (428)
Q Consensus 77 ~~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~ 153 (428)
..++....++|.+.+.+ |+|+||.||++....++ ..+|+|.+....... .|+.....+ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~ 75 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQ-----KLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLY 75 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCC-----cEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEE
Confidence 34445556678887776 99999999999876543 378999886543221 122222222 799999999
Q ss_pred eEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC
Q 014245 154 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
+++...+ ..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++
T Consensus 76 ~~~~~~~----~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 76 YSVTTLK----GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK 146 (267)
T ss_pred EEEecCC----eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence 9998766 3599999999999999986543 689999999999999999999998 999999999999999998
Q ss_pred -CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 234 -NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 234 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
.++|+|||++...... ....|+..|+|||++.+..++.++||||||+++|+|++|..||....... .....+
T Consensus 147 ~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~ 219 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESL 219 (267)
T ss_pred CeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHH
Confidence 9999999998754322 23468999999999998899999999999999999999999997443221 111111
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLEM 367 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~ell~~ 367 (428)
. ....... ......+..+.+++.+||+.+|.+||+ +++++++
T Consensus 220 ~-----------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 220 L-----------KRQQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred H-----------HhhcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 1 0011111 122246678999999999999999995 6988864
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=289.87 Aligned_cols=249 Identities=31% Similarity=0.466 Sum_probs=201.3
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|++.+.||+|++|.||+|.....+ ..|++|.+..... .....+.+|+++++.++|+|++++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETG-----DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD--- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCC-----cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC---
Confidence 4788899999999999999876543 3799999876644 34567899999999999999999999988754
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 73 -SLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred -EEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 459999999999999998654 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
......... .....++..|+|||.+.+..++.++|||+||+++++|++|..||....... .....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~~~~~----------- 211 (254)
T cd06627 147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--ALFRI----------- 211 (254)
T ss_pred eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHH-----------
Confidence 865433211 233568999999999988888999999999999999999999997543211 11000
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ......+...+..+.+++.+||..+|++||++.+++.+
T Consensus 212 ~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 212 VQ----DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred hc----cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 00 01112223346789999999999999999999998853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.08 Aligned_cols=267 Identities=24% Similarity=0.326 Sum_probs=197.4
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
|++.+.||.|+||.||+|.....+ ..+++|.+.... ......+.+|+.+++.++|+||+++++++.+.. ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 73 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTG-----ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--KG 73 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCC-----eEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--CC
Confidence 667889999999999999876543 379999997653 233456889999999999999999999998762 12
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++ +|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+|||+++++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 74 SIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 45999999975 8888886542 4589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......++..|+|||.+.+ ..++.++||||||+++++|++|..||...........+....... ....+
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 226 (287)
T cd07840 149 PYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP-TDENW 226 (287)
T ss_pred eccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-chhhc
Confidence 6543321 11223457889999997765 457899999999999999999999997655332211111000000 00000
Q ss_pred hhh--------cCC--c----CCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQI--------VDP--R----LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~--------~~~--~----l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
... ... . +...+...++..+.+++.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 000 0 0000001126788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=294.89 Aligned_cols=265 Identities=25% Similarity=0.295 Sum_probs=198.8
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
|++.+.||+|++|.||+|....++ ..+++|.+...... ....+..|+.+++.++|+||+++++++.+...
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTG-----EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD--- 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCC-----cEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCC---
Confidence 567789999999999999865433 37999998755332 34678899999999999999999999887653
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+.
T Consensus 73 -~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 73 -LYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred -EEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 4999999965 8888776543 4689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH-hHh-hhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ-WVK-PYLSDAK 321 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~-~~~-~~~~~~~ 321 (428)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............. ... +......
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP 224 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence 654432 112235688899999998876 78999999999999999999999997655332211110 000 0000000
Q ss_pred hhhh------hcCCc----CCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQ------IVDPR----LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~------~~~~~----l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.+ ...+. ........++.++.+++.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00000 0011123457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=294.37 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=192.8
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
||.|+||.||++....++ ..+++|.+..... .....+.+|++++..++|+||+++++.+.... ..++|
T Consensus 1 lg~g~~~~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG-----DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK----NLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECCCC-----CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc----EEEEE
Confidence 689999999999976543 3799999876543 34567889999999999999999998887655 45999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++++|.+++.... .+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 72 MEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 99999999999986543 589999999999999999999998 9999999999999999999999999998754332
Q ss_pred Cc------eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 250 GF------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 250 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
.. ........++..|++||.+.+..++.++||||||+++++|++|..||..........
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--------------- 211 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ--------------- 211 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence 11 112234568889999999988889999999999999999999999997654321111
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
...............+..+.+++.+||+.+|.+||++..+.+.|
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 212 -NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -HHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 11111111111111367899999999999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.74 Aligned_cols=274 Identities=23% Similarity=0.273 Sum_probs=198.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|++.+.||+|+||.||+|....++. .+++|.+...... ....+.+|+++++.++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGR-----VVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCc-----EEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 4689999999999999999999765433 7899988654322 23456789999999999999999998765442
Q ss_pred C----CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEE
Q 014245 162 R----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 237 (428)
Q Consensus 162 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 237 (428)
. ...+++||||+.+ +|...+... ...+++..+..++.|+++||.|||+. +|+|+||||+|||+++++.++|
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 2 2356999999965 666666433 34589999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCce---------eeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH
Q 014245 238 SDFGLARLGPSEGFT---------HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307 (428)
Q Consensus 238 ~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~ 307 (428)
+|||++......... .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999754322111 112335678899999987654 5789999999999999999999999765543322
Q ss_pred HHHHhHhhh-----hhhhhhhhhhc----CCcCCCCc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 308 KLLQWVKPY-----LSDAKQFRQIV----DPRLEGKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 308 ~~~~~~~~~-----~~~~~~~~~~~----~~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+...... +.......... ........ .....+.+.+++.+||+.||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 221111000 00000000000 00000000 01233678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=301.86 Aligned_cols=271 Identities=22% Similarity=0.235 Sum_probs=194.8
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
+|.+.+.||+|+||.||++...... .+..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS---EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC---cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 4788899999999999999976541 134799998864322 2345678999999999 699999999876543222
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
....++++||+. ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 234588999985 6888888543 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce--eeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH-HHhHhhhhh
Q 014245 243 ARLGPSEGFT--HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL-LQWVKPYLS 318 (428)
Q Consensus 243 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~ 318 (428)
+......... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||........... ...... .
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~ 229 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT--P 229 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC--C
Confidence 9754322111 11234578999999998765 4689999999999999999999999976542211110 000000 0
Q ss_pred hhhhhhhh-----------cCCcCCC---CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQI-----------VDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~-----------~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.......+ ....... ......+..+.+++.+||+.||++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 0000000 0011234679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=303.23 Aligned_cols=270 Identities=23% Similarity=0.332 Sum_probs=197.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.....||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTG-----EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCC-----cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 378999999999999999999865443 3799999865422 223567899999999999999999999875432
Q ss_pred C--CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ....++|+||+. .+|..++. ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence 1 124589999995 46666542 2488999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh--
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY-- 316 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-- 316 (428)
||+++..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9998754321 123567889999999876 45889999999999999999999999865432221111110000
Q ss_pred ------hhhhhhhhhhcC--CcCC-CCc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhh
Q 014245 317 ------LSDAKQFRQIVD--PRLE-GKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM--VNKIV 372 (428)
Q Consensus 317 ------~~~~~~~~~~~~--~~l~-~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~--L~~~~ 372 (428)
.... ....... +... ... ....+..+.+++.+||+.||++||++++++.+ ++...
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 236 PEFVQKLEDK-AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHHhccc-chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 0000000 0000 000 01234678899999999999999999999975 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=306.24 Aligned_cols=272 Identities=21% Similarity=0.286 Sum_probs=197.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||.|+||.||+|....++ ..||+|.+........+.+.+|+.+++.++||||+++++++.......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~-----~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCD-----KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCC-----cEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 368999999999999999999865543 389999987766556677889999999999999999998776543211
Q ss_pred ----------ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC-CC
Q 014245 164 ----------IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQ 232 (428)
Q Consensus 164 ----------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~ 232 (428)
...++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+||+++ ++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~ 151 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED 151 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence 14689999996 588887753 2488999999999999999999998 999999999999997 45
Q ss_pred CCeEEeeecccccCCCCCce-eeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 233 WNAKLSDFGLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 233 ~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
+.+||+|||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 67899999999754322111 11123467889999998754 45788999999999999999999999765543322211
Q ss_pred HhHhhhhhh--hhhh----hhhc--CCcCCCC----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 311 QWVKPYLSD--AKQF----RQIV--DPRLEGK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 311 ~~~~~~~~~--~~~~----~~~~--~~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+.... ...+ .... ....... .....+.++.+++.+||+.||.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 110000000 0000 0000 0000000 011245678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.97 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=186.3
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHH---HHhcCCCCCcccEeeEEecCCCCCce
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVN---FLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
+||+|+||.||+|....++ ..||+|.+.+.... ....+..|.. +++...||||+++++++...+ .
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD----K 71 (278)
T ss_pred CcccCCCeEEEEEEEecCC-----CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----E
Confidence 4899999999999865443 38999998764322 1122334433 444568999999999988766 3
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.++||||++||+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 59999999999999888543 4589999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
..... .....|+..|+|||++.++ .++.++||||||+++|+|++|..||.............. .
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------~ 211 (278)
T cd05606 147 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----------T 211 (278)
T ss_pred cCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-----------h
Confidence 43221 2235799999999998754 689999999999999999999999976533221111100 0
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
..... ..+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 212 ~~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 212 LTMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00111 12223457899999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.50 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=192.4
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
....+|+.+.+||+||||.||+++.+-. ++.||||+|.-.. ......+.+|+..|.+|+|||||++|..+.+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlD-----Gr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLD-----GREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeeccc-----chhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 3456788899999999999999986543 4589999997664 233457889999999999999999986432100
Q ss_pred CC------------------------------------------------------------------------------
Q 014245 161 ER------------------------------------------------------------------------------ 162 (428)
Q Consensus 161 ~~------------------------------------------------------------------------------ 162 (428)
..
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 00
Q ss_pred -----------------------------C--------ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHH
Q 014245 163 -----------------------------G--------IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205 (428)
Q Consensus 163 -----------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~ 205 (428)
. ..+||-||||+..+|.++++.+.... .....++++++|++|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHH
Confidence 0 24678899999988888887654211 356788999999999
Q ss_pred HHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC----------------CCCceeeeeeeecCcccCCcch
Q 014245 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP----------------SEGFTHVSTAVVGTMGYAAPEY 269 (428)
Q Consensus 206 L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~ 269 (428)
|.|+|++ |||||||||.||+||+++.|||+|||+|+... ........+..+||.-|+|||+
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999998 99999999999999999999999999998611 0011113457899999999999
Q ss_pred hccCC---CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCC--ccHHHHHHHH
Q 014245 270 VQTGR---LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGK--YSLRLVSKLS 344 (428)
Q Consensus 270 ~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~l~ 344 (428)
+.+.. |+.|+|+|||||+|+||+. ||...-. -. ..+....+..++.. +.....+.-.
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra-------------~iL~~LR~g~iP~~~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RA-------------SILTNLRKGSIPEPADFFDPEHPEEA 848 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHH--HH-------------HHHHhcccCCCCCCcccccccchHHH
Confidence 97654 9999999999999999996 4643211 01 11112222222222 2223334567
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014245 345 HVANLCLVKNARTRPKMSEVLE 366 (428)
Q Consensus 345 ~li~~cl~~dp~~RPs~~ell~ 366 (428)
.+|.++++.||++|||+.|+|.
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 8999999999999999999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=288.38 Aligned_cols=260 Identities=30% Similarity=0.422 Sum_probs=199.4
Q ss_pred CCcccCHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCC
Q 014245 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQN 148 (428)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~n 148 (428)
.+..|+-+.++... .||.|+||+|++-.++.++ +.+|||++..... ...+++..|.+...+- +.||
T Consensus 57 ~~~~F~~~~Lqdlg-------~iG~G~fG~V~KM~hk~sg-----~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~ 124 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLG-------EIGNGAFGTVNKMLHKPSG-----KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPN 124 (361)
T ss_pred cccccccchHHHHH-------HhcCCcchhhhhhhcCccC-----cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcH
Confidence 45567666665533 5999999999998876554 4899999987655 4567888888775554 8999
Q ss_pred cccEeeEEecCCCCCceEEEEEeecCCCCcccccCC---CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCC
Q 014245 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSP---KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225 (428)
Q Consensus 149 Iv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 225 (428)
||++||.+..++.. ++.||+| ..+|+.+... .....+++...-.|....+.||.||-+. ..||||||||+
T Consensus 125 IVkfyGa~F~EGdc----WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPS 197 (361)
T KOG1006|consen 125 IVKFYGALFSEGDC----WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPS 197 (361)
T ss_pred HHHHhhhhhcCCce----eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChh
Confidence 99999999887765 8999999 4577665431 2234588888888999999999999875 58999999999
Q ss_pred ceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHHHhCCCCCCCCCc
Q 014245 226 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRP 303 (428)
Q Consensus 226 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~ 303 (428)
||||+..|.+||||||++...... ...+...|...|||||.+.. ..|+.++||||||++|||+.||..||.....
T Consensus 198 NILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 198 NILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred heEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 999999999999999998654221 11234578899999998864 3589999999999999999999999975432
Q ss_pred hhhHHHHHhHhhhhhhhhhhhhhcCCc---CC-CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 304 RSEQKLLQWVKPYLSDAKQFRQIVDPR---LE-GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---l~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. .+++.+++... +. ..-..+++..+..++..||.+|-++||.+.++.++
T Consensus 275 v---------------feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 275 V---------------FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred H---------------HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 12222332211 11 11123567889999999999999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.50 Aligned_cols=276 Identities=24% Similarity=0.312 Sum_probs=202.4
Q ss_pred cCHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccE
Q 014245 75 FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKL 152 (428)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~ 152 (428)
....++....++|.+.+.||+|+||.||+|....+ +..||+|++..... ...+.+.+|+.+++.++||||+++
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKT-----GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCC-----CeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence 34456666789999999999999999999986543 34899999875422 234567889999999999999999
Q ss_pred eeEEecCCC--CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC
Q 014245 153 VGYCADDDE--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 153 ~~~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~ 230 (428)
++++..... .....+++++++ +++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~ 154 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN 154 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEc
Confidence 998865332 112357888887 78998877543 389999999999999999999998 999999999999999
Q ss_pred CCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014245 231 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309 (428)
Q Consensus 231 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 309 (428)
.++.+||+|||++...... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 155 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 155 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred CCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999998754321 233568899999998866 5688999999999999999999999975443222111
Q ss_pred HHhHhh--------hhhhh--hhhhhhcCCcCCCCc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 310 LQWVKP--------YLSDA--KQFRQIVDPRLEGKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 310 ~~~~~~--------~~~~~--~~~~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..... .+... ......+.......+ ....+.++.+++.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 100000 00000 000000000000000 00135678999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=296.31 Aligned_cols=272 Identities=27% Similarity=0.329 Sum_probs=198.4
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|++.+.||+|+||.||+|.....+ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTG-----ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCC-----cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 3568999999999999999999976543 3789999865432 23356778999999999999999999987654
Q ss_pred C------CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 161 E------RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 161 ~------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
. .....++|+||+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 1 11246999999976 666666543 33589999999999999999999998 9999999999999999999
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (428)
+||+|||++........ .......++..|+|||++.+. .++.++|||||||++++|++|+.||...........+...
T Consensus 155 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 155 IKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred EEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999999976543221 112223567889999988653 5788999999999999999999999765433222211111
Q ss_pred hhhhhhhhhhhhhcC--------------CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVD--------------PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~--------------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
... .....+..+.. .... .....++..+.+++.+||+.+|++||++.+++.+
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGS-PCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCC-CChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00000000000 0000 0011245789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=296.02 Aligned_cols=251 Identities=28% Similarity=0.436 Sum_probs=201.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCC-CCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~ 160 (428)
++|.+.+.||+|+||.||+|....++ ..|++|++..... .....+..|+.+++++. |+||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETN-----KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCC-----CEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 46889999999999999999876543 3799999875322 23456789999999998 999999999987665
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 76 ----~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 ----NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred ----eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 3599999999999999997543 599999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCce------------------eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCC
Q 014245 241 GLARLGPSEGFT------------------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNR 302 (428)
Q Consensus 241 Gla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~ 302 (428)
|++......... .......|+..|+|||++.+..++.++||||||++++++++|..||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 998765432210 12234568899999999988889999999999999999999999998654
Q ss_pred chhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 014245 303 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM----SEVLEM 367 (428)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~ell~~ 367 (428)
.... .. .... .....+..+++.+.+++.+||+.+|.+||++ .+++++
T Consensus 227 ~~~~---~~-------------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 EYLT---FQ-------------KILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHH---HH-------------HHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 2111 11 1110 1112233446789999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=292.58 Aligned_cols=267 Identities=26% Similarity=0.344 Sum_probs=196.6
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcC---CCCCcccEeeEEecCCC
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIV---EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~ 161 (428)
|++.+.||+|+||.||+|....++ ..||+|.+...... ....+.+|+.++..+ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTG-----RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT 75 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCC-----CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence 667889999999999999976532 37999998754322 234566787776655 69999999999987653
Q ss_pred -CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 162 -RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 162 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.....+++|||++ ++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 76 DRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred CCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence 2223699999996 4888887654444589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh-h
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-D 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~ 319 (428)
|++........ .....++..|+|||++.+..++.++|||||||++|+|++|..||.......... ........ .
T Consensus 152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 226 (287)
T cd07838 152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPS 226 (287)
T ss_pred CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCC
Confidence 99876543221 123457889999999998899999999999999999999999997654322111 11110000 0
Q ss_pred hhhh-------hhhcCCcCC---CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQF-------RQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~-------~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+ ......... ..........+.+++.+||+.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 000000000 11122456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.54 Aligned_cols=242 Identities=25% Similarity=0.301 Sum_probs=185.2
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHH-HhcCCCCCcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNF-LGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
+.||+|+||.||+|.....+ ..||+|.+...... ....+..|..+ ....+|+||+++++++...+ ..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTG-----DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----YL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCC-----CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC----eE
Confidence 46899999999999875543 37999998654321 22334455444 44559999999999998765 35
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 73 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999999999999998643 3488999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|..||............. . .
T Consensus 148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~------~- 208 (260)
T cd05611 148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL------S------R- 208 (260)
T ss_pred cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------h------c-
Confidence 32 223568899999999988888999999999999999999999997654321111000 0 0
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 366 (428)
...........++..+.+++.+||+.+|++||++.++.+
T Consensus 209 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 209 -RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred -ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 000111112235678999999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=302.61 Aligned_cols=271 Identities=25% Similarity=0.309 Sum_probs=202.4
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC-CC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD-ER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~ 162 (428)
+|.+.+.||.|+||.||+|....++ ..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTG-----RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCC-----cEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence 5788899999999999999865543 379999987643 334567889999999999999999999987764 12
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
....|+||||++ ++|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.++|+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred ccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 224699999997 58888886443 689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce-eeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh--
Q 014245 243 ARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-- 318 (428)
Q Consensus 243 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 318 (428)
+......... .......+++.|+|||++.+. .++.++||||||+++++|++|..||...........+........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence 9865433210 112345688999999999887 789999999999999999999999976654322111110000000
Q ss_pred -----hhhhhhhhcC---CcCC---CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 -----DAKQFRQIVD---PRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 -----~~~~~~~~~~---~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
........+. .... ......++..+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 0000 00112246788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.00 Aligned_cols=261 Identities=22% Similarity=0.271 Sum_probs=190.3
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC--CcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
+.+|.|+++.||++. . .+..||+|++... .......+..|+.+++.++|+||+++++++.+... .++
T Consensus 8 ~~~~~~~~v~~~~~~--~-----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~----~~~ 76 (314)
T cd08216 8 KCFEDLMIVHLAKHK--P-----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE----LYV 76 (314)
T ss_pred HhhcCCceEEEEEec--C-----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe----EEE
Confidence 344455555555543 2 2348999998754 23345678999999999999999999999987664 499
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCC
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 248 (428)
+|||+++|+|.+++.......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecc
Confidence 99999999999999765445688999999999999999999998 999999999999999999999999998864432
Q ss_pred CCc-----eeeeeeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh----h
Q 014245 249 EGF-----THVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY----L 317 (428)
Q Consensus 249 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~----~ 317 (428)
... ........++..|+|||++.+ ..++.++|||||||+++||++|..||........ ..+..... +
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 231 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLL 231 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCcccc
Confidence 211 111233567889999999876 3588999999999999999999999976432211 11111000 0
Q ss_pred hhh------hhhhh----hcC----CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDA------KQFRQ----IVD----PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~------~~~~~----~~~----~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
... ..... ..+ ..........+..++.+++.+||..||++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 00000 000 001112233566789999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=297.78 Aligned_cols=267 Identities=22% Similarity=0.313 Sum_probs=198.2
Q ss_pred HHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEec
Q 014245 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCAD 158 (428)
Q Consensus 81 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 158 (428)
...+++|++.+.||.|+||.||+|....++ ..||+|.+.... ....+.+..|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 80 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTG-----QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS 80 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCC-----CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence 446789999999999999999999866443 379999876432 2234677899999999999999999999875
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
... ..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||+|+|||+++++.++|+
T Consensus 81 ~~~---~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 81 PLE---DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred CCC---cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeC
Confidence 433 358999999 6688888753 2378888889999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH-hHhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ-WVKPY 316 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~ 316 (428)
|||++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||............. .....
T Consensus 151 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 151 DFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred ccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99998754321 123467889999998765 568999999999999999999999997654422211111 00000
Q ss_pred -------hhhhhhhhhhcCCcCCCCcc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 -------LSDAKQFRQIVDPRLEGKYS-----LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 -------~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
........-...-......+ ..++..+.+++.+||+.+|++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000001111 1245789999999999999999999999775
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=296.63 Aligned_cols=247 Identities=30% Similarity=0.410 Sum_probs=192.8
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.|+..+.||+|+||.||+|....++ ..+++|.+.... .....++.+|+.+++.++|+|++++++++.....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 89 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT- 89 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCC-----cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe-
Confidence 4667788999999999999976543 379999886432 2234567899999999999999999999987653
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||+
T Consensus 90 ---~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 90 ---AWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred ---eEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccc
Confidence 499999996 57777664332 3488999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
+...... ....|++.|+|||++. .+.++.++|||||||++|+|++|..||.......... .
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~-------- 225 (308)
T cd06634 162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--H-------- 225 (308)
T ss_pred ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--H--------
Confidence 8754321 2356889999999874 3567889999999999999999999986543211110 0
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.............++..+.+++.+||+.+|++||++.+++.+.
T Consensus 226 ------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 226 ------IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ------HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0000011111224557789999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=327.62 Aligned_cols=257 Identities=26% Similarity=0.347 Sum_probs=207.5
Q ss_pred HHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC---CcccHHHHHHHHHHHhcCCCCCcccEeeE
Q 014245 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GVQGHKEWMTEVNFLGIVEHQNLVKLVGY 155 (428)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 155 (428)
+++-...+|.++++||+|+||.|..++.+.++. .||+|++.+- .......|..|-.+|..-+.+-|+.+.-.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~-----VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEK-----VYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeecccc-----chhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 334445789999999999999999999887654 8999999763 22334568899999999999999999888
Q ss_pred EecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCe
Q 014245 156 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 235 (428)
Q Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 235 (428)
|+++.. +|||||||+||+|-.++.+.. .+++.+++.++..|+.||.-||+- |+|||||||+|||||..|++
T Consensus 144 FQD~~~----LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 144 FQDERY----LYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred hcCccc----eEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcE
Confidence 888774 599999999999999998655 599999999999999999999987 99999999999999999999
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhc----c-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ----T-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
||+|||.+-.+..++.. .+...+|||.|++||++. + +.|+..+|.||+||++|||+.|..||....-....
T Consensus 215 kLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY--- 290 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY--- 290 (1317)
T ss_pred eeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH---
Confidence 99999999877766543 355679999999999986 3 67999999999999999999999999754322111
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCcc--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYS--LRLVSKLSHVANLCLVKNARTRPK---MSEVLEM 367 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~ell~~ 367 (428)
..+++-.-.-.++ ..++++..+||.+.+ -+|+.|.. ++++..|
T Consensus 291 -------------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 291 -------------GKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -------------HHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 1222111111111 347788889988866 57888887 9988876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=312.65 Aligned_cols=266 Identities=29% Similarity=0.411 Sum_probs=216.8
Q ss_pred CHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEee
Q 014245 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVG 154 (428)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 154 (428)
.++.+...+.-|++..+||.|.+|.||++....+.. ..|+|+..... ...+++..|.+||+.+ +|||++.+||
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~-----~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg 83 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQ-----LAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYG 83 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCc-----eeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEE
Confidence 344455556789999999999999999998765543 67788776543 3446778899999988 8999999999
Q ss_pred EEecCC-CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC
Q 014245 155 YCADDD-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 155 ~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
+|...+ ..+.+++||||||.||+..|++.......+.|..+..|++.++.||.+||.+ .++|||||-.|||++.++
T Consensus 84 ~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 84 AFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENA 160 (953)
T ss_pred EEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccC
Confidence 886433 4456899999999999999999876667799999999999999999999998 999999999999999999
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccC-----CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 308 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 308 (428)
.|||+|||++...+.. .......+|||.|||||++... .|+..+|+||||++.+||.-|.+|+....+...
T Consensus 161 ~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-- 236 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-- 236 (953)
T ss_pred cEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--
Confidence 9999999999876543 2334568999999999998643 478899999999999999999999987654321
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.-.-+|...-.-+.....++.++|..||..|.++||++.+++++
T Consensus 237 -------------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 -------------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -------------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1112223444444466788899999999999999999999999864
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=295.47 Aligned_cols=245 Identities=31% Similarity=0.443 Sum_probs=191.5
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
|...+.||+|+||.||+|....++ ..|++|.+..... .....+.+|+.+++.++|||++++++++.+...
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTN-----EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT-- 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCC-----cEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE--
Confidence 666778999999999999865443 3799999865432 233567899999999999999999999987653
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+. |+|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 96 --~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 96 --AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred --EEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 499999995 5777776533 23589999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
..... .....|+..|+|||++. .+.++.++|||||||++|+|++|..||............
T Consensus 169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~---------- 232 (313)
T cd06633 169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---------- 232 (313)
T ss_pred cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----------
Confidence 64322 12356899999999874 456888999999999999999999999765332211100
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............++..+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 233 ------AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001111122344678999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=299.79 Aligned_cols=268 Identities=24% Similarity=0.307 Sum_probs=197.9
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|++.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCC-----cEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 4678999999999999999999865433 4799999864322 22356789999999999999999999987654
Q ss_pred CC--CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 161 ER--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 161 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.. ....++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 32 12458999999 7799888753 3489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH-HHhHhh-
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL-LQWVKP- 315 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-~~~~~~- 315 (428)
|||++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||..........- ......
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999754322 223567899999998876 4578899999999999999999999976543211110 000000
Q ss_pred ------hhhh--hhhhhhhcCCcCCC---CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 ------YLSD--AKQFRQIVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ------~~~~--~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.. .......+...... .....++..+.+++.+|++.||++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000000000000 0112345678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.81 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=216.3
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceE
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
...++||+|+||+||+|.+--. ....+.+||+|++.... .+...+++.|+.+|.+|+|||+++++|+|..+. +
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----L 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----H
Confidence 3456899999999999998765 45677899999987653 345678999999999999999999999998876 2
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
-||++||++|.|.++++.+. ..+.....+.|..||++||.|||++ .+|||||-..||||..-..+||.|||+++..
T Consensus 773 qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 68999999999999998643 4578888999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (428)
..++.........-.+-|||-|.+....|+.++|||||||++||++| |..||++....+..++++
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------------- 914 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------------- 914 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh--------------
Confidence 76655444444445677999999999999999999999999999999 999998875443333222
Q ss_pred hcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 326 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
...+-..++.++-++..++.+||..|+..||+++++...+..+.+
T Consensus 915 ---~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 915 ---KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ---ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 222223344567789999999999999999999999998877753
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=295.29 Aligned_cols=252 Identities=30% Similarity=0.432 Sum_probs=191.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|+||.||+|....++ ..||+|.+..... .....+..|+.++.++ .|+||+++++++.+...
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~- 88 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTG-----HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD- 88 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCC-----eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe-
Confidence 56888999999999999999976543 3799999875432 2345566777777666 59999999999987663
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||+
T Consensus 89 ---~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 89 ---VFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred ---EEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECcccc
Confidence 499999984 47766664322 3689999999999999999999962 2899999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCC----CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR----LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
+....... ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ...+..
T Consensus 162 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~------- 230 (296)
T cd06618 162 SGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTK------- 230 (296)
T ss_pred chhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHH-------
Confidence 87543221 112345788999999987553 788999999999999999999999653221 111111
Q ss_pred hhhhhhhhcCCcC-CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.... .......++.++.+++.+||..||++||++.+++++
T Consensus 231 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 231 -------ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------HhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111100 000111245689999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=291.37 Aligned_cols=265 Identities=24% Similarity=0.312 Sum_probs=195.9
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~ 164 (428)
|.+.+.||+|+||.||+|....++ ..|++|.+...... ......+|+..++.++ |+||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~---- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETG-----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND---- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCC-----cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC----
Confidence 567889999999999999976543 37999998654322 2234567999999998 999999999998755
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+ +|+|.+++.......+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 349999999 78998888655444689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH-HHhHhhh----hh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL-LQWVKPY----LS 318 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~----~~ 318 (428)
...... ......|+..|+|||++.+ ..++.++||||||+++++|++|..||........... ....... +.
T Consensus 148 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 148 EIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 553321 1223568899999998754 4578999999999999999999999976644322211 1100000 00
Q ss_pred hhhhhhhhcCCcCCC-------CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEG-------KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+........+..+.. ........++.+++.+||+.+|++||++.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000001100000 0011124679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=292.72 Aligned_cols=258 Identities=25% Similarity=0.328 Sum_probs=197.6
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
+|++.+.||+|+||.||++...... ..+..||+|.+..... .....+..|+.++..+ +||||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 4778899999999999999864322 2345799998864321 2335678999999999 6999999999887655
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+||
T Consensus 79 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 79 ----KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred ----EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEEC
Confidence 358999999999999988643 3488999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCC--CCCchhhhhHHHHHHHHHhCCCCCCCCCchhh-HHHHHhHhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYL 317 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~ 317 (428)
|++........ .......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||........ ..+..
T Consensus 150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------ 222 (288)
T cd05583 150 GLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR------ 222 (288)
T ss_pred ccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH------
Confidence 99876433221 1122356899999999987655 78899999999999999999999964322111 11100
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
.+... ....+..++..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 223 -------~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 223 -------RILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------HHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11110 011223355688999999999999999998877776554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=299.25 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=193.5
Q ss_pred cCCCC-ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc--------------HHHHHHHHHHHhcCCCCCc
Q 014245 85 KNFSR-SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--------------HKEWMTEVNFLGIVEHQNL 149 (428)
Q Consensus 85 ~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nI 149 (428)
++|.. .+.||.|+||.||+|.....+ ..||+|.+....... ...+.+|+.+++.++|+||
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTG-----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCC-----CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 45654 467999999999999865433 379999886542221 1247799999999999999
Q ss_pred ccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE
Q 014245 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229 (428)
Q Consensus 150 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl 229 (428)
+++++++..... .++||||++ |+|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++
T Consensus 83 v~~~~~~~~~~~----~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill 152 (335)
T PTZ00024 83 MGLVDVYVEGDF----INLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI 152 (335)
T ss_pred eeeeEEEecCCc----EEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence 999999987653 499999996 6898888543 3488999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeeecccccCCCCCc------------eeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCC
Q 014245 230 DEQWNAKLSDFGLARLGPSEGF------------THVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRR 296 (428)
Q Consensus 230 ~~~~~~kl~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~ 296 (428)
+.++.++|+|||++........ ........+++.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999976541110 1111234568899999988764 46889999999999999999999
Q ss_pred CCCCCCchhhHHHHHhHhhhhhhhh--hhhhhc--------CCcCCC---CccHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 014245 297 PIDRNRPRSEQKLLQWVKPYLSDAK--QFRQIV--------DPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSE 363 (428)
Q Consensus 297 p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--------~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 363 (428)
||...........+. ..+.... .+.... ...... ......+.++.+++.+||+.+|++||++++
T Consensus 233 p~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 309 (335)
T PTZ00024 233 LFPGENEIDQLGRIF---ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309 (335)
T ss_pred CCCCCCHHHHHHHHH---HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence 997665432211111 0000000 000000 000000 001123567899999999999999999999
Q ss_pred HHHH
Q 014245 364 VLEM 367 (428)
Q Consensus 364 ll~~ 367 (428)
++.+
T Consensus 310 ~l~~ 313 (335)
T PTZ00024 310 ALKH 313 (335)
T ss_pred HhcC
Confidence 9985
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=288.88 Aligned_cols=264 Identities=27% Similarity=0.420 Sum_probs=206.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhc--CCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI--VEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~~~ 162 (428)
++....+.||+|.||+||+|.+++. .||||++.... +..+.+|.+|.+- |+|+||+.+++.-..+...
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe-------~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGE-------DVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred heeEEEEEecCccccceeeccccCC-------ceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 4667788999999999999999986 59999997543 4577888888765 5999999999887777777
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-----CCCCCeeeccCCCCceEECCCCCeEE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-----GMDFQIIVRDFKSSNILLDEQWNAKL 237 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivHrDlkp~NILl~~~~~~kl 237 (428)
..+++||++|.+.|+|.|||.. ..++....++++..+|.||++||. +..+.|.|||||..|||+..+|..-|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 7899999999999999999975 348899999999999999999995 35678999999999999999999999
Q ss_pred eeecccccCCCC--CceeeeeeeecCcccCCcchhccCC----CC--CchhhhhHHHHHHHHHhC----------CCCCC
Q 014245 238 SDFGLARLGPSE--GFTHVSTAVVGTMGYAAPEYVQTGR----LA--ARSDVWSYGVFLYELITG----------RRPID 299 (428)
Q Consensus 238 ~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~DvwslG~il~elltg----------~~p~~ 299 (428)
+|+|||...... .........+||.+|||||++.+.- +. ..+||||||.++||++.. +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999754332 1222344679999999999987532 21 359999999999999864 34665
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhc-CCcCCCCc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIV-DPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
...+.+.. .+.+++++ ..++++.. +......+.++|+.||..||.-|.|+-.|-+.|.++..
T Consensus 438 d~Vp~DPs------------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSDPS------------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCCCC------------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 43332211 11122221 22233222 23566789999999999999999999999999988764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=291.36 Aligned_cols=241 Identities=27% Similarity=0.430 Sum_probs=201.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
.+|..+.+||+|+||.|.+|..+++.+ .+|||+++++..- +.+--+.|-++|... +-|.++.+...|+.-+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdE-----LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDE-----LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcch-----hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 468889999999999999998777654 8999999876432 223346788888877 6788999998888777
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
. +|+||||+.||+|--.|++-+. |.+..+..++.+|+-||-|||++ |||.||||.+|||||.+|.+||+||
T Consensus 424 R----LyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 424 R----LYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred h----eeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence 5 4999999999999998876554 88889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|+++..-..+ ..+..++|||.|+|||++...+|+.++|.|||||+||||+.|++||++.+... +
T Consensus 495 GmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---l----------- 558 (683)
T KOG0696|consen 495 GMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L----------- 558 (683)
T ss_pred ccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---H-----------
Confidence 9998543332 34567999999999999999999999999999999999999999999865432 2
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 359 (428)
++.+.+.. -.++..++.+..++....|...|.+|.
T Consensus 559 --F~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 --FQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --HHHHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 22222222 246677888999999999999999995
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=291.14 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=195.0
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
+|++.+.||+|+||.||+|...... ..+..||+|.+..... ...+.+.+|+.++..+ +|+||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH--DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC--CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 4788899999999999999864321 2345799999865322 2345678899999999 6999999998887755
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+||
T Consensus 79 ----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 79 ----KLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred ----eEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeC
Confidence 358999999999999998654 3488899999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccC--CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh-HHHHHhHhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYL 317 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~ 317 (428)
|++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||........ .....
T Consensus 150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~------ 222 (290)
T cd05613 150 GLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR------ 222 (290)
T ss_pred ccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH------
Confidence 99876433211 112245689999999988753 467899999999999999999999964322111 11111
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
..... ...++..+...+.+++.+||+.||++|| ++.+++.+
T Consensus 223 -------~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 -------RILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------Hhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11000 1112233557889999999999999997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=286.83 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=192.2
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|.+.+.||+|+||.||++....... .....++|.+.... ......+..|+.+++.++||||+++++++.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVA--EERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA-- 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCC--cceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc--
Confidence 47888999999999999998654422 11122333332221 1223456789999999999999999999877653
Q ss_pred ceEEEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.++||||+++++|.+++.. .....+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||
T Consensus 77 --~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 77 --FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred --eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccC
Confidence 4899999999999988753 2234689999999999999999999998 9999999999999975 579999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ...
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~---------- 215 (260)
T cd08222 151 VSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVL---------- 215 (260)
T ss_pred ceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH----------
Confidence 987653221 12234568899999999988889999999999999999999999996432211 100
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ......+..++.++.+++.+||..+|++||++.+++++
T Consensus 216 ---~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 ---RIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---HHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1111 11112234566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=296.02 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=200.4
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~ 167 (428)
.++||+|.||+||-|.++.++ +.||||++.+... .....+.+|+.||++++||.||.+...|...+. .|
T Consensus 569 devLGSGQFG~VYgg~hRktG-----rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er----vF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTG-----RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER----VF 639 (888)
T ss_pred HhhccCCcceeeecceecccC-----ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce----EE
Confidence 358999999999999987654 4899999987533 345678899999999999999999988887764 49
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC---CCeEEeeecccc
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ---WNAKLSDFGLAR 244 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~ 244 (428)
.|||-+ +|+.-+.|-....+.+++.....++.||+.||.|||.+ +|+|.||||+||||... .++||||||.|+
T Consensus 640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 999999 45665555444556799999999999999999999998 99999999999999543 469999999999
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
..+... .....+|||.|+|||++++..|+..-|+||.|||+|--++|..||.......++ ++. .
T Consensus 716 iIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQN-----------A 779 (888)
T KOG4236|consen 716 IIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQN-----------A 779 (888)
T ss_pred ecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhc-----------c
Confidence 876543 345689999999999999999999999999999999999999999765432222 110 1
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+ ..+.....++++...+||...|+..-++|.+.+..+.+
T Consensus 780 aF---MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 780 AF---MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred cc---ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 11 12233455677889999999999999999999887654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=288.59 Aligned_cols=265 Identities=27% Similarity=0.343 Sum_probs=197.2
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
|+..+.||+|+||.||+|....++ ..+++|.+.... ....+.+..|+.+++.++|+||+++++++.+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTG-----EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER---- 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCC-----cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC----
Confidence 556778999999999999876543 379999987653 233467789999999999999999999988765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||+|+||++++++.++|+|||++.
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 3499999997 58999987542 3589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHhh----hhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVKP----YLS 318 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~----~~~ 318 (428)
....... ......++..|+|||++.+. .++.++||||||++++||++|..||.......... ....... .+.
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence 6543221 12234567889999998776 78999999999999999999999997654322111 1110000 000
Q ss_pred hhhhh---hhhcCCcCCC---CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQF---RQIVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~---~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..... .......... ......+..+.+++.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 0000000000 0111235689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=297.08 Aligned_cols=268 Identities=24% Similarity=0.302 Sum_probs=198.7
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTG-----RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCC-----cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 3568999999999999999999976543 379999986532 223456778999999999999999998776544
Q ss_pred C--CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 161 E--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 161 ~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
. .....++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEc
Confidence 2 122369999999 6799888864 3489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.......
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~ 235 (343)
T cd07851 161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235 (343)
T ss_pred ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence 99999754322 233568899999998865 367889999999999999999999997654332211110000000
Q ss_pred h----h---hhhhhhh---cCCcCCCCc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 S----D---AKQFRQI---VDPRLEGKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~----~---~~~~~~~---~~~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. . ....... +.......+ ...++.++.+++.+||+.+|++|||+.+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0 0000000 000000000 01235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.29 Aligned_cols=264 Identities=29% Similarity=0.489 Sum_probs=209.8
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCC--CcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDP--SQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
+..+.+.||+|.||.|++|...+.... .....||||.++.... ...+.+..|+++|+.+ .|+||+.++|+|.....
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 445556999999999999987654322 2467899999986544 3567889999999999 79999999999998443
Q ss_pred CCceEEEEEeecCCCCcccccCCCC------------c--ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCce
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKS------------E--TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 227 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NI 227 (428)
.++|+||+..|+|.++++.+. . ..++....+.++.||+.|++||++. ++|||||-..||
T Consensus 377 ----~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 377 ----LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred ----eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 499999999999999997654 0 1388889999999999999999998 999999999999
Q ss_pred EECCCCCeEEeeecccccCCCCCceeeeeeeec--CcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCch
Q 014245 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG--TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 304 (428)
Q Consensus 228 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~ 304 (428)
|+.++..+||+|||+|+.......... ..-.| ...|||||.+....|+.++|||||||+||||+| |..||.+....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999986554433321 11222 335999999999999999999999999999999 99999763211
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
..+.++ +....+-..+..+.+++.+++..||+.+|++||++.++.+.|..++.
T Consensus 529 --~~l~~~--------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 529 --EELLEF--------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HHHHHH--------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111221 22222223344567899999999999999999999999999998653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=278.32 Aligned_cols=273 Identities=22% Similarity=0.340 Sum_probs=203.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+.|....+||+|.||+||+|..++++. .||+|+.-..+. ......++|+++|..|+|+|++.++..|......
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~k-----kvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGK-----KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccc-----hhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 356667789999999999998776543 577776533221 1234567999999999999999999988654332
Q ss_pred Cc----eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 163 GI----QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 163 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.. .+||||++|+. +|..++... ...++..++.+++.++..||.|+|.. .|+|||+||+|+||+.+|.+||+
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence 22 37999999976 888888643 24588999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCc--eeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH--
Q 014245 239 DFGLARLGPSEGF--THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-- 313 (428)
Q Consensus 239 DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-- 313 (428)
|||+++.+..... ....+..+.|..|.+||.+.+ ..|+++.|||+-||++.||+||.+-+.++.......++...
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 9999976543221 112345677999999998876 46999999999999999999999999888766555555432
Q ss_pred ------hhhhhhhhhhhhhcCCcCCCCccHHH---------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 ------KPYLSDAKQFRQIVDPRLEGKYSLRL---------VSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ------~~~~~~~~~~~~~~~~~l~~~~~~~~---------~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+|...+...+..+-.+.+.......+ .++..+|+..+|..||.+|+++++++.+
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 22222222222221121221111111 2467899999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.41 Aligned_cols=147 Identities=30% Similarity=0.403 Sum_probs=127.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.++||+|+||.||+|.....+ ..||+|++..... .....+..|+.++..++|+||+++++++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNS-----KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 357999999999999999999976543 3899999875432 22356889999999999999999998887655
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.+||||||+++++|.+++... ..+++..++.|+.||+.||.|||.+ +||||||||+||||+.++.+||+||
T Consensus 78 ----~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 78 ----NVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred ----EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence 459999999999999998643 3488899999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 014245 241 GLAR 244 (428)
Q Consensus 241 Gla~ 244 (428)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=290.66 Aligned_cols=259 Identities=27% Similarity=0.395 Sum_probs=199.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-------ccHHHHHHHHHHHhcCCCCCcccEeeEEe
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-------QGHKEWMTEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
++|-.+.+||+|||+.||+|..... .+.||+|+-..... ...+...+|..|.+.|+||.||++|+||.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~E-----qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTE-----QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccch-----hheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 4566778999999999999985543 34788887532211 12344678999999999999999999997
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC---CCCC
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWN 234 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~ 234 (428)
-+... +|-|+|||+|.+|+-+|.++ +.+++.++..|+.||+.||.||.+. .++|||-||||.||||- .-|.
T Consensus 538 lDtds---FCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 538 LDTDS---FCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred ecccc---ceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence 65442 48999999999999999654 4589999999999999999999986 67999999999999994 4577
Q ss_pred eEEeeecccccCCCCCce-----eeeeeeecCcccCCcchhccC----CCCCchhhhhHHHHHHHHHhCCCCCCCCCchh
Q 014245 235 AKLSDFGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTG----RLAARSDVWSYGVFLYELITGRRPIDRNRPRS 305 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 305 (428)
+||+||||++.+..+.+. ..+....||.+|++||.+.-+ ..+.++||||+|||+|+++.|+.||+.+..
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-- 689 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-- 689 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--
Confidence 999999999988765443 234567899999999987533 368899999999999999999999986532
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCC-cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDP-RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+++++. . .++.. ...-...+.++.+..++|++||+.--++|.+..++..+
T Consensus 690 QQdILqe-------N----TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 690 QQDILQE-------N----TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred HHHHHhh-------h----chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 2222221 0 11110 01111123466789999999999999999998888654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=279.69 Aligned_cols=237 Identities=30% Similarity=0.413 Sum_probs=190.1
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEE
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv 169 (428)
||+|+||.||++.....+ ..+++|.+...... ....+..|+.+++.++|+||+++++.+.... ..++|
T Consensus 1 lg~G~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG-----KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE----KLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECCCC-----cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC----eeEEE
Confidence 699999999999876532 37999998765332 3457889999999999999999999887665 35999
Q ss_pred EeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 170 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 170 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 72 LEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 99999999999986543 489999999999999999999998 9999999999999999999999999998765332
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
. .......++..|++||.+.+...+.++|+||||+++|+|++|..||....... ... .+...
T Consensus 147 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~-------------~~~~~ 208 (250)
T cd05123 147 G--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE-------------KILKD 208 (250)
T ss_pred C--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH-------------HHhcC
Confidence 1 12334568899999999988888999999999999999999999997553211 111 11111
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 363 (428)
....+...+..+.+++.+||..||++||++.+
T Consensus 209 --~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 --PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11122233578899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=282.16 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=203.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC--CC----cccEeeEEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH--QN----LVKLVGYCA 157 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n----Iv~~~~~~~ 157 (428)
+++|.+..++|+|+||.|-.+..... +..||||+++.- ....+..+-|+++|.++.+ |+ +|.+.+||.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~-----~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRET-----KEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCC-----CceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 78999999999999999999986554 448999998533 2344567789999999932 22 677778887
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC------
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE------ 231 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~------ 231 (428)
..+. .|||+|.+ |-++.+++..++..+++..++..|+.|++++++|||+. +++|-||||+|||+..
T Consensus 162 yrgh----iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 162 YRGH----ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ccCc----eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 7664 49999999 77999999988888999999999999999999999998 9999999999999831
Q ss_pred --------------CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCC
Q 014245 232 --------------QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297 (428)
Q Consensus 232 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 297 (428)
+..++|+|||.|+..... ....+.|..|.|||++.+-.++..+||||+||||+|+.||..-
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 235899999999864332 2457899999999999999999999999999999999999999
Q ss_pred CCCCCchhhHHHHHhHhhhhhh----hhhhhhhcC-CcCC-------C----------------CccHHHHHHHHHHHHH
Q 014245 298 IDRNRPRSEQKLLQWVKPYLSD----AKQFRQIVD-PRLE-------G----------------KYSLRLVSKLSHVANL 349 (428)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~l~-------~----------------~~~~~~~~~l~~li~~ 349 (428)
|......+...+.+.+..-+.. .....+.+. .++. + ........+|.+|+.+
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 9877755544333322110000 000000000 0000 0 0112345679999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 014245 350 CLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 350 cl~~dp~~RPs~~ell~~ 367 (428)
||..||.+|+|+.|++.+
T Consensus 389 mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSH 406 (415)
T ss_pred HHccCccccccHHHHhcC
Confidence 999999999999999886
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=274.31 Aligned_cols=269 Identities=25% Similarity=0.370 Sum_probs=204.1
Q ss_pred CHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEee
Q 014245 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVG 154 (428)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 154 (428)
.+.++...|. ++||+|+|+.|--++...+ ++.+|||++.+.......+..+|++++.+. .|+||+.+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t-----~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLie 143 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQT-----GKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIE 143 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeecc-----chhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHH
Confidence 3555555554 4799999999998875544 348999999988666778899999999998 7999999999
Q ss_pred EEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 155 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
+|.++.. .|||||-|.||.|-..|.++ +.|++.++.++.++|+.||.|||.+ ||.||||||+|||-.....
T Consensus 144 fFEdd~~----FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~ 214 (463)
T KOG0607|consen 144 FFEDDTR----FYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNK 214 (463)
T ss_pred Hhcccce----EEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCC
Confidence 9998875 49999999999999999754 4599999999999999999999998 9999999999999965543
Q ss_pred ---eEEeeecccccCCCCC-----ceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCC
Q 014245 235 ---AKLSDFGLARLGPSEG-----FTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRN 301 (428)
Q Consensus 235 ---~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~ 301 (428)
+|||||.|..-..... ......+.+|+..|||||+.. ...|+.+.|.||||+|||-||+|.+||.+.
T Consensus 215 vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 215 VSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 8999998875322111 111123568999999999764 235899999999999999999999999654
Q ss_pred CchhhHHHHHhHh---hhhhhhhhhhhhcCCcCC--CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 302 RPRSEQKLLQWVK---PYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 302 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
=..+-- |-+ ........+..+.+.... ..-...++.+..+++...|..++.+|.++.+++++
T Consensus 295 Cg~dCG----WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 295 CGADCG----WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cCCcCC----ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 221000 000 000011223333333222 22344678899999999999999999999888774
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=278.23 Aligned_cols=275 Identities=23% Similarity=0.359 Sum_probs=225.8
Q ss_pred HHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeE
Q 014245 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGY 155 (428)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~ 155 (428)
..++.....++....++-+|.||.||.|.++...+......|.+|.++....+ +...+..|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555556678888899999999999999887666666667888887665443 34567899999999999999999999
Q ss_pred EecCCCCCceEEEEEeecCCCCcccccCC------CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE
Q 014245 156 CADDDERGIQRLLVYEYMPNGSVDQYLSP------KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229 (428)
Q Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl 229 (428)
+.+.... .+.++.++.-|+|..|+.. +....++-.+...++.|++.|++|||.. +|||.||...|.+|
T Consensus 356 ~ie~~~~---P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 356 SIEDYAT---PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI 429 (563)
T ss_pred EeeccCc---ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence 9876543 4788999999999999972 2234577778889999999999999998 99999999999999
Q ss_pred CCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014245 230 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQK 308 (428)
Q Consensus 230 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 308 (428)
|+..++||+|=.+++..-..++............||+||.+.+..|+.++||||||++||||+| |+.||...++.+...
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 9999999999999997766666665555666788999999999999999999999999999999 999998776654433
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
. +.++..+. .+.+++++|..++..||+..|++||+++++...|.++-.+
T Consensus 510 y-------lkdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 510 Y-------LKDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred H-------Hhccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 2 22332222 2345788999999999999999999999999999876543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=252.70 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=199.7
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+|...++||+|.||+||+|....+.+ .||+|...-... .......+|+.+|+.|+|.|||+++++...+..
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~e-----ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk-- 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-- 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccc-----eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce--
Confidence 56667789999999999998766544 899999865432 223567899999999999999999999877664
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
+-+|+|||+ .+|..+...-. +.++...+..++.|++.||.|+|++ ++.||||||.|+||+.+|.+||+|||++
T Consensus 76 --ltlvfe~cd-qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 76 --LTLVFEFCD-QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred --eEEeHHHhh-HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 589999994 48888876543 4588999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh--h
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS--D 319 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~--~ 319 (428)
+.++... ......+.|..|.+|.++.+.. |+...|+||-|||+.|+.. |++-|.+.+-.+....+-+...... .
T Consensus 149 rafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred hhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 9765432 2234567899999999998765 8999999999999999998 6666766654443333333211111 0
Q ss_pred hhhhhhhcCCcCCCCcc---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYS---------LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..+.+.-|-..-+.++ +.+...=++++.+.|.-+|..|.++++.+++
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111111111111111 1233445788999999999999999988875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=296.95 Aligned_cols=242 Identities=25% Similarity=0.334 Sum_probs=195.1
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
.++.|.....+|.|+|+.|-.+....+. ...++|++.+... +..+|+.++... +||||+++.+.+.+...
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~-----~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTD-----QEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccc-----cchhheecccccc----ccccccchhhhhcCCCcceeecceecCCce
Confidence 3567888888999999999998866554 3789999977622 233566666555 89999999999988764
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE-CCCCCeEEeee
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL-DEQWNAKLSDF 240 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DF 240 (428)
.++|||++.|+-|.+.+..... +. ..+..|+.+|+.|+.|||++ |||||||||+|||+ +..++++|+||
T Consensus 391 ----~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 391 ----IYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred ----eeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence 4999999999988887764432 33 67778999999999999998 99999999999999 69999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|.++..... ....+-|..|.|||++....|++++|+||||++||+||+|+.||...... ..+
T Consensus 461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----------- 522 (612)
T KOG0603|consen 461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----------- 522 (612)
T ss_pred chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH-----------
Confidence 999876543 23346788999999999999999999999999999999999999765432 111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...-..+.+...++++.++|+..||+.||.+||++.++..+
T Consensus 523 ------~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 523 ------HTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------HHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11111223345678899999999999999999999999886
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=293.69 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=209.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..+++++..||-||||.|-++...... ..+|+|.+++... ...+.+..|-+||...+.|.||++|..|.++.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~-----~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQK-----ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccc-----hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 356777788999999999998876542 2588898887644 34456789999999999999999999998877
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.. ||+||-|-||.|...++.++ .|+...+..++..+++|++|||++ +||.|||||+|.|||.+|-+||.||
T Consensus 494 yv----YmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 494 YV----YMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred hh----hhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeeh
Confidence 44 99999999999999997654 499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|.|+...... .+-+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++.....++-.
T Consensus 565 GFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk-------- 633 (732)
T KOG0614|consen 565 GFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK-------- 633 (732)
T ss_pred hhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--------
Confidence 9999765543 34569999999999999999999999999999999999999999998877655443321
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
.+.. -.++..+.....+|+++....+|.+|.- +.+|-.|
T Consensus 634 -Gid~-------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 634 -GIDK-------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -hhhh-------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1111 1234456677889999999999999975 6666655
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=276.10 Aligned_cols=220 Identities=20% Similarity=0.202 Sum_probs=174.2
Q ss_pred cCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEeecCC
Q 014245 96 GGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN 175 (428)
Q Consensus 96 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~ 175 (428)
|.||.||++....++ ..+|+|.+.... .+..|...+....||||+++++++.+.. ..++||||+++
T Consensus 4 g~~~~v~~~~~~~~~-----~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTRTQ-----QTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED----SVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEccCC-----cEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC----eEEEEEecCCC
Confidence 899999999876554 379999986542 2334555555667999999999988765 35999999999
Q ss_pred CCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeee
Q 014245 176 GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255 (428)
Q Consensus 176 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 255 (428)
|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+...... .
T Consensus 70 ~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~ 139 (237)
T cd05576 70 GKLWSHISKF--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----C 139 (237)
T ss_pred CCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----c
Confidence 9999988643 3489999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred eeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCc
Q 014245 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY 335 (428)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 335 (428)
....++..|+|||++.+..++.++||||||+++|||++|..|+...... ..... ....
T Consensus 140 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------------~~~~~----~~~~ 197 (237)
T cd05576 140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------------INTHT----TLNI 197 (237)
T ss_pred ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------------ccccc----ccCC
Confidence 2345677899999998888999999999999999999999887532110 00000 0012
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCH
Q 014245 336 SLRLVSKLSHVANLCLVKNARTRPKM 361 (428)
Q Consensus 336 ~~~~~~~l~~li~~cl~~dp~~RPs~ 361 (428)
+..++..+.+++.+||+.||++||++
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCC
Confidence 22345688999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=299.87 Aligned_cols=272 Identities=21% Similarity=0.223 Sum_probs=172.2
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEec-C-C
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCAD-D-D 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~-~ 160 (428)
..++|.+.+.||+|+||.||+|.+..+.. ..+..||+|++..... .+.+..| .+....+.+++.++..+.. . .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 46789999999999999999999876521 2244799998764322 1112221 1222223333333222111 0 0
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCc------------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSE------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 222 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl 222 (428)
......+|||||+++++|.+++..... .......+..++.||+.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 122356999999999999988864321 0112334667999999999999998 9999999
Q ss_pred CCCceEECC-CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccC----------------------CCCCch
Q 014245 223 KSSNILLDE-QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG----------------------RLAARS 279 (428)
Q Consensus 223 kp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 279 (428)
||+|||++. ++.+||+|||+|+...... ........||+.|||||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 5799999999997543221 2223457899999999976432 234467
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCcc------HHHHHHHHHHHHHhccc
Q 014245 280 DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYS------LRLVSKLSHVANLCLVK 353 (428)
Q Consensus 280 DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------~~~~~~l~~li~~cl~~ 353 (428)
|||||||+||||+++..|++.. ...+...+...-.+...+.....+....... ........+|+.+||+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999999987765422 1111111110000011111111111100000 00123456899999999
Q ss_pred CCCCCCCHHHHHHH
Q 014245 354 NARTRPKMSEVLEM 367 (428)
Q Consensus 354 dp~~RPs~~ell~~ 367 (428)
||++|||+.++++|
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=266.22 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=194.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
.++|..+++||+|+|++|.++.++.+.. .+|+|++++.-. +...-...|-.+..+- +||.+|-+...|+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~q-----iyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQ-----IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccce-----eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 4689999999999999999998876643 899999876532 2223345666666555 899999999999887
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.. +++|.||.+||+|--++++. ..++++.+..+...|+.||.|||++ |||.||||.+|||||..|.+||+|
T Consensus 324 sr----lffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 324 SR----LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred ce----EEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence 74 59999999999998777643 3499999999999999999999999 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh-hHHHHHhHhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS-EQKLLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~ 318 (428)
+|+++.....+ ..+..++|||.|+|||++.+..|+..+|.|+||++++||+.|+.||+--.... ++....+
T Consensus 395 ygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy------ 466 (593)
T KOG0695|consen 395 YGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY------ 466 (593)
T ss_pred cchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH------
Confidence 99998654333 34567999999999999999999999999999999999999999997432111 1111111
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 359 (428)
.++-++...++ .+...+-....+++.-|++||.+|.
T Consensus 467 ---lfqvilekqir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 467 ---LFQVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---HHHHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 11122222221 2233444566788889999999995
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=288.76 Aligned_cols=275 Identities=19% Similarity=0.254 Sum_probs=185.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCC-----------CCCcceEEEEEEccCCCcccHHH--------------HHHHH
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSE-----------DPSQKVEVAVKQLGRRGVQGHKE--------------WMTEV 138 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~--------------~~~E~ 138 (428)
.++|.+.++||+|+||.||+|...... ....++.||||++........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999753322 11234579999986543222222 34577
Q ss_pred HHHhcCCCCCc-----ccEeeEEecCCC----CCceEEEEEeecCCCCcccccCCCC----------------------c
Q 014245 139 NFLGIVEHQNL-----VKLVGYCADDDE----RGIQRLLVYEYMPNGSVDQYLSPKS----------------------E 187 (428)
Q Consensus 139 ~~l~~l~h~nI-----v~~~~~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~ 187 (428)
.++.+++|.++ ++++++|..... .....+|||||+++++|.+++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766654 677888754211 1124599999999999998885321 1
Q ss_pred ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCc
Q 014245 188 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267 (428)
Q Consensus 188 ~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 267 (428)
..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ........+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence 1246778889999999999999998 99999999999999999999999999997543221 1111123458899999
Q ss_pred chhccCC--------------------CC--CchhhhhHHHHHHHHHhCCC-CCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 268 EYVQTGR--------------------LA--ARSDVWSYGVFLYELITGRR-PIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 268 E~~~~~~--------------------~~--~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
|.+.... |+ .+.||||+||++++|++|.. ||......... + ...-.+...++
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~----~~~~~~~~~~r 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-L----RQYDNDLNRWR 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-H----hhccchHHHHH
Confidence 9875432 11 24799999999999999875 76532211110 0 00000011111
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNA---RTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~ell~~ 367 (428)
........-......++...+++.++|..+| .+|+|++|+++|
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1111111111223456788999999999766 689999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=262.31 Aligned_cols=238 Identities=32% Similarity=0.476 Sum_probs=190.7
Q ss_pred CceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-HHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEeecCC
Q 014245 97 GFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN 175 (428)
Q Consensus 97 ~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~ 175 (428)
+||.||+|....++ ..+++|.+....... .+.+.+|+..+++++|+||+++++++.... ..++++||+++
T Consensus 1 ~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTG-----KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED----KLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC----EEEEEEeCCCC
Confidence 68999999987533 379999987665444 678999999999999999999999998764 35999999999
Q ss_pred CCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeee
Q 014245 176 GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255 (428)
Q Consensus 176 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 255 (428)
++|.+++..... +++..++.++.+++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 72 ~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~ 143 (244)
T smart00220 72 GDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL 143 (244)
T ss_pred CCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence 999999865433 88899999999999999999998 99999999999999999999999999998654332 23
Q ss_pred eeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCc
Q 014245 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY 335 (428)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 335 (428)
....++..|++||.+.+..++.++|||+||+++++|++|..||...... ........ ........
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~-------------~~~~~~~~ 208 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG-------------KPKPPFPP 208 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh-------------ccCCCCcc
Confidence 3466889999999998888999999999999999999999999763211 11111110 01110000
Q ss_pred cH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014245 336 SL-RLVSKLSHVANLCLVKNARTRPKMSEVLE 366 (428)
Q Consensus 336 ~~-~~~~~l~~li~~cl~~dp~~RPs~~ell~ 366 (428)
.. .++.++.+++.+||..+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00 14568999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=282.04 Aligned_cols=207 Identities=29% Similarity=0.401 Sum_probs=173.0
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccH---HHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH---KEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
|..++.||-|+||+|.++...++ ...+|+|.+.+.+.-.. .....|-.||..-+.+-||++|-.|.+.+.
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT-----~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn-- 703 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDT-----RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN-- 703 (1034)
T ss_pred eEEEeeecccccceeEEEeecch-----hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc--
Confidence 56678899999999999986554 34899999987655332 345688999999999999999999998875
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
+|+||||++||++-.+|.+. +.|.+..++.++.++.+|+++.|.. |+|||||||+|||||.+|.+||+||||+
T Consensus 704 --LYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 704 --LYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred --eEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccc
Confidence 49999999999999988654 4699999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCC--------CCce--------------------------------eeeeeeecCcccCCcchhccCCCCCchhhhh
Q 014245 244 RLGPS--------EGFT--------------------------------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWS 283 (428)
Q Consensus 244 ~~~~~--------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 283 (428)
.-+.- .+.. ...-..+||+.|+|||++....|+..+|.||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 53210 0000 0012458999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhhH
Q 014245 284 YGVFLYELITGRRPIDRNRPRSEQ 307 (428)
Q Consensus 284 lG~il~elltg~~p~~~~~~~~~~ 307 (428)
.|||||||+.|+.||-...+...+
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcce
Confidence 999999999999999877665544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=247.74 Aligned_cols=198 Identities=26% Similarity=0.366 Sum_probs=161.0
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC-CcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCceE
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~~~ 166 (428)
.+..||+|++|.|-+-++..++ ...|+|.+... +.+..++...|+++..+. .+|.+|.+||...++...
T Consensus 50 ~i~elGrGayG~vekmrh~~sg-----~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv---- 120 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSG-----TIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV---- 120 (282)
T ss_pred hhhhhcCCccchhhheeeccCC-----eEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE----
Confidence 3446999999998887766543 48999999765 334567788999887665 899999999988776654
Q ss_pred EEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 167 LLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
++.||.| ..+|+.|..+ .....+++...-+|+..|+.||.|||++ ..+||||+||+||||+.+|++||||||++.
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 8999999 5588877643 2345689999999999999999999997 689999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhcc----CCCCCchhhhhHHHHHHHHHhCCCCCCCC
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRPIDRN 301 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~ 301 (428)
...+.. ..+...|...|||||.+.. ..|+.++||||||++++||.+++.||+..
T Consensus 198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 543221 1122568889999998864 36899999999999999999999999754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=257.69 Aligned_cols=137 Identities=22% Similarity=0.295 Sum_probs=118.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-----C---CCcccEeeEE
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-----H---QNLVKLVGYC 156 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~~~~~~ 156 (428)
++|.+.++||.|.|++||++..... .+.||+|+.+... ...+..+.|+++|++++ | .+||+++++|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~-----~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQN-----KRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccC-----CeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 6899999999999999999985544 4589999975432 33456789999999882 3 3699999999
Q ss_pred ecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC
Q 014245 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~ 230 (428)
......+.++|||+|++ |.+|-.+|.....+.++...+.+|+.||+.||.|||.+ .+|||-||||+|||+.
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 99998899999999999 77998898877667799999999999999999999987 4999999999999983
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=254.26 Aligned_cols=271 Identities=22% Similarity=0.291 Sum_probs=201.7
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC--CcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC-C
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER-G 163 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~-~ 163 (428)
.+-.+.||-|+||.||.+. ++.+++.||+|++..- .....+.+.+|+++|..++|.|++..+++....... .
T Consensus 55 i~PDRPIGYGAFGVVWsVT-----DPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVT-----DPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCCcccccceeEEEecc-----CCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 4456789999999999886 5556678999988643 223457889999999999999999998877654311 1
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++|.|+|.| ..+|...|-. ...++...+.-++.||+.||.|||+. +|.||||||.|+|++.+..+||||||++
T Consensus 130 qEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 130 QELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence 2347889999 4588888853 35588899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh--h---
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY--L--- 317 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~--- 317 (428)
+....+...+ .+..+.|-.|.|||++++. .|+.+.||||.|||+.||+..+.-|....+....+++...... +
T Consensus 204 Rvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 204 RTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred cccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 9765544333 3345678899999999875 4899999999999999999999999877776655554322100 0
Q ss_pred -hhhh-hhhhhcCCcCCCCc---------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 318 -SDAK-QFRQIVDPRLEGKY---------SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 318 -~~~~-~~~~~~~~~l~~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
...+ ....++.......- ......+...++..++..||++|.+..+.+.++.
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0001 11122222221110 0122345667888899999999999999888753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=240.24 Aligned_cols=263 Identities=20% Similarity=0.325 Sum_probs=197.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+++|+|-|++||.|....+++ .++||.+++- ..+.+.+|+.||..|. ||||++++++..+....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~e-----K~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNE-----KCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCc-----eEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 4679999999999999999998665544 7899998753 3467889999999995 99999999999887654
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-CeEEeeec
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFG 241 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG 241 (428)
...||+||+++.+...+.. .++...+..++.+++.||.|+|+. ||+|||+||.|++||... .++|+|+|
T Consensus 109 --tpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 109 --TPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred --CchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence 3489999998877766553 377778889999999999999998 999999999999998654 59999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH-----------H
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-----------L 309 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-----------~ 309 (428)
+|.+...... -.-.+.+..|-.||.+.. ..|+.+-|+|||||+|..|+..+.||.......++- +
T Consensus 179 LAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 179 LAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred hHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 9987644321 123456778899998865 458999999999999999999999997665544331 1
Q ss_pred HHhHhhh-hhhhhhhhhhcCCcCCCCc-------cH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 310 LQWVKPY-LSDAKQFRQIVDPRLEGKY-------SL-RLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 310 ~~~~~~~-~~~~~~~~~~~~~~l~~~~-------~~-~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..++..+ +.-...+..++....+... .. -..++..+++.+.|..|.++|+|++|.+.+
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111111 1111122222211111111 01 124788999999999999999999999886
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=282.35 Aligned_cols=245 Identities=26% Similarity=0.374 Sum_probs=182.3
Q ss_pred CCCceeecccCceE-EEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCc
Q 014245 87 FSRSVVIGEGGFGC-VYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 87 ~~~~~~lG~G~~g~-Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~ 164 (428)
|...+++|.|..|+ ||+|.+.+. .||||.+-... .....+|+..|+.- +|||||++|+.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R-------~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q---- 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGR-------EVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ---- 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCc-------eehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc----
Confidence 44556789999986 799998754 79999986432 23556999999888 7999999987666555
Q ss_pred eEEEEEeecCCCCcccccCCCCc--ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC---C--CCeEE
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSE--TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---Q--WNAKL 237 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~--~~~kl 237 (428)
..||..|.| ..+|.+++..... ........+.++.|++.||++||+. +||||||||.||||+. + ..++|
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEe
Confidence 359999999 5599999976311 1111133467899999999999997 9999999999999965 3 46899
Q ss_pred eeecccccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhh
Q 014245 238 SDFGLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 238 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 315 (428)
+|||+++........ .......||-+|+|||++....-+.++|||||||++|+.++ |..||+.....+...
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI------- 725 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI------- 725 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-------
Confidence 999999876543221 12446789999999999999888889999999999999999 599998653221110
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 366 (428)
+.....+.. +.. ..+. +..+||.+|++.+|..||++.+|+.
T Consensus 726 -l~~~~~L~~-----L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 726 -LTGNYTLVH-----LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -hcCccceee-----ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 011111100 000 0111 7889999999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-33 Score=265.90 Aligned_cols=197 Identities=26% Similarity=0.434 Sum_probs=169.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--------cHHHHHHHHHHHhcCC---CCCcccEe
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--------GHKEWMTEVNFLGIVE---HQNLVKLV 153 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~nIv~~~ 153 (428)
..|..++.+|+|+||.|++|.++... ..|+||.+.+...- ..-.+-.|+.||..|+ |+||++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~-----~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENN-----YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred ccceeeeeccccccceEEEeeecccc-----eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 45889999999999999999987654 38999999765321 1112457999999997 99999999
Q ss_pred eEEecCCCCCceEEEEEeec-CCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC
Q 014245 154 GYCADDDERGIQRLLVYEYM-PNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 232 (428)
Q Consensus 154 ~~~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~ 232 (428)
++|.+++. +||+||-. +|-+|.++|..+.+ +++.++..|++||+.|+++||++ +|||||||-+||.++.+
T Consensus 636 dfFEddd~----yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 636 DFFEDDDY----YYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSN 706 (772)
T ss_pred heeecCCe----eEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecC
Confidence 99998874 49999986 67899999986654 89999999999999999999998 99999999999999999
Q ss_pred CCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCC
Q 014245 233 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPID 299 (428)
Q Consensus 233 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~ 299 (428)
|-+||+|||.|....... ...++||..|.|||++.+..| +..-|||+||++||.++....||.
T Consensus 707 g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999987654332 345899999999999999888 567899999999999999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-33 Score=248.44 Aligned_cols=266 Identities=25% Similarity=0.304 Sum_probs=194.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC--CcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.+|..+..+|.|.- .|..+. +......||+|++... .....++..+|+.++..++|+||++++.+|......
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~-----D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAF-----DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeecccCCCCc-eEEecc-----hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 46777778899888 555554 3334458999988654 223346778999999999999999999998654321
Q ss_pred --CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 163 --GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 163 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
....|+||||| .++|...+. -.++...+..|+.|++.|+.|||+. +|+||||||+||++..++.+||.||
T Consensus 91 ~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 91 EEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred HHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence 12358999999 558988876 2378889999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH-----------
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL----------- 309 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~----------- 309 (428)
|+|+..... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|..-|.+....+....
T Consensus 163 g~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 163 GLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred hhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 999854332 345667899999999999988899999999999999999999999875432221100
Q ss_pred -----HHhHhhhhhhhh-----hhhhhc-CCcCCC--CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 310 -----LQWVKPYLSDAK-----QFRQIV-DPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 310 -----~~~~~~~~~~~~-----~~~~~~-~~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..-+..+..... .+.+.+ |..... ..+..-...+++++.+||..||++|.+++++|+|
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000011100000 000110 000000 0011223567899999999999999999999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=268.51 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=203.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
..+|.....+|+|+||.||+++...+.+ ..|+|+++........-+.+|+-+++..+|||||.++|.+...+..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~e-----laavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl- 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGE-----LAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL- 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCc-----hhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCc-
Confidence 3578888999999999999998665543 7888888776666667778999999999999999999999887755
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
+++||||.||+|.+... ..+++++.++....+..++||+|||+. +-+|||||-.|||+++.|.+|++|||.+
T Consensus 88 ---wicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 88 ---WICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred ---EEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence 89999999999999774 346799999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
-..... ......+.||+.|||||+.. .+.|...+|||++|++..|+---++|.....+.....+.. +.
T Consensus 160 aqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--kS----- 230 (829)
T KOG0576|consen 160 AQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--KS----- 230 (829)
T ss_pred hhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--cc-----
Confidence 655432 22345689999999999763 5779999999999999999998888865443332222111 10
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 366 (428)
.+ ..+.+. -.....+.+.++++.||-.+|.+||++..+++
T Consensus 231 -~~---qpp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 -GF---QPPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -CC---CCCccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 00 011111 12235567889999999999999999998876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=232.88 Aligned_cols=211 Identities=38% Similarity=0.593 Sum_probs=179.5
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEe
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYE 171 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e 171 (428)
||+|++|.||++....++ ..+++|.+...... ....+.+|+.+++.+.|++|+++++++.... ..+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG-----KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN----HLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCC-----cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----eEEEEEe
Confidence 689999999999876532 37999998765432 3467889999999999999999999998764 4599999
Q ss_pred ecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-CCCeEEeeecccccCCCCC
Q 014245 172 YMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLARLGPSEG 250 (428)
Q Consensus 172 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 250 (428)
|+++++|.+++.... ..+++..++.++.+++.+|.+||+. +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 999999999987542 3488999999999999999999998 9999999999999999 8999999999997654332
Q ss_pred ceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014245 251 FTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329 (428)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (428)
. ......+...|++||.+... .++.++|+|+||+++++|
T Consensus 148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------- 187 (215)
T cd00180 148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187 (215)
T ss_pred c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence 1 12335678899999998877 788999999999999999
Q ss_pred cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 330 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+.+++..|+..+|++||++.+++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257889999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=253.95 Aligned_cols=267 Identities=22% Similarity=0.269 Sum_probs=201.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC------CCcccEeeEE
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH------QNLVKLVGYC 156 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~~~~~~ 156 (428)
...+|.+....|+|-|++|..|.....+ ..||||+|..... ..+.=..|++||++|+. -|+++++..|
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~-----~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARG-----QEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCC-----CeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 3467888889999999999999855433 3899999975433 34555789999999952 4788888877
Q ss_pred ecCCCCCceEEEEEeecCCCCcccccCCCCc-ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-C
Q 014245 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-N 234 (428)
Q Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~ 234 (428)
...+ ++|||+|-+ ..+|.+.|.+.+. ..|....+..++.|+.-||..|-.. +|+|.||||+|||+++.- .
T Consensus 504 ~hkn----HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 504 KHKN----HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred hhcc----eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 7665 469999988 6689998876443 4577888999999999999999987 999999999999998765 4
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+||||||.|........ +.+..+..|.|||++.|-+|+...|+||.||+||||.||+..|.+........+..-++
T Consensus 576 LKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 79999999976544321 22445667999999999999999999999999999999999999887776655543322
Q ss_pred hhhhh-----hhhhhhhcCCcCC-------------------------------------CCccHHHHHHHHHHHHHhcc
Q 014245 315 PYLSD-----AKQFRQIVDPRLE-------------------------------------GKYSLRLVSKLSHVANLCLV 352 (428)
Q Consensus 315 ~~~~~-----~~~~~~~~~~~l~-------------------------------------~~~~~~~~~~l~~li~~cl~ 352 (428)
--+.+ ..-..+.+|..+. ..-.......|.+|+..||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 11111 0000111111110 01112455689999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 014245 353 KNARTRPKMSEVLEM 367 (428)
Q Consensus 353 ~dp~~RPs~~ell~~ 367 (428)
+||++|.+..+.|+|
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999999876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=231.91 Aligned_cols=254 Identities=20% Similarity=0.395 Sum_probs=187.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 163 (428)
+.|.+.+.||+|.||.+-++.++.++. .+++|-+.+.. ...++|.+|...--.| .|.||+..|++......
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t-----~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d-- 95 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKT-----RIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD-- 95 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCce-----EEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc--
Confidence 468889999999999999999887754 89999887553 3567899998765555 68999999875443332
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE-C-CCCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL-D-EQWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl-~-~~~~~kl~DFG 241 (428)
.+++++||++.|+|..-+...+ +.+.....++.|++.||.|+|++ ++||||||.+|||| + +.-++||||||
T Consensus 96 -~YvF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 96 -AYVFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred -eEEEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence 3589999999999999887543 78888899999999999999998 99999999999999 2 33479999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc---CC--CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
+.+..+.. .....-+..|.+||.... +. .++.+|||.||+++|.++||..||.... ..+.....|.+
T Consensus 169 ~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~-- 240 (378)
T KOG1345|consen 169 LTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQ-- 240 (378)
T ss_pred cccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHH--
Confidence 98754322 112334667999997653 22 4678999999999999999999997432 22222222221
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
+.+-..++++.. ...+++.+.++.++-|..++++|=.+.++.+..
T Consensus 241 ------w~~rk~~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 241 ------WLKRKNPALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ------HhcccCccCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 112222233222 234567888899999999999995555544433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=230.74 Aligned_cols=200 Identities=35% Similarity=0.489 Sum_probs=169.6
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
|.+.+.||+|++|.||+|....++ ..+++|.+...... ..+.+.+|+..+..++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTG-----ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP---- 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCC-----cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc----
Confidence 567789999999999999976533 37999999876554 56788899999999999999999999877653
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.++++||+++++|.+++..... .+++..+..++.+++.+|.+||.. +++|+||+|.||+++.++.++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 4899999999999999865332 178899999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCcchh-ccCCCCCchhhhhHHHHHHHHHhCCCCCCC
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYV-QTGRLAARSDVWSYGVFLYELITGRRPIDR 300 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~~ 300 (428)
...... .......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 148 ~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 543320 122345788899999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=237.77 Aligned_cols=270 Identities=24% Similarity=0.366 Sum_probs=195.5
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
...+.|..+++||+|.|++||++..... ......||+|.+..... ..++.+|+++|..+ .+.||+++.+.+..++
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3456789999999999999999987652 23455899999876543 35788999999998 7999999999998877
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-CCCeEEee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSD 239 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~D 239 (428)
. .++||||+++..-.+++.. ++...+..+++.++.||.++|.+ |||||||||.|+|.+. .+.-.|.|
T Consensus 109 ~----v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 109 Q----VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred e----eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 4 4999999999888887753 66788899999999999999998 9999999999999974 45679999
Q ss_pred ecccccCC-----------------C-----------------CCce--------eeeeeeecCcccCCcchhcc-CCCC
Q 014245 240 FGLARLGP-----------------S-----------------EGFT--------HVSTAVVGTMGYAAPEYVQT-GRLA 276 (428)
Q Consensus 240 FGla~~~~-----------------~-----------------~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~ 276 (428)
||+|.... . .++. .......||++|.|||++.. ..-+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99996110 0 0000 01124579999999999875 4568
Q ss_pred CchhhhhHHHHHHHHHhCCCCCCCCCchhhH--HHHH---------hH---hh--hhh--h----h---hhhhhh----c
Q 014245 277 ARSDVWSYGVFLYELITGRRPIDRNRPRSEQ--KLLQ---------WV---KP--YLS--D----A---KQFRQI----V 327 (428)
Q Consensus 277 ~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~---------~~---~~--~~~--~----~---~~~~~~----~ 327 (428)
+++||||.|+|++.+++++.||.......+. ++.. .+ .. ++. + . ..+... .
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 8999999999999999999999655433111 0000 00 00 000 0 0 000010 0
Q ss_pred CC--c--CCCC-ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 328 DP--R--LEGK-YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 328 ~~--~--l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+ . .... .....+..+.+++.+|+..||.+|.++++.|++
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 0 0001 111233478899999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=272.68 Aligned_cols=200 Identities=18% Similarity=0.219 Sum_probs=139.4
Q ss_pred CCC-CCcccEeeEEecCC---CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 014245 144 VEH-QNLVKLVGYCADDD---ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 219 (428)
Q Consensus 144 l~h-~nIv~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 219 (428)
++| +||++++++|.... .....++++|||+ +++|.++|... ...+++..++.++.||+.||+|||++ +|+|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 456 68888888873221 1112347788988 66999999643 34599999999999999999999998 9999
Q ss_pred ccCCCCceEECCC-------------------CCeEEeeecccccCCCCCc--------------eeeeeeeecCcccCC
Q 014245 220 RDFKSSNILLDEQ-------------------WNAKLSDFGLARLGPSEGF--------------THVSTAVVGTMGYAA 266 (428)
Q Consensus 220 rDlkp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~a 266 (428)
|||||+||||+.. +.+||+|||+++....... .......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 4456666666643211000 000112468999999
Q ss_pred cchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHH
Q 014245 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHV 346 (428)
Q Consensus 267 PE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 346 (428)
||++.+..|+.++|||||||+||||++|..|+..... ...... .....+.. .........+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~---------~~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLR---------HRVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHH---------HhhcChhh-----hhcCHHHHHH
Confidence 9999999999999999999999999999888653211 000000 00111100 1112345688
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 014245 347 ANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 347 i~~cl~~dp~~RPs~~ell~~ 367 (428)
+.+||+.+|.+||++.+++++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 899999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=213.67 Aligned_cols=169 Identities=22% Similarity=0.252 Sum_probs=127.7
Q ss_pred CCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeee
Q 014245 176 GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255 (428)
Q Consensus 176 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 255 (428)
|+|.+++..+ ...+++..++.|+.||+.||.|||++ + ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence 6888888643 34599999999999999999999987 5 999999999999999 9998765432
Q ss_pred eeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCc
Q 014245 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY 335 (428)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 335 (428)
...||+.|||||++.+..++.++|||||||++|||++|..||........ .+....... .. ..+. ....
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~-------~~-~~~~-~~~~ 131 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGM-------PA-DDPR-DRSN 131 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHh-------cc-CCcc-cccc
Confidence 12689999999999999999999999999999999999999965432111 111110000 00 0000 0011
Q ss_pred cHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 336 SLRLVS--KLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 336 ~~~~~~--~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
...... .+.+++.+||..+|.+||++.++++++.....
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 223333 69999999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=224.42 Aligned_cols=264 Identities=21% Similarity=0.252 Sum_probs=198.8
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC----CCcccEeeEEe-cCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH----QNLVKLVGYCA-DDD 160 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~~~~~~~-~~~ 160 (428)
+|.+.+.||+|+||.||+|...... ...+|+|............+..|..++..+.. +++..+++... ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 7999999999999999999865543 34688888765433333367788888888863 58888888874 333
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC-----CCe
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-----WNA 235 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~ 235 (428)
..|+||+.+ |.+|.++........|+..+++.|+.|++.+|.+||+. |++||||||+|+++... ..+
T Consensus 95 ----~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 ----FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred ----eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 239999988 88999988655556799999999999999999999998 99999999999999765 459
Q ss_pred EEeeecccc--cCCCCCce------eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH
Q 014245 236 KLSDFGLAR--LGPSEGFT------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307 (428)
Q Consensus 236 kl~DFGla~--~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~ 307 (428)
.|.|||+++ ........ .....+.||..|+++.++.+...+.+.|+||++.++.+++.|..||.........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999998 32211111 1123456999999999999999999999999999999999999999665432221
Q ss_pred -HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 308 -KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 308 -~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
.+..... ...... .....+..+.++...+-..+..++|....+...|.......
T Consensus 247 ~~~~~~~~---------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 SKFEKDPR---------KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHhh---------hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111000 000000 11223456777777777799999999999999988877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=210.58 Aligned_cols=263 Identities=16% Similarity=0.250 Sum_probs=206.1
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~~ 164 (428)
+|.++++||+|.||..+.|..--+++ .||||...... ...++..|.+..+.| ..++|..+|-|.......
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne-----~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N-- 99 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNE-----PVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN-- 99 (449)
T ss_pred cceeccccccCcceeeecccccccCc-----eEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchh--
Confidence 79999999999999999998665544 89999876553 235677888888887 678999988555544332
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-----CeEEee
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-----NAKLSD 239 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~D 239 (428)
.||||++ |.+|+|+..-.+ ..|+.+++..+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.|+|
T Consensus 100 --iLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 100 --ILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred --hhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence 7999999 899999987544 4599999999999999999999998 999999999999996443 489999
Q ss_pred ecccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 240 FGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 240 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
||+|+...+.... ....+..||.+||+-..+.+.+-+.+.|+-|||-++++.|-|..||.+........-
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k----- 247 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK----- 247 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH-----
Confidence 9999976544322 123467899999999999999999999999999999999999999987654322211
Q ss_pred hhhhhhhhhhhhcCCc---CCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 315 PYLSDAKQFRQIVDPR---LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~---l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
...+-+.+ ........++.++..-+...-..+-.+-|+.+-+...+..+++....
T Consensus 248 --------YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 248 --------YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred --------HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 11111111 11123345678888888888899999999999999988888876543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=220.64 Aligned_cols=177 Identities=19% Similarity=0.182 Sum_probs=131.4
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-----cccHHHHHHHHHHHhcCCCCCcccEeeEEe
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----VQGHKEWMTEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
..++|.+.+.||+|+||+||+|.+.... +..+|||++.... ......+.+|+++|+.++|+||+..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDP----GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCC----CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 4468999999999999999999876421 2257999865331 12345688999999999999998643221
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC-CCCceEECCCCCeE
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF-KSSNILLDEQWNAK 236 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~NILl~~~~~~k 236 (428)
. ..+|||||++|++|... ... . ...++.|++.||.|||++ +|+|||| ||+|||++.++.+|
T Consensus 91 --~----~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 91 --G----KDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred --C----CcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEE
Confidence 1 23999999999999632 111 1 146788999999999998 9999999 99999999999999
Q ss_pred EeeecccccCCCCCceee------eeeeecCcccCCcchhccCC------CCCchhhh
Q 014245 237 LSDFGLARLGPSEGFTHV------STAVVGTMGYAAPEYVQTGR------LAARSDVW 282 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 282 (428)
|+|||+|+.....+.... -....+++.|+|||++.... .+..+|-|
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999999986654321111 13567889999999887533 23346666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=199.59 Aligned_cols=267 Identities=19% Similarity=0.244 Sum_probs=204.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC-CCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH-QNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~ 162 (428)
.++|..+++||+|+||.+|.|......+ .||||...... ...++..|..+.+.|++ ..|..+..|..+....
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge-----~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGE-----EVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCc-----eEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 4689999999999999999999766544 89999875442 34577899999999965 5677777777665543
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC---CCeEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ---WNAKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~D 239 (428)
.||||.+ |.+|++++.-.. ..|+..+++-++-|++.-++|+|.+ +.|||||||+|+|..-+ ..+.|+|
T Consensus 87 ----vlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 87 ----VLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ----eeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 8999999 999999886433 4589999999999999999999998 99999999999998533 3589999
Q ss_pred ecccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 240 FGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 240 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
||+|+...+.... .......||..|.+--.+.+..-+.+.|+-|+|.+|+.+.-|..||.+......+.-.+.
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk-- 235 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK-- 235 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH--
Confidence 9999876432211 123467899999998888888888999999999999999999999988765433221111
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
+.+..-..........++.++.-.+..|-..--++-|+...+-+.+.-+.....
T Consensus 236 --------I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 236 --------ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred --------HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 111111111112233456788889999999999999999988887777665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-27 Score=240.29 Aligned_cols=259 Identities=21% Similarity=0.239 Sum_probs=189.5
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
....++|.|++|.|+.............+.+++| ...... .....+..|+.+-..+.|+|++..+..+.+....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~--- 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI--- 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc---
Confidence 4567899999998887765443332222233333 111111 1112366788888899999998888777665543
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.-+||||++ +|..++... ..+....+-.+++|++.|+.|||.. ||.|||||++|++++.+|.+||+|||.+..
T Consensus 397 -~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 397 -LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred -hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCccee
Confidence 345999999 999998654 3478888899999999999999998 999999999999999999999999999987
Q ss_pred CCCCCce--eeeeeeecCcccCCcchhccCCCCC-chhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 246 GPSEGFT--HVSTAVVGTMGYAAPEYVQTGRLAA-RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 246 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+.-.... ......+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||........+. .+ ....
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~------~~~~- 541 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT------NNYS- 541 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh------hccc-
Confidence 6443333 4556789999999999999999987 6999999999999999999997654332221 00 0000
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 366 (428)
.+.....-.......++...+.+|.++|+.||.+|.|+++|++
T Consensus 542 -~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 542 -DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000001111233456778899999999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=204.19 Aligned_cols=247 Identities=22% Similarity=0.409 Sum_probs=195.9
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
.+|.+...|+.|+|.+.++. +++|++..+... ...+|..|.-.|+.+.||||+.++|.|..... +.+
T Consensus 196 tkl~e~hsgelwrgrwqgnd-------ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn----lv~ 264 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGND-------IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN----LVI 264 (448)
T ss_pred hhhccCCCcccccccccCcc-------hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC----ceE
Confidence 35889999999999998763 667777654332 23578899999999999999999999988764 489
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCC
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 248 (428)
+..||+.|+|...+........+..++.+++.+++.|++|||+. ++-|.---|....+++|++.+.+|+ .+-+++
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kf--- 339 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKF--- 339 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-ccccee---
Confidence 99999999999999877777788899999999999999999986 3334556789999999999998875 111111
Q ss_pred CCceeeeeeeecCcccCCcchhccCCCC---CchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014245 249 EGFTHVSTAVVGTMGYAAPEYVQTGRLA---ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325 (428)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (428)
........-.|.||+||.++..+-+ .++|+|||++++|||.|...||....+.+- -.+
T Consensus 340 ---sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----------------gmk 400 (448)
T KOG0195|consen 340 ---SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----------------GMK 400 (448)
T ss_pred ---eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----------------hhh
Confidence 1112223446899999999876543 479999999999999999999987654321 123
Q ss_pred hcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 326 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
+.-+.++...++..+..+.+|+.-|+..||.+||.++.++-.|+++.
T Consensus 401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 33445666677778889999999999999999999999999998875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=203.85 Aligned_cols=260 Identities=32% Similarity=0.463 Sum_probs=195.3
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCC-CcccEeeEEecCCCC
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQ-NLVKLVGYCADDDER 162 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~ 162 (428)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++++.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~- 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS- 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE-
Confidence 667789999999999999866 36899998766443 356789999999999988 79999999955443
Q ss_pred CceEEEEEeecCCCCcccccCCCCc-ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-CeEEeee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDF 240 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DF 240 (428)
.+++++|+.+++|.+++..... ..+.......++.|++.++.|+|.. +++||||||+||+++..+ .++++||
T Consensus 73 ---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 73 ---LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred ---EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEecc
Confidence 4899999999999976654321 2588899999999999999999998 999999999999999998 6999999
Q ss_pred cccccCCCCCcee----eeeeeecCcccCCcchhcc---CCCCCchhhhhHHHHHHHHHhCCCCCCCCCch-hhHHHHHh
Q 014245 241 GLARLGPSEGFTH----VSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPR-SEQKLLQW 312 (428)
Q Consensus 241 Gla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~-~~~~~~~~ 312 (428)
|++.......... ......||..|++||.+.+ ..++...|+|++|++++++++|..||...... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9998554332221 2356789999999999987 57888999999999999999999997665431 01111111
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..... . .................+.+++..|+..+|..|.+..+....
T Consensus 227 ~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELPT---P---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcCC---c---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 110000 0 000000000002223578899999999999999999887765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=191.91 Aligned_cols=176 Identities=10% Similarity=0.090 Sum_probs=133.9
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHH---------HHHHHHHHhcCCCCCcccEe
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE---------WMTEVNFLGIVEHQNLVKLV 153 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~nIv~~~ 153 (428)
..++|...++||.|+||.||++... . ..+|+|.+.......... +.+|+..+.++.|++|..+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~-~------~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD-Y------GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC-C------CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 3578999999999999999996542 2 259999997654333222 57899999999999999999
Q ss_pred eEEecCCCC----CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE
Q 014245 154 GYCADDDER----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229 (428)
Q Consensus 154 ~~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl 229 (428)
+++...... ....+|||||++|.+|.++.. +++ ....+++.+|..||.. |++||||||+||++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 887654311 124589999999999988742 232 2456999999999998 99999999999999
Q ss_pred CCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh
Q 014245 230 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293 (428)
Q Consensus 230 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 293 (428)
+.+| ++|+|||........... ..++....|+.++|+|+||+++..+..
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9988 999999988654221100 113445567789999999999876643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=180.70 Aligned_cols=139 Identities=14% Similarity=0.070 Sum_probs=105.4
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--c-------H-----------------HHHHHHHHHHhc
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--G-------H-----------------KEWMTEVNFLGI 143 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~ 143 (428)
...||+|+||.||+|...+ +..||+|++...... . . .....|+.++..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~------g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05147 2 NGCISTGKEANVYHATTAN------GEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR 75 (190)
T ss_pred CCccccccceEEEEEECCC------CCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 3579999999999998652 338999998654211 0 0 112359999999
Q ss_pred CCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHh-hcCCCCCeeeccC
Q 014245 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL-HEGMDFQIIVRDF 222 (428)
Q Consensus 144 l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrDl 222 (428)
+.++++.....+.... . +|||||++|+++...+.. ...++...+..++.|++.+|.|| |+. +|+||||
T Consensus 76 l~~~~v~~p~~~~~~~--~----~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 76 LVTAGIPCPEPILLKS--H----VLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred HHHCCCCCCcEEEecC--C----EEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 9888875444332221 1 899999998877654322 23588899999999999999999 677 9999999
Q ss_pred CCCceEECCCCCeEEeeecccccC
Q 014245 223 KSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 223 kp~NILl~~~~~~kl~DFGla~~~ 246 (428)
||+|||++ ++.++|+|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=174.58 Aligned_cols=140 Identities=15% Similarity=0.072 Sum_probs=107.7
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--c------------------------HHHHHHHHHHHhc
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--G------------------------HKEWMTEVNFLGI 143 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~ 143 (428)
...||+|+||.||+|...+ +..||||.+...... . ...+..|...+.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~------g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05145 2 NGCISTGKEANVYHARTGD------GEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR 75 (190)
T ss_pred CceeecCCCcEEEEEEcCC------CCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4689999999999998652 338999998764211 0 1123578999999
Q ss_pred CCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccC
Q 014245 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDF 222 (428)
Q Consensus 144 l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDl 222 (428)
+.|++|.....+.... .+|||||++|+++...... ...++......++.|++.+|.+||+ . ||+||||
T Consensus 76 l~~~~i~~p~~~~~~~------~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDl 144 (190)
T cd05145 76 LYEAGVPVPEPILLKK------NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDL 144 (190)
T ss_pred HHhCCCCCceEEEecC------CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence 9999886554444332 1899999988765443211 2347788889999999999999998 7 9999999
Q ss_pred CCCceEECCCCCeEEeeecccccCC
Q 014245 223 KSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 223 kp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
||+|||++ ++.++|+|||++....
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999 7899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=175.45 Aligned_cols=140 Identities=17% Similarity=0.246 Sum_probs=108.0
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-----CCCCcccEeeEEecCCCC
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-----EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~~~~~ 162 (428)
....+||+|+||.||. +.... ..+||++........+.+.+|+.+++.+ +||||++++|++.++...
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~------~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDA------QRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred CCcceecCCCceEEEE--CCCCc------CeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 3456899999999995 33222 2368888765445567899999999999 679999999999887544
Q ss_pred CceEEEEEee--cCCCCcccccCCCCcccccHHHHHHHHHHHHHHH-HHhhcCCCCCeeeccCCCCceEECC----CCCe
Q 014245 163 GIQRLLVYEY--MPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL-AYLHEGMDFQIIVRDFKSSNILLDE----QWNA 235 (428)
Q Consensus 163 ~~~~~lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivHrDlkp~NILl~~----~~~~ 235 (428)
+..+.+|+|| +.+|+|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.+
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 4334588999 5579999999643 25555 35678888887 999998 9999999999999974 3479
Q ss_pred EEeeeccc
Q 014245 236 KLSDFGLA 243 (428)
Q Consensus 236 kl~DFGla 243 (428)
+|+||+.+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=170.95 Aligned_cols=187 Identities=18% Similarity=0.091 Sum_probs=136.2
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc----HHHHHHHHHHHhcCC-CCCcccEeeEEecCCCC
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG----HKEWMTEVNFLGIVE-HQNLVKLVGYCADDDER 162 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~ 162 (428)
.+...|++|+||+||.+.-. ...++.+.+.....-. ...+.+|+++|++|. |++|++++++. .
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~-------~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~- 72 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGG-------ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G- 72 (218)
T ss_pred ccceeecCCCcceEEEeecC-------CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C-
Confidence 35568999999999976532 2257766665443211 124779999999994 58899998861 1
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC-CCCceEECCCCCeEEeeec
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF-KSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFG 241 (428)
.+++|||+.|.+|.+.+.. ....++.|++.+|.++|++ ||+|||| ||+|||++.++.++|+|||
T Consensus 73 ---~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 73 ---RHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred ---EEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence 2899999999998654321 1135788999999999998 9999999 7999999999999999999
Q ss_pred ccccCCCCCce----e---e----eeeeecCcccCCcchhccC-CCC-CchhhhhHHHHHHHHHhCCCCCCCC
Q 014245 242 LARLGPSEGFT----H---V----STAVVGTMGYAAPEYVQTG-RLA-ARSDVWSYGVFLYELITGRRPIDRN 301 (428)
Q Consensus 242 la~~~~~~~~~----~---~----~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~elltg~~p~~~~ 301 (428)
++......... . . ..-...++.|++|+...-- ..+ ...+.++.|+-+|.++|+..|+...
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 99865433210 0 0 0012367888888854322 334 5678889999999999998887543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-23 Score=201.89 Aligned_cols=229 Identities=26% Similarity=0.347 Sum_probs=178.1
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc--HHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCCceEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
++|+|.||.|+++.-..+. ..+..+|+|++.+..... ......|..++..++ ||.+|++.-.++.+.. .++
T Consensus 1 vlg~g~~gkvfLvrk~~g~--da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k----l~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGA--DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK----LYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhccc--cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc----hhH
Confidence 4799999999987544332 344578888887653321 124456778888886 9999999877776664 489
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCC
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 248 (428)
+++|..||+|...+.... .+.+.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-.
T Consensus 75 ~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred hhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHh
Confidence 999999999988886543 477788888889999999999998 999999999999999999999999999986543
Q ss_pred CCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014245 249 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328 (428)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (428)
.. ..+||..|||||++. ....++|.||||++++||+||..||... . ...++.
T Consensus 150 ~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~----------------~~~Il~ 201 (612)
T KOG0603|consen 150 EK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----T----------------MKRILK 201 (612)
T ss_pred hh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----H----------------HHHHhh
Confidence 22 128999999999988 6678899999999999999999999751 1 111111
Q ss_pred CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH
Q 014245 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM 361 (428)
Q Consensus 329 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 361 (428)
.....+........+++..++..+|..|.-.
T Consensus 202 --~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 --AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1223455677788899999999999999644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=179.08 Aligned_cols=237 Identities=20% Similarity=0.278 Sum_probs=149.4
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCC----------CCcccE
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEH----------QNLVKL 152 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~nIv~~ 152 (428)
.+.....||.|+++.||.+.+..++ ..+|+|++..... ...+++.+|.-....+.+ -.++-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~-----~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETG-----EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCC-----ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 3456778999999999999976654 4899999854432 234566666655544322 122222
Q ss_pred eeEEecC---------C-CCCc---eEEEEEeecCCCCcccccCC-----CCcccccHHHHHHHHHHHHHHHHHhhcCCC
Q 014245 153 VGYCADD---------D-ERGI---QRLLVYEYMPNGSVDQYLSP-----KSETILTWAMRLKIAQDAARGLAYLHEGMD 214 (428)
Q Consensus 153 ~~~~~~~---------~-~~~~---~~~lv~e~~~~g~L~~~l~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 214 (428)
++..... . .... ..+++|+-+ .++|.+++.. .....+....++.+..|+++.+++||..
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-- 164 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-- 164 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc--
Confidence 2222211 0 0000 236788877 5688877531 1122345556677889999999999998
Q ss_pred CCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccC--------CCCCchhhhhHHH
Q 014245 215 FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--------RLAARSDVWSYGV 286 (428)
Q Consensus 215 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslG~ 286 (428)
|+||+||+|+|+|++.+|.++|+||+.....+. .. . ....+..|.+||..... .++.+.|.|+||+
T Consensus 165 -GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~-~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 165 -GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT---RY-R-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp -TEEEST-SGGGEEE-TTS-EEE--GGGEEETTE---EE-E-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred -ceEecccceeeEEEcCCCCEEEcChHHHeecCc---ee-e-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999999988764332 11 1 13456789999976542 4788999999999
Q ss_pred HHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCC
Q 014245 287 FLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 358 (428)
Q Consensus 287 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 358 (428)
++|.|++|..||+...+..... . .-..+. +.++.+..||..+|+.||++|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~------------~---------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPE------------W---------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSG------------G---------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCcccccc------------c---------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999998654321110 0 112233 688899999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=207.52 Aligned_cols=247 Identities=19% Similarity=0.229 Sum_probs=175.6
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHH---HHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHK---EWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~---~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
+|...+.||++.|=+|.+|+++.+ .|+||++-+.... ... +-+.|++ ...++|||.+++..+......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG-------~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG-------LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc-------eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH
Confidence 677788999999999999987655 5889998766532 233 3344555 555699999998766554443
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
. |||=+|..+ +|.|.+..++ .+...+..-|+.|++.||..+|.. ||+|||||.+||||+.=.=+.|+||.
T Consensus 96 A----ylvRqyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 96 A----YLVRQYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred H----HHHHHHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence 3 788888844 9999997654 366777788999999999999998 99999999999999988889999998
Q ss_pred ccccCC--CC---CceeeeeeeecCcccCCcchhccC----------C-CCCchhhhhHHHHHHHHHh-CCCCCCCCCch
Q 014245 242 LARLGP--SE---GFTHVSTAVVGTMGYAAPEYVQTG----------R-LAARSDVWSYGVFLYELIT-GRRPIDRNRPR 304 (428)
Q Consensus 242 la~~~~--~~---~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ellt-g~~p~~~~~~~ 304 (428)
.-+... .+ ++.....+...-..|+|||.+... . .+++-||||+||++.||++ |++||...
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--- 242 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--- 242 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---
Confidence 765322 11 111111222233479999987542 1 5678999999999999999 88888632
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..+-.. .....+.+-+.++ ...++.++..|++.||++|.++++.++.
T Consensus 243 ---QL~aYr~~----~~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 243 ---QLLAYRSG----NADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ---HHHhHhcc----CccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11111110 0111111111111 1268899999999999999999999875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=203.12 Aligned_cols=250 Identities=18% Similarity=0.192 Sum_probs=176.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC---CCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~ 160 (428)
...|.+.+.||+|+||+||+|...+ ++.||+|+-.+...- +|.-=.+++.+|+ -+-|.++...+...+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~------~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN------GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC------CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 3567888899999999999998665 348999997765432 1222223333443 234555544444444
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC-------CCC
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-------EQW 233 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-------~~~ 233 (428)
.. +||+||.+.|+|-+++. ..+.++|..+..+..|++..++.||.. +|||+||||+|.||. +.-
T Consensus 768 ~S----~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 768 AS----VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred cc----eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence 43 89999999999999997 456799999999999999999999998 999999999999993 233
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (428)
.++|+|||.+..+..-.........++|-.+-.+|+..|..++..+|.|.|+.+++-||.|+..-.
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-------------- 904 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-------------- 904 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh--------------
Confidence 489999999975543222344567889999999999999999999999999999999999874310
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.+. -...++..+......+.. -+++..+|+.|-..=|...+|...|+..+..
T Consensus 905 ----~~g--~~~~~~~~~~Ry~~~~~W---~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 905 ----KNG--SSWMVKTNFPRYWKRDMW---NKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred ----cCC--cceeccccchhhhhHHHH---HHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 000 000111111111112222 3445556665555558888888888877654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=188.92 Aligned_cols=217 Identities=27% Similarity=0.468 Sum_probs=160.8
Q ss_pred HhcCCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCe-ee
Q 014245 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQI-IV 219 (428)
Q Consensus 141 l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH 219 (428)
|+.+.|.|+.+++|.+.+... .+.|.+||..|+|.|.+... ...+++.....++++|+.||+|||.. .| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~----~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPE----MIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCc----eEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence 467899999999999998853 48999999999999999753 34589999999999999999999986 44 99
Q ss_pred ccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCC-------CCCchhhhhHHHHHHHHH
Q 014245 220 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-------LAARSDVWSYGVFLYELI 292 (428)
Q Consensus 220 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~ell 292 (428)
+.++..|.++|....+||+|||+.................-...|.|||.+.+.. .+.++||||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999999987653211011111122345799999987642 356799999999999999
Q ss_pred hCCCCCCCCCchhh-HHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 293 TGRRPIDRNRPRSE-QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 293 tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
+...||........ .+++..++. .....+.+.+.... ...+++..++..||..+|.+||+++++-..++.+
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred hccCccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99999986433322 223332221 01111122221111 3445799999999999999999999998877765
Q ss_pred hh
Q 014245 372 VD 373 (428)
Q Consensus 372 ~~ 373 (428)
..
T Consensus 225 ~~ 226 (484)
T KOG1023|consen 225 NK 226 (484)
T ss_pred cc
Confidence 54
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-21 Score=186.49 Aligned_cols=173 Identities=21% Similarity=0.342 Sum_probs=130.6
Q ss_pred eEEEEEeecCCCCcccccCCC-CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPK-SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.+|+.|++|...+|.++|..+ .....++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999643 33457788889999999999999 5 9999999999999999999999999998
Q ss_pred ccCCCCC----ceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 244 RLGPSEG----FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 244 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
....... .....+..+||..||+||.+.+..|+.++||||||++|+|+++ =..+++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------------ 465 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------------ 465 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------------
Confidence 7654433 1223456789999999999999999999999999999999998 2333221
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 363 (428)
...+..+-+..+.+.+..+. ++-..|+.+++.+.|.+||++.+
T Consensus 466 -~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 466 -IATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -HHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 11112222222222221222 23457899999999999994443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=192.84 Aligned_cols=210 Identities=26% Similarity=0.420 Sum_probs=144.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
..+|..+++|-.|+||.||.+.++.+.. .+|+| +.+... |++ ||..+ .+..
T Consensus 82 e~df~~IklisngAygavylvrh~~trq-----rfa~k-iNkq~l-----------ilR-----nilt~----a~np--- 132 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQ-----RFAMK-INKQNL-----------ILR-----NILTF----AGNP--- 132 (1205)
T ss_pred ccccceeEeeccCCCCceeeeecccccc-----chhhc-ccccch-----------hhh-----ccccc----cCCc---
Confidence 3578999999999999999998765533 67874 333221 111 12221 1111
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
+.| |+-...+... +.++.. ++.+++|||+- +|+|||+||+|.||+.-|.+|++|||++
T Consensus 133 ---fvv------gDc~tllk~~--g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 133 ---FVV------GDCATLLKNI--GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred ---cee------chhhhhcccC--CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence 233 3334444322 223332 27899999998 9999999999999999999999999998
Q ss_pred ccCCCCC--------c-----eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 244 RLGPSEG--------F-----THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 244 ~~~~~~~--------~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
+...-.. . .......+|||.|.|||++....|+..+|.|++|+|+||.+-|+.||.+..++.....+
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 7532100 0 01123569999999999999999999999999999999999999999988665432211
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 359 (428)
+.+...+.+- ......+.++++.+.|+.+|..|-
T Consensus 271 ------isd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 271 ------ISDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ------hhhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111111111 222446899999999999999994
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=163.21 Aligned_cols=142 Identities=16% Similarity=0.100 Sum_probs=107.7
Q ss_pred CCCCceeecccCceEEEEEE-EcCCCCCCcceEEEEEEccCCCcc------------------------cHHHHHHHHHH
Q 014245 86 NFSRSVVIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGVQ------------------------GHKEWMTEVNF 140 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~ 140 (428)
-|.+.+.||+|+||.||+|. ...+ +..||+|.+...... ....+..|+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~-----g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGS-----GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCC-----CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 48899999999999999997 3222 237999998653210 01235689999
Q ss_pred HhcCCCCC--cccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCC-e
Q 014245 141 LGIVEHQN--LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ-I 217 (428)
Q Consensus 141 l~~l~h~n--Iv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-i 217 (428)
+.++.+.+ +.+++++ . . .+|||||++|++|....... ..+.......++.|++.+|++||.. + +
T Consensus 104 L~~L~~~~i~~p~~~~~---~-~----~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW---R-R----NVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred HHHHHhcCCCCCeeeEe---c-C----ceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 99997533 3444442 1 1 28999999998887765322 2355666789999999999999998 8 9
Q ss_pred eeccCCCCceEECCCCCeEEeeecccccC
Q 014245 218 IVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 218 vHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
+||||||+||+++ ++.++|+|||.+...
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999999 889999999998643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=167.29 Aligned_cols=202 Identities=19% Similarity=0.294 Sum_probs=142.2
Q ss_pred CCCCcccEeeEEecCCC-----------------------CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHH
Q 014245 145 EHQNLVKLVGYCADDDE-----------------------RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201 (428)
Q Consensus 145 ~h~nIv~~~~~~~~~~~-----------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ 201 (428)
+|||||++.++|.++-. ....+|+||...+. +|..++-.+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 69999999998865321 13356889988854 8888886443 556677789999
Q ss_pred HHHHHHHhhcCCCCCeeeccCCCCceEE--CCCC--CeEEeeecccccCCCCCc----eeeeeeeecCcccCCcchhccC
Q 014245 202 AARGLAYLHEGMDFQIIVRDFKSSNILL--DEQW--NAKLSDFGLARLGPSEGF----THVSTAVVGTMGYAAPEYVQTG 273 (428)
Q Consensus 202 i~~~L~~LH~~~~~~ivHrDlkp~NILl--~~~~--~~kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~ 273 (428)
+++|+.|||.+ ||.|||+|.+|||| |+|+ .+.|+|||.+--....+. ....-..-|.-.-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999998 99999999999999 4444 368999998754322111 1112234466778999987642
Q ss_pred C-----C-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHH
Q 014245 274 R-----L-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA 347 (428)
Q Consensus 274 ~-----~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li 347 (428)
+ . -.++|.|+.|.+.||+++...||........ + ....++-.-+. .+..+++.+++++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~-----------~r~Yqe~qLPa----lp~~vpp~~rqlV 490 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-D-----------TRTYQESQLPA----LPSRVPPVARQLV 490 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-c-----------hhhhhhhhCCC----CcccCChHHHHHH
Confidence 2 2 2489999999999999999999976321110 0 01112222222 3445667889999
Q ss_pred HHhcccCCCCCCCHHHHHHHHH
Q 014245 348 NLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 348 ~~cl~~dp~~RPs~~ell~~L~ 369 (428)
...|+.||++|++..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999998776655543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=160.06 Aligned_cols=134 Identities=20% Similarity=0.305 Sum_probs=108.2
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--------cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
+.||+|++|.||+|.+.+. .+++|........ ....+.+|+.++..+.|++|.....++.+....
T Consensus 2 ~~l~~G~~~~vy~~~~~~~-------~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGI-------KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEeeCCC-------ceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence 4799999999999986332 5788876543211 123577899999999999988777676655433
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
++||||++|++|.+++.... . .+..++.+++.+|.+||.. +++|+|++|.|||++ ++.++|+|||+
T Consensus 75 ----~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 75 ----IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred ----EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 89999999999999885321 2 7788999999999999998 999999999999999 78999999998
Q ss_pred ccc
Q 014245 243 ARL 245 (428)
Q Consensus 243 a~~ 245 (428)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=158.19 Aligned_cols=130 Identities=21% Similarity=0.343 Sum_probs=101.7
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--------cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.||+|+||.||+|.+.+ ..+++|........ ...++.+|++++..+.|+++.....++......
T Consensus 1 ~ig~G~~~~vy~~~~~~-------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~- 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG-------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK- 72 (199)
T ss_pred CCCCCceEEEEEeecCC-------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC-
Confidence 48999999999998543 25888886543211 124577899999999888765554444444433
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
++||||++|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++
T Consensus 73 ---~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 73 ---TIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred ---EEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 89999999999988774321 1 7899999999999998 999999999999999 789999999998
Q ss_pred cc
Q 014245 244 RL 245 (428)
Q Consensus 244 ~~ 245 (428)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 65
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=154.26 Aligned_cols=138 Identities=17% Similarity=0.104 Sum_probs=105.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc----------------------cHHHHHHHHHHHh
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ----------------------GHKEWMTEVNFLG 142 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 142 (428)
..|.+.+.||+|+||.||+|...++ ..||||.+...... .......|+.++.
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDG------NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCC------CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3488889999999999999986532 37999986543210 0113567889999
Q ss_pred cCCCC--CcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeec
Q 014245 143 IVEHQ--NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 220 (428)
Q Consensus 143 ~l~h~--nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHr 220 (428)
.+.|+ .++..++. .. .++||||++|++|...... .....++.+++.++.++|+. +++||
T Consensus 89 ~l~~~~i~v~~~~~~----~~----~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~ 149 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NR----HAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHG 149 (198)
T ss_pred HHHHcCCCCCceeec----CC----ceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcC
Confidence 99887 44554432 11 2899999999999776431 23457889999999999998 99999
Q ss_pred cCCCCceEECCCCCeEEeeecccccCC
Q 014245 221 DFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 221 Dlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
||||+||++++++.++|+|||++....
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.1e-19 Score=179.43 Aligned_cols=138 Identities=20% Similarity=0.283 Sum_probs=108.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEc-cCC-Cc------ccHHHHHHHHHHHhcCCCCCcccEee
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRR-GV------QGHKEWMTEVNFLGIVEHQNLVKLVG 154 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~-~~~-~~------~~~~~~~~E~~~l~~l~h~nIv~~~~ 154 (428)
....|...+.||+|+||.||+|.+.+.. +++|+. .+. .. ...+.+.+|++++..++|++|+..+.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 3455677889999999999999875542 222221 111 10 12346789999999999999998877
Q ss_pred EEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 155 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
++.+.... ++||||++|++|.+++. ....++.+++.+|.+||+. +++||||||+|||+ .++.
T Consensus 404 ~~~~~~~~----~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~ 465 (535)
T PRK09605 404 YDVDPEEK----TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDR 465 (535)
T ss_pred EEEeCCCC----EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCc
Confidence 77665433 89999999999988774 3467899999999999998 99999999999999 6779
Q ss_pred eEEeeeccccc
Q 014245 235 AKLSDFGLARL 245 (428)
Q Consensus 235 ~kl~DFGla~~ 245 (428)
++|+|||+++.
T Consensus 466 ~~liDFGla~~ 476 (535)
T PRK09605 466 LYLIDFGLGKY 476 (535)
T ss_pred EEEEeCccccc
Confidence 99999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-19 Score=186.12 Aligned_cols=258 Identities=24% Similarity=0.306 Sum_probs=191.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~ 162 (428)
.|...+.||+|+|+.|-........ ...+|+|.+.... ....+....|..+-..+. |+|++.+++...+....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~----~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDP----ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred cccccccccccccchhhhhhhcCCC----cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4666667999999999887654332 2356777765543 122334456777777776 99999999988777654
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhh-cCCCCCeeeccCCCCceEECCCC-CeEEeee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH-EGMDFQIIVRDFKSSNILLDEQW-NAKLSDF 240 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~DF 240 (428)
+++++|..|+++.+.+........+....-.++.|+..++.|+| .. ++.|+||||+|.+++..+ .++++||
T Consensus 97 ----~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 97 ----LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred ----ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCc
Confidence 89999999999999883222223555666789999999999999 77 999999999999999999 9999999
Q ss_pred cccccCCC-CCceeeeeeeec-CcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 241 GLARLGPS-EGFTHVSTAVVG-TMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 241 Gla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|+|..... .+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|..
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~--- 245 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS--- 245 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc---
Confidence 99987766 555555667788 9999999988874 4577899999999999999999999765443211 111100
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ................+++.+++..+|..|.+.+++...
T Consensus 246 -~~--------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 246 -NK--------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -cc--------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00 011112233455677888899999999999999887653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=149.42 Aligned_cols=138 Identities=18% Similarity=0.180 Sum_probs=104.8
Q ss_pred eeec-ccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-------------ccHHHHHHHHHHHhcCCCCCc--ccEee
Q 014245 91 VVIG-EGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-------------QGHKEWMTEVNFLGIVEHQNL--VKLVG 154 (428)
Q Consensus 91 ~~lG-~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI--v~~~~ 154 (428)
..|| .||.|+||.+...+. .++||.+..... .....+.+|+.++..|.|++| +..++
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~-------~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~ 109 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGV-------NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA 109 (239)
T ss_pred ceeecCCCCccEEEEEeCCc-------eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence 4688 899999999876532 688888754221 123467889999999998875 67777
Q ss_pred EEecCCCCCceEEEEEeecCC-CCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC
Q 014245 155 YCADDDERGIQRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
+...........++||||++| .+|.+++... .++.. .+.+++.+|.+||++ ||+||||||.|||++.++
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 755443322233699999997 6888887542 24443 357899999999998 999999999999999999
Q ss_pred CeEEeeeccccc
Q 014245 234 NAKLSDFGLARL 245 (428)
Q Consensus 234 ~~kl~DFGla~~ 245 (428)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-16 Score=134.82 Aligned_cols=135 Identities=21% Similarity=0.195 Sum_probs=110.4
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC--CCcccEeeEEecCCCCCceE
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~~~~ 166 (428)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+.++..+.| .+++++++++...+ ..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDG----WS 68 (155)
T ss_pred cceecccccccceEEEEecC-------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC----cc
Confidence 45689999999999998654 2689998865433 4578899999999976 58999988876653 34
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
+++|||++++.+..+ +......++.+++.+|++||.....+++|+||+|+|||+++.+.++++|||.+..
T Consensus 69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999999998887654 3455667899999999999986444799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=141.38 Aligned_cols=135 Identities=20% Similarity=0.144 Sum_probs=94.7
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHH----------------------HHHHHHHHhcCC
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKE----------------------WMTEVNFLGIVE 145 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~ 145 (428)
.+.||+|+||.||+|...++ ..||||++...... .... ...|...+..+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~------~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDG------EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CcccccccceeEEEEECCCC------CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 45799999999999986522 37999987653211 1111 134566666664
Q ss_pred CCC--cccEeeEEecCCCCCceEEEEEeecCCCCcccc-cCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeecc
Q 014245 146 HQN--LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY-LSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRD 221 (428)
Q Consensus 146 h~n--Iv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrD 221 (428)
+.. +.+.++.. ..++||||++++.+... +.... .. .....++.+++.++.++|. . +|+|+|
T Consensus 76 ~~~~~~~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 76 EAGVPVPKPIDLN--------RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred HcCCCCCceEecC--------CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 433 44554431 12899999998654321 21111 11 5567899999999999998 7 999999
Q ss_pred CCCCceEECCCCCeEEeeecccccC
Q 014245 222 FKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 222 lkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
|||+||+++ ++.++|+|||.+...
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CChhhEEEE-CCcEEEEECcccccc
Confidence 999999999 889999999999644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-14 Score=140.54 Aligned_cols=252 Identities=24% Similarity=0.248 Sum_probs=179.2
Q ss_pred cCCCCceeecc--cCceEEEEEEEcCCCCCCcceEEEEEEccC--CCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 85 KNFSRSVVIGE--GGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 85 ~~~~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
+.|.+...+|. |.+|.||.+...+ ..+...+|+|.=+. ........-.+|+...+.+ .|+|.++.+..+...
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 35667778999 9999999987632 22344688887332 2222333445677777777 699999977777766
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHH----HHHHhhcCCCCCeeeccCCCCceEECCC-CC
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----GLAYLHEGMDFQIIVRDFKSSNILLDEQ-WN 234 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~ 234 (428)
+.. |+-+|++ +.+|..+..... ..++....+.++.+... ||.++|.. +++|-|+||+||++..+ ..
T Consensus 191 ~~l----fiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 191 GIL----FIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred Ccc----eeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccce
Confidence 644 8889988 567777765432 23677778888888888 99999998 99999999999999998 88
Q ss_pred eEEeeecccccCCCCCcee---eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014245 235 AKLSDFGLARLGPSEGFTH---VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 311 (428)
.+++|||+........... ......|...|++||... +.++...|||+||.++++..+|..+.......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------- 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------- 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-------
Confidence 9999999998765544222 122336788899999654 67899999999999999999987665432110
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 366 (428)
.+..++.. .+..++......++...+..+++.+|..|++.+.+..
T Consensus 334 -------~W~~~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 -------SWSQLRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -------Cccccccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 01111111 1222333334456667899999999999999888765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.4e-14 Score=141.25 Aligned_cols=141 Identities=18% Similarity=0.157 Sum_probs=95.1
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccH---------------------------------------
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--------------------------------------- 131 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------- 131 (428)
+.||+|++|+||+|...++. .||||+..+......
T Consensus 123 ~plasaSigQVh~A~l~~G~------~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGK------EVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred cceeeeehhheEEEEecCCC------EEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 57999999999999987553 799999865321100
Q ss_pred -HHHHHHHHHHhcC----CCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHH-H
Q 014245 132 -KEWMTEVNFLGIV----EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR-G 205 (428)
Q Consensus 132 -~~~~~E~~~l~~l----~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~ 205 (428)
-+|.+|+..+.++ .|.+-+.+-.++.+... ..+|||||++|++|.++....... .+ ...++.+++. .
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~---~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~ 269 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTS---ERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSF 269 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcC---CceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHH
Confidence 0234455555544 23333333333322111 238999999999999876422111 22 2345666655 4
Q ss_pred HHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 206 L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
+..+|.. |++|+|+||.||+++.++.++|+|||++....
T Consensus 270 l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 270 LNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 6788887 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.9e-15 Score=133.52 Aligned_cols=207 Identities=21% Similarity=0.262 Sum_probs=141.3
Q ss_pred HHHhcCCCCCcccEeeEEecCCC-CCceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCC
Q 014245 139 NFLGIVEHQNLVKLVGYCADDDE-RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDF 215 (428)
Q Consensus 139 ~~l~~l~h~nIv~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 215 (428)
.-|-++.|.|||+++.|+.+... ......++.|||..|+|..+|+.. ....+......+++.||+.||.|||+. ++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 44556689999999999877553 233458899999999999999743 335677778889999999999999985 88
Q ss_pred CeeeccCCCCceEECCCCCeEEeeecccccCCCCC--ceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh
Q 014245 216 QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG--FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293 (428)
Q Consensus 216 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 293 (428)
.|+|+++..+.|++..+|-+||.--.-...-..-. .......-.+-++|.+||.-.....+.++|||+||...++|..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999989985321111000000 0001112346789999997666667789999999999999988
Q ss_pred CCCCCCCCCc-hhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 294 GRRPIDRNRP-RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 294 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..--..... ...+.-+. ..+- .+ ....-+.++..|++..|..||++.+++-|
T Consensus 278 lEiq~tnseS~~~~ee~ia-------------~~i~-~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIA-------------NVII-GL-------ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhh-------------hhee-ec-------cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 7654221111 11111000 0000 00 00122456788999999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.8e-13 Score=117.59 Aligned_cols=130 Identities=18% Similarity=0.121 Sum_probs=93.9
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcc-cEeeEEecCCCCCceEEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV-KLVGYCADDDERGIQRLL 168 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~~~~~l 168 (428)
++.|+.|.++.||++...+ ..+++|....... ....+..|+.++..+.+.+++ +++.+.. ... ++
T Consensus 3 ~~~l~~G~~~~vy~~~~~~-------~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~----~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVAN-------KKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETG----VL 68 (170)
T ss_pred eeecCCcccCceEEEEECC-------eEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCC----eE
Confidence 3568899999999987542 2699998755432 223467899999988665544 4554432 222 79
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCC--CCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM--DFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
||||++|.++...- . ....++.+++.+|+.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 69 v~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 69 ITEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99999998886531 1 11245678999999999872 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.6e-13 Score=133.72 Aligned_cols=146 Identities=16% Similarity=0.085 Sum_probs=94.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc---------------------------------
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--------------------------------- 130 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------- 130 (428)
...|+. +.||+|++|+||+|...+++ ..||||+..+.....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G-----~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNG-----REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCC-----CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 345776 78999999999999987632 379999987542100
Q ss_pred -H------HHHHHHHHHHhcC----CCCCcccEeeEEecCCCCCceEEEEEeecCCCCccccc--CCCC--cccccHHHH
Q 014245 131 -H------KEWMTEVNFLGIV----EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKS--ETILTWAMR 195 (428)
Q Consensus 131 -~------~~~~~E~~~l~~l----~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~--~~~l~~~~~ 195 (428)
. -++.+|+..+.++ .+.+.+.+-.++.+-. ...+|||||++|+.|.++- ...+ ...+....+
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s---t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC---SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccC---CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 0 1234455444444 2443344333333211 1238999999999998742 2111 113444445
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC----CeEEeeecccccCCC
Q 014245 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW----NAKLSDFGLARLGPS 248 (428)
Q Consensus 196 ~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~~ 248 (428)
..++.|+. .. |++|+|+||.||+++.+| .++++|||++.....
T Consensus 270 ~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 55555554 23 999999999999999888 999999999976543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.7e-13 Score=131.17 Aligned_cols=249 Identities=20% Similarity=0.185 Sum_probs=168.7
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHH--HHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE--WMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
.+.+|..+..||.|.|+.|+....+.-+ ...|++|.+.........+ -..|+-+...+ .|.+++..+..+...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~----~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEG----DCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCC----CceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 4567999999999999999997754222 2368888876543322222 23555555555 577777766544443
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC-CCeEEe
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLS 238 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~ 238 (428)
.. .|+-.|||+++++...+. -...+.+...+.+..|++.++.++|+. .++|+|+||+||++..+ +.-+++
T Consensus 339 r~----~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 339 RQ----GYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred cc----ccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcc
Confidence 32 378899999999887762 223477778899999999999999987 99999999999999876 778999
Q ss_pred eecccccCCCCCceeeeeeeecCcccC--CcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYA--APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
|||....+... .....+.-+++ +++......+..++|++|||..+.+.++|..--....
T Consensus 410 ~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------- 470 (524)
T KOG0601|consen 410 DFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------------- 470 (524)
T ss_pred cccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------------
Confidence 99998642211 11122333444 4445556678889999999999999999765322111
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
....+....+. ..+ .....+..+...++..++..||.+.++..+..-
T Consensus 471 -----~~~~i~~~~~p-~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 471 -----QSLTIRSGDTP-NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -----cceeeeccccc-CCC-chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 01111111111 111 122677788888999999999999888776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.9e-11 Score=105.41 Aligned_cols=141 Identities=16% Similarity=0.090 Sum_probs=96.2
Q ss_pred eeecccCceEEEEEEEcCCC-CCCcceEEEEEEccCCCc----------------------ccHHHH----HHHHHHHhc
Q 014245 91 VVIGEGGFGCVYKGLIKNSE-DPSQKVEVAVKQLGRRGV----------------------QGHKEW----MTEVNFLGI 143 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~~ 143 (428)
..||.|--+.||.|...++. .......+|||+...... ...+.+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999744210 011234799998742110 001122 379999998
Q ss_pred CCC--CCcccEeeEEecCCCCCceEEEEEeecCCCCccc-ccCCCCcccccHHHHHHHHHHHHHHHHHh-hcCCCCCeee
Q 014245 144 VEH--QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ-YLSPKSETILTWAMRLKIAQDAARGLAYL-HEGMDFQIIV 219 (428)
Q Consensus 144 l~h--~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH 219 (428)
+.. -++.+++++ .. . +|||||+.++.+.. .+.. ..++......+..+++.+|..| |.. +|||
T Consensus 83 l~~~Gv~vP~pi~~--~~--~----~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL--KK--H----VLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe--cC--C----EEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 843 466777764 22 2 89999997654422 2221 1244556677889999999999 777 9999
Q ss_pred ccCCCCceEECCCCCeEEeeecccccC
Q 014245 220 RDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 220 rDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
+||++.|||+++ +.+.|+|||.+...
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 999999999974 68999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.4e-11 Score=117.20 Aligned_cols=161 Identities=16% Similarity=0.206 Sum_probs=115.6
Q ss_pred EEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHH
Q 014245 117 EVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRL 196 (428)
Q Consensus 117 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~ 196 (428)
+|.|...+...........+-++.|+.|+||||+++++.+..+.. .|||+|.+. -|..++.. +....+.
T Consensus 39 ~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~----~ylvTErV~--Pl~~~lk~-----l~~~~v~ 107 (690)
T KOG1243|consen 39 PVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGT----LYLVTERVR--PLETVLKE-----LGKEEVC 107 (690)
T ss_pred ceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCc----eEEEeeccc--cHHHHHHH-----hHHHHHH
Confidence 566666655443334456678889999999999999998877764 499999873 45555543 3344555
Q ss_pred HHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCC
Q 014245 197 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA 276 (428)
Q Consensus 197 ~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 276 (428)
-.+.||+.||.|||+. .+++|++|.-+.|++++.|..||++|-++........ ......---.|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 6788999999999854 3899999999999999999999999988754322111 011111122456666443222
Q ss_pred CchhhhhHHHHHHHHHhC
Q 014245 277 ARSDVWSYGVFLYELITG 294 (428)
Q Consensus 277 ~~~DvwslG~il~elltg 294 (428)
-..|.|.|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.1e-10 Score=105.80 Aligned_cols=145 Identities=17% Similarity=0.165 Sum_probs=107.8
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCC--CCcccEeeEEecCCCCCceEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~~~~~ 167 (428)
+.||.|.++.||++...++ ..+++|....... .....+..|+.++..+.+ .++.+++.+...... ....+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g------~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~-~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGG------RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV-LGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCC------cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc-cCCce
Confidence 4689999999999886542 2688998754332 134578899999999965 346777777654321 11238
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCC----------------------------------
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM---------------------------------- 213 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------- 213 (428)
+||||++|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 99999999999887642 23677777788889999998888521
Q ss_pred -------------------CCCeeeccCCCCceEECC--CCCeEEeeeccccc
Q 014245 214 -------------------DFQIIVRDFKSSNILLDE--QWNAKLSDFGLARL 245 (428)
Q Consensus 214 -------------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 245 (428)
...++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-12 Score=134.57 Aligned_cols=248 Identities=21% Similarity=0.227 Sum_probs=164.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC---CcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
+.|.+.+-+-+|.++.++.+.-....+ ..++|+.... .....+....+-.++-...||-++...--+.-..
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh-----~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs- 877 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGH-----TRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS- 877 (1205)
T ss_pred ccceecccccCCCCcccccCCcccccc-----ccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC-
Confidence 345556677889999988876544432 2333332211 1111222333333333334565554432222222
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..+||++|+.+++|...++..+ ..+..........+..+++|||.. .++|+|++|.|+|+..+|..+++|||
T Consensus 878 ---P~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 878 ---PLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred ---CcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccc
Confidence 3489999999999988886443 355566667777889999999986 69999999999999999999999998
Q ss_pred ccccCCCC----Cc-------------------------eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHH
Q 014245 242 LARLGPSE----GF-------------------------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELI 292 (428)
Q Consensus 242 la~~~~~~----~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 292 (428)
........ +. ........||+.|.+||.+.+......+|.|++|++++|.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 44321100 00 01123467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCC-CccHHHHHHHHHHHHHhcccCCCCCCCHH
Q 014245 293 TGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEG-KYSLRLVSKLSHVANLCLVKNARTRPKMS 362 (428)
Q Consensus 293 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 362 (428)
+|.+||....+... ++.+....+.. ..+...+....+++...+..+|.+|..+.
T Consensus 1030 ~g~pp~na~tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCCCCCcchhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999987654321 22222222221 22334556788899999999999997665
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.8e-10 Score=111.50 Aligned_cols=219 Identities=16% Similarity=0.222 Sum_probs=152.1
Q ss_pred eEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEeecCC-CC
Q 014245 99 GCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN-GS 177 (428)
Q Consensus 99 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~-g~ 177 (428)
.+.|++..... +..|++|++.............-+++++++.|+|||++.++|.........++||++|.++ ++
T Consensus 290 ~Ttyk~~s~~D-----G~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 290 ITTYKATSNVD-----GNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ceeEeeeeccC-----CceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 46788875433 3479999995444433334456678899999999999999988655555678999999875 56
Q ss_pred cccccCCC-------------CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 178 VDQYLSPK-------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 178 L~~~l~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
|.++.-.. .....++...|.++.|+..||.++|+. |+..+-|.|.+||++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 65543211 123477889999999999999999998 99999999999999999999999988876
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
+...+. + +| +.+ -.+-|.=.||.+++.|.||..--..... .+.. .+.
T Consensus 442 vl~~d~---------~-----~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~--~~~s------------~~~ 488 (655)
T KOG3741|consen 442 VLQEDP---------T-----EP--LES---QQQNDLRDLGLLLLALATGTENSNRTDS--TQSS------------HLT 488 (655)
T ss_pred eecCCC---------C-----cc--hhH---HhhhhHHHHHHHHHHHhhcccccccccc--hHHH------------HHH
Confidence 543322 0 11 111 2256888999999999998643211110 0000 000
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.....++.++++++......++++ -++.+++.++
T Consensus 489 ---------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 489 ---------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ---------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 112345567778888888888887 5777777653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1e-10 Score=99.56 Aligned_cols=130 Identities=23% Similarity=0.342 Sum_probs=93.1
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEE-ccCC--Ccc-----cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ-LGRR--GVQ-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~-~~~~--~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++++|+-+.+|.+.+.+. .+++|. +++. ... ...+-.+|+.++.++.--.|.-.+=|..+.+..
T Consensus 3 ~i~~GAEa~i~~~~~~g~-------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~- 74 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG- 74 (204)
T ss_pred hhhCCcceeEEeeeccCc-------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-
Confidence 578999999999876543 234443 2221 111 123456899999988544443333344454443
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.|+|||++|-.|.+.+... ...++..|-.-+.-||.. +|||+||.++||++..++ +.++||||+
T Consensus 75 ---~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 75 ---LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred ---EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcc
Confidence 7999999999988888643 245677777888889998 999999999999998774 999999998
Q ss_pred cc
Q 014245 244 RL 245 (428)
Q Consensus 244 ~~ 245 (428)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 64
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-10 Score=98.90 Aligned_cols=143 Identities=21% Similarity=0.246 Sum_probs=99.6
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEEEE-ccCC--Cc-----ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ-LGRR--GV-----QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~-~~~~--~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
...+|-+|+-+.|+++.+.+. ...||. +.+. .. -...+..+|+++|.++.--.|.-..=++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge-------~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGE-------AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccCCc-------eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence 566889999999999987653 334443 3222 11 12345678999998885444433333455544
Q ss_pred CCCceEEEEEeecCC-CCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC---eE
Q 014245 161 ERGIQRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN---AK 236 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~---~k 236 (428)
.. .|+|||++| .++.+++...............++..|-+.|.-||.+ +|||+||..+||+|..++. +.
T Consensus 84 ~~----~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 84 GG----QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred CC----eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence 43 799999976 4677777544333333333468889999999999998 9999999999999966554 58
Q ss_pred Eeeeccccc
Q 014245 237 LSDFGLARL 245 (428)
Q Consensus 237 l~DFGla~~ 245 (428)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.9e-09 Score=102.13 Aligned_cols=274 Identities=17% Similarity=0.215 Sum_probs=164.1
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEe---cCCCCC
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCA---DDDERG 163 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~---~~~~~~ 163 (428)
...+.||+|+-+.+|-.---. --+.|+..........+ .+..|... .||-+-.-+.|=. .....+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~--------d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~ 82 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR--------DQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRG 82 (637)
T ss_pred CCCccccCCccceeeecchhh--------chhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence 345679999999999632111 12335554443322222 22333333 5654333111110 111111
Q ss_pred ceEEEEEeecCCC-CcccccCC----CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 164 IQRLLVYEYMPNG-SVDQYLSP----KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 164 ~~~~lv~e~~~~g-~L~~~l~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
...-++|..+.+. -+.+++.. .+-..+.|...++.++.++.+.+-||.. |.+-+|+.++|+|+.+++.+.|.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LV 159 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLV 159 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEE
Confidence 2246777777653 12222221 1223588999999999999999999998 99999999999999999999998
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhC-CCCCCCCCchhh-----H
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRSE-----Q 307 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~-----~ 307 (428)
|=..-... .. .......+|...|.+||.-. +..-+...|.|.||+++++++.| +.||.+...... +
T Consensus 160 dsDsfqi~-~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 160 DSDSFQIN-AN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred cccceeec-cC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 73221111 11 22334568999999999654 33456789999999999999995 999976432211 1
Q ss_pred -HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhhhhhhcCCCC
Q 014245 308 -KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKN--ARTRPKMSEVLEMVNKIVDASAEAGSP 381 (428)
Q Consensus 308 -~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~d--p~~RPs~~ell~~L~~~~~~~~~~~~~ 381 (428)
.+.... +.....-..-..+........-+++++..+..+|+... +.-|||++..+..|..+.+....+...
T Consensus 237 ~~Ia~g~---f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~ 310 (637)
T COG4248 237 TDIAHGR---FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVS 310 (637)
T ss_pred hhhhcce---eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhc
Confidence 111000 00000000001111111222346678899999998543 678999999999998887776655433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-09 Score=99.55 Aligned_cols=143 Identities=13% Similarity=0.028 Sum_probs=97.0
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cH----------HHHHHHHHHHhcCCCCC--cccEeeEEec
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GH----------KEWMTEVNFLGIVEHQN--LVKLVGYCAD 158 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~n--Iv~~~~~~~~ 158 (428)
.+-......|+++.+.+ ..|.||........ .. ..+.+|...+..|..-+ ++..+++...
T Consensus 29 ~v~~~~~rrvvr~~~~g-------~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~ 101 (268)
T PRK15123 29 VFRELEGRRTLRFELAG-------KSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGER 101 (268)
T ss_pred EEecCCCceEEEEEECC-------EEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEe
Confidence 34434444466665433 26888876433211 01 13778998888874333 3445666543
Q ss_pred CCCC-CceEEEEEeecCCC-CcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-----
Q 014245 159 DDER-GIQRLLVYEYMPNG-SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE----- 231 (428)
Q Consensus 159 ~~~~-~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~----- 231 (428)
.... ...-+||||++++. +|.+++........+......++.+++..+.-||.. ||+|+|+++.|||++.
T Consensus 102 ~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 102 GSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred cCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 2211 12348999999876 788887533223355667778999999999999998 9999999999999975
Q ss_pred --CCCeEEeeecccc
Q 014245 232 --QWNAKLSDFGLAR 244 (428)
Q Consensus 232 --~~~~kl~DFGla~ 244 (428)
++.+.|+||+.+.
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 4679999999875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=116.84 Aligned_cols=150 Identities=23% Similarity=0.346 Sum_probs=107.0
Q ss_pred HHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCC-ce------eeeeeeecCcccCCcchhccC
Q 014245 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG-FT------HVSTAVVGTMGYAAPEYVQTG 273 (428)
Q Consensus 201 ~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~------~~~~~~~gt~~y~aPE~~~~~ 273 (428)
+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+....... +. .......-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 455999999975 589999999999999999999999999875432211 00 011122345689999999998
Q ss_pred CCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcc
Q 014245 274 RLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLV 352 (428)
Q Consensus 274 ~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~ 352 (428)
..+.++|+||||+++|.+.. |+.-+......... .+....+..-...++..++.++.+-+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------------SFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchh--------------hhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 88999999999999999995 55444433222111 1111222222334556788899999999999
Q ss_pred cCCCCCCCHHHHHH
Q 014245 353 KNARTRPKMSEVLE 366 (428)
Q Consensus 353 ~dp~~RPs~~ell~ 366 (428)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998777654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-09 Score=94.21 Aligned_cols=98 Identities=20% Similarity=0.237 Sum_probs=64.8
Q ss_pred HHHHHHHHHhcCCCC--CcccEeeEEecCCCCCceEEEEEeecC--CCCcccccCCCCcccccHHHHHHHHHHHHHHHHH
Q 014245 133 EWMTEVNFLGIVEHQ--NLVKLVGYCADDDERGIQRLLVYEYMP--NGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208 (428)
Q Consensus 133 ~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~ 208 (428)
...+|++.|.++..- ++.+++++. .. +|||||++ |..+..+.... ++......++.+++..+..
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~--~~------~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~ 121 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN--RN------VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIK 121 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE--TT------EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe--CC------EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHH
Confidence 356899999999665 567776553 22 89999998 55554433211 2233455677788886655
Q ss_pred -hhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 209 -LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 209 -LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
+|.. ||+|+||.+.|||++++ .+.|+|||.+...
T Consensus 122 ~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 122 MLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHHhc---CceecCCChhhEEeecc-eEEEEecCcceec
Confidence 5677 99999999999999988 9999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1e-08 Score=91.95 Aligned_cols=110 Identities=24% Similarity=0.255 Sum_probs=85.8
Q ss_pred HHHHHHHHHHHhcCCC--CCcccEeeEEecCCCCCceEEEEEeecCCC-CcccccCCCCcccccHHHHHHHHHHHHHHHH
Q 014245 131 HKEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGIQRLLVYEYMPNG-SVDQYLSPKSETILTWAMRLKIAQDAARGLA 207 (428)
Q Consensus 131 ~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~ 207 (428)
.....+|...+..|.. =.+.+.+++...........+||+|++++. +|.+++..... .+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3467788888877743 345666777766444334558999999874 78888865322 555667889999999999
Q ss_pred HhhcCCCCCeeeccCCCCceEECCCC---CeEEeeeccccc
Q 014245 208 YLHEGMDFQIIVRDFKSSNILLDEQW---NAKLSDFGLARL 245 (428)
Q Consensus 208 ~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 245 (428)
-||.+ ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99998 999999999999999887 799999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=3e-08 Score=87.45 Aligned_cols=143 Identities=17% Similarity=0.096 Sum_probs=103.8
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCC------CcccHHHHHHHHHHHhcCCCC--CcccEeeEEecCCCCCc
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------GVQGHKEWMTEVNFLGIVEHQ--NLVKLVGYCADDDERGI 164 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~ 164 (428)
-|+||.+.|+...+.+. .+-+|+-... .......|.+|+..|..|..- .+.+++...........
T Consensus 26 ~~rgG~SgV~r~~~~g~-------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~ 98 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEW 98 (216)
T ss_pred cCCCCcceEEEEEeCCc-------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCce
Confidence 36788888998766543 4777775411 123567899999999888432 25555522223333344
Q ss_pred eEEEEEeecCC-CCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC--eEEeeec
Q 014245 165 QRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--AKLSDFG 241 (428)
Q Consensus 165 ~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFG 241 (428)
+-+||+|-++| -+|.+++....-...+......++.+++..|.-||.. |+.|+|+-+.|||++.++. ++++||-
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 56899998753 6788887654444567777889999999999999998 9999999999999986677 9999997
Q ss_pred cccc
Q 014245 242 LARL 245 (428)
Q Consensus 242 la~~ 245 (428)
-++.
T Consensus 176 k~r~ 179 (216)
T PRK09902 176 KSRR 179 (216)
T ss_pred ccch
Confidence 6653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.1e-08 Score=90.62 Aligned_cols=134 Identities=18% Similarity=0.112 Sum_probs=92.4
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc------------------c----cHHHHHHHHHHHhcC
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV------------------Q----GHKEWMTEVNFLGIV 144 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------------------~----~~~~~~~E~~~l~~l 144 (428)
..++..||-|--+.||.|....+. ++|||.-..... . ......+|.++|..|
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~------~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L 166 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGR------KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL 166 (304)
T ss_pred HhhccccccCccceEEEEECCCCC------EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence 456679999999999999866443 789987432110 0 122356899999999
Q ss_pred CCC--CcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC
Q 014245 145 EHQ--NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 222 (428)
Q Consensus 145 ~h~--nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl 222 (428)
.-. .|.+.+++-. . .+||||++|-.|...-- +....-.|+..|++-+.-+-.. |+||+|+
T Consensus 167 ~~~G~~VP~P~~~nR----H----aVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~---GiVHGDl 228 (304)
T COG0478 167 YPEGVKVPKPIAWNR----H----AVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRR---GIVHGDL 228 (304)
T ss_pred hhcCCCCCCcccccc----c----eeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence 655 6777765532 1 79999999877765431 1122223444444444444344 9999999
Q ss_pred CCCceEECCCCCeEEeeecccc
Q 014245 223 KSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 223 kp~NILl~~~~~~kl~DFGla~ 244 (428)
++-|||++++|.+.++||--+.
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred chheEEEecCCCEEEEeCcccc
Confidence 9999999999999999996554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.8e-07 Score=82.52 Aligned_cols=153 Identities=16% Similarity=0.133 Sum_probs=100.4
Q ss_pred cccCHHHHHHHhcCCCCceeecc---cCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-------------------c
Q 014245 73 KEFTIAELKSATKNFSRSVVIGE---GGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-------------------G 130 (428)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~lG~---G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------~ 130 (428)
...+...+.....+..+..+.|. |--+.||+|...+ +..+|+|+....... .
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~------~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~ 106 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGD------GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSN 106 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC------CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCC
Confidence 34456666666677777666665 5555799986433 347999998532211 1
Q ss_pred HHH-----HHHHHHHHhcC--CCCCcccEeeEEecCCCCCceEEEEEeecCCC-CcccccCCCCcccccHHHHHHHHHHH
Q 014245 131 HKE-----WMTEVNFLGIV--EHQNLVKLVGYCADDDERGIQRLLVYEYMPNG-SVDQYLSPKSETILTWAMRLKIAQDA 202 (428)
Q Consensus 131 ~~~-----~~~E~~~l~~l--~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i 202 (428)
.++ ...|+..|.++ .+-.+.+-+++... .|||||+... .-.-.|.. ..+.......+..++
T Consensus 107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~n--------VLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~ 175 (268)
T COG1718 107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRNN--------VLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDV 175 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecCC--------eEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHH
Confidence 111 23577778777 34556666665432 8999999542 11222221 123333566778888
Q ss_pred HHHHHHhhc-CCCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 203 ARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 203 ~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
++.+.-|-. . ++||+||+.-|||+. ++.+.|+|||-|...
T Consensus 176 v~~~~~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 176 VEYMRRLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHHHHHhc---CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 888888876 5 999999999999999 789999999988643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.4e-09 Score=105.21 Aligned_cols=189 Identities=21% Similarity=0.147 Sum_probs=132.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC-cccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~ 162 (428)
+..+....-+++|+++++||.+..... ....+.+.. .....-++++|.+++||| .+..++-+..++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaek------lL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~-- 307 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEK------LLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGED-- 307 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhh------heeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCccc--
Confidence 334445556899999999987532221 233444332 244556889999999999 444444333333
Q ss_pred CceEEEEEeecCCC-CcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 163 GIQRLLVYEYMPNG-SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 163 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
...++++++.++ +-...+. ..+..+...+...+...-+++|++||+. .-+|+| |||..+ +..+..||+
T Consensus 308 --~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 308 --YLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred --ccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-ccccccccc
Confidence 347899999877 3333322 1223355555666777788999999975 458898 888776 589999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCC
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~ 299 (428)
......... ......+|+.++|||+..++.+....|+|++|.--.+|.-|.+|-.
T Consensus 377 v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 377 VPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 987655433 3456789999999999999999999999999998888888877754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.2e-07 Score=79.11 Aligned_cols=140 Identities=12% Similarity=0.102 Sum_probs=91.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHH---------HHHHHHHhcCC---CCCccc
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---------MTEVNFLGIVE---HQNLVK 151 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---h~nIv~ 151 (428)
.++|...+++-......|.+-...+. .+.+|..........+.| .+++..+..+. --....
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~-------kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGK-------KYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCc-------EEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 46788888888888777887765543 689998765543222222 23333333332 223333
Q ss_pred EeeEEecCC-CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC
Q 014245 152 LVGYCADDD-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 152 ~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~ 230 (428)
++-+..-.. ......+|||||++|..|.++.. +++ .++..++++|.-||.. |++|+|+.|.|++++
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS 169 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence 332222111 11123468999999998887653 222 2456677889999998 999999999999999
Q ss_pred CCCCeEEeeecccc
Q 014245 231 EQWNAKLSDFGLAR 244 (428)
Q Consensus 231 ~~~~~kl~DFGla~ 244 (428)
++ .++++||+..+
T Consensus 170 ~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 170 NN-GIRIIDTQGKR 182 (229)
T ss_pred CC-cEEEEECcccc
Confidence 65 49999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.7e-07 Score=94.18 Aligned_cols=140 Identities=18% Similarity=0.134 Sum_probs=86.9
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc----------------------------------------
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG---------------------------------------- 130 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------------- 130 (428)
..|+.++-|+||+|.+.++. .||||+..+.-...
T Consensus 131 ~PiAsASIaQVH~A~L~sG~------~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGE------EVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred CchhhhhHhhheeEEecCCC------EEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 57899999999999998754 89999985432100
Q ss_pred HHHHHHHHHHHhcC----C-CCCcccEeeEEec-CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHH
Q 014245 131 HKEWMTEVNFLGIV----E-HQNLVKLVGYCAD-DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204 (428)
Q Consensus 131 ~~~~~~E~~~l~~l----~-h~nIv~~~~~~~~-~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~ 204 (428)
+-++.+|+..+.++ + .++ +++=.++.+ .. ..+|+|||++|-.+.+...-+. ..++...+.....++.-
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPD-VYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccC----CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence 01133455555444 1 232 222222222 12 2389999999999988853222 12443332222222211
Q ss_pred HHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 205 ~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
-.-+-| |++|.|..|.||+++.+|.+.+.|||+.....
T Consensus 279 ~q~~~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 279 RQLLRD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHhc-----CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 111223 99999999999999999999999999987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.8e-06 Score=75.91 Aligned_cols=100 Identities=26% Similarity=0.295 Sum_probs=80.1
Q ss_pred HHHHHHhcCCC-CCcccEeeEEecCCCCCceEEEEEeecCCCCcccc---cCCCCcccccHHHHHHHHHHHHHHHHHhhc
Q 014245 136 TEVNFLGIVEH-QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY---LSPKSETILTWAMRLKIAQDAARGLAYLHE 211 (428)
Q Consensus 136 ~E~~~l~~l~h-~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~ 211 (428)
.|.-+|+.+.+ +++++++|+|-+ ++|.||...+++... +.+. ...+|..+.+|+.++++.+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhc
Confidence 57888888866 699999999943 789999987766421 1111 126899999999999999999998
Q ss_pred CCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 212 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.....+.-.|++++|+-++++|++|++|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 6444566699999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.4e-06 Score=77.64 Aligned_cols=132 Identities=18% Similarity=0.121 Sum_probs=81.0
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC--cccEeeEEecCCCCCceEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN--LVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~~~~~l 168 (428)
..||+|..+.||+.. +. .+++|...... ......+|.+++..+..-. +.+.+++..+.+. ..+
T Consensus 7 ~~i~~G~t~~~y~~~---~~------~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~----~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TG------KWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR----LGL 71 (226)
T ss_pred eeecCCCCcceeEec---CC------CEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe----eee
Confidence 368999999999831 11 46788876432 3345688999999886443 4667777765543 378
Q ss_pred EEeecCCCC-cccccCCCCcccccHHHHHHHHHHHHHH---------------------------------------HHH
Q 014245 169 VYEYMPNGS-VDQYLSPKSETILTWAMRLKIAQDAARG---------------------------------------LAY 208 (428)
Q Consensus 169 v~e~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~~i~~~---------------------------------------L~~ 208 (428)
|||+++|.+ +...+... ......++.+++.. ..+
T Consensus 72 v~e~i~G~~~~~~~~~~~------~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~ 145 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDN------PSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAF 145 (226)
T ss_pred eeeecCCccchhhhhcCC------HHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHH
Confidence 999998863 22222100 00000111111111 111
Q ss_pred hhcC-CCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 209 LHEG-MDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 209 LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
|... ....++|+|+.|.||++++++ +.|+||+.+.
T Consensus 146 l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 146 IKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 2111 133578999999999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=9e-07 Score=88.80 Aligned_cols=139 Identities=18% Similarity=0.120 Sum_probs=88.4
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-------------------------------------cHHH
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-------------------------------------GHKE 133 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~ 133 (428)
+.||.-+.|+||+|+.+++. .||||+=++.-.. .+-+
T Consensus 167 ~piaaASlaQVhrA~L~~G~------~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGE------DVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred chhhhcchhheEEEEecCCC------EEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 47999999999999998854 7999986443110 0112
Q ss_pred HHHHHHHHhc----CCCCC------cccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHH
Q 014245 134 WMTEVNFLGI----VEHQN------LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 203 (428)
Q Consensus 134 ~~~E~~~l~~----l~h~n------Iv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~ 203 (428)
|.+|++...+ +.|-+ |.++|-.+.. ..+|+||||+|..+.|.-.-... .++...+..-+.++.
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st------~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLST------KRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAY 313 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCc------ceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHH
Confidence 3445443332 34555 4555433322 24899999999999886432222 244444333333333
Q ss_pred HHHHHhhcCCCCCeeeccCCCCceEEC----CCCCeEEeeecccccCC
Q 014245 204 RGLAYLHEGMDFQIIVRDFKSSNILLD----EQWNAKLSDFGLARLGP 247 (428)
Q Consensus 204 ~~L~~LH~~~~~~ivHrDlkp~NILl~----~~~~~kl~DFGla~~~~ 247 (428)
.-+-+.| |.+|.|-.|.||++. .++.+.+.|||+.....
T Consensus 314 ~~qIf~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 314 LEQIFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHhc-----CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2233333 899999999999998 36789999999987543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.6e-06 Score=78.83 Aligned_cols=145 Identities=17% Similarity=0.152 Sum_probs=83.3
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCC--CcccEeeEEecCCCCCceEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQ--NLVKLVGYCADDDERGIQRL 167 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~~~~~ 167 (428)
++.|+.|..+.||+....++ .+++|..... .....+..|..+++.+... .+.+++.+....... ...+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~-------~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~-~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDG-------RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFN-GFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTS-------EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEET-SEEE
T ss_pred CccCCCCCeeeEEEEEECCc-------EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccc-ccce
Confidence 45799999999999886552 6899986544 3456777899998888433 356777655443322 2368
Q ss_pred EEEeecCCCCccccc----------------C---CC--CcccccHHH---------HHHH------------HHHHHH-
Q 014245 168 LVYEYMPNGSVDQYL----------------S---PK--SETILTWAM---------RLKI------------AQDAAR- 204 (428)
Q Consensus 168 lv~e~~~~g~L~~~l----------------~---~~--~~~~l~~~~---------~~~i------------~~~i~~- 204 (428)
++|++++|..+.... . .. ....+.... .... ...+..
T Consensus 72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (239)
T PF01636_consen 72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER 151 (239)
T ss_dssp EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence 999999998887711 0 00 000001000 0000 111222
Q ss_pred HHHHhhc----CCCCCeeeccCCCCceEEC-CCCCeEEeeecccc
Q 014245 205 GLAYLHE----GMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLAR 244 (428)
Q Consensus 205 ~L~~LH~----~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~ 244 (428)
.+..++. .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 152 LLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2333331 1234799999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.1e-06 Score=72.90 Aligned_cols=127 Identities=19% Similarity=0.220 Sum_probs=86.2
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCccc-EeeEEecCCCCCceEE
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK-LVGYCADDDERGIQRL 167 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-~~~~~~~~~~~~~~~~ 167 (428)
..+.||+|++|.||+|.+.+. .+|+|+=.. ......+..|+++|..+.--++.+ +|.|.. + +
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-------~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~--~------~ 88 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-------EVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE--D------F 88 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-------eEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech--h------h
Confidence 456799999999999998765 688887443 344578899999999997766654 444332 2 5
Q ss_pred EEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC-CC-ceEECCCCCeEEeeeccccc
Q 014245 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK-SS-NILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 168 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk-p~-NILl~~~~~~kl~DFGla~~ 245 (428)
+.|||++|-.|.+.-... +..+.+ .+++.---|-.. ||-|+.|. |. ||++. ++.+.|+||.-|+.
T Consensus 89 i~me~i~G~~L~~~~~~~-----~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG-----DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVN-DRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc-----cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence 679999998887765421 223333 333332223333 89999887 44 55554 44999999988863
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.8e-06 Score=74.91 Aligned_cols=138 Identities=19% Similarity=0.157 Sum_probs=80.5
Q ss_pred ecccCc-eEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCCceEEEEE
Q 014245 93 IGEGGF-GCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 93 lG~G~~-g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~lv~ 170 (428)
|-.|.+ ..||+....+ ..+.+|...... ...+.+|+.++..+. +--+.+++++....+. .++||
T Consensus 6 ~~~g~~~~~v~~~~~~~-------~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~----~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-------PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGR----AWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcCCC-------CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc----cEEEE
Confidence 445655 7799875432 157888765432 335678999888883 4446677777665432 38999
Q ss_pred eecCCCCcccccC-------------------CCC--cccccHH--HHHHH-----------------------HHHHHH
Q 014245 171 EYMPNGSVDQYLS-------------------PKS--ETILTWA--MRLKI-----------------------AQDAAR 204 (428)
Q Consensus 171 e~~~~g~L~~~l~-------------------~~~--~~~l~~~--~~~~i-----------------------~~~i~~ 204 (428)
|+++|.+|..... ... ...+... ..+.. +.++..
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 9999988764421 000 0001000 00000 011111
Q ss_pred HHHHhh-cCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 205 GLAYLH-EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 205 ~L~~LH-~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.|.... ......++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 111111 0113469999999999999998778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.3e-05 Score=84.73 Aligned_cols=86 Identities=15% Similarity=0.195 Sum_probs=58.4
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCC-CCCc--ccEeeEEecCCCCCce
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVE-HQNL--VKLVGYCADDDERGIQ 165 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~~~~~~~ 165 (428)
...|+.|.+..+|+.....+. ....+++|+...... .....+.+|+.+|+.+. |.+| .+++.+|.+....+ .
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~---~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G-~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG---SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG-T 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC---cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC-C
Confidence 567899999999997754431 112467777544322 23456889999999995 6665 78888887653222 3
Q ss_pred EEEEEeecCCCCcc
Q 014245 166 RLLVYEYMPNGSVD 179 (428)
Q Consensus 166 ~~lv~e~~~~g~L~ 179 (428)
.|+||||++|..+.
T Consensus 119 ~flVME~v~G~~~~ 132 (822)
T PLN02876 119 AFYIMEYLEGRIFV 132 (822)
T ss_pred ceEEEEecCCcccC
Confidence 48999999886544
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.24 E-value=3e-05 Score=68.06 Aligned_cols=138 Identities=25% Similarity=0.314 Sum_probs=95.4
Q ss_pred CCcccCHHHHHHHhcCCCCceeecccCc-eEEEEEEEcCCCCCCcceEEEEEEccC---CCc------------------
Q 014245 71 NLKEFTIAELKSATKNFSRSVVIGEGGF-GCVYKGLIKNSEDPSQKVEVAVKQLGR---RGV------------------ 128 (428)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~-g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~------------------ 128 (428)
.+..|+. -+.+++.++.||.|.- |.||++...+. .+|+|.+.. ...
T Consensus 28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~-------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (207)
T PF13095_consen 28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGR-------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPA 95 (207)
T ss_pred CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCe-------EEEEEEeeccccCCCccccccccccccccchhh
Confidence 4555655 1268889999999999 99999988764 799999321 100
Q ss_pred ccHHHHHHHHHHHhcC---CCCCc--ccEeeEEecCC--------------CCCceEEEEEeecCCCCcccccCCCCccc
Q 014245 129 QGHKEWMTEVNFLGIV---EHQNL--VKLVGYCADDD--------------ERGIQRLLVYEYMPNGSVDQYLSPKSETI 189 (428)
Q Consensus 129 ~~~~~~~~E~~~l~~l---~h~nI--v~~~~~~~~~~--------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 189 (428)
.....|..|.+...+| .+.++ |+.+||..-.. .....+.||.||.+... .
T Consensus 96 ~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~ 164 (207)
T PF13095_consen 96 HYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------P 164 (207)
T ss_pred hhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------c
Confidence 1123577888887776 45566 99999984331 12234578888876543 1
Q ss_pred ccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 190 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 190 l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
+.. .-+.+|..-|..+|.. ||+-+|+++.|.. .-||+|||.+
T Consensus 165 ~~~----~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQI----RDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cch----hHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 222 2345677778889988 9999999999985 4589999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.2e-06 Score=89.86 Aligned_cols=200 Identities=20% Similarity=0.201 Sum_probs=140.0
Q ss_pred HHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCC
Q 014245 134 WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 213 (428)
Q Consensus 134 ~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 213 (428)
...|+..+.++.|+|++.+++|-......+....+..|++..-++...+... ...+....+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 3456777888899999999998877655543334556888888887777543 3477888888999999999999987
Q ss_pred CCCeeeccCCCC---ceEECCCCCeEEe--eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCc--hhhhhHHH
Q 014245 214 DFQIIVRDFKSS---NILLDEQWNAKLS--DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAAR--SDVWSYGV 286 (428)
Q Consensus 214 ~~~ivHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwslG~ 286 (428)
...|.-+..+ +...+..+.+.++ ||+.+......... ....-+..+.++|......++.+ .|+|.+|.
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 5555555444 5555677777777 99888765543322 22345567888887776666554 79999999
Q ss_pred HHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014245 287 FLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366 (428)
Q Consensus 287 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 366 (428)
.+..+..|..+-..... ...+++.. ....+.+....|+..++++|+++.+++.
T Consensus 381 l~~~~~~~~~i~~~~~~-------------------~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV-------------------PVSLLDVL--------STSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHhhhhhcCcccccccc-------------------hhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhhh
Confidence 99999998765432110 00111110 1115677888999999999999999998
Q ss_pred HH
Q 014245 367 MV 368 (428)
Q Consensus 367 ~L 368 (428)
+.
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 74
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.6e-05 Score=69.76 Aligned_cols=78 Identities=10% Similarity=0.112 Sum_probs=47.4
Q ss_pred eeecccCce-EEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCC---CcccEeeEEecCCCCCceE
Q 014245 91 VVIGEGGFG-CVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQ---NLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 91 ~~lG~G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~~~~~~~~~~ 166 (428)
+.|+.||.. .||+.. . .+++|..... .....+.+|+.+|..|... -+.++++....... ....
T Consensus 3 ~~~~~gG~~n~vy~~~----~------~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~-~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRLG----D------DMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEG-YPWP 69 (235)
T ss_pred eeccCCCcccceEEcC----C------ceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccC-CCcc
Confidence 467877776 489741 1 3677765432 2345788999999888532 34444444332211 1123
Q ss_pred EEEEeecCCCCcccc
Q 014245 167 LLVYEYMPNGSVDQY 181 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~ 181 (428)
++||++++|.++.+.
T Consensus 70 ~~l~~~i~G~~l~~~ 84 (235)
T cd05155 70 WSVYRWLEGETATAA 84 (235)
T ss_pred eEEEEeecCCCCCcc
Confidence 789999999888654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.5e-05 Score=66.90 Aligned_cols=128 Identities=19% Similarity=0.268 Sum_probs=83.2
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC----------------cccHHHHHHHHHHHhcCC------CC
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------------VQGHKEWMTEVNFLGIVE------HQ 147 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~ 147 (428)
...||+|+.=.||. +.... ...||+..... ....++..+|+.-...+. +.
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp------~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~ 77 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDP------NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWS 77 (199)
T ss_pred CcccccCCCceEEE--CCCCC------CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccc
Confidence 45799999999995 33322 36777776554 122455666766555554 88
Q ss_pred CcccEeeEEecCCCCCceEEEEEeecCC------CCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeecc
Q 014245 148 NLVKLVGYCADDDERGIQRLLVYEYMPN------GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRD 221 (428)
Q Consensus 148 nIv~~~~~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD 221 (428)
+|.+++|+...+... -+|+|.+.+ -+|.+++... .++. .....+. +-..||-+. +|+.+|
T Consensus 78 ~i~r~~G~veT~~G~----Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~---~f~~~l~~~---~Iv~~d 143 (199)
T PF10707_consen 78 HIPRFYGFVETNLGL----GLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALD---EFKRYLLDH---HIVIRD 143 (199)
T ss_pred ccccEeEEEecCCce----EEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHH---HHHHHHHHc---CCeecC
Confidence 999999999887765 677777532 3456666322 2444 3333333 334566655 899999
Q ss_pred CCCCceEECCCC----CeEEee
Q 014245 222 FKSSNILLDEQW----NAKLSD 239 (428)
Q Consensus 222 lkp~NILl~~~~----~~kl~D 239 (428)
|+|.||++.... .+.|+|
T Consensus 144 l~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 144 LNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CCcccEEEEecCCCceEEEEEe
Confidence 999999994332 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00012 Score=69.35 Aligned_cols=82 Identities=15% Similarity=0.125 Sum_probs=55.6
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC---CCcccEeeEEecCCCCCc
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH---QNLVKLVGYCADDDERGI 164 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~~~~~~ 164 (428)
...+.||.|..+.||.....++ .+.+|..+.. .....+..|+..|+.|.- -.+.++++++.+....+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-------~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g- 86 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-------NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG- 86 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-------CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC-
Confidence 3455799999999998753322 3566664321 123578899999998843 36888898886542211
Q ss_pred eEEEEEeecCCCCcc
Q 014245 165 QRLLVYEYMPNGSVD 179 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~ 179 (428)
..+||||+++|+++.
T Consensus 87 ~~~LVmE~i~G~~~~ 101 (297)
T PRK10593 87 PDVLLLERLRGVSVE 101 (297)
T ss_pred CeEEEEeccCCEecC
Confidence 249999999987763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00014 Score=66.43 Aligned_cols=76 Identities=17% Similarity=0.209 Sum_probs=46.3
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC-cccEeeEEecCCCCCceEEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDERGIQRLLV 169 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~~~~~lv 169 (428)
+.|..|-...+|+....+. ....|++|........ .....+|+.++..+...+ .+++++.+. . .+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~----~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~------~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED----NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N------GLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCCC----CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C------cEE
Confidence 4677788889999864420 1126888876543221 122347888888884433 444444322 2 479
Q ss_pred EeecCCCCcc
Q 014245 170 YEYMPNGSVD 179 (428)
Q Consensus 170 ~e~~~~g~L~ 179 (428)
|||++|.++.
T Consensus 71 ~e~i~G~~l~ 80 (235)
T cd05157 71 YEFIPGRTLE 80 (235)
T ss_pred EEeeCCCcCC
Confidence 9999997764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00014 Score=67.47 Aligned_cols=137 Identities=12% Similarity=0.036 Sum_probs=75.9
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCc-ccEeeEEecCCCCCceEEEEEe
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLLVYE 171 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~~~~~lv~e 171 (428)
+..|-.+.+|+....+ ..+++|..........-...+|..+++.+....+ .++++.. .+ ++|||
T Consensus 4 ~~~G~tn~~y~~~~~~-------~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~------~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPG-------ISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EH------WLLVE 68 (256)
T ss_pred CCCcCcCCeEEEEeCC-------ccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CC------EEEEE
Confidence 4567788899876221 2577887544322211234678889988854433 4444433 22 68999
Q ss_pred ecCCCCccccc-----------------CCC--CcccccHH-HHHHHHHHH---------HHHHHHhhcC-----CCCCe
Q 014245 172 YMPNGSVDQYL-----------------SPK--SETILTWA-MRLKIAQDA---------ARGLAYLHEG-----MDFQI 217 (428)
Q Consensus 172 ~~~~g~L~~~l-----------------~~~--~~~~l~~~-~~~~i~~~i---------~~~L~~LH~~-----~~~~i 217 (428)
|++|..+.... +.. ....++.. ....+..++ ...+..+-.. ....+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 99987765420 000 01111111 111111111 1111111111 12368
Q ss_pred eeccCCCCceEECCCCCeEEeeeccccc
Q 014245 218 IVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 218 vHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
+|+|+.|.||++++++ +.|+||..+..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999877 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00011 Score=69.78 Aligned_cols=145 Identities=14% Similarity=0.095 Sum_probs=81.9
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC--cccEeeEEecCC--CCCce
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN--LVKLVGYCADDD--ERGIQ 165 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~--~~~~~ 165 (428)
.+.|..|....+|+....++ .+++|.... .....+..|+.++..|.+.+ +.+++....... .....
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-------~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-------RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred eecccCccccceEEEEeCCC-------cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 45677787789998764332 488888764 22345667888887774332 444443211000 00113
Q ss_pred EEEEEeecCCCCccccc----C--------------CCCc-----ccccHHHHH----------HHHHHHHHHHHHhhc-
Q 014245 166 RLLVYEYMPNGSVDQYL----S--------------PKSE-----TILTWAMRL----------KIAQDAARGLAYLHE- 211 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l----~--------------~~~~-----~~l~~~~~~----------~i~~~i~~~L~~LH~- 211 (428)
.++|++|++|..+...- . .... ....|.... .....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 48999999998765410 0 0000 001111110 011112233444432
Q ss_pred ---CCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 212 ---GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 212 ---~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
....+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 123479999999999999998777899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00096 Score=63.98 Aligned_cols=31 Identities=23% Similarity=0.265 Sum_probs=26.5
Q ss_pred CCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 214 DFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 214 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||+|+.|.|||++++...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3489999999999999976556899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00064 Score=64.69 Aligned_cols=145 Identities=21% Similarity=0.272 Sum_probs=81.5
Q ss_pred eeecccCceEEEEEEEcCCC-CCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC-cccEeeEEecCCCCCceEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSE-DPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~~~~~l 168 (428)
+.|..|-...+|+....++. ....+..+++|...... ....+..+|..++..+.... ..++++++. + .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~------~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N------GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C------Cc
Confidence 35666777789988754310 00112368888865432 22235568888888884333 345555543 2 35
Q ss_pred EEeecCCCCcccc-cC----------------CCCcc-------ccc--HHHHHH-------------------------
Q 014245 169 VYEYMPNGSVDQY-LS----------------PKSET-------ILT--WAMRLK------------------------- 197 (428)
Q Consensus 169 v~e~~~~g~L~~~-l~----------------~~~~~-------~l~--~~~~~~------------------------- 197 (428)
|+||++|..+... +. ..... ..+ +.....
T Consensus 75 v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (302)
T cd05156 75 IEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELS 154 (302)
T ss_pred hhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHH
Confidence 8999998777542 10 00000 000 111100
Q ss_pred -HHHHHHHHHHHhhc------CCCCCeeeccCCCCceEECCC----CCeEEeeecccc
Q 014245 198 -IAQDAARGLAYLHE------GMDFQIIVRDFKSSNILLDEQ----WNAKLSDFGLAR 244 (428)
Q Consensus 198 -i~~~i~~~L~~LH~------~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~ 244 (428)
+...+...+..|-. .....++|+|+.+.|||++++ +.+.|+||..|.
T Consensus 155 ~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 155 LFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 11122222333431 234579999999999999985 889999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0019 Score=61.64 Aligned_cols=160 Identities=16% Similarity=0.138 Sum_probs=87.2
Q ss_pred CHHHHHHHhcCCCC-----ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC--
Q 014245 76 TIAELKSATKNFSR-----SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN-- 148 (428)
Q Consensus 76 ~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-- 148 (428)
+.+++......|.+ ++.++.|....+|+....++ .+++|...... .......|+.++..|....
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-------~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~p 78 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-------RYILTLYEKRV--KAEELPFFLALTTHLAARGLP 78 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-------cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCC
Confidence 34555555555544 34567777788998764322 47788765422 2234556777777763222
Q ss_pred cccEeeEEecC--CCCCceEEEEEeecCCCCccccc--------------CCCCc-------c---cccHHHHH------
Q 014245 149 LVKLVGYCADD--DERGIQRLLVYEYMPNGSVDQYL--------------SPKSE-------T---ILTWAMRL------ 196 (428)
Q Consensus 149 Iv~~~~~~~~~--~~~~~~~~lv~e~~~~g~L~~~l--------------~~~~~-------~---~l~~~~~~------ 196 (428)
+.+++...... .......++|+||++|..+.... +.... . .-.|....
T Consensus 79 vp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~ 158 (307)
T TIGR00938 79 VPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEA 158 (307)
T ss_pred CCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhc
Confidence 34444321100 00112458999999986654210 00000 0 01111100
Q ss_pred ------HHHHHHHHHHHHhhc----CCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 197 ------KIAQDAARGLAYLHE----GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 197 ------~i~~~i~~~L~~LH~----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.....+...++++.. ....+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 159 ~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 159 APQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001123334555532 124589999999999999998777899998774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0011 Score=65.05 Aligned_cols=77 Identities=19% Similarity=0.139 Sum_probs=51.5
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC------C-cccHHHHHHHHHHHhcCC---CCCcccEeeEEecC
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------G-VQGHKEWMTEVNFLGIVE---HQNLVKLVGYCADD 159 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~ 159 (428)
.+.||.|.+..||++...++. +.++||.-.+. . ....+++..|.+.|..+. -.++.+++.+..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~-----~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGG-----KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCC-----eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--
Confidence 357899999999999865431 26899985421 1 123456778888888762 346777877633
Q ss_pred CCCCceEEEEEeecCCCC
Q 014245 160 DERGIQRLLVYEYMPNGS 177 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~ 177 (428)
... ++||||+++..
T Consensus 104 ~~~----~lVME~L~~~~ 117 (401)
T PRK09550 104 ELA----VTVMEDLSDHK 117 (401)
T ss_pred CCC----EEEEecCCCcc
Confidence 222 89999997643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.47 E-value=8.5e-06 Score=88.70 Aligned_cols=160 Identities=13% Similarity=0.028 Sum_probs=115.2
Q ss_pred HHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCc--ccccHHHHHHHHHHHHHHHHHhhcC
Q 014245 135 MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE--TILTWAMRLKIAQDAARGLAYLHEG 212 (428)
Q Consensus 135 ~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~ 212 (428)
..|.+-++...|+++...+.-....... ..+.+++|+.+|.+...|.+..+ ..+....+.....+.+.+..-+|..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~--ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSEST--EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCCh--HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3455555667899888776555443322 33789999999999998865432 2233333433334435666666654
Q ss_pred C--CCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHH
Q 014245 213 M--DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYE 290 (428)
Q Consensus 213 ~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e 290 (428)
. ..-.+|++||+.|.+|..+.++|++++|+.+..... ........+++.|++|++...-.++.++|+|..|+.+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 3 234799999999999999999999999999843221 223345678899999999888889999999999999999
Q ss_pred HHhCCCCC
Q 014245 291 LITGRRPI 298 (428)
Q Consensus 291 lltg~~p~ 298 (428)
..-|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 99888776
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0036 Score=60.72 Aligned_cols=143 Identities=15% Similarity=0.193 Sum_probs=80.0
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCc-ccEeeEEecCCCCCceEEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~~~~~lv~ 170 (428)
.|-.|-.-.+|++....+.. .....|++|.......... +-.+|..++..+..-++ .++++.+.. ..|.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~-~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~--------g~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEG-NLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN--------GRVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCCCC-CCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC--------ceEE
Confidence 45457778899987543211 1234688888765432222 23678888888854444 455655422 2589
Q ss_pred eecCCCCcccc-c----------------CCC---C-cccccHHHHHHHHHHH-----------------HHHHHH----
Q 014245 171 EYMPNGSVDQY-L----------------SPK---S-ETILTWAMRLKIAQDA-----------------ARGLAY---- 208 (428)
Q Consensus 171 e~~~~g~L~~~-l----------------~~~---~-~~~l~~~~~~~i~~~i-----------------~~~L~~---- 208 (428)
||+++.+|... + +.. . .....+..+..+..++ ...+..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99988776421 1 000 0 0011122222222111 111111
Q ss_pred hhc-CCCCCeeeccCCCCceEECC-CCCeEEeeecccc
Q 014245 209 LHE-GMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLAR 244 (428)
Q Consensus 209 LH~-~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~ 244 (428)
+.. .....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 221 22347899999999999986 4679999998775
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00047 Score=64.42 Aligned_cols=134 Identities=16% Similarity=0.053 Sum_probs=89.4
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-----------------c---cc--HHHHHHHHHHHhc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----------------V---QG--HKEWMTEVNFLGI 143 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------------~---~~--~~~~~~E~~~l~~ 143 (428)
=++.++.||-|--+.||.+....++ +.++|.-.... . .. .-...+|+..|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~------~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka 166 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGN------PLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA 166 (465)
T ss_pred hhhhccccccccccceEEEecCCCC------chhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence 3678889999999999999876554 56666531100 0 00 1123578888888
Q ss_pred CC-CCC-cccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeecc
Q 014245 144 VE-HQN-LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRD 221 (428)
Q Consensus 144 l~-h~n-Iv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD 221 (428)
|. |.. |.+.+++... ++|||++.|-.|...-.- .+... +...+..-+.-|..+ |+||+|
T Consensus 167 L~e~gfpVPkpiD~~RH--------~Vvmelv~g~Pl~~v~~v-----~d~~~---ly~~lm~~Iv~la~~---GlIHgD 227 (465)
T KOG2268|consen 167 LYERGFPVPKPIDHNRH--------CVVMELVDGYPLRQVRHV-----EDPPT---LYDDLMGLIVRLANH---GLIHGD 227 (465)
T ss_pred HHHcCCCCCCcccccce--------eeHHHhhcccceeeeeec-----CChHH---HHHHHHHHHHHHHHc---Cceecc
Confidence 83 332 4455544322 889999999888765422 22222 333444445556665 999999
Q ss_pred CCCCceEECCCCCeEEeeecccc
Q 014245 222 FKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 222 lkp~NILl~~~~~~kl~DFGla~ 244 (428)
..-=||++++++.++++||--..
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cchheeEEecCCCEEEeechHhh
Confidence 99999999999999999996543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0079 Score=56.37 Aligned_cols=30 Identities=27% Similarity=0.450 Sum_probs=25.5
Q ss_pred CeeeccCCCCceEECCCCC-eEEeeeccccc
Q 014245 216 QIIVRDFKSSNILLDEQWN-AKLSDFGLARL 245 (428)
Q Consensus 216 ~ivHrDlkp~NILl~~~~~-~kl~DFGla~~ 245 (428)
.++|+|+.|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0097 Score=56.46 Aligned_cols=121 Identities=21% Similarity=0.283 Sum_probs=75.2
Q ss_pred EEEEEEccC--CCcccHHHHHHHHHHHhcCCC--CCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccH
Q 014245 117 EVAVKQLGR--RGVQGHKEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTW 192 (428)
Q Consensus 117 ~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~ 192 (428)
.+++. ... ..........+|+.+|+.+.- --+...+++|.+.. .+ ..|.||+|++|..+......... .
T Consensus 50 ~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~-~g-~pf~v~~~veGe~~~~~~~~~~~---~- 122 (321)
T COG3173 50 KYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY-LG-TPFYVMEWVEGEVVWSALPPESL---G- 122 (321)
T ss_pred eEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC-CC-CceEEEEEecceeccCcCCcccc---h-
Confidence 56776 332 223344556688888887732 23455577777766 22 34899999988655444322111 1
Q ss_pred HHHHHHH-HHHHHHHHHhh--------------------------------------------------cC-----CCCC
Q 014245 193 AMRLKIA-QDAARGLAYLH--------------------------------------------------EG-----MDFQ 216 (428)
Q Consensus 193 ~~~~~i~-~~i~~~L~~LH--------------------------------------------------~~-----~~~~ 216 (428)
.+++ ..++..|+-|| .+ ....
T Consensus 123 ---~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~ 199 (321)
T COG3173 123 ---RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV 199 (321)
T ss_pred ---HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence 0111 23444444444 21 2356
Q ss_pred eeeccCCCCceEECCCCCeEEeeecccccCC
Q 014245 217 IIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247 (428)
Q Consensus 217 ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 247 (428)
++|+|+.+.||+++.++.+-|.||+++...+
T Consensus 200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 9999999999999999889999999997654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0051 Score=58.52 Aligned_cols=105 Identities=20% Similarity=0.197 Sum_probs=71.7
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..|++|++- |++|...- .-.+.++..|+++.+..+.-+..+ ...-|||+.-.||||+ +|++.|+||-+++
T Consensus 300 y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 300 YLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence 457777776 66664322 245788889999988887777654 6889999999999999 8999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHH
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 287 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 287 (428)
.....+.. .-...--|-.+. |.-+.+-|||-+--.
T Consensus 370 l~~~q~~i-------sy~rldhp~lF~-G~dd~QFeIYrlMr~ 404 (488)
T COG5072 370 LSYSQGII-------SYNRLDHPDLFN-GVDDYQFEIYRLMRR 404 (488)
T ss_pred cccCCcee-------eccccCchhhhc-CccceeeeHHHHHHH
Confidence 64433211 111222344444 333677788765433
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.034 Score=54.59 Aligned_cols=80 Identities=14% Similarity=0.070 Sum_probs=51.6
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-------ccHHHHHHHHHHHhcCC---CCCcccEeeEEecC
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-------QGHKEWMTEVNFLGIVE---HQNLVKLVGYCADD 159 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~ 159 (428)
.+.||-|....||+....+ ..++||+-..... ....+-..|+..|..+. -.++.+++.++.+.
T Consensus 37 ~~eiggGn~N~VyrV~~~~-------~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSS-------GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM 109 (418)
T ss_pred EEEcCCCceeeEEEEEcCC-------ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC
Confidence 4578999999999976432 1488888652211 12334445666666553 35788899888754
Q ss_pred CCCCceEEEEEeecCC--CCccccc
Q 014245 160 DERGIQRLLVYEYMPN--GSVDQYL 182 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~--g~L~~~l 182 (428)
. +++|||+++ ..+.+.+
T Consensus 110 ~------vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 110 A------LIGMRYLEPPHIILRKGL 128 (418)
T ss_pred C------EEEEeecCCcceehhhhh
Confidence 3 899999976 3444443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0048 Score=55.32 Aligned_cols=30 Identities=30% Similarity=0.452 Sum_probs=21.4
Q ss_pred CCeeeccCCCCceEE-CCCCCeEEeeecccc
Q 014245 215 FQIIVRDFKSSNILL-DEQWNAKLSDFGLAR 244 (428)
Q Consensus 215 ~~ivHrDlkp~NILl-~~~~~~kl~DFGla~ 244 (428)
..++|+||.+.|||+ +.++.++|+||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 368999999999999 888999999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.015 Score=55.54 Aligned_cols=136 Identities=16% Similarity=0.153 Sum_probs=86.4
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---------c----------------cHHH-HHHHHHHHhcCC
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---------Q----------------GHKE-WMTEVNFLGIVE 145 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------~----------------~~~~-~~~E~~~l~~l~ 145 (428)
.|..|--+.||.|.-.++. .+|||+++-.-. . ..+- ...|++-|.+|+
T Consensus 151 CiSTGKEANVYHat~~dG~------~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGS------EFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred ccccCccceeEeeecCCCc------eEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 4667778889998765554 699998742100 0 0011 235777777776
Q ss_pred CCCcccEeeEEecCCCCCceEEEEEeecCCCC-cccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCC
Q 014245 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGS-VDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 224 (428)
Q Consensus 146 h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp 224 (428)
.-.|.-.--+..... +|||+|+.... -.-.|. ...++...+..+-.|++.-+.-|-+. .++||.||.-
T Consensus 225 ~aGIP~PePIlLk~h------VLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSE 293 (520)
T KOG2270|consen 225 NAGIPCPEPILLKNH------VLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSE 293 (520)
T ss_pred hcCCCCCCceeeecc------eEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhh
Confidence 544332222222222 89999994311 111221 22366667777888888888888765 3899999999
Q ss_pred CceEECCCCCeEEeeeccccc
Q 014245 225 SNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 225 ~NILl~~~~~~kl~DFGla~~ 245 (428)
-|+|+-+ |.+.|+|.+-+..
T Consensus 294 fN~Lyhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 294 FNLLYHD-GKLYIIDVSQSVE 313 (520)
T ss_pred hhheEEC-CEEEEEEcccccc
Confidence 9999865 5899999887643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0051 Score=61.00 Aligned_cols=51 Identities=20% Similarity=0.369 Sum_probs=39.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCC
Q 014245 131 HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK 185 (428)
Q Consensus 131 ~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 185 (428)
..++.-.+.+++.+.|+|+..++++-...... ..+|||++ +.+|++.+..+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r---~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHER---VIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccce---EEEEehhh-ccchHHHHHhc
Confidence 34566678889999999999998877655443 57899999 67999887543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.11 Score=49.74 Aligned_cols=142 Identities=17% Similarity=0.221 Sum_probs=78.2
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC---CC---cccEeeEEecCCCCCceE
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH---QN---LVKLVGYCADDDERGIQR 166 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~n---Iv~~~~~~~~~~~~~~~~ 166 (428)
|.+ .-..||+....++ .+++|+.... ....++..|+..|..|.- +- |..+=|-....-......
T Consensus 34 l~s-~eN~~f~~~~~~g-------~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 34 LNS-EENSNFRVQTEDG-------RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccc-ccCceEEEEecCC-------CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 444 4456888876554 3588887665 344566777777777622 11 122212111110000245
Q ss_pred EEEEeecCCCCccc-ccC------------------C----CC--cccccHHH-------------HHHHHHHHHHHHHH
Q 014245 167 LLVYEYMPNGSVDQ-YLS------------------P----KS--ETILTWAM-------------RLKIAQDAARGLAY 208 (428)
Q Consensus 167 ~lv~e~~~~g~L~~-~l~------------------~----~~--~~~l~~~~-------------~~~i~~~i~~~L~~ 208 (428)
+-|++|++|..+.. .-. . +. .....|.. ......++...+..
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 78999999988883 210 0 00 01223320 01122333334444
Q ss_pred hhcC----CCCC---eeeccCCCCceEECCCCC-eEEeeecccc
Q 014245 209 LHEG----MDFQ---IIVRDFKSSNILLDEQWN-AKLSDFGLAR 244 (428)
Q Consensus 209 LH~~----~~~~---ivHrDlkp~NILl~~~~~-~kl~DFGla~ 244 (428)
+.+. .... +||+|+.|.|||++.+.. +.+.||+-+.
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 4322 1223 999999999999999875 8999999775
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.012 Score=52.20 Aligned_cols=103 Identities=13% Similarity=0.115 Sum_probs=67.0
Q ss_pred EEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHH
Q 014245 117 EVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 195 (428)
Q Consensus 117 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~ 195 (428)
...+|++...... ....|..+..++.+++ .|+++. .+ .+..+-++.|+|-.... ..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---ND---n~~~yGvIlE~Cy~~~i-----------~~---- 143 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---ND---NNYKYGVILERCYKIKI-----------NF---- 143 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cC---CCceeEEEEeeccCccc-----------ch----
Confidence 4566666554443 3456678888888764 366665 22 22345789999832111 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 196 ~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++..=+.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+..
T Consensus 144 ~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 144 SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 11222224678888965 458999999999999999999999997643
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.023 Score=54.28 Aligned_cols=32 Identities=19% Similarity=0.252 Sum_probs=28.5
Q ss_pred CCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 214 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 214 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
..+++|+|+.++|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44799999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.04 Score=54.11 Aligned_cols=80 Identities=15% Similarity=0.230 Sum_probs=45.8
Q ss_pred eeecccCceEEEEEEEcCCC-CCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCc-ccEeeEEecCCCCCceEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSE-DPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~~~~~l 168 (428)
+.|..|-...+|++...+.. .....+.|.++...... ...-.-.+|+.++..+...++ .++++.+. + ++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--~------g~ 126 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--D------FT 126 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC--C------EE
Confidence 45555888899998754332 11111224444432221 111122478999999965544 45555553 2 68
Q ss_pred EEeecCCCCcc
Q 014245 169 VYEYMPNGSVD 179 (428)
Q Consensus 169 v~e~~~~g~L~ 179 (428)
|.||++|..|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999997775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.043 Score=51.62 Aligned_cols=75 Identities=17% Similarity=0.241 Sum_probs=44.1
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC---CCCCcccEeeEEecCCCCCc
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV---EHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~~ 164 (428)
+..+.|+-|....+|+.. .+ ...+.||.-.. .....|..|+.-|+.| .--.+.+++++....+..
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~------~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~-- 87 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TD------GGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA-- 87 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TT------S-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC--
T ss_pred eeeEecCCCChhheEEEE-CC------CccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc--
Confidence 344578888899999876 22 22688888652 2334677888877777 344577888888766544
Q ss_pred eEEEEEeecCCC
Q 014245 165 QRLLVYEYMPNG 176 (428)
Q Consensus 165 ~~~lv~e~~~~g 176 (428)
+|||||++.+
T Consensus 88 --fLlle~l~~~ 97 (288)
T PF03881_consen 88 --FLLLEFLEMG 97 (288)
T ss_dssp --EEEEE-----
T ss_pred --eEEEEeecCC
Confidence 9999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.058 Score=51.98 Aligned_cols=142 Identities=16% Similarity=0.205 Sum_probs=77.3
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCc-ccEeeEEecCCCCCceEEEEE
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLLVY 170 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~~~~~lv~ 170 (428)
.|..|=.-.+|+....+.. .....|++|....... ..-.-.+|..+++.+..-++ .++++++. . .+|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~--~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~------G~i~ 89 (330)
T PLN02421 21 RISGGITNLLLKVSVKEEN--GNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG--N------GMIQ 89 (330)
T ss_pred EeCCcccceEEEEEecCCC--CCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC--C------cEee
Confidence 4544667788988654321 1122588887755332 12223578888888865555 45565542 2 2589
Q ss_pred eecCCCCccc--c-----c----------CCCC---c-ccccHHHHHHHHHHH-------------------------HH
Q 014245 171 EYMPNGSVDQ--Y-----L----------SPKS---E-TILTWAMRLKIAQDA-------------------------AR 204 (428)
Q Consensus 171 e~~~~g~L~~--~-----l----------~~~~---~-~~l~~~~~~~i~~~i-------------------------~~ 204 (428)
+|++|..|.. + + +... . ..--+..+..+..++ +.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9998776632 1 0 0000 0 011122222222111 11
Q ss_pred HHHHhh-c-CCCCCeeeccCCCCceEECC-CCCeEEeeecccc
Q 014245 205 GLAYLH-E-GMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLAR 244 (428)
Q Consensus 205 ~L~~LH-~-~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~ 244 (428)
.+..+. . ..+.-++|+|+.+.|||+++ ++.++++||..|.
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 111111 1 11234899999999999975 5789999998874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.08 Score=51.12 Aligned_cols=73 Identities=14% Similarity=0.082 Sum_probs=44.3
Q ss_pred eecccCceEEEEEEEcCCCCCCcceEEEEEEccCC------C-cccHHHHHHHHHHHhcCC--CC-CcccEeeEEecCCC
Q 014245 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------G-VQGHKEWMTEVNFLGIVE--HQ-NLVKLVGYCADDDE 161 (428)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~~~ 161 (428)
.||-|....||++...++ ...|+||+-.+. . .....+...|...|+... -| .+.++|.|-. ..
T Consensus 2 EigdGnlN~VfrV~~~~g-----~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~--e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEG-----DRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT--EM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCC-----CeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc--cc
Confidence 478899999999985322 136888886421 1 122345567777776652 34 4555654432 22
Q ss_pred CCceEEEEEeecCC
Q 014245 162 RGIQRLLVYEYMPN 175 (428)
Q Consensus 162 ~~~~~~lv~e~~~~ 175 (428)
. .+|||+++.
T Consensus 75 ~----~~vMEdL~~ 84 (370)
T TIGR01767 75 A----VTVMEDLSH 84 (370)
T ss_pred c----eehHhhCcc
Confidence 2 689999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.057 Score=52.78 Aligned_cols=75 Identities=20% Similarity=0.233 Sum_probs=46.5
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC---C---cccHHHHHHHHHHHhcCC--CC-CcccEeeEEecCC
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---G---VQGHKEWMTEVNFLGIVE--HQ-NLVKLVGYCADDD 160 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~~ 160 (428)
.+.||-|.-.-||++....+. ..|+||+-... . .-..++...|.++|+.+. .| .+.++|.+-. .
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~-----~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKN-----ISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--V 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCC-----ceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--H
Confidence 457899999999999863211 25888886421 1 123456667777777652 34 4556654432 2
Q ss_pred CCCceEEEEEeecCC
Q 014245 161 ERGIQRLLVYEYMPN 175 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~ 175 (428)
.. .+|||+++.
T Consensus 107 ~~----~~vMEdL~~ 117 (409)
T PRK12396 107 MN----CCVMEDLSD 117 (409)
T ss_pred Hh----hHHHHhCcc
Confidence 22 689999854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.16 Score=56.37 Aligned_cols=32 Identities=38% Similarity=0.371 Sum_probs=26.6
Q ss_pred CCCeeeccCCCCceEECCCC--CeE-Eeeeccccc
Q 014245 214 DFQIIVRDFKSSNILLDEQW--NAK-LSDFGLARL 245 (428)
Q Consensus 214 ~~~ivHrDlkp~NILl~~~~--~~k-l~DFGla~~ 245 (428)
..++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 34899999999999999875 554 999998753
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.27 Score=49.34 Aligned_cols=81 Identities=12% Similarity=0.122 Sum_probs=47.4
Q ss_pred ceeecccCceEEEEEEEcCCCC---CCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcc-cEeeEEecCCCCCce
Q 014245 90 SVVIGEGGFGCVYKGLIKNSED---PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV-KLVGYCADDDERGIQ 165 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~~~ 165 (428)
++.|..|-.-.+|++....... ...+..|.+++.......-. .-..|..++..+...+|- ++++.+. +
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--g----- 181 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS--G----- 181 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC--C-----
Confidence 4456667677889887653211 11234688887755432221 334688888777554443 4555542 2
Q ss_pred EEEEEeecCCCCcc
Q 014245 166 RLLVYEYMPNGSVD 179 (428)
Q Consensus 166 ~~lv~e~~~~g~L~ 179 (428)
..|.||++|..|.
T Consensus 182 -g~I~efi~g~~l~ 194 (442)
T PTZ00296 182 -GRIEEWLYGDPLR 194 (442)
T ss_pred -CEEEEeeCCccCC
Confidence 5689999987554
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.04 Score=53.46 Aligned_cols=60 Identities=23% Similarity=0.178 Sum_probs=43.1
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
+|+-+|..|-++..++.... .+++....++.-.+.||--+--. -+.+|.|+.|.||++-.
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF 380 (565)
T ss_pred eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence 67888999999999887544 45555666666666665433321 17999999999999943
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.36 Score=45.55 Aligned_cols=29 Identities=38% Similarity=0.471 Sum_probs=24.3
Q ss_pred CeeeccCCCCceEECCC--C---CeEEeeecccc
Q 014245 216 QIIVRDFKSSNILLDEQ--W---NAKLSDFGLAR 244 (428)
Q Consensus 216 ~ivHrDlkp~NILl~~~--~---~~kl~DFGla~ 244 (428)
-++|||++..|||+..+ | .+++.||-+++
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeecccccc
Confidence 59999999999999654 3 58999998765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.26 Score=44.26 Aligned_cols=56 Identities=27% Similarity=0.392 Sum_probs=37.6
Q ss_pred EEEEEEccCCCcccHHHHHHHHHHHhcCC---CCCcccEeeEEecCCCCCceEEEEEeecCCCCcc
Q 014245 117 EVAVKQLGRRGVQGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 179 (428)
Q Consensus 117 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 179 (428)
.+.+|.-.. .....|..|+.-|..|. --++.+++.+...... .|+||||++-|.++
T Consensus 41 ~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~----sylVle~L~~~~~d 99 (286)
T COG3001 41 PFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDH----SYLVLEYLPTGPLD 99 (286)
T ss_pred ceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCe----eEEEEeeccCCCCC
Confidence 678886432 23356777877777663 3457777766655543 49999999987776
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 428 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-57 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-39 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 467 bits (1205), Expect = e-166
Identities = 111/322 (34%), Positives = 167/322 (51%), Gaps = 29/322 (9%)
Query: 64 SMSQRPSNLKEFTIAELKSATKNFSRSV------VIGEGGFGCVYKGLIKNSEDPSQKVE 117
S+ + F+ ELK+ T NF +GEGGFG VYKG + N+
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT------- 56
Query: 118 VAVKQLG----RRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYM 173
VAVK+L + +++ E+ + +H+NLV+L+G+ +D D LVY YM
Sbjct: 57 VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DLCLVYVYM 112
Query: 174 PNGSVDQYL-SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 232
PNGS+ L L+W MR KIAQ AA G+ +LHE I RD KS+NILLDE
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA 169
Query: 233 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELI 292
+ AK+SDFGLAR T +++ +VGT Y APE + G + +SD++S+GV L E+I
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228
Query: 293 TGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLV 352
TG +D +R Q LL + + K +D ++ V + VA+ CL
Sbjct: 229 TGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLH 285
Query: 353 KNARTRPKMSEVLEMVNKIVDA 374
+ RP + +V +++ ++ +
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 438 bits (1130), Expect = e-154
Identities = 114/311 (36%), Positives = 167/311 (53%), Gaps = 16/311 (5%)
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
+ S P + +L+ AT NF +IG G FG VYKG++++ +V
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA------KV 66
Query: 119 AVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 178
A+K+ QG +E+ TE+ L H +LV L+G+C + + + +L+Y+YM NG++
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN----EMILIYKYMENGNL 122
Query: 179 DQYL--SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236
++L S ++W RL+I AARGL YLH II RD KS NILLDE + K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPK 179
Query: 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 296
++DFG+++ G TH+ST V GT+GY PEY GRL +SDV+S+GV L+E++ R
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 297 PIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNAR 356
I ++ PR L +W + Q QIVDP L K + K A CL ++
Sbjct: 240 AIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 357 TRPKMSEVLEM 367
RP M +VL
Sbjct: 299 DRPSMGDVLWK 309
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 415 bits (1068), Expect = e-145
Identities = 135/302 (44%), Positives = 185/302 (61%), Gaps = 17/302 (5%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG 130
LK F++ EL+ A+ NFS ++G GGFG VYKG + + VAVK+L QG
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT------LVAVKRLKEERTQG 69
Query: 131 HK-EWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSE 187
+ ++ TEV + + H+NL++L G+C +RLLVY YM NGSV L P+S+
Sbjct: 70 GELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLVYPYMANGSVASCLRERPESQ 125
Query: 188 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247
L W R +IA +ARGLAYLH+ D +II RD K++NILLDE++ A + DFGLA+L
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307
THV+TAV GT+G+ APEY+ TG+ + ++DV+ YGV L ELITG+R D R ++
Sbjct: 186 -YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 308 K--LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
LL WVK L + K+ +VD L+G Y V +L VA LC + RPKMSEV+
Sbjct: 245 DVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 366 EM 367
M
Sbjct: 304 RM 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 1e-82
Identities = 76/328 (23%), Positives = 125/328 (38%), Gaps = 34/328 (10%)
Query: 64 SMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL 123
S+ + L + V G FGCV+K + N VAVK
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-------VAVKIF 55
Query: 124 GRRGVQGHKEWM--TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY 181
Q + W EV L ++H+N+++ +G + L+ + GS+ +
Sbjct: 56 PI---QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112
Query: 182 LSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ-------IIVRDFKSSNILLDEQWN 234
L +++W IA+ ARGLAYLHE + I RD KS N+LL
Sbjct: 113 LK---ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
Query: 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA-----RSDVWSYGVFLY 289
A ++DFGLA + + VGT Y APE ++ R D+++ G+ L+
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 290 ELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV-----DPRLEGKY-SLRLVSKL 343
EL + D + + + S +++V P L + ++ L
Sbjct: 230 ELASRCTAADGPVDEYMLPFEEEIGQHPSLE-DMQEVVVHKKKRPVLRDYWQKHAGMAML 288
Query: 344 SHVANLCLVKNARTRPKMSEVLEMVNKI 371
C +A R V E + ++
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 3e-63
Identities = 76/338 (22%), Positives = 127/338 (37%), Gaps = 43/338 (12%)
Query: 74 EFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE 133
E +E N +IG G +G VYKG + VAVK Q
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-------VAVKVFSFANRQ---N 51
Query: 134 WMTEVN--FLGIVEHQNLVKLVGYCADDDERG-IQRLLVYEYMPNGSVDQYLSPKSETIL 190
++ E N + ++EH N+ + + G ++ LLV EY PNGS+ +YLS +
Sbjct: 52 FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---S 108
Query: 191 TWAMRLKIAQDAARGLAYLHEGMDF------QIIVRDFKSSNILLDEQWNAKLSDFGLAR 244
W ++A RGLAYLH + I RD S N+L+ +SDFGL+
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 245 ------LGPSEGFTHVSTAVVGTMGYAAPEYVQ-------TGRLAARSDVWSYGVFLYEL 291
L + + + VGT+ Y APE ++ + D+++ G+ +E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 292 ITGRRPIDRNRPRSEQKL-LQWVKPYLSDAKQFRQIVD-----PRLEGKYSL--RLVSKL 343
+ E ++ Q + + +V P+ + V L
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
Query: 344 SHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSP 381
C ++A R E + +++ S
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-58
Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 41/291 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLGIVEHQNL 149
IG G FG V++ S+ VAVK L + E++ EV + + H N+
Sbjct: 44 KIGAGSFGTVHRAEWHGSD-------VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQDAARGLAY 208
V +G I V EY+ GS+ + L + L RL +A D A+G+ Y
Sbjct: 97 VLFMGAVTQPPNLSI----VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268
LH + I+ R+ KS N+L+D+++ K+ DFGL+RL S + S + GT + APE
Sbjct: 153 LH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPE 209
Query: 269 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328
++ +SDV+S+GV L+EL T + +P+ Q+V
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQ------------------QPW--GNLNPAQVVA 249
Query: 329 PRLEGKYSLRLVS----KLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375
L + +++ + C RP + +++++ ++ ++
Sbjct: 250 AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-56
Identities = 76/314 (24%), Positives = 119/314 (37%), Gaps = 49/314 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
V+G G FG V K + + VA+KQ+ K ++ E+ L V H N+VK
Sbjct: 15 VVGRGAFGVVCKAKWRAKD-------VAIKQI--ESESERKAFIVELRQLSRVNHPNIVK 65
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQDAARGLAYLH 210
L G C + LV EY GS+ L + T A + ++G+AYLH
Sbjct: 66 LYGACLNP------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 211 EGMDFQIIVRDFKSSNILLDEQWN-AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
+I RD K N+LL K+ DFG A T G+ + APE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEV 174
Query: 270 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329
+ + + DV+S+G+ L+E+IT R+P D A + V
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDE---------------IGGPAFRIMWAV-- 217
Query: 330 RLEGKYSLRLV------SKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRR 383
R + + C K+ RP M E+++++ ++ A P +
Sbjct: 218 ----HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273
Query: 384 PLRSSTSRETPDHT 397
+ D
Sbjct: 274 YPCQHSLPPGEDGR 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-56
Identities = 63/291 (21%), Positives = 121/291 (41%), Gaps = 50/291 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLGIVEHQNL 149
+ E G ++KG + ++ + VK L R +++ E L I H N+
Sbjct: 17 KLNENHSGELWKGRWQGND-------IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
+ ++G C L+ +MP GS+ L + ++ + +K A D ARG+A+L
Sbjct: 70 LPVLGACQSPPAPHP--TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
H ++ I S ++++DE A++S + + S + + APE
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179
Query: 270 VQTGRLAA---RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326
+Q +D+WS+ V L+EL+T P + LS+ + ++
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP--------------F--ADLSNMEIGMKV 223
Query: 327 VDPRLEGKYSLRLV------SKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
LEG LR +S + +C+ ++ RPK ++ ++ K+
Sbjct: 224 A---LEG---LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-56
Identities = 69/316 (21%), Positives = 115/316 (36%), Gaps = 49/316 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
V+G+G FG K + + + +K+L R + + ++ EV + +EH N++K
Sbjct: 17 VLGKGCFGQAIKVTHRETG-----EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
+G D + + EY+ G++ + ++ W+ R+ A+D A G+AYLH
Sbjct: 72 FIGVLYKDK----RLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT------------HVSTAVV 259
II RD S N L+ E N ++DFGLARL E VV
Sbjct: 127 ---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319
G + APE + + DV+S+G+ L E+I PR+
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT-------------- 229
Query: 320 AKQFRQIVDPRLEGKYSLRLVS----KLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375
+ G + C + RP ++ + +
Sbjct: 230 -----MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL-RMH 283
Query: 376 AEAGSPRRPLRSSTSR 391
P P R
Sbjct: 284 LAGHLPLGPQLEQLDR 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 6e-56
Identities = 71/301 (23%), Positives = 129/301 (42%), Gaps = 60/301 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH-------KEWMTEVNFLGIV 144
IG+GGFG V+KG + K VA+K L +G +E+ EV + +
Sbjct: 26 QIGKGGFGLVHKGRLV-----KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
H N+VKL G + +V E++P G + L + W+++L++ D A
Sbjct: 81 NHPNIVKLYGLMHN------PPRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIAL 133
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQW-----NAKLSDFGLARLGPSEGFTHVSTAVV 259
G+ Y+ + I+ RD +S NI L AK++DFGL++ H + ++
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLL 187
Query: 260 GTMGYAAPEYVQTGRLAA---RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316
G + APE + ++D +S+ + LY ++TG P +
Sbjct: 188 GNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP------------------F 228
Query: 317 LSDAKQFRQIVDPRLEGKYSLRLV------SKLSHVANLCLVKNARTRPKMSEVLEMVNK 370
D + +I + + LR +L +V LC + + RP S +++ +++
Sbjct: 229 --DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
Query: 371 I 371
+
Sbjct: 287 L 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-54
Identities = 70/301 (23%), Positives = 112/301 (37%), Gaps = 36/301 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM--TEVNFLGIVEHQNL 149
+G+G +G V++G + VAVK + K W TE+ ++ H+N+
Sbjct: 15 CVGKGRYGEVWRGSWQGEN-------VAVKIFSS---RDEKSWFRETELYNTVMLRHENI 64
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
+ + Q L+ Y GS+ YL + L L+I A GLA+L
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHL 121
Query: 210 HEGMDFQ-----IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV--STAVVGTM 262
H + I RD KS NIL+ + ++D GLA + + VGT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 263 GYAAPE------YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316
Y APE V R D+W++G+ L+E+ + V P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY--KPPFYDVVPN 239
Query: 317 LSDAKQFRQIV---DPRLEGKYSLRLVSKLSHVANL---CLVKNARTRPKMSEVLEMVNK 370
+ R++V R L+ +A L C +N R + + + K
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 371 I 371
I
Sbjct: 300 I 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-54
Identities = 65/303 (21%), Positives = 111/303 (36%), Gaps = 34/303 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM--TEVNFLGIVEHQNL 149
IG+G +G V+ G + + VAVK W TE+ ++ H+N+
Sbjct: 44 QIGKGRYGEVWMGKWRGEK-------VAVKVFFT---TEEASWFRETEIYQTVLMRHENI 93
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
+ + Q L+ +Y NGS+ YL + L LK+A + GL +L
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHL 150
Query: 210 HEGMDFQ-----IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH--VSTAVVGTM 262
H + I RD KS NIL+ + ++D GLA S+ VGT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 263 GYAAPE------YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316
Y PE + +D++S+G+ L+E+ R + V
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSD 269
Query: 317 LSDAKQFRQIVD----PRLEGKYSLRLV-SKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
S + P ++S ++ + C N +R V + + K+
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 372 VDA 374
++
Sbjct: 330 SES 332
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-54
Identities = 75/296 (25%), Positives = 118/296 (39%), Gaps = 54/296 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH----KEWMTEVNFLGIVEHQ 147
+IG GGFG VY+ E VAVK + + E +++H
Sbjct: 14 IIGIGGFGKVYRAFWIGDE-------VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
N++ L G C + + V E+ G +++ LS K + + + A ARG+
Sbjct: 67 NIIALRGVCLKEPNLCL----VMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMN 119
Query: 208 YLHEGMDFQIIVRDFKSSNILLDE--------QWNAKLSDFGLARLGPSEGFTHVSTAVV 259
YLH+ II RD KSSNIL+ + K++DFGLAR +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAA 175
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319
G + APE ++ + SDVWSYGV L+EL+TG P+
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------------------VPF--R 215
Query: 320 AKQFRQIVDPRLEGKYSLRLVS----KLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
+ K +L + S + + C + +RP + +L+ + I
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-53
Identities = 81/285 (28%), Positives = 122/285 (42%), Gaps = 36/285 (12%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
IG G FG VYKG +VAVK L Q + + EV L H N++
Sbjct: 32 IGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
+GY Q +V ++ S+ +L SET + IA+ ARG+ YLH
Sbjct: 84 LFMGYSTAP-----QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH 137
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE-- 268
II RD KS+NI L E K+ DFGLA +H + G++ + APE
Sbjct: 138 AK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 269 -YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-DAKQFRQI 326
+ + +SDV+++G+ LYEL+TG+ P R +Q + + LS D + R
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLSPDLSKVRSN 253
Query: 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
++ + CL K RP +L + ++
Sbjct: 254 CPK------------RMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 5e-53
Identities = 71/360 (19%), Positives = 128/360 (35%), Gaps = 60/360 (16%)
Query: 45 TSQNVSAISVESEARPSYPSMSQRPSNLKEFTI--AELKSATKNFSRSVVIGEGGFGCVY 102
N+S +S S R + SQ L+E+ I +L+ IG+G FG VY
Sbjct: 2 PEMNLSLLSARSFPRKA----SQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVY 50
Query: 103 KGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLGIVEHQNLVKLVGYCADDD 160
G EVA++ + K + EV H+N+V +G C
Sbjct: 51 HGRWHG--------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 220
I + ++ + ++ +L +IAQ+ +G+ YLH I+ +
Sbjct: 103 HLAI----ITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHK 154
Query: 221 DFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS---TAVVGTMGYAAPEYVQTGRLAA 277
D KS N+ D ++DFGL + G + + APE ++
Sbjct: 155 DLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 278 ---------RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328
SDV++ G YEL P E + Q + + +
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--EAIIWQ-M------GTGMKPNLS 264
Query: 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSS 388
+ + ++S + C RP +++++M+ K+ + P +S+
Sbjct: 265 Q-------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSA 317
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 8e-53
Identities = 70/302 (23%), Positives = 121/302 (40%), Gaps = 38/302 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTE--VNFLGIVEHQNL 149
IG+G FG V++G + E VAVK + + W E + ++ H+N+
Sbjct: 49 SIGKGRFGEVWRGKWRGEE-------VAVKIFSS---REERSWFREAEIYQTVMLRHENI 98
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
+ + D+ Q LV +Y +GS+ YL+ + +T +K+A A GLA+L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 155
Query: 210 HEGMDFQ-----IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH--VSTAVVGTM 262
H + I RD KS NIL+ + ++D GLA S T VGT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 263 GYAAPEYVQTGRLAA-------RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315
Y APE V + R+D+++ G+ +E+ + Q + P
Sbjct: 216 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED--YQLPYYDLVP 272
Query: 316 YLSDAKQFRQIV---DPRLEGKYSLRLVSKLSHVANL---CLVKNARTRPKMSEVLEMVN 369
++ R++V R + L +A + C N R + + ++
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 370 KI 371
++
Sbjct: 333 QL 334
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-43
Identities = 64/332 (19%), Positives = 112/332 (33%), Gaps = 45/332 (13%)
Query: 56 SEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQK 115
+ + S R + + + + + K++ +GEGGF V E
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDN--KHYLFIQKLGEGGFSYVDLV-----EGLHDG 54
Query: 116 VEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN 175
A+K++ Q +E E + + H N+++LV YC + + L+ +
Sbjct: 55 HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114
Query: 176 GSVDQYLS--PKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233
G++ + LT L + RGL +H RD K +NILL ++
Sbjct: 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEG 171
Query: 234 NAKLSDFGLARLGPSEGFTHVS-------TAVVGTMGYAAPEYVQTGRLAA---RSDVWS 283
L D G A T+ Y APE R+DVWS
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231
Query: 284 YGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKL 343
G LY ++ G P D + + L ++ + S+ +
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVAL-------------------AVQNQLSIPQSPRH 272
Query: 344 SHVA-NL---CLVKNARTRPKMSEVLEMVNKI 371
S L + + RP + +L + +
Sbjct: 273 SSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 76/320 (23%), Positives = 129/320 (40%), Gaps = 36/320 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G+G FG V D + VAVKQL G +++ E+ L + +VK
Sbjct: 30 QLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
G + ++ LV EY+P+G + +L + L + L + +G+ YL
Sbjct: 89 YRGVSYGPGRQSLR--LVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YAA 266
+ RD + NIL++ + + K++DFGLA+L P + VV G + A
Sbjct: 146 -RRC--VHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYA 198
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325
PE + + +SDVWS+GV LYEL T + + + P LS +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL-- 256
Query: 326 IVDPRLEGKYSLRLV------SKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAG 379
LE RL +++ + LC + + RP S + ++ + S
Sbjct: 257 -----LEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS---- 305
Query: 380 SPRRPLRSSTSRETPDHTKT 399
+ E H+ +
Sbjct: 306 RGCETHAFTAHPEGKHHSLS 325
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 22/232 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
+GEG FG V D + +VAVK L G + E+ L + H+N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
K G C +D GI+ L+ E++P+GS+ +YL PK++ + +LK A +G+ YL
Sbjct: 87 KYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YA 265
+ + RD + N+L++ + K+ DFGL + ++ V +
Sbjct: 144 S-RQY--VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----EYYTVKDDRDSPVFWY 196
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPY 316
APE + + SDVWS+GV L+EL+T L +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSD----SSPMALFLKMIGPTH 244
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-41
Identities = 67/323 (20%), Positives = 122/323 (37%), Gaps = 40/323 (12%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WM 135
+ ++ + S ++G+G V++G K + A+K + M
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKT-----GDLFAIKVFNNISFLRPVDVQM 55
Query: 136 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAM 194
E L + H+N+VKL + +++ ++L+ E+ P GS+ L P + L +
Sbjct: 56 REFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSE 249
L + +D G+ +L E I+ R+ K NI+ D Q KL+DFG AR L E
Sbjct: 114 FLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 250 GFTHVSTAVVGTMGYAAPEYVQTGRLA--------ARSDVWSYGVFLYELITGRRP-IDR 300
F ++ GT Y P+ + L A D+WS GV Y TG P
Sbjct: 171 QFV----SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 301 NRPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA--------NLC 350
PR ++++ + ++ + ++ + + LS
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
Query: 351 LVKNARTRPKMSEVLEMVNKIVD 373
L + + + I+
Sbjct: 287 LEADQEKCWGFDQFFAETSDILH 309
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-41
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 18/230 (7%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G+G FG V +D + VAVK+L + +++ E+ L ++H N+VK
Sbjct: 17 QLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
G C R ++ L+ EY+P GS+ YL K + + L+ +G+ YL
Sbjct: 76 YKGVCYSAGRRNLK--LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YAA 266
+ I RD + NIL++ + K+ DFGL ++ P + V G + A
Sbjct: 133 -KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EFFKVKEPGESPIFWYA 185
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316
PE + + + SDVWS+GV LYEL T P +E +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEK--SKSPPAEFMRMIGNDKQ 233
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLGIVEHQNL 149
V+G G FG VYKGL E K+ VA+K+L R KE + E + V++ ++
Sbjct: 22 VLGSGAFGTVYKGLWIP-EGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHV 79
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
+L+G C L+ + MP G + Y+ + + + L A+G+ YL
Sbjct: 80 CRLLGICLTS-----TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTM---GYA 265
E + RD + N+L+ + K++DFGLA+ LG E H G +
Sbjct: 134 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE----GGKVPIKWM 186
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
A E + +SDVWSYGV ++EL+T G +P
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 18/230 (7%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G+G FG V +D + VAVK+L + +++ E+ L ++H N+VK
Sbjct: 48 QLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
G C R ++ L+ EY+P GS+ YL K + + L+ +G+ YL
Sbjct: 107 YKGVCYSAGRRNLK--LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YAA 266
+ I RD + NIL++ + K+ DFGL ++ P + V G + A
Sbjct: 164 -KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EYYKVKEPGESPIFWYA 216
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316
PE + + + SDVWS+GV LYEL T P +E +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEK--SKSPPAEFMRMIGNDKQ 264
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 66/323 (20%), Positives = 121/323 (37%), Gaps = 40/323 (12%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WM 135
+ ++ + S ++G+G V++G K + A+K + M
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKT-----GDLFAIKVFNNISFLRPVDVQM 55
Query: 136 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAM 194
E L + H+N+VKL + +++ ++L+ E+ P GS+ L P + L +
Sbjct: 56 REFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSE 249
L + +D G+ +L E I+ R+ K NI+ D Q KL+DFG AR L E
Sbjct: 114 FLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARS--------DVWSYGVFLYELITGRRP-IDR 300
F ++ GT Y P+ + L D+WS GV Y TG P
Sbjct: 171 QFV----SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 301 NRPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA--------NLC 350
PR ++++ + ++ + ++ + + LS
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
Query: 351 LVKNARTRPKMSEVLEMVNKIVD 373
L + + + I+
Sbjct: 287 LEADQEKCWGFDQFFAETSDILH 309
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG G FG V+ G N K +VA+K + R G ++++ E + + H LV+
Sbjct: 15 EIGSGQFGLVHLGYWLN------KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L G C + LV E+M +G + YL + L + D G+AYL E
Sbjct: 68 LYGVCLEQAPI----CLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-E 121
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAPE 268
I RD + N L+ E K+SDFG+ R + +T + GT +A+PE
Sbjct: 122 EACV--IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----SSTGTKFPVKWASPE 175
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
R +++SDVWS+GV ++E+ + G+ P
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-40
Identities = 74/232 (31%), Positives = 101/232 (43%), Gaps = 24/232 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
+GEG FG V + D VAVK L G Q W E++ L + H++++
Sbjct: 38 DLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
K G C D +Q LV EY+P GS+ YL S + A L AQ G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 151
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YA 265
+ I RD + N+LLD K+ DFGLA+ P V G +
Sbjct: 152 A-QHY--IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSPVFWY 204
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPY 316
APE ++ + SDVWS+GV LYEL+T + + L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSS----QSPPTKFLELIGIAQ 252
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-40
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G+G FG V+ G VA+K L + G + ++ E + + H+ LV+
Sbjct: 191 KLGQGCFGEVWMGTWNG------TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L +++ +V EYM GS+ +L ++ L + +A A G+AY+ E
Sbjct: 244 LYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-E 297
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 271
M++ + RD +++NIL+ E K++DFGLARL +T A + + APE
Sbjct: 298 RMNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 354
Query: 272 TGRLAARSDVWSYGVFLYELIT-GRRP 297
GR +SDVWS+G+ L EL T GR P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 57/213 (26%), Positives = 113/213 (53%), Gaps = 21/213 (9%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLGIVEHQN 148
+ +G G FG V +G+ + ++++VA+K L ++G + +E M E + +++
Sbjct: 16 IELGCGNFGSVRQGVYRM---RKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
+V+L+G C + +LV E G + ++L K E + + ++ + G+ Y
Sbjct: 72 IVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKY 125
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYA 265
L E +F + RD + N+LL + AK+SDFGL++ ++ + + + +
Sbjct: 126 L-EEKNF--VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWY 180
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
APE + + ++RSDVWSYGV ++E ++ G++P
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 71/354 (20%), Positives = 131/354 (37%), Gaps = 55/354 (15%)
Query: 54 VESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPS 113
++ +++ + K + NF IG G F VY+ D
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRA--ACLLD-- 56
Query: 114 QKVEVAVKQLGRRGVQGHKE---WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 170
V VA+K++ + K + E++ L + H N++K +D+E I V
Sbjct: 57 -GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI----VL 111
Query: 171 EYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 222
E G + + + T+ + ++L L ++H +++ RD
Sbjct: 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL------CSALEHMH---SRRVMHRDI 162
Query: 223 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVW 282
K +N+ + KL D GL R S+ T + ++VGT Y +PE + +SD+W
Sbjct: 163 KPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
Query: 283 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSK 342
S G LYE+ + P + + L + K + P YS +
Sbjct: 221 SLGCLLYEMAALQSPFYGD-KMNLYSLCK---------KIEQCDYPPLPSDHYS----EE 266
Query: 343 LSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDH 396
L + N+C+ + RP ++ V ++ ++ SS H
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRM----------HACTASSLEHHHHHH 310
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFLGIVEHQNL 149
+G G FG V KG + VAVK L E + E N + +++ +
Sbjct: 24 ELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
V+++G C + +LV E G +++YL + +++ + G+ YL
Sbjct: 81 VRMIGICEAE-----SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 133
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----Y 264
E +F + RD + N+LL Q AK+SDFGL++ ++ + T G +
Sbjct: 134 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADE----NYYKAQTHGKWPVKW 186
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
APE + + +++SDVWS+GV ++E + G++P
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G FG V+ +VAVK + + G + ++ E N + ++H LVK
Sbjct: 195 KLGAGQFGEVWMATYNK------HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L + ++ E+M GS+ +L + + + A G+A++ E
Sbjct: 248 LHAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-E 301
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG---YAAPE 268
++ I RD +++NIL+ K++DFGLAR+ +T A G + APE
Sbjct: 302 QRNY--IHRDLRAANILVSASLVCKIADFGLARVIEDNEYT----AREGAKFPIKWTAPE 355
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ G +SDVWS+G+ L E++T GR P
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
IG G FG V+ G ++ VAVK R + +++ E L H N+
Sbjct: 121 QIGRGNFGEVFSGRLRA-----DNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
V+L+G C +V E + G +L + L L++ DAA G+ YL
Sbjct: 175 VRLIGVCTQKQPI----YIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYL 229
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
I RD + N L+ E+ K+SDFG++R + + + APE
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 270 VQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ GR ++ SDVWS+G+ L+E + G P
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G FG V G + + +VA+K + + G E++ E + + H+ LV+
Sbjct: 31 ELGTGQFGVVKYGKWRG------QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L G C ++ EYM NG + YL + L++ +D + YL E
Sbjct: 84 LYGVCTKQRPI----FIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL-E 137
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAPE 268
F + RD + N L+++Q K+SDFGL+R + +T + VG+ ++ PE
Sbjct: 138 SKQF--LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPE 191
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + +++SD+W++GV ++E+ + G+ P
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 27/210 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG+G FG V G + ++ VAVK + + + ++ E + + + H NLV+
Sbjct: 200 TIGKGEFGDVMLGDYRGNK-------VAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQ 250
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+G ++ +V EYM GS+ YL + ++L LK + D + YL E
Sbjct: 251 LLGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-E 306
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPE 268
G +F + RD + N+L+ E AK+SDFGL + S+ + + APE
Sbjct: 307 GNNF--VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPE 356
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
++ + + +SDVWS+G+ L+E+ + GR P
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 15/207 (7%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G +G VY+G+ K + VAVK L + +E++ E + ++H NLV+
Sbjct: 227 KLGGGQYGEVYEGVWKKYS-----LTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+G C + ++ E+M G++ YL + ++ + L +A + + YL E
Sbjct: 281 LLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-E 335
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 271
+F I R+ + N L+ E K++DFGL+RL + +T + A + + APE +
Sbjct: 336 KKNF--IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLA 392
Query: 272 TGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + +SDVW++GV L+E+ T G P
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 68/242 (28%), Positives = 110/242 (45%), Gaps = 24/242 (9%)
Query: 68 RPSNLKEFTIAELKSATKNFSRSVV-----IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ 122
S L + ++ S +V IG G FGCVY G + +++ +K+ AVK
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKS 60
Query: 123 L-GRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY 181
L + +++TE + H N++ L+G C + L+V YM +G + +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNF 117
Query: 182 LSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241
+ T + A+G+ YL F + RD + N +LDE++ K++DFG
Sbjct: 118 IR-NETHNPTVKDLIGFGLQVAKGMKYL-ASKKF--VHRDLAARNCMLDEKFTVKVADFG 173
Query: 242 LARLGPSEGFTHVSTAVVGT-----MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GR 295
LAR + + V M A E +QT + +SDVWS+GV L+EL+T G
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVKWM---ALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230
Query: 296 RP 297
P
Sbjct: 231 PP 232
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G FG V G K + +VAVK + + G E+ E + + H LVK
Sbjct: 15 ELGSGQFGVVKLGKWKG------QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
G C+ + +V EY+ NG + YL + L + L++ D G+A+L E
Sbjct: 68 FYGVCSKEY----PIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL-E 121
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAPE 268
F I RD + N L+D K+SDFG+ R + + + VGT ++APE
Sbjct: 122 SHQF--IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAPE 175
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ +++SDVW++G+ ++E+ + G+ P
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G +G VY+G+ K + VAVK L + +E++ E + ++H NLV+
Sbjct: 20 KLGGGQYGEVYEGVWKK-----YSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+G C + ++ E+M G++ YL + ++ + L +A + + YL E
Sbjct: 74 LLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-E 128
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPE 268
+F I RD + N L+ E K++DFGL+RL + + TA G + + APE
Sbjct: 129 KKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPE 182
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + + +SDVW++GV L+E+ T G P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G+G FG V+ G VA+K L + G + ++ E + + H+ LV+
Sbjct: 274 KLGQGCFGEVWMGTWNG------TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L +++ +V EYM GS+ +L ++ L + +A A G+AY+ E
Sbjct: 327 LYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-E 380
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 271
M++ + RD +++NIL+ E K++DFGLARL +T A + + APE
Sbjct: 381 RMNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 437
Query: 272 TGRLAARSDVWSYGVFLYELIT-GRRP 297
GR +SDVWS+G+ L EL T GR P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
V+G G FG V+KG+ E S K+ V +K + + G Q + + +G ++H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
+L+G C LV +Y+P GS+ ++ + L + L A+G+ YL
Sbjct: 79 RLLGLCPGS-----SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL- 131
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAP 267
E + R+ + N+LL +++DFG+A L P + + + + A
Sbjct: 132 EEHGM--VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS---EAKTPIKWMAL 186
Query: 268 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
E + G+ +SDVWSYGV ++EL+T G P
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 71/268 (26%), Positives = 120/268 (44%), Gaps = 24/268 (8%)
Query: 42 SELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVV-----IGEG 96
EL++ E+ ++ S L + ++ S +V IG G
Sbjct: 41 EELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRG 100
Query: 97 GFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGY 155
FGCVY G + +++ +K+ AVK L + +++TE + H N++ L+G
Sbjct: 101 HFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158
Query: 156 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDF 215
C + L+V YM +G + ++ ++ T + A+G+ +L F
Sbjct: 159 CLRSEG---SPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL-ASKKF 213
Query: 216 QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT-----MGYAAPEYV 270
+ RD + N +LDE++ K++DFGLAR + F V M A E +
Sbjct: 214 --VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM---ALESL 268
Query: 271 QTGRLAARSDVWSYGVFLYELIT-GRRP 297
QT + +SDVWS+GV L+EL+T G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-38
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G FG V+ G +VAVK L ++G ++ E N + ++HQ LV+
Sbjct: 20 RLGAGQFGEVWMGYYNG------HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L + ++ EYM NGS+ +L S LT L +A A G+A++ E
Sbjct: 73 LYAVVTQE-----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-E 126
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAPE 268
++ I RD +++NIL+ + + K++DFGLARL +T G + APE
Sbjct: 127 ERNY--IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPE 180
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ G +SDVWS+G+ L E++T GR P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 73/304 (24%), Positives = 116/304 (38%), Gaps = 52/304 (17%)
Query: 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGVQGHKEWMTE 137
+ S +++ IG G +G K K+ + K+ G + ++E
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSD-----GKILVWKELDYGSMTEAEKQMLVSE 55
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS--------ETI 189
VN L ++H N+V+ Y D +V EY G + ++ + E +
Sbjct: 56 VNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 190 LTWAMRLKIAQDAARGLAYLHE--GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG 246
L +L L H ++ RD K +N+ LD + N KL DFGLAR L
Sbjct: 114 LRVMTQL------TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167
Query: 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306
F VGT Y +PE + +SD+WS G LYEL P S+
Sbjct: 168 HDTSFAK---TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQ 221
Query: 307 QKLLQWVKPYLSDAKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363
++L +I + R+ +YS +L+ + L RP + E
Sbjct: 222 KEL-------------AGKIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEE 264
Query: 364 VLEM 367
+LE
Sbjct: 265 ILEN 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 33/213 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG+G FG V G + ++ VAVK + + + ++ E + + + H NLV+
Sbjct: 28 TIGKGEFGDVMLGDYRGNK-------VAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQ 78
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+G ++ +V EYM GS+ YL + ++L LK + D + YL E
Sbjct: 79 LLGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-E 134
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT------MGYA 265
G +F + RD + N+L+ E AK+SDFGL + S+
Sbjct: 135 GNNF--VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWT--- 181
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
APE ++ + + +SDVWS+G+ L+E+ + GR P
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
V+G G FG VYKGL E K+ VA+K+L R + +KE + E + V++ ++
Sbjct: 22 VLGSGAFGTVYKGLWI-PEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHV 79
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
+L+G C L+ + MP G + Y+ + + + L A+G+ YL
Sbjct: 80 CRLLGICLTS-----TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPE 268
E + RD + N+L+ + K++DFGLA+ LG E H V + + A E
Sbjct: 134 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 269 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ +SDVWSYGV ++EL+T G +P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-38
Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLGIVEHQNL 149
++GEG FG VY+G+ N + +K+ VAVK ++ +++M+E + ++H ++
Sbjct: 19 ILGEGFFGEVYEGVYTNHK--GEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
VKL+G ++ ++ E P G + YL +++ L + + + +AYL
Sbjct: 76 VKLIGIIEEE-----PTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAA 266
E ++ + RD NIL+ KL DFGL+R E + S T + +
Sbjct: 130 -ESINC--VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS----VTRLPIKWMS 182
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
PE + R SDVW + V ++E+++ G++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-38
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFLGIVEHQNL 149
++GEG FG V +G +K + S K VAVK + + +E+++E + H N+
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLK--VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 150 VKLVGYCADDDERGIQRLLV-YEYMPNGSVDQYL----SPKSETILTWAMRLKIAQDAAR 204
++L+G C + +GI + +V +M G + YL + LK D A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV---VGT 261
G+ YL +F + RD + N +L + ++DFGL++ S + V
Sbjct: 159 GMEYL-SNRNF--LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ A E + ++SDVW++GV ++E+ T G P
Sbjct: 216 I---AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 67/282 (23%), Positives = 107/282 (37%), Gaps = 39/282 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
IG G F VYKGL D VEVA +L R + + + E L ++H N+
Sbjct: 33 EIGRGSFKTVYKGL-----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
V+ + +LV E M +G++ YL K ++ + + +GL +L
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 210 HEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268
H II RD K NI + + K+ D GLA L + + AV+GT + APE
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPE 200
Query: 269 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328
+ DV+++G+ + E+ T P S+ + QI
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYP-------------------YSECQNAAQIYR 240
Query: 329 PRLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 366
G C+ +N R + ++L
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
VIG+G FG VY G + + A+K L +Q + ++ E + + H N++
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQC--AIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
L+G + ++ YM +G + Q++ + T + ARG+ YL
Sbjct: 86 ALIGIMLPPEGL---PHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYL- 140
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT-----MGYA 265
F + RD + N +LDE + K++DFGLAR + V
Sbjct: 141 AEQKF--VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT--- 195
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
A E +QT R +SDVWS+GV L+EL+T G P
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 72/373 (19%), Positives = 136/373 (36%), Gaps = 64/373 (17%)
Query: 66 SQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--L 123
S + T + + + R IGEG FG + +K+ +
Sbjct: 5 HHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTED-----GRQYVIKEINI 59
Query: 124 GRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS 183
R + +E EV L ++H N+V+ ++ I V +Y G + + ++
Sbjct: 60 SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI----VMDYCEGGDLFKRIN 115
Query: 184 PKS------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 237
+ + IL W +++ L ++H+ +I+ RD KS NI L + +L
Sbjct: 116 AQKGVLFQEDQILDWFVQI------CLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL 166
Query: 238 SDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 296
DFG+AR L + A +GT Y +PE + +SD+W+ G LYEL T +
Sbjct: 167 GDFGIARVLNSTVELAR---ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 297 PIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVK 353
+ S + L +I+ P + YS L + + +
Sbjct: 224 AFE---AGSMKNL-------------VLKIISGSFPPVSLHYS----YDLRSLVSQLFKR 263
Query: 354 NARTRPKMSEVLE-----------MVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHK 402
N R RP ++ +LE + +++ + + + P +
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSIS 323
Query: 403 RRIIESKTRESGT 415
+ T+ +
Sbjct: 324 VMPAQKITKPAAK 336
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
+IG G G V G ++ + V VA+K L + G + +++++E + +G +H N+
Sbjct: 56 IIGSGDSGEVCYGRLRV--PGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
++L G ++V EYM NGS+D +L + T + + + G+ YL
Sbjct: 113 IRLEGVVTRGR----LAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTM---GYA 265
+ + + RD + N+L+D K+SDFGL+R L + +T G +
Sbjct: 168 -SDLGY--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT---GGKIPIRWT 221
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
APE + ++ SDVWS+GV ++E++ G RP
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFLGIVEHQNL 149
++G+G FG V + +K + V+VAVK L +E++ E + +H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGS--FVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 150 VKLVGYCADDDERGIQR--LLVYEYMPNGSVDQYL----SPKSETILTWAMRLKIAQDAA 203
KLVG +G +++ +M +G + +L ++ L ++ D A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV---VG 260
G+ YL +F I RD + N +L E ++DFGL+R S + A V
Sbjct: 148 CGMEYL-SSRNF--IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 261 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ A E + SDVW++GV ++E++T G+ P
Sbjct: 205 WL---ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 62/323 (19%), Positives = 121/323 (37%), Gaps = 52/323 (16%)
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
S + + ++ + +S IG GG V++ L + +
Sbjct: 7 HSSGVDLGTENLYFQSMSVK-----GRIYSILKQIGSGGSSKVFQVLNEKKQ------IY 55
Query: 119 AVKQLGRRGVQGH--KEWMTEVNFLGIVEHQNL--VKLVGYCADDDERGIQRLLVYEYMP 174
A+K + + E+ +L ++ + ++L Y D I +V E
Sbjct: 56 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--I--YMVMECG- 110
Query: 175 NGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234
N ++ +L K + + R ++ + +H I+ D K +N L+ +
Sbjct: 111 NIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-M 164
Query: 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----------TGRLAARSDVWS 283
KL DFG+A + + V + VGT+ Y PE ++ +++ +SDVWS
Sbjct: 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 224
Query: 284 YGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKL 343
G LY + G+ P + ++ + I+DP E ++ L
Sbjct: 225 LGCILYYMTYGKTPFQQ---------------IINQISKLHAIIDPNHEIEFPDIPEKDL 269
Query: 344 SHVANLCLVKNARTRPKMSEVLE 366
V CL ++ + R + E+L
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLA 292
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 4e-37
Identities = 59/211 (27%), Positives = 114/211 (54%), Gaps = 17/211 (8%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQN 148
+ +G G FG V +G+ + ++++VA+K L ++G +E M E + +++
Sbjct: 342 IELGCGNFGSVRQGVYRM---RKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
+V+L+G C + +LV E G + ++L K E + + ++ + G+ Y
Sbjct: 398 IVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKY 451
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAP 267
L E +F + R+ + N+LL + AK+SDFGL++ LG + + +A + + AP
Sbjct: 452 L-EEKNF--VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 268 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
E + + ++RSDVWSYGV ++E ++ G++P
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 34/226 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+GEG FG V+ N K+ VAVK L + K++ E L ++H+++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAMRLKI 198
G C D D ++V+EYM +G ++++L +++ L + L I
Sbjct: 83 YGVCGDGD----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A A G+ YL F + RD + N L+ K+ DFG++R S + V
Sbjct: 139 ASQIASGMVYL-ASQHF--VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 193
Query: 259 VGT------MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
T M PE + + SDVWS+GV L+E+ T G++P
Sbjct: 194 -HTMLPIRWM---PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 65/215 (30%), Positives = 114/215 (53%), Gaps = 24/215 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
VIG G FG VYKG++K S ++V VA+K L + G + +++ E +G H N+
Sbjct: 51 VIGAGEFGEVYKGMLKTS-SGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
++L G + +++ EYM NG++D++L + + + + + + A G+ YL
Sbjct: 109 IRLEGVISKYKPM----MIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG------ 263
M++ + RD + NIL++ K+SDFGL+R+ + A T G
Sbjct: 164 -ANMNY--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEATYTTSGGKIPIR 215
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ APE + + + SDVWS+G+ ++E++T G RP
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-37
Identities = 63/297 (21%), Positives = 107/297 (36%), Gaps = 53/297 (17%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGVQGHKEWMTEVNFLG 142
+F +IG GGFG V+K K+ D +K+ EV L
Sbjct: 11 MDFKEIELIGSGGFGQVFKA--KHRID---GKTYVIKRVKYNNEKA------EREVKALA 59
Query: 143 IVEHQNLVKLVGYCADDDERGIQRL------------LVYEYMPNGSVDQYLSPKSETIL 190
++H N+V G D + E+ G+++Q++ + L
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 191 TWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 250
+ L++ + +G+ Y+H ++I RD K SNI L + K+ DFGL ++G
Sbjct: 120 DKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 251 FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310
T GT+ Y +PE + + D+++ G+ L EL+ K
Sbjct: 177 KR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF 228
Query: 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367
+ D + + K + L K RP SE+L
Sbjct: 229 T-------------DLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRT 268
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-37
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 27/223 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+GEG FG V+ N K+ VAVK L +++ E L +++HQ++V+
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL-------------SPKSETILTWAMRLKI 198
G C + L+V+EYM +G ++++L + L L +
Sbjct: 108 FFGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
A A G+ YL G+ F + RD + N L+ + K+ DFG++R S + V
Sbjct: 164 ASQVAAGMVYL-AGLHF--VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 259 ---VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ M PE + + SDVWS+GV L+E+ T G++P
Sbjct: 221 MLPIRWM---PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGVQGHKEWMTEVNFLGIVEHQN 148
+G+G FG V +G + V VAVK L + +++ EVN + ++H+N
Sbjct: 25 KLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
L++L G +V E P GS+ L L + + A A G+ Y
Sbjct: 83 LIRLYGVVLTP-----PMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMGY 136
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYA-- 265
L E F I RD + N+LL + K+ DFGL R L ++ + + +A
Sbjct: 137 L-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH--RKVPFAWC 191
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
APE ++T + SD W +GV L+E+ T G+ P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
IGEG FG V++G+ + E+P + VA+K + ++++ E + +H ++
Sbjct: 22 CIGEGQFGDVHQGIYMSPENP--ALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
VKL+G ++ ++ E G + +L + L A + A + LAYL
Sbjct: 79 VKLIGVITEN-----PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL 132
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAA 266
E F + RD + N+L+ KL DFGL+R + S + A
Sbjct: 133 -ESKRF--VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS----KGKLPIKWMA 185
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
PE + R + SDVW +GV ++E++ G +P
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 64/341 (18%), Positives = 127/341 (37%), Gaps = 49/341 (14%)
Query: 41 GSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGC 100
GS + + + P + ++ +K + +S IG GG
Sbjct: 14 GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG--RIYSILKQIGSGGSSK 71
Query: 101 VYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL--VKLVGYC 156
V++ L + + A+K + Q + E+ +L ++ + ++L Y
Sbjct: 72 VFQVLNEKKQ------IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ 216
D +V E N ++ +L K + + R ++ + +H+
Sbjct: 126 ITDQYI----YMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQ---HG 175
Query: 217 IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ----- 271
I+ D K +N L+ + KL DFG+A + + V + VG + Y PE ++
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 272 ------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325
+++ +SDVWS G LY + G+ P + ++ +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQISKLHA 279
Query: 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
I+DP E ++ L V CL ++ + R + E+L
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 38/224 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQ--KVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL 149
+G+G F ++KG+ + D Q + EV +K L + + + + + + H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
V G C DE +LV E++ GS+D YL K++ + +L++A+ A + +L
Sbjct: 75 VLNYGVCVCGDE----NILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL 129
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWN--------AKLSDFGLARLGPSEGFTHVSTAVVGT 261
E I + + NILL + + KLSD G++ V+
Sbjct: 130 -EENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPK 174
Query: 262 MGY------AAPEYVQTGRL-AARSDVWSYGVFLYELIT-GRRP 297
PE ++ + +D WS+G L+E+ + G +P
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-36
Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 47/297 (15%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLG 142
+ +S IG GG V++ L + + A+K + + E+ +L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQ------IYAIKYVNLEEADNQTLDSYRNEIAYLN 62
Query: 143 IVEHQNL--VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 200
++ + ++L Y D I +V E N ++ +L K + + R +
Sbjct: 63 KLQQHSDKIIRLYDYEITDQY--I--YMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWK 115
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 260
+ + +H I+ D K +N L+ + KL DFG+A + + V + VG
Sbjct: 116 NMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 261 TMGYAAPEYVQ-----------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309
T+ Y PE ++ +++ +SDVWS G LY + G+ P +
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------- 222
Query: 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
++ + I+DP E ++ L V CL ++ + R + E+L
Sbjct: 223 ------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
V+G G FG V G +K ++ VA+K L + G + ++++ E + +G +H N+
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKK--EISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
++L G ++V EYM NGS+D +L K + T + + + A G+ YL
Sbjct: 109 IRLEGVVTKSKPV----MIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG------ 263
M + + RD + NIL++ K+SDFGL R+ + A T G
Sbjct: 164 -SDMGY--VHRDLAARNILINSNLVCKVSDFGLGRVLEDD-----PEAAYTTRGGKIPIR 215
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ +PE + + + SDVWSYG+ L+E+++ G RP
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 71/329 (21%), Positives = 123/329 (37%), Gaps = 46/329 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFL-GIVEHQNLV 150
V+ EGGF VY+ +D E A+K+L + ++ + EV F+ + H N+V
Sbjct: 35 VLAEGGFAFVYEA-----QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 151 KLVGYCADDDERGIQR----LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
+ + E LL+ E V+ +S L+ LKI R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA---RLGPSEGFTHVSTAVV---- 259
++H II RD K N+LL Q KL DFG A P ++ A+V
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 260 ---GTMGYAAPEYVQTGR---LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313
T Y PE + + + D+W+ G LY L + P + ++ +++
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG---AKLRIVN-- 263
Query: 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373
++ S + L N R ++EV+ + +I
Sbjct: 264 -------GKYSIPPHDT----QYTVFHSLIRA----MLQVNPEERLSIAEVVHQLQEI-- 306
Query: 374 ASAEAGSPRRPLRSSTSRETPDHTKTKHK 402
A+A +P+ P+ + + T +
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-36
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVEHQNLV 150
+G GGFG V + + +++ +VA+KQ + ++E W E+ + + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDT-----GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 151 KLVGYCADDDERGIQR----LLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQDAARG 205
D + + LL EY G + +YL ++ L + D +
Sbjct: 76 SA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
L YLHE II RD K NI+L ++ K+ D G A+ VGT+
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTL 187
Query: 263 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
Y APE ++ + D WS+G +E ITG RP
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNL 149
+G+G FG VY+G+ K + VA+K + ++ E++ E + + ++
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------SPKSETILTWAMRLKIAQD 201
V+L+G + L++ E M G + YL + + + +++A +
Sbjct: 91 VRLLGVVSQGQ----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
A G+AYL F + RD + N ++ E + K+ DFG+ R + G
Sbjct: 147 IADGMAYL-NANKF--VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RKGG 198
Query: 262 MGY-----AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
G +PE ++ G SDVWS+GV L+E+ T +P
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
+GE FG VYKG + Q VA+K L + +E+ E ++H N+
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAMR 195
V L+G D +++ Y +G + ++L ++ L
Sbjct: 75 VCLLGVVTKDQ----PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
+ + A G+ YL + +D + N+L+ ++ N K+SD GL R +
Sbjct: 131 VHLVAQIAAGMEYL-SSHHV--VHKDLATRNVLVYDKLNVKISDLGLFREVYAA-----D 182
Query: 256 TAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ + APE + G+ + SD+WSYGV L+E+ + G +P
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 63/284 (22%), Positives = 115/284 (40%), Gaps = 16/284 (5%)
Query: 17 TTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFT 76
F IR + Q V + +V Y + +
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEW 134
+ + + IGEG FG V++G+ + E+P + VA+K + +++
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENP--AMAVAIKTC-KNCTSDSVREKF 438
Query: 135 MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAM 194
+ E + +H ++VKL+G ++ ++ E G + +L + + L A
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKFS-LDLAS 492
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
+ A + LAYL E F + RD + N+L+ KL DFGL+R +
Sbjct: 493 LILYAYQLSTALAYL-ESKRF--VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
S + + + APE + R + SDVW +GV ++E++ G +P
Sbjct: 550 SKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
+G G FG VY+G + + ++VAVK L Q +++ E + HQN+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQDAARG 205
+ +G R ++ E M G + +L P + L L +A+D A G
Sbjct: 97 RCIGVSLQSL----PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWN---AKLSDFGLARLGPSEGFTHVSTAVVGTM 262
YL E F I RD + N LL AK+ DFG+AR + G
Sbjct: 153 CQYL-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGC 204
Query: 263 GY-----AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
PE G +++D WS+GV L+E+ + G P
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 42/229 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLG-IVEHQN 148
VIGEG FG V K IK +++ A+K++ + H+++ E+ L + H N
Sbjct: 32 VIGEGNFGQVLKARIKK---DGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAM 194
++ L+G C L EY P+G++ +L + + + L+
Sbjct: 88 IINLLGACEHRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
L A D ARG+ YL Q I RD + NIL+ E + AK++DFGL+R
Sbjct: 144 LLHFAADVARGMDYL-SQK--QFIHRDLAARNILVGENYVAKIADFGLSR--------GQ 192
Query: 255 STAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
V TMG + A E + SDVWSYGV L+E+++ G P
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 73/322 (22%), Positives = 114/322 (35%), Gaps = 49/322 (15%)
Query: 50 SAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNS 109
+S EA + S PS + F ++F R +G G +G V+K ++
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQ-------QSFQRLSRLGHGSYGEVFKV--RSK 79
Query: 110 EDPSQKVEVAVKQ--LGRRGVQGHKEWMTEVNFL-GIVEHQNLVKLVGYCADDDERGIQR 166
ED AVK+ RG + + EV + +H V+L +
Sbjct: 80 ED---GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-----I 131
Query: 167 L-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225
L L E S+ Q+ L A +D LA+LH ++ D K +
Sbjct: 132 LYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPA 186
Query: 226 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYG 285
NI L + KL DFGL + G V G Y APE +Q A +DV+S G
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSYGTA-ADVFSLG 242
Query: 286 VFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSH 345
+ + E+ Q+L + + P S S+L
Sbjct: 243 LTILEVACNMELPHGGEGW--QQL-------------RQGYLPPEFTAGLS----SELRS 283
Query: 346 VANLCLVKNARTRPKMSEVLEM 367
V + L + + R +L +
Sbjct: 284 VLVMMLEPDPKLRATAEALLAL 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNLV 150
+G G FG VY+G + + ++VAVK L Q +++ E + HQN+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETILTWAMR--LKIAQDAARG 205
+ +G R ++ E M G + +L P+ + AM L +A+D A G
Sbjct: 138 RCIGVSLQSL----PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWN---AKLSDFGLARLGPSEGFTHVSTAVVGTM 262
YL E F I RD + N LL AK+ DFG+AR G+ G
Sbjct: 194 CQYL-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGC 245
Query: 263 GY-----AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
PE G +++D WS+GV L+E+ + G P
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFL-GIVEHQN 148
+G G FG V + + + VAVK L + G H+ M+E+ L I H N
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAM 194
+V L+G C +++ E+ G++ YL + LT
Sbjct: 93 VVNLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
+ + A+G+ +L I RD + NILL E+ K+ DFGLAR +
Sbjct: 150 LICYSFQVAKGMEFL-ASRKC--IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 255 STAV---VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ M APE + +SDVWS+GV L+E+ + G P
Sbjct: 207 KGDARLPLKWM---APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 56/360 (15%), Positives = 115/360 (31%), Gaps = 78/360 (21%)
Query: 45 TSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKG 104
+S S + ++ + ++ I + +G F +
Sbjct: 3 LGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIR------------TLNQGKFNKIILC 50
Query: 105 LIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT-----------------EVNFLGIVEHQ 147
N A+K+ + ++ +++ E+ + ++++
Sbjct: 51 EKDNKF-------YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103
Query: 148 NLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRL------KIAQ 200
+ G + D + ++YEYM N S+ ++ + + I +
Sbjct: 104 YCLTCEGIITNYD-----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 260
+Y+H + I RD K SNIL+D+ KLSDFG + + + + G
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGS-RG 212
Query: 261 TMGYAAPEYVQTGRLA---ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--- 314
T + PE+ + A+ D+WS G+ LY + P S +L ++
Sbjct: 213 TYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVPFSLK--ISLVELFNNIRTKN 269
Query: 315 ---PYLSDAKQFRQIVDPRLEGKYSL-----RLVSKLSHVANLCLVKNARTRPKMSEVLE 366
P + + L + L KN R + L+
Sbjct: 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF-------LRKNPAERITSEDALK 322
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 62/238 (26%), Positives = 88/238 (36%), Gaps = 52/238 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFL-GIVEHQN 148
+G G FG V + + VAVK L + + + M+E+ L + H N
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL----------------SPKSETILTW 192
+V L+G C L++ EY G + +L E L
Sbjct: 89 IVNLLGACTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 193 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 252
L + A+G+A+L I RD + NILL K+ DFGLAR
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARD------- 194
Query: 253 HVSTAVVGTMGYA------------APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+ Y APE + SDVWSYG+FL+EL + G P
Sbjct: 195 -----IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-33
Identities = 43/358 (12%), Positives = 83/358 (23%), Gaps = 57/358 (15%)
Query: 42 SELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCV 101
EL E A + + P N + + L + + G V
Sbjct: 19 EELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVV 78
Query: 102 YKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT---EVNFLGIVEHQNLVKLVGYC-- 156
+ D + + A+K E + ++ +
Sbjct: 79 FLV-----RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133
Query: 157 --------------------ADDDERGIQRLLVYEYMPNGSVDQYLS-----PKSETILT 191
DD LL+ + ++ S
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEG 192
Query: 192 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 251
+ R A L ++ F N+ + L D +
Sbjct: 193 ILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT--- 246
Query: 252 THVSTAVVGTMGYAAPEYVQTGRLA--ARSDVWSYGVFLYELITGRRPIDRNRPRSEQK- 308
A + YA E++ + W G+ +Y + P P +
Sbjct: 247 --RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
++ +D+ F K L+ + L + R R E +E
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVK---TLIGRF-------LNFDRRRRLLPLEAME 352
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-33
Identities = 59/302 (19%), Positives = 107/302 (35%), Gaps = 47/302 (15%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGI 143
+F +G GGFG V++ KN D A+K++ + +E M EV L
Sbjct: 5 TDFEPIQCLGRGGFGVVFE--AKNKVD---DCNYAIKRIRLPNRELAREKVMREVKALAK 59
Query: 144 VEHQNLVKLVGYCADDDERGIQ-----RLLVY---EYMPNGSVDQYLSP-KSETILTWAM 194
+EH +V+ + + ++ +Y + ++ +++ + ++
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--------- 245
L I A + +LH ++ RD K SNI K+ DFGL
Sbjct: 120 CLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 246 -GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 304
T VGT Y +PE + + + D++S G+ L+EL+ P
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--- 230
Query: 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 364
E+ R + P L + + L + RP+ +
Sbjct: 231 MERVRT---------LTDVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPMERPEAINI 277
Query: 365 LE 366
+E
Sbjct: 278 IE 279
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 57/287 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT-----EVNFLGIVEH 146
+G+G FG VY K S K +A+K L + ++ + EV + H
Sbjct: 16 PLGKGKFGNVYLAREKQS-----KFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRH 68
Query: 147 QNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
N+++L GY D R+ L+ EY P G+V + L + + + A
Sbjct: 69 PNILRLYGYFHDAT-----RVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANA 121
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
L+Y H ++I RD K N+LL K++DFG + PS T + GT+ Y
Sbjct: 122 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYL 174
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVK----PYLS-D 319
PE ++ + D+WS GV YE + G+ P + +++ + V+ +++
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEG 233
Query: 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
A+ L+S+L L N RP + EVLE
Sbjct: 234 AR----------------DLISRL-------LKHNPSQRPMLREVLE 257
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 64/236 (27%), Positives = 96/236 (40%), Gaps = 43/236 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
IGEG FG V++ VAVK L + ++ E + ++ N+
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNI 112
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL----------------------SPKSE 187
VKL+G CA L++EYM G ++++L S
Sbjct: 113 VKLLGVCAVGK----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 188 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247
L+ A +L IA+ A G+AYL F + RD + N L+ E K++DFGL+R
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYL-SERKF--VHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 248 SEGFTHVSTAVVGTMGY-----AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
S PE + R SDVW+YGV L+E+ + G +P
Sbjct: 226 SA-----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 69/290 (23%), Positives = 115/290 (39%), Gaps = 63/290 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK-----QLGRRGVQGHKEWMTEVNFLGIVEH 146
+G+G FG VY K + K +A+K QL + GV+ E+ + H
Sbjct: 21 PLGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEGVEHQLR--REIEIQSHLRH 73
Query: 147 QNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDA 202
N++++ Y D R+ L+ E+ P G + + L E + +
Sbjct: 74 PNILRMYNYFHDRK-----RIYLMLEFAPRGELYKELQKHGRFDE----QRSATFMEE-L 123
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
A L Y HE ++I RD K N+L+ + K++DFG + PS GT+
Sbjct: 124 ADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTM---CGTL 176
Query: 263 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVK----PYL 317
Y PE ++ + D+W GV YE + G P + + ++++ V P+L
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-VDLKFPPFL 235
Query: 318 S-DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
S +K L+SKL L + R + V+E
Sbjct: 236 SDGSK----------------DLISKL-------LRYHPPQRLPLKGVME 262
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 75/288 (26%), Positives = 116/288 (40%), Gaps = 58/288 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT-----EVNFLGIVEHQ 147
+G+G F VY ++ +EVA+K + ++ + M EV ++H
Sbjct: 19 LGKGSFAGVY--RAESIHT---GLEVAIKMIDKKAMYKAG--MVQRVQNEVKIHCQLKHP 71
Query: 148 NLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
++++L Y D + + LV E NG +++YL + + R + Q G+
Sbjct: 72 SILELYNYFEDSN-----YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ-IITGM 125
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
YLH I+ RD SN+LL N K++DFGLA H + GT Y +
Sbjct: 126 LYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYIS 180
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------PYLS- 318
PE SDVWS G Y L+ GR P D + + L V +LS
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT---DTVKNTLNKVVLADYEMPSFLSI 237
Query: 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+AK L+ +L L +N R +S VL+
Sbjct: 238 EAK----------------DLIHQL-------LRRNPADRLSLSSVLD 262
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 58/293 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNF-LGIVEHQNL 149
+G G +G V K PS ++ +AVK++ Q K + +++ + V+
Sbjct: 14 ELGRGAYGVVEKMRHV----PSGQI-MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-------SPKSETILTWAMRLKIAQDA 202
V G + + I E M + S+D++ E IL KIA
Sbjct: 69 VTFYGALFREGDVWI----CMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAVSI 118
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGT 261
+ L +LH +I RD K SN+L++ K+ DFG+ L G
Sbjct: 119 VKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI----DAGC 172
Query: 262 MGYAAPEYVQTGRLAA----RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317
Y APE + +SD+WS G+ + EL R P D +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD---------------SWG 217
Query: 318 SDAKQFRQIVD---PRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ +Q +Q+V+ P+L K+S ++ + CL KN++ RP E+++
Sbjct: 218 TPFQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 48/234 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFL-GIVEHQN 148
+G G FG V + ++VAVK L + + M+E+ + + +H+N
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL------------SPKSETILTWAMRL 196
+V L+G C L++ EY G + +L + + + L
Sbjct: 112 IVNLLGACTHGGP----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 197 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST 256
+ A+G+A+L + I RD + N+LL AK+ DFGLAR
Sbjct: 168 HFSSQVAQGMAFL-ASKNC--IHRDVAARNVLLTNGHVAKIGDFGLARD----------- 213
Query: 257 AVVGTMGYA------------APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
++ Y APE + +SDVWSYG+ L+E+ + G P
Sbjct: 214 -IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 59/243 (24%), Positives = 93/243 (38%), Gaps = 57/243 (23%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFL-GIVEHQN 148
V+G G FG V ++VAVK L + + M+E+ + + H+N
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHEN 110
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---------------------SPKSE 187
+V L+G C L++EY G + YL +
Sbjct: 111 IVNLLGACTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 188 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247
+LT+ L A A+G+ +L + RD + N+L+ K+ DFGLAR
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD-- 221
Query: 248 SEGFTHVSTAVVGTMGYA------------APEYVQTGRLAARSDVWSYGVFLYELIT-G 294
++ Y APE + G +SDVWSYG+ L+E+ + G
Sbjct: 222 ----------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271
Query: 295 RRP 297
P
Sbjct: 272 VNP 274
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 90/378 (23%), Positives = 139/378 (36%), Gaps = 79/378 (20%)
Query: 64 SMSQ--RPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVK 121
SM+ +L E ++ L+ F ++G G +G VYKG + A+K
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKT-----GQLAAIK 55
Query: 122 QLGRRGVQGHKEWMTEVNFLG-IVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSV 178
+ G +E E+N L H+N+ G + + +L LV E+ GSV
Sbjct: 56 VMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV 114
Query: 179 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238
+ L I ++ RGL++LH+ ++I RD K N+LL E KL
Sbjct: 115 TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171
Query: 239 DFGL-ARLGPSEGFTHVSTAVVGT---MGYAAPEYVQTGRLA-----ARSDVWSYGVFLY 289
DFG+ A+L +T +GT M APE + +SD+WS G+
Sbjct: 172 DFGVSAQL--DRTVGRRNT-FIGTPYWM---APEVIACDENPDATYDFKSDLWSLGITAI 225
Query: 290 ELITGRRP------------IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEG-KYS 336
E+ G P I RN PRL+ K+S
Sbjct: 226 EMAEGAPPLCDMHPMRALFLIPRNPA-------------------------PRLKSKKWS 260
Query: 337 LRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDH 396
K CLVKN RP ++++ + + R L+ R
Sbjct: 261 ----KKFQSFIESCLVKNHSQRPATEQLMK--HPFIRDQPNERQVRIQLKDHIDR----- 309
Query: 397 TKTKHKRRIIESKTRESG 414
K + E++ SG
Sbjct: 310 -TKKKRGEKDETEYEYSG 326
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 1e-31
Identities = 50/406 (12%), Positives = 107/406 (26%), Gaps = 80/406 (19%)
Query: 32 FNDNEVGR--IGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSR 89
F + G I + + SE S S ++S R
Sbjct: 19 FRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR 78
Query: 90 SV----VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-------------------- 125
++ V+G+ + D V
Sbjct: 79 TLVRGTVLGQEDPYAYLEA-----TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 126 --RGVQGHKEWMTEVNFLG---IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ 180
RG++ K+ + F+ +V+ K++ D+ + + ++
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 181 YLSPKSETI-----LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 235
+ L RL++ R LA LH + ++ + +I+LD++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGV 250
Query: 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV-----QTGRLAARSDVWSYGVFLYE 290
L+ F + + A + + D W+ G+ +Y
Sbjct: 251 FLTGFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 291 LITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD-PRLEGKYSLRLVSKLSHVANL 349
+ P + + +W+ FR + P+ L+
Sbjct: 310 IWCADLPNTDD---AALGGSEWI---------FRSCKNIPQ----PVRALLEGF------ 347
Query: 350 CLVKNARTRPKMSEVLE------MVNKIVDASAEAGSPRRPLRSST 389
L R + +E + ++ A + P R
Sbjct: 348 -LRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGG 392
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 62/244 (25%), Positives = 106/244 (43%), Gaps = 30/244 (12%)
Query: 64 SMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL 123
SM E + E VV+G+G +G VY G ++ +V +A+K++
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSN-----QVRIAIKEI 55
Query: 124 GRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS 183
R + + E+ ++H+N+V+ +G +++ I E +P GS+ L
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI----FMEQVPGGSLSALLR 111
Query: 184 ------PKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAK 236
+E + + GL YLH+ QI+ RD K N+L++ K
Sbjct: 112 SKWGPLKDNEQTIG-----FYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLK 163
Query: 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELIT 293
+SDFG ++ G + GT+ Y APE + G A +D+WS G + E+ T
Sbjct: 164 ISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMAT 220
Query: 294 GRRP 297
G+ P
Sbjct: 221 GKPP 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 84/320 (26%), Positives = 125/320 (39%), Gaps = 68/320 (21%)
Query: 65 MSQRPSNLKEFTIAELKS-ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL 123
M+ P + LK+ + F++ IG+G FG V+KG+ + + VA+K +
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRT-----QKVVAIKII 55
Query: 124 GRRGVQGHKE-WMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQ 180
+ E E+ L + + K G Y D L ++ EY+ GS
Sbjct: 56 DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK------LWIIMEYLGGGSALD 109
Query: 181 YLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238
L P ET + I ++ +GL YLH + I RD K++N+LL E KL+
Sbjct: 110 LLEPGPLDETQIAT-----ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLA 161
Query: 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP- 297
DFG+A G VGT + APE ++ +++D+WS G+ EL G P
Sbjct: 162 DFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219
Query: 298 -----------IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHV 346
I +N P P LEG YS L
Sbjct: 220 SELHPMKVLFLIPKNNP-------------------------PTLEGNYS----KPLKEF 250
Query: 347 ANLCLVKNARTRPKMSEVLE 366
CL K RP E+L+
Sbjct: 251 VEACLNKEPSFRPTAKELLK 270
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 67/234 (28%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNL 149
+GEG FG V K + + + VAVK L + ++ ++E N L V H ++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL----------------------SPKSE 187
+KL G C+ D LL+ EY GS+ +L E
Sbjct: 89 IKLYGACSQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 188 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247
LT + A ++G+ YL M + RD + NIL+ E K+SDFGL+R
Sbjct: 145 RALTMGDLISFAWQISQGMQYL-AEMKL--VHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 248 SEGFTHVSTAV---VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
E + V M A E + +SDVWS+GV L+E++T G P
Sbjct: 202 EEDSYVKRSQGRIPVKWM---AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 55/227 (24%), Positives = 83/227 (36%), Gaps = 29/227 (12%)
Query: 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTE 137
E + + +G G FG V++ D + AVK+ V+ + E
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMK-----DKQTGFQCAVKK-----VRLEVFRVEE 100
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAM 194
+ + +V L G + I E + GS+ Q + E
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNI----FMELLEGGSLGQLIKQMGCLPEDRA---- 152
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGLA-RLGPSEGFT 252
L A GL YLH +I+ D K+ N+LL A L DFG A L P
Sbjct: 153 -LYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208
Query: 253 HVSTA--VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
+ T + GT + APE V A+ D+WS + ++ G P
Sbjct: 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 62/308 (20%), Positives = 107/308 (34%), Gaps = 54/308 (17%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI 143
+F V+G+G FG V K +N+ D A+K++ + ++EV L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA--RNALD---SRYYAIKKIRHTEEK-LSTILSEVMLLAS 58
Query: 144 VEHQNLVKLVGYCADDDERGIQRL---------LVYEYMPNGSVDQYLSPK---SETILT 191
+ HQ +V+ + + EY NG++ + + +
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 192 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 251
W ++ + L+Y+H II RD K NI +DE N K+ DFGLA+
Sbjct: 119 W----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 252 THVS------------TAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGRRPI 298
T+ +GT Y A E + TG + D++S G+ +E+I
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST- 230
Query: 299 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 358
R +KL + P + + + + R
Sbjct: 231 GMERVNILKKLRSVSIEF-----------PPDFDDNKMKVEKKIIRL----LIDHDPNKR 275
Query: 359 PKMSEVLE 366
P +L
Sbjct: 276 PGARTLLN 283
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 68/331 (20%), Positives = 115/331 (34%), Gaps = 91/331 (27%)
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
P + P + + + +G+GGF ++ D K A
Sbjct: 2 KEIPEVLVDPRSRRRYVRGRF------------LGKGGFAKCFEI-----SDADTKEVFA 44
Query: 120 VKQLGRRGVQGHK---EWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY---EYM 173
K + + + + E++ + HQ++V G+ D+D V+ E
Sbjct: 45 GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-------VFVVLELC 97
Query: 174 PNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------GLAYLHEGMDFQIIVRDFKSS 225
S+ + + L + AR G YLH +I RD K
Sbjct: 98 RRRSLLELHKRRK--------ALT--EPEARYYLRQIVLGCQYLHRNR---VIHRDLKLG 144
Query: 226 NILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSY 284
N+ L+E K+ DFGLA ++ V GT Y APE + + DVWS
Sbjct: 145 NLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIAPEVLSKKGHSFEVDVWSI 201
Query: 285 GVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSL------- 337
G +Y L+ G+ P + S K + +I + +YS+
Sbjct: 202 GCIMYTLLVGKPPFE----TSCLKET------------YLRIK----KNEYSIPKHINPV 241
Query: 338 --RLVSKLSHVANLCLVKNARTRPKMSEVLE 366
L+ K+ L + RP ++E+L
Sbjct: 242 AASLIQKM-------LQTDPTARPTINELLN 265
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 75/291 (25%), Positives = 115/291 (39%), Gaps = 55/291 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RGVQGHKEWMTEVNFL-GIVEHQNL 149
+G G G V+K + + +AVKQ+ R + +K + +++ + + +
Sbjct: 32 EMGSGTCGQVWKMRFRKT-----GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMRLKIAQDAARGL 206
V+ G + + I E M + P E IL K+ + L
Sbjct: 87 VQCFGTFITNTDVFI----AMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKAL 137
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYA 265
YL E +I RD K SNILLDE+ KL DFG+ RL + G Y
Sbjct: 138 YYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA----KDRSAGCAAYM 191
Query: 266 APEYVQTGRLA-----ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320
APE + R+DVWS G+ L EL TG+ P +D
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK---------------NCKTDF 236
Query: 321 KQFRQIVD---PRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ +++ P L G +S S + CL K+ R RPK +++LE
Sbjct: 237 EVLTKVLQEEPPLLPGHMGFSGDFQSFV----KDCLTKDHRKRPKYNKLLE 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 85/297 (28%), Positives = 124/297 (41%), Gaps = 62/297 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RGVQGHKEWMTEVNF-LGIVEHQNL 149
IG G +G V K + K S +AVK++ + K+ + +++ + + +
Sbjct: 29 EIGRGAYGSVNKMVHKPS-----GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--------PKSETILTWAMRLKIAQD 201
V+ G + + I E M + S D++ E IL KI
Sbjct: 84 VQFYGALFREGDCWI----CMELM-STSFDKFYKYVYSVLDDVIPEEILG-----KITLA 133
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVG 260
+ L +L E + +II RD K SNILLD N KL DFG+ +L S T G
Sbjct: 134 TVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR----DAG 187
Query: 261 TMGYAAPEYVQTGRLAA----RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316
Y APE + RSDVWS G+ LYEL TGR P +
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP---------------KW 232
Query: 317 LSDAKQFRQIVD---PRL----EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
S Q Q+V P+L E ++S ++ + NLCL K+ RPK E+L+
Sbjct: 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFV----NLCLTKDESKRPKYKELLK 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 65/299 (21%), Positives = 106/299 (35%), Gaps = 58/299 (19%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFL-GIV 144
+F V+G G G + + ++ +VAVK++ EV L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNR------DVAVKRILPECFSFADR---EVQLLRESD 75
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
EH N+++ +C + D + + E ++ +Y+ K L + Q
Sbjct: 76 EHPNVIRY--FCTEKDRQFQ--YIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTS 129
Query: 205 GLAYLHEGMDFQIIV-RDFKSSNILLDEQWN-----AKLSDFGLAR-LGPSEGFTHVSTA 257
GLA+LH IV RD K NIL+ A +SDFGL + L +
Sbjct: 130 GLAHLHS----LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 258 VVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314
V GT G+ APE + D++S G Y +I+
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH----------------- 228
Query: 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL-------CLVKNARTRPKMSEVLE 366
P+ ++ I L G SL + H + + + + RP VL+
Sbjct: 229 PFGKSLQRQANI----LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 92 VIGEGGFGCVYKGLIKN--SEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFL-GIVEH 146
+GEG FG V + P + V VAVK L + + + ++E+ + I +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTW 192
+N++ L+G C D ++ EY G++ +YL + E +T+
Sbjct: 101 KNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 193 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 252
+ ARG+ YL I RD + N+L+ E K++DFGLAR + +
Sbjct: 157 KDLVSCTYQLARGMEYL-ASQKC--IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 253 HVSTAVVGT------MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+T M APE + +SDVWS+GV ++E+ T G P
Sbjct: 214 KKTT---NGRLPVKWM---APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 7e-31
Identities = 44/354 (12%), Positives = 91/354 (25%), Gaps = 79/354 (22%)
Query: 55 ESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQ 114
A S S S + +EL + R V+G+ + D
Sbjct: 43 MQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEA-----TDQET 97
Query: 115 KVEVAVKQLGR----------------------RGVQGHKEWMTEVNFLG---IVEHQNL 149
V RG++ K+ + F+ +V+
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS-----PKSETILTWAMRLKIAQDAAR 204
K++ D+ + + ++ + + L RL++ R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
LA LH + ++ + +I+LD++ L+ F + G+
Sbjct: 218 LLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD------GARVVSSVSRGF 268
Query: 265 AAPEYVQTGRLAA-----------RSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQW 312
PE + D W+ G+ +Y + P + + +
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS 328
Query: 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
K + L+ L R + +E
Sbjct: 329 CKNIPQPVRA----------------LLEGF-------LRYPKEDRLLPLQAME 359
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-31
Identities = 56/312 (17%), Positives = 100/312 (32%), Gaps = 71/312 (22%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGVQGHKEWMTEVNFL 141
T F IG G FG V+K D A+K+ G + + EV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC--VKRLD---GCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 142 -GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--PKSETILTWAMRLKI 198
+ +H ++V+ A+DD IQ EY GS+ +S + + A +
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQ----NEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-------------------QWNAKLSD 239
RGL Y+H ++ D K SNI + + K+ D
Sbjct: 121 LLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ--TGRLAARSDVWSYGVFLYELITGRRP 297
G S G + A E +Q L +D+++ + +
Sbjct: 178 LGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGA--- 227
Query: 298 IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKN 354
+P + Q+ +I PR+ S + + + + + +
Sbjct: 228 ----------------EPLPRNGDQWHEIRQGRLPRIPQVLS----QEFTELLKVMIHPD 267
Query: 355 ARTRPKMSEVLE 366
RP +++
Sbjct: 268 PERRPSAMALVK 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 42/254 (16%), Positives = 79/254 (31%), Gaps = 24/254 (9%)
Query: 60 PSYPSMSQRPSNLKEFTI-AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
SYP+ + L E + +K ++GEG F VY+ + D K +
Sbjct: 39 SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF 98
Query: 119 AVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 178
+K + L +K + +LV E G++
Sbjct: 99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG----SVLVGELYSYGTL 154
Query: 179 DQYL---SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL------ 229
+ E ++ + + A + +H+ +II D K N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211
Query: 230 -----DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWS 283
D L D G + + TA T G+ E + + + + D +
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFG 270
Query: 284 YGVFLYELITGRRP 297
+Y ++ G
Sbjct: 271 VAATVYCMLFGTYM 284
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 74/339 (21%), Positives = 124/339 (36%), Gaps = 67/339 (19%)
Query: 45 TSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKG 104
+ V A P P+ + + E + + + + R +G+GGF ++
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEI 60
Query: 105 LIKNSEDPSQKVEVAVKQLGRRGVQGHK---EWMTEVNFLGIVEHQNLVKLVGYCADDDE 161
D K A K + + + + E++ + HQ++V G+ D+D
Sbjct: 61 -----SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115
Query: 162 RGIQRLLVY---EYMPNGSVDQYLSPKSETILT-WAMRLKIAQDAARGLAYLHEGMDFQI 217
V+ E S+ + K LT R + Q G YLH +
Sbjct: 116 -------VFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQ-IVLGCQYLHRNR---V 162
Query: 218 IVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA 276
I RD K N+ L+E K+ DFGLA ++ V GT Y APE + +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIAPEVLSKKGHS 219
Query: 277 ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYS 336
DVWS G +Y L+ G+ P + S K + +I + +YS
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFE----TSCLKET------------YLRI----KKNEYS 259
Query: 337 L---------RLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ L+ K+ L + RP ++E+L
Sbjct: 260 IPKHINPVAASLIQKM-------LQTDPTARPTINELLN 291
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 92 VIGEGGFGCVYKGLIKN--SEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFL-GIVEH 146
+GEG FG V + P++ +VAVK L + + + ++E+ + I +H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKH 134
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTW 192
+N++ L+G C D ++ EY G++ +YL S E L+
Sbjct: 135 KNIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 193 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 252
+ A ARG+ YL I RD + N+L+ E K++DFGLAR +
Sbjct: 191 KDLVSCAYQVARGMEYL-ASKKC--IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 253 HVSTAVVGT------MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+T M APE + +SDVWS+GV L+E+ T G P
Sbjct: 248 KKTT---NGRLPVKWM---APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 82/310 (26%), Positives = 125/310 (40%), Gaps = 60/310 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLV 150
+G G G V+K K S + +A K + + + E+ L +V
Sbjct: 40 ELGAGNGGVVFKVSHKPS-----GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETILTWAMRLKIAQDAARGLA 207
G D E I E+M GS+DQ L E IL K++ +GL
Sbjct: 95 GFYGAFYSDGEISI----CMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLT 145
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAA 266
YL E +I+ RD K SNIL++ + KL DFG++ +L S + V GT Y +
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMS 198
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPI--------------------------DR 300
PE +Q + +SD+WS G+ L E+ GR PI R
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
Query: 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRL-EGKYSLRLVSKLSHVANLCLVKNAR 356
R K +P ++ + IV+ P+L G +SL + N CL+KN
Sbjct: 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV----NKCLIKNPA 314
Query: 357 TRPKMSEVLE 366
R + +++
Sbjct: 315 ERADLKQLMV 324
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 81/331 (24%), Positives = 134/331 (40%), Gaps = 54/331 (16%)
Query: 46 SQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGL 105
S V + + + Q + L+ + + V IGEG G V
Sbjct: 8 SSGVDLGTENLYFQSGVVTHEQFKAALRM--VVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 106 IKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGI 164
K+S +VAVK + R Q + EV + +H N+V++ Y ++
Sbjct: 66 EKHS-----GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE---- 116
Query: 165 QRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 223
L ++ E++ G++ +S L + + + LAYLH +I RD K
Sbjct: 117 --LWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 224 SSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVW 282
S +ILL KLSDFG A++ S+ + +VGT + APE + A D+W
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKS-LVGTPYWMAPEVISRSLYATEVDIW 225
Query: 283 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD--AKQFRQIVD---PRLEG--KY 335
S G+ + E++ G P PY SD + +++ D P+L+ K
Sbjct: 226 SLGIMVIEMVDG-EP-----------------PYFSDSPVQAMKRLRDSPPPKLKNSHKV 267
Query: 336 SLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
S L L LV++ + R E+L+
Sbjct: 268 SPVLRDFLE----RMLVRDPQERATAQELLD 294
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 92 VIGEGGFGCVYKGLIKN--SEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFL-GIVEH 146
+GEG FG V + P + V VAVK L + + + ++E+ + I +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTW 192
+N++ L+G C D ++ EY G++ +YL + E +T+
Sbjct: 147 KNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 193 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 252
+ ARG+ YL I RD + N+L+ E K++DFGLAR + +
Sbjct: 203 KDLVSCTYQLARGMEYL-ASQKC--IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 253 HVSTAVVGT------MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297
+T M APE + +SDVWS+GV ++E+ T G P
Sbjct: 260 KKTT---NGRLPVKWM---APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 50/216 (23%), Positives = 82/216 (37%), Gaps = 32/216 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFL---------- 141
++G GG G VY+ ED ++ VA+K + + ++ F
Sbjct: 41 LVGRGGMGDVYEA-----EDTVRERIVALKLM-------SETLSSDPVFRTRMQREARTA 88
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
G ++ ++V + + D Q + + + L + + L + I +
Sbjct: 89 GRLQEPHVVPIHDFGEIDG----QLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQ 142
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
L H RD K NIL+ A L DFG+A E T + VGT
Sbjct: 143 IGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGT 198
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
+ Y APE R+D+++ LYE +TG P
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 42/288 (14%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI 143
K ++R IG+G G VY + + EVA++Q+ + + + E+ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVAT-----GQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 144 VEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
++ N+V + Y D+ L +V EY+ GS+ ++ T + + ++
Sbjct: 74 NKNPNIVNYLDSYLVGDE------LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRE 124
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVG 260
+ L +LH Q+I RD KS NILL + KL+DFG A++ + + ST +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRST-MVG 178
Query: 261 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320
T + APE V + D+WS G+ E+I G P P L+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----- 233
Query: 321 KQFRQIVDPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
P L+ K S L+ CL + R E+L+
Sbjct: 234 --------PELQNPEKLSAIFRDFLN----RCLEMDVEKRGSAKELLQ 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFL----------G 142
+G GG V+ D +VAVK L + + +F
Sbjct: 20 LGFGGMSEVHLA-----RDLRDHRDVAVKVL-------RADLARDPSFYLRFRREAQNAA 67
Query: 143 IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA 202
+ H +V + + G +V EY+ ++ + +E +T +++ DA
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADA 125
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST-AVVGT 261
+ L + H+ II RD K +NI++ K+ DFG+AR G + T AV+GT
Sbjct: 126 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
Y +PE + + ARSDV+S G LYE++TG P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 32/215 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFL----------G 142
+G GG VY ED ++VA+K + + L
Sbjct: 19 LGGGGMSTVYLA-----EDTILNIKVAIKAI-------FIPPREKEETLKRFEREVHNSS 66
Query: 143 IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA 202
+ HQN+V + D DE LV EY+ ++ +Y+ +S L+ +
Sbjct: 67 QLSHQNIVSM--I--DVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQI 120
Query: 203 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
G+ + H+ +I+ RD K NIL+D K+ DFG+A+ T + V+GT+
Sbjct: 121 LDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTV 176
Query: 263 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
Y +PE + +D++S G+ LYE++ G P
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 81/321 (25%), Positives = 123/321 (38%), Gaps = 55/321 (17%)
Query: 63 PSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ 122
S N ++ + E VIG G V P ++ VA+K+
Sbjct: 5 SSALPWSINRDDYELQE------------VIGSGATAVVQAAYCA----PKKEK-VAIKR 47
Query: 123 LGRRGVQGHKEWM-TEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVD 179
+ Q + + E+ + H N+V + D+ L LV + + GSV
Sbjct: 48 INLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE------LWLVMKLLSGGSVL 101
Query: 180 QYLSPKSETILTWAMRLK------IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233
+ + L I ++ GL YLH+ I RD K+ NILL E
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDG 158
Query: 234 NAKLSDFGL-ARLGPSEGFTHVS--TAVVGT---MGYAAPEYVQTGRL-AARSDVWSYGV 286
+ +++DFG+ A L T VGT M APE ++ R ++D+WS+G+
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM---APEVMEQVRGYDFKADIWSFGI 215
Query: 287 FLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSH 345
EL TG P + P + LQ P L Q D + KY +S
Sbjct: 216 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ-----DKEMLKKYGKSFRKMIS- 269
Query: 346 VANLCLVKNARTRPKMSEVLE 366
LCL K+ RP +E+L
Sbjct: 270 ---LCLQKDPEKRPTAAELLR 287
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 86/356 (24%), Positives = 128/356 (35%), Gaps = 83/356 (23%)
Query: 42 SELTSQNVSAISVESEARPSYPSM------SQRPSNLKEFTIAELKSA---TKNFSRSVV 92
S + + + + R +LK+ +AEL K FS
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQNL 149
IG G FG VY + + VA+K++ G Q +++W + EV FL + H N
Sbjct: 62 IGHGSFGAVYFARDVRNSE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 150 VKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
++ G Y + LV EY + D + L + A +GLA
Sbjct: 117 IQYRGCYLREHT------AWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLA 168
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYAA 266
YLH +I RD K+ NILL E KL DFG + + P+ F VGT + A
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-------VGTPYWMA 218
Query: 267 PEYVQTGRLA---ARSDVWSYGVFLYELITGRRP------------IDRNRPRSEQKLLQ 311
PE + + DVWS G+ EL + P I +N
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------- 270
Query: 312 WVKPYLSDAKQFRQIVDPRLE-GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
P L+ G +S + + CL K + RP +L+
Sbjct: 271 -----------------PALQSGHWSEYFRNFVD----SCLQKIPQDRPTSEVLLK 305
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 27/266 (10%)
Query: 51 AISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSE 110
+ E +Q P ++ ++F ++GEG F V L + E
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRP-------EDFKFGKILGEGSFSTVV--LAR--E 51
Query: 111 DPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 167
+ + A+K L +R + + E + + ++H VKL DD+ +L
Sbjct: 52 LATSRE-YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----KL 105
Query: 168 -LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226
Y NG + +Y+ K + R A+ L YLH II RD K N
Sbjct: 106 YFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPEN 160
Query: 227 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGV 286
ILL+E + +++DFG A++ E + + VGT Y +PE + SD+W+ G
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 220
Query: 287 FLYELITGRRP-IDRNRPRSEQKLLQ 311
+Y+L+ G P N QK+++
Sbjct: 221 IIYQLVAGLPPFRAGNEYLIFQKIIK 246
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 77/369 (20%), Positives = 127/369 (34%), Gaps = 79/369 (21%)
Query: 27 SSCATF-NDNEVGRIGS-ELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSAT 84
S TF N VG+ L + + A+S+ + ++ ++ K+
Sbjct: 81 SGNGTFVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYP------KALR 134
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW--------MT 136
+ S +G G G V + + +VA++ + +R T
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKT-----CKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 137 EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRL 196
E+ L + H ++K+ + +D +V E M G + + L A
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKV--VGNKRLKEATCK 242
Query: 197 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTH 253
+ YLHE II RD K N+LL +E K++DFG +++
Sbjct: 243 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM- 298
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARS---DVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310
+ GT Y APE + + A + D WS GV L+ ++G P +R
Sbjct: 299 --RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-------- 348
Query: 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNART 357
+ QI GKY+ LV KL LV + +
Sbjct: 349 -------TQVSLKDQI----TSGKYNFIPEVWAEVSEKALDLVKKL-------LVVDPKA 390
Query: 358 RPKMSEVLE 366
R E L
Sbjct: 391 RFTTEEALR 399
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 71/308 (23%), Positives = 122/308 (39%), Gaps = 75/308 (24%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI 143
+ + +G+G FG VYK K + A K + + + ++++ E+ L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKET-----GALAAAKVIETKSEEELEDYIVEIEILAT 72
Query: 144 VEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
+H +VKL+G Y D L ++ E+ P G+VD + LT + +
Sbjct: 73 CDHPYIVKLLGAYYHDGK------LWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQ 125
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVG 260
L +LH +II RD K+ N+L+ + + +L+DFG+ A+ + + +G
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDS-FIG 179
Query: 261 T---MGYAAPEYVQTGRLA-----ARSDVWSYGVFLYELITGRRP------------IDR 300
T M APE V + ++D+WS G+ L E+ P I +
Sbjct: 180 TPYWM---APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236
Query: 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTR 358
+ P P L K+S+ L + L KN TR
Sbjct: 237 SDP-------------------------PTLLTPSKWSVEFRDFLK----IALDKNPETR 267
Query: 359 PKMSEVLE 366
P +++LE
Sbjct: 268 PSAAQLLE 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 77/300 (25%), Positives = 123/300 (41%), Gaps = 66/300 (22%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI 143
+ F +GEG +G VYK + K + VA+KQ+ +E + E++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKET-----GQIVAIKQVPVE--SDLQEIIKEISIMQQ 80
Query: 144 VEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
+ ++VK G Y + D L +V EY GSV + + LT I Q
Sbjct: 81 CDSPHVVKYYGSYFKNTD------LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQS 133
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVG 260
+GL YLH + I RD K+ NILL+ + +AKL+DFG+ +L ++ +T V+G
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNT-VIG 187
Query: 261 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP------------IDRNRPRSEQK 308
T + APE +Q +D+WS G+ E+ G+ P I N P
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP----- 242
Query: 309 LLQWVKPYLSDAKQFRQIVDPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
P +S + CLVK+ R +++L+
Sbjct: 243 --------------------PTFRKPELWSDNFTDFVK----QCLVKSPEQRATATQLLQ 278
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 66/378 (17%), Positives = 111/378 (29%), Gaps = 61/378 (16%)
Query: 66 SQRPSNLKEFTIAELKSATKNFSRSVVIGEG--GFGCVYKGLIKNSEDPSQKVEVAVKQ- 122
NL ++ + VIG+G V K P+ + V V++
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYK----PTGEY-VTVRRI 60
Query: 123 -LGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVD 179
L + E++ + H N+V + AD++ L +V +M GS
Sbjct: 61 NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE------LWVVTSFMAYGSAK 114
Query: 180 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239
+ + I Q + L Y+H + R K+S+IL+ LS
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSG 171
Query: 240 FGLARLGPSEG-----FTHVSTAVVGTMGYAAPEYVQTGRLA--ARSDVWSYGVFLYELI 292
S G V + + +PE +Q A+SD++S G+ EL
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 293 TGRRP------------IDRNRP----------------RSEQKLLQWVKPYLSDAKQFR 324
G P + + R
Sbjct: 232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPR 291
Query: 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE------MVNKIVDASAEA 378
Y H CL +N RP S +L + + +A E
Sbjct: 292 PSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPEL 351
Query: 379 GSPRRPLRSSTSRETPDH 396
P P+ + ++ DH
Sbjct: 352 LRPVTPITNFEGSQSQDH 369
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 71/323 (21%), Positives = 121/323 (37%), Gaps = 49/323 (15%)
Query: 55 ESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQ 114
S R + + F ++ ++ + R +G G +G V K +
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT----- 61
Query: 115 KVEVAVKQLGRRGVQGHKEWM--TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEY 172
VE A+K + + V EV L +++H N++KL + D LV E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR----NYYLVMEC 117
Query: 173 MPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL--- 229
G + + I + G+ YLH+ I+ RD K N+LL
Sbjct: 118 YKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESK 172
Query: 230 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLY 289
++ K+ DFGL+ + +GT Y APE V + + DVWS GV L+
Sbjct: 173 EKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILF 228
Query: 290 ELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLV--SKLSHVA 347
L+ G P +++Q++ R++ +GKY+ +S A
Sbjct: 229 ILLAGYPPFGG---QTDQEI-------------LRKV----EKGKYTFDSPEWKNVSEGA 268
Query: 348 ----NLCLVKNARTRPKMSEVLE 366
L +++ R + LE
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALE 291
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 55/288 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT-EVNFLGIVEHQNLVK 151
+GEG +G V + + VAVK + + E + E+ ++ H+N+VK
Sbjct: 15 LGEGAYGEVQLA-----VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR------- 204
G+ + + L EY G + + P + + A+
Sbjct: 70 FYGHRREGNI--Q--YLFLEYCSGGELFDRIEPDI--------GMP--EPDAQRFFHQLM 115
Query: 205 -GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA---RLGPSEGFTHVSTAVVG 260
G+ YLH I RD K N+LLDE+ N K+SDFGLA R E + G
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM---CG 169
Query: 261 TMGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318
T+ Y APE + R A DVWS G+ L ++ G P D+ S Q+ W +
Sbjct: 170 TLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKE---- 223
Query: 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
K+ +++ L L+ K+ LV+N R + ++ +
Sbjct: 224 --KKTYLNPWKKID-SAPLALLHKI-------LVENPSARITIPDIKK 261
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 65/318 (20%), Positives = 102/318 (32%), Gaps = 55/318 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPS-QKVEVAVKQL-GRRGVQGHKEWMTEVNFLGIVEHQNL 149
I GG G +Y D + V +K L + M E FL V H ++
Sbjct: 87 CIAHGGLGWIYLA-----LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 150 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
V++ + D G +V EY+ S+ + K L A + + L+Y
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSY 197
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268
LH ++ D K NI+L E+ KL D G + GT G+ APE
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFG-YLYGTPGFQAPE 247
Query: 269 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328
V +D+++ G L L D
Sbjct: 248 IV-RTGPTVATDIYTVGRTLAALTLDLP------------------TRNGRYVDGLPEDD 288
Query: 329 PRLEGKYSL-RLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPR----R 383
P L+ S RL+ + + + R R +E EM ++ E + R
Sbjct: 289 PVLKTYDSYGRLLRR-------AIDPDPRQRFTTAE--EMSAQLTGVLREVVAQDTGVPR 339
Query: 384 PLRSSTSRETPDHTKTKH 401
P S+ +
Sbjct: 340 PGLSTIFSPSRSTFGVDL 357
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 37/224 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT----EVNFLGIVEHQ 147
++GEG +G V + D AVK L ++ ++ E+ L + H+
Sbjct: 12 LLGEGSYGKVKEV-----LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVD--QYLSPKSETILTWAMRLKIAQDAAR- 204
N+++LV +++++ + +V EY G + + K R + Q A
Sbjct: 67 NVIQLVDVLYNEEKQKM--YMVMEYCVCGMQEMLDSVPEK---------RFPVCQ--AHG 113
Query: 205 -------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
GL YLH I+ +D K N+LL K+S G+A
Sbjct: 114 YFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 258 VVGTMGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPID 299
G+ + PE + D+WS GV LY + TG P +
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 59/305 (19%), Positives = 107/305 (35%), Gaps = 61/305 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLV 150
++G G G V VAVK++ + E+ L +H N++
Sbjct: 22 ILGYGSSGTVVFQGSFQGR------PVAVKRMLI---DFCDIALMEIKLLTESDDHPNVI 72
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQDAARG 205
+ YC++ +R + + E N ++ + S ++ + + + + A G
Sbjct: 73 RY--YCSETTDRFL--YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 206 LAYLHEGMDFQIIV-RDFKSSNILLD-------------EQWNAKLSDFGLAR-LGPSE- 249
+A+LH I+ RD K NIL+ E +SDFGL + L +
Sbjct: 128 VAHLHS----LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARS-------DVWSYGVFLYELIT-GRRPIDRN 301
F GT G+ APE ++ D++S G Y +++ G+ P
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 302 RPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM 361
R + R ++ E L+S+ + + RP
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIA---EAT---DLISQ-------MIDHDPLKRPTA 290
Query: 362 SEVLE 366
+VL
Sbjct: 291 MKVLR 295
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 55/288 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT-EVNFLGIVEHQNLVK 151
+GEG +G V + + VAVK + + E + E+ ++ H+N+VK
Sbjct: 15 LGEGAYGEVQLA-----VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR------- 204
G+ + + L EY G + + P + + A+
Sbjct: 70 FYGHRREGNI--Q--YLFLEYCSGGELFDRIEPDI--------GMP--EPDAQRFFHQLM 115
Query: 205 -GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA---RLGPSEGFTHVSTAVVG 260
G+ YLH I RD K N+LLDE+ N K+SDFGLA R E + G
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM---CG 169
Query: 261 TMGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318
T+ Y APE + R A DVWS G+ L ++ G P D+ S Q+ W +
Sbjct: 170 TLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKE---- 223
Query: 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
K+ +++ L L+ K+ LV+N R + ++ +
Sbjct: 224 --KKTYLNPWKKID-SAPLALLHKI-------LVENPSARITIPDIKK 261
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 73/288 (25%), Positives = 116/288 (40%), Gaps = 60/288 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH--KEWMTEVNFLGIVEHQNLV 150
IG+G F V + EVA+K + + + ++ EV + I+ H N+V
Sbjct: 23 IGKGNFAKVKLARHILT-----GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR------ 204
KL + + E+ + L+ EY G V YL R+K + AR
Sbjct: 78 KL--FEVIETEKTL--YLIMEYASGGEVFDYLVAHG--------RMK--EKEARSKFRQI 123
Query: 205 --GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
+ Y H+ I+ RD K+ N+LLD N K++DFG + G G
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAP 177
Query: 263 GYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320
YAAPE Q G+ DVWS GV LY L++G P D +
Sbjct: 178 PYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ----------------NLK 220
Query: 321 KQFRQIVDPRLEGKYSL--RLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ ++ L GKY + + + ++ LV N R + ++++
Sbjct: 221 ELRERV----LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 72/283 (25%), Positives = 120/283 (42%), Gaps = 42/283 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQN 148
V+G+G FG V K + E AVK + +R V+ + + EV L ++H N
Sbjct: 33 VLGKGSFGEVILCKDKIT-----GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
++KL + D LV E G + + S + +I + G+ Y
Sbjct: 88 IMKLYEFFEDKG----YFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITY 141
Query: 209 LHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
+H+ +I+ RD K N+LL + N ++ DFGL+ + +GT Y
Sbjct: 142 MHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYI 195
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAKQF 323
APE V G + DVWS GV LY L++G P + +E +L+ V+ Y + Q+
Sbjct: 196 APE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNG---ANEYDILKKVEKGKYTFELPQW 251
Query: 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+++ + K L+ K+ L R + L+
Sbjct: 252 KKVSE---SAK---DLIRKM-------LTYVPSMRISARDALD 281
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 57/326 (17%), Positives = 104/326 (31%), Gaps = 62/326 (19%)
Query: 63 PSMSQRPSNLKEFTIAELKSATKNFSR-----SVVIGEGGFGCVYKGLIKNSEDPSQKVE 117
S+ E + + V+G G G V + + + +
Sbjct: 2 AHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRT-----GQK 56
Query: 118 VAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNG 176
A+K L + EV+ ++V ++ + L++ E M G
Sbjct: 57 CALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG 111
Query: 177 SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQW 233
+ + + + T +I +D + +LH I RD K N+L ++
Sbjct: 112 ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDA 168
Query: 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
KL+DFG A+ T Y APE + + D+WS GV +Y L+
Sbjct: 169 VLKLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 224
Query: 294 GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LV 340
G P N ++ + R+I G+Y L+
Sbjct: 225 GFPPFYSNTGQAISPGM------------KRRI----RLGQYGFPNPEWSEVSEDAKQLI 268
Query: 341 SKLSHVANLCLVKNARTRPKMSEVLE 366
L L + R +++ +
Sbjct: 269 RLL-------LKTDPTERLTITQFMN 287
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 66/302 (21%), Positives = 108/302 (35%), Gaps = 83/302 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG G +G V + K + ++ A K++ + V+ + E+ + ++H N+++
Sbjct: 16 TIGRGSWGEVKIAVQKGT-----RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR---- 204
L D+ + LV E G + + + K E DAAR
Sbjct: 71 LYETFEDNTD----IYLVMELCTGGELFERVVHKRVFRE------------SDAARIMKD 114
Query: 205 ---GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVSTA 257
+AY H+ + RD K N L KL DFGLA P +
Sbjct: 115 VLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM----RT 167
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317
VGT Y +P+ V G D WS GV +Y L+ G P ++ ++
Sbjct: 168 KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSA---PTDSEV-------- 215
Query: 318 SDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMSEV 364
+I EG ++ L+ +L L K+ + R +
Sbjct: 216 -----MLKI----REGTFTFPEKDWLNVSPQAESLIRRL-------LTKSPKQRITSLQA 259
Query: 365 LE 366
LE
Sbjct: 260 LE 261
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 65/306 (21%), Positives = 103/306 (33%), Gaps = 87/306 (28%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM-TEVNFLGIVEHQNLV 150
+G G FG V+ ++S +E +K + + Q E + E+ L ++H N++
Sbjct: 29 KLGSGAFGDVHLVEERSS-----GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDAA 203
K+ D +V E G S SE A
Sbjct: 84 KIFEVFEDYHNM----YIVMETCEGGELLERIVSAQARGKALSE------------GYVA 127
Query: 204 R-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFT 252
LAY H ++ +D K NIL K+ DFGLA E T
Sbjct: 128 ELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312
GT Y APE V + + D+WS GV +Y L+TG P S +++
Sbjct: 185 ----NAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG---TSLEEV--- 233
Query: 313 VKPYLSDAKQFRQIVDPRLEGKYSLR------------LVSKLSHVANLCLVKNARTRPK 360
++ + + L+ ++ L K+ RP
Sbjct: 234 ----------QQKA----TYKEPNYAVECRPLTPQAVDLLKQM-------LTKDPERRPS 272
Query: 361 MSEVLE 366
++VL
Sbjct: 273 AAQVLH 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 74/405 (18%), Positives = 131/405 (32%), Gaps = 109/405 (26%)
Query: 10 DKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRP 69
+K+ + R ++ ++ ++A+P + +
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK-GTENLYF 74
Query: 70 SNLKEFTIAELKSATKNFSR----SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR 125
++ +A K F + VIG G V + + + + E AVK +
Sbjct: 75 QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT-----GHEFAVKIMEV 129
Query: 126 RGVQGHKEWM--------TEVNFL-GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNG 176
+ E + E + L + H +++ L+ + + LV++ M G
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY--ESSSFM--FLVFDLMRKG 185
Query: 177 -------SVDQYLSPKSETILTWAMRLKIAQDAAR-------GLAYLHEGMDFQIIV-RD 221
SE ++ +++LH IV RD
Sbjct: 186 ELFDYLTEKVAL----SE------------KETRSIMRSLLEAVSFLHA----NNIVHRD 225
Query: 222 FKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS- 279
K NILLD+ +LSDFG + L P E + GT GY APE ++
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPGEKL----RELCGTPGYLAPEILKCSMDETHPG 281
Query: 280 -----DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGK 334
D+W+ GV L+ L+ G P R + + R I +EG+
Sbjct: 282 YGKEVDLWACGVILFTLLAGSPPFWH---RRQILM-------------LRMI----MEGQ 321
Query: 335 YSLR-------------LVSKLSHVANLCLVKNARTRPKMSEVLE 366
Y L+S+L L + R + L+
Sbjct: 322 YQFSSPEWDDRSSTVKDLISRL-------LQVDPEARLTAEQALQ 359
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 39/220 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM---TEVNFLGIVEHQNL 149
+G G FG V G E +VAVK L R+ ++ E+ L + H ++
Sbjct: 19 LGVGTFGKVKIG-----EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 204
+KL Y +V EY+ G + Y+ R++ + AR
Sbjct: 74 IKL--YQVISTPTDF--FMVMEYVSGGELFDYICKHG--------RVE--EMEARRLFQQ 119
Query: 205 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
+ Y H ++ RD K N+LLD NAK++DFGL+ + F S G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 173
Query: 262 MGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPID 299
YAAPE + GRL D+WS GV LY L+ G P D
Sbjct: 174 PNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 69/352 (19%), Positives = 112/352 (31%), Gaps = 91/352 (25%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT---------EVNFLGI 143
+G G FG V+ D + EV VK + + V W+ E+ L
Sbjct: 32 LGSGAFGFVWTA-----VDKEKNKEVVVKFIKKEKVLEDC-WIEDPKLGKVTLEIAILSR 85
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGS-VDQYLSPKSETILTWAMRLKIAQDA 202
VEH N++K+ +++ Q LV E +G + ++ RL +
Sbjct: 86 VEHANIIKV--LDIFENQGFFQ--LVMEKHGSGLDLFAFIDRHP--------RLD--EPL 131
Query: 203 AR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 254
A + YL II RD K NI++ E + KL DFG A +
Sbjct: 132 ASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 255 STAVVGTMGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312
GT+ Y APE + G ++WS GV LY L+ P
Sbjct: 189 F---CGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENPFC------------- 231
Query: 313 VKPYLSDAKQFRQIVDPRLEGKYSL---------RLVSKLSHVANLCLVKNARTRPKMSE 363
+ + +E LVS L L R + +
Sbjct: 232 ---------ELEET----VEAAIHPPYLVSKELMSLVSGL-------LQPVPERRTTLEK 271
Query: 364 VLEM--VNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRES 413
++ V + V+ + + S + R + + +
Sbjct: 272 LVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 71/297 (23%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGIVEHQNL 149
++G+G FG V K + + + E AVK + + + + EV L ++H N+
Sbjct: 29 MLGKGSFGEVLKCKDRIT-----QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDA 202
+KL D +V E G ++ SE DA
Sbjct: 84 MKLFEILEDSS----SFYIVGELYTGGELFDEIIKRKRF----SE------------HDA 123
Query: 203 AR-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARL-GPSEGF 251
AR G+ Y+H+ I+ RD K NILL ++ + K+ DFGL+ +
Sbjct: 124 ARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 252 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311
+GT Y APE V G + DVWS GV LY L++G P ++E +L+
Sbjct: 181 K----DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDILK 232
Query: 312 WVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
V+ Y D Q+R I D + K L+ K+ L + R ++ LE
Sbjct: 233 RVETGKYAFDLPQWRTISD---DAK---DLIRKM-------LTFHPSLRITATQCLE 276
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 75/313 (23%), Positives = 120/313 (38%), Gaps = 75/313 (23%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLV 150
V+GEG V + + E AVK + ++ EV L H+N++
Sbjct: 20 VLGEGAHARVQTCINLIT-----SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR--- 204
+L+ + ++D LV+E M GS+ ++ + +E +A+
Sbjct: 75 ELIEFFEEEDR----FYLVFEKMRGGSILSHIHKRRHFNE------------LEASVVVQ 118
Query: 205 ----GLAYLHEGMDFQIIV-RDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVS 255
L +LH + I RD K NIL ++ K+ DF L + + + +S
Sbjct: 119 DVASALDFLHN----KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 256 TA----VVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPIDRNRPRSE 306
T G+ Y APE V+ A D+WS GV LY L++G P R S+
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV-GRCGSD 233
Query: 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVK 353
+ F I EGKY L+SKL LV+
Sbjct: 234 CGWDRGEACPACQNMLFESI----QEGKYEFPDKDWAHISCAAKDLISKL-------LVR 282
Query: 354 NARTRPKMSEVLE 366
+A+ R ++VL+
Sbjct: 283 DAKQRLSAAQVLQ 295
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 65/341 (19%), Positives = 117/341 (34%), Gaps = 69/341 (20%)
Query: 45 TSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKG 104
+S + S R S+ + K E + + ++G GGFG VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 105 LIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT------EVNFLGIVEHQ--NLVKLVGYC 156
D + VA+K + + + E EV L V +++L+ +
Sbjct: 63 --IRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117
Query: 157 ADDDERGIQRLLVYEYMPNGSVD--QYLSPKSETILTWAMRL------KIAQDAARGLAY 208
D +L+ E P D +++ + L + +
Sbjct: 118 ERPDSF----VLILER-PEPVQDLFDFITERG--------ALQEELARSFFWQVLEAVRH 164
Query: 209 LHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
H + ++ RD K NIL+D + KL DFG L + GT Y+ P
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDF---DGTRVYSPP 217
Query: 268 EYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-DAKQFRQ 325
E+++ R + VWS G+ LY+++ G P + + ++ + + +S + +
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV--FFRQRVSSECQH--- 272
Query: 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
L+ CL RP E+
Sbjct: 273 -------------LIRW-------CLALRPSDRPTFEEIQN 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 73/320 (22%), Positives = 118/320 (36%), Gaps = 94/320 (29%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT---------------- 136
IG+G +G V N D A+K L ++ + +
Sbjct: 21 IGKGSYGVVKLA--YNEND---NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 137 ----------EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 186
E+ L ++H N+VKLV D +E + +V+E + G V + + K
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL--YMVFELVNQGPVMEVPTLK- 132
Query: 187 ETILTWAMRL------KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240
L QD +G+ YLH +II RD K SN+L+ E + K++DF
Sbjct: 133 --------PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 241 GLARL-GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA---ARSDVWSYGVFLYELITGRR 296
G++ S+ + VGT + APE + R DVW+ GV LY + G+
Sbjct: 182 GVSNEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 297 PIDRNRPRSEQKLLQWVK---------PYLS-DAKQFRQIVDPRLEGKYSLRLVSKLSHV 346
P L +K P ++ D K L++++
Sbjct: 239 PFMDE---RIMCLHSKIKSQALEFPDQPDIAEDLK----------------DLITRM--- 276
Query: 347 ANLCLVKNARTRPKMSEVLE 366
L KN +R + E+
Sbjct: 277 ----LDKNPESRIVVPEIKL 292
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 74/346 (21%), Positives = 119/346 (34%), Gaps = 87/346 (25%)
Query: 60 PSYPSMSQRPSNLKEFTIAE---LKSATKNFSR----SVVIGEGGFGCVYKGLIKNSEDP 112
+ S + + I ++ +G G +G V KN
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG--- 60
Query: 113 SQKVEVAVKQLGRRGVQGHKEWMT-------------EVNFLGIVEHQNLVKLVGYCADD 159
E A+K + + + E++ L ++H N++KL D
Sbjct: 61 --HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118
Query: 160 DERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDAAR-------G 205
LV E+ G + ++ E DAA G
Sbjct: 119 K----YFYLVTEFYEGGELFEQIINRHKF----DE------------CDAANIMKQILSG 158
Query: 206 LAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
+ YLH+ I+ RD K NILL + N K+ DFGL+ + +GT
Sbjct: 159 ICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTA 212
Query: 263 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDA 320
Y APE V + + DVWS GV +Y L+ G P +++Q +++ V+ Y D
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGG---QNDQDIIKKVEKGKYYFDF 268
Query: 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
++ I D E K L+ + L + R E L
Sbjct: 269 NDWKNISD---EAK---ELIKLM-------LTYDYNKRCTAEEALN 301
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 74/342 (21%), Positives = 131/342 (38%), Gaps = 84/342 (24%)
Query: 50 SAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNS 109
S ++ + P+ P P K+ E + ++G+GGFG V+ G
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFE-----AEYRLGPLLGKGGFGTVFAG--HRL 53
Query: 110 EDPSQKVEVAVKQLGRRGVQGHKEWMT------EVNFLGIV----EHQNLVKLVGYCADD 159
D +++VA+K + R V G EV L V H +++L+ +
Sbjct: 54 TD---RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110
Query: 160 DERGIQRLLVYEY-MPNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------GLAYLH 210
+ +LV E +P + Y++ K + + +R + + H
Sbjct: 111 EG--F--MLVLERPLPAQDLFDYITEKG----------PLGEGPSRCFFGQVVAAIQHCH 156
Query: 211 EGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
++ RD K NIL+D + AKL DFG L E + GT Y+ PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDF---DGTRVYSPPEW 209
Query: 270 VQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ---WVKPYLS-DAKQFR 324
+ + A + VWS G+ LY+++ G P + +Q++L+ ++S D
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEILEAELHFPAHVSPDCCA-- 262
Query: 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
L+ + CL +RP + E+L
Sbjct: 263 --------------LIRR-------CLAPKPSSRPSLEEILL 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 70/319 (21%), Positives = 104/319 (32%), Gaps = 103/319 (32%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---------MTEVNFL- 141
++G G V + + K + E AVK + G + EV+ L
Sbjct: 24 ILGRGVSSVVRRCIHKPT-----CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAM 194
+ H N+++L + LV++ M G SE
Sbjct: 79 KVSGHPNIIQLKDTY--ETNTFF--FLVFDLMKKGELFDYLTEKVTL----SE------- 123
Query: 195 RLKIAQDAAR-------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG 246
++ + + LH+ I+ RD K NILLD+ N KL+DFG + L
Sbjct: 124 -----KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS------DVWSYGVFLYELITGRRPIDR 300
P E V GT Y APE ++ D+WS GV +Y L+ G P
Sbjct: 176 PGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
Query: 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVA 347
R + + R I + G Y LVS+
Sbjct: 232 ---RKQMLM-------------LRMI----MSGNYQFGSPEWDDYSDTVKDLVSRF---- 267
Query: 348 NLCLVKNARTRPKMSEVLE 366
LV + R E L
Sbjct: 268 ---LVVQPQKRYTAEEALA 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 60/326 (18%), Positives = 104/326 (31%), Gaps = 79/326 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK-----QLGRRGVQGHKEWMTEVNFLGIVEH 146
IG+G +G V + + + A+K ++ + + + TEV + + H
Sbjct: 33 AIGQGSYGVVRVAIENQT-----RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ------ 200
N+ +L D+ LV E G + L+ + +
Sbjct: 88 PNIARLYEVYEDEQYI----CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 201 -------------------------DAAR-------GLAYLHEGMDFQIIVRDFKSSNIL 228
+ L YLH I RD K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 229 L--DEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA--ARSDVW 282
++ + KL DFGL++ + G + T GT + APE + T + + D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 283 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLV 340
S GV L+ L+ G P ++ + V + + + + L+
Sbjct: 261 SAGVLLHLLLMGAVPFPG---VNDADTISQVLNKKLCFENPNYNVLSP---LAR---DLL 311
Query: 341 SKLSHVANLCLVKNARTRPKMSEVLE 366
S L L +N R L+
Sbjct: 312 SNL-------LNRNVDERFDAMRALQ 330
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 63/305 (20%), Positives = 99/305 (32%), Gaps = 89/305 (29%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
V+G G F V+ + A+K + + E+ L ++H+N+V
Sbjct: 16 VLGSGAFSEVFLV-----KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 152 LVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDAAR 204
L LV + + G Y +E +DA+
Sbjct: 71 LEDIYESTTHY----YLVMQLVSGGELFDRILERGVY----TE------------KDASL 110
Query: 205 -------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHV 254
+ YLH + I+ RD K N+L +E ++DFGL+++ + +
Sbjct: 111 VIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-- 165
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314
GT GY APE + + D WS GV Y L+ G P +E KL
Sbjct: 166 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE---ETESKL----- 215
Query: 315 PYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKM 361
F +I EG Y + L L K+ R
Sbjct: 216 --------FEKI----KEGYYEFESPFWDDISESAKDFICHL-------LEKDPNERYTC 256
Query: 362 SEVLE 366
+ L
Sbjct: 257 EKALS 261
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 67/220 (30%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT---EVNFLGIVEHQNL 149
+G G FG V G + +VAVK L R+ ++ E+ L + H ++
Sbjct: 24 LGVGTFGKVKVG-----KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 204
+KL Y I +V EY+ G + Y+ RL + +R
Sbjct: 79 IKL--YQVISTPSDI--FMVMEYVSGGELFDYICKNG--------RLD--EKESRRLFQQ 124
Query: 205 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
G+ Y H M ++ RD K N+LLD NAK++DFGL+ + F S G+
Sbjct: 125 ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 178
Query: 262 MGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPID 299
YAAPE + GRL D+WS GV LY L+ G P D
Sbjct: 179 PNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 73/298 (24%), Positives = 103/298 (34%), Gaps = 75/298 (25%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
IG G FG D K VAVK + R E+ + H N+V+
Sbjct: 28 IGSGNFGVARLM-----RDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF 81
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR-------- 204
I + EY G + + + R +D AR
Sbjct: 82 KEVILTPTHLAI----IMEYASGGELYERICNAG--------RFS--EDEARFFFQQLLS 127
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQW--NAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
G++Y H QI RD K N LLD K+ DFG ++ + VGT
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTP 181
Query: 263 GYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVKPYLSD 319
Y APE V + +DVWS GV LY ++ G P D PR +K +Q +
Sbjct: 182 AYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI------ 234
Query: 320 AKQFRQIVDPRLEGKYSL-----------RLVSKLSHVANLCLVKNARTRPKMSEVLE 366
L KYS+ L+S++ V + TR + E+
Sbjct: 235 -----------LSVKYSIPDDIRISPECCHLISRI-------FVADPATRISIPEIKT 274
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 72/308 (23%), Positives = 113/308 (36%), Gaps = 93/308 (30%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM--TEVNFLGIVEHQNL 149
++G+G FG V K + + + E AVK + + + EV L ++H N+
Sbjct: 29 MLGKGSFGEVLKCKDRIT-----QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDA 202
+KL D +V E G ++ SE DA
Sbjct: 84 MKLFEILEDSSSF----YIVGELYTGGELFDEIIKRKRF----SE------------HDA 123
Query: 203 AR-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGF 251
AR G+ Y+H I+ RD K NILL ++ + K+ DFGL+ +
Sbjct: 124 ARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 252 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311
+GT Y APE V G + DVWS GV LY L++G P ++E +
Sbjct: 181 K----DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDI-- 230
Query: 312 WVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTR 358
+++ GKY+ L+ K+ L + R
Sbjct: 231 -----------LKRV----ETGKYAFDLPQWRTISDDAKDLIRKM-------LTFHPSLR 268
Query: 359 PKMSEVLE 366
++ LE
Sbjct: 269 ITATQCLE 276
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 76/367 (20%), Positives = 149/367 (40%), Gaps = 47/367 (12%)
Query: 13 DEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAIS-VESEARPSYPSMSQRPSN 71
++L+ + D+ G ++ N + +++ + P+
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 72 LKEFTIAELKSATKNFS------RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR 125
F + + + ++ ++G G FG V+K + +++A K +
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT-----GLKLAAKIIKT 124
Query: 126 RGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK 185
RG++ +E E++ + ++H NL++L ++ +LV EY+ G + + +
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI----VLVMEYVDGGELFDRIIDE 180
Query: 186 SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV-RDFKSSNILLDEQWNA--KLSDFGL 242
S LT + + G+ ++H+ I+ D K NIL + K+ DFGL
Sbjct: 181 SYN-LTELDTILFMKQICEGIRHMHQ----MYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 243 AR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRN 301
AR P E GT + APE V ++ +D+WS GV Y L++G P +
Sbjct: 236 ARRYKPREKLK----VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291
Query: 302 RPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359
++ + L + + + ++F+ I + E K +SKL L+K R
Sbjct: 292 ---NDAETLNNILACRWDLEDEEFQDISE---EAK---EFISKL-------LIKEKSWRI 335
Query: 360 KMSEVLE 366
SE L+
Sbjct: 336 SASEALK 342
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQN 148
IG+G FG V ++ K A+K + ++ E E+ + +EH
Sbjct: 22 AIGKGSFGKVCIVQKNDT-----KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 149 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
LV L Y D+E + +V + + G + +L ++ ++L I + L
Sbjct: 77 LVNLW-YSFQDEED----MFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICE-LVMALD 129
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
YL +II RD K NILLDE + ++DF +A + P E T + GT Y AP
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 268 EYVQTGRLAARS---DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311
E + + A S D WS GV YEL+ GRRP S ++++
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 40/220 (18%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM---TEVNFLGIVEHQNL 149
+GEG FG V + +VA+K + R+ ++ M E+++L ++ H ++
Sbjct: 17 LGEGSFGKVKLA-----THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 204
+KL Y I ++V EY G + Y+ K R+ +D R
Sbjct: 72 IKL--YDVITTPTDI--VMVIEYA-GGELFDYIVEKK--------RMT--EDEGRRFFQQ 116
Query: 205 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
+ Y H +I+ RD K N+LLD+ N K++DFGL+ + F S G+
Sbjct: 117 IICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGS 170
Query: 262 MGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPID 299
YAAPE + G+L DVWS G+ LY ++ GR P D
Sbjct: 171 PNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 68/326 (20%), Positives = 119/326 (36%), Gaps = 44/326 (13%)
Query: 46 SQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGL 105
+ + +P +K+ S + +G G FG V++ +
Sbjct: 18 YDGPKINDYDKFYEDIWKKYVPQPVEVKQ------GSVYDYYDILEELGSGAFGVVHRCV 71
Query: 106 IKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165
K + K + E++ + + H L+ L D E
Sbjct: 72 EKAT-----GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM--- 123
Query: 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225
+L+ E++ G + ++ + ++ A + + A GL ++HE I+ D K
Sbjct: 124 -VLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPE 178
Query: 226 NILLDEQWNA--KLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVW 282
NI+ + + + K+ DFGLA L P E T +AAPE V + +D+W
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVK----VTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 283 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLV 340
+ GV Y L++G P + + LQ VK + D F + E K +
Sbjct: 235 AIGVLGYVLLSGLSPFAGE---DDLETLQNVKRCDWEFDEDAFSSVSP---EAK---DFI 285
Query: 341 SKLSHVANLCLVKNARTRPKMSEVLE 366
L L K R R + + LE
Sbjct: 286 KNL-------LQKEPRKRLTVHDALE 304
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 6e-23
Identities = 55/343 (16%), Positives = 101/343 (29%), Gaps = 82/343 (23%)
Query: 85 KNFSRSVVIGEGGFGCVYKGL--------------IKNSEDPSQKVEVAVKQLGRRG--- 127
+F +G GGFG V++ + N E +KV VK L +
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 128 -VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL------------------- 167
V+ W+ E +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 168 ------------LVYEYMPNGSVDQYLSP-KSETILTWAMRLKIAQDAARGLAYLHEGMD 214
+ + ++ +++ S + L I A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182
Query: 215 FQIIVRDFKSSNILLDEQWNAKLSDFGLAR----------LGPSEGFTHVSTAVVGTMGY 264
++ RD K SNI K+ DFGL + T VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324
+PE + + + D++S G+ L+EL+ + E+ + R
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSF------STQMERVRI---------ITDVR 287
Query: 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367
+ P L + + + L + RP+ ++++E
Sbjct: 288 NLKFPLLFTQKY----PQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 70/304 (23%), Positives = 112/304 (36%), Gaps = 84/304 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLV 150
IG G + + + K + +E AVK + + E+ L +H N++
Sbjct: 29 DIGVGSYSVCKRCIHKAT-----NMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNII 79
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR--- 204
L DD + + +V E M G + + + SE ++A+
Sbjct: 80 TLKDVY--DDGKYV--YVVTELMKGGELLDKILRQKFFSE------------REASAVLF 123
Query: 205 ----GLAYLHEGMDFQIIV-RDFKSSNILL-DEQWNA---KLSDFGLARLGPSEGFTHVS 255
+ YLH Q +V RD K SNIL DE N ++ DFG A+ +E +
Sbjct: 124 TITKTVEYLHA----QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLL 177
Query: 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315
T + APE ++ A D+WS GV LY ++TG P + +++
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI------ 231
Query: 316 YLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMS 362
+I GK+SL LVSK+ L + R +
Sbjct: 232 -------LARI----GSGKFSLSGGYWNSVSDTAKDLVSKM-------LHVDPHQRLTAA 273
Query: 363 EVLE 366
VL
Sbjct: 274 LVLR 277
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 69/269 (25%), Positives = 113/269 (42%), Gaps = 36/269 (13%)
Query: 64 SMSQRPSNLKEF---------TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQ 114
S +R N+ E+ + +++ ++F VIG G FG V ++K +
Sbjct: 44 SPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVA--VVK--LKNAD 99
Query: 115 KVEVAVKQLGRRGVQGHKE---WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVY 170
KV A+K L + + E + E + L + + + L + A D+ L LV
Sbjct: 100 KV-FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDN---NLYLVM 153
Query: 171 EYMPNGSVDQYLSPKSETILTWAM-RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229
+Y G + LS K E L M R +A+ + +H+ + RD K NIL+
Sbjct: 154 DYYVGGDLLTLLS-KFEDRLPEEMARFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILM 208
Query: 230 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSY 284
D + +L+DFG +G S A VGT Y +PE +Q D WS
Sbjct: 209 DMNGHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 285 GVFLYELITGRRP-IDRNRPRSEQKLLQW 312
GV +YE++ G P + + K++
Sbjct: 268 GVCMYEMLYGETPFYAESLVETYGKIMNH 296
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 64/308 (20%), Positives = 110/308 (35%), Gaps = 92/308 (29%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGIVEHQNL 149
+G+G F V + + K + +E A K + + + ++ E ++H N+
Sbjct: 13 ELGKGAFSVVRRCVHKTT-----GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDA 202
V+L ++ LV++ + G + + Y SE DA
Sbjct: 68 VRLHDSIQEESFH----YLVFDLVTGGELFEDIVAREFY----SE------------ADA 107
Query: 203 AR-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGF 251
+ +AY H I+ R+ K N+LL + KL+DFGLA + SE +
Sbjct: 108 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164
Query: 252 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311
GT GY +PE ++ + D+W+ GV LY L+ G P + +L
Sbjct: 165 H----GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRL-- 215
Query: 312 WVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTR 358
+ QI G Y L+ + L N + R
Sbjct: 216 -----------YAQI----KAGAYDYPSPEWDTVTPEAKSLIDSM-------LTVNPKKR 253
Query: 359 PKMSEVLE 366
+ L+
Sbjct: 254 ITADQALK 261
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 71/341 (20%), Positives = 111/341 (32%), Gaps = 106/341 (31%)
Query: 65 MSQRPSNLKE-FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL 123
MS P L++ + +++ +G G G V + + +VA+K +
Sbjct: 1 MSVYPKALRDEYIMSK------------TLGSGACGEVKLAFERKT-----CKKVAIKII 43
Query: 124 GRRGVQGHKEW--------MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN 175
+R TE+ L + H ++K+ + +D +V E M
Sbjct: 44 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEG 98
Query: 176 GSVDQYLSPK---SETILTWAMRLKIAQDAAR-------GLAYLHEGMDFQIIVRDFKSS 225
G + + E + YLHE II RD K
Sbjct: 99 GELFDKVVGNKRLKE------------ATCKLYFYQMLLAVQYLHENG---IIHRDLKPE 143
Query: 226 NILL---DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAAR---- 278
N+LL +E K++DFG +++ + GT Y APE V A
Sbjct: 144 NVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPE-VLVSVGTAGYNRA 199
Query: 279 SDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR 338
D WS GV L+ ++G P +R + QI GKY+
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHR---------------TQVSLKDQI----TSGKYNFI 240
Query: 339 -------------LVSKLSHVANLCLVKNARTRPKMSEVLE 366
LV KL LV + + R E L
Sbjct: 241 PEVWAEVSEKALDLVKKL-------LVVDPKARFTTEEALR 274
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 58/306 (18%), Positives = 95/306 (31%), Gaps = 84/306 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLV 150
V+G G G V + K + + + A+K L + EV + ++V
Sbjct: 69 VLGLGINGKVLQIFNKRT-----QEKFALKMLQDC-----PKARREVELHWRASQCPHIV 118
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGS-----VDQYLSPKSETILTWAMRLKIAQDAAR- 204
++V + L+V E + G D+ +E ++A+
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE------------REASEI 166
Query: 205 ------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHV 254
+ YLH I RD K N+L KL+DFG A+ T
Sbjct: 167 MKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-- 221
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWV 313
T Y APE + + D+WS GV +Y L+ G P + +
Sbjct: 222 --TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---- 275
Query: 314 KPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPK 360
+I G+Y L+ L L R
Sbjct: 276 ---------KTRI----RMGQYEFPNPEWSEVSEEVKMLIRNL-------LKTEPTQRMT 315
Query: 361 MSEVLE 366
++E +
Sbjct: 316 ITEFMN 321
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 70/342 (20%), Positives = 123/342 (35%), Gaps = 97/342 (28%)
Query: 63 PSMSQRPSNLKEFTIAE-LKSATKNFSRS----VVIGEGGFGCVYKGLIKNSEDPSQKVE 117
P M+ + +E + +A+ FS + +G+G F V + + K + +E
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTT-----GLE 56
Query: 118 VAVKQLGRRGVQG--HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN 175
A K + + + ++ E ++H N+V+L ++ LV++ +
Sbjct: 57 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH----YLVFDLVTG 112
Query: 176 G-------SVDQYLSPKSETILTWAMRLKIAQDAAR-------GLAYLHEGMDFQIIVRD 221
G + + Y SE DA+ +AY H I+ R+
Sbjct: 113 GELFEDIVAREFY----SE------------ADASHCIQQILESIAYCHSNG---IVHRN 153
Query: 222 FKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA 277
K N+LL + KL+DFGLA + SE + GT GY +PE ++ +
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGYLSPEVLKKDPYSK 209
Query: 278 RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSL 337
D+W+ GV LY L+ G P + +L + QI G Y
Sbjct: 210 PVDIWACGVILYILLVGYPPFWD---EDQHRL-------------YAQI----KAGAYDY 249
Query: 338 R-------------LVSKLSHVANLCLVKNARTRPKMSEVLE 366
L+ + L N + R + L+
Sbjct: 250 PSPEWDTVTPEAKSLIDSM-------LTVNPKKRITADQALK 284
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-22
Identities = 71/360 (19%), Positives = 137/360 (38%), Gaps = 48/360 (13%)
Query: 14 EPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLK 73
+P + +V G + + + + ++ + +P +K
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151
Query: 74 EFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE 133
+ ++ +G G FG V++ + + A K + +
Sbjct: 152 HDHV------LDHYDIHEELGTGAFGVVHRVTERAT-----GNNFAAKFVMTPHESDKET 200
Query: 134 WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGS-VDQYLSPKSETILTW 192
E+ + ++ H LV L DD+E +++YE+M G ++ ++ ++
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKVADEHNK--MSE 254
Query: 193 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLAR-LGPSE 249
++ + +GL ++HE + D K NI+ + + KL DFGL L P +
Sbjct: 255 DEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQK 308
GT +AAPE + + +D+WS GV Y L++G P N + +
Sbjct: 312 SVKVT----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDE 363
Query: 309 LLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
L+ VK + D F I + +GK + KL L+ + TR + + LE
Sbjct: 364 TLRNVKSCDWNMDDSAFSGISE---DGK---DFIRKL-------LLADPNTRMTIHQALE 410
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-22
Identities = 73/353 (20%), Positives = 135/353 (38%), Gaps = 56/353 (15%)
Query: 8 NWDKKDEPPTTPKSLFSIRSSCAT---------FNDNEVGRIGSELTSQNVSAISVESEA 58
++K + I + F+ + + + L + V +
Sbjct: 91 KYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYI 150
Query: 59 RPSYPSMSQRP-----SNLKEFTIAELKSATKN-------FSRSVVIGEGGFGCVYKGLI 106
++ + K + K+ N FS +IG GGFG VY
Sbjct: 151 EEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRK 210
Query: 107 KNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQN---LVKLVGYCADDD 160
++ K+ A+K L ++ ++ + + E L +V + +V + Y
Sbjct: 211 ADT----GKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTP 264
Query: 161 ERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 219
++ L + + M G + +LS + MR A+ GL ++H ++
Sbjct: 265 DK----LSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAE-IILGLEHMHN---RFVVY 315
Query: 220 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS 279
RD K +NILLDE + ++SD GLA + H A VGT GY APE +Q G S
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFS-KKKPH---ASVGTHGYMAPEVLQKGVAYDSS 371
Query: 280 -DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------PYLS-DAKQF 323
D +S G L++L+ G P +++ + + ++ + S + +
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 68/302 (22%), Positives = 109/302 (36%), Gaps = 76/302 (25%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLV 150
+GEG F K + K S AVK + +R ++ E+ L H N+V
Sbjct: 18 PLGEGSFSICRKCVHKKS-----NQAFAVKIISKRMEANTQK---EITALKLCEGHPNIV 69
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR--- 204
KL D LV E + G + + + K SE +A+
Sbjct: 70 KLHEVFHDQLH----TFLVMELLNGGELFERIKKKKHFSE------------TEASYIMR 113
Query: 205 ----GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHVSTA 257
++++H D ++ RD K N+L ++ K+ DFG ARL P +
Sbjct: 114 KLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKT 168
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317
T+ YAAPE + D+WS GV LY +++G+ P +
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT--------- 219
Query: 318 SDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMSEV 364
S + ++I +G +S L+ L L + R KMS +
Sbjct: 220 SAVEIMKKI----KKGDFSFEGEAWKNVSQEAKDLIQGL-------LTVDPNKRLKMSGL 268
Query: 365 LE 366
Sbjct: 269 RY 270
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 42/257 (16%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE--- 133
I +L+ +++ VIG G FG V L+++ ++KV A+K L + + +
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKS--TRKV-YAMKLLSKFEMIKRSDSAF 115
Query: 134 WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTW 192
+ E + + +V+L + A D+R L +V EYMP G + +S
Sbjct: 116 FWEERDIMAFANSPWVVQL--FYAFQDDR---YLYMVMEYMPGGDLVNLMS--------- 161
Query: 193 AMRLKIAQDAAR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244
+ + AR L +H I RD K N+LLD+ + KL+DFG
Sbjct: 162 --NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAAR----SDVWSYGVFLYELITGRRP-ID 299
EG TA VGT Y +PE +++ D WS GVFLYE++ G P
Sbjct: 217 KMNKEGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275
Query: 300 RNRPRSEQKLLQWVKPY 316
+ + K++
Sbjct: 276 DSLVGTYSKIMNHKNSL 292
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 65/240 (27%), Positives = 98/240 (40%), Gaps = 34/240 (14%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFL 141
F V+G GGFG V+ +K + K+ A K+L ++ ++ K + M E L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT----GKL-YACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 200
V + +V L Y + L LV M G + ++ E +
Sbjct: 240 AKVHSRFIVSLA-YAFETKTD----LCLVMTIMNGGDIRYHIYNVDE------DNPGFQE 288
Query: 201 DAAR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 252
A GL +LH+ II RD K N+LLD+ N ++SD GLA +
Sbjct: 289 PRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQ 311
+ GT G+ APE + D ++ GV LYE+I R P R ++L Q
Sbjct: 346 --TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 68/307 (22%), Positives = 117/307 (38%), Gaps = 83/307 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK-----QLGRRGVQGHKEWMTEVNFLGIVEH 146
VIG+G F V + + + + + AVK + ++ E + +++H
Sbjct: 31 VIGKGPFSVVRRCINRET-----GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNG-----------SVDQYLSPKSETILTWAMR 195
++V+L+ + D +V+E+M + Y SE + + MR
Sbjct: 86 PHIVELLETYSSDGML----YMVFEFMDGADLCFEIVKRADAGFVY----SEAVASHYMR 137
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFT 252
+I + L Y H+ + II RD K +LL + KL FG+A G
Sbjct: 138 -QILE----ALRYCHD-NN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL- 188
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312
V+ VGT + APE V+ DVW GV L+ L++G P ++++L
Sbjct: 189 -VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERL--- 240
Query: 313 VKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRP 359
F I ++GKY + LV ++ L+ + R
Sbjct: 241 ----------FEGI----IKGKYKMNPRQWSHISESAKDLVRRM-------LMLDPAERI 279
Query: 360 KMSEVLE 366
+ E L
Sbjct: 280 TVYEALN 286
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 69/245 (28%), Positives = 110/245 (44%), Gaps = 24/245 (9%)
Query: 74 EFTIAELKSATKN-FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK 132
++ E + TKN F + V+G+GGFG V ++ + K+ A K+L ++ ++ K
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT----GKM-YACKKLEKKRIKKRK 226
Query: 133 EW---MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSET 188
+ E L V + +V L Y + + L LV M G + ++ +
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLA-YAYETKDA----LCLVLTLMNGGDLKFHIYHMGQA 281
Query: 189 ILTWA-MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 247
A A+ GL LH +I+ RD K NILLD+ + ++SD GLA P
Sbjct: 282 GFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSE 306
VGT+GY APE V+ R D W+ G LYE+I G+ P R +
Sbjct: 338 EGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394
Query: 307 QKLLQ 311
+++ +
Sbjct: 395 EEVER 399
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 60/307 (19%), Positives = 107/307 (34%), Gaps = 89/307 (28%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM--TEVNFLGIVEHQNL 149
+G+G F V + + + E A + + + E +++H N+
Sbjct: 18 ELGKGAFSVVRRCVKVLA-----GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDA 202
V+L +++ L+++ + G + + Y SE DA
Sbjct: 73 VRLHDSISEEGHH----YLIFDLVTGGELFEDIVAREYY----SE------------ADA 112
Query: 203 AR-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFT 252
+ + + H+ M ++ R+ K N+LL + KL+DFGLA E
Sbjct: 113 SHCIQQILEAVLHCHQ-MG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-- 167
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312
GT GY +PE ++ D+W+ GV LY L+ G P + +L
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD---EDQHRL--- 221
Query: 313 VKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRP 359
++QI G Y L++K+ L N R
Sbjct: 222 ----------YQQI----KAGAYDFPSPEWDTVTPEAKDLINKM-------LTINPSKRI 260
Query: 360 KMSEVLE 366
+E L+
Sbjct: 261 TAAEALK 267
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 33/223 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
+G G +G VYK K D + A+KQ+ G+ E+ L ++H N++ L
Sbjct: 29 VGRGTYGHVYKAKRK---DGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISL 83
Query: 153 VGYCADDDERGIQRLLVYEYMPN------GSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
+R + L+++Y + + K L M + G+
Sbjct: 84 QKVFLSHADRKV--WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNA----KLSDFGLARL--GPSEGFTHVSTAVVG 260
YLH ++ RD K +NIL+ + K++D G ARL P + + VV
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197
Query: 261 TMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 298
T Y APE + L AR D+W+ G EL+T PI
Sbjct: 198 TFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLT-SEPI 235
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 66/254 (25%), Positives = 102/254 (40%), Gaps = 40/254 (15%)
Query: 56 SEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQK 115
A P + + +F I LK VIG G F V ++K + +
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFEI--LK----------VIGRGAFSEVA--VVK--MKQTGQ 87
Query: 116 VEVAVKQLGRRGVQGHKE---WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYE 171
V A+K + + + E + E + L + + + +L + A DE L LV E
Sbjct: 88 V-YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDEN---YLYLVME 141
Query: 172 YMPNGSVDQYLSPKSETILTWAM-RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230
Y G + LS K + M R +A+ + +H + RD K NILLD
Sbjct: 142 YYVGGDLLTLLS-KFGERIPAEMARFYLAEIVM-AIDSVHR---LGYVHRDIKPDNILLD 196
Query: 231 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-------DVWS 283
+ +L+DFG ++G A VGT Y +PE +Q + D W+
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVA-VGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255
Query: 284 YGVFLYELITGRRP 297
GVF YE+ G+ P
Sbjct: 256 LGVFAYEMFYGQTP 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 73/295 (24%), Positives = 113/295 (38%), Gaps = 61/295 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW------MTEVNFLGIVE 145
+G G F V K K++ +E A K + +R + + EV+ L V
Sbjct: 19 ELGSGQFAIVKKCREKST-----GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKI 198
H N++ L + + +L+ E + G + SE T ++ +I
Sbjct: 74 HHNVITLHDVYENRTDV----VLILELVSGGELFDFLAQKESL----SEEEATSFIK-QI 124
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSEGFTH 253
G+ YLH +I D K NI+L + KL DFGLA + F
Sbjct: 125 LD----GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK- 176
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313
+ GT + APE V L +D+WS GV Y L++G P + ++Q+ L +
Sbjct: 177 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANI 230
Query: 314 K--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
Y D + F + K + KL LVK R R + E L
Sbjct: 231 TSVSYDFDEEFFSHTSE---LAK---DFIRKL-------LVKETRKRLTIQEALR 272
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 61/294 (20%), Positives = 114/294 (38%), Gaps = 67/294 (22%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G FG V++ + +S K K + +G E++ L I H+N++
Sbjct: 12 DLGRGEFGIVHRCVETSS-----KKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65
Query: 152 LVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDAAR 204
L +E ++++E++ + L+ + +
Sbjct: 66 LHESFESMEEL----VMIFEFISGLDIFERINTSAFELNER---------------EIVS 106
Query: 205 -------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLAR-LGPSEGFTHV 254
L +LH I D + NI+ + ++ K+ +FG AR L P + F
Sbjct: 107 YVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR-- 161
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314
+ Y APE Q ++ +D+WS G +Y L++G P + Q++++ +
Sbjct: 162 --LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIM 216
Query: 315 --PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
Y D + F++I E V +L LVK ++R SE L+
Sbjct: 217 NAEYTFDEEAFKEISI---EAM---DFVDRL-------LVKERKSRMTASEALQ 257
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 67/233 (28%), Positives = 94/233 (40%), Gaps = 34/233 (14%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNF 140
AT + IG G +G VYK +S VA+K + R V +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGH-----FVALKSV--R-VPNGGGGGGGLPI 56
Query: 141 -----------LGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKS 186
L EH N+V+L+ CA ++ LV+E++ D YL
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAP 113
Query: 187 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL- 245
L + + RGL +LH I+ RD K NIL+ KL+DFGLAR+
Sbjct: 114 PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298
T V VV T+ Y APE + A D+WS G E+ R+P+
Sbjct: 171 SYQMALTPV---VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-21
Identities = 65/307 (21%), Positives = 104/307 (33%), Gaps = 85/307 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW------MTEVNFLGIVE 145
+G G F V K K + E A K + +R + + EVN L +
Sbjct: 12 ELGSGQFAIVRKCRQKGT-----GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKI 198
H N++ L + + +L+ E + G + +E T ++ +I
Sbjct: 67 HPNIITLHDIFENKTDV----VLILELVSGGELFDFLAEKESL----TEDEATQFLK-QI 117
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSEGFTH 253
G+ YLH +I D K NI+L KL DFG+A + F
Sbjct: 118 LD----GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK- 169
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQW 312
+ GT + APE V L +D+WS GV Y L++G P +
Sbjct: 170 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET----------- 215
Query: 313 VKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRP 359
+ I Y + +L LVK+ + R
Sbjct: 216 ------KQETLTNI----SAVNYDFDEEYFSNTSELAKDFIRRL-------LVKDPKRRM 258
Query: 360 KMSEVLE 366
+++ LE
Sbjct: 259 TIAQSLE 265
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 67/261 (25%), Positives = 104/261 (39%), Gaps = 41/261 (15%)
Query: 53 SVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSV------VIGEGGFGCVYKGLI 106
S P + + R + VIG G FG V++ +
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61
Query: 107 KNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL--VGYCADDDERGI 164
S+ EVA+K++ +Q + E+ + IV+H N+V L Y D + +
Sbjct: 62 VESD------EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111
Query: 165 QRLLVYEYMPNGSVDQYL--SPKSETILTWAM-RLKIAQDAARGLAYLHEGMDFQIIVRD 221
LV EY+P +V + K + + + +L + Q R LAY+H I RD
Sbjct: 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAYIHS---IGICHRD 166
Query: 222 FKSSNILLDEQWNA-KLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS 279
K N+LLD KL DFG A+ L E + + Y APE + A +
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS----YICSRYYRAPELI----FGATN 218
Query: 280 -----DVWSYGVFLYELITGR 295
D+WS G + EL+ G+
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQ 239
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 62/302 (20%), Positives = 108/302 (35%), Gaps = 77/302 (25%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGIVEHQ-N 148
+G G F V + + K++ E A K L +R E + E+ L + +
Sbjct: 36 ELGRGKFAVVRQCISKST-----GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGS-----VDQYLSPKSETILTWAMRLKIAQDAA 203
++ L + E +L+ EY G + + SE + ++ +I +
Sbjct: 91 VINLHEVYENTSEI----ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK-QILE--- 142
Query: 204 RGLAYLHEGMDFQIIV-RDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVSTAV 258
G+ YLH+ IV D K NILL + K+ DFG++R +G + +
Sbjct: 143 -GVYYLHQ----NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR----EI 193
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWVKPYL 317
+GT Y APE + + +D+W+ G+ Y L+T P + +
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---------------- 237
Query: 318 SDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMSEV 364
+ + + I + + L LVKN RP
Sbjct: 238 -NQETYLNI----SQVNVDYSEETFSSVSQLATDFIQSL-------LVKNPEKRPTAEIC 285
Query: 365 LE 366
L
Sbjct: 286 LS 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 74/295 (25%), Positives = 115/295 (38%), Gaps = 61/295 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM------TEVNFLGIVE 145
+G G F V K K++ +E A K + +R + + + EV+ L V
Sbjct: 19 ELGSGQFAIVKKCREKST-----GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKI 198
H N++ L + + +L+ E + G + SE T ++ +I
Sbjct: 74 HPNIITLHDVYENRTDV----VLILELVSGGELFDFLAQKESL----SEEEATSFIK-QI 124
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSEGFTH 253
G+ YLH +I D K NI+L + KL DFGLA + F
Sbjct: 125 LD----GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK- 176
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313
+ GT + APE V L +D+WS GV Y L++G P + ++Q+ L +
Sbjct: 177 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANI 230
Query: 314 K--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
Y D + F Q + K + KL LVK R R + E L
Sbjct: 231 TAVSYDFDEEFFSQTSE---LAK---DFIRKL-------LVKETRKRLTIQEALR 272
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 43/231 (18%)
Query: 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGVQGHKEWMT-- 136
S++ F + +G G + VYKGL K + VA+K++ G T
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVY-----VALKEVKLDSEEGTP-----STAI 51
Query: 137 -EVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPN---GSVDQYLSPKSETILT 191
E++ + ++H+N+V+L ++ +L LV+E+M N +D + L
Sbjct: 52 REISLMKELKHENIVRLYDVIHTEN-----KLTLVFEFMDNDLKKYMDSRTVGNTPRGLE 106
Query: 192 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSE 249
+ +GLA+ HE +I+ RD K N+L++++ KL DFGLAR P
Sbjct: 107 LNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163
Query: 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
F+ VV T+ Y AP+ + + +R+ D+WS G L E+ITG+
Sbjct: 164 TFSSE---VV-TLWYRAPDVL----MGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 8e-21
Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 47/231 (20%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMT---E 137
+ + + IGEG +G V+K + + + VA+K++ GV + E
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI-----VALKRVRLDDDDEGVP-----SSALRE 51
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETILTWAM 194
+ L ++H+N+V+L D ++L LV+E+ D +Y + + +
Sbjct: 52 ICLLKELKHKNIVRLH-----DVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIV 103
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFT 252
+ + Q +GL + H ++ RD K N+L++ KL++FGLAR P ++
Sbjct: 104 KSFLFQ-LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 298
VV T+ Y P+ + A+ D+WS G EL RP+
Sbjct: 160 AE---VV-TLWYRPPDVL----FGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-21
Identities = 66/302 (21%), Positives = 112/302 (37%), Gaps = 75/302 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL------GRRGVQGHKEWMTEVNFLGIVE 145
+G G F V K K++ ++ A K + R ++ EV+ L ++
Sbjct: 18 ELGSGQFAVVKKCREKST-----GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKI 198
H N++ L + + +L+ E + G + +E
Sbjct: 73 HPNVITLHEVYENKTDV----ILILELVAGGELFDFLAEKESL----TE----------- 113
Query: 199 AQDAAR-------GLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LG 246
++A G+ YLH QI D K NI+L + K+ DFGLA +
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306
F + GT + APE V L +D+WS GV Y L++G P + ++
Sbjct: 170 FGNEFK----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TK 222
Query: 307 QKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 364
Q+ L V Y + + F K + +L LVK+ + R + +
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSA---LAK---DFIRRL-------LVKDPKKRMTIQDS 269
Query: 365 LE 366
L+
Sbjct: 270 LQ 271
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 69/276 (25%), Positives = 108/276 (39%), Gaps = 37/276 (13%)
Query: 41 GSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGC 100
GSE S + + + + SQ + L +F +K +G G FG
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDR--IK----------TLGTGSFGR 56
Query: 101 VYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQNLVKLVGYCA 157
V L+K S A+K L ++ V K+ + E L V LVKL
Sbjct: 57 VM--LVK--HKESGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 158 DDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ 216
D+ L +V EY+ G + +L + R AQ YLH
Sbjct: 112 DNS-----NLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ-IVLTFEYLHS---LD 161
Query: 217 IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA 276
+I RD K N+L+D+Q +++DFG A+ +T + GT APE + +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYN 216
Query: 277 ARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQ 311
D W+ GV +YE+ G P + +K++
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 34/232 (14%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMT 136
A + + IGEG +G V+K ++ ++ + V A+K++ G G+ ++
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFV--ALKRVRVQTGEEGMP-----LS 57
Query: 137 ---EVNFL---GIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSE 187
EV L EH N+V+L C +L LV+E++ D YL E
Sbjct: 58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPE 114
Query: 188 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-G 246
+ + RGL +LH +++ RD K NIL+ KL+DFGLAR+
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298
T V VV T+ Y APE + A D+WS G E+ R+P+
Sbjct: 172 FQMALTSV---VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW--MT---EVNF 140
+ + IGEG +G V+K +++ VA+K+ E+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQ-----IVAIKKFL---ESEDDPVIKKIALREIRM 55
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 199
L ++H NLV L+ + R +RL LV+EY + +V L + + + + I
Sbjct: 56 LKQLKHPNLVNLL-----EVFRRKRRLHLVFEYCDH-TVLHELD-RYQRGVPEHLVKSIT 108
Query: 200 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTA 257
+ + + H+ I RD K NIL+ + KL DFG ARL GPS+ +
Sbjct: 109 WQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD---- 161
Query: 258 VVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
V T Y +PE + + DVW+ G EL++G
Sbjct: 162 EVATRWYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 43/279 (15%)
Query: 40 IGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSV-------- 91
+ + + + + ++ SM + + + R
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
VIG G FG VY+ + +S + VA+K++ +Q + E+ + ++H N+V+
Sbjct: 61 VIGNGSFGVVYQAKLCDSGE-----LVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 111
Query: 152 L--VGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETILTWA-MRLKIAQDAARGL 206
L Y + + + + LV +Y+P +V + +++ L ++L + Q R L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 169
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLAR-LGPSEGFTHVSTAVVGTMGY 264
AY+H F I RD K N+LLD KL DFG A+ L E + + Y
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----YICSRYY 222
Query: 265 AAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 298
APE + A DVWS G L EL+ G +PI
Sbjct: 223 RAPELI----FGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 72/302 (23%), Positives = 108/302 (35%), Gaps = 83/302 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G VY+ + + A+K L + K TE+ L + H N++K
Sbjct: 60 ELGRGATSIVYRC-----KQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIK 112
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR---- 204
L E LV E + G + + K SE +DAA
Sbjct: 113 LKEIFETPTEI----SLVLELVTGGELFDRIVEKGYYSE------------RDAADAVKQ 156
Query: 205 ---GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVSTA 257
+AYLHE I+ RD K N+L K++DFGL++ +
Sbjct: 157 ILEAVAYLHE-NG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK----T 209
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317
V GT GY APE ++ D+WS G+ Y L+ G P R +Q +
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY--DERGDQFM-------- 259
Query: 318 SDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMSEV 364
FR+I L +Y LV KL +V + + R +
Sbjct: 260 -----FRRI----LNCEYYFISPWWDEVSLNAKDLVRKL-------IVLDPKKRLTTFQA 303
Query: 365 LE 366
L+
Sbjct: 304 LQ 305
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 6e-20
Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 47/242 (19%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLG 142
+F +G G FG V+ LI+ + + A+K L + V K+ E L
Sbjct: 7 DFQILRTLGTGSFGRVH--LIR--SRHNGRY-YAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 143 IVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
IV H ++++ G D ++ ++ +Y+ G + L KS+ +
Sbjct: 62 IVTHPFIIRMWGTFQDAQ-----QIFMIMDYIEGGELFSLLR-KSQ---------RFPNP 106
Query: 202 AAR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 253
A+ L YLH II RD K NILLD+ + K++DFG A+ P +T
Sbjct: 107 VAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT- 162
Query: 254 VSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKL 309
+ GT Y APE V T + D WS+G+ +YE++ G P D N ++ +K+
Sbjct: 163 ----LCGTPDYIAPEVVSTKPYNKSI---DWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215
Query: 310 LQ 311
L
Sbjct: 216 LN 217
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 8e-20
Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 48/232 (20%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMT 136
+ + + + +GEG +G VYK VA+K++ G+ T
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR------IVALKRIRLDAEDEGIP-----ST 65
Query: 137 ---EVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETIL 190
E++ L + H N+V L+ D + L LV+E+M D + L +
Sbjct: 66 AIREISLLKELHHPNIVSLI-----DVIHSERCLTLVFEFMEK---DLKKVLDENKTGLQ 117
Query: 191 TWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPS 248
+++ + Q RG+A+ H+ +I+ RD K N+L++ KL+DFGLAR P
Sbjct: 118 DSQIKIYLYQ-LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173
Query: 249 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
+TH VV T+ Y AP+ + + ++ D+WS G E+ITG+
Sbjct: 174 RSYTHE---VV-TLWYRAPDVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 58/307 (18%)
Query: 42 SELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCV 101
++ ++V+ E R + + ++ F + LK V+G G +G V
Sbjct: 23 ADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFEL--LK----------VLGTGAYGKV 70
Query: 102 YKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW----MTEVNFLGIVEHQN-LVKLVGYC 156
+ L++ A+K L + + + TE L + LV L Y
Sbjct: 71 F--LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YA 127
Query: 157 ADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------GLA 207
+ + L L+ +Y+ G + +LS R + + + L
Sbjct: 128 FQTETK----LHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGEIVLALE 173
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
+LH+ II RD K NILLD + L+DFGL++ ++ GT+ Y AP
Sbjct: 174 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAP 229
Query: 268 EYVQTGRLAARSDV--WSYGVFLYELITGRRP-----IDRNRPRSEQKLLQ---WVKPYL 317
+ V+ G V WS GV +YEL+TG P ++ +++L+ +
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289
Query: 318 S-DAKQF 323
S AK
Sbjct: 290 SALAKDL 296
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 62/242 (25%), Positives = 92/242 (38%), Gaps = 30/242 (12%)
Query: 65 MSQRPSNLKEFTIAELKSAT----KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
M R F E+ +T K + IG G G V D + VA+
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAY-----DAILERNVAI 55
Query: 121 KQLGR--RGVQGHKEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMP-- 174
K+L R + K E+ + V H+N++ L+ + Q + +V E M
Sbjct: 56 KKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN 115
Query: 175 -NGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233
+ L + + L + M G+ +LH II RD K SNI++
Sbjct: 116 LCQVIQMELDHERMSYLLYQM--------LCGIKHLHSA---GIIHRDLKPSNIVVKSDC 164
Query: 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
K+ DFGLAR + T V T Y APE + D+WS G + E+I
Sbjct: 165 TLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
Query: 294 GR 295
G
Sbjct: 222 GG 223
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW-----MTEVNF 140
+ ++GEG +G V K K++ VA+K+ + M E+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGR-----IVAIKKF-LESDD--DKMVKKIAMREIKL 77
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 199
L + H+NLV L+ + + +R LV+E++ + ++ L + ++ +
Sbjct: 78 LKQLRHENLVNLL-----EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLF 131
Query: 200 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTA 257
Q G+ + H II RD K NIL+ + KL DFG AR P E +
Sbjct: 132 Q-IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD---- 183
Query: 258 VVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
V T Y APE + + DVW+ G + E+ G
Sbjct: 184 EVATRWYRAPELL----VGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 70/295 (23%), Positives = 124/295 (42%), Gaps = 61/295 (20%)
Query: 48 NVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIK 107
++ I++ + + +F + LK V+G+G FG V+ L+K
Sbjct: 4 SIKEIAITHHVKEGHEKAD-----PSQFEL--LK----------VLGQGSFGKVF--LVK 44
Query: 108 NSEDPSQKVEVAVKQLGRRGVQGHKEW--MTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165
+ A+K L + ++ E + L V H +VKL Y + +
Sbjct: 45 KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGK--- 100
Query: 166 RL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------GLAYLHEGMDFQ 216
L L+ +++ G + LS + ++ + L +LH
Sbjct: 101 -LYLILDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLHS---LG 146
Query: 217 IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---G 273
II RD K NILLDE+ + KL+DFGL++ + + GT+ Y APE V
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHT 204
Query: 274 RLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQ---WVKPYLS-DAKQF 323
+ A D WS+GV ++E++TG P ++R + +L+ + +LS +A+
Sbjct: 205 QSA---DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 256
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 43/237 (18%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVK------QLGRRGVQGHKEW 134
+ F + G+G FG V G K++ VA+K + R +Q
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMS-----VAIKKVIQDPRFRNRELQ----- 68
Query: 135 MTEVNFLGIVEHQNLVKLVGY---CADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETI 189
+ L ++ H N+V+L Y + D R I +V EY+P+ ++ + + +
Sbjct: 69 --IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVA 125
Query: 190 LTWA-MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGLAR-LG 246
+++ + Q R + LH + RD K N+L++E KL DFG A+ L
Sbjct: 126 PPPILIKVFLFQ-LIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 298
PSE + + Y APE + + D+WS G E++ G PI
Sbjct: 184 PSEPNVA----YICSRYYRAPELI----FGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 48/228 (21%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGVQGHKEWMT---E 137
+ + IGEG +G VYK E A+K++ G+ T E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGE------TFALKKIRLEKEDEGIP-----STTIRE 50
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETILTWAM 194
++ L ++H N+VKL RL LV+E++ D + L + +
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKK-----RLVLVFEHLDQ---DLKKLLDVCEGGLESVTA 102
Query: 195 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFT 252
+ + Q G+AY H+ +++ RD K N+L++ + K++DFGLAR P +T
Sbjct: 103 KSFLLQ-LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158
Query: 253 HVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
H +V T+ Y AP+ + + ++ D+WS G E++ G
Sbjct: 159 HE---IV-TLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 46/227 (20%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGVQGHKEWMT---EV 138
+ + + +GEG + VYKG K +++ VA+K++ G T EV
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL-----VALKEIRLEHEEGAP-----CTAIREV 51
Query: 139 NFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETILTWAMR 195
+ L ++H N+V L D + L LV+EY+ D QYL I ++
Sbjct: 52 SLLKDLKHANIVTLH-----DIIHTEKSLTLVFEYLDK---DLKQYLDDCGNIINMHNVK 103
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTH 253
L + Q RGLAY H +++ RD K N+L++E+ KL+DFGLAR P++ + +
Sbjct: 104 LFLFQ-LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
VV T+ Y P+ + L + D+W G YE+ TGR
Sbjct: 160 E---VV-TLWYRPPDIL----LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 3e-19
Identities = 70/236 (29%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---M 135
++KS K + + +GEG F VYK KN+ VA+K++ + G + +
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI-----VAIKKI-KLGHRSEAKDGINR 57
Query: 136 T---EVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETI 189
T E+ L + H N++ L+ + LV+++M D + S +
Sbjct: 58 TALREIKLLQELSHPNIIGLLDAFGHKS-----NISLVFDFMET---DLEVIIKDNS-LV 108
Query: 190 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GP 247
LT + +GL YLH+ I+ RD K +N+LLDE KL+DFGLA+ P
Sbjct: 109 LTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 248 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 298
+ +TH VV T Y APE + AR D+W+ G L EL+ R P
Sbjct: 166 NRAYTHQ---VV-TRWYRAPELL----FGARMYGVGVDMWAVGCILAELLL-RVPF 212
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 59/267 (22%), Positives = 104/267 (38%), Gaps = 55/267 (20%)
Query: 52 ISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSED 111
++ + + A ++ + R +GEG +G VYK + + +
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 112 PSQKVEVAVKQL----GRRGVQGHKEWMT---EVNFLGIVEHQNLVKLVGYCADDDERGI 164
VA+K++ GV T EV+ L ++H+N+++L +
Sbjct: 61 T-----VAIKRIRLEHEEEGVP-----GTAIREVSLLKELQHRNIIELKSVIHHNH---- 106
Query: 165 QRL-LVYEYMPN---GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 220
RL L++EY N +D+ I ++ +L G+ + H + + R
Sbjct: 107 -RLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHSR---RCLHR 156
Query: 221 DFKSSNILLDEQWNA-----KLSDFGLARL--GPSEGFTHVSTAVVGTMGYAAPEYVQTG 273
D K N+LL + K+ DFGLAR P FTH ++ T+ Y PE +
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE---II-TLWYRPPEIL--- 209
Query: 274 RLAARS-----DVWSYGVFLYELITGR 295
L +R D+WS E++
Sbjct: 210 -LGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 46/253 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK---EW-MTEVNFLGIVEHQ 147
V+G+GG+G V+ ++ + A+K L + + + E N L V+H
Sbjct: 24 VLGKGGYGKVF--QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 148 NLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR-- 204
+V L+ Y + L L+ EY+ G + L E I +D A
Sbjct: 82 FIVDLI-YAFQTGGK----LYLILEYLSGGELFMQLE--REGIFM--------EDTACFY 126
Query: 205 ------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 258
L +LH+ II RD K NI+L+ Q + KL+DFGL + +G +
Sbjct: 127 LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTF 181
Query: 259 VGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQ--- 311
GT+ Y APE + R D WS G +Y+++TG P NR ++ K+L+
Sbjct: 182 CGTIEYMAPEILMRSGHNRAV---DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238
Query: 312 WVKPYLS-DAKQF 323
+ PYL+ +A+
Sbjct: 239 NLPPYLTQEARDL 251
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 60/253 (23%), Positives = 97/253 (38%), Gaps = 29/253 (11%)
Query: 53 SVESEARPSYPSMSQRPSNLKEFTIAELKSA---TKNFSRSVVIGEGGFGCVYKGLIKNS 109
V+ + +MS+ + + +++ S K + IG G G V
Sbjct: 27 QVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAY---- 82
Query: 110 EDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQR 166
D VA+K+L R + K E+ + V H+N++ L+ + Q
Sbjct: 83 -DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141
Query: 167 L-LVYEYMP---NGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 222
+ LV E M + L + + L + M G+ +LH II RD
Sbjct: 142 VYLVMELMDANLCQVIQMELDHERMSYLLYQM--------LCGIKHLHSA---GIIHRDL 190
Query: 223 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVW 282
K SNI++ K+ DFGLAR + T V T Y APE + D+W
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIW 247
Query: 283 SYGVFLYELITGR 295
S G + E++ +
Sbjct: 248 SVGCIMGEMVRHK 260
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 54/239 (22%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW----MT---EV 138
+ + IG+G FG V+K + + VA+K+ V E +T E+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQK-----VALKK-----VLMENEKEGFPITALREI 67
Query: 139 NFLGIVEHQNLVKLVGYCADDDERGIQRL----LVYEYMPNGSVDQ----YLSPKSETIL 190
L +++H+N+V L+ C + LV+++ + LS
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVK-F 121
Query: 191 TWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL----- 245
T + ++ Q GL Y+H +I+ RD K++N+L+ KL+DFGLAR
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 246 -GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 298
+T+ VV T+ Y PE + L R D+W G + E+ T R PI
Sbjct: 179 NSQPNRYTNR---VV-TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWT-RSPI 228
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 24/212 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEV-AVKQLGRRGVQGHKEW---MTEVNFLGIVEHQ 147
++G+G FG V K + A+K L + + E +TE L H
Sbjct: 155 LLGKGTFGKVILVKEKATG------RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 148 NLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
L L Y +R L V EY G + +LS + R A+ L
Sbjct: 209 FLTALK-YSFQTHDR----LCFVMEYANGGELFFHLS-RERVFSEDRARFYGAE-IVSAL 261
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
YLH + ++ RD K N++LD+ + K++DFGL + G +G T GT Y A
Sbjct: 262 DYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLA 317
Query: 267 PEYVQTGRLAARS-DVWSYGVFLYELITGRRP 297
PE V R+ D W GV +YE++ GR P
Sbjct: 318 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 36/307 (11%), Positives = 86/307 (28%), Gaps = 63/307 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGVQGHKEWMTEVNFLGIVEHQN 148
G ++ D + +VA+ + G +E ++ L ++
Sbjct: 38 FHGGVPPLQFWQA-----LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
+ + V G L+V E++ GS+ + +T + ++ Q A
Sbjct: 93 VAR-VLDVVHTRAGG---LVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADA 144
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268
H + + S + + + L+
Sbjct: 145 AHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA 179
Query: 269 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYLSDAKQFRQIV 327
+ D+ G LY L+ R P+ RS + + + +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232
Query: 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRS 387
++ + ++ + + R S +L ++ + A A+ P+
Sbjct: 233 PFQIS-----AVAAR-------SVQGDGGIRSA-STLLNLMQQ-ATAVADRTEVLGPIDE 278
Query: 388 STSRETP 394
+ P
Sbjct: 279 APVSAAP 285
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 69/302 (22%), Positives = 114/302 (37%), Gaps = 25/302 (8%)
Query: 2 KCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPS 61
+ +K K L G G+E Q + +
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318
Query: 62 YPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVK 121
+ S + + +F+ +V+G+G FG V K +++ AVK
Sbjct: 319 EEKTANTISKFDNNGNRD-RMKLTDFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVK 372
Query: 122 QLGRRGVQGHKEW---MTEVNFLGIV-EHQNLVKLVGYCADDDERGIQRL-LVYEYMPNG 176
L + V + M E L + + L +L C +R L V EY+ G
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDR----LYFVMEYVNGG 427
Query: 177 SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236
D + + A + A GL +L II RD K N++LD + + K
Sbjct: 428 --DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIK 482
Query: 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 295
++DFG+ + +G T + GT Y APE + + +S D W++GV LYE++ G+
Sbjct: 483 IADFGMCKENIWDGVT--TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
Query: 296 RP 297
P
Sbjct: 540 AP 541
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 75/259 (28%), Positives = 103/259 (39%), Gaps = 43/259 (16%)
Query: 55 ESEARPSYPSMSQRPSNLKEFTIAELKSAT-KNFSRSVVIGEGGFGCVYKGLIKNSEDPS 113
E E + P+ PS + A +F VIG+G FG V K E
Sbjct: 7 EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEE--- 63
Query: 114 QKVEV-AVKQLGRRGVQGHKEW---MTEVN-FLGIVEHQNLVKLVGYCADDDERGIQRL- 167
AVK L ++ + KE M+E N L V+H LV L + ++ L
Sbjct: 64 ---VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADK----LY 115
Query: 168 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------GLAYLHEGMDFQIIV 219
V +Y+ G + +L E + AR L YLH I+
Sbjct: 116 FVLDYINGGELFYHLQ--RERCFL--------EPRARFYAAEIASALGYLHS---LNIVY 162
Query: 220 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS 279
RD K NILLD Q + L+DFGL + T ++ GT Y APE V + R+
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPE-VLHKQPYDRT 219
Query: 280 -DVWSYGVFLYELITGRRP 297
D W G LYE++ G P
Sbjct: 220 VDWWCLGAVLYEMLYGLPP 238
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 63/212 (29%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEV-AVKQLGRRGVQGHKEW---MTEVNFLGIVEHQ 147
++G+G FG V K + A+K L + + E +TE L H
Sbjct: 12 LLGKGTFGKVILVREKATG------RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 148 NLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
L L Y +R L V EY G + +LS + R A+ L
Sbjct: 66 FLTALK-YAFQTHDR----LCFVMEYANGGELFFHLS-RERVFTEERARFYGAE-IVSAL 118
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
YLH ++ RD K N++LD+ + K++DFGL + G S+G T GT Y A
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 173
Query: 267 PEYVQTGRLAARS-DVWSYGVFLYELITGRRP 297
PE V R+ D W GV +YE++ GR P
Sbjct: 174 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFL 141
K + +G G +G V + D +VA+K+L R + K E+ L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAI-----DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77
Query: 142 GIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 199
++H+N++ L+ + R LV +M +T L M LK +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-------------QTDLQKIMGLKFS 124
Query: 200 QD--------AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 251
++ +GL Y+H ++ RD K N+ ++E K+ DFGLAR
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR-----HA 176
Query: 252 THVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 295
T V T Y APE + + ++ D+WS G + E++TG+
Sbjct: 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 66/242 (27%), Positives = 105/242 (43%), Gaps = 32/242 (13%)
Query: 63 PSMSQ-RPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVK 121
P +++ RPS + I ++F ++G+G FG V+ K + + A+K
Sbjct: 1 PELNKERPSLQIKLKI-------EDFILHKMLGKGSFGKVFLAEFKKT----NQF-FAIK 48
Query: 122 QLGRRGVQGHKEW---MTEVNFLGIV-EHQNLVKLVGYCADDDERGIQRL-LVYEYMPNG 176
L + V + M E L + EH L + E L V EY+ G
Sbjct: 49 ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKEN----LFFVMEYLNGG 103
Query: 177 SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236
+ ++ + L+ A A+ GL +LH I+ RD K NILLD+ + K
Sbjct: 104 DLMYHIQSCHKFDLSRA-TFYAAE-IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIK 158
Query: 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 295
++DFG+ + + GT Y APE + G+ S D WS+GV LYE++ G+
Sbjct: 159 IADFGMCKENMLGDAK--TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
Query: 296 RP 297
P
Sbjct: 216 SP 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 50/223 (22%), Positives = 79/223 (35%), Gaps = 39/223 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT-----------EVNF 140
I G +G V G+ VA+K++ G + E+
Sbjct: 29 FISSGSYGAVCAGVDSEGI------PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPN------GSVDQYLSPKSETILTWA 193
L H N++ L +E + +L LV E M +SP+ +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 194 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 253
+ GL LHE ++ RD NILL + + + DF LAR ++
Sbjct: 143 I--------LLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-- 189
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 295
T V Y APE V + + D+WS G + E+ +
Sbjct: 190 -KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-16
Identities = 53/306 (17%), Positives = 88/306 (28%), Gaps = 105/306 (34%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLV 150
V+G G G V + K + + + A+K L + EV + ++V
Sbjct: 25 VLGLGINGKVLQIFNKRT-----QEKFALKMLQDC-----PKARREVELHWRASQCPHIV 74
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGS-----VDQYLSPKSETILTWAMRLKIAQDAAR- 204
++V + L+V E + G D+ +E ++A+
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE------------REASEI 122
Query: 205 ------GLAYLHEGMDFQIIV-RDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHV 254
+ YLH I RD K N+L KL+DFG A
Sbjct: 123 MKSIGEAIQYLHS----INIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------- 167
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWV 313
E + D+WS GV +Y L+ G P + +
Sbjct: 168 ------------KE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---- 210
Query: 314 KPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPK 360
+I G+Y L+ L L R
Sbjct: 211 ---------KTRI----RMGQYEFPNPEWSEVSEEVKMLIRNL-------LKTEPTQRMT 250
Query: 361 MSEVLE 366
++E +
Sbjct: 251 ITEFMN 256
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 42/221 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEV-AVKQLGRRGVQGHKEW---MTEVN-FLGIVEH 146
VIG G + V +K ++ + A+K + + V ++ TE + F H
Sbjct: 16 VIGRGSYAKVLLVRLKKTD------RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 147 QNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR- 204
LV L C + R L V EY+ G + ++ + K+ ++ AR
Sbjct: 70 PFLVGLH-SCFQTESR----LFFVIEYVNGGDLMFHMQRQR----------KLPEEHARF 114
Query: 205 -------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
L YLHE II RD K N+LLD + + KL+D+G+ + G G T ++
Sbjct: 115 YSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TST 169
Query: 258 VVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 297
GT Y APE + G S D W+ GV ++E++ GR P
Sbjct: 170 FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
L +LH+ II RD K N+LLD + + KL+DFG+ + G G T + GT Y
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDY 190
Query: 265 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 297
APE + L + D W+ GV LYE++ G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
GL +L II RD K N++LD + + K++DFG+ + +G T + GT Y
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDY 187
Query: 265 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 297
APE + + +S D W++GV LYE++ G+ P
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 42/218 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFL-GIVEHQNLVK 151
+G G + V++ + + + +V VK L + V+ K+ E+ L + N++
Sbjct: 44 LGRGKYSEVFEAI-----NITNNEKVVVKIL--KPVK-KKKIKREIKILENLRGGPNIIT 95
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET--------ILTWAMRLKIAQDAA 203
L D R LV+E++ N Q ++ IL
Sbjct: 96 LADIVKDPVSR--TPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL------------- 140
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLG-PSEGFTHVSTAVVGT 261
+ L Y H I+ RD K N+++D E +L D+GLA P + + V +
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR----VAS 193
Query: 262 MGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 298
+ PE + ++ S D+WS G L +I + P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 35/131 (26%), Positives = 58/131 (44%), Gaps = 10/131 (7%)
Query: 171 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230
+ + + ++ + LT + + A+G+ +L + I RD + NILL
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 227
Query: 231 EQWNAKLSDFGLARLGPSEGFTHVSTAV---VGTMGYAAPEYVQTGRLAARSDVWSYGVF 287
E+ K+ DFGLAR + + M APE + +SDVWS+GV
Sbjct: 228 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM---APETIFDRVYTIQSDVWSFGVL 284
Query: 288 LYELIT-GRRP 297
L+E+ + G P
Sbjct: 285 LWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 26/101 (25%), Positives = 42/101 (41%), Gaps = 5/101 (4%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFL-GIVEHQNL 149
+G G FG V + + + VAVK L H+ M+E+ L I H N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETIL 190
V L+G C +++ E+ G++ YL K +
Sbjct: 89 VNLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFV 126
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 42/221 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEV-AVKQLGRRGVQGHKEW---MTEVN-FLGIVEH 146
VIG G + V +K ++ + A++ + + V ++ TE + F H
Sbjct: 59 VIGRGSYAKVLLVRLKKTD------RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 147 QNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR- 204
LV L C + R L V EY+ G + ++ + K+ ++ AR
Sbjct: 113 PFLVGLH-SCFQTESR----LFFVIEYVNGGDLMFHMQRQR----------KLPEEHARF 157
Query: 205 -------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
L YLHE II RD K N+LLD + + KL+D+G+ + G G T ++
Sbjct: 158 YSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TST 212
Query: 258 VVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 297
GT Y APE + G S D W+ GV ++E++ GR P
Sbjct: 213 FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 58/257 (22%), Positives = 99/257 (38%), Gaps = 68/257 (26%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT-EVNFLG 142
+K +S +G G FG V + S A+K+ V + E++ +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKR-----FALKK-----VLQDPRYKNRELDIMK 55
Query: 143 IVEHQNLVKL--VGYCADDDERGIQRL--------------------------------L 168
+++H N++KL Y D+E + +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 169 VYEYMPNGSVDQYL--SPKSETILTWA-MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225
+ EY+P+ ++ + L +S + + + I Q R + ++H I RD K
Sbjct: 116 IMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQ 170
Query: 226 NILLD-EQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS---- 279
N+L++ + KL DFG A+ L PSE + + Y APE + L A
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY----ICSRFYRAPELM----LGATEYTPS 222
Query: 280 -DVWSYGVFLYELITGR 295
D+WS G ELI G+
Sbjct: 223 IDLWSIGCVFGELILGK 239
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFL 141
+ + +G G +G V D + VAVK+L R + + K E+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 142 GIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 199
++H+N++ L+ + + LV M D K + + ++ I
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG---ADLNNIVKCQKLTDDHVQFLIY 139
Query: 200 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 259
Q RGL Y+H II RD K SN+ ++E K+ DFGLAR T V
Sbjct: 140 Q-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYV 190
Query: 260 GTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 295
T Y APE + ++ D+WS G + EL+TGR
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 61/249 (24%), Positives = 95/249 (38%), Gaps = 44/249 (17%)
Query: 65 MSQRPSNLKEFTIAELKSA----TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
MS P F E+ + +G G +G V + D +VA+
Sbjct: 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAI 55
Query: 121 KQLGR--RGVQGHKEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNG 176
K+L R + K E+ L + H+N++ L+ + D+ LV +M
Sbjct: 56 KKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--- 112
Query: 177 SVDQYLSPKSETILTWAMRLKIAQDA---------ARGLAYLHEGMDFQIIVRDFKSSNI 227
T L M+ + + +GL Y+H II RD K N+
Sbjct: 113 ----------GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNL 159
Query: 228 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGV 286
++E K+ DFGLAR T V T Y APE + ++ D+WS G
Sbjct: 160 AVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 214
Query: 287 FLYELITGR 295
+ E+ITG+
Sbjct: 215 IMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 42/229 (18%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLG 142
++ IGEG +G V D KV VA+K++ Q + + + E+ L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAY-----DNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 143 IVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
H+N++ + ++ + +V + M ET L ++ + +
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-------------ETDLYKLLKTQHLSN 127
Query: 202 A---------ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGF 251
RGL Y+H ++ RD K SN+LL+ + K+ DFGLAR P
Sbjct: 128 DHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 252 THVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
T T V T Y APE + L ++ D+WS G L E+++ R
Sbjct: 185 TGFLTEYVATRWYRAPEIM----LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 33/221 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G GG G V+ + D VA+K++ Q K + E+ + ++H N+VK
Sbjct: 18 PLGCGGNGLVFSAV-----DNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 152 LV------GYCADDDERGIQRL----LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
+ G DD + L +V EYM D + +L RL + Q
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYME---TDLANVLEQGPLLEEHARLFMYQ- 128
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLAR-LGPSEGFTHVSTAVV 259
RGL Y+H ++ RD K +N+ ++ E K+ DFGLAR + P + +
Sbjct: 129 LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 260 GTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
T Y +P + L+ + D+W+ G E++TG+
Sbjct: 186 VTKWYRSPRLL----LSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/303 (19%), Positives = 101/303 (33%), Gaps = 62/303 (20%)
Query: 38 GRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGG 97
G++ T + + S + P ++ I + +IG G
Sbjct: 12 HNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI------PDRYEIRHLIGTGS 65
Query: 98 FGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH----KEWMTEVNFLGIVEHQNLVKLV 153
+G V + D +K VA+K++ R V K + E+ L + H ++VK++
Sbjct: 66 YGHVCEAY-----DKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 154 GYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 212
D L +V E D ++ LT + + G+ Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA 175
Query: 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP----- 267
I+ RD K +N L+++ + K+ DFGLAR + +
Sbjct: 176 ---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 268 ---------EYVQTGR--------LAARS-----DVWSYGVFLYELIT----------GR 295
+V T R L + DVWS G EL+ R
Sbjct: 233 TKNLKRQLTGHVVT-RWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 296 RPI 298
P+
Sbjct: 292 GPL 294
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 39/239 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFLGIVEHQNL 149
+IG G +G VY D + + VA+K++ R + K + E+ L ++ +
Sbjct: 33 LIGRGSYGYVYLAY-----DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 150 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWA-MRLKIAQDAARGLA 207
++L DD L +V E D K+ LT ++ + G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIAD---SDLKKLFKTPIFLTEEHIKTILYN-LLLGEN 143
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
++HE II RD K +N LL++ + K+ DFGLAR SE T++ +
Sbjct: 144 FIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 268 ---------EYVQTGR--------LAARS-----DVWSYGVFLYELITGRRPIDRNRPR 304
+V T R L + D+WS G EL+ + +
Sbjct: 201 NKNLKKQLTSHVVT-RWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 51/228 (22%), Positives = 82/228 (35%), Gaps = 49/228 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLGIVEHQNLV 150
++GEG +G V VA+K++ + E+ L +H+N++
Sbjct: 18 LLGEGAYGVVCSAT-----HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 151 KLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA------- 202
+ D + ++ E M +T L + ++ D
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELM-------------QTDLHRVISTQMLSDDHIQYFIY 119
Query: 203 --ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS----- 255
R + LH +I RD K SN+L++ + K+ DFGLAR+ +
Sbjct: 120 QTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 256 ---TAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 295
V T Y APE + L + DVWS G L EL R
Sbjct: 177 SGMVEFVATRWYRAPEVM----LTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 57/237 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGVQGHKEWMTEVNFLG-IVEHQN 148
+G+G +G V+K + D VAVK++ + + E+ L + H+N
Sbjct: 16 KLGKGAYGIVWKSI-----DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA------ 202
+V L+ D++R + LV++YM ET L +R I +
Sbjct: 71 IVNLLNVLRADNDRDV--YLVFDYM-------------ETDLHAVIRANILEPVHKQYVV 115
Query: 203 ---ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 259
+ + YLH G ++ RD K SNILL+ + + K++DFGL+R + + +
Sbjct: 116 YQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 260 GTMGYAAP--------EYVQTGR--------LAARS-----DVWSYGVFLYELITGR 295
+YV T R L + D+WS G L E++ G+
Sbjct: 173 INENTENFDDDQPILTDYVAT-RWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 46/229 (20%), Positives = 76/229 (33%), Gaps = 35/229 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
IG+GGFGC+Y + +SE VK + TE+ F ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD----NGPLFTELKFYQRAAKPEQIQK 98
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVD------QYLSPKSETILTWAMR-------LKIA 199
G+ + + I + L+++
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLS 158
Query: 200 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK--LSDFGLA-RLGPSEGFTHVS- 255
L Y+HE + + D K+SN+LL+ + + L D+GLA R P +
Sbjct: 159 LRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 256 ---TAVVGTMGYA---APEYVQTGRLAARSDVWSYG-VFLYELITGRRP 297
GT+ + A V R R D+ G + +TG P
Sbjct: 216 DPKRCHDGTIEFTSIDAHNGVAPSR---RGDLEILGYCMIQ-WLTGHLP 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 5e-10
Identities = 73/472 (15%), Positives = 135/472 (28%), Gaps = 179/472 (37%)
Query: 4 FPFTNWDKKDEPPTTPKSLF-SIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSY 62
F + + P+ ++ R +NDN+V NVS R
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDR--LYNDNQV------FAKYNVS--------RL-- 134
Query: 63 PSMSQRPSNLKEFTIAELKSATKNFSRSVVI-GEGGFGCVYKGLIKNSEDPSQKVEVAVK 121
Q L++ + EL+ A V+I G G G K VA+
Sbjct: 135 ----QPYLKLRQ-ALLELRPAKN-----VLIDGVLGSG---------------KTWVALD 169
Query: 122 QLGRRGVQGHKE----WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL--LVYEYMPN 175
VQ + W+ + C + ++ L L+Y+ PN
Sbjct: 170 VCLSYKVQCKMDFKIFWLN----------------LKNCNSPETV-LEMLQKLLYQIDPN 212
Query: 176 GS--VDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233
+ D + K +R+ Q R L + + +++ ++L
Sbjct: 213 WTSRSDHSSNIK--------LRIHSIQAELRRL----------LKSKPYENCLLVLLNVQ 254
Query: 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
NAK + F ++ T R +D FL T
Sbjct: 255 NAKAWN----------AFNLSCKILLTT------------RFKQVTD------FLSAATT 286
Query: 294 GRRPIDRNR-----PRSEQKLLQWVKPYLSD----------------AKQFRQIVDPRLE 332
+D + + LL+++ D A+ R + +
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA-TWD 345
Query: 333 GKYSLRLVSKLSHVANLCL--VKNARTR---------PK----MSEVLE----------- 366
+ KL+ + L ++ A R P + +L
Sbjct: 346 N-WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 367 --MVNKIVDASAEAGSPRRPLRSSTS--------RETPDHTKTKHKRRIIES 408
+VNK+ S ++P S+ S + ++ H R I++
Sbjct: 405 MVVVNKLHKYSLVE---KQPKESTISIPSIYLELKVKLENEYALH-RSIVDH 452
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 4e-04
Identities = 39/252 (15%), Positives = 83/252 (32%), Gaps = 66/252 (26%)
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH--VSTAVVGTMGYAAP 267
H MDF+ ++ +IL + +A + +F + + +S + + +
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFE-DAFVDNFDCKDV---QDMPKSILSKEEIDHIIMSKD 59
Query: 268 EYVQTGRLAARSDVWS--------YGVFL-------YELITGR-RPIDRNRPRSEQKLLQ 311
T RL W+ F+ Y+ + + R + ++
Sbjct: 60 AVSGTLRL-----FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE 114
Query: 312 WVKPYLSDAKQFRQIVDPRLEGKYSLR-LVSKLSHVANL-----------CLV----KNA 355
+D + F + RL+ LR + +L N+ + +
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSY 174
Query: 356 RTRPKMS---------------EVLEMVNKI---VDASAEAGSPRRPLRSSTSRETPDHT 397
+ + KM VLEM+ K+ +D + + R SS +
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS----RSDHSSNIKLRIHSI 230
Query: 398 KTKHKRRIIESK 409
+ + RR+++SK
Sbjct: 231 QAE-LRRLLKSK 241
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 1e-07
Identities = 31/205 (15%), Positives = 56/205 (27%), Gaps = 55/205 (26%)
Query: 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL------------GRRGVQG 130
T+ R IGEG FG V++ + ++ VA+K + + +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTP-------VAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 131 HKE-----WMTEVNFLGIVEHQNLVKLVG--------------------------YCADD 159
E ++ ++ + + L D
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 219
+ Q +V E+ G L + + A I LA +
Sbjct: 131 FFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEH 185
Query: 220 RDFKSSNILLDEQWNAKLSDFGLAR 244
RD N+LL + KL +
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 59/226 (26%), Positives = 87/226 (38%), Gaps = 55/226 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
VIG+G FG V K D VA+K + R + H++ E+ L ++L K
Sbjct: 104 VIGKGSFGQVVKAY-----DHKVHQHVALKMV-RNEKRFHRQAAEEIRIL-----EHLRK 152
Query: 152 LVGYCAD-DDERGIQRLL-------------------VYEYMPNGSVDQYLSPKSETILT 191
D D+ + +L +YE + Q S
Sbjct: 153 -----QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNK-FQGFSLP------ 200
Query: 192 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLARLGPSE 249
+R K A + L LH +II D K NILL +Q + K+ DFG +
Sbjct: 201 -LVR-KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255
Query: 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 295
+T++ + Y APE + R D+WS G L EL+TG
Sbjct: 256 VYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 43/221 (19%), Positives = 82/221 (37%), Gaps = 31/221 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFL---------- 141
+G G F V+ ++D VA+K + R + E+ L
Sbjct: 26 KLGWGHFSTVWL-----AKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 142 -GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 200
+ +++KL+ + G+ ++V+E + ++ + + +I++
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDE------QWNAKLSDFGLARLGPSEGFTHV 254
GL Y+H II D K N+L++ K++D G A +
Sbjct: 139 QLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 255 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 295
T Y +PE + +D+WS ++ELITG
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 39/231 (16%), Positives = 75/231 (32%), Gaps = 39/231 (16%)
Query: 93 IGEGGFGCVYKG---LIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL 149
G +Y+ + QK + ++K L + + E ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 150 VKLVGYCADDDERGIQRLL---VYEYMPNGSVDQYLSPKSETILTWAMR--------LKI 198
KL I + V++ V L ++ L + + L++
Sbjct: 109 KKLYS----TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQV 164
Query: 199 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK--LSDFGLARLGPSEGFTHV-- 254
A L +LHE + + + + NI +D + ++ L+ +G A G HV
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG-KHVAY 220
Query: 255 ----STAVVGTMGYA---APEYVQTGRLAARSDVWSYG-VFLYELITGRRP 297
+ G + + + R RSD+ S G L + G P
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSR---RSDLQSLGYCMLK-WLYGFLP 267
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 51/224 (22%), Positives = 78/224 (34%), Gaps = 45/224 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH-QNLVK 151
IG G FG +Y G D + EVA+K + H + E +++ +
Sbjct: 17 IGSGSFGDIYLG-----TDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPT 69
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-------LKIAQDAAR 204
+ A+ D Y M V + L P E + + R L +A
Sbjct: 70 IRWCGAEGD---------YNVM----VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMIS 116
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK---LSDFGLARL-GPSEGFTHV----ST 256
+ Y+H I RD K N L+ + DFGLA+ + H+ +
Sbjct: 117 RIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 257 AVVGTMGYA---APEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
+ GT YA ++ R R D+ S G L G P
Sbjct: 174 NLTGTARYASINTHLGIEQSR---RDDLESLGYVLMYFNLGSLP 214
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 35/217 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+IG+G FG V K D ++ VA+K + + + EV L +
Sbjct: 61 LIGKGSFGQVVKAY-----DRVEQEWVAIKII-KNKKAFLNQAQIEVRLL---------E 105
Query: 152 LVGYCADDDERGIQRL-----------LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 200
L+ + + I L LV+E + + ++ L + ++ + K AQ
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ 164
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLARLGPSEGFTHVSTAV 258
L +L + II D K NILL + K+ DFG + + ++ +
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 223
Query: 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 295
Y +PE + D+WS G L E+ TG
Sbjct: 224 -----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 41/227 (18%), Positives = 70/227 (30%), Gaps = 49/227 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGVQGHKEWMTEVNFLGIVEHQNLV 150
IGEG FG +++G + +VA+K Q E+ T G +
Sbjct: 18 IGEGSFGVIFEG-----TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIP 69
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-------LKIAQDAA 203
+ + + + + V L P E +L R A+
Sbjct: 70 NVYYFGQEGL---------HNVL----VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQML 116
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK-----LSDFGLARL-GPSEGFTHV--- 254
+ +HE + RD K N L+ + + DFG+ + H+
Sbjct: 117 ARVQSIHE-KSL--VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 255 -STAVVGTMGYA---APEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
+ GT Y + R R D+ + G + G P
Sbjct: 174 EKKNLSGTARYMSINTHLGREQSR---RDDLEALGHVFMYFLRGSLP 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 47/237 (19%), Positives = 84/237 (35%), Gaps = 54/237 (22%)
Query: 93 IGEGGFGCVYKGL--------------IKNSEDPSQKVEVAV-KQLGRRGVQGHKEWMTE 137
IG GGFG +Y ++ E+ E+ +++ ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-- 195
+++LGI G + + R +V E L + I
Sbjct: 105 LDYLGI------PLFYGSGLTEFKGRSYRFMVME---------RLGIDLQKISGQNGTFK 149
Query: 196 ----LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK--LSDFGLA-RLGPS 248
L++ L Y+HE + + D K++N+LL + + L+D+GL+ R P+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 249 EGFTHVS----TAVVGTMGYA---APEYVQTGRLAARSDVWSYG-VFLYELITGRRP 297
GT+ + A + V R RSDV G L + G+ P
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR---RSDVEILGYCMLR-WLCGKLP 259
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 45/226 (19%), Positives = 70/226 (30%), Gaps = 47/226 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH-QNLVK 151
IG G FG + G ++ VA+K + E F + + +
Sbjct: 17 IGCGNFGELRLG-----KNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQ 69
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-------LKIAQDAAR 204
+ + Y M V + L P E + R L IA
Sbjct: 70 VYYFGPCGK---------YNAM----VLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK-----LSDFGLARL-GPSEGFTHV---- 254
+ Y+H +I RD K N L+ N + DF LA+ E H+
Sbjct: 117 RMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 255 STAVVGTMGYA---APEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
++ GT Y + R R D+ + G + G P
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSR---RDDLEALGHMFMYFLRGSLP 216
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 48/223 (21%), Positives = 79/223 (35%), Gaps = 43/223 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKL 152
IG G FG +Y G + EVA+K + H + + E I++ +
Sbjct: 15 IGSGSFGEIYLG-----TNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPN 67
Query: 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-------LKIAQDAARG 205
V + + + Y + V L P E + + R L +A
Sbjct: 68 VRWFGVEGD--------YNVL----VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAK---LSDFGLARL-GPSEGFTHV----STA 257
+ ++H + RD K N L+ A + DFGLA+ + H+ +
Sbjct: 116 VEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
Query: 258 VVGTMGYA---APEYVQTGRLAARSDVWSYGVFLYELITGRRP 297
+ GT YA ++ R R D+ S G L + G P
Sbjct: 173 LTGTARYASVNTHLGIEQSR---RDDLESLGYVLMYFLRGSLP 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 32/152 (21%), Positives = 44/152 (28%), Gaps = 56/152 (36%)
Query: 197 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL--------------------------- 229
KI Q +GL YLH +II D K NILL
Sbjct: 150 KIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 230 ----------------------DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
E+ K++D G A T + T Y +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-----KHFTEDIQTRQYRSL 262
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRPID 299
E + +D+WS +EL TG +
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 428 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.51 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.3 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.14 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.99 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.73 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.68 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.46 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.46 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.4 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.31 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.2 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.72 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.12 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.14 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.8 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.41 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.91 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=457.59 Aligned_cols=267 Identities=26% Similarity=0.449 Sum_probs=218.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||+||+|.+.+......+..||||++........++|.+|+.+|++|+|||||+++|+|.+.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~--- 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP--- 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE---
Confidence 46888899999999999999987655555677899999987766667889999999999999999999999988664
Q ss_pred eEEEEEeecCCCCcccccCCCC-----------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKS-----------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
++||||||++|+|.++|.... ...++|..++.|+.||+.||+|||++ +||||||||+||||++++
T Consensus 90 -~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 90 -LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp -EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred -EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 499999999999999996432 34699999999999999999999998 999999999999999999
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHh
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 312 (428)
.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||....... +...
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~ 242 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC 242 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999986554443344445679999999999999999999999999999999999 999998754322 1111
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
+. .. .....+..+++++.+|+.+||+.||++|||+++|++.|+.+....
T Consensus 243 i~-------------~~-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 243 IT-------------QG-RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HH-------------HT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HH-------------cC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11 00 011223345678999999999999999999999999999887653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=457.20 Aligned_cols=266 Identities=24% Similarity=0.441 Sum_probs=211.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.++||+|+||+||+|.+.+......+..||||++........++|.+|+.+|++|+|||||+++|+|.+...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~--- 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP--- 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE---
Confidence 35677889999999999999987654445677899999987766667889999999999999999999999987664
Q ss_pred eEEEEEeecCCCCcccccCCCC-------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKS-------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
++||||||++|+|.+++.... ...++|..++.|+.||+.||+|||++ +||||||||+||||++
T Consensus 118 -~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 118 -LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp -EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred -EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 499999999999999986532 24599999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~ 310 (428)
++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||........ .
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---I 270 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---H
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---H
Confidence 99999999999987654444444456789999999999999999999999999999999999 9999986543221 1
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
..+. .- .....+..+++++.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 271 ~~i~----------~g----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCIT----------QG----RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHH----------HT----CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHH----------cC----CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111 00 01122334567899999999999999999999999999988754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=449.91 Aligned_cols=262 Identities=22% Similarity=0.387 Sum_probs=211.2
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++++.+.||+|+||+||+|.+.+..+...++.||||.+..... ...++|.+|+.+|++++|||||+++|+|.+....
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~-- 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL-- 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE--
Confidence 4566789999999999999987654455667899999975533 3457899999999999999999999999887654
Q ss_pred eEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~ 230 (428)
+||||||++|+|.++|..+. ...++|..++.|+.||+.||+|||++ +||||||||+||||+
T Consensus 105 --~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 105 --SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179 (308)
T ss_dssp --EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred --EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence 99999999999999985432 24589999999999999999999998 999999999999999
Q ss_pred CCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHH
Q 014245 231 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKL 309 (428)
Q Consensus 231 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~ 309 (428)
+++++||+|||+|+..............+||+.|||||++.++.|+.++|||||||+||||+| |..||....... +
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999986544333333455789999999999999999999999999999999999 899998764322 2
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
...+. .. .....+..++.++.+|+.+||+.||++|||+.+|+++|+..
T Consensus 257 ~~~i~-------------~~-~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIR-------------NR-QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHH-------------TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHH-------------cC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 21111 11 11123345667899999999999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=443.42 Aligned_cols=261 Identities=30% Similarity=0.463 Sum_probs=205.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||+||+|.+.+ .||||+++... ....+.|.+|+.+|++++|||||+++|++.++.
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-- 105 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDN-- 105 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCe--
Confidence 467888999999999999998643 58999986543 234567999999999999999999999986532
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
++||||||+||+|.++|.... ..+++..++.|+.||+.||+|||++ +||||||||+||||++++++||+|||+
T Consensus 106 ---~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 106 ---LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp ---CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred ---EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccC
Confidence 489999999999999996432 4599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhcc---CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|+..............+||+.|||||++.+ +.|+.++|||||||+||||+||+.||.......... ..+.
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~--~~~~----- 251 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII--FMVG----- 251 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHH-----
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH--HHHh-----
Confidence 987654333334456789999999999864 468999999999999999999999998654332111 1000
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.....+.+ ...+..+++++.+|+.+||+.||++|||+.+|+++|+.+...
T Consensus 252 ----~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 252 ----RGYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp ----TTCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ----cCCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 01111111 123335667899999999999999999999999999887643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-59 Score=446.10 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=210.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
..|+..+.||+|+||+||+|.+..++ ..||||++........+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~---- 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD---- 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCC-----CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 46999999999999999999987654 389999997665556677899999999999999999999999876
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.+|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 45999999999999999864 3499999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
...... ......+||+.|||||++.+..|+.++|||||||++|||++|..||...........+ .
T Consensus 219 ~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------~ 283 (346)
T 4fih_A 219 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------R 283 (346)
T ss_dssp ECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------H
T ss_pred ecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------H
Confidence 764332 2234679999999999999999999999999999999999999999865432221111 1
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+. ......+++++.+|+.+||+.||++|||+.|++++
T Consensus 284 ~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 284 DNLPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSSCCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 12233466789999999999999999999999885
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-59 Score=449.55 Aligned_cols=271 Identities=25% Similarity=0.386 Sum_probs=223.7
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCC-CCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEH-QNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~ 160 (428)
..++|++.+.||+|+||+||+|.+.+.......+.||||.+...... ..+.|.+|+.+|.+++| ||||+++|+|...+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 34689999999999999999999988777777889999999765443 35679999999999965 89999999997654
Q ss_pred CCCceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
. .++||||||++|+|.++|.... ...+++..++.|+.||+.||+|||++ +||||||||+|
T Consensus 142 ~---~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N 215 (353)
T 4ase_A 142 G---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 215 (353)
T ss_dssp S---CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred C---EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence 3 2489999999999999996432 23589999999999999999999998 99999999999
Q ss_pred eEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchh
Q 014245 227 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 305 (428)
Q Consensus 227 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 305 (428)
|||++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |..||.......
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987655444444556789999999999999999999999999999999998 999998654321
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
. +...+. . ......+..+++++.+++.+||+.||++|||+.+|+++|+.+++..
T Consensus 296 ~--~~~~i~----------~----g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 296 E--FCRRLK----------E----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp H--HHHHHH----------H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H--HHHHHH----------c----CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 1 111110 1 1111223345678999999999999999999999999999988754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=450.73 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=204.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++++.||+|+||+||+|.+..++ +.||||++..... ...+.+.+|+.+|++|+|||||++++++.+.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-- 96 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDG-----RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-- 96 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTC-----CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred cceEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--
Confidence 58999999999999999999976554 3899999976533 33567899999999999999999999998866
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.+|||||||+||+|.++|.......+++..++.|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||+
T Consensus 97 --~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 97 --SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp --EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred --EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 459999999999999999765556689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
|+..... .......+||+.|||||++.+..|+.++|||||||+||||+||+.||........ ..
T Consensus 172 a~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~----------- 235 (350)
T 4b9d_A 172 ARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---VL----------- 235 (350)
T ss_dssp ESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH-----------
T ss_pred ceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HH-----------
Confidence 9865321 1223457899999999999999999999999999999999999999986543221 11
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.++.... ...+..+++++.+|+.+||+.||++|||++|++++
T Consensus 236 --~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 236 --KIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 11233456789999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=440.30 Aligned_cols=263 Identities=23% Similarity=0.265 Sum_probs=211.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+.|.+.++||+|+||+||+|.+..++ ..||||++..... ..+|+.+|+.|+|||||++++++.+..
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g-----~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~---- 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTG-----FQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP---- 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT----
T ss_pred hheEeCcEeccCCCeEEEEEEECCCC-----CEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 46788889999999999999977654 3899999975432 247999999999999999999998766
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-CeEEeeeccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGLA 243 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla 243 (428)
.+|||||||+||+|.++|... +.+++..++.|+.||+.||+|||++ +||||||||+||||+.+| .+||+|||+|
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred EEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 459999999999999999643 4599999999999999999999998 999999999999999988 5999999999
Q ss_pred ccCCCCCcee---eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 244 RLGPSEGFTH---VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 244 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
+......... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...........+. ..
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~- 271 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SE- 271 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HS-
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cC-
Confidence 8765432211 2234689999999999999999999999999999999999999997654432221111 00
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcCCCC
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSP 381 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~~~~ 381 (428)
+......+..+++++.+++.+||+.||++|||+.||+++|...+........|
T Consensus 272 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 272 --------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp --------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred --------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 00001223345678999999999999999999999999999888765554444
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=440.70 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=210.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|+++++||+|+||+||+|....++ +.||+|++.+.. ....+.+.+|+++|+.|+|||||++++++.+.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATS-----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE- 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cccEEEEEEecccCeEEEEEEECCCC-----CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 46999999999999999999977654 389999997542 234567899999999999999999999998876
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+|||||||+||+|.++|... +.+++..+..|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||
T Consensus 106 ---~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 106 ---KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp ---EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 459999999999999999643 4599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+|+..............+||+.|||||++.+..|+.++|||||||++|||++|..||....... +..
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~---------- 244 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFA---------- 244 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----------
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----------
Confidence 9997654444444566899999999999999999999999999999999999999997654322 111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.++...+ .++..+++++.+|+.+||+.||++|||++|++.+
T Consensus 245 ---~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 245 ---KIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ---HHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ---HHHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 1111111 1223456789999999999999999999997654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=432.16 Aligned_cols=250 Identities=24% Similarity=0.430 Sum_probs=200.4
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
...+.||+|+||+||+|.+..++ ..||+|.+..... ...+.|.+|+.+|++|+|||||+++++|.+.......
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC-----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 56678999999999999977654 4899999965432 3356789999999999999999999999764333335
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEEC-CCCCeEEeeecc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLD-EQWNAKLSDFGL 242 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DFGl 242 (428)
+|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++ + ||||||||+||||+ .+|.+||+|||+
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 79999999999999999643 4599999999999999999999987 6 99999999999997 479999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||....... .+..
T Consensus 179 a~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~----------- 240 (290)
T 3fpq_A 179 ATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR----------- 240 (290)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH-----------
T ss_pred CEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHH-----------
Confidence 9864432 2345789999999998865 69999999999999999999999997543321 1111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.........+...++++.+|+.+||+.||++|||++|+++|
T Consensus 241 --~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 241 --RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --HHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111222344679999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-58 Score=448.47 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=211.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+.|++.+.||+|+||.||+|.+..++ ..||||++........+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~---- 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD---- 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCC-----CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC----
Confidence 56999999999999999999987654 389999998766666678899999999999999999999999876
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.+|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence 45999999999999999864 3499999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
...... ......+||+.|||||++.+..|+.++|||||||++|||++|..||...........+ .
T Consensus 296 ~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------~ 360 (423)
T 4fie_A 296 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------R 360 (423)
T ss_dssp ECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------H
T ss_pred ECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------H
Confidence 764332 2235679999999999999999999999999999999999999999765433221111 1
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+.+ .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 361 ~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 361 DNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HSCCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 1222356789999999999999999999999885
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=420.19 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=191.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||+||+|....++ ..||+|++.+... .....+.+|+.+|+.++|||||++++++.+.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTG-----QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD- 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTC-----CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-
Confidence 68999999999999999999866543 4899999976532 23567899999999999999999999998866
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+||||||| +|+|.+++..+ ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||
T Consensus 87 ---~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 87 ---EIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp ---EEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred ---EEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence 459999999 67999988654 3599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
+|+...... .....+||+.|||||++.+..| +.++|||||||++|+|+||+.||....... +...+
T Consensus 158 la~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i------- 224 (275)
T 3hyh_A 158 LSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNI------- 224 (275)
T ss_dssp CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH-------
T ss_pred CCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH-------
Confidence 998654322 2345789999999999998876 579999999999999999999997653221 11111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ..++..+++++.+|+.+||+.||++|||++|++++
T Consensus 225 ------~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 225 ------SNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------HHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------HcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111 01223356789999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=428.53 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=199.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++++.||+|+||+||+|....+. ..++.||+|++.+... .....+.+|+.+|++++|||||++++++.+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-- 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGS--DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-- 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSST--TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT--
T ss_pred cccEEEEEEecCCCeEEEEEEEccCC--CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence 47999999999999999999865322 2355899999976532 23456889999999999999999999998876
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.+|||||||+||+|.+++... +.+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+
T Consensus 100 --~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 172 (304)
T 3ubd_A 100 --KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL 172 (304)
T ss_dssp --EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred --EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccc
Confidence 459999999999999999643 4599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
|+...... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......... .
T Consensus 173 a~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~----------- 236 (304)
T 3ubd_A 173 SKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---T----------- 236 (304)
T ss_dssp EEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H-----------
T ss_pred ceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH---H-----------
Confidence 98643322 2234578999999999999999999999999999999999999999865432211 1
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~ell~~ 367 (428)
.+....+ .++..+++++.+|+.+||+.||++|||+ +|+++|
T Consensus 237 --~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 237 --MILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --HHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --HHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1111111 1233456789999999999999999984 677664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=423.27 Aligned_cols=278 Identities=24% Similarity=0.290 Sum_probs=203.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||+||+|.+.+ ..||||++..... ....+..|+..+.+++|||||+++|+|.+.+....
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g-------~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT-------EEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 356778899999999999998743 3799999965432 11223456666778999999999999988765555
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeccCCCCceEECCCCCeEEee
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG-----MDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.+|||||||++|+|.+++... .+++..++.|+.|++.||+|||++ ..++||||||||+||||+.++++||+|
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 679999999999999999643 489999999999999999999975 245899999999999999999999999
Q ss_pred ecccccCCCCCce--eeeeeeecCcccCCcchhccC------CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014245 240 FGLARLGPSEGFT--HVSTAVVGTMGYAAPEYVQTG------RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311 (428)
Q Consensus 240 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 311 (428)
||+|+........ ......+||+.|||||++.+. .|+.++|||||||+||||+||..||.......... ..
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~ 230 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YD 230 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hh
Confidence 9999865433222 122346899999999999764 36779999999999999999988775432110000 00
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
..............+....+.... ....+..+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 000000000001111222222221 235667899999999999999999999999999988654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=413.98 Aligned_cols=256 Identities=20% Similarity=0.336 Sum_probs=191.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC-
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER- 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~- 162 (428)
++|++++.||+|+||+||+|.+..++ ..||||++...... ..+.+.+|+.+|++|+|||||++++++.+.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDD-----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTC-----CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCC-----CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 46899999999999999999976554 38999999755433 346789999999999999999999998765431
Q ss_pred -------CceEEEEEeecCCCCcccccCCCCc-ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 163 -------GIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 163 -------~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
...+|||||||++|+|.+++..+.. ...++..++.|+.||+.||+|||++ +||||||||+||||+.++.
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~ 156 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDV 156 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCc
Confidence 2246899999999999999975533 3356677889999999999999998 9999999999999999999
Q ss_pred eEEeeecccccCCCCCce----------eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCch
Q 014245 235 AKLSDFGLARLGPSEGFT----------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 304 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~ 304 (428)
+||+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-- 231 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-- 231 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--
Confidence 999999999875432211 11235689999999999999999999999999999999996 775321
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... ..+.+... ........+.+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~-------------~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 232 ERVRTL-------------TDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHH-------------HHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHH-------------HHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 11111111 11223344667899999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=415.15 Aligned_cols=272 Identities=22% Similarity=0.271 Sum_probs=205.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC-
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE- 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~- 161 (428)
++|++++.||+|+||+||+|.+..++ ..||||++..... ...+.+.+|+.+|+.|+|||||++++++.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTG-----QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCC-----CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence 57999999999999999999977654 3899999975432 334678899999999999999999999875421
Q ss_pred -CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 162 -RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 162 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
....+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++ +||||||||+|||++.+|.+||+||
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence 1235699999995 6899988654 4599999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCC--ceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 241 GLARLGPSEG--FTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 241 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|+|+...... ........+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.........+.......
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998653321 12233467999999999998875 56999999999999999999999998765443333222111000
Q ss_pred hh-------hhhhhhh---cCCcCCCC---ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SD-------AKQFRQI---VDPRLEGK---YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~-------~~~~~~~---~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ....... +....... .....++++.+||.+||..||++|||+.|+++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000000 00000000 011235688999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=402.83 Aligned_cols=268 Identities=22% Similarity=0.303 Sum_probs=200.4
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
...++|++.+.||+|+||+||+|..+.. ...++.||+|.+.... ...++.+|+++|+.+ +|||||++++++.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQ--VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBT--TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEccc--CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3467899999999999999999986521 2345689999986543 345788999999988 7999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC-CCeEEee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSD 239 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~D 239 (428)
.+|||||||+||+|.+++. .+++..+..++.||+.||+|||++ +||||||||+|||++.+ +.+||+|
T Consensus 94 ----~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 94 ----HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp ----EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ----EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 4599999999999999984 389999999999999999999998 99999999999999876 7999999
Q ss_pred ecccccCCCCCc--------------------------eeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHH
Q 014245 240 FGLARLGPSEGF--------------------------THVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELI 292 (428)
Q Consensus 240 FGla~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell 292 (428)
||+|+....... .......+||+.|||||++.+. .|+.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999975432211 0112346899999999999875 5899999999999999999
Q ss_pred hCCCCCCCCCchhhHHHHHhHhhhhhhh------------------------hhh-hhh--cC---CcC---------CC
Q 014245 293 TGRRPIDRNRPRSEQKLLQWVKPYLSDA------------------------KQF-RQI--VD---PRL---------EG 333 (428)
Q Consensus 293 tg~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~-~~~--~~---~~l---------~~ 333 (428)
+|+.||........+ +.... ..+... ... ... .+ +.. ..
T Consensus 242 ~G~~Pf~~~~~~~~~-l~~I~-~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 319 (361)
T 4f9c_A 242 SGRYPFYKASDDLTA-LAQIM-TIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNL 319 (361)
T ss_dssp HTCSSSSCCSSHHHH-HHHHH-HHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------
T ss_pred HCCCCCCCCCCHHHH-HHHHH-HhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccc
Confidence 999999655433221 11100 000000 000 000 00 000 00
Q ss_pred CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 334 KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 334 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+++++.+|+.+||+.||++|||++|+++|
T Consensus 320 ~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 320 EGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp --CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0112345678999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=421.45 Aligned_cols=254 Identities=21% Similarity=0.345 Sum_probs=211.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|++.+.||+|+||.||+|..+.++ ..||+|.+........+.+.+|+.+|+.|+|||||+++++|.+..
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg-----~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATG-----NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--- 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS---
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC---
Confidence 468999999999999999999987654 389999998766666678899999999999999999999998866
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC--CCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ--WNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFG 241 (428)
.+|||||||+||+|.++|.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 228 -~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 228 -EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp -EEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred -EEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence 4599999999999999886432 4599999999999999999999998 99999999999999854 899999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|..||...........+. .
T Consensus 303 ~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~---~------ 370 (573)
T 3uto_A 303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK---S------ 370 (573)
T ss_dssp SCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---T------
T ss_pred ceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---h------
Confidence 998765432 2345789999999999999999999999999999999999999998654332211111 0
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..+.......+++++.+||.+||+.||++|||+.|+++|
T Consensus 371 -----~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 371 -----CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -----TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111222233456789999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=389.69 Aligned_cols=286 Identities=39% Similarity=0.687 Sum_probs=236.5
Q ss_pred cCHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEee
Q 014245 75 FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVG 154 (428)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~ 154 (428)
+...++...+++|.+.+.||+|+||.||+|.+.++ ..||+|.+........+.+.+|+.+++.++||||+++++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 102 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG------AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTC------CEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCC------CEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 33344555678999999999999999999986533 379999988766666778999999999999999999999
Q ss_pred EEecCCCCCceEEEEEeecCCCCcccccCCCC--cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC
Q 014245 155 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 232 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~ 232 (428)
++.+.+.. ++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 103 ~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~ 175 (321)
T 2qkw_B 103 FCDERNEM----ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDEN 175 (321)
T ss_dssp ECCCTTCC----EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTT
T ss_pred EEcCCCeE----EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCC
Confidence 99876644 99999999999999997543 23589999999999999999999998 99999999999999999
Q ss_pred CCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 233 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 233 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
+.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........|
T Consensus 176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred CCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 99999999999865433323333456799999999999999999999999999999999999999987665544444444
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
..... ....+...+++.+........+..+.+++.+||+.||++|||+.+++++|+.+++.
T Consensus 256 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 256 AVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp THHHH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhhcc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 33211 12234455566666677888999999999999999999999999999999988754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=422.18 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=202.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHH---HHHHHHhcCCCCCcccEeeEEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWM---TEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
.++|+++++||+|+||+||+|....++ ..||+|++.+... .....+. .++.+++.++|||||+++++|.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg-----~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCC-----CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 367999999999999999999987654 4899999965421 1222233 4467778889999999999999
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEE
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 237 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 237 (428)
+.+ .+|||||||+||+|.++|... +.+++..+..|+.||+.||+|||++ +||||||||+||||+.+|.+||
T Consensus 263 ~~~----~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 263 TPD----KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp CSS----EEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ECC----EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence 876 459999999999999999653 4599999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
+|||+|+...... ....+||+.|||||++.+ ..|+.++|||||||++|||++|..||..........+...
T Consensus 334 ~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---- 405 (689)
T 3v5w_A 334 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---- 405 (689)
T ss_dssp CCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH----
T ss_pred cccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----
Confidence 9999998754332 345789999999999975 5799999999999999999999999975433222222111
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
+.... ..++..+++++.+||.+||+.||++|++ ++||++|
T Consensus 406 ---------i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 406 ---------TLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---------HHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---------hcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11111 1223346678999999999999999998 6888775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=379.19 Aligned_cols=289 Identities=46% Similarity=0.768 Sum_probs=234.8
Q ss_pred CCCcccCHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCC
Q 014245 70 SNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQN 148 (428)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~n 148 (428)
..+..|+..++....++|.+.+.||+|+||.||+|...++ ..||+|.+...... ....+.+|+.+++.++|||
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 88 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG------TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSS------CCEEEEECCC-----CCCHHHHHHHGGGTCCCTT
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCC------CEEEEEEeccccCchHHHHHHHHHHHHHhccCCC
Confidence 3467789999999999999999999999999999975432 37999998765332 2347899999999999999
Q ss_pred cccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCC--cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 149 Iv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
|+++++++.+.... ++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+++..+|+||||||+|
T Consensus 89 iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 89 LLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164 (326)
T ss_dssp BCCCCEEECCSSCC----EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred ccceEEEEecCCce----EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence 99999999877654 89999999999999987543 2359999999999999999999998756689999999999
Q ss_pred eEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCC--ch
Q 014245 227 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNR--PR 304 (428)
Q Consensus 227 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~--~~ 304 (428)
||++.++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..
T Consensus 165 il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 165 ILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp EEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred EEECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 999999999999999998764332 223345679999999999998899999999999999999999999995211 01
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
.......|...... ........+..+...+....+..+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 244 DDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred cchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 11122333333222 233445566666777888899999999999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=382.76 Aligned_cols=268 Identities=26% Similarity=0.436 Sum_probs=216.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCC--CCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSE--DPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
.++|.+.+.||+|+||.||+|.+.... ....+..||+|.+..... ...+.+.+|+.+|+.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357899999999999999999875422 234566899999976533 3356789999999999 899999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCC
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 225 (428)
... |+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 160 ~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~ 232 (370)
T 2psq_A 160 GPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232 (370)
T ss_dssp SSC----EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred CCE----EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence 654 99999999999999986432 23588999999999999999999998 9999999999
Q ss_pred ceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCch
Q 014245 226 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 304 (428)
Q Consensus 226 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~ 304 (428)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986544332222334567889999999999999999999999999999999 99999865432
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
.....+ ........+..++.++.+++.+||+.||++||++.++++.|+.++...
T Consensus 313 ~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 313 ELFKLL-----------------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GHHHHH-----------------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHH-----------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 211111 001111223345678999999999999999999999999999988654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=382.02 Aligned_cols=278 Identities=24% Similarity=0.370 Sum_probs=223.8
Q ss_pred CHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEe
Q 014245 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLV 153 (428)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~ 153 (428)
.........++|.+.+.||+|+||.||+|.+.+......++.||||.+..... ...+.+.+|+.++..+ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 34444455688999999999999999999987655666778999999976533 3346789999999999 899999999
Q ss_pred eEEecCCCCCceEEEEEeecCCCCcccccCCCCc----------------------------------------------
Q 014245 154 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE---------------------------------------------- 187 (428)
Q Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------- 187 (428)
+++.+.+. ..++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 93 GACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEECSTTS---CCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeecCCC---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99987554 24899999999999999865432
Q ss_pred ------------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCC
Q 014245 188 ------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249 (428)
Q Consensus 188 ------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 249 (428)
..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 1289999999999999999999998 9999999999999999999999999999866444
Q ss_pred CceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014245 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328 (428)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (428)
..........||+.|+|||++.+..++.++|||||||++|||++ |..||......... .... ..
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~----------~~--- 311 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRL----------KE--- 311 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHH----------HH---
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHH----------Hc---
Confidence 33344456788999999999999999999999999999999998 99999765432211 1100 00
Q ss_pred CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 329 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
......+..+++++.+++.+||+.||++|||+.+++++|+.++.+.
T Consensus 312 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 312 -GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0111122234568999999999999999999999999999988764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=368.38 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=208.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||+||+|....++ ..||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--- 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC---
Confidence 468999999999999999999865443 489999987665556678899999999999999999999998766
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 91 -ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp -EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred -EEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 359999999999999998643 489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------------ 229 (297)
T 3fxz_A 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------------ 229 (297)
T ss_dssp EECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------------
T ss_pred eecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------
Confidence 86543322 2345689999999999999999999999999999999999999997654322211110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. .......+..++..+.+++.+||+.||++|||+.+++++
T Consensus 230 -~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 230 -TN--GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -HH--CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -hC--CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 001111233456789999999999999999999999885
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=375.56 Aligned_cols=280 Identities=25% Similarity=0.316 Sum_probs=212.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|++.++||+|+||+||+|.+.+ ..||||++.... .....+..|+.++..++||||+++++++.......
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLN-------EYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETT-------EEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred hhhchhhheecccCceEEEEEEECC-------CEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 3689999999999999999998653 379999986543 23345567999999999999999999998876555
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcC-------CCCCeeeccCCCCceEECCCCCeE
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG-------MDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
..+++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred ceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 5679999999999999999643 389999999999999999999974 123899999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccC-----CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 311 (428)
|+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999765443332233446799999999999863 45668899999999999999999997654322111111
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
........................ ....+.++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000000000001111111111111 124567799999999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=369.54 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=203.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|...+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHG-------SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred hhHceeeeEeecCCCeEEEEEEECC-------CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 4689999999999999999997643 3799999876543 234578899999999999999999999987765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCc-ccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEECCCCCeEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~ 238 (428)
. ++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+
T Consensus 109 ~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 109 L----SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp C----EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred e----EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence 4 999999999999999975432 3489999999999999999999998 8 9999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~------- 252 (309)
T 3p86_A 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG------- 252 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-------
T ss_pred CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------
Confidence 999997543321 12345679999999999999999999999999999999999999998654332111110
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
........+..+++++.+++.+||+.||.+|||+.++++.|+.++...
T Consensus 253 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 253 ---------FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ---------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ---------hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 001111223345578999999999999999999999999999988653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=371.59 Aligned_cols=265 Identities=26% Similarity=0.403 Sum_probs=213.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.++||+|+||+||+|.+..++ ..||+|.+........+.+.+|+.+++.++||||+++++++.+..
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 80 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETG-----EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK---- 80 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----
T ss_pred hHeeccceecCCCCEEEEEEEECCCC-----cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC----
Confidence 57889999999999999999976543 389999987666666778999999999999999999999998765
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred eeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccce
Confidence 459999999999999999753 24589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCcee------------eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 245 LGPSEGFTH------------VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 245 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---- 232 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---- 232 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----
Confidence 654322111 1114679999999999999999999999999999999999999987543321110
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
........+.. .+..+++.+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 233 -------~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 233 -------GLNVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp -------SBCHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -------hhhhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00000111111 1122345789999999999999999999999999998876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=382.86 Aligned_cols=270 Identities=25% Similarity=0.407 Sum_probs=213.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|.+.+..+...+..||||.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~- 149 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR- 149 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC-
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC-
Confidence 5789999999999999999998765455567789999997543 23445788999999999999999999999876654
Q ss_pred ceEEEEEeecCCCCcccccCCCC-----cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC---Ce
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKS-----ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---NA 235 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~~ 235 (428)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+
T Consensus 150 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 150 ---FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp ---EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred ---EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999986432 13589999999999999999999998 999999999999999555 59
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHh
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 314 (428)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........... +.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~---i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH
Confidence 9999999975322221222334678999999999999999999999999999999998 9999986543221111 10
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcC
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEA 378 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~ 378 (428)
. ......+..++..+.+|+.+||+.||++||++.+|+++|+.+.......
T Consensus 301 -------------~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 301 -------------S-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350 (367)
T ss_dssp -------------T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred -------------c-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence 0 0111122334568999999999999999999999999999987765443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=359.12 Aligned_cols=284 Identities=38% Similarity=0.627 Sum_probs=227.7
Q ss_pred CCcccCHHHHHHHhcCCCCc------eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC----cccHHHHHHHHHH
Q 014245 71 NLKEFTIAELKSATKNFSRS------VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----VQGHKEWMTEVNF 140 (428)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~ 140 (428)
....|+..++..++++|... +.||+|+||.||+|...+ ..||+|.+.... ....+.+.+|+.+
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~ 83 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-------TTVAVKKLAAMVDITTEELKQQFDQEIKV 83 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSS-------CEEEEEEECCCTTSCTTTHHHHHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECC-------ceEEEEEEecccCcchHHHHHHHHHHHHH
Confidence 45678999999999998877 899999999999998632 279999986532 2235678899999
Q ss_pred HhcCCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCC-cccccHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 014245 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 219 (428)
Q Consensus 141 l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 219 (428)
++.++||||+++++++.+.... ++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+|
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H 156 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDL----CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIH 156 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSC----EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred HHhcCCCCeEEEEEEEecCCce----EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---Ceec
Confidence 9999999999999999876644 99999999999999886432 34589999999999999999999998 9999
Q ss_pred ccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCC
Q 014245 220 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299 (428)
Q Consensus 220 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~ 299 (428)
|||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999999986654333333445679999999998864 58899999999999999999999997
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
......... .+..........+...++..+ .......+..+.+++.+||+.||.+||++.+++++|+++.
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 236 EHREPQLLL--DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTBSSSBTT--HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred cCcchHHHH--HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 654322111 111111111222334444443 2345678889999999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=370.37 Aligned_cols=267 Identities=27% Similarity=0.401 Sum_probs=218.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|..........+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467999999999999999999875544344567899999976533 3456788999999999999999999999876654
Q ss_pred CceEEEEEeecCCCCcccccCCCCc----------------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeec
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSE----------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 220 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHr 220 (428)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||
T Consensus 102 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 102 ----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp ----EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred ----EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 999999999999999865322 3489999999999999999999998 99999
Q ss_pred cCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCC
Q 014245 221 DFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 299 (428)
Q Consensus 221 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~ 299 (428)
||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654433333345567899999999999899999999999999999999 999998
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
..........+. .......+..+++.+.+++.+||+.||++||++.+++++|+++...
T Consensus 255 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPERLFNLLK-----------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGGGHHHHHH-----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHhh-----------------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 665432221111 0111122234567899999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=369.46 Aligned_cols=264 Identities=24% Similarity=0.433 Sum_probs=212.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|.+..++. ....||||.+..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 125 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQ--RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA- 125 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTS--CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC-
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCC--CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc-
Confidence 578999999999999999999865432 345799999976533 3456789999999999999999999999876643
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 126 ---~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 126 ---MIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp ---EEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred ---EEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 99999999999999996442 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCc-eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 244 RLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----------- 267 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV----------- 267 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-----------
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-----------
Confidence 87643321 122234467889999999999999999999999999999999 99999765432211110
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
. .......+..++..+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 268 -----~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 268 -----E-EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -----H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -----H-cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 0 01111223345678999999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=372.12 Aligned_cols=269 Identities=25% Similarity=0.425 Sum_probs=215.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|.+........+..||+|.+.... ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46899999999999999999998655455567789999997543 23456789999999999 99999999999988664
Q ss_pred CCceEEEEEeecCCCCcccccCCCCc---------------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSE---------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 220 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHr 220 (428)
. ++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||
T Consensus 124 ~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 124 I----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp C----EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred c----EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 4 999999999999999975432 2478999999999999999999998 99999
Q ss_pred cCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCC
Q 014245 221 DFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 299 (428)
Q Consensus 221 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~ 299 (428)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986544333333445678899999999999999999999999999999998 999997
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
........ .. .+........+..+++++.+++.+||+.||.+||++.+|+++|..+....
T Consensus 277 ~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 277 GIPVDANF--YK--------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TCCCSHHH--HH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCcHHHH--HH--------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 65432211 11 11111111222334578999999999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=370.92 Aligned_cols=264 Identities=26% Similarity=0.435 Sum_probs=208.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.++||+|+||.||+|.+..++. .....||+|.+.... ....+.+.+|+.++++++||||++++++|.+..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS---
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCc-eEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---
Confidence 579999999999999999999765532 334568999886543 244578999999999999999999999998754
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++|+||+++|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 --~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 --VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp --EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred --eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 379999999999999986533 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+.
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----------- 233 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------- 233 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----------
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-----------
Confidence 87654443333445667899999999999999999999999999999999 999998765433221111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
.......+..++.++.+++.+||+.||++||++.+++++|+.+....
T Consensus 234 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 234 ------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ------TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ------cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 11111222334568999999999999999999999999999887543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=371.89 Aligned_cols=270 Identities=27% Similarity=0.431 Sum_probs=216.5
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
...++|.+.+.||+|+||.||+|...+......+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999987654445567899999976543 33567899999999999999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCC----------------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKS----------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQII 218 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 218 (428)
.. ++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+
T Consensus 124 ~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 124 PM----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp SC----EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ce----EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 44 99999999999999986532 14689999999999999999999998 999
Q ss_pred eccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCC
Q 014245 219 VRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 297 (428)
Q Consensus 219 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 297 (428)
||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999976533222222344678999999999999999999999999999999999 9999
Q ss_pred CCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 298 IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
|......... .. +.+... ...+..++..+.+++.+||+.||++||++.+++++|+++.+..
T Consensus 277 ~~~~~~~~~~---~~-------------~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 277 YYGMAHEEVI---YY-------------VRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTSCHHHHH---HH-------------HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCCChHHHH---HH-------------HhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 9765432111 11 111111 1122345578999999999999999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=365.03 Aligned_cols=269 Identities=26% Similarity=0.406 Sum_probs=219.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|..........+..||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 357999999999999999999876544455677899999976543 3456789999999999 99999999999987765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCc----------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCC
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSE----------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 225 (428)
. ++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+
T Consensus 102 ~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 102 T----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp C----EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred c----EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 4 999999999999999865432 2489999999999999999999998 9999999999
Q ss_pred ceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCch
Q 014245 226 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 304 (428)
Q Consensus 226 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~ 304 (428)
|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987654443333445678899999999999999999999999999999999 99999765432
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
... .... .. ......+...+..+.+++.+||+.||.+|||+.+++++|++++...
T Consensus 255 ~~~--~~~~----------~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 SKF--YKMI----------KE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHH--HHHH----------HH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hHH--HHHh----------cc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 211 1100 01 1111112234578999999999999999999999999999988654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=368.15 Aligned_cols=264 Identities=25% Similarity=0.416 Sum_probs=211.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.++||+|+||.||+|.+..++. .....||+|.+.... ......+.+|+.++..++||||+++++++.+.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGE-SIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS---- 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTC-SCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS----
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCc-eEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence 578999999999999999999876533 334568999886543 23345677999999999999999999998643
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 88 -~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 88 -SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp -SEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred -ccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence 248999999999999998754 34689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---------- 232 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK---------- 232 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT----------
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc----------
Confidence 87655444444455678899999999999999999999999999999999 9999987654332222111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
......+..++.++.+++.+||+.||++||++.+++++|..+....
T Consensus 233 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 233 -------GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -------TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -------CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0011111223456889999999999999999999999999987554
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=372.20 Aligned_cols=285 Identities=17% Similarity=0.231 Sum_probs=217.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-----------HHHHHHHHHHHhcCCCCCcccE
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-----------HKEWMTEVNFLGIVEHQNLVKL 152 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~~ 152 (428)
.++|.+.+.||+|+||.||+|.+..+.....++.||+|.+....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45899999999999999999998876555556789999987654211 1234556677888899999999
Q ss_pred eeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC--
Q 014245 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-- 230 (428)
Q Consensus 153 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-- 230 (428)
++++..........+|||||+ +++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 999987644334579999999 99999998653 24599999999999999999999998 999999999999998
Q ss_pred CCCCeEEeeecccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh
Q 014245 231 EQWNAKLSDFGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 305 (428)
Q Consensus 231 ~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 305 (428)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999765432111 11234569999999999999999999999999999999999999998533222
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcCCC
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGS 380 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~~~ 380 (428)
.. ........ ...+..+++..+.. ..++.++.+++..||..||++||++.+|++.|..++........
T Consensus 269 ~~--~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 269 KY--VRDSKIRY--RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp HH--HHHHHHHH--HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred HH--HHHHHHHh--hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 11 11111100 11122222222110 12346899999999999999999999999999999887654433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=365.46 Aligned_cols=281 Identities=23% Similarity=0.378 Sum_probs=212.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|++.+.||+|+||.||+|.+... +...+..||+|.+........+.+.+|+.+++.++||||+++++++...+..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPL-QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR- 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTT-CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT-
T ss_pred HHHhhhhheeeccCCEEEEEEEEecc-cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC-
Confidence 35799999999999999999986532 2234568999999876656667899999999999999999999998654322
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 87 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 -NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp -SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred -ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 2489999999999999996543 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh---h
Q 014245 244 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS---D 319 (428)
Q Consensus 244 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~ 319 (428)
......... .......|++.|+|||++.+..++.++||||||+++|+|++|..|+...... .......... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMI 237 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchh
Confidence 865432211 1223445778899999999999999999999999999999999998643211 1100000000 0
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
.......+........+..+++++.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 00111111111122233455678999999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=374.54 Aligned_cols=270 Identities=26% Similarity=0.420 Sum_probs=218.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCC--CCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSE--DPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
.++|.+.+.||+|+||.||+|...... .......||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357899999999999999999976432 224456899999976533 3346788999999999 999999999999877
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCC
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 225 (428)
... ++||||+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+
T Consensus 148 ~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 148 GPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp SSC----EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred Cce----EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 654 99999999999999986543 24589999999999999999999998 9999999999
Q ss_pred ceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCch
Q 014245 226 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 304 (428)
Q Consensus 226 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~ 304 (428)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986654332233344568899999999999999999999999999999999 99999765432
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
... ..+. .......+..++.++.+++.+||+.||++||++.+|+++|+.+......
T Consensus 301 ~~~---~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 301 ELF---KLLK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHH---HHHH--------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHH---HHHH--------------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 211 1111 0111112223457899999999999999999999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=369.35 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=205.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++..... ...+.+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 87 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTG-----REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK- 87 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 468999999999999999999976543 3899999875432 34567889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 88 ---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 88 ---TLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp ---EEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ---EEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence 459999999999999998643 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCC-CchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
++....... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...........
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----------- 225 (328)
T 3fe3_A 160 FSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----------- 225 (328)
T ss_dssp CCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------
T ss_pred CceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----------
Confidence 997654332 23456899999999999988875 799999999999999999999987543221111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..... ..+...+.++.+++.+||..||.+|||+.+++++
T Consensus 226 -----i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 226 -----VLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----HHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----HHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111111 1122345688999999999999999999999885
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=367.09 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=204.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-- 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCC-----cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 468999999999999999999877543 3899999865432 23456889999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 79 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 79 --IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp --EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred --eEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence 459999999999999999654 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+................||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ...+.
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-------- 222 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-------- 222 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH--------
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh--------
Confidence 986543333333445789999999999987775 77999999999999999999999765432111 11110
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...........++..+.+|+.+||+.||++|||+.|++++
T Consensus 223 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 223 ------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111111122355788999999999999999999999885
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=362.17 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=213.9
Q ss_pred ccCHHHHHHHhcC----------CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhc
Q 014245 74 EFTIAELKSATKN----------FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI 143 (428)
Q Consensus 74 ~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~ 143 (428)
.|+.+++..+++. |...+.||+|+||.||+|....++ ..||||.+........+.+.+|+.+++.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG-----RQVAVKMMDLRKQQRRELLFNEVVIMRD 98 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCC-----cEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence 4677777777654 677789999999999999876443 3899999987666667789999999999
Q ss_pred CCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 014245 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 223 (428)
Q Consensus 144 l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 223 (428)
++||||+++++++.... ..++||||+++|+|.+++... .+++..++.++.|++.||.|||++ +|+|||||
T Consensus 99 l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlk 168 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGE----ELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168 (321)
T ss_dssp CCCTTBCCEEEEEEETT----EEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred CCCCCcceEEEEEEECC----EEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCC
Confidence 99999999999998765 459999999999999998643 489999999999999999999998 99999999
Q ss_pred CCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCc
Q 014245 224 SSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 303 (428)
Q Consensus 224 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~ 303 (428)
|+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 169 p~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 169 SDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999986543221 22356899999999999999999999999999999999999999976543
Q ss_pred hhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 304 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ... .....+.+ .....+++.+.+++.+||+.||++|||+.+++++
T Consensus 247 ~~~~---~~~----------~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 VQAM---KRL----------RDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHH---HHH----------HHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHH---HHH----------hcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2211 110 11111111 1122345689999999999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=377.76 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=210.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+|+.++||||+++++++.+....
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADN-----TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCC-----eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 357888999999999999999987543 3899999875432 2335688999999999999999999999876644
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
++||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 188 ----~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 188 ----YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp ----EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ----EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 9999999999999998643 23589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...........+
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~----------- 328 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV----------- 328 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-----------
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----------
Confidence 986543222111122346788999999999999999999999999999998 99999865432211111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
........+..+++++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 329 ------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 329 ------EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 01111112233557899999999999999999999999999988653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=367.25 Aligned_cols=284 Identities=22% Similarity=0.365 Sum_probs=199.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|.+...+. ....||+|.+.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDG--SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCC--cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 4689999999999999999998665431 22369999997652 3345788999999999999999999999987653
Q ss_pred CC--ceEEEEEeecCCCCcccccCCCC----cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCe
Q 014245 162 RG--IQRLLVYEYMPNGSVDQYLSPKS----ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 235 (428)
Q Consensus 162 ~~--~~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 235 (428)
.+ ...++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 21 12389999999999999885321 12589999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHh
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 314 (428)
||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---- 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL---- 252 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----
Confidence 9999999986544333333344567889999999999999999999999999999999 99999865543221111
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcCCCCCCCCCCCC
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSST 389 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~~~~~~~~~~~~ 389 (428)
... .....+..++.++.+++.+||+.||++|||+.++++.|++++...........|.....
T Consensus 253 ------------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~~ 314 (323)
T 3qup_A 253 ------------IGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINI 314 (323)
T ss_dssp ------------HTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------------
T ss_pred ------------hcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCCC
Confidence 110 01112234557899999999999999999999999999999877655554444444433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=363.45 Aligned_cols=278 Identities=24% Similarity=0.369 Sum_probs=223.0
Q ss_pred HHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEee
Q 014245 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVG 154 (428)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~ 154 (428)
........++|.+.+.||+|+||.||+|.+........+..||+|.+..... .....+.+|+.++..+ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3344445678999999999999999999976655556678999999976543 2346788999999999 7999999999
Q ss_pred EEecCCCCCceEEEEEeecCCCCcccccCCCCc--------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeec
Q 014245 155 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE--------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 220 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHr 220 (428)
++..... ..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||
T Consensus 99 ~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 99 ACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EECCTTS---CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEecCCC---ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 9976543 24999999999999999975432 2289999999999999999999998 99999
Q ss_pred cCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCC
Q 014245 221 DFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 299 (428)
Q Consensus 221 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~ 299 (428)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986654433333445678999999999999999999999999999999998 999997
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
........ .... ..... ...+...++.+.+++.+||+.||.+|||+.+++++|+.++....
T Consensus 253 ~~~~~~~~--~~~~----------~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDEEF--CRRL----------KEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSHHH--HHHH----------HHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhHHH--HHHh----------ccCcc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 65432211 1100 00001 11122345689999999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=367.33 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=205.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+.+.. ......+.+|+.+|+.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence 357999999999999999999976543 389999986542 234567889999999999999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 79 ----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 79 ----RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence 459999999999999988643 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........
T Consensus 150 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~----------- 216 (337)
T 1o6l_A 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------- 216 (337)
T ss_dssp TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------
T ss_pred cchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH-----------
Confidence 9998643322 123457899999999999999999999999999999999999999976543211111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
+....+ .++..+++++.+++.+||+.||++|| ++.+++++
T Consensus 217 -----i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 217 -----ILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----HHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111111 12234567899999999999999999 89999886
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=369.17 Aligned_cols=251 Identities=26% Similarity=0.353 Sum_probs=205.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc------cHHHHHHHHHHHhcCCCCCcccEeeEEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ------GHKEWMTEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+...... ..+.+.+|+.+|+.++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTG-----LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCC-----CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 467999999999999999999977543 38999999765332 3467899999999999999999999998
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC----
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---- 233 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---- 233 (428)
+.. ..++||||++||+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 86 ~~~----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 86 NRT----DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp CSS----EEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred eCC----EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence 765 459999999999999999654 3599999999999999999999998 999999999999998877
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (428)
.+||+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 157 ~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~---- 229 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---- 229 (361)
T ss_dssp CEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----
T ss_pred CEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----
Confidence 79999999998654322 12346799999999999999999999999999999999999999976543221111
Q ss_pred hhhhhhhhhhhhhcCCcC--CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRL--EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..... .......++..+.+|+.+||..||++|||+.+++++
T Consensus 230 ------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 230 ------------ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ------------HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------------HHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111100 101112345689999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=364.89 Aligned_cols=265 Identities=26% Similarity=0.436 Sum_probs=208.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.++||+|+||.||+|.+..++. .....|++|.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTC-SCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCc-eEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence 3579999999999999999999876543 334568899886543 345678999999999999999999999998754
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++|+||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 91 ---~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 91 ---VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp ---EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred ---ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 389999999999999986543 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---------- 233 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---------- 233 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----------
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----------
Confidence 987644333333344567889999999999999999999999999999999 999998765433221111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
.......+..++.++.+++.+||+.||.+||++.++++.|..+....
T Consensus 234 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 234 -------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -------TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -------cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11111222335568999999999999999999999999999988654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=356.56 Aligned_cols=253 Identities=27% Similarity=0.363 Sum_probs=198.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--------------------------cHHHHHHH
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--------------------------GHKEWMTE 137 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E 137 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|++...... ..+.+.+|
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEND-----NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTT-----TEEEEEEEEECC-------------------------------CHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCC-----CcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 36899999999999999999987654 348999998654321 13568899
Q ss_pred HHHHhcCCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 014245 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQI 217 (428)
Q Consensus 138 ~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 217 (428)
+.+++.++||||+++++++.+.... ..++||||+++++|.+++.. ..+++..++.++.||+.||+|||++ +|
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNED--HLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSS--EEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCC--EEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 9999999999999999999874432 56999999999999987653 3589999999999999999999998 99
Q ss_pred eeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCC---CCCchhhhhHHHHHHHHHhC
Q 014245 218 IVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR---LAARSDVWSYGVFLYELITG 294 (428)
Q Consensus 218 vHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg 294 (428)
+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred eccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 999999999999999999999999998654332 1234568999999999988665 37789999999999999999
Q ss_pred CCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 295 RRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 295 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..||........ .... ............+++++.+++.+||+.||++||++.+++++
T Consensus 237 ~~pf~~~~~~~~---~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 237 QCPFMDERIMCL---HSKI-------------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SCSSCCSSHHHH---HHHH-------------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCCCccHHHH---HHHH-------------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 999976532211 1100 00011111112345689999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=370.77 Aligned_cols=264 Identities=26% Similarity=0.476 Sum_probs=200.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|.+.... ..+..||||.+..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 121 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPS--KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV- 121 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTT--SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC-
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCC--CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce-
Confidence 57999999999999999999865321 2344799999976532 3456789999999999999999999999876644
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 122 ---~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 122 ---MIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp ---EEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred ---EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 99999999999999997543 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 244 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||........ ...+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~i-------- 263 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAV-------- 263 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHHH--------
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH--------
Confidence 865432211 11223346788999999999999999999999999999998 9999976543221 1111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
........+..++..+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 264 ------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 264 ------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ------HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ------HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 011111122235578999999999999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=355.37 Aligned_cols=257 Identities=26% Similarity=0.475 Sum_probs=209.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||.||+|.+.++. .||+|.+..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 79 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKD------KVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--- 79 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTE------EEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred hhceeeheecCCCccEEEEEEecCCC------eEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc---
Confidence 57889999999999999999876432 699999976543 45678999999999999999999999987664
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 80 -~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 80 -ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp -EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred -eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccc
Confidence 499999999999999996433 4589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
...... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||......... ...
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~---~~~---------- 220 (269)
T 4hcu_A 155 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDI---------- 220 (269)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH----------
T ss_pred cccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHH----------
Confidence 654321 111223457788999999999999999999999999999999 99999865432211 110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.. ......+...+..+.+++.+||+.||++||++.+++++|+++.+.
T Consensus 221 ---~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 221 ---ST-GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---HT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---hc-CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00 011112223456899999999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=367.34 Aligned_cols=269 Identities=25% Similarity=0.385 Sum_probs=217.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|.....+.......||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 468999999999999999999987766555667899999976543 3456788999999999 89999999999987664
Q ss_pred CCceEEEEEeecCCCCcccccCCCC------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKS------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl 229 (428)
. ++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 125 ~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 125 V----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp C----EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred e----EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 4 99999999999999986431 23478999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014245 230 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQK 308 (428)
Q Consensus 230 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~ 308 (428)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~- 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence 9999999999999986543333333345678899999999999999999999999999999999 99999765432211
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
..... . ......+...+..+.+++.+||+.||.+|||+.+|+++|+.+....
T Consensus 277 -~~~~~----------~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 -YKLVK----------D----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -HHHHH----------H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHh----------c----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11000 0 0111112223568999999999999999999999999999887654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=359.27 Aligned_cols=263 Identities=23% Similarity=0.373 Sum_probs=205.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.++..++||||+++++++.+.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILN-----IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTC-----SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCC-----CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 357999999999999999999876543 3899999854432 23467889999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 85 ----~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 85 ----CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ----eEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence 459999999999999998643 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|++....... ........||+.|+|||++.+..++.++||||||+++|+|++|..||......... ...... .
T Consensus 156 g~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~---~- 228 (294)
T 4eqm_A 156 GIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHIQD---S- 228 (294)
T ss_dssp SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHHSS---C-
T ss_pred CCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhhc---c-
Confidence 9998654322 12233467999999999999999999999999999999999999999865432111 010000 0
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhh
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-KMSEVLEMVNKIVDA 374 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ell~~L~~~~~~ 374 (428)
.+.........+++.+.+++.+||+.||++|| +++++.+.|..+...
T Consensus 229 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 229 -------VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -------CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -------CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 00000111223457899999999999999998 899999988876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=364.54 Aligned_cols=285 Identities=22% Similarity=0.335 Sum_probs=217.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||.||+|.+... +...+..||+|.+........+.+.+|+.++++++||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-- 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPL-GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ-- 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTT-SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC--
T ss_pred hhhhhhhhccCCCCeEEEEEEeccC-CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc--
Confidence 5799999999999999999986533 2334568999999877666667899999999999999999999998765433
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 4689999999999999986432 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-hhhhhhhhh
Q 014245 245 LGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-KPYLSDAKQ 322 (428)
Q Consensus 245 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 322 (428)
........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .... .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL---RMMGCERDVPALSR 252 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH---HHCC----CCHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh---hhcccccccccHHH
Confidence 76543322 223345688999999999999999999999999999999999999864321100 0000 000000111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcCC
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAG 379 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~~ 379 (428)
....+........+..+++.+.+++.+||+.||++|||+.+++++|+.+........
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 122222222333344566789999999999999999999999999999887665443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=357.22 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=202.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhc--CCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI--VEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||+||+|.+. +..||||++... ....+..|.+++.. ++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 468999999999999999999873 237999998653 33556667776665 799999999999876544
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhh--------cCCCCCeeeccCCCCceEECCCC
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH--------EGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
.....++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||++.++
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred CCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence 445679999999999999999643 4899999999999999999999 76 999999999999999999
Q ss_pred CeEEeeecccccCCCCCcee--eeeeeecCcccCCcchhccC------CCCCchhhhhHHHHHHHHHhC----------C
Q 014245 234 NAKLSDFGLARLGPSEGFTH--VSTAVVGTMGYAAPEYVQTG------RLAARSDVWSYGVFLYELITG----------R 295 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~ 295 (428)
.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999997644332221 12345799999999999876 445799999999999999999 8
Q ss_pred CCCCCCCchhhH--HHHHhHhhhhhhhhhhhhhcCCcCC-CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 296 RPIDRNRPRSEQ--KLLQWVKPYLSDAKQFRQIVDPRLE-GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 296 ~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
.||......... ...... ......+.+. .......+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVV---------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHH---------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHH---------hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 888654322111 000000 0000111111 112345778999999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=356.12 Aligned_cols=275 Identities=24% Similarity=0.304 Sum_probs=213.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.++||+|+||+||+|....++ ..||+|++..... ...+.+.+|+.+++.++||||+++++++......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 82 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTG-----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR- 82 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC-
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCC-----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc-
Confidence 57999999999999999999977543 3899999875432 3456788999999999999999999999876543
Q ss_pred ceEEEEEeecCCCCcccccCCCCc-ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE----CCCCCeEEe
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLS 238 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~ 238 (428)
..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+
T Consensus 83 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 83 -HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp -CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred -eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEc
Confidence 45999999999999999975432 2389999999999999999999998 99999999999999 888889999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhc--------cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh-HHH
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ--------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKL 309 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~ 309 (428)
|||+++...... ......||+.|+|||++. +..++.++|||||||++|||++|..||........ ...
T Consensus 159 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 159 DFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred cCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 999998764432 123467999999999986 56789999999999999999999999975433221 111
Q ss_pred HHhHhhhhhh--hhhhhhh------c--CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 310 LQWVKPYLSD--AKQFRQI------V--DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 310 ~~~~~~~~~~--~~~~~~~------~--~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
...+...... ...+... . ...........+...+.+++.+||+.||++|||++|++++..+..
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111100000 0000000 0 011122456788899999999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=352.33 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=210.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|...++ ..||+|.+..... ..+++.+|+.++..++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-- 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQ------YDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP-- 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred hhheeeeeeeccCCCceEEEEEecCc------eeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc--
Confidence 45799999999999999999987653 3699999976543 45678999999999999999999999977654
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 78 --~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 78 --IYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp --EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred --eEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence 49999999999999998643 23589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~----------- 219 (268)
T 3sxs_A 152 RYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS----------- 219 (268)
T ss_dssp EECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----------
T ss_pred eecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-----------
Confidence 87654332 22334567788999999999899999999999999999999 999997654332111100
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.. .....+...++.+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 220 --~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 220 --QG----HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --TT----CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --cC----CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 00 01111122346899999999999999999999999999887654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=369.80 Aligned_cols=250 Identities=27% Similarity=0.399 Sum_probs=200.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
.++|++.++||+|+||.||+|....++ ..||+|++.+.. ......+..|..++..+ +||||+++++++.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETG-----DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCC-----CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 468999999999999999999977654 389999987542 22345678999999988 799999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. .+||||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+|
T Consensus 97 ~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 97 D----RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp S----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcc
Confidence 6 459999999999999998643 3499999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||..........
T Consensus 168 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~----------- 234 (353)
T 3txo_A 168 FGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE----------- 234 (353)
T ss_dssp CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------
T ss_pred ccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 99998543222 22345789999999999999899999999999999999999999998654322111
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~ell~~ 367 (428)
.+..... .++..++..+.+++.+||+.||++||++ .+++++
T Consensus 235 -----~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 235 -----AILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -----HHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -----HHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1111111 1222355789999999999999999998 778774
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=352.32 Aligned_cols=253 Identities=27% Similarity=0.503 Sum_probs=204.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-------HHHHHHHHHHHhcCCCCCcccEeeEEe
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-------HKEWMTEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+....... .+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDK-----SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTC-----CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred ccceehhccccCCceeEEEEEEcCCc-----eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 57999999999999999999976543 389999986543321 167889999999999999999999986
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEECCCCC-
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLDEQWN- 234 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~~~~~- 234 (428)
+.. ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++.
T Consensus 94 ~~~------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 94 NPP------RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp TTT------EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTT
T ss_pred CCC------eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCC
Confidence 644 79999999999988886443 4589999999999999999999998 8 999999999999988776
Q ss_pred ----eEEeeecccccCCCCCceeeeeeeecCcccCCcchhc--cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH
Q 014245 235 ----AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ--TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 308 (428)
Q Consensus 235 ----~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 308 (428)
+||+|||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||..........
T Consensus 164 ~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 238 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238 (287)
T ss_dssp CSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred CceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence 99999999975432 234467999999999984 4557899999999999999999999997654432211
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
.. ...........+..+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus 239 ~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 239 IN--------------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH--------------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HH--------------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 11111122223344567899999999999999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=361.78 Aligned_cols=267 Identities=16% Similarity=0.201 Sum_probs=211.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|....+ +..||||.+..... ...+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-- 78 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYT-----NEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-- 78 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTT-----TEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--
T ss_pred cCCeEEEEEeeccCCceEEEEEECCC-----CcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--
Confidence 35799999999999999999986544 35899999865432 34688999999999 9999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC-----eEE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-----AKL 237 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl 237 (428)
..++||||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||
T Consensus 79 --~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl 151 (330)
T 2izr_A 79 --YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI 151 (330)
T ss_dssp --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred --ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence 459999999 99999998753 34599999999999999999999998 9999999999999998887 999
Q ss_pred eeecccccCCCCCcee-----eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 238 SDFGLARLGPSEGFTH-----VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|..||..............
T Consensus 152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~ 231 (330)
T 2izr_A 152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231 (330)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence 9999998654322111 12457899999999999999999999999999999999999999987654433332222
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
+...... ... ... ....+ ++.+++..||+.||.+||++.+|++.|..+......
T Consensus 232 i~~~~~~-~~~-~~~--------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 232 IGDTKRA-TPI-EVL--------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHHHH-SCH-HHH--------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhhhcc-CCH-HHH--------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 1110000 000 000 00123 899999999999999999999999999988876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=359.25 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=205.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+.... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSS-----KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME--- 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT---
T ss_pred hhceEeeeEEecCCCeEEEEEEECCC-----CcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC---
Confidence 46899999999999999999987654 3489999987543 34456889999999999999999999998766
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC--CCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE--QWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFG 241 (428)
..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 75 -ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp -EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred -EEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 4599999999999999996543 3589999999999999999999998 9999999999999987 7899999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 150 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------------ 214 (321)
T 1tki_A 150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------------ 214 (321)
T ss_dssp TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------------
T ss_pred CCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH------------
Confidence 998765432 23456899999999999988899999999999999999999999976543221111
Q ss_pred hhhhhcCCcCC--CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+...... ......++.++.+++.+||..||.+|||+.+++++
T Consensus 215 ----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 215 ----IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111000 00111345789999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=357.80 Aligned_cols=280 Identities=26% Similarity=0.407 Sum_probs=216.4
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
|.+.+.||+|+||.||++.+... +...+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.... .
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA--S 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSC-C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT--E
T ss_pred HhhhheecCCCCeEEEEEEEccC-CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc--e
Confidence 48999999999999999987643 334567899999976543 3356789999999999999999999999876433 5
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.++||||+++|+|.+++... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 69999999999999999654 389999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 246 GPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 246 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .....+..... ....+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-TVLRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-HHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-hHHHHH
Confidence 6543322 22345678899999999999899999999999999999999999986432110 00000000000 011112
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
..+........+..++.++.+++.+||+.||++|||+.++++.|+.+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 22222222333445667899999999999999999999999999999877643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=375.84 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=209.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|.+.+ ..||||.+.... ..+.|.+|+.+|++++||||+++++++.....
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~-------~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 260 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-- 260 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------EEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS--
T ss_pred hHHeEEEeeecCcCCeeEEEEEecC-------CeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC--
Confidence 4578889999999999999998753 379999997653 45789999999999999999999999877543
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 261 -~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 261 -GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred -ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 359999999999999999765555579999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+..... .....+++.|+|||++.+..++.++|||||||++|||++ |..||...........+
T Consensus 337 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i------------ 399 (450)
T 1k9a_A 337 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV------------ 399 (450)
T ss_dssp EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH------------
T ss_pred cccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------
Confidence 854321 122367899999999999999999999999999999998 99999865433221111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
........+..+++.+.++|.+||+.||++|||+.+|++.|+.+...
T Consensus 400 -----~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 400 -----EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 00111122334567899999999999999999999999999988754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=359.65 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=204.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc------cHHHHHHHHHHHhcCCCCCcccEeeEEec
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ------GHKEWMTEVNFLGIVEHQNLVKLVGYCAD 158 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 158 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+...... ..+.+.+|+.+|+.++||||+++++++.+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cceEeceEEeeCCCeEEEEEEECCCC-----cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 47999999999999999999976543 38999998754321 35678999999999999999999999987
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC----C
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW----N 234 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~----~ 234 (428)
.. ..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .
T Consensus 86 ~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 86 KT----DVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp SS----EEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCC
T ss_pred CC----EEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCC
Confidence 65 459999999999999999654 4589999999999999999999998 999999999999999887 7
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..
T Consensus 157 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-- 231 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-- 231 (326)
T ss_dssp EEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH--
T ss_pred EEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh--
Confidence 9999999998654322 12346799999999999999999999999999999999999999976543221111100
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.............+..+.+++.+||+.||++|||+.+++++
T Consensus 232 ------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 232 ------------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011111112345688999999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=353.48 Aligned_cols=263 Identities=22% Similarity=0.380 Sum_probs=201.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|.+.... .....||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-- 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCC--CCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCc--
Confidence 357899999999999999999976532 2345799999876433 33567889999999999999999999985432
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 90 ---~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 90 ---VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp ---CEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred ---cEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence 389999999999999986432 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----------- 230 (281)
T 1mp8_A 163 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----------- 230 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----------
T ss_pred ccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-----------
Confidence 986543221 12234567889999999999999999999999999999997 99999865433221111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
... .....+..+++.+.+++.+||+.||++||++.++++.|+.+.+..
T Consensus 231 -----~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 231 -----ENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -----HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 010 011122345678999999999999999999999999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=380.50 Aligned_cols=258 Identities=22% Similarity=0.420 Sum_probs=210.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|.+..+ ..||||.+.... ...+.|.+|+.+|+.++||||+++++++... .
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-~-- 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKH------TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKE-P-- 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTT------EEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSS-S--
T ss_pred hHHeEEEEEcccCCceEEEEEEECCc------cEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCC-c--
Confidence 46788999999999999999987643 379999997654 4567899999999999999999999998633 2
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 257 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 257 --IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp --CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred --cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 48999999999999999765444688999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... .......+|+.|+|||++..+.++.++|||||||++|||++ |..||......... ..+.
T Consensus 332 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~-------- 399 (454)
T 1qcf_A 332 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALE-------- 399 (454)
T ss_dssp GGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHH--------
T ss_pred eEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH--------
Confidence 86543211 11223456789999999999999999999999999999999 99999865432211 1110
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
. ......+..+++++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 400 --~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 400 --R----GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp --H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred --c----CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0 011112234567899999999999999999999999999987654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=350.11 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=207.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||.||+|.+.+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQG-------NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETT-------EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred HHhHHHHHhcCCCcceEEEEEECC-------eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 579999999999999999999752 3799999876532 3346789999999999999999999999876322
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEECCCCCeEEeee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++|+|.+++.......+++..++.++.|++.||+|||++ + |+||||||+|||++.++.++|+||
T Consensus 83 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 83 --HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp --SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred --CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEec
Confidence 349999999999999999876555699999999999999999999997 7 999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCC---chhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA---RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
|++..... ....||+.|+|||++.+..++. ++||||||+++|+|++|..||..........
T Consensus 158 ~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--------- 221 (271)
T 3kmu_A 158 DVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM--------- 221 (271)
T ss_dssp GSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH---------
T ss_pred cceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH---------
Confidence 88754322 2357899999999998765544 7999999999999999999997654322111
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
...........+..++..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 222 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 222 -------KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------HHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111111222333456789999999999999999999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=360.68 Aligned_cols=269 Identities=25% Similarity=0.429 Sum_probs=215.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCC--CCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSE--DPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
.++|.+.+.||+|+||.||+|...... ....+..||+|.+..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 357999999999999999999976432 223456899999976533 3456788999999999 999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCC
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 225 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 225 (428)
... ++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+
T Consensus 114 ~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 114 GPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp SCC----EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred Cce----EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 643 99999999999999987543 13489999999999999999999998 9999999999
Q ss_pred ceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCch
Q 014245 226 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 304 (428)
Q Consensus 226 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~ 304 (428)
|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987654433333445567899999999998899999999999999999999 99999765432
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
... ..+. ... ....+..++.++.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 267 ~~~---~~~~----------~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 267 ELF---KLLK----------EGH----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHH---HHHH----------HTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHH---HHHh----------cCC----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 211 1110 000 111223345789999999999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=383.47 Aligned_cols=259 Identities=24% Similarity=0.446 Sum_probs=214.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
..+|.+.+.||+|+||.||+|.+... +..||||.+.... ...+.|.+|+.+|++++||||++++++|.+....
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~- 291 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKY-----SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF- 291 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGG-----TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC-
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCC-----CeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE-
Confidence 35688899999999999999998753 3489999997653 3467899999999999999999999999877644
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
+|||||+++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 292 ---~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 292 ---YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp ---EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred ---EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 9999999999999999765556689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 366 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~------------- 431 (495)
T 1opk_A 366 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------------- 431 (495)
T ss_dssp ECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------------
T ss_pred eeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------------
Confidence 87643322 22233456789999999999999999999999999999999 9999987653322111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
+........+..+++.+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 432 ----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 432 ----LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11111122233456789999999999999999999999999988753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=365.32 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=207.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+..........+.+|+.+|+.++||||+++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--- 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--- 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS---
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCC-----CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC---
Confidence 468999999999999999999976543 389999997765555667899999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC--CCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE--QWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFG 241 (428)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 122 -~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 122 -EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp -EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred -EEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 4599999999999999987543 3589999999999999999999998 9999999999999974 5779999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+..
T Consensus 197 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~~------ 264 (387)
T 1kob_A 197 LATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKR------ 264 (387)
T ss_dssp TCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH------
T ss_pred cceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHHh------
Confidence 9987654322 23457999999999999999999999999999999999999999865432111 11100
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............++.++.+++.+||+.||++|||+.+++++
T Consensus 265 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 265 -----CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -----CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00011111222356789999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=349.66 Aligned_cols=254 Identities=29% Similarity=0.465 Sum_probs=195.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----ccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----QGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
.++|++.+.||+|+||.||+|.+.+ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIG-------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETT-------EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEcC-------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578999999999999999998652 3799999865432 2346788999999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC--------
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-------- 231 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-------- 231 (428)
... ++||||+++++|.+++.. ..+++..++.++.|++.||.|||++...+|+||||||+|||++.
T Consensus 79 ~~~----~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~ 151 (271)
T 3dtc_A 79 PNL----CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151 (271)
T ss_dssp --C----EEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred Cce----EEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence 643 999999999999999863 34899999999999999999999981112999999999999986
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 311 (428)
++.+||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---- 223 (271)
T 3dtc_A 152 NKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA---- 223 (271)
T ss_dssp SCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----
T ss_pred CcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----
Confidence 7789999999997544322 22457999999999999999999999999999999999999999765432111
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
............+..+++.+.+++.+||+.||++|||+.+++++|+.+
T Consensus 224 ------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 ------------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------------HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111111222223334567899999999999999999999999999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=353.88 Aligned_cols=258 Identities=24% Similarity=0.443 Sum_probs=207.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|.+.++ ..||+|.+..... ..+++.+|+.++..++||||+++++++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-- 93 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-- 93 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTT------EEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCC------CeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC--
Confidence 35789999999999999999987643 3799999976543 35678999999999999999999999987654
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 94 --~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 94 --IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp --EEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred --eEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccc
Confidence 49999999999999999753 23589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 168 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~------------ 234 (283)
T 3gen_A 168 RYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------------ 234 (283)
T ss_dssp GGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------------
T ss_pred ccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH------------
Confidence 8654321 111223456788999999999999999999999999999998 99999865432211111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
... .....+...++.+.+++.+||+.||++|||+.+++++|..+.+.
T Consensus 235 -~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 235 -AQG----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -HTT----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -hcc----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 011 11111222356899999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=377.40 Aligned_cols=259 Identities=26% Similarity=0.446 Sum_probs=206.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|.+.++ ..||||.+.... ...+.|.+|+.+|++++||||+++++++.+ ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~-- 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP-- 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT------EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS--
T ss_pred hhHceeeeeecCCCCeEEEEEEECCC------ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc--
Confidence 45788999999999999999998653 269999997654 345789999999999999999999999876 22
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 253 --~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 253 --IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp --CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred --eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence 38999999999999999754445589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||......... ..+
T Consensus 328 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i--------- 394 (452)
T 1fmk_A 328 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQV--------- 394 (452)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHH---------
T ss_pred eecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHH---------
Confidence 86543221 12234567889999999999999999999999999999999 99999765432211 110
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
........+..+++.+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 395 -----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 395 -----ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp -----HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 001111223345678999999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=358.53 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=204.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNG-----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence 357999999999999999999976543 389999986542 134567789999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 80 ----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 80 ----QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp ----EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence 459999999999999999653 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 151 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------- 212 (318)
T 1fot_A 151 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------------- 212 (318)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------
T ss_pred CcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------------
Confidence 999865432 23468999999999999999999999999999999999999999765432111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
..++...+ .++..++.++.+++.+||..||++|| ++++++++
T Consensus 213 ---~~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 213 ---EKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---HHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11111111 12233557899999999999999999 89999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=350.68 Aligned_cols=260 Identities=27% Similarity=0.475 Sum_probs=211.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|...++ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP--- 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCC------cEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCC---
Confidence 35789999999999999999987543 379999987543 34578899999999999999999999986433
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 82 --~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 82 --IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp --CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred --cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 38999999999999999764434689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
........ .......+++.|+|||++.++.++.++||||||+++|+|++ |..||........ .....
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~-------- 224 (279)
T 1qpc_A 157 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLE-------- 224 (279)
T ss_dssp EECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHH--------
T ss_pred ccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHHh--------
Confidence 87644321 22234567889999999998899999999999999999999 9999976543211 11110
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
. ......+..++..+.+++.+||..||++|||+.++++.|+.+.....
T Consensus 225 --~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 225 --R----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp --T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --c----ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 0 01111222345789999999999999999999999999999887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=353.90 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=201.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||.||+|.+.+ ..||+|.+... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 73 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP----- 73 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETT-------EEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-----
T ss_pred hHeeeeeEeecCCCceEEEEEECC-------eeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence 478889999999999999998753 37999998643 3456789999999999999999999988643
Q ss_pred eEEEEEeecCCCCcccccCCCCc-ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC-eEEeeecc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-AKLSDFGL 242 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGl 242 (428)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+..+|+||||||+|||++.++. +||+|||+
T Consensus 74 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 74 -VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp -TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred -cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 2899999999999999975433 34788999999999999999999932239999999999999998887 79999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ...
T Consensus 153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~--------- 217 (307)
T 2eva_A 153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-WAV--------- 217 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH-HHH---------
T ss_pred ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH-HHH---------
Confidence 9754321 2235699999999999999999999999999999999999999975433221110 000
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcC
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEA 378 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~ 378 (428)
.. .........++..+.+++.+||+.||++|||+.++++.|+.+.......
T Consensus 218 -~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 218 -HN----GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp -HT----TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred -hc----CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 00 0111122334568999999999999999999999999999987665443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=364.63 Aligned_cols=270 Identities=22% Similarity=0.433 Sum_probs=215.2
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
...++|.+.+.||+|+||.||+|.+.+......+..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999876433334456899999976533 33456889999999999999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCC--------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 232 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~ 232 (428)
.. ++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 102 ~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 102 PT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp SC----EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred cc----EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 44 99999999999999986422 13468899999999999999999998 99999999999999999
Q ss_pred CCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 014245 233 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQ 311 (428)
Q Consensus 233 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~ 311 (428)
+.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-- 252 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-- 252 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH--
Confidence 9999999999976543322222334567899999999999999999999999999999999 8999976543211111
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
+..... ......++..+.+++.+||+.||++||++.+++++|+.+....
T Consensus 253 --------------~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 253 --------------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp --------------HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred --------------HHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 111111 1122335578999999999999999999999999998876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=352.07 Aligned_cols=260 Identities=30% Similarity=0.487 Sum_probs=196.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|.... .||+|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ- 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCc-
Confidence 4689999999999999999997542 489999875432 33467899999999999999999999765432
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 94 ----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 94 ----LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp ----CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred ----cEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence 38999999999999998644 34589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
++................||+.|+|||++. +..++.++||||||+++|+|++|..||........ +......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~--- 240 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGR--- 240 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHH---
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcc---
Confidence 997654322223334567999999999986 56788899999999999999999999976543321 1111110
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
....+. .......+++.+.+++.+||+.||++||++.++++.|+++.
T Consensus 241 ------~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 241 ------GSLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ------TSCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------cccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 001111 11122345578999999999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=367.09 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=204.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+|+.++||||+++++++.+..
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~- 88 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTK-----KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE- 88 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence 57999999999999999999977654 389999986532 223467889999999999999999999998776
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||++||+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||||+.+|.+||+|||
T Consensus 89 ---~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 89 ---DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp ---EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccc
Confidence 459999999999999999754 3599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc---CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
++....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||..........+......
T Consensus 161 ~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--- 234 (384)
T 4fr4_A 161 IAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--- 234 (384)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---
T ss_pred eeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---
Confidence 998654322 2345789999999999874 4589999999999999999999999976544333322221111
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLE 366 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~ell~ 366 (428)
. ...++..++..+.+|+.+||+.||.+||+ ++++++
T Consensus 235 ----------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 ----------T--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----------C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----------c--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 11122335578999999999999999998 777765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=353.77 Aligned_cols=261 Identities=25% Similarity=0.452 Sum_probs=217.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-- 83 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKY-----SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-- 83 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGG-----TEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred ccceeEEeecCCCCceeEEEeEecCC-----CEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC--
Confidence 46789999999999999999997654 3489999987543 345778999999999999999999999987664
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 84 --~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 84 --FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp --EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred --EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 49999999999999999765566799999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||............
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~------------ 225 (288)
T 3kfa_A 159 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL------------ 225 (288)
T ss_dssp GTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH------------
T ss_pred eeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------
Confidence 87654332 23344567899999999999999999999999999999999 99999865433222111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
........+..+++.+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 226 -----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 226 -----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111222345578999999999999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=372.87 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=204.4
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|.+.+.||+|+||.||+|....+ +..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~-----~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLA-----GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTT-----TEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCC-----CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 356899999999999999999986654 34899999876543 23456889999999999999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC---CCCCeEE
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKL 237 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl 237 (428)
..++||||++||+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||
T Consensus 84 ----~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 84 ----HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp ----EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ----EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEE
Confidence 459999999999999988654 3489999999999999999999998 999999999999998 5678999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
+|||++....... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+ ..
T Consensus 155 ~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i---~~-- 227 (444)
T 3soa_A 155 ADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI---KA-- 227 (444)
T ss_dssp CCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HH--
T ss_pred ccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH---Hh--
Confidence 9999997654332 2223468999999999999999999999999999999999999999765432211111 00
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ...........+++++.+|+.+||+.||++|||+.+++++
T Consensus 228 -------~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 228 -------G--AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -------T--CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------C--CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0011111122345789999999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=363.70 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=205.0
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|.+.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCC-----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 3468999999999999999999976543 3899999976533 23467889999999999999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC---CeEE
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---NAKL 237 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl 237 (428)
..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||
T Consensus 102 ----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 102 ----FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp ----EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred ----EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 359999999999999988654 3589999999999999999999998 999999999999997654 5999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+..
T Consensus 173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---~~i~~-- 244 (362)
T 2bdw_A 173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQIKA-- 244 (362)
T ss_dssp CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH--
T ss_pred eecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHh--
Confidence 9999998654322 123468999999999999989999999999999999999999999765432111 11100
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ...........+++++.+|+.+||+.||++||++.+++++
T Consensus 245 -------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 245 -------G--AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -------T--CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -------C--CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0001111122356789999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=368.03 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=202.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
.++|.+.++||+|+||.||+|....++ ..||+|++.+... .....+..|..++.++ +||||+++++++.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTD-----RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 357999999999999999999977653 4899999976432 2334678999999887 899999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. .++|||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+|
T Consensus 126 ~----~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 126 S----RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp S----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 6 459999999999999988643 3599999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||........... ...
T Consensus 197 FGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~ 267 (396)
T 4dc2_A 197 YGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTE 267 (396)
T ss_dssp CTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCH
T ss_pred cceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhH
Confidence 99998533222 224457899999999999999999999999999999999999999964322111000 000
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~ell~~ 367 (428)
......+....+ .++..++.++.+|+.+||+.||++||++ .+++++
T Consensus 268 ~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 268 DYLFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHHHHhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 000111111111 1233456789999999999999999985 577664
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=354.28 Aligned_cols=271 Identities=22% Similarity=0.389 Sum_probs=204.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|..... ...+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECT--TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred HHHeeeccceeecCCeEEEEEEEecc--CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 46799999999999999999987643 23456899999875532 334678899999999999999999999987553
Q ss_pred CC-ceEEEEEeecCCCCcccccCC----CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeE
Q 014245 162 RG-IQRLLVYEYMPNGSVDQYLSP----KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 162 ~~-~~~~lv~e~~~~g~L~~~l~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
.+ ...++||||+++|+|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 21 235899999999999998832 2235699999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 315 (428)
|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------ 261 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY------ 261 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH------
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH------
Confidence 999999986544332233344567889999999999999999999999999999999 8999976543321111
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
+... .....+..++..+.+++.+||..||.+||++.+++++|+.+....+
T Consensus 262 ----------~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 262 ----------LLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ----------HHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----------HHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1110 1112223455789999999999999999999999999999987643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=357.72 Aligned_cols=257 Identities=19% Similarity=0.319 Sum_probs=200.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+.||+|+||.||+|....++ ..||||++..... ...+.+.+|+.+|++++||||+++++++.+....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDD-----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTC-----CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCC-----cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 457999999999999999999976543 3899999975433 3456789999999999999999999998664321
Q ss_pred -----------------------------------------------------CceEEEEEeecCCCCcccccCCCCc-c
Q 014245 163 -----------------------------------------------------GIQRLLVYEYMPNGSVDQYLSPKSE-T 188 (428)
Q Consensus 163 -----------------------------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~-~ 188 (428)
....++||||+++|+|.+++..... .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 1136999999999999999976433 3
Q ss_pred cccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCce----------eeeeee
Q 014245 189 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT----------HVSTAV 258 (428)
Q Consensus 189 ~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~ 258 (428)
..++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 456777899999999999999998 9999999999999999999999999999876543211 122345
Q ss_pred ecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHH
Q 014245 259 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR 338 (428)
Q Consensus 259 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 338 (428)
.||+.|+|||++.+..++.++|||||||++|+|++|..|+.. ..... ....... .......
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~-------------~~~~~~~-~~~~~~~ 297 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRII-------------TDVRNLK-FPLLFTQ 297 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHH-------------HHHHTTC-CCHHHHH
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHH-------------HHhhccC-CCccccc
Confidence 799999999999999999999999999999999998766421 11111 0111111 1112234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 339 LVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 339 ~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+.+.+++.+||+.||++||++.+++++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 55678999999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=358.89 Aligned_cols=264 Identities=26% Similarity=0.369 Sum_probs=200.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+...... ....+.+|+.++..++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRD-----HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCC-----CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 36899999999999999999987544 348999999765332 2457889999999999999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..+...++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 5545569999999999999998643 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......... .... .
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~~----~ 234 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHVR----E 234 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHH----C
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhc----C
Confidence 999765432211 22334679999999999999999999999999999999999999997654322111 1000 0
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH-HHHh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM-VNKI 371 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~-L~~~ 371 (428)
...........++.++.+++.+||+.||++||+..+++.+ +...
T Consensus 235 --------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 235 --------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000000011245689999999999999999977776654 4443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=360.20 Aligned_cols=269 Identities=25% Similarity=0.409 Sum_probs=207.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|.+.+..+...+..||+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35899999999999999999986654344456689999997543 23456788999999999999999999999877654
Q ss_pred CceEEEEEeecCCCCcccccCCCCc-----ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC---CCC
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSE-----TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWN 234 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~ 234 (428)
++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. +..
T Consensus 109 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 109 ----FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ----EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred ----EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence 999999999999999865422 3489999999999999999999998 9999999999999984 446
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 313 (428)
+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......... ..+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EFV 258 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHH
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---HHH
Confidence 99999999975433322222344578999999999999999999999999999999998 99999765432111 111
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
. . .........++..+.+++.+||+.||.+||++.+++++|..+.....
T Consensus 259 ~-------------~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 259 T-------------S-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp H-------------T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred h-------------c-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 0 0 00111222345689999999999999999999999999998876544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=351.98 Aligned_cols=267 Identities=15% Similarity=0.219 Sum_probs=211.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+.... ....+.+|+.++..+ +|+||+++++++.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-- 79 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLN-----NQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-- 79 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTT-----TEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred ccceEEEEEEeecCCEEEEEEEECCC-----CcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--
Confidence 35799999999999999999986543 3489999986543 234678999999999 8999999999997665
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC-----eEE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-----AKL 237 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl 237 (428)
..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||
T Consensus 80 --~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 80 --HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp --EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred --eeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 459999999 999999997442 3589999999999999999999998 9999999999999987776 999
Q ss_pred eeecccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 238 SDFGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 238 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..............
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 999999865433221 123456799999999999999999999999999999999999999987554333322221
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
+...... ..... ....+++++.+++.+||+.||++||++++|++.|+++.....
T Consensus 233 ~~~~~~~-~~~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 233 IGEKKQS-TPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHH-SCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhhccC-ccHHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 1110000 00000 011245689999999999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=353.97 Aligned_cols=277 Identities=23% Similarity=0.357 Sum_probs=211.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|+||.||+|.+... +...+..||+|.+..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~- 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN- 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTT-SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C-
T ss_pred hhhhhhhccCCCCceEEEEEEEccc-cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc-
Confidence 4688999999999999999986543 234566899999975432 3457789999999999999999999999876433
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 99 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 -GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred -eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 3589999999999999985432 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh--hhh
Q 014245 244 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL--SDA 320 (428)
Q Consensus 244 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~ 320 (428)
......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+..... .......+.. ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTV 249 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCH
Confidence 876543322 223456788899999999999999999999999999999999998643211 0000000000 000
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
..+...+........+..+++.+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111112222233456678999999999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=361.95 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=204.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+.+.. ....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 114 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS- 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCC-----CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-
Confidence 57999999999999999999976543 389999986542 234567889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 115 ---~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 115 ---NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccc
Confidence 459999999999999998643 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||......... .
T Consensus 187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~---------- 248 (350)
T 1rdq_E 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---E---------- 248 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----------
T ss_pred cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH---H----------
Confidence 99865432 23468999999999999999999999999999999999999999765432211 1
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
.+....+ .++..++.++.+++.+||+.||.+||+ +++|+++
T Consensus 249 ---~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 249 ---KIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---HHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1111111 122335678999999999999999998 8888875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=372.11 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=205.4
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEec
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCAD 158 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 158 (428)
...++|.+.++||+|+||.||+|....++ ..||+|++.+... .....+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTR-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCC-----cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 34578999999999999999999987654 3899999865321 223457899999999999999999999987
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.. .+||||||++||+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+
T Consensus 141 ~~----~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 141 DR----YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp SS----EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CC----EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEe
Confidence 65 459999999999999998643 489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCC----CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR----LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
|||+++....... ......+||+.|+|||++.+.. |+.++|||||||++|||++|..||...........+.
T Consensus 211 DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--- 286 (410)
T 3v8s_A 211 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM--- 286 (410)
T ss_dssp CCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---
T ss_pred ccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH---
Confidence 9999987654332 2334678999999999998665 7899999999999999999999998654332211111
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ell~~ 367 (428)
.... ....+ ....++.++.+|+.+||..+|.+ ||++++|++|
T Consensus 287 ---~~~~---~~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 287 ---NHKN---SLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---THHH---HCCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---hccc---cccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000 00000 11124578999999999999988 9999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=364.37 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=201.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-----cccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETG-----QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 57999999999999999999876543 389999985421 12456789999999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCC--cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC---
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--- 234 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~--- 234 (428)
. ..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 99 ~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 99 G----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp T----EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCC
T ss_pred C----EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCc
Confidence 5 4599999999999988775332 23489999999999999999999998 9999999999999987655
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+||+|||++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+....
T Consensus 172 vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i- 244 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI- 244 (351)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH-
T ss_pred EEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH-
Confidence 9999999998765432 123346799999999999999999999999999999999999999976421 111110
Q ss_pred hhhhhhhhhhhhcCCcCC--CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... ......++.++.+|+.+||+.||++||++.+++++
T Consensus 245 ------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 245 ------------IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ------------HHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------------HcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 00011245689999999999999999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=364.53 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=204.0
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcC-CCCCcccEeeEEec
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCAD 158 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 158 (428)
..++|.+.++||+|+||.||+|....++ ..||+|.+.+.. ......+..|..++..+ +||||+++++++.+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 4578999999999999999999976543 489999997542 22345678899999876 99999999999987
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.. ..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+
T Consensus 90 ~~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 90 KE----NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp SS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CC----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEe
Confidence 66 459999999999999998643 3489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+ ..
T Consensus 161 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~~--- 232 (345)
T 1xjd_A 161 DFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RM--- 232 (345)
T ss_dssp CCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH---
T ss_pred EChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hh---
Confidence 999998543221 1234578999999999999999999999999999999999999999765432211111 00
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS-EVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ell~~ 367 (428)
... .++..++.++.+++.+||+.||++||++. +|+++
T Consensus 233 --------~~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 233 --------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp --------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --------CCC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 011 12223557899999999999999999997 77653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=377.29 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=207.8
Q ss_pred HHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEee
Q 014245 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVG 154 (428)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~ 154 (428)
.++....++|++.++||+|+||+||+|....++ ..||+|++.+... .....+.+|..++..++||||+++++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 141 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD-----KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCC-----cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 334445678999999999999999999987643 4899999865321 12234789999999999999999999
Q ss_pred EEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 155 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
+|.+.. .++|||||++||+|.+++... ...+++..++.++.||+.||.|||++ +||||||||+||||+.++.
T Consensus 142 ~~~~~~----~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 142 AFQDDN----NLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp EEECSS----EEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred EEeeCC----EEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCC
Confidence 998866 459999999999999999753 24599999999999999999999998 9999999999999999999
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 309 (428)
+||+|||+++....... ......+||+.|+|||++. .+.|+.++|||||||++|||++|+.||...........
T Consensus 214 vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 292 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292 (437)
T ss_dssp EEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh
Confidence 99999999976544332 2234568999999999987 46689999999999999999999999986543322211
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014245 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 367 (428)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ell~~ 367 (428)
+. ... .....+. ....+++++.+||.+||..+|++ ||++++++++
T Consensus 293 i~------~~~---~~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 IM------NHK---ERFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HH------THH---HHCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hh------hcc---ccccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11 000 0001111 11124568999999999888888 9999999886
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=356.64 Aligned_cols=267 Identities=27% Similarity=0.489 Sum_probs=206.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.+|.+.+.||+|+||.||+|...... ......||+|.+..... .....+.+|+.++..++||||+++++++.+...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 120 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP-- 120 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred HHhhcccEEecCCCeEEEEEEEecCC-CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC--
Confidence 46778899999999999999876543 23455799999976533 334578899999999999999999999977653
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 121 --~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 121 --MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp --EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred --cEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 49999999999999998643 24589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 244 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ ...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~--------- 262 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKA--------- 262 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH---------
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HHH---------
Confidence 865432211 11223456889999999999999999999999999999999 9999976543211 111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
+.+. .....+..++..+.+++.+||+.||++||++.++++.|+++......
T Consensus 263 ----~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 263 ----INDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp ----HHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ----HHCC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 1010 11112223557899999999999999999999999999998876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=350.39 Aligned_cols=266 Identities=22% Similarity=0.309 Sum_probs=199.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|+||+||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred CCceeeeEecCCCCeEEEEEEECCCC-----ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--
Confidence 57899999999999999999976543 3899999975433 23467889999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++ +|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 75 --~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 75 --KLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp --EEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred --EEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 45999999976 554444322 24599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh----
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL---- 317 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---- 317 (428)
+....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... +........
T Consensus 148 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTE 224 (292)
T ss_dssp CEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCT
T ss_pred ceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCCh
Confidence 98654322 1223467899999999998766 799999999999999999988886443322211 111111000
Q ss_pred hhhhhhhhhcC---------CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVD---------PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~---------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..........+ ..........++.++.+|+.+||+.||++|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000000 000011122456788999999999999999999999885
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=355.00 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=199.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||+||+|....+ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQG------RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTS------CEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCC------CEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 46899999999999999999987543 3799999865432 224678899999999999999999999987653
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.++||||+++ +|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 94 ----~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 94 ----LTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp ----EEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ----EEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence 5999999975 7777776433 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-hh----
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-KP---- 315 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~---- 315 (428)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... ..
T Consensus 165 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 165 LARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242 (311)
T ss_dssp TCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred CceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence 998654322 12234578999999999876 56899999999999999999999999876544332211110 00
Q ss_pred hhhhhhhhhhhcC---CcCCCC----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQIVD---PRLEGK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~~---~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..........+ ...... ....+++++.+|+.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000000000 000000 111234688999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=349.65 Aligned_cols=263 Identities=23% Similarity=0.410 Sum_probs=209.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|.+.... ..+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-- 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS--
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--
Confidence 457899999999999999999876532 2455799999976532 34567899999999999999999999986543
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 87 ---~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 87 ---TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp ---CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred ---CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCC
Confidence 28999999999999998643 23489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---------- 228 (281)
T 3cc6_A 160 SRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---------- 228 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH----------
T ss_pred Ccccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh----------
Confidence 986543221 12234567889999999999999999999999999999998 999997654332221111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
... ....+..+++.+.+++.+||+.||++||++.+++++|+.+....
T Consensus 229 ---~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 229 ---KGD----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ---HTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---cCC----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 000 01112234568999999999999999999999999999987653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=382.23 Aligned_cols=263 Identities=23% Similarity=0.413 Sum_probs=207.6
Q ss_pred CCCCce-eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++.+.. .||+|+||.||+|.+.... .+..||||.+..... ...+.+.+|+.+|++++|||||++++++..+.
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--- 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA--- 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSS---CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSS---
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCC---CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCC---
Confidence 344444 7999999999999876432 245799999976533 35678999999999999999999999997632
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 410 --~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 410 --LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp --EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred --eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 59999999999999998654 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCc-eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 244 RLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---------- 553 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---------- 553 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH----------
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----------
Confidence 86543221 111223456789999999999999999999999999999998 999998765432221111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
.......+..+++++.+||.+||+.||++||++.+|++.|+.+......
T Consensus 554 -------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 554 -------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred -------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 0111122334567899999999999999999999999999998876544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=354.01 Aligned_cols=258 Identities=23% Similarity=0.433 Sum_probs=205.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCC--CCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....+++ ......||+|.+........+.+.+|+.+++.++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578999999999999999998765432 11235799999977666667789999999999999999999999987665
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC-------
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN------- 234 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~------- 234 (428)
. ++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 87 ~----~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 87 N----ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp C----EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred C----EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 4 8999999999999999754 33489999999999999999999998 9999999999999998887
Q ss_pred -eEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCC-CCCCCCchhhHHHHH
Q 014245 235 -AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRR-PIDRNRPRSEQKLLQ 311 (428)
Q Consensus 235 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~ 311 (428)
+||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.. ||.............
T Consensus 159 ~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~ 232 (289)
T 4fvq_A 159 FIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232 (289)
T ss_dssp EEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred eeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence 99999999875432 123568999999999987 678999999999999999999554 444332211111000
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
. ...+. ...+.++.+++.+||+.||++|||+.+++++|+.+...
T Consensus 233 -------~--------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 233 -------D--------RHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp -------T--------TCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred -------c--------cCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0 01111 11235688999999999999999999999999988754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=361.78 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=204.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
.++|.+.++||+|+||.||+|....+ +..||+|.+.+.. ....+.+..|..++..+ +||||+++++++.+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGT-----DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTE-----EEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCC-----CCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 46899999999999999999987653 4589999987542 23446788999999988 899999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 94 ~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 94 D----RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp S----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEe
Confidence 5 459999999999999998643 3489999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||........ ..
T Consensus 165 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~-------- 231 (353)
T 2i0e_A 165 FGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQ-------- 231 (353)
T ss_dssp CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH--------
T ss_pred CCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---HH--------
Confidence 99998543222 123457899999999999999999999999999999999999999976543211 11
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
.+....+ .++..++.++.+++.+||..||.+||+ +.+|+++
T Consensus 232 -----~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 232 -----SIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----HHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----HHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111111 122345678999999999999999995 5777765
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=362.46 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=193.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 89 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTK-----ELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT--- 89 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTC-----CEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCC-----cEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC---
Confidence 358999999999999999999976543 3899999975432 3467889999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC--eEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--AKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 90 -~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 90 -HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp -EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred -EEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 459999999999999988543 3489999999999999999999998 9999999999999987765 9999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCc-hhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAAR-SDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......... .
T Consensus 164 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~--------- 229 (361)
T 3uc3_A 164 YSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--K--------- 229 (361)
T ss_dssp CC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--H---------
T ss_pred cccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--H---------
Confidence 99743221 12334679999999999988888665 899999999999999999997643321111 0
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..+............+++.+.+|+.+||+.||++|||+.+++++
T Consensus 230 -~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 230 -TIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -HHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -HHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0111111111111111345788999999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=348.31 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=197.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||.||+|....+ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR- 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS------CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-
T ss_pred ccchhhhhcccCCCEEEEEEEcCCC------CEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe-
Confidence 5789999999999999999987433 3799999865432 234678899999999999999999999987653
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++||||+++ +|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 75 ---~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 75 ---LVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp ---EEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred ---EEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 5999999975 8888886432 4589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh-Hhhh-hhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW-VKPY-LSD 319 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~-~~~ 319 (428)
+....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.. .... ...
T Consensus 147 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 147 ARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence 97653221 122345789999999998764 589999999999999999999999986543322111110 0000 000
Q ss_pred hhhhhh--hcCCcCC-------CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQ--IVDPRLE-------GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~--~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... ..++... ......+++++.+++.+||+.||++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 0000000 01112345788999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=365.18 Aligned_cols=270 Identities=20% Similarity=0.257 Sum_probs=204.3
Q ss_pred hcCCCCceeeccc--CceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEG--GFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
.++|++.++||+| +||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTG-----EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCC-----CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 3579999999999 99999999987543 3899999975432 2346678899999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..++||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 99 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 99 N----ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp T----EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred C----EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 6 459999999999999999765445699999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCce-----eeeeeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 240 FGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 240 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
||.+......+.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~ 249 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EK 249 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HH
Confidence 9998654222111 11223478999999999987 578999999999999999999999997654332211 10
Q ss_pred Hhhhhh---h-h----hh-------------hhhhc---------CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHH
Q 014245 313 VKPYLS---D-A----KQ-------------FRQIV---------DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 362 (428)
Q Consensus 313 ~~~~~~---~-~----~~-------------~~~~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 362 (428)
...... . . .. ..... ...........+++.+.+|+.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 000000 0 0 00 00000 00000112234567899999999999999999999
Q ss_pred HHHHH
Q 014245 363 EVLEM 367 (428)
Q Consensus 363 ell~~ 367 (428)
+++++
T Consensus 330 ell~h 334 (389)
T 3gni_B 330 TLLNH 334 (389)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=358.88 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=202.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
++|.+.+.||+|+||.||+|....+ +..||+|++.+... .....+.+|..++.++ +||||+++++++.+..
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKT-----DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hheEEEEEEEecCCeEEEEEEECCC-----CCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 5789999999999999999997654 34899999976532 2345678999999987 8999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 84 ----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 84 ----RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp ----EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCG
T ss_pred ----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEec
Confidence 459999999999999988643 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH--HHHHhHhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ--KLLQWVKPYLS 318 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~ 318 (428)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......... .....
T Consensus 155 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------ 226 (345)
T 3a8x_A 155 GMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY------ 226 (345)
T ss_dssp GGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH------
T ss_pred cccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH------
Confidence 9998543222 1234578999999999999999999999999999999999999999653211100 00000
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~ell~~ 367 (428)
....+....+ .++..++.++.+++.+||+.||++||++ .+++++
T Consensus 227 ---~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 227 ---LFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---HHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---HHHHHHcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0011111111 1223456789999999999999999995 677664
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=362.27 Aligned_cols=265 Identities=28% Similarity=0.451 Sum_probs=201.1
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.|.+.++||+|+||.||+|.+.... .....||+|.+..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--- 164 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG--- 164 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS---
T ss_pred eeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC---
Confidence 4667789999999999999875432 2355799999875432 345789999999999999999999999865432
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence 2489999999999999997543 4588999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCce--eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 245 LGPSEGFT--HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 245 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
........ .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.............
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~---------- 310 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---------- 310 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH----------
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH----------
Confidence 65332211 11234567889999999999999999999999999999999 778887654332211110
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
.. .....+..++..+.+++.+||+.||++||++.++++.|+.+.....
T Consensus 311 ------~~-~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 311 ------QG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ------TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------cC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 0011122345689999999999999999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=360.50 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=196.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCC--CCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEH--QNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~ 159 (428)
.++|.+.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|+.+|..++| +||+++++++.+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEK------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTT------SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCC------CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 3579999999999999999998643 23799999875433 334678899999999976 9999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..++|||+ .+++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++ ++.+||+|
T Consensus 82 ~----~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 82 Q----YIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp S----EEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred C----EEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence 5 45999995 588999999654 3589999999999999999999998 999999999999997 57899999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhcc-----------CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 308 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 308 (428)
||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--- 227 (343)
T 3dbq_A 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--- 227 (343)
T ss_dssp CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---
T ss_pred cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---
Confidence 999987654333333445689999999999865 678999999999999999999999997543221
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
..+...+++.....++...+.++.+++.+||+.||.+|||+.+++++-
T Consensus 228 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 228 ------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111222232222233333446789999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=346.62 Aligned_cols=267 Identities=24% Similarity=0.410 Sum_probs=213.0
Q ss_pred cCCCCce-eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.. .||+|+||.||+|.+.... .+..||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--- 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred HHhhhhhccccccCceeEEEeEeccCC---CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC---
Confidence 4566665 9999999999999865332 245799999976533 3456789999999999999999999999543
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 83 --ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp --SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred --CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccc
Confidence 249999999999999998643 34589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 243 ARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 243 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
+......... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~--------- 227 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE--------- 227 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---------
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh---------
Confidence 9876433221 12233467899999999998889999999999999999998 999997654432111110
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcCCC
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGS 380 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~~~ 380 (428)
. ......+..+++.+.+++.+||+.||++||++.+++++|..+.........
T Consensus 228 ----~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 228 ----Q----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp ----T----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred ----c----CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 0 011122334567899999999999999999999999999999887765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=363.63 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=197.2
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEE
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
..++||+|+||.||+|....++ ..||+|++........+.+.+|+.+|++++||||+++++++.+.. ..+|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~l 163 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATG-----LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN----DIVL 163 (373)
T ss_dssp EEEECC-----CEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEEE
T ss_pred cceEEecCcCEEEEEEEEcCCC-----cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEEE
Confidence 3568999999999999876543 389999998776666678999999999999999999999998765 4599
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE--CCCCCeEEeeecccccC
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL--DEQWNAKLSDFGLARLG 246 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl--~~~~~~kl~DFGla~~~ 246 (428)
||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 164 v~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999888643 24589999999999999999999998 99999999999999 66788999999999876
Q ss_pred CCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 247 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.......... .....
T Consensus 240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~i~~~----------- 303 (373)
T 2x4f_A 240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN--NILAC----------- 303 (373)
T ss_dssp CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHHT-----------
T ss_pred CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhc-----------
Confidence 43321 234579999999999998899999999999999999999999998654322111 10000
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+.......+++++.+|+.+||+.||.+||++.+++++
T Consensus 304 -~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 304 -RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -CCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001111122345789999999999999999999999984
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=348.48 Aligned_cols=266 Identities=28% Similarity=0.449 Sum_probs=206.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
..+|.+.++||+|+||.||+|...... .....+|+|.+..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG- 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS-
T ss_pred ceehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC-
Confidence 346888999999999999999876432 2345689999876433 345678899999999999999999999765443
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 101 --~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 101 --SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp --CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred --ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccc
Confidence 248999999999999999653 34588999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc--eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 243 ARLGPSEGF--THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 243 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
+........ ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.............
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-------- 246 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------- 246 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH--------
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh--------
Confidence 986543221 112334568899999999999999999999999999999999 666665543322111100
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
. ......+..++..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 247 --------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 247 --------Q-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp --------T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred --------c-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 0011112224568999999999999999999999999999988654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=346.29 Aligned_cols=266 Identities=27% Similarity=0.404 Sum_probs=209.6
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
.|...++||+|+||.||+|.+.... .....+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL-- 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC--
T ss_pred EEccCceeccCCCceEEEEEEecCC--CceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC--
Confidence 4566789999999999999876533 2355799999876433 3456788999999999999999999999765532
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 98 -~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 98 -PHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp -CEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred -cEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 38999999999999999753 34589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCc--eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCC-CCCCCchhhHHHHHhHhhhhhhhh
Q 014245 245 LGPSEGF--THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 245 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
....... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |.............
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~---------- 242 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA---------- 242 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----------
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----------
Confidence 5433221 1122345688999999999999999999999999999999995555 44333222111110
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
.......+..++..+.+++.+||+.||.+|||+.++++.|+++......
T Consensus 243 -------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 243 -------QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -------cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0111112223456899999999999999999999999999999877543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=357.36 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=189.8
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
..++|.+.+.||+|+||.||+|....++ ..||+|.+.... ..+.+.+|+.++..++||||+++++++.+..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQ-----KPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-- 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS--
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCC-----cEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC--
Confidence 3468999999999999999999977543 379999987543 3456789999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC---CCCeEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~D 239 (428)
..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|
T Consensus 122 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 122 --EISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp --EEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred --eEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence 459999999999999998654 3489999999999999999999998 9999999999999975 88999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...
T Consensus 195 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~-------- 261 (349)
T 2w4o_A 195 FGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR-------- 261 (349)
T ss_dssp CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH--------
T ss_pred CccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH--------
Confidence 9999865332 123346799999999999999999999999999999999999999976543211 111
Q ss_pred hhhhhhhcCCc--CCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPR--LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~--l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.... ........++.++.+|+.+||+.||++|||+.+++++
T Consensus 262 -----~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 262 -----RILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----HHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----HHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111110 1111223455789999999999999999999999885
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=353.73 Aligned_cols=268 Identities=25% Similarity=0.386 Sum_probs=189.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+.||+|+||.||+|....+ +..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTT-----GVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-- 76 (317)
T ss_dssp ---------------CEEEEEECSSS-----CCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT--
T ss_pred ccceeEeeEECCCCCEEEEEEEECCC-----CcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC--
Confidence 46799999999999999999986544 34899999875433 23467889999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCC----CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPK----SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
..++||||++ |+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 77 --~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 77 --KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp --EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred --eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence 4599999997 5898887532 123589999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh--
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-- 315 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-- 315 (428)
|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 151 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 151 DFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999998654321 11234578999999999876 4689999999999999999999999987654332222111000
Q ss_pred ---hhhhhhhhhhhcCCcCC----C--------CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 ---YLSDAKQFRQIVDPRLE----G--------KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ---~~~~~~~~~~~~~~~l~----~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+........ ..+.+. . .....++.++.+++.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 229 NESLWPSVTKLPK-YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTTCGGGGGCTT-CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChhHhhhhhhhhh-cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000 000000 0 0011244689999999999999999999999885
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=363.86 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=194.4
Q ss_pred hcCCCCc-eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHh-cCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+. ++||+|+||+||+|....++ ..||||++.. ...+.+|+.++. ..+||||+++++++.....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~-----~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccceeccceeeeccCeEEEEEEECCCC-----CEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 3567766 68999999999999976554 3899999853 245678888874 4589999999999875322
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC---CCCeEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~ 238 (428)
....+||||||++||+|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+|||++. ++.+||+
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence 223569999999999999999876556699999999999999999999998 9999999999999987 7889999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH-HHHHhHhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQWVKPYL 317 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~ 317 (428)
|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||......... .....+.
T Consensus 207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--- 280 (400)
T 1nxk_A 207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--- 280 (400)
T ss_dssp CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---
T ss_pred ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---
Confidence 999998654321 234568999999999999999999999999999999999999999765432110 0000000
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
. -...........++.++.+|+.+||+.||++|||+.+++++-
T Consensus 281 -------~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 281 -------M-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp -------H-TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -------c-CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 000011111123557899999999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=345.04 Aligned_cols=257 Identities=26% Similarity=0.456 Sum_probs=208.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||.||+|...++ ..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-- 78 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI-- 78 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC--
T ss_pred hheeeeeEecCCCceeEEEEEecCC------CeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe--
Confidence 5788999999999999999987643 3799999976543 346789999999999999999999999876643
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 79 --~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 79 --CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp --EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred --EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccc
Confidence 9999999999999998643 24589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
...... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||......... ..+.
T Consensus 153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~i~--------- 219 (267)
T 3t9t_A 153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDIS--------- 219 (267)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHH---------
T ss_pred cccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH---HHHh---------
Confidence 653221 111223457889999999998999999999999999999999 89999765432111 1110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.. .....+...+..+.+++.+||+.||++||++.+++++|+.+.+.
T Consensus 220 -~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 220 -TG----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -TT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -cC----CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 01111223456899999999999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=373.50 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=195.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC---CcccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|++.++||+|+||.||+|....++ ..||+|.+... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATG-----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCC-----CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 467999999999999999999976543 38999998653 2223456789999999999999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.++|||||+++|+|.+++... ..+++..+..++.||+.||+|||+ + +|+||||||+||||+.++.+||+|
T Consensus 222 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 222 ----RLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp ----EEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred ----EEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence 359999999999999988643 458999999999999999999997 7 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+
T Consensus 293 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------- 361 (446)
T 4ejn_A 293 FGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------- 361 (446)
T ss_dssp CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------
T ss_pred CCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---------
Confidence 99997543322 2234578999999999999999999999999999999999999999765432211111
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.... ..++..+++++.+|+.+||+.||.+|| ++.+++++
T Consensus 362 -------~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 362 -------LMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -------HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------HhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1010 112223457899999999999999999 99999885
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=361.96 Aligned_cols=277 Identities=21% Similarity=0.254 Sum_probs=210.4
Q ss_pred CcccCHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-----C
Q 014245 72 LKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-----H 146 (428)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h 146 (428)
...|++.+.....++|.+.++||+|+||.||+|....++ ..||+|++... ......+..|+.+++.+. |
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h 95 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNK-----KYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINN 95 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCC-----eEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCC
Confidence 334455554555689999999999999999999976543 38999998643 233456778999999886 9
Q ss_pred CCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 147 ~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
|||+++++++...+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|
T Consensus 96 ~~iv~~~~~~~~~~----~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 167 (360)
T 3llt_A 96 NNIVKYHGKFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPEN 167 (360)
T ss_dssp GGBCCEEEEEEETT----EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred CCeecccceeeECC----eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCccc
Confidence 99999999998765 459999999 99999999766555699999999999999999999998 99999999999
Q ss_pred eEECC-------------------------CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhh
Q 014245 227 ILLDE-------------------------QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDV 281 (428)
Q Consensus 227 ILl~~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 281 (428)
||++. ++.+||+|||++...... .....||+.|+|||++.+..++.++||
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di 242 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDM 242 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccch
Confidence 99975 789999999999864432 234679999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh-------hhhhhcC-Cc----CCC----------------
Q 014245 282 WSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK-------QFRQIVD-PR----LEG---------------- 333 (428)
Q Consensus 282 wslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~----l~~---------------- 333 (428)
|||||++|+|++|+.||...........+........... .....++ .. ...
T Consensus 243 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 322 (360)
T 3llt_A 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322 (360)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence 9999999999999999987654433222221110000000 0000000 00 000
Q ss_pred CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 334 KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 334 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.....+.+.+|+.+||+.||++|||+.|++++
T Consensus 323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0001112678899999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=351.10 Aligned_cols=265 Identities=24% Similarity=0.397 Sum_probs=209.3
Q ss_pred hcCCCCce-eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+ .||+|+||.||+|.+... ..+..||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE- 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS---SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-
T ss_pred chhhhhccCccccccCeeeEeeeecCC---CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCC-
Confidence 35788887 999999999999976432 2356899999976532 2356789999999999999999999999432
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 91 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 91 ----SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp ----SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred ----CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence 248999999999999999654 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 241 GLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 241 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------- 234 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------- 234 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------
Confidence 999876443322 22233457789999999998889999999999999999999 999998654322111110
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcC
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEA 378 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~ 378 (428)
.......+..++..+.+++.+||+.||++||++.++++.|+.+.......
T Consensus 235 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 235 ----------KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp ----------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred ----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 00111222345678999999999999999999999999999998776543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=363.68 Aligned_cols=270 Identities=23% Similarity=0.355 Sum_probs=194.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCC-CCCcccEeeEEecC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADD 159 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~ 159 (428)
..++|.+.+.||+|+||.||+|....++ ..||+|++.... ......+.+|+.++..+. ||||+++++++...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTG-----EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTC-----CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCC-----CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 4578999999999999999999876554 389999986542 234567789999999997 99999999999865
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
+.. .+|+|||||+ |+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 82 ~~~--~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 152 (388)
T 3oz6_A 82 NDR--DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVAD 152 (388)
T ss_dssp TSS--CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred CCC--EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecC
Confidence 533 4599999996 589888864 3489999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCC-------------------ceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCC
Q 014245 240 FGLARLGPSEG-------------------FTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPID 299 (428)
Q Consensus 240 FGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~ 299 (428)
||+++...... ........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.
T Consensus 153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 99998643210 1112345689999999999886 678999999999999999999999998
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhh---------------c---CCcCCCCcc------------HHHHHHHHHHHHH
Q 014245 300 RNRPRSEQKLLQWVKPYLSDAKQFRQI---------------V---DPRLEGKYS------------LRLVSKLSHVANL 349 (428)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~---~~~l~~~~~------------~~~~~~l~~li~~ 349 (428)
+.........+...... .....+..+ . .......+. ...++++.+|+.+
T Consensus 233 ~~~~~~~~~~i~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 233 GSSTMNQLERIIGVIDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp CSSHHHHHHHHHHHHCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 76543332222110000 000000000 0 000000000 0234678999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 014245 350 CLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 350 cl~~dp~~RPs~~ell~~ 367 (428)
||+.||++|||+.|+++|
T Consensus 312 ~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKH 329 (388)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred hhccCcccCCCHHHHhCC
Confidence 999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=354.78 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=195.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----ccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----QGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
.++|.+.+.||+|+||.||+|..... ...+..||+|++.+... .....+.+|+.+|+.++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTG--ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSS--TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEecc--CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 35799999999999999999987421 12345899999976532 2345678999999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.. .++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 94 ~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 94 GK----LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp SC----EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECC
T ss_pred CE----EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEe
Confidence 64 59999999999999998643 3488999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .
T Consensus 165 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~-------- 231 (327)
T 3a62_A 165 FGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI---D-------- 231 (327)
T ss_dssp CSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H--------
T ss_pred CCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH---H--------
Confidence 99997543221 1233467999999999999999999999999999999999999999865432111 1
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.+..... ..+..++.++.+++.+||+.||++|| ++.+++++
T Consensus 232 -----~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 232 -----KILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----HHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----HHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1111111 12223457899999999999999999 78888875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.85 Aligned_cols=259 Identities=23% Similarity=0.287 Sum_probs=200.4
Q ss_pred HHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC-----CcccHHHHHHHHHHHhcCCCCCcccEeeE
Q 014245 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GVQGHKEWMTEVNFLGIVEHQNLVKLVGY 155 (428)
Q Consensus 81 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 155 (428)
....++|.+.+.||+|+||.||+|....++ ..||+|.+... .....+.+.+|+.+++.++||||++++++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTR-----AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCC-----ceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence 344568999999999999999999876543 38999998643 22345678999999999999999999999
Q ss_pred EecCCCCCceEEEEEeecCCCCcccccCCC--------------------------------------CcccccHHHHHH
Q 014245 156 CADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------------------------------SETILTWAMRLK 197 (428)
Q Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------~~~~l~~~~~~~ 197 (428)
+.+.. ..++||||+++|+|.+++... ....+++..++.
T Consensus 97 ~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 97 YEDEQ----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp EECSS----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred hccCC----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 98765 459999999999999988421 022357788899
Q ss_pred HHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC--CeEEeeecccccCCCCC--ceeeeeeeecCcccCCcchhcc-
Q 014245 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW--NAKLSDFGLARLGPSEG--FTHVSTAVVGTMGYAAPEYVQT- 272 (428)
Q Consensus 198 i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~- 272 (428)
++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++....... .........||+.|+|||++.+
T Consensus 173 i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 249 (345)
T 3hko_A 173 IMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249 (345)
T ss_dssp HHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred HHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence 999999999999998 999999999999998776 89999999997543211 1112345679999999999875
Q ss_pred -CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCc--CCCCccHHHHHHHHHHHHH
Q 014245 273 -GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPR--LEGKYSLRLVSKLSHVANL 349 (428)
Q Consensus 273 -~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~l~~li~~ 349 (428)
..++.++|||||||++|+|++|..||.......... .+.... ........+++.+.+++.+
T Consensus 250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS----------------QVLNKKLCFENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH----------------HHHhcccccCCcccccCCHHHHHHHHH
Confidence 678999999999999999999999997654322111 111111 1111112345789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 014245 350 CLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 350 cl~~dp~~RPs~~ell~~ 367 (428)
||+.||.+||++.+++++
T Consensus 314 ~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HSCSCTTTSCCHHHHHHS
T ss_pred HcCCChhHCCCHHHHhcC
Confidence 999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=343.40 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=204.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-- 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCC-----cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC--
Confidence 467999999999999999999876543 3899999865432 34567889999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 79 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 79 --IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp --EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred --EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCC
Confidence 459999999999999999653 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+................||+.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-------- 222 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-------- 222 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHH--------
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhh--------
Confidence 976543332233345679999999999987665 67999999999999999999999765432111 11111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...........++..+.+++.+||+.||++|||+.+++++
T Consensus 223 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 223 ------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0000011122345688999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=360.03 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=201.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQ-----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 468999999999999999999976554 389999986432 123457889999999999999999999998866
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+ +|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 83 ----~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 83 ----DIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp ----EEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred ----EEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence 359999999 78898888543 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 153 G~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------- 216 (336)
T 3h4j_B 153 GLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------------- 216 (336)
T ss_dssp SCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------
T ss_pred ccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------
Confidence 9998654322 2234679999999999988776 6899999999999999999999975432110
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+... ....+..+++.+.+++.+||+.||.+|||+.|++++
T Consensus 217 ---~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 217 ---FKKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ---BCCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ---HHHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0011110 111233356789999999999999999999999886
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=371.15 Aligned_cols=273 Identities=23% Similarity=0.295 Sum_probs=188.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC-
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD- 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~- 160 (428)
.++|.+.++||+|+||.||+|....++ ..||||++.... ....+.+.+|+.+|+.++||||+++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEK-----RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCC-----cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 368999999999999999999876543 389999986542 234567889999999999999999999996543
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.....+|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||++ +||||||||+||||+.++.+||+||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccc
Confidence 2223569999998 57898888643 4599999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCc-------------------------eeeeeeeecCcccCCcchh-ccCCCCCchhhhhHHHHHHHHHh-
Q 014245 241 GLARLGPSEGF-------------------------THVSTAVVGTMGYAAPEYV-QTGRLAARSDVWSYGVFLYELIT- 293 (428)
Q Consensus 241 Gla~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt- 293 (428)
|+++....... .......+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99986542211 0123456899999999976 45679999999999999999999
Q ss_pred ----------CCCCCCCCCchh-----------------hHHHHHhHhhhhhhh-------------hhhhhhcCCcCC-
Q 014245 294 ----------GRRPIDRNRPRS-----------------EQKLLQWVKPYLSDA-------------KQFRQIVDPRLE- 332 (428)
Q Consensus 294 ----------g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~-------------~~~~~~~~~~l~- 332 (428)
|.++|.+..... .......+...+... ......+.....
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 666665433110 000000000000000 000000000000
Q ss_pred --CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 333 --GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 333 --~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.......+.++.+|+.+||..||++|||++|++++
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00112336789999999999999999999999996
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=365.77 Aligned_cols=268 Identities=22% Similarity=0.272 Sum_probs=198.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC--CcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||||++... .....+++.+|+.+|+.++||||+++++++.....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVL-----DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTT-----TEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCC-----CCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 46899999999999999999987654 348999999754 22345678899999999999999999999976542
Q ss_pred --CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 --RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.....||||||+++ +|.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 136 ~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred cccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence 22356999999976 46555542 388999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-hh---
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-KP--- 315 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~--- 315 (428)
||+++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+... ..
T Consensus 208 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 208 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp CCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999865432 1234578999999999999999999999999999999999999999876543222111100 00
Q ss_pred -hhhh-hhhhhhhcCC--cCC----------------CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 -YLSD-AKQFRQIVDP--RLE----------------GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 -~~~~-~~~~~~~~~~--~l~----------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.. .......+.. ... .......++++.+|+.+||+.||++|||++|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000111110 000 01112236789999999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=369.19 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=205.8
Q ss_pred HHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEee
Q 014245 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVG 154 (428)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~ 154 (428)
.+.....++|++.++||+|+||.||+|....++ ..||+|++.+... .....+.+|..++..++||||+++++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~-----~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG-----QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 344445688999999999999999999986543 3899999865321 22345789999999999999999999
Q ss_pred EEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 155 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
++.+.. .+||||||++||+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.
T Consensus 129 ~~~~~~----~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 129 AFQDEN----YLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EEECSS----EEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred EEeeCC----EEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCC
Confidence 998866 4599999999999999996432 3589999999999999999999998 9999999999999999999
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhc-------cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~ 307 (428)
+||+|||+++....... ......+||+.|+|||++. +..|+.++|||||||++|||++|+.||.........
T Consensus 201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279 (412)
T ss_dssp EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred EEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999987644332 2233468999999999987 356899999999999999999999999865433221
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR---PKMSEVLEM 367 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~ell~~ 367 (428)
..+.... .....+ .....++.++.+||.+||. +|.+| |+++++++|
T Consensus 280 ~~i~~~~---------~~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVHYK---------EHLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTHH---------HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHhcc---------cCcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1111000 000001 1122355789999999999 99998 589999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=346.68 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=201.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|...+ ..||+|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 88 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-- 88 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC----
T ss_pred hhhceEEeEEecCCCceEEEEEEcC-------CEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC--
Confidence 3579999999999999999998642 379999987543 45678999999999999999999999765442
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 89 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 89 -GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred -ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence 249999999999999999754444588999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~----------- 225 (278)
T 1byg_A 165 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P----------- 225 (278)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---H-----------
T ss_pred cccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H-----------
Confidence 754322 223467899999999999999999999999999999998 99999765432211 1
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.+........+..+++.+.+++.+||+.||++||++.++++.|+.+...
T Consensus 226 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 226 ---RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 0111111122334567899999999999999999999999999988754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=348.32 Aligned_cols=271 Identities=26% Similarity=0.315 Sum_probs=203.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-----ccHHHHHHHHHHHhcC---CCCCcccEeeE
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-----QGHKEWMTEVNFLGIV---EHQNLVKLVGY 155 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~nIv~~~~~ 155 (428)
.++|++.+.||+|+||+||+|....+ +..||+|.+..... .....+.+|+.+++.+ +||||++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHS-----GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTT-----CCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCC-----CcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 57899999999999999999986544 34899999864321 1234667788777766 49999999999
Q ss_pred EecCCC-CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 156 CADDDE-RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 156 ~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
+..... .....++||||++ |+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 977543 2234689999996 5999999776655699999999999999999999998 9999999999999999999
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus 159 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 159 VKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp EEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999998654322 2345689999999999999999999999999999999999999998765433221111000
Q ss_pred hhhhhhhhhh-------hhcCCcCCC---CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDAKQFR-------QIVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~-------~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ...+. ....+.... .....+++.+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPP-EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCC-TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCC-hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000 00000 000000000 0111345788999999999999999999999885
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=355.82 Aligned_cols=272 Identities=17% Similarity=0.203 Sum_probs=200.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-----------cHHHHHHHHHHHhcCCCCCcccE
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-----------GHKEWMTEVNFLGIVEHQNLVKL 152 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~~ 152 (428)
.++|.+.+.||+|+||.||+|...... .....+|+|.+...... ....+.+|+.++..++||||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKP--EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSC--GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCC--CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 357999999999999999999986521 23457999998765321 12346788899999999999999
Q ss_pred eeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC
Q 014245 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 232 (428)
Q Consensus 153 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~ 232 (428)
++++..........++||||+ +++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 999987433334679999999 999999997543 699999999999999999999998 99999999999999888
Q ss_pred C--CeEEeeecccccCCCCCc-----eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh
Q 014245 233 W--NAKLSDFGLARLGPSEGF-----THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 305 (428)
Q Consensus 233 ~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 305 (428)
+ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999976532211 111134679999999999999999999999999999999999999996432221
Q ss_pred hHHHHHhHhhhhhh-hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 306 EQKLLQWVKPYLSD-AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 306 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
... .......... ...+..... ...++.++.+++.+||..||++||++.+|++.|+.+
T Consensus 268 ~~~-~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAV-QTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHH-HHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHH-HHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111 1100000000 000001000 002446899999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=354.43 Aligned_cols=266 Identities=24% Similarity=0.315 Sum_probs=205.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+........+.+.+|+.+++.++||||+++++++.......
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDG-----HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTC-----CEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCC-----cEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 367999999999999999999875543 389999987665556678899999999999999999999997544333
Q ss_pred ceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
...++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence 4679999999999999988642 235589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcee-------eeeeeecCcccCCcchhccCC---CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014245 242 LARLGPSEGFTH-------VSTAVVGTMGYAAPEYVQTGR---LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311 (428)
Q Consensus 242 la~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 311 (428)
++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||........
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----- 254 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD----- 254 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-----
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-----
Confidence 987543211000 012345799999999987554 68899999999999999999999953110000
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
.................++..+.+++.+||+.||.+||++.+++++|+.+.
T Consensus 255 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 255 ----------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ----------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ----------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000000001111112334578999999999999999999999999998865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=349.45 Aligned_cols=246 Identities=24% Similarity=0.271 Sum_probs=192.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
++|++.++||+|+||+||+|....++ ..||||++..... .....+..|+..+..+ +||||++++++|.+..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~- 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDG-----RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG- 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTS-----CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hheeeeheeccCCCeEEEEEEECCCC-----eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-
Confidence 57999999999999999999976543 3899999865432 2334455666666555 9999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 131 ---~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 131 ---ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp ---EEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred ---EEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 459999999 778988876432 4599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------------ 260 (311)
T 3p1a_A 203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------------ 260 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------------
T ss_pred eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------------
Confidence 997654322 2334679999999998875 799999999999999999999776643210
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+............+++++.+++.+||+.||++|||+.+++++
T Consensus 261 -~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 261 -WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 011111111111222345789999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=357.83 Aligned_cols=260 Identities=15% Similarity=0.166 Sum_probs=205.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC---CCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~ 160 (428)
.++|.+.++||+|+||.||+|.+....+...+..||+|++.... ..++..|+.++..++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 46799999999999999999975544444556689999997543 456777888877775 999999999998876
Q ss_pred CCCceEEEEEeecCCCCcccccCCC---CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC------
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE------ 231 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~------ 231 (428)
. .+|||||+++|+|.+++... ....+++..++.|+.||+.||+|||++ +||||||||+||||+.
T Consensus 141 ~----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 141 G----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp C----EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred C----cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 4 49999999999999999632 235699999999999999999999998 9999999999999998
Q ss_pred -----CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh
Q 014245 232 -----QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306 (428)
Q Consensus 232 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 306 (428)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 89999999999975432222334456789999999999999999999999999999999999999995432110
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhhh
Q 014245 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR-PKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~ell~~L~~~~~~~ 375 (428)
......+... ...+.+.+++..||+.+|.+| |+++++.+.|+.++...
T Consensus 293 ------------------~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ------------------CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ------------------EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------------eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0011111111 124578889999999999999 68888888898887654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=363.49 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=195.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCC--CCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVE--HQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~ 160 (428)
.+|.+.+.||+|+||.||+|.... +..||||.+..... .....+.+|+.+|..+. ||||+++++++....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 469999999999999999998654 23799999865432 34567899999999996 599999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.++|||| +.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++ ++.+||+||
T Consensus 130 ----~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 130 ----YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp ----EEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred ----EEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence 3599999 55889999986543 588889999999999999999998 999999999999996 579999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhcc-----------CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 309 (428)
|+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---- 274 (390)
T 2zmd_A 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---- 274 (390)
T ss_dssp SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----
T ss_pred CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----
Confidence 99986644332223345689999999999875 468899999999999999999999997543221
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+..++++.....++...+.++.+|+.+||+.||++||++.+++++
T Consensus 275 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 -----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11122222222222222235688999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=361.26 Aligned_cols=277 Identities=23% Similarity=0.303 Sum_probs=214.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.++||+|+||.||+|.+..++ ..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~- 82 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTG-----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR- 82 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC-
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCC-----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC-
Confidence 57999999999999999999977543 3899999975432 3456788999999999999999999999876533
Q ss_pred ceEEEEEeecCCCCcccccCCCCc-ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE----CCCCCeEEe
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLS 238 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~ 238 (428)
..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+
T Consensus 83 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 83 -HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp -CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred -eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEe
Confidence 45999999999999999975432 2389999999999999999999998 99999999999999 788889999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhcc--------CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh-hHHH
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT--------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRS-EQKL 309 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~ 309 (428)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... ....
T Consensus 159 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 159 DFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp CGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred cCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 999998654322 1234679999999999875 567889999999999999999999996533221 1111
Q ss_pred HHhHhhhhhh--hhhhhhhc--------CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 310 LQWVKPYLSD--AKQFRQIV--------DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 310 ~~~~~~~~~~--~~~~~~~~--------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.......... ........ +..........+...+.+++.+||+.||++||++.++++.+..++..
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111000000 00000000 01112234577889999999999999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=380.52 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=209.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|.+.++ ..||||.+.... ...+.|.+|+.+|++++||||+++++++.+. .
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~-- 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-P-- 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT------EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S--
T ss_pred hhhhhhheecccCCCeEEEEEEECCC------ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeec-c--
Confidence 35688889999999999999998653 269999997654 3457899999999999999999999998762 2
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.+|||||+++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 336 --~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 336 --IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp --CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred --ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 38999999999999999754445589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... .......++..|+|||++.++.++.++|||||||+||||++ |..||......... ..+.
T Consensus 411 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~---~~i~-------- 478 (535)
T 2h8h_A 411 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVE-------- 478 (535)
T ss_dssp TTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH---HHHH--------
T ss_pred eecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH--------
Confidence 86542211 11223456789999999999999999999999999999999 99999765432211 1110
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.......+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 479 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 479 ------RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0111112234567899999999999999999999999999987644
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=375.82 Aligned_cols=254 Identities=29% Similarity=0.438 Sum_probs=208.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.++||+|+||.||+|....++ ..||+|.+.+.. ......+.+|+.+|..++||||+++++++.+..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 467999999999999999999986543 389999986532 223456889999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.++|||||++||+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+||
T Consensus 258 ----~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ----ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp ----EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 459999999999999998766555699999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh-HHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~ 319 (428)
|+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........ ..+.....
T Consensus 331 Gla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----- 402 (576)
T 2acx_A 331 GLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----- 402 (576)
T ss_dssp TTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-----
T ss_pred ccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-----
Confidence 9998764332 22346899999999999998999999999999999999999999986543211 11111110
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
. ....++..++.++.+|+.+||+.||.+|| ++.+|++|
T Consensus 403 --------~--~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 403 --------E--VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --------H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --------c--ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 01122334567899999999999999999 78999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=347.48 Aligned_cols=268 Identities=22% Similarity=0.292 Sum_probs=199.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTG-----QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR- 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-
Confidence 368999999999999999999976543 38999998655332 2456789999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 76 ---~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 76 ---RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp ---EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ---eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 459999999999999887643 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-h---
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-Y--- 316 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~--- 316 (428)
++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+..... .
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
T 4agu_A 148 FARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence 998654322 12234679999999999876 5689999999999999999999999987654433322221100 0
Q ss_pred ----hhhhhhhhhhcCCcCCCCc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 ----LSDAKQFRQIVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ----~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............+...... ...++..+.+++.+||+.||++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000000000 01345678999999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=345.47 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=201.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCC-----cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 467999999999999999999876654 3799999864321 23457889999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 83 ----~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 83 ----RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp ----EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSC
T ss_pred ----EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEec
Confidence 459999999999999988643 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------- 220 (279)
T 3fdn_A 154 GWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 220 (279)
T ss_dssp CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---------
T ss_pred cccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH---------
Confidence 998654322 1234679999999999999999999999999999999999999998654322111110
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. .. ...+..++..+.+++.+||+.||++||++.+++++
T Consensus 221 ----~-~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 221 ----R-VE----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----H-TC----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----h-CC----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 01 11222345688999999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=344.28 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=201.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
..|.+.+.||+|+||.||+|....++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCc-----eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 34778889999999999999876543 479999986543 23456788999999999999999999998765444
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEEC-CCCCeEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLD-EQWNAKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~D 239 (428)
....++||||+++|+|.+++... ..+++..++.++.|++.||.|||++ + |+||||||+|||++ .++.+||+|
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred CceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence 44679999999999999999643 3489999999999999999999998 7 99999999999997 789999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||++....... .....||+.|+|||++. +.++.++||||||+++|+|++|..||......... ..
T Consensus 176 fg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~-------- 240 (290)
T 1t4h_A 176 LGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR-------- 240 (290)
T ss_dssp TTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH--------
T ss_pred CCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HH--------
Confidence 99997654332 23467999999999876 46999999999999999999999999764432211 11
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...............++++.+++.+||+.||.+|||+.+++++
T Consensus 241 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 241 -----RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111111111222234679999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=367.08 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=204.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|.+..++ ..||||.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTG-----HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTC-----CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 368999999999999999999976543 3899999865422 23457889999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 90 ----~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 90 ----DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp ----EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence 459999999999999999754 3599999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........
T Consensus 161 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----------- 226 (476)
T 2y94_A 161 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----------- 226 (476)
T ss_dssp SSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH-----------
T ss_pred cchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH-----------
Confidence 9998754332 2334689999999999988776 689999999999999999999998654322111
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.+... ..+..+++++.+|+.+||+.||++|||+.+++++
T Consensus 227 -----~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 227 -----KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -----HHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----HHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1111111 1122345689999999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=342.69 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=204.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|....+. ..+|+|.+........+.+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTR-----IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT--- 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCC-----cEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 467999999999999999999976654 379999987765566788999999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE---CCCCCeEEeee
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDF 240 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DF 240 (428)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 80 -~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 80 -DIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp -EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred -eEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 459999999999999888643 3489999999999999999999998 99999999999999 88899999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+. ..
T Consensus 154 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~----- 222 (277)
T 3f3z_A 154 GLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR--EG----- 222 (277)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HC-----
T ss_pred ccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hC-----
Confidence 9998654332 2234679999999998865 48999999999999999999999997654322111100 00
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...........+++.+.+++.+||+.||++||++.+++++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 223 -------TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp -------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -------CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000001245789999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=346.16 Aligned_cols=269 Identities=25% Similarity=0.374 Sum_probs=204.1
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC--CCCCcccEeeEEecC
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV--EHQNLVKLVGYCADD 159 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~~~~~~~~~ 159 (428)
...++|.+.+.||+|+||.||+|.+.+ ..||+|++... ....+..|.+++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWRG-------EKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEETT-------EEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccceEEEeEeecCCCeEEEEEEECC-------ceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 345689999999999999999998752 37999998543 234455666666554 999999999999877
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeccCCCCceEECCCCC
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM-----DFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivHrDlkp~NILl~~~~~ 234 (428)
.......++||||+++|+|.+++... .+++..++.++.|++.||.|||++. ..+|+||||||+|||++.++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 54334679999999999999999643 4899999999999999999999741 238999999999999999999
Q ss_pred eEEeeecccccCCCCCcee--eeeeeecCcccCCcchhccCCCCCc------hhhhhHHHHHHHHHhC----------CC
Q 014245 235 AKLSDFGLARLGPSEGFTH--VSTAVVGTMGYAAPEYVQTGRLAAR------SDVWSYGVFLYELITG----------RR 296 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg----------~~ 296 (428)
+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|||++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997654322111 1224579999999999988776665 9999999999999999 66
Q ss_pred CCCCCCchhhHHHHHhHhhhhhhhhhhhh-hcCCcCCCCc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 297 PIDRNRPRSEQKLLQWVKPYLSDAKQFRQ-IVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 297 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
||.......... ..... .....+.... ...+++++.+++.+||+.||++|||+.+|+++|+.
T Consensus 261 p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 261 PYHDLVPSDPSY------------EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTTTTSCSSCCH------------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cHhhhcCCCCch------------hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 665432211100 00001 1111111111 23678899999999999999999999999999999
Q ss_pred hhhhh
Q 014245 371 IVDAS 375 (428)
Q Consensus 371 ~~~~~ 375 (428)
+.+..
T Consensus 329 l~~~~ 333 (337)
T 3mdy_A 329 MSESQ 333 (337)
T ss_dssp HHHTT
T ss_pred HHhhc
Confidence 88654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=352.64 Aligned_cols=261 Identities=28% Similarity=0.473 Sum_probs=206.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||.||+|....++ ....+|+|.+.... ....+.+.+|+.++.++ +||||+++++++.+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT---EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHccceeeeecCCCceEEEEEEccCC---cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC--
Confidence 57999999999999999999876543 12245899886532 23456788999999999 9999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 228 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NIL 228 (428)
..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl 174 (327)
T 1fvr_A 100 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 174 (327)
T ss_dssp --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred --ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEE
Confidence 4599999999999999997543 23589999999999999999999998 9999999999999
Q ss_pred ECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhH
Q 014245 229 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQ 307 (428)
Q Consensus 229 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~ 307 (428)
++.++.+||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 175 ~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-- 249 (327)
T 1fvr_A 175 VGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-- 249 (327)
T ss_dssp ECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred EcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--
Confidence 99999999999999974321 112233467889999999998889999999999999999998 999997654321
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
+... +........+..+++.+.+++.+||+.||++||++.+++++|..+....
T Consensus 250 -~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 250 -LYEK--------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -HHHH--------------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -HHHH--------------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1110 0011111222345578999999999999999999999999999988754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=347.58 Aligned_cols=266 Identities=23% Similarity=0.372 Sum_probs=199.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDG-----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTC-----CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCC-----ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 357999999999999999999876443 389999987532 234567889999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+
T Consensus 106 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 106 ----ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLG 178 (310)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred ----cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEE
Confidence 459999999999999988632 234589999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .+...
T Consensus 179 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~------ 249 (310)
T 2wqm_A 179 DLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKK------ 249 (310)
T ss_dssp CC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHH------
T ss_pred eccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHH------
Confidence 999997654322 122345799999999999999999999999999999999999999975432211 11110
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
+............++.++.+++.+||+.||++||++.++++.|+++......
T Consensus 250 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 250 -------IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -------HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -------hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 1111111111223457899999999999999999999999999999876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=349.54 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=204.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc------cHHHHHHHHHHHhcCCCCCcccEeeEEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ------GHKEWMTEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTG-----LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCC-----eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 357999999999999999999976543 38999998754322 3567899999999999999999999998
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC----
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---- 233 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---- 233 (428)
+.. ..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 86 ~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 86 NRT----DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp CSS----EEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred cCC----EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence 765 459999999999999999653 3589999999999999999999998 999999999999999888
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (428)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 157 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-- 231 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-- 231 (321)
T ss_dssp CEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--
T ss_pred CEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--
Confidence 79999999998654322 1234579999999999999999999999999999999999999997654322111100
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. . ............+..+.+++.+||+.||++|||+.+++++
T Consensus 232 -~----------~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 232 -S----------V-SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -T----------T-CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -h----------c-ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 0000001112244679999999999999999999999885
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=360.95 Aligned_cols=245 Identities=29% Similarity=0.389 Sum_probs=191.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHH-HhcCCCCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNF-LGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~ 160 (428)
++|.+.++||+|+||.||+|....++ ..||+|++.+... .....+..|..+ ++.++||||+++++++.+..
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEE-----VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTC-----CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 57999999999999999999977654 3899999976533 223456677776 57789999999999998866
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 113 ----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 113 ----KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeC
Confidence 459999999999999988643 3588999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 184 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------------- 248 (373)
T 2r5t_A 184 GLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------------- 248 (373)
T ss_dssp CBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-------------
T ss_pred ccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-------------
Confidence 9998532221 1234578999999999999999999999999999999999999999765432111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 363 (428)
..++...+ .++..++..+.+|+.+||+.||.+||++.+
T Consensus 249 ---~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 249 ---DNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---HHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---HHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11111111 122235578999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=351.96 Aligned_cols=280 Identities=24% Similarity=0.380 Sum_probs=214.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|.+.+.||+|+||.||+|.+... +...+..||+|.+........+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPL-QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR-- 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTT-SSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHceeeeeeccCCCeEEEEEEeccc-cCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC--
Confidence 5688999999999999999986432 2234568999999876656667899999999999999999999998765432
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 3489999999999999997543 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh---hh
Q 014245 245 LGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS---DA 320 (428)
Q Consensus 245 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~ 320 (428)
........ .......++..|+|||++.+..++.++||||||+++|+|++|..||...... .......... ..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIV 269 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhH
Confidence 76543322 1223356788899999999888999999999999999999999998642110 0000000000 00
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
..+.+.+........+..++.++.+++.+||+.||++||++.+|++.|+.+.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0111111111111223345678999999999999999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=355.30 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=201.4
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
..++|.+.+.||+|+||.||+|....+ +..||+|.+.+... ...+|+.++.++ +||||+++++++.+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~- 89 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKAT-----NMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGK- 89 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSS-
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCC-----CCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCC-
Confidence 346799999999999999999997654 34899999976543 234688888887 8999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC-C---CeEE
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-W---NAKL 237 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~---~~kl 237 (428)
..|+||||++||+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+..+ + .+||
T Consensus 90 ---~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 90 ---YVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp ---EEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred ---EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence 459999999999999988654 3589999999999999999999998 99999999999998433 3 4999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........+...+..
T Consensus 162 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~-- 237 (342)
T 2qr7_A 162 CDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS-- 237 (342)
T ss_dssp CCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH--
T ss_pred EECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc--
Confidence 99999986543321 23346899999999999888899999999999999999999999986433322222221110
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
-...+.......+++++.+|+.+||..||++||++.+++++
T Consensus 238 ---------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 238 ---------GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---------CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---------CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00111122223456789999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=346.27 Aligned_cols=270 Identities=26% Similarity=0.397 Sum_probs=209.5
Q ss_pred HHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhc--CCCCCcccEeeEEec
Q 014245 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI--VEHQNLVKLVGYCAD 158 (428)
Q Consensus 81 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~ 158 (428)
....++|.+.+.||+|+||.||+|... +..||+|.+... ....+.+|++++.. ++||||+++++++..
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-------CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 444578999999999999999999864 247999998643 34567788888877 799999999999988
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhh--------cCCCCCeeeccCCCCceEEC
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH--------EGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivHrDlkp~NILl~ 230 (428)
........++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 764434569999999999999999643 4899999999999999999999 66 999999999999999
Q ss_pred CCCCeEEeeecccccCCCCCcee--eeeeeecCcccCCcchhccCC------CCCchhhhhHHHHHHHHHhC--------
Q 014245 231 EQWNAKLSDFGLARLGPSEGFTH--VSTAVVGTMGYAAPEYVQTGR------LAARSDVWSYGVFLYELITG-------- 294 (428)
Q Consensus 231 ~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg-------- 294 (428)
.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999997654332211 223457999999999988653 33689999999999999999
Q ss_pred --CCCCCCCCchhh--HHHHHhHhhhhhhhhhhhhhcCCcCCCC-ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 295 --RRPIDRNRPRSE--QKLLQWVKPYLSDAKQFRQIVDPRLEGK-YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 295 --~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
..||........ ..+...+ ......+.+... ........+.+|+.+||+.||++|||+.+|+++|+
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVV---------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHH---------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHHHHHH---------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 778865432211 1111000 001111111111 12367788999999999999999999999999999
Q ss_pred Hhhhhh
Q 014245 370 KIVDAS 375 (428)
Q Consensus 370 ~~~~~~ 375 (428)
.+.+..
T Consensus 333 ~i~~~~ 338 (342)
T 1b6c_B 333 QLSQQE 338 (342)
T ss_dssp HHHHTT
T ss_pred HHHHHh
Confidence 987653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=354.19 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=179.0
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCCceEEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
.+.||+|+||.||+|....++ ..||+|.+... ....+.+|+.++..+. ||||+++++++.+.. ..++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~----~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSN-----QAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL----HTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTC-----CEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EEEE
T ss_pred CCccccCCCeEEEEEEECCCC-----CEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC----EEEE
Confidence 478999999999999976543 38999998643 3457789999999996 999999999998765 4599
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC---CeEEeeeccccc
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---NAKLSDFGLARL 245 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 245 (428)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999999999654 4599999999999999999999998 999999999999997765 799999999986
Q ss_pred CCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014245 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325 (428)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (428)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ........
T Consensus 159 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---------~~~~~~~~ 227 (325)
T 3kn6_A 159 KPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT---------SAVEIMKK 227 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC---------CHHHHHHH
T ss_pred cCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc---------cHHHHHHH
Confidence 54332 22345678999999999999999999999999999999999999997643211000 00011111
Q ss_pred hcCCcC--CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 326 IVDPRL--EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 326 ~~~~~l--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..... .......+++++.+|+.+||+.||++|||+.+++++
T Consensus 228 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 228 IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 111111 111123456789999999999999999999998864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=344.24 Aligned_cols=269 Identities=19% Similarity=0.272 Sum_probs=206.4
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
..++|.+.+.||+|+||.||+|....+ +..||+|.+..... ...+.+|+.++..++|++++..++++.....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~- 78 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAA-----GEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD- 78 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTT-----TEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT-
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCC-----CceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCC-
Confidence 346899999999999999999986544 34899998654432 2457899999999999988888877755433
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE---CCCCCeEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~D 239 (428)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|
T Consensus 79 --~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 79 --YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp --EEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred --ceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence 459999999 999999986332 3489999999999999999999998 99999999999999 7899999999
Q ss_pred ecccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 240 FGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 240 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 9999865433221 11235689999999999999999999999999999999999999998654332222111111
Q ss_pred h-hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 315 P-YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 315 ~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
. ..... . .. ....+++++.+++.+||+.||++||++.+|++.|+.+......
T Consensus 232 ~~~~~~~--~-~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 232 EKKMSTP--I-EV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHSC--H-HH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred cccccch--h-hh--------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0 00000 0 00 0012346899999999999999999999999999999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=361.24 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=192.7
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--------ccHHHHHHHHHHHhcCCCCCcccEe
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--------QGHKEWMTEVNFLGIVEHQNLVKLV 153 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~ 153 (428)
...++|.+.+.||+|+||.||+|....+. ..||+|.+..... .....+.+|+.+|++++||||++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 206 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTC-----KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCC-----cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 34578999999999999999999976654 3899999865321 1223578999999999999999999
Q ss_pred eEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC
Q 014245 154 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
+++... ..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 207 ~~~~~~-----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 207 NFFDAE-----DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp EEEESS-----EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred EEEecC-----ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 998643 248999999999999998654 3589999999999999999999998 999999999999996544
Q ss_pred ---CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc---CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH
Q 014245 234 ---NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307 (428)
Q Consensus 234 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~ 307 (428)
.+||+|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 277 ~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~ 353 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred CcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence 5999999999865432 22345689999999999853 56888999999999999999999999764322111
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCC--CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. .+...... ......+++.+.+++.+||+.||++||++.+++++
T Consensus 354 --~~-------------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 354 --KD-------------QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HH-------------HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HH-------------HHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000000 00111245789999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=349.99 Aligned_cols=284 Identities=25% Similarity=0.398 Sum_probs=201.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHH--HhcCCCCCcccEeeEEecCC-
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNF--LGIVEHQNLVKLVGYCADDD- 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~~~~~~~~~~- 160 (428)
.++|.+.+.||+|+||.||+|...+ ..||+|++.... ...+..|.++ +..++||||+++++++....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDE-------RPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETT-------EEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred hHHhheeeecccCCCeEEEEEEECC-------eEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 3589999999999999999997632 489999986432 3344455555 45589999999998664322
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCC------CCCeeeccCCCCceEECCCCC
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM------DFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivHrDlkp~NILl~~~~~ 234 (428)
.....+++||||+++|+|.+++.... +++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 22235689999999999999996433 588899999999999999999752 228999999999999999999
Q ss_pred eEEeeecccccCCCCCc------eeeeeeeecCcccCCcchhcc-------CCCCCchhhhhHHHHHHHHHhCCCCCCCC
Q 014245 235 AKLSDFGLARLGPSEGF------THVSTAVVGTMGYAAPEYVQT-------GRLAARSDVWSYGVFLYELITGRRPIDRN 301 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~p~~~~ 301 (428)
+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999986543211 112234579999999999986 35667899999999999999997776433
Q ss_pred Cchhh-HHHHHhHhhhhhhhhhhhhh-----cCCcCCCC--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 302 RPRSE-QKLLQWVKPYLSDAKQFRQI-----VDPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 302 ~~~~~-~~~~~~~~~~~~~~~~~~~~-----~~~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
..... .................... ..+.+... .....++++.+++.+||+.||++|||+.++++.|+.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 22111 00000000000000000010 11111111 123467789999999999999999999999999999998
Q ss_pred hhhcCCC
Q 014245 374 ASAEAGS 380 (428)
Q Consensus 374 ~~~~~~~ 380 (428)
.+.....
T Consensus 319 ~~~~~~~ 325 (336)
T 3g2f_A 319 IWERNKS 325 (336)
T ss_dssp CCCC---
T ss_pred HHHhccc
Confidence 8765543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=340.98 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=201.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC----cccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETL-----CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTC-----CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCC-----cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 468999999999999999999865443 489999986542 23456789999999999999999999998654
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
... ..++||||++++ |.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 79 ~~~--~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 79 EKQ--KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp -----CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CCC--eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence 432 459999999876 66666554456699999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCC--CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
||++................||+.|+|||++.+.. ++.++||||||+++|+|++|..||......... ..+.
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~i~--- 226 (305)
T 2wtk_C 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF---ENIG--- 226 (305)
T ss_dssp CTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHH---
T ss_pred cccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHHh---
Confidence 99998765433333344567999999999987644 377999999999999999999999865422111 1000
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ... .+..++..+.+++.+||+.||++||++.+++++
T Consensus 227 -------~~-~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 -------KG-SYA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------HC-CCC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------cC-CCC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 011 112345688999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=377.95 Aligned_cols=254 Identities=24% Similarity=0.415 Sum_probs=202.0
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
+.||+|+||.||+|.+... .....||||.+..... ...+++.+|+.+|.+++|||||++++++.... .+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-----WML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECS---SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-----EEE
T ss_pred CEeccCCCEEEEEEEEcCC---CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEE
Confidence 4799999999999976543 2346899999976432 23578999999999999999999999996532 489
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCC
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 248 (428)
||||+++|+|.+++... ..+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 447 v~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 99999999999999643 3589999999999999999999998 999999999999999999999999999986643
Q ss_pred CCc-eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 249 EGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 249 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...........+
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i---------------- 585 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------------- 585 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----------------
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------------
Confidence 321 122334567889999999999999999999999999999998 99999876443211111
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
........+..++.++.+||.+||+.||++||++.+|++.|+.+...
T Consensus 586 -~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 586 -EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11111122334567899999999999999999999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=347.99 Aligned_cols=268 Identities=25% Similarity=0.317 Sum_probs=196.9
Q ss_pred cCCCCc-eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
+.|.+. ++||+|+||.||+|....+ +..||||++..........+.+|+.++.++ +||||+++++++.+.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-- 84 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLIT-----SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED-- 84 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSS-----CCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred eeEEecCceecCCceEEEEEEEEcCC-----CcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--
Confidence 467774 7899999999999986543 348999999776655677899999999885 8999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC---eEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN---AKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~D 239 (428)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|
T Consensus 85 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 85 --RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp --EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred --EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEE
Confidence 459999999999999998643 3589999999999999999999998 9999999999999988776 99999
Q ss_pred ecccccCCCCCc-----eeeeeeeecCcccCCcchhcc-----CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014245 240 FGLARLGPSEGF-----THVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309 (428)
Q Consensus 240 FGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 309 (428)
||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 999875432211 111224569999999999875 5588999999999999999999999976543210000
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCC--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 310 LQWVKPYLSDAKQFRQIVDPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.....+. ........+........ ....++.++.+|+.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 238 RGEACPA-CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp ---CCHH-HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchh-HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000 00000011111111100 001245689999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=342.71 Aligned_cols=268 Identities=18% Similarity=0.265 Sum_probs=209.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+..... ...+.+|+.++..++|++++..++++.....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAA-----GEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD-- 78 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT-----TEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT--
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCC-----CcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCC--
Confidence 46899999999999999999986544 34899999865432 3568899999999999988887777655433
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE---CCCCCeEEeee
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDF 240 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DF 240 (428)
..++||||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 79 -~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 79 -YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp -EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred -ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 459999999 99999998633 23589999999999999999999998 99999999999999 48899999999
Q ss_pred cccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 241 GLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 241 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
|++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 999865433221 112456899999999999999999999999999999999999999986543322211111110
Q ss_pred -hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 316 -YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 316 -~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
..... . . .....+++++.+++.+||+.||++||++.+|++.|+.+......
T Consensus 233 ~~~~~~--~-~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 233 KKMSTP--I-E--------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHSC--H-H--------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cccCCc--h-H--------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00000 0 0 00112346899999999999999999999999999998876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.45 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=203.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES- 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCC-----ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-
Confidence 468999999999999999999876543 3799999865432 23467889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC---eEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN---AKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~ 238 (428)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++. +||+
T Consensus 79 ---~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 79 ---FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred ---EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 359999999999998887543 3489999999999999999999998 9999999999999976655 9999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. .
T Consensus 151 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~--- 221 (284)
T 3kk8_A 151 DFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK---A--- 221 (284)
T ss_dssp CCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H---
T ss_pred eceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH---h---
Confidence 999997654322 1234679999999999999999999999999999999999999997654322111110 0
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ...........+++++.+++.+||+.||++|||+.+++++
T Consensus 222 ------~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 222 ------G--AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ------T--CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------c--cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0001111112345689999999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=356.03 Aligned_cols=266 Identities=26% Similarity=0.365 Sum_probs=204.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 104 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSG-----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--- 104 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT---
T ss_pred ccceeeeeecCCCCeEEEEEEECCCC-----cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC---
Confidence 57999999999999999999977543 3899999876532 33567889999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||++
T Consensus 105 -~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 105 -EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp -EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred -EEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 459999999999999999643 3489999999999999999999973 17999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH----------
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV---------- 313 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~---------- 313 (428)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 180 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 180 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp HHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred cccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 643211 123467999999999999999999999999999999999999999865543322111000
Q ss_pred ----------------hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 ----------------KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ----------------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..........+............++.++.+|+.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000001111111111111122345689999999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=347.65 Aligned_cols=258 Identities=22% Similarity=0.349 Sum_probs=204.2
Q ss_pred HHHhcCCCCc-eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcC-CCCCcccEeeEE
Q 014245 81 KSATKNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIV-EHQNLVKLVGYC 156 (428)
Q Consensus 81 ~~~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 156 (428)
....++|.+. +.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.++..+ +||||+++++++
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTG-----QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3345567777 89999999999999976543 389999987543 23457889999999999 569999999999
Q ss_pred ecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC---CC
Q 014245 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QW 233 (428)
Q Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~ 233 (428)
.+.. ..++||||+++|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++. ++
T Consensus 99 ~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 99 ENTS----EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp ECSS----EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred EeCC----eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence 8765 459999999999999999765556799999999999999999999998 9999999999999987 78
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (428)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 172 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-- 246 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS-- 246 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--
T ss_pred cEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH--
Confidence 99999999998654322 1234679999999999999999999999999999999999999997654322111111
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ............++..+.+++.+||+.||++|||+.+++++
T Consensus 247 -----------~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 -----------Q-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----------H-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----------h-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 01111112223355789999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=355.00 Aligned_cols=275 Identities=16% Similarity=0.248 Sum_probs=208.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCC---cceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCccc----------
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPS---QKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK---------- 151 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~---------- 151 (428)
++|.+.+.||+|+||.||+|....+.... .+..||+|.+... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 58999999999999999999987531110 2447999998654 46789999999999999888
Q ss_pred -----EeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 152 -----LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 152 -----~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
+++++..... ..++||||+ +++|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+|
T Consensus 117 ~~i~~~~~~~~~~~~---~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 117 LAIPTCMGFGVHQDK---YRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp CSCCCCCEEEEETTT---EEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred cCccchhhccccCCc---EEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 5667765332 469999999 99999999765446699999999999999999999998 99999999999
Q ss_pred eEECCCC--CeEEeeecccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCC
Q 014245 227 ILLDEQW--NAKLSDFGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 299 (428)
Q Consensus 227 ILl~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~ 299 (428)
||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999765432111 11134579999999999999999999999999999999999999997
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhcC
Q 014245 300 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEA 378 (428)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~~ 378 (428)
........ +........... ....... .....++.++.+++.+||+.||++||++.+|++.|+.+.......
T Consensus 270 ~~~~~~~~-~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 270 NCLPNTED-IMKQKQKFVDKP---GPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GGTTCHHH-HHHHHHHHHHSC---CCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCcCHHH-HHHHHHhccCCh---hhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 65422211 111111100000 0000000 001123578999999999999999999999999999998776543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=352.03 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=201.1
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--------cHHHHHHHHHHHhcCCCCCcccEee
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--------GHKEWMTEVNFLGIVEHQNLVKLVG 154 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~ 154 (428)
..++|.+.+.||+|+||.||+|....+ +..||+|.+...... ....+.+|+.+++.++||||+++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 96 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEK-----NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD 96 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTT-----TEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEE
T ss_pred cccceEEEeEEEecCCEEEEEEEECCC-----CcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 456899999999999999999986654 348999998765321 2345678999999999999999999
Q ss_pred EEecCCCCCceEEEEEeecCCC-CcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC
Q 014245 155 YCADDDERGIQRLLVYEYMPNG-SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
++.+.. ..++||||+.+| +|.+++.... .+++..++.|+.||+.||.|||++ +|+||||||+|||++.++
T Consensus 97 ~~~~~~----~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 97 IFENQG----FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp EEECSS----EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred EEeeCC----EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence 998765 459999999766 9999886543 489999999999999999999998 999999999999999999
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 168 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------- 235 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------- 235 (335)
T ss_dssp CEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------
T ss_pred cEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------
Confidence 99999999998764432 1234679999999999988876 7899999999999999999999964211
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....... .+..++.++.+++.+||+.||++|||+.+++++
T Consensus 236 -------------~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -------------TVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------------GTTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------------HHhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111 111245689999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=346.35 Aligned_cols=263 Identities=20% Similarity=0.246 Sum_probs=198.9
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
..++|.+.+.||+|+||.||+|....+ +..||+|.+...... ..+.+.+|+.++..++||||+++++++...
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVR-----ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTT-----TEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCC-----CeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 357899999999999999999987644 348999998754322 246788999999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 107 ~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 107 G----QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp T----EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred C----eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEec
Confidence 5 459999999999999998643 3589999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... +......
T Consensus 178 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~---- 249 (309)
T 2h34_A 178 FGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGAHINQ---- 249 (309)
T ss_dssp CCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHHHHHS----
T ss_pred CccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHHHhcc----
Confidence 999976543221 12234679999999999999999999999999999999999999997643221 1110000
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhhh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-KMSEVLEMVNKIVDAS 375 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ell~~L~~~~~~~ 375 (428)
. . .........++.++.+++.+||+.||++|| +++++++.|+..+...
T Consensus 250 ~------~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 250 A------I--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp C------C--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred C------C--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0 0 000112223456899999999999999999 9999999999876544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=350.25 Aligned_cols=263 Identities=25% Similarity=0.317 Sum_probs=190.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCC--
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDD-- 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~-- 160 (428)
..+|.+.++||+|+||.||+|.+..++ ..||+|.+..........+.+|+.++.++. ||||+++++++....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSG-----REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCC-----cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 357999999999999999999976543 389999987666556678899999999995 999999999995321
Q ss_pred --CCCceEEEEEeecCCCCcccccCCC-CcccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEECCCCCe
Q 014245 161 --ERGIQRLLVYEYMPNGSVDQYLSPK-SETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLDEQWNA 235 (428)
Q Consensus 161 --~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~~~~~~ 235 (428)
......++||||++ |+|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 22335699999995 6888887531 234599999999999999999999998 7 9999999999999999999
Q ss_pred EEeeecccccCCCCCcee----------eeeeeecCcccCCcchh---ccCCCCCchhhhhHHHHHHHHHhCCCCCCCCC
Q 014245 236 KLSDFGLARLGPSEGFTH----------VSTAVVGTMGYAAPEYV---QTGRLAARSDVWSYGVFLYELITGRRPIDRNR 302 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~ 302 (428)
||+|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998654322111 11245699999999998 56678899999999999999999999996532
Q ss_pred chhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 303 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
... +.............+..+.+++.+||+.||.+||++.+++++|..+....
T Consensus 258 ~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 258 KLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 210 00000111111122346889999999999999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=368.88 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=205.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.++||+|+||.||+|....++ ..||+|++.+... .....+.+|+.+|..++||||+++++++.+..
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~- 258 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATG-----KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT- 258 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-
Confidence 67889999999999999999976543 3899999965422 23467889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCC--cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+||||+.+|.+||+|
T Consensus 259 ---~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~D 332 (543)
T 3c4z_A 259 ---DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISD 332 (543)
T ss_dssp ---EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred ---EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEee
Confidence 4599999999999999886543 34699999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh-HHHHHhHhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~ 318 (428)
||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||........ ..+..
T Consensus 333 FGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~------- 403 (543)
T 3c4z_A 333 LGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------- 403 (543)
T ss_dssp CTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH-------
T ss_pred cceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH-------
Confidence 99998654332 123346899999999999999999999999999999999999999976532211 11111
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~ell~~ 367 (428)
.+.... ..++..++..+.+++.+||+.||++||++ ++|+++
T Consensus 404 ------~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 404 ------RVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ------HHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ------HHhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 111111 11233456789999999999999999965 667654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=353.98 Aligned_cols=248 Identities=31% Similarity=0.421 Sum_probs=198.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
+.|...+.||+|+||.||+|....+ +..||||.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRN-----SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hheeeeeEEccCCCEEEEEEEEccC-----CeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 4588999999999999999986543 34899999875432 23356889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||++ |+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 128 ---~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 128 ---TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp ---EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ---eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 4599999997 5777777432 24589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
++...... ....||+.|+|||++. ++.++.++|||||||++|||++|..||......... ...
T Consensus 200 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~------ 265 (348)
T 1u5q_A 200 SASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHI------ 265 (348)
T ss_dssp TCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHH------
T ss_pred CceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH------
Confidence 99765422 2467999999999985 567899999999999999999999999765432111 000
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.....+. .....+++.+.+++.+||+.||++|||+.+++++.
T Consensus 266 -----~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 266 -----AQNESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -----HHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -----HhcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0000111 11223456789999999999999999999998864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=341.63 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=196.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|....++ ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSG-----LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH--- 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---
T ss_pred hheeecceeccCCCeEEEEEEEccCC-----ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC---
Confidence 47999999999999999999876543 3799999876532 34578899999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE---CCCCCeEEe
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLS 238 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~ 238 (428)
..++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+
T Consensus 94 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 94 -NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp -EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred -eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEE
Confidence 459999999999999988532 124589999999999999999999998 99999999999999 556789999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||++....... ......||+.|+|||++. +.++.++||||||+++|+|++|..||..............
T Consensus 170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------ 239 (285)
T 3is5_A 170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------ 239 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------
Confidence 999997644321 234567999999999876 5789999999999999999999999986543322111110
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... .....+++.+.+++.+||+.||++|||+.|++++
T Consensus 240 --------~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 240 --------KEPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --------CCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --------CCcccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0001134678899999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=339.31 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=205.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCC---
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD--- 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--- 160 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+.... ..+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDG-----KTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTC-----CEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred ccccceeeeeccCCceEEEEEEEcCCC-----eEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 457999999999999999999976443 389999987543 35678999999999999999999886411
Q ss_pred ---------CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 161 ---------ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 161 ---------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
......++||||+++|+|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 1122469999999999999999765455699999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 311 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~ 311 (428)
++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+... ...
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~-- 227 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKF-- 227 (284)
T ss_dssp TTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHH--
T ss_pred CCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHH--
Confidence 9999999999998654432 123457999999999999999999999999999999999999887421 100
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
........+. ..++..+.+++.+||+.||.+||++.+++++|..+...
T Consensus 228 -----------~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 228 -----------FTDLRDGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -----------HHHHHTTCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -----------HHHhhccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0111111122 22346788999999999999999999999999887644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=342.85 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=200.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||.||+|.+.... .....||+|.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 57999999999999999999875432 234468999987542 234567889999999999999999999998754
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 95 ----~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 95 ----MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp ----CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ----ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence 38999999999999998643 24589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 242 LARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 242 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~-------- 235 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---H-------- 235 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H--------
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---H--------
Confidence 99876543322 22334568889999999998889999999999999999999 99999765432111 1
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
.+............++..+.+++.+||+.||++||++.+++++|.++..
T Consensus 236 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 236 -----KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -----HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -----HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111111111223456789999999999999999999999999988754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=345.87 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=203.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCC-----cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC
Confidence 468999999999999999999876543 3899999875432 334678899999999999999999998865433
Q ss_pred CCceEEEEEeecCCCCcccccCCCC--cccccHHHHHHHHHHHHHHHHHhhcCCCCC-----eeeccCCCCceEECCCCC
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQ-----IIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivHrDlkp~NILl~~~~~ 234 (428)
. ..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ + |+||||||+|||++.++.
T Consensus 80 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~ 154 (279)
T 2w5a_A 80 T--TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQN 154 (279)
T ss_dssp T--EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSC
T ss_pred c--eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCC
Confidence 2 5699999999999999986432 23489999999999999999999998 7 999999999999999999
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...+.
T Consensus 155 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i~ 229 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGKIR 229 (279)
T ss_dssp EEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HHHHh
Confidence 99999999986543221 12345789999999999998999999999999999999999999986543211 11110
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 369 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 369 (428)
....+ ..+..++.++.+++.+||+.||++||++.+|++++.
T Consensus 230 ----------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 230 ----------EGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ----------HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ----------hcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 00011 122235578999999999999999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.69 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=203.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||.||+|....+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 87 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK- 87 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hhceeeheecCCCCeEEEEEEEcCC-----CcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-
Confidence 5799999999999999999987654 3489999986432 123467889999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 88 ---~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 88 ---RIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp ---EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred ---EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccc
Confidence 459999999999999998643 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------------- 222 (284)
T 2vgo_A 160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------------- 222 (284)
T ss_dssp TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------
T ss_pred ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH-------------
Confidence 987654321 234679999999999999999999999999999999999999997654321111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.... ..++..++..+.+++.+||+.||.+||++.+++++
T Consensus 223 ---~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 223 ---RIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ---HHHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ---HHhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111111 11223345788999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=350.34 Aligned_cols=266 Identities=27% Similarity=0.411 Sum_probs=201.9
Q ss_pred cCHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEe
Q 014245 75 FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLV 153 (428)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~ 153 (428)
+++.++....++|.+.+.||+|+||.||+|....++ ..||+|.+.... .....+.+|+.++..+ +||||++++
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCC-----CeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeee
Confidence 333444445688999999999999999999976543 389999986543 3456788999999999 899999999
Q ss_pred eEEecCCCC--CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC
Q 014245 154 GYCADDDER--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 154 ~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~ 231 (428)
+++...... ....++||||+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~ 164 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTE 164 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECT
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcC
Confidence 999764311 23569999999999999999765556689999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 306 (428)
++.+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 242 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242 (326)
T ss_dssp TCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence 9999999999987653221 1223467999999999987 56789999999999999999999999976543221
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... .....+. .....++..+.+++.+||..||.+||++.+++++
T Consensus 243 ~~~~-------------~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 LFLI-------------PRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHH-------------HHSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHh-------------hcCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1100 0000111 1112245689999999999999999999999885
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=348.37 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=195.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-HHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+....... ...+.+|+.+++.++||||+++++++.+...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTD-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-- 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC--
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCC-----cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE--
Confidence 57899999999999999999976543 389999986543221 2245579999999999999999999987664
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||++ |+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 75 --~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 75 --LTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp --EEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred --EEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 499999997 58888876443 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh------
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY------ 316 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------ 316 (428)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (324)
T 3mtl_A 148 RAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225 (324)
T ss_dssp ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc
Confidence 7543221 22334578999999999876 56899999999999999999999999876543322222111000
Q ss_pred --hhhhhhhhhhcCCcCCCC----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 --LSDAKQFRQIVDPRLEGK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 --~~~~~~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
......+.....+..... ....++.++.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000011100110000 011245688999999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=350.05 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=192.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||+||+|....+ +..||+|.+...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVT-----NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH- 106 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTT-----TEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCC-----CceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-
Confidence 46899999999999999999986654 348999999755332 2456789999999999999999999998766
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE-----CCCCCeE
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL-----DEQWNAK 236 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl-----~~~~~~k 236 (428)
..++||||++ |+|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+|
T Consensus 107 ---~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 107 ---RLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp ---EEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEE
T ss_pred ---EEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEE
Confidence 4599999997 59999886543 489999999999999999999998 99999999999999 4555699
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
|+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.....
T Consensus 178 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 178 IGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence 99999997654221 123345789999999999874 489999999999999999999999987543322211110000
Q ss_pred hhhhhhhhhhh--------cCCcCCCC-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQI--------VDPRLEGK-----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~--------~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. .....+... ..+..... ....++.++.+|+.+||+.||++|||+.|++++
T Consensus 256 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 256 L-PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp C-CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 000000000 00000000 011145788999999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.94 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=201.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+..........+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 79 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTG-----KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT--- 79 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred hccceeeeeccCCCCceEEEEEECCCC-----CEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC---
Confidence 457999999999999999999876543 389999998655445567889999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE---CCCCCeEEeee
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDF 240 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DF 240 (428)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 80 -HYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp -EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred -EEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence 459999999999999988543 3489999999999999999999998 99999999999999 78899999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...+.. .
T Consensus 154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~---~- 222 (304)
T 2jam_A 154 GLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FEKIKE---G- 222 (304)
T ss_dssp STTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHH---C-
T ss_pred CcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHc---C-
Confidence 999754322 12335799999999999999999999999999999999999999976543211 111100 0
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...........++..+.+++.+||..||++||++.+++++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 223 -------YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -------CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011111223355789999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=341.88 Aligned_cols=260 Identities=21% Similarity=0.293 Sum_probs=201.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|+||.||+|....++ ..||+|.+... ..+.+.+|+.+++.++ ||||+++++++.+....
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~- 106 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR- 106 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC-
T ss_pred CceEEEEEecccCCeEEEEEEECCCC-----cEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC-
Confidence 57999999999999999999876543 38999998743 3467889999999996 99999999999875433
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-CeEEeeecc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGL 242 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGl 242 (428)
..++||||+++++|.+++. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 107 -~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 107 -TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp -CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred -ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 4599999999999999884 288899999999999999999998 999999999999999776 899999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh-
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA- 320 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 320 (428)
++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... +...... +...
T Consensus 178 a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~-~~~~~ 252 (330)
T 3nsz_A 178 AEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKV-LGTED 252 (330)
T ss_dssp CEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHH-HCHHH
T ss_pred ceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHh-cCCch
Confidence 98654332 1234579999999999877 67899999999999999999999999654433221 1111100 0000
Q ss_pred -------------hhhhhhcCC--------cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 -------------KQFRQIVDP--------RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 -------------~~~~~~~~~--------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+...... .........++.++.+|+.+||+.||++|||+++++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 01111122256789999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=340.03 Aligned_cols=252 Identities=26% Similarity=0.432 Sum_probs=183.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
..++|.+.+.||+|+||.||+|....++ ..||+|.+..... .....+.+|+.++..++||||+++++++.+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTG-----LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCC-----ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence 3467999999999999999999875443 3899999864321 2346788999999999999999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 84 ~----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 84 N----YVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp S----EEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECC
T ss_pred C----eEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEe
Confidence 5 4599999999999999987542 4589999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------- 220 (278)
T 3cok_A 156 FGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------------- 220 (278)
T ss_dssp CTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------
T ss_pred ecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------------
Confidence 999986543221 12346799999999999988899999999999999999999999976532211
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
......... ..+..++.++.+++.+||+.||++||++.+++++
T Consensus 221 ---~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 221 ---LNKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ------CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---HHHHhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 011111111 1222345688999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=351.36 Aligned_cols=267 Identities=25% Similarity=0.316 Sum_probs=198.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....++ ..||||++..... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC-----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCC-----CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 468999999999999999999876543 3899999865432 234678899999999999999999999976532
Q ss_pred C--CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ....|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred cccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence 1 12459999999 8899998864 3489999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh--
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY-- 316 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-- 316 (428)
||+++..... ....+||+.|+|||++.+ ..++.++|||||||+++||++|+.||.+.........+......
T Consensus 172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999865432 234679999999999887 67999999999999999999999999876543322211110000
Q ss_pred ------hhh--hhhhhhhcCCcCC---CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 ------LSD--AKQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ------~~~--~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.. ...+...+..... .......++.+.+|+.+||..||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 0000000000000 01112345789999999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.89 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=200.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc------ccHHHHHHHHHHHhcCCCCCcccEeeEEec
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV------QGHKEWMTEVNFLGIVEHQNLVKLVGYCAD 158 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 158 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTG-----KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCC-----CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence 46899999999999999999977543 3899999865432 135778999999999999999999999987
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC----C
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW----N 234 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~----~ 234 (428)
.. ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .
T Consensus 80 ~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 80 KT----DVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp SS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred CC----eEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence 65 459999999999999998643 3589999999999999999999998 999999999999998877 7
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 151 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--- 224 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS--- 224 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---
T ss_pred eEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH---
Confidence 9999999998654322 1234579999999999999999999999999999999999999997654322111110
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. .............+..+.+++.+||..||++||++.+++++
T Consensus 225 ~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 225 A-----------VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp T-----------TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred h-----------cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 00000101112235679999999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=342.11 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=205.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+.|.+.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 93 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--- 93 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCC-----cEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---
Confidence 57899999999999999999876543 3899999875532 34578899999999999999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 94 -~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 94 -KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp -EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred -eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence 45999999999999999864 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+
T Consensus 167 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------- 231 (303)
T 3a7i_A 167 GQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI------------- 231 (303)
T ss_dssp EECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------
T ss_pred eecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-------------
Confidence 7654322 1223467999999999999999999999999999999999999999765432211110
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.....+.+ ...++..+.+++.+||+.||++|||+.+++++.
T Consensus 232 ~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 232 PKNNPPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHSCCCCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred hcCCCCCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 01111111 223456799999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=341.29 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=204.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTK-----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCC-----ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 357999999999999999999976554 3799999865422 33467889999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 89 ----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred ----EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence 459999999999999988543 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------------ 225 (294)
T 2rku_A 160 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------------ 225 (294)
T ss_dssp TTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------------
T ss_pred cCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 99986543221 1234679999999999998889999999999999999999999997654321111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.... ...+..++..+.+++.+||+.||++||++.+++++
T Consensus 226 ----~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 226 ----RIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----HHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000100 01122345688999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=347.94 Aligned_cols=269 Identities=25% Similarity=0.314 Sum_probs=196.4
Q ss_pred HHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-----cHHHHHHHHHHHhcCCCCCcccEeeE
Q 014245 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-----GHKEWMTEVNFLGIVEHQNLVKLVGY 155 (428)
Q Consensus 81 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~ 155 (428)
....++|.+.+.||+|+||.||+|....++ ..||+|.+...... ....+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCC-----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCC-----cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 334578999999999999999999876543 38999998753221 13467899999999999999999999
Q ss_pred EecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCe
Q 014245 156 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 235 (428)
Q Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 235 (428)
+.+.... ++||||+++ +|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 81 ~~~~~~~----~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 81 FGHKSNI----SLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp ECCTTCC----EEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred EeeCCce----EEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence 9876644 999999976 8888876433 4588899999999999999999998 99999999999999999999
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... ....
T Consensus 152 kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~i~~ 227 (346)
T 1ua2_A 152 KLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFE 227 (346)
T ss_dssp EECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH
T ss_pred EEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHH
Confidence 999999998654322 123346799999999998764 58999999999999999999999998764332211 1111
Q ss_pred hhhh-hhhhhh------hhcCCcCCCCc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLS-DAKQFR------QIVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~-~~~~~~------~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... ....+. ..+........ ....+.++.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 000000 00000000000 12345789999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=378.22 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=206.1
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcC-CCCCcccEeeEEec
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCAD 158 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 158 (428)
..++|.++++||+|+||.||+|....++ ..||||++.+.. ....+.+..|..+|..+ +||||+++++++.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~-----~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTD-----ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSC-----CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCC-----cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence 3468999999999999999999987654 389999987532 23346678999999988 79999999999987
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.. .+||||||++||+|.+++... ..+++..++.|+.||+.||+|||++ +||||||||+||||+.+|.+||+
T Consensus 414 ~~----~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 414 MD----RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp SS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred CC----EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence 65 459999999999999999653 3499999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------------ 550 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------------ 550 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------------
Confidence 9999986433221 23457899999999999999999999999999999999999999986543211
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~ell~~ 367 (428)
+..++...+ .++..++.++.+||.+||+.||++||++ ++|+++
T Consensus 551 ----~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 551 ----FQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----HHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----HHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 112222211 2333466789999999999999999997 777664
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=348.80 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=204.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTK-----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 467999999999999999999976654 389999986542 234567889999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ----~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 ----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp ----EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred ----eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence 459999999999999988643 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 186 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------- 254 (335)
T 2owb_A 186 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--------- 254 (335)
T ss_dssp TTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---------
T ss_pred cCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh---------
Confidence 99986543221 1234679999999999999899999999999999999999999997654321111000
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. .... .+..++..+.+++.+||+.||++||++.+++++
T Consensus 255 ----~-~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 255 ----K-NEYS----IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----H-TCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----c-CCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0011 112344678999999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=350.29 Aligned_cols=267 Identities=25% Similarity=0.380 Sum_probs=200.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||.||+|....++ ..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 97 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTG-----RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-- 97 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTC-----CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred hhheeeeEEeecCCEEEEEEEECCCC-----ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC--
Confidence 57999999999999999999976543 38999998654332 2456789999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 98 --~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 98 --RWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp --EEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred --EEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCC
Confidence 459999999999998876543 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-h------
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-K------ 314 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~------ 314 (428)
+....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+... .
T Consensus 171 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 171 ARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 97654322 122346799999999999875 6899999999999999999999999876543322111100 0
Q ss_pred -hhhhhhhhhhhhcCCcCCCCc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 -PYLSDAKQFRQIVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 -~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+...........+.+.... ...+++.+.+|+.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000011111111111111 11346789999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=338.33 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=199.0
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
+|....+||+|+||.||+|....++ ..||+|.+........+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQ-----VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG----F 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTC-----CEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT----E
T ss_pred CCCCcEEEeecCcEEEEEEEECCCC-----eEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC----c
Confidence 4566669999999999999976543 389999998766556678999999999999999999999998765 4
Q ss_pred EEEEEeecCCCCcccccCCCC-cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-CCCeEEeeeccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLA 243 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla 243 (428)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ +|+|+||||+|||++. ++.+||+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccc
Confidence 599999999999999986542 23467889999999999999999998 9999999999999987 899999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCC--CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.............
T Consensus 171 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---------- 238 (295)
T 2clq_A 171 KRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---------- 238 (295)
T ss_dssp EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH----------
T ss_pred cccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh----------
Confidence 8654321 1223467999999999987654 8899999999999999999999996543221110000
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
......+ ..+..++.++.+++.+||+.||++||++.+++++
T Consensus 239 -~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 239 -GMFKVHP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -HHHCCCC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -ccccccc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000111 2223455789999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.28 Aligned_cols=246 Identities=20% Similarity=0.293 Sum_probs=196.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.++..+ +||||+++++++.+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDG-----CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCC-----ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 467999999999999999999976543 389999987643 23456788999999999 9999999999998766
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCc--ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC------
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSE--TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ------ 232 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~------ 232 (428)
..++||||+++++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 85 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 85 ----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------
T ss_pred ----eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccc
Confidence 45999999999999999964321 4589999999999999999999998 99999999999999844
Q ss_pred -------------CCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCC
Q 014245 233 -------------WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPI 298 (428)
Q Consensus 233 -------------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~ 298 (428)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 479999999998654322 24599999999999866 5668999999999999999998876
Q ss_pred CCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 299 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..... . ..+..... ...+..++..+.+++.+||+.||++|||+.+++++
T Consensus 232 ~~~~~-----~--------------~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 232 RNGDQ-----W--------------HEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSSHH-----H--------------HHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cchhH-----H--------------HHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 43210 0 01111111 11222345789999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=359.32 Aligned_cols=204 Identities=28% Similarity=0.386 Sum_probs=166.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||||++.... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNT-----EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTT-----TEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCC-----CcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 46899999999999999999997654 3489999997542 2345678999999999999999999999976532
Q ss_pred -CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 162 -RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 162 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.....|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+||
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred CcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence 1124699999995 5999998643 4589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCce--------------------eeeeeeecCcccCCcchh-ccCCCCCchhhhhHHHHHHHHHhCCCCC
Q 014245 241 GLARLGPSEGFT--------------------HVSTAVVGTMGYAAPEYV-QTGRLAARSDVWSYGVFLYELITGRRPI 298 (428)
Q Consensus 241 Gla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~ 298 (428)
|+++........ ......+||+.|+|||++ ....|+.++|||||||++|||++|..||
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 999875432211 123567899999999986 5567999999999999999999854444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=364.30 Aligned_cols=257 Identities=23% Similarity=0.378 Sum_probs=200.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+++.||+|+||+||+|....++ ..||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 109 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTH-----VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR- 109 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTC-----CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCC-----cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 347999999999999999999976543 389999987653 233567899999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC---CCeEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ---WNAKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~ 238 (428)
..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.. +.+||+
T Consensus 110 ---~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 110 ---NYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp ---EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ---EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence 459999999999998888543 3489999999999999999999998 99999999999999764 459999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||++....... .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||...........+. .
T Consensus 182 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~--- 251 (494)
T 3lij_A 182 DFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE---K--- 251 (494)
T ss_dssp CCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H---
T ss_pred ECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---
Confidence 999998654322 233467999999999886 569999999999999999999999998754332211111 0
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhh
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM--VNKIV 372 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~--L~~~~ 372 (428)
. ...........++..+.+++.+||+.||.+|||+.+++++ +....
T Consensus 252 ~--------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 252 G--------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp T--------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred C--------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 0 0001111112345789999999999999999999999986 44443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=364.91 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=204.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.++||+|+||.||+|....++ ..||||++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITG-----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCC-----CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 357999999999999999999976543 389999986543 234577899999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE---CCCCCeEE
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKL 237 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl 237 (428)
..++||||+.+|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||
T Consensus 100 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 100 ----YFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp ----EEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred ----EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 459999999999999988654 3489999999999999999999998 99999999999999 56789999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
+|||++....... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||...........+. .
T Consensus 171 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~-- 241 (484)
T 3nyv_A 171 IDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE---K-- 241 (484)
T ss_dssp CCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H--
T ss_pred EeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---c--
Confidence 9999998654332 1234579999999999875 79999999999999999999999998754322111110 0
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ...........+++.+.+++.+||+.||.+|||+.+++++
T Consensus 242 -------~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 242 -------G--KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -------C--CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------C--CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 0001111123456789999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.03 Aligned_cols=274 Identities=22% Similarity=0.306 Sum_probs=202.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTG-----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTC-----CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCC-----CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 358999999999999999999976543 3899999865433 234578899999999999999999999987532
Q ss_pred C----CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEE
Q 014245 162 R----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 237 (428)
Q Consensus 162 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 237 (428)
. ....++||||+++ +|.+.+.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl 165 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 165 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEE
Confidence 1 2356999999975 6666665432 3489999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCc--eeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 238 SDFGLARLGPSEGF--THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 238 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999986542211 122345678999999998876 458999999999999999999999998765443332222111
Q ss_pred hhh-----hhhh---hhhhhcC-CcCCCCccHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYL-----SDAK---QFRQIVD-PRLEGKYSLR-----LVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~-----~~~~---~~~~~~~-~~l~~~~~~~-----~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
... .... ....... .......... .++.+.+|+.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000 0000 0000000 0000001111 13568899999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=363.04 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=201.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.++||+|+||+||+|....++ ..||+|++.... ......+.+|+.+|++++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 94 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQ-----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS- 94 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTC-----CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCC-----CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-
Confidence 357999999999999999999976543 389999986432 234567899999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC---CCCCeEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~ 238 (428)
..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+
T Consensus 95 ---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 95 ---SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred ---EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEE
Confidence 459999999999999888543 3589999999999999999999998 999999999999995 55679999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||+++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...........+. .
T Consensus 167 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~--- 236 (486)
T 3mwu_A 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE---T--- 236 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H---
T ss_pred ECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---
Confidence 999997654321 2334679999999999875 69999999999999999999999997654322111111 0
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ...........+++++.+++.+||+.||++|||+.+++++
T Consensus 237 ------~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 ------G--KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------T--CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------C--CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0001111123356789999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=359.86 Aligned_cols=266 Identities=18% Similarity=0.264 Sum_probs=205.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcc-cEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLV-KLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~ 162 (428)
.++|.+.++||+|+||.||+|.+..++ ..||||++..... ..++..|+.++..|.|++++ .+..++....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~-- 76 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGD-- 76 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTC-----CEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETT--
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCC-----cEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC--
Confidence 468999999999999999999976543 3899998765432 24578999999999875544 4444444433
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE---CCCCCeEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~D 239 (428)
..+|||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +||||||||+|||| +.++.+||+|
T Consensus 77 --~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~D 149 (483)
T 3sv0_A 77 --YNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIID 149 (483)
T ss_dssp --EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred --EEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEe
Confidence 459999999 999999986432 3599999999999999999999998 99999999999999 6889999999
Q ss_pred ecccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 240 FGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 240 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||..............+.
T Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (483)
T ss_dssp CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence 9999865433221 11235789999999999999999999999999999999999999998765443333222211
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
.... ...... ....++.++.+++..||+.+|++||++.+|++.|+.++...
T Consensus 230 ~~~~-~~~~~~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 230 EKKV-ATSIEA---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHH-HSCHHH---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hccc-cccHHH---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1000 000000 01123468999999999999999999999999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=348.79 Aligned_cols=271 Identities=23% Similarity=0.297 Sum_probs=203.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC-C
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD-E 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~ 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+..... .....+.+|+.++.+++||||+++++++.... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLN-----KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCC-----CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 46899999999999999999986644 35899999975433 23467889999999999999999999997654 1
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.....++||||++ |+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 2224699999996 589888854 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce-eeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 242 LARLGPSEGFT-HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 242 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~- 252 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS- 252 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC-
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC-
Confidence 99865432111 11234689999999998754 4589999999999999999999999987654433222211000000
Q ss_pred hhhh--------hhh-cCCcCCCC-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQF--------RQI-VDPRLEGK-----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~--------~~~-~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+ ... ........ ....++.++.+|+.+||+.||++|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000 00000000 111245689999999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=344.10 Aligned_cols=263 Identities=26% Similarity=0.423 Sum_probs=185.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+..... .....+.+|+.++..++||||+++++++...+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 87 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPK-----KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE- 87 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC---------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC-
T ss_pred hhhhhhhheeccccceEEEEEEECCC-----CcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC-
Confidence 46899999999999999999986543 33899999865432 334678899999999999999999999988764
Q ss_pred CceEEEEEeecCCCCcccccCC------CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSP------KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
.++||||+++++|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|
T Consensus 88 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 88 ---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp ---EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred ---cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEE
Confidence 4999999999999998853 1234589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCc---eeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 237 LSDFGLARLGPSEGF---THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 237 l~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
|+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||............
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-- 239 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-- 239 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--
Confidence 999999976543211 112234679999999999876 56899999999999999999999999876543221110
Q ss_pred Hhhhhhhhhhhh-hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 313 VKPYLSDAKQFR-QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 313 ~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
... ...... ...+.. ....++.++.+++.+||+.||.+||++.+++++
T Consensus 240 ~~~---~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQN---DPPSLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTS---SCCCTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hcc---CCCccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000 000000 000111 112244678999999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=345.65 Aligned_cols=264 Identities=19% Similarity=0.302 Sum_probs=203.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCccc-----------------HHHHHHHHHHHhcCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-----------------HKEWMTEVNFLGIVEH 146 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 146 (428)
.++|.+.+.||+|+||.||+|.. . +..||+|.+....... ...+.+|+.++..++|
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-D------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-T------TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-C------CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 46899999999999999999987 2 3489999986432211 1788999999999999
Q ss_pred CCcccEeeEEecCCCCCceEEEEEeecCCCCcccc------cCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeee
Q 014245 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY------LSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIV 219 (428)
Q Consensus 147 ~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH 219 (428)
|||+++++++.+.+ ..++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ + +|+|
T Consensus 103 ~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H 175 (348)
T 2pml_X 103 EYCLTCEGIITNYD----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH 175 (348)
T ss_dssp TTBCCCSEEEESSS----EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred CCcceEEEEEeeCC----eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence 99999999998865 45999999999999999 665445679999999999999999999998 7 9999
Q ss_pred ccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCC-chhhhhHHHHHHHHHhCCCC
Q 014245 220 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAA-RSDVWSYGVFLYELITGRRP 297 (428)
Q Consensus 220 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~p 297 (428)
|||||+|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..|
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999865432 23456799999999999877 6666 99999999999999999999
Q ss_pred CCCCCchhhHHHHHhHhhh-hhhhhhhhhhcC---CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 298 IDRNRPRSEQKLLQWVKPY-LSDAKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
|....... .....+... ............ ..........++..+.+++.+||+.||.+||++.+++++
T Consensus 252 f~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 252 FSLKISLV--ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SCCSSCSH--HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCcHH--HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 98654421 111111100 000000000000 000000113456789999999999999999999999884
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=355.05 Aligned_cols=265 Identities=21% Similarity=0.274 Sum_probs=202.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC------CCCCcccEeeEEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV------EHQNLVKLVGYCA 157 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~~~~~ 157 (428)
..+|.+.++||+|+||.||+|....+ +..||||++... ......+.+|+.++..+ +|+||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKV-----HQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTT-----TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCC-----CcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 45799999999999999999987654 348999998653 23345677888888776 6779999999998
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC--e
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--A 235 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~--~ 235 (428)
... ..++||||+. ++|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||+.++. +
T Consensus 170 ~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 170 FRN----HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp ETT----EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred cCC----eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence 765 4599999995 6899988766555699999999999999999999998 9999999999999999987 9
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK- 314 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~- 314 (428)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~ 316 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316 (429)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999999764432 234689999999999999999999999999999999999999998765433222111110
Q ss_pred ----hhhhhhhhhhhhcCCcC--------------------------------CCCc----cHHHHHHHHHHHHHhcccC
Q 014245 315 ----PYLSDAKQFRQIVDPRL--------------------------------EGKY----SLRLVSKLSHVANLCLVKN 354 (428)
Q Consensus 315 ----~~~~~~~~~~~~~~~~l--------------------------------~~~~----~~~~~~~l~~li~~cl~~d 354 (428)
.++.........++..- .... ....++.+.+|+.+||+.|
T Consensus 317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 00000011111111000 0000 0012467899999999999
Q ss_pred CCCCCCHHHHHHH
Q 014245 355 ARTRPKMSEVLEM 367 (428)
Q Consensus 355 p~~RPs~~ell~~ 367 (428)
|++|||+.|++++
T Consensus 397 P~~Rpta~e~L~H 409 (429)
T 3kvw_A 397 PAVRMTPGQALRH 409 (429)
T ss_dssp TTTSCCHHHHHTS
T ss_pred hhhCCCHHHHhCC
Confidence 9999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=342.15 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=198.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+........+.+.+|+.++..++||||+++++++.+...
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 90 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETG-----ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK-- 90 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTC-----CEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C--
T ss_pred ccceeecceeccCCCeEEEEEEEcCCC-----cEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe--
Confidence 468999999999999999999976543 3899999987666667889999999999999999999999987653
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++
T Consensus 91 --~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 91 --LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp --EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred --EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 49999999999999987642 23489999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
...... ........||+.|+|||++. +..++.++||||||+++|+|++|..||......... ....
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~----- 235 (302)
T 2j7t_A 165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIA----- 235 (302)
T ss_dssp HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHH-----
T ss_pred cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HHHh-----
Confidence 532110 01123457999999999884 567899999999999999999999999865432111 0000
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ........+..++..+.+++.+||+.||++|||+.+++++
T Consensus 236 ------~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 236 ------K--SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------H--SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------c--cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0000111223345689999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=344.19 Aligned_cols=268 Identities=24% Similarity=0.291 Sum_probs=194.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAIL-----ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred hhheeEeeeeEecCCEEEEEEEECCC-----CceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 46899999999999999999986544 3489999987542 2334678899999999999999999999976542
Q ss_pred --CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 --RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.....++||||+++ +|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 170 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 170 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEE
Confidence 12356999999965 78777742 388999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh-------
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW------- 312 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~------- 312 (428)
||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..
T Consensus 171 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 171 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred eecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999765322 123346899999999999999999999999999999999999999987543322111100
Q ss_pred --Hh-------hhhhhh-----hhhhhhcCCcC---CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 313 --VK-------PYLSDA-----KQFRQIVDPRL---EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 313 --~~-------~~~~~~-----~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. .+.... ..+........ ........+.++.+|+.+||+.||++|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 000000 00000000000 001122346789999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=347.32 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=203.3
Q ss_pred HHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--------cHHHHHHHHHHHhcC-CCCCc
Q 014245 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--------GHKEWMTEVNFLGIV-EHQNL 149 (428)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~nI 149 (428)
......++|.+.+.||+|+||.||+|....++ ..||||++...... ..+.+.+|+.++..+ +||||
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 162 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG-----HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI 162 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCC-----cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 34455678999999999999999999976443 38999998654321 134678999999999 89999
Q ss_pred ccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE
Q 014245 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229 (428)
Q Consensus 150 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl 229 (428)
+++++++.... ..++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 163 v~~~~~~~~~~----~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~ 233 (365)
T 2y7j_A 163 ITLIDSYESSS----FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILL 233 (365)
T ss_dssp CCEEEEEEBSS----EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred eEEEEEEeeCC----EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 99999998765 459999999999999998643 3589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc------CCCCCchhhhhHHHHHHHHHhCCCCCCCCCc
Q 014245 230 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT------GRLAARSDVWSYGVFLYELITGRRPIDRNRP 303 (428)
Q Consensus 230 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~ 303 (428)
+.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 234 ~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 310 (365)
T 2y7j_A 234 DDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310 (365)
T ss_dssp CTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999998654332 1234689999999999864 3588899999999999999999999976542
Q ss_pred hhhHHHHHhHhhhhhhhhhhhhhcCCcCCCC--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 304 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... +. ....... .....+..+.+++.+||+.||++||++.+++++
T Consensus 311 ~~~~~~---i~-------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 311 ILMLRM---IM-------------EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHH---HH-------------HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHH---HH-------------hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 211111 10 0000000 001234679999999999999999999999885
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=348.42 Aligned_cols=278 Identities=21% Similarity=0.257 Sum_probs=201.4
Q ss_pred CHHHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-----------cHHHHHHHHHHHhcC
Q 014245 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-----------GHKEWMTEVNFLGIV 144 (428)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l 144 (428)
.+.++....++|.+.+.||+|+||.||+|.... +..||||.+...... ..+.+.+|+.+++.+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 86 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC
Confidence 456778888999999999999999999998644 348999998643221 136789999999999
Q ss_pred CCCCcccEeeEEecCC-CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 014245 145 EHQNLVKLVGYCADDD-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 223 (428)
Q Consensus 145 ~h~nIv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 223 (428)
+||||+++++++.... ......++||||++ |+|.+++... ...+++..++.++.||+.||.|||++ +|+|||||
T Consensus 87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 161 (362)
T 3pg1_A 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLH 161 (362)
T ss_dssp CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCC
T ss_pred CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCC
Confidence 9999999999986543 22335799999997 5887777643 34589999999999999999999998 99999999
Q ss_pred CCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCC
Q 014245 224 SSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNR 302 (428)
Q Consensus 224 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~ 302 (428)
|+|||++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999754322 12334679999999999877 678999999999999999999999998755
Q ss_pred chhhHHHHH-hHhhh-hh-----hhhhhhhhcCCcCC---CC----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 303 PRSEQKLLQ-WVKPY-LS-----DAKQFRQIVDPRLE---GK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 303 ~~~~~~~~~-~~~~~-~~-----~~~~~~~~~~~~l~---~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.......+. ..... .. ............+. .. .....++.+.+|+.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 332221111 00000 00 00001111111110 00 111235679999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=363.04 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=200.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-------------ccHHHHHHHHHHHhcCCCCCc
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-------------QGHKEWMTEVNFLGIVEHQNL 149 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI 149 (428)
..++|.+.++||+|+||+||+|....++ ..||+|.+..... ...+.+.+|+.+|+.++||||
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 108 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGH-----SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNI 108 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTC-----CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTB
T ss_pred cccceEEEeEecccCCeEEEEEEECCCC-----cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCC
Confidence 3568999999999999999999977654 3899999875432 234678899999999999999
Q ss_pred ccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE
Q 014245 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229 (428)
Q Consensus 150 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl 229 (428)
+++++++.+.. ..++|||||++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 109 v~~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 109 IKLFDVFEDKK----YFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179 (504)
T ss_dssp CCEEEEEECSS----EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CeEEEEEEcCC----EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence 99999998765 459999999999999888543 3489999999999999999999998 99999999999999
Q ss_pred CCCC---CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh
Q 014245 230 DEQW---NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306 (428)
Q Consensus 230 ~~~~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 306 (428)
+.++ .+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|..||........
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 255 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 8776 69999999998664332 223467999999999887 5699999999999999999999999987543322
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCC--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+. ....... ....++.++.+|+.+||+.||.+|||+.+++++
T Consensus 256 ~~~i~----------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 256 IKKVE----------------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHH----------------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH----------------cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111 0000000 011245789999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=351.76 Aligned_cols=273 Identities=21% Similarity=0.294 Sum_probs=199.5
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
...++|.+.+.||+|+||.||+|....++ ..||+|++..... ...+|+.+|+.++||||+++++++.....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESG-----KRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTC-----CEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCC-----CEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCc
Confidence 44678999999999999999999876543 3899999865422 23479999999999999999999865331
Q ss_pred ----------------------------------CCceEEEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHH
Q 014245 162 ----------------------------------RGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARG 205 (428)
Q Consensus 162 ----------------------------------~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~ 205 (428)
.....++||||++ |+|.+.+.. .....+++..++.++.||+.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 1224689999997 577776643 223458999999999999999
Q ss_pred HHHhhcCCCCCeeeccCCCCceEEC-CCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhh
Q 014245 206 LAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWS 283 (428)
Q Consensus 206 L~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws 283 (428)
|+|||++ +|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||
T Consensus 154 L~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 9999998 999999999999997 68899999999998654332 12346789999999998765 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh-hhhhh-------hhcCCcCCCC-----ccHHHHHHHHHHHHHh
Q 014245 284 YGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD-AKQFR-------QIVDPRLEGK-----YSLRLVSKLSHVANLC 350 (428)
Q Consensus 284 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~-------~~~~~~l~~~-----~~~~~~~~l~~li~~c 350 (428)
|||++|+|++|+.||...........+ +...-.. ...+. ...-+.+... .+...+.++.+|+.+|
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i--~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRI--IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 999999999999999876543322111 1100000 00000 0000111111 1223456799999999
Q ss_pred cccCCCCCCCHHHHHHH--HHHhh
Q 014245 351 LVKNARTRPKMSEVLEM--VNKIV 372 (428)
Q Consensus 351 l~~dp~~RPs~~ell~~--L~~~~ 372 (428)
|+.||++|||+.|++++ +..+.
T Consensus 306 L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp CCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred ccCChhhCCCHHHHhcCHHHHHHH
Confidence 99999999999999975 44443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=360.88 Aligned_cols=247 Identities=17% Similarity=0.219 Sum_probs=189.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC---CcccHHHHHHHH---HHHhcCCCCCcccEe----
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GVQGHKEWMTEV---NFLGIVEHQNLVKLV---- 153 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~~~---- 153 (428)
.++|.+.+.||+|+||.||+|....++ ..||||++... .....+.+.+|+ .+++.++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETG-----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCC-----CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCC-----cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 467888999999999999999865433 38999999743 223456788999 455556899999998
Q ss_pred ---eEEecCCC----------CC---ceEEEEEeecCCCCcccccCCCC-----cccccHHHHHHHHHHHHHHHHHhhcC
Q 014245 154 ---GYCADDDE----------RG---IQRLLVYEYMPNGSVDQYLSPKS-----ETILTWAMRLKIAQDAARGLAYLHEG 212 (428)
Q Consensus 154 ---~~~~~~~~----------~~---~~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~ 212 (428)
+++.+.+. .. ...||||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 66655422 00 0258999999 689999986421 13355688889999999999999998
Q ss_pred CCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccC-----------CCCCchhh
Q 014245 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-----------RLAARSDV 281 (428)
Q Consensus 213 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv 281 (428)
+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||
T Consensus 226 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 226 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ---CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999999999999999999999985332 2345678 999999999887 89999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCH
Q 014245 282 WSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM 361 (428)
Q Consensus 282 wslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 361 (428)
|||||++|||++|+.||....... ....+... ...+++++.+++.+||+.||++||++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~----------------~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALG----------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------C----------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HHHHHHHHHHHHCCCCCccccccc----------------chhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCH
Confidence 999999999999999997543211 01111110 01234689999999999999999999
Q ss_pred HHHHHH
Q 014245 362 SEVLEM 367 (428)
Q Consensus 362 ~ell~~ 367 (428)
.+++++
T Consensus 355 ~e~l~h 360 (377)
T 3byv_A 355 LQAMET 360 (377)
T ss_dssp HHHHTS
T ss_pred HHHhhC
Confidence 999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=348.97 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=186.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||||++.... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKT-----GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTT-----TEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCC-----CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 46899999999999999999986544 3589999987542 2345678899999999999999999999976421
Q ss_pred --CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 --RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.....++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~D 175 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 175 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEee
Confidence 112359999999 7899998864 3489999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh--
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY-- 316 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-- 316 (428)
||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+......
T Consensus 176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 176 FGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred cccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999764322 334689999999999887 67899999999999999999999999876543322221110000
Q ss_pred ---hhh--hhhhhhhcC--CcCCC-Cc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 ---LSD--AKQFRQIVD--PRLEG-KY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ---~~~--~~~~~~~~~--~~l~~-~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.. .......+. +.... .+ ....++.+.+|+.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 000000000 00000 00 01234678999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=338.10 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=199.8
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
..++|.+.+.||+|+||.||+|....++ ..||+|.+.... ....+.+|+.++..++||||+++++++....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETG-----QIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-- 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTC-----CEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCC-----CEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--
Confidence 3568999999999999999999876543 389999987543 3467889999999999999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||+
T Consensus 98 --~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 98 --DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp --EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred --EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 459999999999999998632 24589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 172 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------ 237 (314)
T 3com_A 172 AGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI------------ 237 (314)
T ss_dssp CEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------------
T ss_pred chhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------------
Confidence 97654321 1223457999999999999989999999999999999999999999765432211100
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ........+..++..+.+++.+||..||.+||++.+++++
T Consensus 238 -~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 238 -PT--NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -HH--SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -hc--CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 0000111122345789999999999999999999999885
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=350.94 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=201.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----ccHHHHHHHHHHHhcC-CCCCcccEeeEEecC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 159 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 159 (428)
++|.+.+.||+|+||.||+|..... ...+..||||++..... ...+.+.+|+.++..+ +||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cceEEEEEeccCCCEEEEEEEEccc--CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 5799999999999999999987432 12345899999875421 2345677899999999 799999999999876
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 132 ~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 132 T----KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp T----EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESC
T ss_pred c----eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEee
Confidence 5 459999999999999998643 3589999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccC--CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH-HHHHhHhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQWVKPY 316 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~ 316 (428)
||+++...... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||......... .+...
T Consensus 203 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---- 277 (355)
T 1vzo_A 203 FGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR---- 277 (355)
T ss_dssp SSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH----
T ss_pred CCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH----
Confidence 99998653322 1123346799999999999863 4789999999999999999999999754322111 11110
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEMV 368 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~L 368 (428)
+... ...++..++..+.+|+.+||..||++|| ++.+++++.
T Consensus 278 ---------~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 278 ---------ILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---------HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---------Hhcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0000 1112233556889999999999999999 999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=350.76 Aligned_cols=270 Identities=20% Similarity=0.243 Sum_probs=203.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC--------CCCcccEeeE
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE--------HQNLVKLVGY 155 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~~~~~ 155 (428)
.++|.+.++||+|+||.||+|....+ +..||+|++... ....+.+.+|+.+++.++ |+||++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQG-----KKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCC-----CeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 36899999999999999999986654 358999998744 234567889999999885 7889999999
Q ss_pred EecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC--
Q 014245 156 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-- 233 (428)
Q Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-- 233 (428)
+..........++||||+ +++|.+++.......+++..++.|+.||+.||+|||++ .+|+||||||+||||+.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchh
Confidence 875433334679999999 55666666544445699999999999999999999984 2899999999999999775
Q ss_pred -----------------------------------------------CeEEeeecccccCCCCCceeeeeeeecCcccCC
Q 014245 234 -----------------------------------------------NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266 (428)
Q Consensus 234 -----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 266 (428)
.+||+|||++...... .....||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 7999999999865432 234579999999
Q ss_pred cchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh---HHHHHhHhhhhhh--------hhhhhhhcCC-----c
Q 014245 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE---QKLLQWVKPYLSD--------AKQFRQIVDP-----R 330 (428)
Q Consensus 267 PE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~--------~~~~~~~~~~-----~ 330 (428)
||++.+..++.++|||||||++|+|++|..||........ ..........+.. .......... .
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 9999999999999999999999999999999976543221 1111111000000 0000000000 0
Q ss_pred C--------------CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 331 L--------------EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 331 l--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+ ........+..+.+|+.+||+.||++|||+.+++++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 012345678899999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.10 Aligned_cols=261 Identities=22% Similarity=0.360 Sum_probs=198.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|.... .+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 4689999999999999999998753 389999865422 234567789999999999999999999987664
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.++||||+++++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||
T Consensus 104 ----~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 104 ----LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp ----EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred ----eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence 499999999999999997543 4589999999999999999999998 999999999999998 6799999999
Q ss_pred ccccCCCCC---ceeeeeeeecCcccCCcchhcc---------CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014245 242 LARLGPSEG---FTHVSTAVVGTMGYAAPEYVQT---------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309 (428)
Q Consensus 242 la~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 309 (428)
++....... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 987543211 1112234569999999999874 4578899999999999999999999976543221110
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhhc
Q 014245 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 377 (428)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~~ 377 (428)
. .....+.. ....++.++.+++.+||..||++|||+.++++.|+.+......
T Consensus 255 ---~----------~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 255 ---M----------GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp ---H----------HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred ---h----------ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 00011111 1112345789999999999999999999999999988766443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=341.77 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=196.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--------ccHHHHHHHHHHHhcCCCCCcccEeeE
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--------QGHKEWMTEVNFLGIVEHQNLVKLVGY 155 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~ 155 (428)
.++|.+.+.||+|+||.||+|....+ +..||||.+..... .....+.+|+.+++.++||||++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKT-----CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCC-----CcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence 45799999999999999999987654 34899999865421 123457899999999999999999999
Q ss_pred EecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC-
Q 014245 156 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN- 234 (428)
Q Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~- 234 (428)
+.... .++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 84 ~~~~~-----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 84 FDAED-----YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp EESSS-----EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSS
T ss_pred EcCCc-----eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCC
Confidence 87643 48999999999999988643 4589999999999999999999998 9999999999999987665
Q ss_pred --eEEeeecccccCCCCCceeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014245 235 --AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309 (428)
Q Consensus 235 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~ 309 (428)
+||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.........
T Consensus 154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-- 228 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-- 228 (322)
T ss_dssp CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--
T ss_pred CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--
Confidence 9999999998654321 123457999999999874 467899999999999999999999999764332111
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... . ...........++..+.+++.+||+.||++||++.+++++
T Consensus 229 ~~~~~~----------~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 229 KDQITS----------G-KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHH----------T-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHh----------C-ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 010000 0 0000000111245689999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=353.39 Aligned_cols=259 Identities=13% Similarity=0.078 Sum_probs=183.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcC--CCCCcccEe------
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIV--EHQNLVKLV------ 153 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~~~------ 153 (428)
.+|.+.+.||+|+||.||+|.+..+ +..||+|++..... ...+.+.+|+.++..| +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVER-----LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCC-----CceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 4588999999999999999997654 34899999987543 2345667785544444 699988855
Q ss_pred -eEEecCCCC-------------CceEEEEEeecCCCCcccccCCCCcccccHHHH------HHHHHHHHHHHHHhhcCC
Q 014245 154 -GYCADDDER-------------GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR------LKIAQDAARGLAYLHEGM 213 (428)
Q Consensus 154 -~~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~ 213 (428)
+++...... ...++|||||++ |+|.+++.... ..+.+..+ +.++.||+.||+|||++
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~- 213 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK- 213 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence 444433220 034699999998 89999997532 22444555 67889999999999998
Q ss_pred CCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHH
Q 014245 214 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYEL 291 (428)
Q Consensus 214 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el 291 (428)
+|+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred --CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 9999999999999999999999999999865321 224567899999999987 6799999999999999999
Q ss_pred HhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 292 ITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 292 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
++|+.||.......... +. ...................+++.+.+|+.+||+.||++|||+.+++++
T Consensus 287 ltg~~Pf~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGS--------WK-RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHSSCSTTBCCTTCTTC--------CC-BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HhCCCCCCCcCcccccc--------hh-hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99999998654321110 00 000000011111111122456789999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=332.93 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=194.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTG-----HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCC-----ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 368999999999999999999976443 389999986532 223467889999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.+||+||
T Consensus 85 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 85 ----DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred ----eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 459999999999999998643 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ .....
T Consensus 156 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~----- 224 (276)
T 2h6d_A 156 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKKIR----- 224 (276)
T ss_dssp CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH-----
T ss_pred ccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhh-----
Confidence 9998654322 2234579999999999987765 6899999999999999999999976432211 11110
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. .. ..+..++..+.+++.+||+.||++|||+.+++++
T Consensus 225 -----~~-~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 225 -----GG-VF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----HC-CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cC-cc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 00 1112244678999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.22 Aligned_cols=265 Identities=25% Similarity=0.332 Sum_probs=196.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC--C
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--R 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--~ 162 (428)
.+|.+.++||+|+||.||+|.+..++ ..||||++.... ..+.+|+.+|+.++||||++++++|..... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSG-----ELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCC-----cEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 46889999999999999999986543 389999986542 223479999999999999999999865322 2
Q ss_pred CceEEEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC-CCeEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~D 239 (428)
...+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+||||+.+ +.+||+|
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEecc
Confidence 2346799999975 56555432 1234589999999999999999999998 99999999999999965 5689999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
||+++...... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||........ +...+...-.
T Consensus 201 FG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~ 275 (420)
T 1j1b_A 201 FGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGT 275 (420)
T ss_dssp CTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCS
T ss_pred chhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCC
Confidence 99998654322 12346799999999998765 789999999999999999999999987543322 1111111000
Q ss_pred -hhhhhhhh-------cCCcCCCC-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 -DAKQFRQI-------VDPRLEGK-----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 -~~~~~~~~-------~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+... ..+.+... +....+.++.+|+.+||+.||.+||++.|++++
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00111111 00111111 112345789999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=369.86 Aligned_cols=263 Identities=22% Similarity=0.383 Sum_probs=208.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|.+...+. ....||+|.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPEN--PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-- 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSS--CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCC--ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCc--
Confidence 3578899999999999999999865432 345799999875433 33467899999999999999999999985432
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 465 ---~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 465 ---VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp ---CEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ---eEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 38999999999999999643 23589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......... ..+.
T Consensus 538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~------- 606 (656)
T 2j0j_A 538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIE------- 606 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHH-------
T ss_pred CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH-------
Confidence 986543321 12234567889999999999999999999999999999997 99999865432211 1110
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
... ....+..+++.+.+++.+||+.||++||++.+|++.|+.+.+..
T Consensus 607 ---~~~----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 607 ---NGE----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ---HTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---cCC----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 000 11122345578999999999999999999999999999987653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=339.42 Aligned_cols=271 Identities=20% Similarity=0.289 Sum_probs=197.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCC---
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD--- 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--- 160 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+........+.+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDC-----DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTT-----TEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCC-----CeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 46899999999999999999997654 3489999997766566678899999999999999999999985432
Q ss_pred -------CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC-CC
Q 014245 161 -------ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQ 232 (428)
Q Consensus 161 -------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~ 232 (428)
......++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++ ++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 11235699999997 699998864 3489999999999999999999998 999999999999997 56
Q ss_pred CCeEEeeecccccCCCCCc-eeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 233 WNAKLSDFGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 233 ~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
+.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7899999999986542211 112234567999999998865 67899999999999999999999999876543222111
Q ss_pred HhHhhhhhhhhhhhhh-----------cCCcCC--CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 311 QWVKPYLSDAKQFRQI-----------VDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~-----------~~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+.... ....+. ...... ......++.++.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 238 LESIPVVHE-EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHSCCCCH-HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhcCCCch-hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 110000000 000000 000000 00111345789999999999999999999999885
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=338.06 Aligned_cols=266 Identities=19% Similarity=0.254 Sum_probs=204.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCC------CcccEeeEEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQ------NLVKLVGYCA 157 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~~~~~~~ 157 (428)
.++|.+.+.||+|+||.||+|..... .+..||+|++... ....+.+.+|+.++..++|+ +|+++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKA----GGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCC----CCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 36899999999999999999986322 2358999998643 23456788999999888665 4999999998
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC------
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE------ 231 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~------ 231 (428)
+.. ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 88 ~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 88 HHG----HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp ETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEE
T ss_pred cCC----cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccc
Confidence 766 459999999 88999998766555689999999999999999999998 9999999999999987
Q ss_pred -------------CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCC
Q 014245 232 -------------QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298 (428)
Q Consensus 232 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~ 298 (428)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 678999999999864432 23467999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHHHhHhhhhhhh-------------------------hhhhhhcCCc-CCCCccHHHHHHHHHHHHHhcc
Q 014245 299 DRNRPRSEQKLLQWVKPYLSDA-------------------------KQFRQIVDPR-LEGKYSLRLVSKLSHVANLCLV 352 (428)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~-l~~~~~~~~~~~l~~li~~cl~ 352 (428)
...........+.......... ........+. -........++++.+|+.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 8765443322222111000000 0000000000 0001123467889999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 014245 353 KNARTRPKMSEVLEM 367 (428)
Q Consensus 353 ~dp~~RPs~~ell~~ 367 (428)
.||++|||+.|++++
T Consensus 315 ~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 315 YDPAKRITLREALKH 329 (339)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred cCcccccCHHHHhcC
Confidence 999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=333.47 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=202.7
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---------ccHHHHHHHHHHHhcCC-CCCcccE
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---------QGHKEWMTEVNFLGIVE-HQNLVKL 152 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~~ 152 (428)
..++|.+.+.||+|+||.||+|....+ +..||+|.+..... ...+.+.+|+.+++++. ||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPT-----CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCc-----CceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 346899999999999999999997654 34899999865431 12356789999999995 9999999
Q ss_pred eeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC
Q 014245 153 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 232 (428)
Q Consensus 153 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~ 232 (428)
++++.... ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.+
T Consensus 90 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 90 KDTYETNT----FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD 160 (298)
T ss_dssp EEEEECSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred eeeeccCC----eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence 99998765 459999999999999998643 3589999999999999999999998 99999999999999999
Q ss_pred CCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhc------cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhh
Q 014245 233 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306 (428)
Q Consensus 233 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~ 306 (428)
+.+||+|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||........
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 237 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237 (298)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence 999999999998654322 123467999999999885 45688999999999999999999999976543221
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+. . . ...........++..+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~---~---------~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 238 LRMIM---S---------G--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHH---H---------T--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHh---c---------C--CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11100 0 0 0011111122456789999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=334.77 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=185.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cH-HHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GH-KEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|++.+.||+|+||.||+|....+ +..||+|.+...... .. ..+.++...++.++||||+++++++.+...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPS-----GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCC-----CeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 46799999999999999999997544 348999998765322 22 334455566888999999999999987664
Q ss_pred CCceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.++||||++ |+|.+++... ....+++..++.++.|++.||+|||++ .+|+||||||+|||++.++.+||+|
T Consensus 81 ----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 81 ----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp ----EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred ----EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEee
Confidence 499999997 4887776431 234599999999999999999999973 2899999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchh----ccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYV----QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
||++....... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||........ .+.
T Consensus 154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----- 224 (290)
T 3fme_A 154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLK----- 224 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHH-----
T ss_pred cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHH-----
Confidence 99997654322 22335799999999996 456789999999999999999999999975432211 111
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..............++.++.+++.+||+.||++|||+.+++++
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 225 ---------QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---------HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---------HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1111111111122345789999999999999999999999984
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=338.07 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=194.6
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCC--CCCcccEeeEEec
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVE--HQNLVKLVGYCAD 158 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~ 158 (428)
..++|.+.+.||+|+||.||+|.... +..||+|.+..... .....+.+|+.++..++ |+||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEK------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCC------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34679999999999999999998654 23799999865432 34567889999999996 5999999999987
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEe
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.. ..++||| +.+++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||+++ +.+||+
T Consensus 100 ~~----~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 100 DQ----YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp SS----EEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred CC----EEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence 65 4599999 5588999998654 3589999999999999999999998 9999999999999965 799999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhcc-----------CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~ 307 (428)
|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 247 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS- 247 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-
Confidence 9999986543332222345679999999999875 4688899999999999999999999976533211
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+....++......+...+.++.+++.+||+.||++||++.+++++
T Consensus 248 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 --------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1112222222222222335689999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=340.94 Aligned_cols=258 Identities=20% Similarity=0.268 Sum_probs=176.5
Q ss_pred hcCCCCce-eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+ +||+|+||.||+|....++ ..||+|++.... ....+....++.++||||+++++++......
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTG-----QKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCC-----CEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 45888854 6999999999999977543 389999986431 1222233345667999999999999764433
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC---CCCeEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~D 239 (428)
....++||||+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 34569999999999999999876656799999999999999999999998 9999999999999976 45599999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............. .
T Consensus 175 fg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~---- 243 (336)
T 3fhr_A 175 FGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---R---- 243 (336)
T ss_dssp CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred cccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---H----
Confidence 99998654321 234678999999999988889999999999999999999999997543321100000 0
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+ ..............++.++.+|+.+||+.||++|||+.+++++
T Consensus 244 --~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 244 --RI-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --hh-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000011111112356789999999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=332.00 Aligned_cols=258 Identities=22% Similarity=0.359 Sum_probs=194.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC--
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE-- 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-- 161 (428)
.++|++.+.||+|+||.||+|....++ ..||+|.+... ......+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDS-----RYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCC-----eEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 457999999999999999999876543 38999998543 2345678899999999999999999999876421
Q ss_pred -------CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC
Q 014245 162 -------RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 234 (428)
Q Consensus 162 -------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~ 234 (428)
.....++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 123579999999999999999743 34578899999999999999999998 9999999999999999999
Q ss_pred eEEeeecccccCCCCC------------ceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCC
Q 014245 235 AKLSDFGLARLGPSEG------------FTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRN 301 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~ 301 (428)
+||+|||++....... .........||+.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999997653211 01122346799999999999864 68999999999999999998 55321
Q ss_pred CchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 302 RPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
........... . ....+...+....+..+.+++.+||+.||.+|||+.+++++
T Consensus 232 --~~~~~~~~~~~----------~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 --MERVNILKKLR----------S-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHHHHHHH----------S-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhHHHHHHhcc----------c-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111111100 0 11122233444556788999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=348.52 Aligned_cols=272 Identities=22% Similarity=0.313 Sum_probs=183.7
Q ss_pred cCCCC-ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSR-SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+.|.+ .++||+|+||.||+|.+.+.. .+..||+|.+..... ...+.+|+.+|+.++||||+++++++......
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~- 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGK---DDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADR- 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSS---CCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT-
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCC---CCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC-
Confidence 34665 458999999999999976432 234799999975532 35788999999999999999999999764433
Q ss_pred ceEEEEEeecCCCCcccccCCC-------CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE----CCC
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPK-------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQ 232 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~ 232 (428)
..++||||++ |+|.+++... ....+++..++.|+.||+.||+|||++ +|+||||||+|||| +.+
T Consensus 94 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 94 -KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp -EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT
T ss_pred -eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC
Confidence 5699999996 4777776421 122489999999999999999999998 99999999999999 778
Q ss_pred CCeEEeeecccccCCCCCc-eeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchh-----
Q 014245 233 WNAKLSDFGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRS----- 305 (428)
Q Consensus 233 ~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~----- 305 (428)
+.+||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 8999999999986543211 1223456899999999999874 58999999999999999999999997654321
Q ss_pred --hHHHHHhHhhh-------hhh------hhh-hhhhcCCcCCCCcc--------HHHHHHHHHHHHHhcccCCCCCCCH
Q 014245 306 --EQKLLQWVKPY-------LSD------AKQ-FRQIVDPRLEGKYS--------LRLVSKLSHVANLCLVKNARTRPKM 361 (428)
Q Consensus 306 --~~~~~~~~~~~-------~~~------~~~-~~~~~~~~l~~~~~--------~~~~~~l~~li~~cl~~dp~~RPs~ 361 (428)
...+....... +.. ... .............. ...+..+.+|+.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 01111100000 000 000 00000000000000 0014578899999999999999999
Q ss_pred HHHHHH
Q 014245 362 SEVLEM 367 (428)
Q Consensus 362 ~ell~~ 367 (428)
.|++++
T Consensus 329 ~e~L~h 334 (405)
T 3rgf_A 329 EQAMQD 334 (405)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=350.07 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=194.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC--C
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--R 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--~ 162 (428)
.+|.+.++||+|+||.||+|....+. .+|+|++..... ...+|+.+|+.++||||+++++++..... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~------~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESD------EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTE------EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCC------eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 47999999999999999999876543 588888754322 22379999999999999999999865442 2
Q ss_pred CceEEEEEeecCCCCcccccC-CCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC-CCCCeEEeee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLS-PKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDF 240 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DF 240 (428)
....++||||++++.+..... ......+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+||
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 234689999997754433221 11234589999999999999999999998 999999999999999 7999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..... ...
T Consensus 187 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g-~p~ 262 (394)
T 4e7w_A 187 GSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG-TPS 262 (394)
T ss_dssp TTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCC
T ss_pred CCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCC
Confidence 9998654322 12346789999999998765 589999999999999999999999987654322211111000 000
Q ss_pred hhhhhh----hcC---CcCCC-----CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQ----IVD---PRLEG-----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~----~~~---~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+.. ... +.... .+....++++.+|+.+||+.||++|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000 000 01110 0112245789999999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=344.03 Aligned_cols=269 Identities=20% Similarity=0.298 Sum_probs=202.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-----------CCCcccEe
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-----------HQNLVKLV 153 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~~ 153 (428)
++|.+.+.||+|+||.||+|....+ +..||+|.+.... .....+.+|+.++..++ |+||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVN-----NTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CeEEEEEeeeecCCeEEEEEEecCC-----CcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 5899999999999999999986544 3489999987432 33466789999998886 89999999
Q ss_pred eEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC---
Q 014245 154 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD--- 230 (428)
Q Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--- 230 (428)
+++..........++||||+ +++|.+++.......+++..++.++.||+.||+|||++ .+|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccC
Confidence 99987654444679999999 89999998765555699999999999999999999983 2899999999999994
Q ss_pred ---CCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh--
Q 014245 231 ---EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS-- 305 (428)
Q Consensus 231 ---~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-- 305 (428)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4447999999999865432 234579999999999999999999999999999999999999997654221
Q ss_pred --hHHHHHhHhhh-------hhhhhhhhhhcCC-------------------cCCCCccHHHHHHHHHHHHHhcccCCCC
Q 014245 306 --EQKLLQWVKPY-------LSDAKQFRQIVDP-------------------RLEGKYSLRLVSKLSHVANLCLVKNART 357 (428)
Q Consensus 306 --~~~~~~~~~~~-------~~~~~~~~~~~~~-------------------~l~~~~~~~~~~~l~~li~~cl~~dp~~ 357 (428)
...+....... +.........++. .-...++...+.++.+|+.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111111000 0000000000000 0011244678889999999999999999
Q ss_pred CCCHHHHHHH
Q 014245 358 RPKMSEVLEM 367 (428)
Q Consensus 358 RPs~~ell~~ 367 (428)
|||+.+++++
T Consensus 325 Rpt~~ell~h 334 (373)
T 1q8y_A 325 RADAGGLVNH 334 (373)
T ss_dssp CBCHHHHHTC
T ss_pred cCCHHHHhhC
Confidence 9999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=338.21 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=199.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRS-----GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccEEEEeEEecCCCeEEEEEEECCC-----CCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 46899999999999999999987654 34899999976432 234678899999999999999999999987653
Q ss_pred CC--ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 RG--IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
.. ...++||||++ ++|.+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred cccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence 21 12389999996 688887742 389999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh--
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY-- 316 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-- 316 (428)
||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 188 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 9999754322 234678999999999887 67899999999999999999999999876533222111100000
Q ss_pred ------hhh--hhhhhhhcCCcCCCC---ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 ------LSD--AKQFRQIVDPRLEGK---YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ------~~~--~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+.. .......+....... ....+++.+.+|+.+||+.||++|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 000000001100111 011245789999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=340.55 Aligned_cols=268 Identities=22% Similarity=0.234 Sum_probs=201.6
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CC-----CcccEeeEE
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQ-----NLVKLVGYC 156 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~~~~~~ 156 (428)
..++|.+.+.||+|+||+||+|....+ +..||||++.... .....+..|+.++..++ |+ +|+++++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVE-----QEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTT-----TEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCC-----CcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 457899999999999999999987654 3489999997432 33456778888888884 55 499999999
Q ss_pred ecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC--CCCC
Q 014245 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD--EQWN 234 (428)
Q Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--~~~~ 234 (428)
.... ..++||||++ |+|.+++.......+++..++.++.|++.||.|||.+ ..+|+||||||+|||++ .++.
T Consensus 126 ~~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 126 MFRN----HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EETT----EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred ccCC----ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence 8765 4599999995 5999998765545689999999999999999999952 23899999999999994 5788
Q ss_pred eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 235 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 235 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 200 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 274 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274 (382)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999999865432 234679999999999999999999999999999999999999998765433222111100
Q ss_pred h-----hhhhhhhhhhhcCCcC-----------------------------------------CCCccHHHHHHHHHHHH
Q 014245 315 P-----YLSDAKQFRQIVDPRL-----------------------------------------EGKYSLRLVSKLSHVAN 348 (428)
Q Consensus 315 ~-----~~~~~~~~~~~~~~~l-----------------------------------------~~~~~~~~~~~l~~li~ 348 (428)
. .+.........++... .........+++.+|+.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 0 0000000000000000 00112234468999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 014245 349 LCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 349 ~cl~~dp~~RPs~~ell~~ 367 (428)
+||+.||++|||+.|++++
T Consensus 355 ~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTS
T ss_pred HhcCCChhhCCCHHHHhcC
Confidence 9999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.98 Aligned_cols=275 Identities=21% Similarity=0.291 Sum_probs=192.1
Q ss_pred HHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEe
Q 014245 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
.......++|.+.+.||+|+||.||+|....++ ..||||.+.... .....+.+|+..+..++||||+++++++.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTG-----MSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTC-----CEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 345566789999999999999999999976543 389999886543 23346678888899999999999999997
Q ss_pred cCCC---CCceEEEEEeecCCCCcccccCC--CCcccccHHHHHHHHHHHHHHHHHhh--cCCCCCeeeccCCCCceEEC
Q 014245 158 DDDE---RGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLH--EGMDFQIIVRDFKSSNILLD 230 (428)
Q Consensus 158 ~~~~---~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivHrDlkp~NILl~ 230 (428)
.... .....++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| ++ +|+||||||+|||++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVN 165 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEE
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEe
Confidence 6432 22346899999976 44333321 22345889999999999999999999 76 999999999999999
Q ss_pred C-CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHH
Q 014245 231 E-QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 308 (428)
Q Consensus 231 ~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~ 308 (428)
. ++.+||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..........
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 6 8999999999998654332 123467899999999987654 8999999999999999999999998765432221
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcC----------------CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 309 LLQWVKPYLSDAKQFRQIVDPRL----------------EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+ ...............++.. ........+.++.+|+.+||+.||.+|||+.|++++
T Consensus 243 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 243 EI--VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HH--HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HH--HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 1100000000000010000 001111246789999999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.99 Aligned_cols=272 Identities=24% Similarity=0.314 Sum_probs=201.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCC-C
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD-E 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~ 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||||.+..... .....+.+|+.+++.++||||+++++++.... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPT-----GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCC-----CcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 46899999999999999999987654 34899999965432 23457889999999999999999999987542 1
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 1234699999996 589888864 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcee--------eeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 242 LARLGPSEGFTH--------VSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 242 la~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 998654321111 1223578999999998765 6789999999999999999999999987653322211111
Q ss_pred Hhhhhh--------hhhhhhhhcC--CcCCC----CccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 313 VKPYLS--------DAKQFRQIVD--PRLEG----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 313 ~~~~~~--------~~~~~~~~~~--~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... ......+... +.... .....++.++.+++.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0000000000 00000 0112345788999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=336.22 Aligned_cols=273 Identities=25% Similarity=0.326 Sum_probs=202.6
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcC---CCCCcccEeeEEe
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIV---EHQNLVKLVGYCA 157 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~ 157 (428)
..++|.+.+.||+|+||.||+|..... .+..||+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC----CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 357899999999999999999987422 234799999864322 1223566777777766 8999999999987
Q ss_pred cC-CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeE
Q 014245 158 DD-DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 236 (428)
Q Consensus 158 ~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 236 (428)
.. .......++||||++ |+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 32 112235699999997 6999998765555689999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....
T Consensus 161 l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~- 236 (326)
T 1blx_A 161 LADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG- 236 (326)
T ss_dssp ECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-
T ss_pred EecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC-
Confidence 9999999765322 122346799999999999999999999999999999999999999987653322111110000
Q ss_pred hhhhhhhh-------hhcCC---cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 LSDAKQFR-------QIVDP---RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~-------~~~~~---~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
......+. ..... .........++..+.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 00000 00011122356789999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=335.11 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=201.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC------cccEeeEEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN------LVKLVGYCA 157 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~~~~ 157 (428)
.++|.+.+.||+|+||.||+|.....+ +..||+|.+... ......+.+|+.+++.++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARG----KSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT----TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCC----ceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 468999999999999999999875432 247999998643 234567788999999987765 899999988
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE--------
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL-------- 229 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl-------- 229 (428)
... ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 93 ~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 93 FHG----HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp ETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEE
T ss_pred eCC----eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccc
Confidence 765 459999999 66777776555445699999999999999999999998 99999999999999
Q ss_pred -----------CCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCC
Q 014245 230 -----------DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 298 (428)
Q Consensus 230 -----------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~ 298 (428)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 56789999999999864332 23467999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHHHhHhhhhhh-----h--------------------hhhhhhcCC-cCCCCccHHHHHHHHHHHHHhcc
Q 014245 299 DRNRPRSEQKLLQWVKPYLSD-----A--------------------KQFRQIVDP-RLEGKYSLRLVSKLSHVANLCLV 352 (428)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~-----~--------------------~~~~~~~~~-~l~~~~~~~~~~~l~~li~~cl~ 352 (428)
...........+......... . ........+ ..........+.++.+|+.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 876543322222111100000 0 000000000 00001122456789999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 014245 353 KNARTRPKMSEVLEM 367 (428)
Q Consensus 353 ~dp~~RPs~~ell~~ 367 (428)
.||++|||+.+++++
T Consensus 320 ~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 320 FDPAQRITLAEALLH 334 (355)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=334.66 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=199.4
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||||.+..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRS-----GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCC-----CCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 36799999999999999999987654 34899999976432 234678899999999999999999999987543
Q ss_pred C--CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ....++||||++ ++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D 169 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 169 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECS
T ss_pred cccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEee
Confidence 2 123489999996 688888743 389999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh--
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY-- 316 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-- 316 (428)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999754322 234678999999999887 67899999999999999999999999876533221111100000
Q ss_pred ------hhhh--hhhhhhcCCcCC---CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 ------LSDA--KQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ------~~~~--~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+... ......+..... .......+.++.+++.+||+.||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 000000000000 11123456789999999999999999999999885
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.48 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=200.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
..++|.+.+.||+|+||.||+|....++ ..||+|.+.... ......+.+|+.++++++||||+++++++.+..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQ-----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCC-----cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 4568999999999999999999876543 389999986542 234578899999999999999999999998765
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC---CCeEE
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ---WNAKL 237 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl 237 (428)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.+ +.+||
T Consensus 95 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 95 ----SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp ----EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred ----eEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEE
Confidence 459999999999998887543 3489999999999999999999998 99999999999999754 46999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......... ..+..
T Consensus 166 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~-- 236 (287)
T 2wei_A 166 IDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---KRVET-- 236 (287)
T ss_dssp CSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH--
T ss_pred eccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHc--
Confidence 9999997654322 1223568999999998875 5899999999999999999999999865432211 11000
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
... .........++.++.+++.+||..||++|||+.+++++
T Consensus 237 -------~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 237 -------GKY--AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -------CCC--CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------CCC--CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000 00001112345689999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=334.09 Aligned_cols=245 Identities=26% Similarity=0.455 Sum_probs=191.5
Q ss_pred HHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc------cHHHHHHHHHHHhcC----CCCCcc
Q 014245 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ------GHKEWMTEVNFLGIV----EHQNLV 150 (428)
Q Consensus 81 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nIv 150 (428)
....++|.+.+.||+|+||.||+|....+ +..||+|.+...... ....+.+|+.++.++ +||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTD-----RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTT-----CCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccC-----CeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 33457899999999999999999986544 348999999765332 223456789999888 899999
Q ss_pred cEeeEEecCCCCCceEEEEEee-cCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE
Q 014245 151 KLVGYCADDDERGIQRLLVYEY-MPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229 (428)
Q Consensus 151 ~~~~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl 229 (428)
++++++.+.+.. ++|||| +.+++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 102 ~~~~~~~~~~~~----~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 102 RLLDWFETQEGF----MLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILI 172 (312)
T ss_dssp CEEEEC-----C----EEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEE
T ss_pred eEEEEEecCCeE----EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEE
Confidence 999999876643 899999 7899999998643 3589999999999999999999998 99999999999999
Q ss_pred C-CCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCC-CchhhhhHHHHHHHHHhCCCCCCCCCchhhH
Q 014245 230 D-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307 (428)
Q Consensus 230 ~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~ 307 (428)
+ .++.+||+|||++....... .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||....
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----- 243 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----- 243 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----
Confidence 9 88999999999998764432 2346799999999999877764 58999999999999999999996421
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.... . . ......++..+.+++.+||+.||++||++.+++++
T Consensus 244 ~~~~-------------~--~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 EILE-------------A--E----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHH-------------T--C----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHhh-------------h--c----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0 0 01122345688999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=332.44 Aligned_cols=253 Identities=30% Similarity=0.440 Sum_probs=177.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHH-HHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVN-FLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+.||+|+||.||+|....+ +..||+|.+..... ....++..|+. +++.++||||+++++++.+.+
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-- 94 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPS-----GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-- 94 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTT-----TEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS--
T ss_pred HHhhehheeccCCCEEEEEEEEcCC-----CCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC--
Confidence 5788999999999999999997654 34899999976533 23345566665 778889999999999998765
Q ss_pred CceEEEEEeecCCCCcccccCC---CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSP---KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
..++||||+++ +|.+++.. .....+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|
T Consensus 95 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 95 --DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp --EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECC
T ss_pred --ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEcc
Confidence 45999999975 77776642 1234589999999999999999999973 2899999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchh----ccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYV----QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
||++....... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||........
T Consensus 170 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------- 237 (327)
T 3aln_A 170 FGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------- 237 (327)
T ss_dssp CSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------
T ss_pred CCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------
Confidence 99997654321 12334799999999998 456789999999999999999999999975422100
Q ss_pred hhhhhhhhhhhc---CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQIV---DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.... .+.+.......++..+.+++.+||+.||++||++.+++++
T Consensus 238 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 238 ------QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ------HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 001111 1111111122355789999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=341.31 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=184.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 163 (428)
+.|...++||+|+||+||.+.... +..||||++... ..+.+.+|+.+|..+ +||||+++++++.+..
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~------g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--- 82 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQ------GRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDR--- 82 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESS------SSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS---
T ss_pred heeeccCeEeeCCCeEEEEEEEEC------CeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC---
Confidence 345567889999999998654332 338999998643 235678999999876 8999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCccc-----ccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC------
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETI-----LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ------ 232 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~------ 232 (428)
..++||||++ |+|.+++....... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 83 -~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 83 -FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp -EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSC
T ss_pred -eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccc
Confidence 4599999995 69999997543211 12334578999999999999998 99999999999999654
Q ss_pred -------CCeEEeeecccccCCCCCce--eeeeeeecCcccCCcchhcc-------CCCCCchhhhhHHHHHHHHHh-CC
Q 014245 233 -------WNAKLSDFGLARLGPSEGFT--HVSTAVVGTMGYAAPEYVQT-------GRLAARSDVWSYGVFLYELIT-GR 295 (428)
Q Consensus 233 -------~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~ 295 (428)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 47999999999876543211 11234689999999999975 568999999999999999999 99
Q ss_pred CCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc-CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 296 RPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV-DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 296 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.||....... ..... ... .+.........++.++.+++.+||+.||++||++.+++++
T Consensus 238 ~Pf~~~~~~~-~~i~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 238 HPFGDKYSRE-SNIIR-------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp CTTCSTTTHH-HHHHH-------------TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCchhhH-HHHhc-------------CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 9997543321 11110 011 1111222345678899999999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=334.38 Aligned_cols=244 Identities=24% Similarity=0.447 Sum_probs=197.6
Q ss_pred HHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc------cHHHHHHHHHHHhcCC--CCCcccEe
Q 014245 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ------GHKEWMTEVNFLGIVE--HQNLVKLV 153 (428)
Q Consensus 82 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~~~ 153 (428)
...++|.+.+.||+|+||.||+|....+ +..||+|.+...... ....+.+|+.+++.++ |+||++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSD-----NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTT-----TEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCC-----CcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 3457899999999999999999986554 358999998654321 2245678999999995 59999999
Q ss_pred eEEecCCCCCceEEEEEeecCC-CCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC-C
Q 014245 154 GYCADDDERGIQRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-E 231 (428)
Q Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~ 231 (428)
+++.... ..++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++ .
T Consensus 115 ~~~~~~~----~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 115 DWFERPD----SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN 185 (320)
T ss_dssp EEEECSS----EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred EEEecCC----cEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence 9998765 35999999976 8999988643 4589999999999999999999998 999999999999999 7
Q ss_pred CCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 232 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 232 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|..||.... ...
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~ 256 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII 256 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH
T ss_pred CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhh
Confidence 8899999999998654322 234679999999999987776 678999999999999999999996421 000
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 311 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.. ... ....+++++.+++.+||+.||++||++.+|+++
T Consensus 257 -------------~~--~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 -------------RG--QVF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -------------HC--CCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------------cc--ccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000 112244689999999999999999999999884
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.80 Aligned_cols=253 Identities=28% Similarity=0.399 Sum_probs=178.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cH-HHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GH-KEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||.||+|....++ ..||+|.+...... .. +.+.++..+++.++||||+++++++.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~- 97 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTG-----HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT- 97 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTC-----CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred hccccccceeeecCCeeEEEEEEecCC-----eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Confidence 357899999999999999999976543 38999999765432 22 33445556788889999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..++||||+ ++.+..+.. .....+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+||
T Consensus 98 ---~~~lv~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 98 ---DVFIAMELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp ---EEEEEECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ---cEEEEEecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence 459999999 555554443 223458999999999999999999997 5 8999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 315 (428)
|++....... ......||+.|+|||++. +..++.++||||||+++|+|++|..||........ .....
T Consensus 170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~-- 242 (318)
T 2dyl_A 170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTKV-- 242 (318)
T ss_dssp TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHH--
T ss_pred CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHHH--
Confidence 9997543321 223457999999999984 45688999999999999999999999976432211 11100
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ....+.+. ....++.++.+++.+||+.||.+||++.+++++
T Consensus 243 -~-------~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 243 -L-------QEEPPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -H-------HSCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -h-------ccCCCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 00011111 111245689999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.96 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=182.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 163 (428)
.+|...++||+|+||+||...... +..||||++...... .+.+|+.+|+.+ +|||||++++++.+..
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~------~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--- 91 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFD------NRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQ--- 91 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESS------SSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETT---
T ss_pred EEEecCCeeecCcCEEEEEEEEeC------CeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCC---
Confidence 468889999999999965433322 237999998754332 356899999999 8999999999998765
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-----CCCeEEe
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-----QWNAKLS 238 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~ 238 (428)
..+|||||++ |+|.+++..... .+.+..++.++.||+.||.|||++ +|+||||||+|||++. ...+||+
T Consensus 92 -~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 92 -FQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp -EEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred -EEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 3599999995 599998875432 344455678999999999999998 9999999999999943 3357899
Q ss_pred eecccccCCCCCc-eeeeeeeecCcccCCcchhc---cCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014245 239 DFGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 239 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 313 (428)
|||+++....... ........||+.|+|||++. ...++.++|||||||++|||++ |..||............
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~--- 242 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--- 242 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT---
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh---
Confidence 9999986543221 12234567999999999997 4567889999999999999999 99999654322111100
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....... ..........+.+|+.+||+.||++|||+.+++++
T Consensus 243 ----------~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 243 ----------GACSLDC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ----------TCCCCTT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----------ccCCccc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000000 01122456678899999999999999999999853
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.60 Aligned_cols=247 Identities=24% Similarity=0.324 Sum_probs=195.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|.+.+.||+|+||.||+|.+... .+..||||.+..... .....+.+|+.++..++||||+++++++...+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG----TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC----CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 36899999999999999999987542 134799999865433 3445788999999999999999999999876542
Q ss_pred Cc-eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 163 GI-QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 163 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
+. ..||||||++|++|.+++.. .+++..++.|+.||+.||.|||++ +|+||||||+|||++.+ .+||+|||
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 21 24999999999999988754 489999999999999999999998 99999999999999986 99999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+++..... ....||+.|+|||++.++ ++.++|||||||++|+|++|..||......
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------- 282 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------- 282 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------
T ss_pred cchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------
Confidence 99865432 345799999999998765 488999999999999999999888642110
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHhhh
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLEMVNKIVD 373 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~ell~~L~~~~~ 373 (428)
...........++.+.+++.+||+.||++||+ ++++...|..++.
T Consensus 283 -------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 283 -------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00011112234568999999999999999995 5666666666553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=314.31 Aligned_cols=232 Identities=14% Similarity=0.145 Sum_probs=182.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|.+.+.||+|+||.||+|....+ +..||+|.+...... ..+.+.+|+.++..++||||+++++++.+.+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~- 104 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTAL-----DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA- 104 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTT-----TEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred CcEEEEEEEcccCCeEEEEEEecCC-----CceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-
Confidence 5799999999999999999987643 348999999765432 2367899999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..|+||||++|++|.+++... .....+..|+.|++.||+|||++ +|+||||||+|||++.+|.+||+++|
T Consensus 105 ---~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 105 ---GGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp ---EEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred ---cEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence 459999999999999999542 34456788999999999999998 99999999999999999999998543
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
|++ .++.++|||||||++|+|++|+.||..........
T Consensus 175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------- 212 (286)
T 3uqc_A 175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------- 212 (286)
T ss_dssp ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-------------
T ss_pred ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-------------
Confidence 333 37889999999999999999999998654321000
Q ss_pred hhhhhcCCcCC--CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 322 QFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 322 ~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
........... ......+++++.+++.+||+.||++| |+.++++.|..+....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00000000000 01112355789999999999999999 9999999999876543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=347.25 Aligned_cols=275 Identities=25% Similarity=0.370 Sum_probs=202.6
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC-
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE- 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~- 161 (428)
.++|.+.+.||+|+||.||+|....+ +..||+|.+.... ....+.+.+|+.++..++||||+++++++.....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~t-----g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDT-----GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTT-----TCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCC-----CcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 36899999999999999999986543 3379999987643 2345678999999999999999999998765211
Q ss_pred -CCceEEEEEeecCCCCcccccCCCC-cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCC---eE
Q 014245 162 -RGIQRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN---AK 236 (428)
Q Consensus 162 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~---~k 236 (428)
.....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEE
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEE
Confidence 1224589999999999999987543 23588899999999999999999998 9999999999999987765 89
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 237 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 237 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|....
T Consensus 165 L~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i 236 (676)
T 3qa8_A 165 IIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKV 236 (676)
T ss_dssp ECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTC
T ss_pred Eccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhh
Confidence 99999998654332 234468999999999999999999999999999999999999999754221 1111100
Q ss_pred hhhhhh---hhhhcC--------CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHH-----HHHHHHhhhh
Q 014245 317 LSDAKQ---FRQIVD--------PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV-----LEMVNKIVDA 374 (428)
Q Consensus 317 ~~~~~~---~~~~~~--------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el-----l~~L~~~~~~ 374 (428)
...... ...... ..........++..+.+++.+||..||++|||+.++ ++.+..+...
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000000 000000 011123445678899999999999999999999884 4556655543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=314.29 Aligned_cols=235 Identities=21% Similarity=0.262 Sum_probs=181.1
Q ss_pred hcCCCCc-eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHH-hcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFL-GIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+. ++||+|+||.||+|....++ ..||+|.+.. ...+.+|+.++ +.++||||+++++++.....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCC-----cEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 3567777 78999999999999976543 3899999853 24677888888 56699999999999876222
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC---CCCeEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~ 238 (428)
.....++||||+++|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 233569999999999999999766556799999999999999999999998 9999999999999998 7889999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||++.... +..++.++|||||||++|+|++|..||.........
T Consensus 163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------- 207 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------- 207 (299)
T ss_dssp CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------
T ss_pred ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------
Confidence 999986432 245778999999999999999999999754321100
Q ss_pred hhhhhhhhcCCcCCCC--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
......+........ ....++.++.+++.+||+.||++|||+.+++++
T Consensus 208 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 208 -PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000000000000 002346789999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=328.39 Aligned_cols=246 Identities=16% Similarity=0.205 Sum_probs=182.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHHHHHHHHhcCCC-CCcccE-------
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLGIVEH-QNLVKL------- 152 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~nIv~~------- 152 (428)
+.+|...++||+|+||.||+|.+..++. .||||++..... ...+.+.+|+.++..+.| +|+..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~-----~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGE-----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCC-----ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 3457788899999999999999765433 899999874332 235778999999999987 322111
Q ss_pred --eeE------------EecCC-CCCceEEEEEeecCCCCcccccC-----CCCcccccHHHHHHHHHHHHHHHHHhhcC
Q 014245 153 --VGY------------CADDD-ERGIQRLLVYEYMPNGSVDQYLS-----PKSETILTWAMRLKIAQDAARGLAYLHEG 212 (428)
Q Consensus 153 --~~~------------~~~~~-~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 212 (428)
++. +.... ......+++|+++ +++|.+++. ......+++..++.|+.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 11111 0012347777766 789999884 23345688999999999999999999998
Q ss_pred CCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchh----------ccCCCCCchhhh
Q 014245 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV----------QTGRLAARSDVW 282 (428)
Q Consensus 213 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvw 282 (428)
+|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||
T Consensus 231 ---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 231 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp ---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred ---CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 9999999999999999999999999998764321 345678 999999999 555688899999
Q ss_pred hHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHH
Q 014245 283 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 362 (428)
Q Consensus 283 slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 362 (428)
||||++|||++|+.||....... ....++... ..+++.+.+|+.+||+.||++||++.
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~----------------~~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALG----------------GSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGS----------------CSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHCCCCCCCcchhh----------------hHHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999999997543211 111111111 12347899999999999999999988
Q ss_pred HHHH
Q 014245 363 EVLE 366 (428)
Q Consensus 363 ell~ 366 (428)
++++
T Consensus 360 ~~l~ 363 (413)
T 3dzo_A 360 QAME 363 (413)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8855
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.07 Aligned_cols=247 Identities=17% Similarity=0.200 Sum_probs=184.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--------ccHHHHHHHHHHHhcCC---------C
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--------QGHKEWMTEVNFLGIVE---------H 146 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h 146 (428)
.++|.+.+.||+|+||+||+|... +..||||++..... ...+.+.+|+.+++.++ |
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h 91 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIAD-------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT 91 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEET-------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred cccchheeeecccCceEEEEEEeC-------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence 357899999999999999999862 24899999976532 23367889999988885 8
Q ss_pred CCcccEeeEEecCC--------------------------CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHH
Q 014245 147 QNLVKLVGYCADDD--------------------------ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 200 (428)
Q Consensus 147 ~nIv~~~~~~~~~~--------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~ 200 (428)
|||+++++.+.... ......+|||||+++|++.+.+.. ..+++..++.|+.
T Consensus 92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILH 168 (336)
T ss_dssp CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHH
T ss_pred CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHH
Confidence 88888877653210 002256999999999977666643 3489999999999
Q ss_pred HHHHHHHHhh-cCCCCCeeeccCCCCceEECCCC--------------------CeEEeeecccccCCCCCceeeeeeee
Q 014245 201 DAARGLAYLH-EGMDFQIIVRDFKSSNILLDEQW--------------------NAKLSDFGLARLGPSEGFTHVSTAVV 259 (428)
Q Consensus 201 ~i~~~L~~LH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~ 259 (428)
||+.||+||| ++ +|+||||||+||||+.++ .+||+|||+|+.... ...+
T Consensus 169 qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~ 238 (336)
T 2vuw_A 169 QLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVV 238 (336)
T ss_dssp HHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEE
T ss_pred HHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEE
Confidence 9999999999 88 999999999999999887 899999999986532 2358
Q ss_pred cCcccCCcchhccCCCCCchhhhhHHHH-HHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh-hcCCcCCCCccH
Q 014245 260 GTMGYAAPEYVQTGRLAARSDVWSYGVF-LYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ-IVDPRLEGKYSL 337 (428)
Q Consensus 260 gt~~y~aPE~~~~~~~~~~~DvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~ 337 (428)
||+.|+|||++.+.. +.++||||||++ .+++++|..||... .|...... ..... ............
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~--~~~~~~~~~~~~~~~~~~ 306 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTD--KMLKQMTFKTKCNTPAMK 306 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHH--HHHHTCCCSSCCCSHHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHH--hhhhhhccCcccchhhhh
Confidence 999999999998665 889999998777 77888899998421 01000000 00001 011111222345
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHH-HH
Q 014245 338 RLVSKLSHVANLCLVKNARTRPKMSEVL-EM 367 (428)
Q Consensus 338 ~~~~~l~~li~~cl~~dp~~RPs~~ell-~~ 367 (428)
.+++++.+|+.+||+.| |+.|++ ++
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 68899999999999976 899988 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-34 Score=290.43 Aligned_cols=185 Identities=17% Similarity=0.100 Sum_probs=126.0
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----------ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCC
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----------QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 161 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 161 (428)
++.|++|.+..+..... +..+++|.+.+... ...++|.+|+++|+++ .|+||+++++++.++..
T Consensus 242 ~~~~~~~~h~~~rr~~f-----g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFF-----GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp -C--------CCEEEEE-----CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred cccCCcccccccccccc-----cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 44555555444332221 22589999875421 1235689999999999 79999999999988764
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.||||||++|++|.++|.... .++.. +|+.||+.||+|||++ |||||||||+||||+.+|++||+|||
T Consensus 317 ----~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG 384 (569)
T 4azs_A 317 ----GWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG 384 (569)
T ss_dssp ----EEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred ----EEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence 599999999999999997543 46654 5889999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCC
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 297 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 297 (428)
+|+...... ......+||+.|||||++.+ .+..++|+|++|+++++|.++..+
T Consensus 385 lAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 385 SIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 998654332 22345789999999999875 567789999999998887766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=260.13 Aligned_cols=186 Identities=18% Similarity=0.255 Sum_probs=142.4
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc--------cHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ--------GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
...++||+|+||.||+|...+. .+++|........ ..+++.+|+.+|++++||||+++..++.+.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~-------~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDF-------DVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL 411 (540)
T ss_dssp ---------CCEEEEEEECSSC-------EEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET
T ss_pred CCCCEEeeCCCEEEEEEEECCC-------eEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC
Confidence 4456899999999999954432 6788876443211 134578999999999999999655555554
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
... +|||||+++++|.+++.. ++.++.|++.||.|||++ +|+||||||+|||++. .+||+|
T Consensus 412 ~~~----~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 412 DNK----RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp TTT----EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred Ccc----EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence 443 999999999999999964 458999999999999998 9999999999999999 999999
Q ss_pred ecccccCCCCCcee-----eeeeeecCcccCCcchhcc--CCCCCchhhhhHHHHHHHHHhCCCCCC
Q 014245 240 FGLARLGPSEGFTH-----VSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPID 299 (428)
Q Consensus 240 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~ 299 (428)
||+++......... ......||+.|||||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99998765422111 1235789999999999987 568888999999999999888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-26 Score=211.82 Aligned_cols=151 Identities=14% Similarity=0.069 Sum_probs=117.6
Q ss_pred HHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc------------------ccHHHHHHHHHHH
Q 014245 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV------------------QGHKEWMTEVNFL 141 (428)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l 141 (428)
+......|.+.+.||+|+||.||+|.. .+ +..||+|.+..... .....+.+|+.+|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~-----g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l 158 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EK-----FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 158 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-TT-----TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-CC-----CCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence 333445677789999999999999987 32 34899999864321 1245688999999
Q ss_pred hcCCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeecc
Q 014245 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRD 221 (428)
Q Consensus 142 ~~l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD 221 (428)
+.++ | +++++++... . .++||||++||+|.+ +.. .....++.|++.||.|||+. +|+|||
T Consensus 159 ~~l~--~-~~v~~~~~~~-~----~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrD 218 (282)
T 1zar_A 159 QKLQ--G-LAVPKVYAWE-G----NAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGD 218 (282)
T ss_dssp HHTT--T-SSSCCEEEEE-T----TEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred Hhcc--C-CCcCeEEecc-c----eEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCC
Confidence 9998 4 6666655432 2 389999999999998 532 12346999999999999998 999999
Q ss_pred CCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc
Q 014245 222 FKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 272 (428)
Q Consensus 222 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 272 (428)
|||+|||++ ++.+||+|||+++ .+..|+|||++..
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSV---------------EVGEEGWREILER 253 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHHH
Confidence 999999999 9999999999986 3445789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=180.42 Aligned_cols=137 Identities=17% Similarity=0.080 Sum_probs=101.9
Q ss_pred CCCceeecccCceEEEEEEEcCCCCCCcceE--EEEEEccCCCcc------------------------cHHHHHHHHHH
Q 014245 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVE--VAVKQLGRRGVQ------------------------GHKEWMTEVNF 140 (428)
Q Consensus 87 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~ 140 (428)
|.+.+.||+|+||.||+|....+ +.. ||||++...... ....+.+|+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~-----g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFD-----GKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEET-----TEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCC-----CcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 56788999999999999987322 236 999987543111 01357899999
Q ss_pred HhcCCCCCc--ccEeeEEecCCCCCceEEEEEeecCC-C----CcccccCCCCcccccHHHHHHHHHHHHHHHHHhh-cC
Q 014245 141 LGIVEHQNL--VKLVGYCADDDERGIQRLLVYEYMPN-G----SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH-EG 212 (428)
Q Consensus 141 l~~l~h~nI--v~~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~ 212 (428)
|..+.|++| +.++++ . . .+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.
T Consensus 124 l~~l~~~~i~~p~~~~~--~--~----~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY--M--K----NVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HHHHHHTTCCCCCEEEE--E--T----TEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHhCCCCCCeEEEc--C--C----CEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence 999988864 444432 1 2 2899999942 4 44443321 234467789999999999999 87
Q ss_pred CCCCeeeccCCCCceEECCCCCeEEeeecccccC
Q 014245 213 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 246 (428)
Q Consensus 213 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 246 (428)
+|+||||||+|||++. .++|+|||+|...
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999998 9999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=6.1e-18 Score=162.97 Aligned_cols=137 Identities=15% Similarity=0.081 Sum_probs=97.5
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--------------ccHHH--------HHHHHHHHhc
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--------------QGHKE--------WMTEVNFLGI 143 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~ 143 (428)
=|++...||+|+||.||+|.... +..||||++..... ..... ...|...|.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~------G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK------GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT------CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCC------CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 38999999999999999998644 34899998753210 00111 1346666777
Q ss_pred CCCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 014245 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 223 (428)
Q Consensus 144 l~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 223 (428)
+.+.++.-..-+.... . +|||||++|++|.++.... ....++.|++.+|.|||+. ||||||||
T Consensus 170 L~~~gv~vp~p~~~~~--~----~LVME~i~G~~L~~l~~~~--------~~~~l~~qll~~l~~lH~~---gIVHrDLK 232 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQSR--H----TIVMSLVDALPMRQVSSVP--------DPASLYADLIALILRLAKH---GLIHGDFN 232 (397)
T ss_dssp HHHTTCSCCCEEEEET--T----EEEEECCSCEEGGGCCCCS--------CHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred HHhcCCCCCeeeeccC--c----eEEEEecCCccHhhhcccH--------HHHHHHHHHHHHHHHHHHC---CCcCCCCC
Confidence 7544432221121221 1 7999999999987765321 2346789999999999998 99999999
Q ss_pred CCceEECCCCC----------eEEeeeccccc
Q 014245 224 SSNILLDEQWN----------AKLSDFGLARL 245 (428)
Q Consensus 224 p~NILl~~~~~----------~kl~DFGla~~ 245 (428)
|.|||+++++. +.|+||+-+..
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999988773 89999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=126.52 Aligned_cols=147 Identities=15% Similarity=0.073 Sum_probs=110.6
Q ss_pred HHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCCcccEeeEEec
Q 014245 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQNLVKLVGYCAD 158 (428)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 158 (428)
+......|.+...++.|+.+.||++...+ ..+++|............+.+|+.+++.+ .+..+.++++++.+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~-------~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGEN-------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECSS-------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECCC-------CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 44556789888889999999999986432 27999998653222334688999999988 46778899998876
Q ss_pred CCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCC-------------------------
Q 014245 159 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM------------------------- 213 (428)
Q Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------- 213 (428)
.. ..|+||||++|.+|.+.+... .....++.+++.+|..||+..
T Consensus 82 ~~----~~~lv~e~i~G~~l~~~~~~~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 82 DG----WSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp TT----EEEEEEECCSSEEHHHHCCTT-------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred CC----ceEEEEEecCCeehhhccCCc-------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 54 349999999999987764211 122367889999999999810
Q ss_pred -------------------------------CCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 214 -------------------------------DFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 214 -------------------------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1359999999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.8e-12 Score=116.10 Aligned_cols=137 Identities=14% Similarity=0.066 Sum_probs=95.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC--cccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN--LVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~ 162 (428)
.+|.+..+.+.|..+.||++...++ ..+++|..... ....+..|+.+++.+.+.+ +.+++++....+.
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g------~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~- 89 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGR------PVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR- 89 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTS------CCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-
T ss_pred CCCceEecccCCCCceEEEEecCCC------CeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC-
Confidence 3454443334566699999864332 25889987543 2245778999999885544 5568887766542
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCC-----------------------------
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM----------------------------- 213 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------- 213 (428)
.++||||++|.+|. ... .. ...++.+++..|..||...
T Consensus 90 ---~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (264)
T 1nd4_A 90 ---DWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD 156 (264)
T ss_dssp ---EEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred ---CEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence 49999999998884 321 11 1256778888888888642
Q ss_pred --------------------------CCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 214 --------------------------DFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 214 --------------------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
...++|+|++|.|||+++++.+.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=4.3e-11 Score=115.52 Aligned_cols=147 Identities=14% Similarity=0.188 Sum_probs=106.4
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEcc--CCC-cccHHHHHHHHHHHhcCC--CCCcccEeeEEecCCCC
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG--RRG-VQGHKEWMTEVNFLGIVE--HQNLVKLVGYCADDDER 162 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~ 162 (428)
...+.|+.|.++.||+....+. .+++|+.. ... ......+.+|+.+++.|. +..+.+++.++.+....
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~-------~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~ 113 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQ-------TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI 113 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSC-------EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred ceEEEcCCcccceEEEEEECCc-------eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence 3466899999999999875432 68888765 322 122346778999999986 45688899888765322
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCC-----------------------------
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM----------------------------- 213 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------- 213 (428)
+ ..|+||||++|..+.+... ..++......++.+++..|+.||...
T Consensus 114 g-~~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 114 G-RAFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp S-SCEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred C-CeEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 1 3489999999988865321 12677788889999999999999721
Q ss_pred --------------------------CCCeeeccCCCCceEECCCCC--eEEeeecccccC
Q 014245 214 --------------------------DFQIIVRDFKSSNILLDEQWN--AKLSDFGLARLG 246 (428)
Q Consensus 214 --------------------------~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~ 246 (428)
...++|+|+++.|||++.++. +.|+||+.+...
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=5.2e-11 Score=112.18 Aligned_cols=186 Identities=20% Similarity=0.216 Sum_probs=120.5
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcC-CCCC--cccEeeEEecCCCCCceE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV-EHQN--LVKLVGYCADDDERGIQR 166 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--Iv~~~~~~~~~~~~~~~~ 166 (428)
.+.++.|.+..||+.. . .+++|..... .....+.+|+.+|+.+ .+.. +.+++.+...... ....
T Consensus 25 i~~~~~G~~n~v~~v~----~------~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~-~~~~ 91 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----R------DFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSET-YQMS 91 (304)
T ss_dssp CCEEEECSSEEEEEST----T------SEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS-CSCS
T ss_pred eEecCCCCcceEEEEC----C------EEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCC-CCcc
Confidence 4568999999999852 1 4788875422 3346788999999887 3333 4455554433221 1123
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG---------------------------------- 212 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------- 212 (428)
|+|||+++|.+|.+... ..++......++.+++..|..||..
T Consensus 92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 88999999988865321 2256667778888888888888851
Q ss_pred ---------------------CCCCeeeccCCCCceEECC--CCCeEEeeecccccCCCCCceeeeeeeecCccc---CC
Q 014245 213 ---------------------MDFQIIVRDFKSSNILLDE--QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY---AA 266 (428)
Q Consensus 213 ---------------------~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~a 266 (428)
....++|+|++|.|||+++ +..+.|+||+.+....... . ......+ ..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-D-----l~~~~~~~~~~~ 241 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-D-----FISLMEDDEEYG 241 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-H-----HHTTCCTTTSCC
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-H-----HHHHHhhccccC
Confidence 1135899999999999988 5567899999987543210 0 0001111 23
Q ss_pred cchhcc-----CCC---------CCchhhhhHHHHHHHHHhCCCCC
Q 014245 267 PEYVQT-----GRL---------AARSDVWSYGVFLYELITGRRPI 298 (428)
Q Consensus 267 PE~~~~-----~~~---------~~~~DvwslG~il~elltg~~p~ 298 (428)
|+.... +.. ....+.|++|.+++.+.+|..+|
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 332111 111 12268999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=8e-07 Score=83.46 Aligned_cols=137 Identities=18% Similarity=0.146 Sum_probs=90.6
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCC---CcccEeeEEecCCCCCceE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQ---NLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~~~~~~~~~~ 166 (428)
...++.|....||+. + . .+++|.-. .......+..|+.+|..|.+. .+.+++.++..... ..
T Consensus 24 v~~l~~G~~n~v~~v---g-~------~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g---~~ 88 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---N-G------DWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDG---NP 88 (306)
T ss_dssp EEEEEECSSEEEEEE---T-T------TEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTS---CE
T ss_pred eeecCCCcceeEEEE---C-C------EEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCC---ce
Confidence 456888888899987 2 1 47788742 223346788999999999653 35666777653222 34
Q ss_pred EEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 014245 167 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG---------------------------------- 212 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------- 212 (428)
++||||++|..|.+..- ..++......++.+++..|..||..
T Consensus 89 ~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 89 FVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp EEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred EEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 89999999988865211 0133344445555555555555532
Q ss_pred -----------------------CCCCeeeccCCCCceEECC---CCCe-EEeeeccccc
Q 014245 213 -----------------------MDFQIIVRDFKSSNILLDE---QWNA-KLSDFGLARL 245 (428)
Q Consensus 213 -----------------------~~~~ivHrDlkp~NILl~~---~~~~-kl~DFGla~~ 245 (428)
....++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 4554 8999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=8.7e-07 Score=84.95 Aligned_cols=91 Identities=9% Similarity=0.014 Sum_probs=56.4
Q ss_pred ceee-cccCceEEEEEEEcCCCCC-CcceEEEEEEccCCC---cccHHHHHHHHHHHhcCC-C--CCcccEeeEEecCCC
Q 014245 90 SVVI-GEGGFGCVYKGLIKNSEDP-SQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVE-H--QNLVKLVGYCADDDE 161 (428)
Q Consensus 90 ~~~l-G~G~~g~Vy~~~~~~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~~~ 161 (428)
.+.| +.|....+|+.......+. ..+..+++|...... ......+.+|+.+++.|. + -.+.+++.++.+...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 8888899998764300000 012368888764422 111245778888888883 2 357788888765432
Q ss_pred CCceEEEEEeecCCCCcccc
Q 014245 162 RGIQRLLVYEYMPNGSVDQY 181 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~ 181 (428)
.+ ..++||||++|..+.+.
T Consensus 105 ~g-~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 105 LG-TPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp TS-SCEEEEECCCCBCCCBT
T ss_pred cC-CceEEEEecCCCChhhc
Confidence 11 23899999999887653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=9e-07 Score=81.31 Aligned_cols=141 Identities=19% Similarity=0.127 Sum_probs=91.9
Q ss_pred cCCCCceeecccCce-EEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFG-CVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~ 162 (428)
..|+.. .+..|..| .||+.....+. ..+++|.-... ....+..|..+|+.|. +--+.++++++.+.+.
T Consensus 25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~-----~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~- 94 (272)
T 4gkh_A 25 YGYRWA-RDNVGQSGATIYRLYGKPNA-----PELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD- 94 (272)
T ss_dssp TTCEEE-EEECSSSSCEEEEEECCTTC-----CCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE-
T ss_pred cCCeEE-EccCCCcCCeEEEEEecCCC-----eEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe-
Confidence 344432 44556655 68986643322 25788875432 3456778999998873 3346788888877653
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG------------------------------ 212 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------ 212 (428)
.++|||+++|.++.+..... ......+..+++..|..||..
T Consensus 95 ---~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (272)
T 4gkh_A 95 ---AWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDAS 165 (272)
T ss_dssp ---EEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGG
T ss_pred ---EEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhh
Confidence 49999999998776544211 112234555666666666631
Q ss_pred -------------------------CCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 213 -------------------------MDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 213 -------------------------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
....++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 166 DFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 11237999999999999988777899998874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=2.9e-06 Score=82.62 Aligned_cols=76 Identities=13% Similarity=0.026 Sum_probs=47.7
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-------ccHHHHHHHHHHHhcCCC--C-CcccEeeEEecC
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-------QGHKEWMTEVNFLGIVEH--Q-NLVKLVGYCADD 159 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~~~~~~~~~ 159 (428)
.+.||.|.++.||++....+ +..+++|....... ....++..|.++|..+.. + .+.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~-----~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEH-----DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T
T ss_pred EEECCCCceEEEEEEEECCC-----CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C
Confidence 56799999999999964432 23689997653211 123456789988887732 3 344666442 2
Q ss_pred CCCCceEEEEEeecCCC
Q 014245 160 DERGIQRLLVYEYMPNG 176 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g 176 (428)
... ++||||+++.
T Consensus 108 ~~~----~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMA----VTVMEDLSHL 120 (397)
T ss_dssp TTT----EEEECCCTTS
T ss_pred Ccc----EEEEEeCCCc
Confidence 222 8999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.14 E-value=2.3e-05 Score=74.24 Aligned_cols=31 Identities=19% Similarity=0.242 Sum_probs=27.7
Q ss_pred CCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 214 DFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 214 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3489999999999999888899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.8e-05 Score=72.02 Aligned_cols=138 Identities=13% Similarity=0.081 Sum_probs=87.2
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC---CCCcccEeeEEecCCCCCce
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~~~ 165 (428)
..+.|+.|.+..+|+....+ ..+++|..... ....+..|+..|+.|. ...+.++++++...+ .
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~-------~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g----~ 105 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEV-------QTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG----H 105 (312)
T ss_dssp EEEEECCSSSSEEEEEESSS-------CEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS----E
T ss_pred eeEEeCCccceeeeEEEECC-------CeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC----c
Confidence 34678999999999986421 26888876532 2456788999988883 356888888876643 3
Q ss_pred EEEEEeecCCCCccccc-----------CCCCc------------c--------cccHHHHH---HHH------------
Q 014245 166 RLLVYEYMPNGSVDQYL-----------SPKSE------------T--------ILTWAMRL---KIA------------ 199 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l-----------~~~~~------------~--------~l~~~~~~---~i~------------ 199 (428)
.++||||++|..+..-. ..... + .-+|...+ ++.
T Consensus 106 ~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~ 185 (312)
T 3jr1_A 106 SFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLI 185 (312)
T ss_dssp EEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCC
T ss_pred eEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCC
Confidence 59999999998764211 00000 0 01343321 011
Q ss_pred ----HHHHHHH-HHhhc-CCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 200 ----QDAARGL-AYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 200 ----~~i~~~L-~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++..+ ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 186 ~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 186 FGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred hHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1122222 23421 2245899999999999999887 8899973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.86 E-value=5.7e-05 Score=69.94 Aligned_cols=80 Identities=14% Similarity=0.123 Sum_probs=56.3
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC---CCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH---QNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~~~~ 162 (428)
....+..+|.|..+.||+....++. .|.+|+...........|..|+..|+.|.- --+.+++++. ..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~------~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~-- 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGT------PLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DR-- 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSC------EEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TT--
T ss_pred CeEEEEecCCCCCeEEEEEEECCCC------EEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--Cc--
Confidence 4555678999999999999876653 789998765444444567889999988842 2355565542 22
Q ss_pred CceEEEEEeecCCCCcc
Q 014245 163 GIQRLLVYEYMPNGSVD 179 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~ 179 (428)
++||||++++...
T Consensus 86 ----~lv~e~l~~~~~~ 98 (288)
T 3f7w_A 86 ----TLAMEWVDERPPT 98 (288)
T ss_dssp ----EEEEECCCCCCCC
T ss_pred ----eEEEEeecccCCC
Confidence 7999999876653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=6.1e-05 Score=73.79 Aligned_cols=76 Identities=13% Similarity=0.219 Sum_probs=45.8
Q ss_pred CCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeec--CcccCCcchhccCC---CCCchhhhhHHHHHH
Q 014245 215 FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG--TMGYAAPEYVQTGR---LAARSDVWSYGVFLY 289 (428)
Q Consensus 215 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwslG~il~ 289 (428)
..++|+|++|.|||++.++ ++|+||+.+...... .. ... ..+ ...|++|+...... -....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~D-la~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FD-IGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HH-HHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HH-HHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3899999999999999876 999999988653311 00 000 000 13456665443111 112345557777777
Q ss_pred HHHhC
Q 014245 290 ELITG 294 (428)
Q Consensus 290 elltg 294 (428)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77665
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.73 E-value=0.0002 Score=67.18 Aligned_cols=161 Identities=11% Similarity=0.107 Sum_probs=86.2
Q ss_pred ccCHHHHHHHhcCCCCc-----eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC
Q 014245 74 EFTIAELKSATKNFSRS-----VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN 148 (428)
Q Consensus 74 ~~~~~~~~~~~~~~~~~-----~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 148 (428)
.++.+++......|... +.|+.|....+|+....++ .+++|...... ....+..|+.++..|...+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-------~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g 76 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-------PLILTLYEKRV--EKNDLPFFLGLMQHLAAKG 76 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-------CEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-------cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCC
Confidence 45666777776667652 3566788889999875432 47888876531 2235566777777663222
Q ss_pred --cccEeeEEecCCC---CCceEEEEEeecCCCCcccc--------------cC----C--CC----cccccHHHHHH--
Q 014245 149 --LVKLVGYCADDDE---RGIQRLLVYEYMPNGSVDQY--------------LS----P--KS----ETILTWAMRLK-- 197 (428)
Q Consensus 149 --Iv~~~~~~~~~~~---~~~~~~lv~e~~~~g~L~~~--------------l~----~--~~----~~~l~~~~~~~-- 197 (428)
+.+++... +... .....++||+|++|..+... ++ . .. .....|...+.
T Consensus 77 ~~vP~~~~~~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~ 155 (322)
T 2ppq_A 77 LSCPLPLPRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS 155 (322)
T ss_dssp CCCCCBCCBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred CCCCcccCCC-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHH
Confidence 23333211 0000 01134899999998765421 00 0 00 00011221100
Q ss_pred ----------HHHHHHHHHHHhhc----CCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 198 ----------IAQDAARGLAYLHE----GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 198 ----------i~~~i~~~L~~LH~----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
+...+...++.+.. ....+++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 156 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113334444442 113479999999999999987666899998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.0002 Score=66.62 Aligned_cols=130 Identities=12% Similarity=0.100 Sum_probs=75.0
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCc-ccEeeEEecCCCCCceE
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQR 166 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~~~~ 166 (428)
.-.+.|+.|....+|+. . .+++|........ .....+|+.+++.+...++ .++++++.+..
T Consensus 21 ~~i~~l~gG~tN~~~~~----~-------~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~------ 82 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA----G-------DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATG------ 82 (301)
T ss_dssp CSCEEEESCSSEEEEEE----T-------TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTC------
T ss_pred cceeEcCCcccccccee----e-------eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCC------
Confidence 33678999999999997 1 4788877543211 1123467877777643233 46665432222
Q ss_pred EEEEeec-CCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 014245 167 LLVYEYM-PNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE---------------------------------- 211 (428)
Q Consensus 167 ~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~---------------------------------- 211 (428)
++|+||+ +|.+|..... . ....++.+++..|.-||.
T Consensus 83 ~~v~e~i~~g~~l~~~~~-------~--~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (301)
T 3dxq_A 83 VMVTRYIAGAQTMSPEKF-------K--TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYH 153 (301)
T ss_dssp CEEEECCTTCEECCHHHH-------H--HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHH
T ss_pred EEEEeecCCCccCCHhhH-------h--hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHH
Confidence 6899999 6655532100 0 000112222222222222
Q ss_pred ----------------CCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 212 ----------------GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 212 ----------------~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
.....++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 154 ~l~~~~~~l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 154 DVVREAGGVRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHHHHHHHHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 11335899999999999 5566789999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00044 Score=67.86 Aligned_cols=80 Identities=14% Similarity=0.163 Sum_probs=50.6
Q ss_pred ceeecccCceEEEEEEEcCCCCC--CcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC-cccEeeEEecCCCCCceE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDP--SQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDERGIQR 166 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~~~~ 166 (428)
.+.|+.|....||++...+.... .....+++|+..... ....+..|+.++..|...+ ..++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~------ 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G------ 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C------
Confidence 45678888899999876532100 012368888874321 1245668999998884333 366776553 2
Q ss_pred EEEEeecCCCCcc
Q 014245 167 LLVYEYMPNGSVD 179 (428)
Q Consensus 167 ~lv~e~~~~g~L~ 179 (428)
.+|+||++|.+|.
T Consensus 148 g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 148 GRLEEYIPSRPLS 160 (429)
T ss_dssp EEEECCCCEEECC
T ss_pred CEEEEEeCCcccC
Confidence 4799999875554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0028 Score=59.36 Aligned_cols=159 Identities=11% Similarity=0.075 Sum_probs=85.0
Q ss_pred cCHHHHHHHhcCCC-----CceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC-
Q 014245 75 FTIAELKSATKNFS-----RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN- 148 (428)
Q Consensus 75 ~~~~~~~~~~~~~~-----~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n- 148 (428)
.+.+.+......|. ....|+ |....||+....++ ..+++|...... .....+..|..++..|....
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g------~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~ 82 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDR------RRFVVKFYRPER-WTADQILEEHQFALQLVNDEV 82 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTC------CCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCC------CEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCC
Confidence 44445544444443 234577 88889998754332 258899876332 13456677888887773222
Q ss_pred -cccEeeEEecCCC---CCceEEEEEeecCCCCcccc----c--------------CCC---CcccccHHHH--------
Q 014245 149 -LVKLVGYCADDDE---RGIQRLLVYEYMPNGSVDQY----L--------------SPK---SETILTWAMR-------- 195 (428)
Q Consensus 149 -Iv~~~~~~~~~~~---~~~~~~lv~e~~~~g~L~~~----l--------------~~~---~~~~l~~~~~-------- 195 (428)
+++++.. +... .....++||||++|..+... + ... ....+++...
T Consensus 83 ~vp~~~~~--~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (328)
T 1zyl_A 83 PVAAPVAF--NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLF 160 (328)
T ss_dssp SBCCCCCB--TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHH
T ss_pred eecceeec--CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHH
Confidence 4444433 1110 01244789999988655420 0 000 0011121110
Q ss_pred --------------HHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 196 --------------LKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 196 --------------~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
...+..++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 161 EDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1112222222222211 1234789999999999999 4 899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00097 Score=65.87 Aligned_cols=76 Identities=13% Similarity=0.111 Sum_probs=46.9
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCc-ccEeeEEecCCCCCceEEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~~~~~l 168 (428)
++.|+.|-...+|++...+. ...+++|+....... .-.-.+|+.++..|...++ .++++++. + .+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~-----~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~------G~ 178 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSK-----QAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N------GR 178 (458)
T ss_dssp EEEECC--CEEEEEEEETTT-----TEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T------EE
T ss_pred EEEcCCCeEeEEEEEEECCC-----CceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C------eE
Confidence 45677788899999876541 236788876443211 1112488888888855444 56777662 2 36
Q ss_pred EEeecCCCCcc
Q 014245 169 VYEYMPNGSVD 179 (428)
Q Consensus 169 v~e~~~~g~L~ 179 (428)
||||++|.+|.
T Consensus 179 v~e~I~G~~l~ 189 (458)
T 2qg7_A 179 IEEFMDGYALS 189 (458)
T ss_dssp EEECCCSEECC
T ss_pred EEEeeCCccCC
Confidence 99999986654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00081 Score=64.70 Aligned_cols=146 Identities=15% Similarity=0.158 Sum_probs=81.6
Q ss_pred ceeecccCceEEEEEEEcCCC--CCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCCceE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSE--DPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~ 166 (428)
.+.|..|-...+|++...++. .......+++|+.... ........+|..+++.|. +.-..++++++.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-------- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-------- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------
Confidence 345766888889998764210 0112246888885332 234456678999998883 3334667766532
Q ss_pred EEEEeecCCCCcccc-cC----------------CC---Ccccc--cHHHHHHHHHHHHH-------------------H
Q 014245 167 LLVYEYMPNGSVDQY-LS----------------PK---SETIL--TWAMRLKIAQDAAR-------------------G 205 (428)
Q Consensus 167 ~lv~e~~~~g~L~~~-l~----------------~~---~~~~l--~~~~~~~i~~~i~~-------------------~ 205 (428)
.+||||++|..|..- +. .. ..... -+..+.++..++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 379999998766421 10 00 00111 23444444433321 1
Q ss_pred HHHh----hc-CCCCCeeeccCCCCceEECCC----CCeEEeeecccc
Q 014245 206 LAYL----HE-GMDFQIIVRDFKSSNILLDEQ----WNAKLSDFGLAR 244 (428)
Q Consensus 206 L~~L----H~-~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~ 244 (428)
+..| .. .....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2222 21 123479999999999999876 789999998774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.001 Score=62.68 Aligned_cols=33 Identities=33% Similarity=0.510 Sum_probs=28.1
Q ss_pred CCCeeeccCCCCceEECCC----CCeEEeeecccccC
Q 014245 214 DFQIIVRDFKSSNILLDEQ----WNAKLSDFGLARLG 246 (428)
Q Consensus 214 ~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~ 246 (428)
...++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3489999999999999874 67899999988654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00086 Score=64.28 Aligned_cols=80 Identities=11% Similarity=0.088 Sum_probs=44.3
Q ss_pred ceeecccCceEEEEEEEcCCC---CCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCC-cccEeeEEecCCCCCce
Q 014245 90 SVVIGEGGFGCVYKGLIKNSE---DPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDERGIQ 165 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~~~ 165 (428)
...|+.|....+|+....++. .......+++|+..... ........|..++..|...+ +.++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~----- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG----- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CC-----
Confidence 346777888899998754310 00011368888765432 11112357888888774333 45676554 22
Q ss_pred EEEEEeecCCCCc
Q 014245 166 RLLVYEYMPNGSV 178 (428)
Q Consensus 166 ~~lv~e~~~~g~L 178 (428)
++||||++|..+
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 689999988655
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0038 Score=54.46 Aligned_cols=97 Identities=12% Similarity=0.064 Sum_probs=63.0
Q ss_pred CcccccCCCCcccccHHHHHHHHHHHHHHHHHhh-cCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeee
Q 014245 177 SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH-EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255 (428)
Q Consensus 177 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 255 (428)
+|.+.|... ..++++.++|.++.|.+.+|.-+- .+ .-..+=+.|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 567777643 357999999999999999987762 11 111233457899999999998764 2111
Q ss_pred eeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh
Q 014245 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293 (428)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 293 (428)
.....+.+||... ...+.+.=|||||+++|..+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888653 344678899999999999987
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0061 Score=57.63 Aligned_cols=31 Identities=16% Similarity=0.316 Sum_probs=27.7
Q ss_pred CCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 215 FQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 215 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.03 Score=54.51 Aligned_cols=81 Identities=9% Similarity=0.054 Sum_probs=47.9
Q ss_pred ceeecccCceEEEEEEEcCCCCC--CcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCCceE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDP--SQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++.|..|-...+|+......... .....+++++..... ...-.-.+|..+++.|. +.-..++++.+ .+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~------ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE------ 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT------
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC------
Confidence 35677788889999876532110 012368888864432 11122357888888773 33345666543 22
Q ss_pred EEEEeecCCCCcc
Q 014245 167 LLVYEYMPNGSVD 179 (428)
Q Consensus 167 ~lv~e~~~~g~L~ 179 (428)
++||||++|..|.
T Consensus 146 ~~I~efI~G~~l~ 158 (424)
T 3mes_A 146 GRIEEFIDGEPLT 158 (424)
T ss_dssp EEEEECCCSEECC
T ss_pred CEEEEEeCCccCC
Confidence 7899999987653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.14 E-value=0.093 Score=50.64 Aligned_cols=29 Identities=31% Similarity=0.387 Sum_probs=24.6
Q ss_pred CeeeccCCCCceEE------CCCCCeEEeeecccc
Q 014245 216 QIIVRDFKSSNILL------DEQWNAKLSDFGLAR 244 (428)
Q Consensus 216 ~ivHrDlkp~NILl------~~~~~~kl~DFGla~ 244 (428)
.++|+|+.+.|||+ +++..+.++||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456779999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.80 E-value=1.1 Score=38.75 Aligned_cols=115 Identities=9% Similarity=0.068 Sum_probs=76.9
Q ss_pred CCCCcccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCC
Q 014245 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 224 (428)
Q Consensus 145 ~h~nIv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp 224 (428)
.||+.+.. .+-.+++ -+++.|-...+...|-.- ..++....++++.+|+....+++. -+|--|.|
T Consensus 43 ~~~~Fl~~-~I~e~eD------~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELRD------SFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECSS------EEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred cCCcccce-EEEEccc------EEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 68888866 3444444 234445433333333321 236778889999999988877664 47889999
Q ss_pred CceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhh-hHHHHHHHHHhCCCCCC
Q 014245 225 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVW-SYGVFLYELITGRRPID 299 (428)
Q Consensus 225 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw-slG~il~elltg~~p~~ 299 (428)
+||+++.++.++|.-.|+...+ +|. ..+ ..|.| .+=|++..+++++..|+
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTB-------------------SCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999987765322 221 111 12333 57889999999998885
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.41 E-value=1.4 Score=38.36 Aligned_cols=80 Identities=11% Similarity=0.140 Sum_probs=59.5
Q ss_pred ccHHHHHHHHHHHHHHHH-HhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcc
Q 014245 190 LTWAMRLKIAQDAARGLA-YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268 (428)
Q Consensus 190 l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 268 (428)
++...+++++.+|+.... +++ .-+|--|.|+||++|.++.++|.-.|+-.. ++|.
T Consensus 82 ~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP~ 137 (219)
T 4ano_A 82 TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKES-------------------LPPD 137 (219)
T ss_dssp SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTT-------------------BSSC
T ss_pred cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCccc-------------------CCCC
Confidence 677888999999988777 666 457889999999999999999998876532 2332
Q ss_pred hhccCCCCCchhhh-hHHHHHHHHHhCCCCCC
Q 014245 269 YVQTGRLAARSDVW-SYGVFLYELITGRRPID 299 (428)
Q Consensus 269 ~~~~~~~~~~~Dvw-slG~il~elltg~~p~~ 299 (428)
- .+ ..|.| .+=|++..++.++..|+
T Consensus 138 e-----~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 138 E-----WD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp S-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred C-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 1 11 22333 57888999999888774
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.91 E-value=0.09 Score=51.82 Aligned_cols=63 Identities=10% Similarity=0.122 Sum_probs=17.5
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEE------EEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecC
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV------KQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 159 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 159 (428)
+.+.|| ||.||+|.+.... .+||+ |....... .....+.+|..++..++|||+++.+++....
T Consensus 146 l~~~lG---fG~v~~g~~~~~~-----~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~~ 216 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKH-----MPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVHT 216 (463)
T ss_dssp STTTSS---BCCC--------------CCBGGGC-----------------------------------CBCCCEEEEC
T ss_pred ccccCC---chhhhcccccccC-----CchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEee
Confidence 345665 9999999986532 25676 66543222 2234678899999999999999998877543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 428 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 7e-69
Identities = 78/285 (27%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
IG G FG VYKG +VAVK L Q + + EV L H N+
Sbjct: 15 RIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
+ +GY Q +V ++ S+ +L ET + IA+ A+G+ YL
Sbjct: 67 LLFMGYSTAP-----QLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYL 120
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
H II RD KS+NI L E K+ DFGLA + +H + G++ + APE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 270 VQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326
++ + +SDV+++G+ LYEL+TG+ P R + + R
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----------RGY 226
Query: 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
+ P L K + + CL K RP ++L + +
Sbjct: 227 LSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (537), Expect = 5e-66
Identities = 77/312 (24%), Positives = 143/312 (45%), Gaps = 41/312 (13%)
Query: 75 FTIAELKSATKNFSRSV---------VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR 125
FT + A + F++ + VIG G FG V G +K +++ VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLK--LPGKREIFVAIKTLKS 64
Query: 126 RGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSP 184
+ +++++E + +G +H N++ L G +++ E+M NGS+D +L
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV----MIITEFMENGSLDSFLRQ 120
Query: 185 KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244
T + + + A G+ YL D + RD + NIL++ K+SDFGL+R
Sbjct: 121 NDGQF-TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 245 LGPSEGFTHVSTAVVG---TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 300
+ T+ +G + + APE +Q + + SDVWSYG+ ++E+++ G RP
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 360
+ Q ++ ++ D RL + S L + C K+ RPK
Sbjct: 237 ---MTNQDVINAIEQ------------DYRLP--PPMDCPSALHQLMLDCWQKDRNHRPK 279
Query: 361 MSEVLEMVNKIV 372
+++ ++K++
Sbjct: 280 FGQIVNTLDKMI 291
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-64
Identities = 73/286 (25%), Positives = 118/286 (41%), Gaps = 36/286 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G FG V+ G +VAVK L ++G ++ E N + ++HQ LV+
Sbjct: 20 RLGAGQFGEVWMGYYNGHT------KVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L + ++ EYM NGS+ +L S LT L +A A G+A++ E
Sbjct: 73 LYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 271
I RD +++NIL+ + + K++DFGLARL + + APE +
Sbjct: 128 ---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAIN 183
Query: 272 TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE--QKLLQWVKPYLSDAKQFRQIVDP 329
G +SDVWS+G+ L E++T R E Q L + + D
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD---------- 233
Query: 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375
+L + LC + RP + ++ A+
Sbjct: 234 --------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-64
Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 32/290 (11%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV 144
+ IG G FG V+ G N + +VA+K + R G ++++ E + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKD------KVAIKTI-REGAMSEEDFIEEAEVMMKL 57
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
H LV+L G C + LV+E+M +G + Y + L + D
Sbjct: 58 SHPKLVQLYGVCLEQAPI----CLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCE 112
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
G+AYL E +I RD + N L+ E K+SDFG+ R + +T ST + +
Sbjct: 113 GMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKW 168
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324
A+PE R +++SDVWS+GV ++E+ + + NR SE +++ +
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI-------STGF 219
Query: 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374
++ PRL + ++++ C + RP S +L + +I ++
Sbjct: 220 RLYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-62
Identities = 65/289 (22%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV 144
K+ + +G G FG V G + +VA+K + + G E++ E + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQY------DVAIKMI-KEGSMSEDEFIEEAKVMMNL 56
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
H+ LV+L G C ++ EYM NG + YL L++ +D
Sbjct: 57 SHEKLVQLYGVCTKQRPI----FIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCE 111
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
+ YL Q + RD + N L+++Q K+SDFGL+R + +T S + +
Sbjct: 112 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRW 167
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE--QKLLQWVKPYLSDAKQ 322
+ PE + + +++SD+W++GV ++E+ + + SE + + Q ++ Y
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------ 221
Query: 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
P L + K+ + C + A RP +L + +
Sbjct: 222 -----RPHLASE-------KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 2e-62
Identities = 64/278 (23%), Positives = 114/278 (41%), Gaps = 31/278 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
IG G F VYKGL D VEVA +L R + + + E L ++H N+
Sbjct: 16 EIGRGSFKTVYKGL-----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
V+ + +LV E M +G++ YL K ++ + + +GL +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 210 HEGMDFQIIVRDFKSSNILL-DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 268
H II RD K NI + + K+ D GLA L + + AV+GT + APE
Sbjct: 129 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPE 183
Query: 269 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328
+ + DV+++G+ + E+ T P + ++ +R++
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---------------IYRRVTS 227
Query: 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ + ++ + C+ +N R + ++L
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-62
Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 31/305 (10%)
Query: 70 SNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ 129
++ I S +F+ VIG G FGCVY G + +++ +K+ AVK L R
Sbjct: 15 QAVQHVVIGP-SSLIVHFNE--VIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDI 69
Query: 130 GH-KEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET 188
G +++TE + H N++ L+G C + L+V YM +G + ++ ++
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS---PLVVLPYMKHGDLRNFIRNETHN 126
Query: 189 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248
T + A+G+ +L + + RD + N +LDE++ K++DFGLAR
Sbjct: 127 -PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 249 EGF--THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 306
+ F H T + + A E +QT + +SDVWS+GV L+EL+T P P +
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPD 237
Query: 307 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
L R+++ P L V C A RP SE++
Sbjct: 238 VNTFDITVYLLQG----RRLLQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 367 MVNKI 371
++ I
Sbjct: 287 RISAI 291
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (508), Expect = 1e-61
Identities = 72/318 (22%), Positives = 118/318 (37%), Gaps = 46/318 (14%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWM 135
+ L+ N IGEG FG V++ VAVK L ++
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 136 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL------------- 182
E + ++ N+VKL+G CA L++EYM G ++++L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 183 ---------SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233
S L+ A +L IA+ A G+AYL E + + RD + N L+ E
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 293
K++DFGL+R S + + + PE + R SDVW+YGV L+E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 294 GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVK 353
E + D + +L ++ LC K
Sbjct: 238 YGLQPYYGMAHEE---------------VIYYVRDGNIL-ACPENCPLELYNLMRLCWSK 281
Query: 354 NARTRPKMSEVLEMVNKI 371
RP + ++ ++
Sbjct: 282 LPADRPSFCSIHRILQRM 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-61
Identities = 72/315 (22%), Positives = 121/315 (38%), Gaps = 46/315 (14%)
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTE 137
ELK +F + +G G G V+K + +A K + + + E
Sbjct: 2 ELK--DDDFEKISELGAGNGGVVFKV-----SHKPSGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 197
+ L +V G D E + E+M GS+DQ L K + + K
Sbjct: 55 LQVLHECNSPYIVGFYGAFYSDGEI----SICMEHMDGGSLDQVL--KKAGRIPEQILGK 108
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
++ +GL YL E I+ RD K SNIL++ + KL DFG++ ++ +
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANS 162
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV---- 313
VGT Y +PE +Q + +SD+WS G+ L E+ GR PI + + +
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
Query: 314 ----------------------KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCL 351
+P ++ + IV+ S + N CL
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 352 VKNARTRPKMSEVLE 366
+KN R + +++
Sbjct: 283 IKNPAERADLKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-61
Identities = 69/302 (22%), Positives = 112/302 (37%), Gaps = 40/302 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLG-IVEHQNL 149
+G G FG V + + VAVK L +E M+E+ L + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK----------------SETILTWA 193
V L+G C L++ EY G + +L K E L
Sbjct: 90 VNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 194 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 253
L + A+G+A+L I RD + NILL K+ DFGLAR ++
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313
V + + APE + SDVWSYG+FL+EL + P
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------- 255
Query: 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373
+F +++ +++ + C + RP ++++++ K +
Sbjct: 256 --------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 374 AS 375
S
Sbjct: 308 ES 309
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-61
Identities = 67/299 (22%), Positives = 122/299 (40%), Gaps = 28/299 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG+G FG V++G + E VAVK R + E+ ++ H+N++
Sbjct: 10 SIGKGRFGEVWRGKWRGEE-------VAVKIFSSREER-SWFREAEIYQTVMLRHENILG 61
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
+ D+ Q LV +Y +GS+ YL+ + +T +K+A A GLA+LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHM 118
Query: 212 GMDFQ-----IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT--HVSTAVVGTMGY 264
+ I RD KS NIL+ + ++D GLA S T VGT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 265 AAPEYVQT------GRLAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYL 317
APE + R+D+++ G+ +E+ + + L P +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 318 SDAKQF--RQIVDPRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373
+ ++ Q + P + ++ S + ++ + C N R + + ++++
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 7e-61
Identities = 67/299 (22%), Positives = 111/299 (37%), Gaps = 45/299 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLG-IVEHQNL 149
V+G G FG V ++VAVK L + +E M+E+ + + H+N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE---------------------T 188
V L+G C L++EY G + YL K E
Sbjct: 104 VNLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159
Query: 189 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248
+LT+ L A A+G+ +L + RD + N+L+ K+ DFGLAR S
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 249 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 308
+ V + + APE + G +SDVWSYG+ L+E+ + P
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-- 274
Query: 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367
F +++ + ++ + C ++R RP +
Sbjct: 275 -------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 8e-61
Identities = 66/291 (22%), Positives = 134/291 (46%), Gaps = 27/291 (9%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHK-EWMTEVNFLGIV 144
+R VIG G FG VYKG++K S ++V VA+K L + + +++ E +G
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTS-SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
H N+++L G + +++ EYM NG++D++ + + + + + + A
Sbjct: 67 SHHNIIRLEGVISKYKPM----MIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAA 121
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG-FTHVSTAVVGTMG 263
G+ YL + RD + NIL++ K+SDFGL+R+ + T+ ++ +
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323
+ APE + + + SDVWS+G+ ++E++T E
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------V 222
Query: 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374
+ ++ + S + + C + RPK ++++ +++K++ A
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 4e-60
Identities = 65/297 (21%), Positives = 134/297 (45%), Gaps = 33/297 (11%)
Query: 79 ELKSATKNFS-RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMT 136
+L N + +G G FG V +G+ + + +++VA+K L + + +E M
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMR 58
Query: 137 EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRL 196
E + +++ +V+L+G C + +LV E G + ++L K E + +
Sbjct: 59 EAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVA 112
Query: 197 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVS 255
++ + G+ YL + + RD + N+LL + AK+SDFGL++ LG + +
Sbjct: 113 ELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 314
+A + + APE + + ++RSDVWSYGV ++E ++ G++P + +++ +++
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK---MKGPEVMAFIE 226
Query: 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
Q + +L + + C + RP V + +
Sbjct: 227 ----------QGKRMECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-60
Identities = 65/280 (23%), Positives = 113/280 (40%), Gaps = 36/280 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG+G FG V G + ++ VAVK + + ++ E + + + H NLV+
Sbjct: 14 TIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+G ++ +V EYM GS+ YL + ++L LK + D + YL
Sbjct: 65 LLGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 271
+ RD + N+L+ E AK+SDFGL + S + + APE ++
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALR 173
Query: 272 TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRL 331
+ + +SDVWS+G+ L+E+ + R P + + +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------------VPRVEKGYKMDA 221
Query: 332 EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
+ V C +A RP ++ E + I
Sbjct: 222 PDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-59
Identities = 69/297 (23%), Positives = 115/297 (38%), Gaps = 32/297 (10%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIV 144
++ V +G+G FG V+ G + VA+K L + G + ++ E + +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTL-KPGTMSPEAFLQEAQVMKKL 69
Query: 145 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 204
H+ LV+L +++ +V EYM GS+ +L ++ L + +A A
Sbjct: 70 RHEKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 205 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 264
G+AY+ + RD +++NIL+ E K++DFGLARL +T + +
Sbjct: 125 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 180
Query: 265 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324
APE GR +SDVWS+G+ L EL T R E
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------L 224
Query: 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSP 381
V+ L + C K RP + + ++ P
Sbjct: 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (493), Expect = 1e-59
Identities = 65/308 (21%), Positives = 123/308 (39%), Gaps = 35/308 (11%)
Query: 64 SMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL 123
+M N ++ + + + +G G +G VY+G + VAVK L
Sbjct: 1 AMDPSSPNYDKWEMER-----TDITMKHKLGGGQYGEVYEG-----VWKKYSLTVAVKTL 50
Query: 124 GRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS 183
+ +E++ E + ++H NLV+L+G C + I E+M G++ YL
Sbjct: 51 -KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII----TEFMTYGNLLDYLR 105
Query: 184 PKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243
+ ++ + L +A + + YL + I RD + N L+ E K++DFGL+
Sbjct: 106 ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 162
Query: 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 303
RL + + + APE + + + +SDVW++GV L+E+ T
Sbjct: 163 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI- 220
Query: 304 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363
D Q ++++ + K+ + C N RP +E
Sbjct: 221 ---------------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 265
Query: 364 VLEMVNKI 371
+ + +
Sbjct: 266 IHQAFETM 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 7e-59
Identities = 70/291 (24%), Positives = 112/291 (38%), Gaps = 32/291 (10%)
Query: 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVN 139
S +++ IG G +G K S + K+L + + ++EVN
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKI-----RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 140 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETILTWAMRLK 197
L ++H N+V+ D + +V EY G + + K L L+
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTL--YIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113
Query: 198 IAQDAARGLAYLHEGMD--FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
+ L H D ++ RD K +N+ LD + N KL DFGLAR+ + T +
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFA 171
Query: 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315
A VGT Y +PE + +SD+WS G LYEL P
Sbjct: 172 KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-------------- 217
Query: 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
S + +I + + + R +L+ + L RP + E+LE
Sbjct: 218 --SQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-57
Identities = 72/297 (24%), Positives = 119/297 (40%), Gaps = 46/297 (15%)
Query: 73 KEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---Q 129
+++ + ++F +G+G FG VY + K +A+K L + +
Sbjct: 1 RQWAL-------EDFEIGRPLGKGKFGNVYLA-----REKQSKFILALKVLFKAQLEKAG 48
Query: 130 GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI 189
+ EV + H N+++L GY D + + EY P G+V + L + +
Sbjct: 49 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL----ILEYAPLGTVYREL--QKLSK 102
Query: 190 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 249
+ A L+Y H ++I RD K N+LL K++DFG + PS
Sbjct: 103 FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159
Query: 250 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309
T + GT+ Y PE ++ + D+WS GV YE + G+ P + N + K
Sbjct: 160 RRTTL----CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 215
Query: 310 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ V+ F V L+S+ L N RP + EVLE
Sbjct: 216 ISRVEF------TFPDFVTEGAR-----DLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-57
Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 31/284 (10%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGVQGHKEWMTEVNFLGI 143
+++ +GEG +G V + + VAVK + +R V + E+ +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLA-----VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 59
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 203
+ H+N+VK G+ + + + L EY G + + + + + +
Sbjct: 60 LNHENVVKFYGHRREGNIQ----YLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLM 113
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
G+ YLH I RD K N+LLDE+ N K+SDFGLA + + + GT+
Sbjct: 114 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 264 YAAPEYVQTGRLAAR-SDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322
Y APE ++ A DVWS G+ L ++ G P D+ ++
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---------------SCQE 215
Query: 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ + + ++ S + + LV+N R + ++ +
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 6e-57
Identities = 71/286 (24%), Positives = 126/286 (44%), Gaps = 27/286 (9%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVE 145
F + V+G G FG VYKGL E K+ VA+K+L + +KE + E + V+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
+ ++ +L+G C + L+ + MP G + Y + + + L A+G
Sbjct: 70 NPHVCRLLGICLTSTVQ-----LITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKG 123
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 265
+ YL D +++ RD + N+L+ + K++DFGLA+L +E + + + +
Sbjct: 124 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 266 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 325
A E + +SDVWSYGV ++EL+T P SE
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISS 224
Query: 326 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
I++ + + C + +A +RPK E++ +K+
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 7e-57
Identities = 62/284 (21%), Positives = 115/284 (40%), Gaps = 34/284 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGIVEHQNL 149
+G G FG V KG + + VAVK L E + E N + +++ +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKV---VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
V+++G C + +LV E G +++YL + +++ + G+ YL
Sbjct: 71 VRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 123
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPE 268
+ + RD + N+LL Q AK+SDFGL++ L E + T + + APE
Sbjct: 124 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 269 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-DAKQFRQIV 327
+ + +++SDVWS+GV ++E + + PY + ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQK-----------------PYRGMKGSEVTAML 223
Query: 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
+ ++ + NLC + RP + V +
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-57
Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 35/280 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G+G FG VYK ++ V A K + + + +++M E++ L +H N+VK
Sbjct: 19 ELGDGAFGKVYKA-----QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L+ ++ ++ E+ G+VD + + E LT + + + L YLH+
Sbjct: 74 LLDAFYYENNL----WILIEFCAGGAVDAVM-LELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 212 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 271
+II RD K+ NIL + KL+DFG++ + +GT + APE V
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVM 183
Query: 272 TGRLA-----ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326
++DVWS G+ L E+ P P + LL+ K + +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIAK------SEPPTL 235
Query: 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
P + K CL KN R S++L+
Sbjct: 236 AQPSRWSSNFKDFLKK-------CLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 8e-57
Identities = 75/289 (25%), Positives = 108/289 (37%), Gaps = 42/289 (14%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNF 140
K FS IG G FG VY D VA+K++ G Q +++W + EV F
Sbjct: 14 EKLFSDLREIGHGSFGAVYFA-----RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 141 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 200
L + H N ++ G + LV EY + D + L +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTH 122
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 260
A +GLAYLH +I RD K+ NILL E KL DFG A + + VG
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVG 173
Query: 261 TMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317
T + APE + G+ + DVWS G+ EL + P+ +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------------M 217
Query: 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ I S + + CL K + RP +L+
Sbjct: 218 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-56
Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 34/293 (11%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFL 141
K+ +G+G FG V +G + V VAVK L + + +++ EVN +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWD--APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
++H+NL++L G + +V E P GS+ K + + A
Sbjct: 66 HSLDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQ 119
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV-STAVVG 260
A G+ YL + I RD + N+LL + K+ DFGL R P +V
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 261 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY--LS 318
+ APE ++T + SD W +GV L+E+ T + P+ L+
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLN 219
Query: 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
++ +I + +V C RP + + + +
Sbjct: 220 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 6e-56
Identities = 69/301 (22%), Positives = 118/301 (39%), Gaps = 37/301 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG-HKEWMTEVNFLG-IVEHQNL 149
+G G FG V + + + VAVK L H+ M+E+ L I H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMR 195
V L+G C +++ E+ G++ YL K + LT
Sbjct: 80 VNLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
+ + A+G+ +L + I RD + NILL E+ K+ DFGLAR +
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315
+ + APE + +SDVWS+GV L+E+ + P K+ +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEF-- 246
Query: 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375
++ ++ R + ++ C RP SE++E + ++ A+
Sbjct: 247 ----CRRLKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
Query: 376 A 376
A
Sbjct: 299 A 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 7e-56
Identities = 74/305 (24%), Positives = 128/305 (41%), Gaps = 45/305 (14%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLG- 142
+ VIGEG FG V K IK +++ A+K++ H+++ E+ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 143 IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSET 188
+ H N++ L+G C L EY P+G++ +L + + +
Sbjct: 67 LGHHPNIINLLGACEHRGYL----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 189 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248
L+ L A D ARG+ YL + Q I RD + NIL+ E + AK++DFGL+R
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179
Query: 249 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 308
T + + A E + SDVWSYGV L+E+++ + +
Sbjct: 180 Y---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAE 234
Query: 309 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368
L + + RLE L ++ + C + RP +++L +
Sbjct: 235 LYEKLPQ------------GYRLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
Query: 369 NKIVD 373
N++++
Sbjct: 281 NRMLE 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 5e-54
Identities = 62/298 (20%), Positives = 127/298 (42%), Gaps = 32/298 (10%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGI 143
+ + S +G+G FG VY+G+ K + VA+K + ++ E++ E + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI--------LTWAMR 195
++V+L+G + L++ E M G + YL + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
+++A + A G+AYL+ + + RD + N ++ E + K+ DFG+ R +
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315
+ + + +PE ++ G SDVWS+GV L+E+ T +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-------------- 238
Query: 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373
LS+ + R +++ L K L + +C N + RP E++ + + ++
Sbjct: 239 -LSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 9e-54
Identities = 71/295 (24%), Positives = 115/295 (38%), Gaps = 40/295 (13%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM 135
+I + K ++R IG+G G VY D + EVA++Q+ + + +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTA-----MDVATGQEVAIRQMNLQQQPKKELII 65
Query: 136 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 195
E+ + ++ N+V + DE +V EY+ GS+ ++
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTDVVTETCMD---EGQI 118
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
+ ++ + L +LH Q+I RD KS NILL + KL+DFG E
Sbjct: 119 AAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 173
Query: 256 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 315
+ +VGT + APE V + D+WS G+ E+I G P P
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------------ 221
Query: 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 366
+ I G L+ KLS + N CL + R E+L+
Sbjct: 222 ----LRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-52
Identities = 60/284 (21%), Positives = 116/284 (40%), Gaps = 31/284 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVEHQNLV 150
IGEG FG V++G+ + E+P + VA+K +E ++ E + +H ++V
Sbjct: 14 CIGEGQFGDVHQGIYMSPENP--ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
KL+G ++ ++ E G + + + L A + A + LAYL
Sbjct: 72 KLIGVITEN-----PVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 270
+ + RD + N+L+ KL DFGL+R + ++ + + APE +
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESI 181
Query: 271 QTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329
R + SDVW +GV ++E++ G +P + ++ + P
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----PMPPNCPP 236
Query: 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373
L + C + RP+ +E+ ++ I++
Sbjct: 237 TLY------------SLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 172 bits (436), Expect = 2e-51
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 33/287 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG---HKEWMTEVNFLGIVEHQN 148
++G GG V+ D +VAVK L + + + E + H
Sbjct: 14 ILGFGGMSEVHLA-----RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 149 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 208
+V + + G +V EY+ ++ + +E +T +++ DA + L +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNF 126
Query: 209 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAP 267
H+ II RD K +NI++ K+ DFG+AR + S + AV+GT Y +P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327
E + + ARSDV+S G LYE++TG P + S Q V
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----------------SPVSVAYQHV 227
Query: 328 --DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLEMVNKI 371
DP L + L V L KN R + +E+ + ++
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 8e-51
Identities = 69/303 (22%), Positives = 125/303 (41%), Gaps = 41/303 (13%)
Query: 92 VIGEGGFGCVYKGLIK--NSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLG-IVEHQ 147
+GEG FG V + + P++ +VAVK L + + ++E+ + I +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWA 193
N++ L+G C D ++ EY G++ +YL S E L+
Sbjct: 80 NIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135
Query: 194 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 253
+ A ARG+ YL + I RD + N+L+ E K++DFGLAR +
Sbjct: 136 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 254 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313
+T + + APE + +SDVWS+GV L+E+ T P
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--------- 243
Query: 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373
++ +++ ++L + C RP +++E +++IV
Sbjct: 244 -------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
Query: 374 ASA 376
++
Sbjct: 297 LTS 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (433), Expect = 5e-50
Identities = 67/355 (18%), Positives = 126/355 (35%), Gaps = 51/355 (14%)
Query: 68 RPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG 127
+P +K + + ++ +G G FG V++ + + A K +
Sbjct: 15 QPVEIKHDHVLD------HYDIHEELGTGAFGVVHRV-----TERATGNNFAAKFVMTPH 63
Query: 128 VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE 187
+ E+ + ++ H LV L DD+E +++YE+M G + + +
Sbjct: 64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKV-ADEH 118
Query: 188 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--AKLSDFGLARL 245
++ ++ + +GL ++HE + D K NI+ + + KL DFGL
Sbjct: 119 NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 246 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 305
+ V GT +AAPE + + +D+WS GV Y L++G P
Sbjct: 176 LDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---- 228
Query: 306 EQKLLQWVKPYLSDAKQFRQIV--DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 363
+D + R + D ++ + L+ + TR + +
Sbjct: 229 ------------NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 364 VLEM--VNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTL 416
LE + P R + +SR T K K G +
Sbjct: 277 ALEHPWLTPGNA-------PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRI 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 7e-50
Identities = 66/288 (22%), Positives = 112/288 (38%), Gaps = 35/288 (12%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTE 137
K ++F ++GEG F V + + E A+K L +R + E
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLA-----RELATSREYAIKILEKRHIIKENKVPYVTRE 58
Query: 138 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 197
+ + ++H VKL DD++ Y NG + +Y+
Sbjct: 59 RDVMSRLDHPFFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIRKIG--SFDETCTRF 112
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 257
+ L YLH II RD K NILL+E + +++DFG A++ E + +
Sbjct: 113 YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
Query: 258 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317
VGT Y +PE + SD+W+ G +Y+L+ G P
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---------------- 213
Query: 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 365
++ F++I+ +LE + + K + LV +A R E+
Sbjct: 214 NEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 165 bits (418), Expect = 8e-48
Identities = 58/281 (20%), Positives = 106/281 (37%), Gaps = 40/281 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G FG V++ + + K + E++ + + H L+
Sbjct: 36 ELGSGAFGVVHRC-----VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L D E +L+ E++ G + ++ + ++ A + + A GL ++HE
Sbjct: 91 LHDAFEDKYEM----VLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 212 GMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
I+ D K NI+ + + + K+ DFGLA + V T +AAPE
Sbjct: 146 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEI 199
Query: 270 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329
V + +D+W+ GV Y L++G P D + + +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE----------------DDLETLQNVK-- 241
Query: 330 RLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 366
R + ++ S +S A L K R R + + LE
Sbjct: 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 7e-47
Identities = 59/278 (21%), Positives = 101/278 (36%), Gaps = 33/278 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-WMTEVNFLGIVEHQNLV 150
V+G G F V ED + VA+K + ++ ++G + E+ L ++H N+V
Sbjct: 16 VLGTGAFSEVILA-----EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
L L+ + + G + + + T ++ + YLH
Sbjct: 71 ALDDIYESGGHL----YLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 270
+ ++ LDE +SDFGL+++ E V + GT GY APE +
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 181
Query: 271 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV--D 328
+ D WS GV Y L+ G P +DAK F QI+ +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDE----------------NDAKLFEQILKAE 225
Query: 329 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ Y + + K+ R + L+
Sbjct: 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-46
Identities = 75/334 (22%), Positives = 122/334 (36%), Gaps = 32/334 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGH-KEWMTEVNFLGIVEHQNLV 150
IGEG +G V D KV VA+K++ Q + + + E+ L H+N++
Sbjct: 15 YIGEGAYGMVCSA-----YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
+ ++ + + ++ + + L + L+ RGL Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH 126
Query: 211 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH-VSTAVVGTMGYAAPEY 269
++ RD K SN+LL+ + K+ DFGLAR+ + T V T Y APE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 270 VQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 328
+ + +S D+WS G L E+++ R + + + S I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 329 PRLEGKYSL---------RLVSKLSHVA----NLCLVKNARTRPKMSEVLEM--VNKIVD 373
SL RL A + L N R ++ + L + + D
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 374 ASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIE 407
S E P E D K K K I E
Sbjct: 304 PSDE---PIAEAPFKFDMELDDLPKEKLKELIFE 334
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (394), Expect = 4e-45
Identities = 65/299 (21%), Positives = 102/299 (34%), Gaps = 51/299 (17%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---------QGHKEWMT 136
N+ ++G G V + E AVK + G + + +
Sbjct: 4 NYEPKEILGRGVSSVVRRC-----IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 58
Query: 137 EVNFLGIV-EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 195
EV+ L V H N+++L + LV++ M G + YL + L+
Sbjct: 59 EVDILRKVSGHPNIIQLKDTYETNTFF----FLVFDLMKKGELFDYL--TEKVTLSEKET 112
Query: 196 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 255
KI + + LH+ I+ RD K NILLD+ N KL+DFG +
Sbjct: 113 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKL 166
Query: 256 TAVVGTMGYAAPEYVQTGRLAAR------SDVWSYGVFLYELITGRRPIDRNRPRSEQKL 309
V GT Y APE ++ D+WS GV +Y L+ G P
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-------- 218
Query: 310 LQWVKPYLSDAKQFRQIV--DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
R I+ + + + + + LV + R E L
Sbjct: 219 --------KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-44
Identities = 53/277 (19%), Positives = 105/277 (37%), Gaps = 33/277 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
+G G FG V++ + S K K + +G E++ L I H+N++
Sbjct: 12 DLGRGEFGIVHRC-----VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
L +E ++++E++ + + ++ S L + L +LH
Sbjct: 66 LHESFESMEEL----VMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 212 GMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
I D + NI+ + ++ K+ +FG AR + Y APE
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEV 174
Query: 270 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329
Q ++ +D+WS G +Y L++G P +Q + + + ++ + +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKEISI 232
Query: 330 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ V + LVK ++R SE L+
Sbjct: 233 EA-----MDFVDR-------LLVKERKSRMTASEALQ 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-44
Identities = 66/289 (22%), Positives = 106/289 (36%), Gaps = 24/289 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNF---LGIVEH 146
IGEG +G V+K + VA+K++ + + + EV L EH
Sbjct: 14 EIGEGAYGKVFKARDL----KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
N+V+L C +L + + + YL E + + RGL
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
+LH +++ RD K NIL+ KL+DFGLAR+ T+VV T+ Y A
Sbjct: 130 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRA 183
Query: 267 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326
PE + A D+WS G E+ + + + + V + R +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 327 VDPR-----LEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 366
PR + + V+ + + CL N R L
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (392), Expect = 5e-44
Identities = 66/281 (23%), Positives = 114/281 (40%), Gaps = 40/281 (14%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWMTEVNFLG 142
+FS +IG GGFG VY A+K L ++ + QG + E L
Sbjct: 5 DFSVHRIIGRGGFGEVYGC-----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59
Query: 143 IV---EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 199
+V + +V + D+ + + M G + +L + + A A
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHL--SQHGVFSEADMRFYA 113
Query: 200 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 259
+ GL ++H ++ RD K +NILLDE + ++SD GLA + V
Sbjct: 114 AEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 166
Query: 260 GTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318
GT GY APE +Q G + +D +S G L++L+ G P +++ + + ++ + L+
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT 223
Query: 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359
A + P L L+ L ++ R
Sbjct: 224 MAVELPDSFSPELR-----SLLEG-------LLQRDVNRRL 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-43
Identities = 61/280 (21%), Positives = 108/280 (38%), Gaps = 39/280 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIV-EHQ 147
++G+G FG V+ E A+K L + V + M E L + EH
Sbjct: 9 MLGKGSFGKVFLA-----EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 148 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
L + + EY+ G + ++ +S + A + GL
Sbjct: 64 FLTHMFCTFQTKENLFFV----MEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQ 117
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
+LH I+ RD K NILLD+ + K++DFG+ + GT Y AP
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAP 172
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327
E + + D WS+GV LYE++ G+ P + E++L ++ D + + +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIR---MDNPFYPRWL 226
Query: 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-SEVLE 366
+ + L+ K V+ R + ++ +
Sbjct: 227 EKEAK-----DLLVK-------LFVREPEKRLGVRGDIRQ 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-43
Identities = 54/279 (19%), Positives = 96/279 (34%), Gaps = 30/279 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLV 150
V+G G G V + + + + A+K L Q + EV + ++V
Sbjct: 19 VLGLGINGKVLQI-----FNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIV 68
Query: 151 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 210
++V + L+V E + G + + + + T +I + + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 211 EGMDFQIIVRDFKSSNILLDEQWN---AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
I RD K N+L + KL+DFG A+ S T Y AP
Sbjct: 129 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAP 182
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 327
E + + D+WS GV +Y L+ G P N + + K ++
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------KTRIRMG 232
Query: 328 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
+ ++ + L R ++E +
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-43
Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 40/296 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE-----WMTEVNFLGIVEH 146
+GEG F VYK D + VA+K++ K+ + E+ L + H
Sbjct: 5 FLGEGQFATVYKA-----RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59
Query: 147 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
N++ L+ LV+++M + +LT + +GL
Sbjct: 60 PNIIGLLDAFGHKSNI----SLVFDFMETDLEVII--KDNSLVLTPSHIKAYMLMTLQGL 113
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
YLH+ I+ RD K +N+LLDE KL+DFGLA+ S + T V T Y A
Sbjct: 114 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRA 168
Query: 267 PEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRN--------------RPRSEQKLLQ 311
PE + R+ D+W+ G L EL+ + + P EQ
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228
Query: 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367
P K F I + L+ + + N R ++ L+M
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG----LFLFNPCARITATQALKM 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 2e-42
Identities = 51/288 (17%), Positives = 97/288 (33%), Gaps = 33/288 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IG G FG +Y G D + EVA+K + H + E +++ +
Sbjct: 14 KIGSGSFGDIYLG-----TDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
+ +C + + ++V E + D + + + L +A + Y+H
Sbjct: 67 TIRWCGAEGDY---NVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 121
Query: 212 GMDFQIIVRDFKSSNIL---LDEQWNAKLSDFGLARLGPSEG-----FTHVSTAVVGTMG 263
I RD K N L + + DFGLA+ + + GT
Sbjct: 122 K---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323
YA+ + R D+ S G L G P + ++++ + + ++
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------EKK 232
Query: 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
L Y S+ + N C +P S + ++ +
Sbjct: 233 MSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 8e-41
Identities = 61/285 (21%), Positives = 111/285 (38%), Gaps = 41/285 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMT------EVNFLGIVE 145
+G G F V K + S ++ A K + +R + + ++ EV+ L ++
Sbjct: 17 ELGSGQFAVVKKC-----REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 146 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
H N++ L + + +L+ E + G + + + LT + + G
Sbjct: 72 HPNVITLHEVYENKTDV----ILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNG 125
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQW----NAKLSDFGLARLGPSEGFTHVSTAVVGT 261
+ YLH QI D K NI+L ++ K+ DFGLA F + + GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGT 179
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
+ APE V L +D+WS GV Y L++G P + + + V D
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-- 237
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
++ + + + LVK+ + R + + L+
Sbjct: 238 EYFSNTSALAK-----DFIRR-------LLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-40
Identities = 62/285 (21%), Positives = 98/285 (34%), Gaps = 51/285 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL------GRRGVQGHKEWMTEVNFLGIV- 144
++G GGFG VY G S + VA+K + + EV L V
Sbjct: 11 LLGSGGFGSVYSG-----IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 145 -EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 203
+++L+ + D +L+ E L +
Sbjct: 66 SGFSGVIRLLDWFERPD----SFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVL 120
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 262
+ + H ++ RD K NIL+D + KL DFG L +T GT
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTR 173
Query: 263 GYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
Y+ PE+++ R RS VWS G+ LY+++ G P + + ++
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF----------- 222
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 366
FRQ V + L+ CL RP E+
Sbjct: 223 -FRQRVSSECQ-----HLIRW-------CLALRPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (363), Expect = 1e-40
Identities = 40/290 (13%), Positives = 87/290 (30%), Gaps = 35/290 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVK 151
IGEG FG +++G + +VA+K RR + E ++ +
Sbjct: 12 RIGEGSFGVIFEG-----TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIP 64
Query: 152 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 211
V Y + + LV + + D + A+ + +HE
Sbjct: 65 NVYYFGQEGLHNV---LVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE 119
Query: 212 GMDFQIIVRDFKSSNILLDEQWN-----AKLSDFGLARLGPSEG-----FTHVSTAVVGT 261
++ RD K N L+ + + DFG+ + + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
Y + + R D+ + G + G P + + ++ + + +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG------E 230
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371
+ + L + + + P + + +K+
Sbjct: 231 KKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-40
Identities = 62/302 (20%), Positives = 109/302 (36%), Gaps = 31/302 (10%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNF 140
+ +++ + VIG G FG VY+ + VA+K++ +Q + E+
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQA-----KLCDSGELVAIKKV----LQDKRFKNRELQI 66
Query: 141 LGIVEHQNLVKLVGYCADDDERG--IQRLLVYEYMPNGSVDQYLS-PKSETILTWAMRLK 197
+ ++H N+V+L + E+ + LV +Y+P +++ L
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 198 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVST 256
R LAY+H I RD K N+LLD + KL DFG A+ +
Sbjct: 127 YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVS 181
Query: 257 AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP------------IDRNRPR 304
+ A + DVWS G L EL+ G+ I +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 305 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 364
++ ++ + P ++ K F QI + R + + + L R E
Sbjct: 242 PTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 365 LE 366
Sbjct: 301 CA 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (360), Expect = 6e-40
Identities = 66/280 (23%), Positives = 108/280 (38%), Gaps = 44/280 (15%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKE---WMTEVNFL 141
++F +G G FG V+ A+K L + V K+ E L
Sbjct: 4 QDFQILRTLGTGSFGRVHLI-----RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
IV H ++++ G D Q ++ +Y+ G + L + A +
Sbjct: 59 SIVTHPFIIRMWGTFQDAQ----QIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAE 112
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
L YLH II RD K NILLD+ + K++DFG A+ P +T + GT
Sbjct: 113 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGT 164
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
Y APE V T D WS+G+ +YE++ G P + + K
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----------------NTMK 208
Query: 322 QFRQIV--DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359
+ +I+ + R ++ + LS + ++ R
Sbjct: 209 TYEKILNAELRFPPFFNEDVKDLLSR----LITRDLSQRL 244
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-40
Identities = 60/298 (20%), Positives = 117/298 (39%), Gaps = 33/298 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQG--HKEWMTEVNFLGIVEHQNL 149
IG+G FG V+K +VA+K++ + + E+ L +++H+N+
Sbjct: 17 KIGQGTFGEVFKA-----RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 150 VKLVGYCADDDERGIQR----LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 205
V L+ C + LV+++ + + + T + ++ Q G
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNG 129
Query: 206 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMG 263
L Y+H +I+ RD K++N+L+ KL+DFGLAR + T V T+
Sbjct: 130 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 264 YAAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS---- 318
Y PE + R D+W G + E+ T + N + + L+ + ++
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 319 -------DAKQFRQIVDPRLEGKYSLRLVSKLSHVANL---CLVKNARTRPKMSEVLE 366
++ + + + K L+ + + +L LV + R + L
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-39
Identities = 59/294 (20%), Positives = 108/294 (36%), Gaps = 27/294 (9%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFLGI 143
NF + IGEG +G VYK + VA+K++ + E++ L
Sbjct: 3 NFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 57
Query: 144 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 203
+ H N+VKL+ +++ LV+E++ +++ + T + +
Sbjct: 58 LNHPNIVKLLDVIHTENKL----YLVFEFLHQDL-KKFMDASALTGIPLPLIKSYLFQLL 112
Query: 204 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 263
+GLA+ H ++ RD K N+L++ + KL+DFGLAR + VV
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWY 168
Query: 264 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAK 321
A + + D+WS G E++T R + + + P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 322 QFRQIVD-----PRLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 366
+ D P+ + ++V L + L + R L
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (349), Expect = 1e-38
Identities = 53/288 (18%), Positives = 101/288 (35%), Gaps = 29/288 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFLGIVEHQNL 149
IGEG +G VYK E A+K++ + + E++ L ++H N+
Sbjct: 9 KIGEGTYGVVYKAQNNYGE------TFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
VKL +LV+E++ E L G+AY
Sbjct: 63 VKLYDVIHTKKRL----VLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
H+ +++ RD K N+L++ + K++DFGLAR + +V A
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVL 172
Query: 270 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329
+ + + + D+WS G E++ G + + + + P
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 330 RLEGKYSL-------RLVSKLSHVA----NLCLVKNARTRPKMSEVLE 366
+ + +++ + L + L + R + LE
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-36
Identities = 77/335 (22%), Positives = 122/335 (36%), Gaps = 39/335 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
+G G +G V D +VA+K+L R K E+ L + H+N+
Sbjct: 25 PVGSGAYGAVCSA-----VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 150 VKLVGYCADDDERGIQR--LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
+ L+ D+ LV +M K L + +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLKGLR 135
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
Y+H II RD K N+ ++E K+ DFGLAR S ++ VV A
Sbjct: 136 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPE 188
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL---------QWVKPYLS 318
+ R D+WS G + E+ITG+ + + K + ++V+ S
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLEM--VNKIV 372
D + P LE K +++ S +A LV +A R E L +
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 373 DASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIE 407
D E P+ + S + D T + KR +
Sbjct: 309 DTEDE---PQVQ-KYDDSFDDVDRTLDEWKRVTYK 339
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (335), Expect = 4e-36
Identities = 63/338 (18%), Positives = 118/338 (34%), Gaps = 45/338 (13%)
Query: 53 SVESEARPSYPSMSQRPSNLKEFTIAELKSATKN-FSRSVVIGEGGFGCVYKGLIKNSED 111
V S AR + RP ++ ++ ++ + +G G + V++ +
Sbjct: 2 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEA-----IN 56
Query: 112 PSQKVEVAVKQLGRRGVQGHKEWMTEVNFLG-IVEHQNLVKLVGYCADDDERGIQRLLVY 170
+ +V VK L K+ E+ L + N++ L D R LV+
Sbjct: 57 ITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA--LVF 111
Query: 171 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 230
E++ N Q LT + + L Y H I+ RD K N+++D
Sbjct: 112 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMID 163
Query: 231 -EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFL 288
E +L D+GLA V + + PE + ++ D+WS G L
Sbjct: 164 HEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 289 YELITGRRPIDRNRPRSEQ-----------KLLQWVKPY-LSDAKQFRQIVDPRLEGKYS 336
+I + P +Q L ++ Y + +F I+ ++
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 337 LRLVSKLSHVANL--------CLVKNARTRPKMSEVLE 366
+ S+ H+ + L + ++R E +E
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-35
Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 37/280 (13%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFL 141
+F ++G+G FG V + + A+K L + + E +TE L
Sbjct: 5 NDFDYLKLLGKGTFGKVILV-----REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
H L L D EY G + +L E + T +
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFV----MEYANGGELFFHL--SRERVFTEERARFYGAE 113
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 261
L YLH ++ RD K N++LD+ + K++DFGL + G S+G T GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 262 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321
Y APE ++ D W GV +YE++ GR P + ++L + + L +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELI---LMEEI 222
Query: 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM 361
+F + + P L++ L K+ + R
Sbjct: 223 RFPRTLSPEA-----KSLLAG-------LLKKDPKQRLGG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-34
Identities = 57/289 (19%), Positives = 98/289 (33%), Gaps = 29/289 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGVQGHKEWMTEVNFLGIVEHQNL 149
IGEG +G V+K ++ VA+K++ + E+ L ++H+N+
Sbjct: 9 KIGEGTYGTVFKA-----KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 209
V+L D + + V+E+ + S + +GL +
Sbjct: 64 VRLHDVLHSDKKLTL----VFEFCDQDLKKYFDSCNGDLDPEIVKS--FLFQLLKGLGFC 117
Query: 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 269
H ++ RD K N+L++ KL++FGLAR S VV
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVL 173
Query: 270 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 329
+ D+WS G EL RP+ +Q + +Q+ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 330 RLEGKYSL--------RLVSKLSHVA----NLCLVKNARTRPKMSEVLE 366
Y + +V KL+ L N R E L+
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 73/346 (21%), Positives = 118/346 (34%), Gaps = 48/346 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNL 149
IG G G V D VA+K+L R K E+ + V H+N+
Sbjct: 24 PIGSGAQGIVCAA-----YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 150 VKLVGYCADDD--ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 207
+ L+ E LV E M + G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIK 133
Query: 208 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 267
+LH II RD K SNI++ K+ DFGLAR + G + + T V T Y AP
Sbjct: 134 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 187
Query: 268 EYVQTGRLAARSDVWSYGVFLYELITGRRP----------------IDRNRPRSEQKLLQ 311
E + D+WS G + E++ + + P +KL
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 312 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL--------CLVKNARTRPKMSE 363
V+ Y+ + ++ + P+L S+ + + LV + R + +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 364 VLEM--VNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIE 407
L+ +N D + P P + +HT + K I +
Sbjct: 308 ALQHPYINVWYDPAEVEAPP--PQIYDKQLDEREHTIEEWKELIYK 351
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 7e-32
Identities = 71/363 (19%), Positives = 128/363 (35%), Gaps = 43/363 (11%)
Query: 63 PSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ 122
P+ ++ N + + E + +G G +G V D + VAVK+
Sbjct: 2 PTFYRQELNKTIWEVPE------RYQNLSPVGSGAYGSVCAA-----FDTKTGLRVAVKK 50
Query: 123 L--GRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE-RGIQRLLVYEYMPNGSVD 179
L + + K E+ L ++H+N++ L+ + + ++ ++
Sbjct: 51 LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 110
Query: 180 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239
+ + LT + RGL Y+H II RD K SN+ ++E K+ D
Sbjct: 111 NIVKCQK---LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 164
Query: 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-- 297
FGLAR E +V+T A + D+WS G + EL+TGR
Sbjct: 165 FGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
Query: 298 ----------IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLS-HV 346
I R +LL+ + + P++ + L+ +
Sbjct: 221 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
Query: 347 ANLCLVKNARTRPKMSEVLEM--VNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRR 404
LV ++ R ++ L + D E + P S E+ D + K
Sbjct: 281 LEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PY--DQSFESRDLLIDEWKSL 336
Query: 405 IIE 407
+
Sbjct: 337 TYD 339
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 2e-31
Identities = 63/282 (22%), Positives = 102/282 (36%), Gaps = 34/282 (12%)
Query: 41 GSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGC 100
GSE S + + + + SQ + L +F + +G G FG
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK------------TLGTGSFGR 56
Query: 101 VYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEW---MTEVNFLGIVEHQNLVKLVGYCA 157
V + A+K L ++ V K+ + E L V LVKL
Sbjct: 57 VMLV-----KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQI 217
D+ + V EY+ G + +L + A YLH +
Sbjct: 112 DNSNLYM----VMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 218 IVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA 277
I RD K N+L+D+Q +++DFG A+ +T + GT APE + +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNK 217
Query: 278 RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319
D W+ GV +YE+ G P ++P + + K
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS 259
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-29
Identities = 60/275 (21%), Positives = 104/275 (37%), Gaps = 33/275 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----QGHKEWMTEVNFLGIVEHQ 147
V+G G +G V+ + D + A+K L + + + + TE L +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGK--LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 148 -NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 206
LV L + + + +Y+ G + +LS + +
Sbjct: 89 PFLVTLHYAFQTETKLHLI----LDYINGGELFTHLSQRERFTEHEVQI-----YVGEIV 139
Query: 207 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 266
L II RD K NILLD + L+DFGL++ ++ T + GT+ Y A
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMA 198
Query: 267 PEYVQTGRLA--ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324
P+ V+ G D WS GV +YEL+TG P + + + + L +
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSEPPYP 256
Query: 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 359
Q + + L+ + L+K+ + R
Sbjct: 257 QEMSALAK-----DLIQR-------LLMKDPKKRL 279
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 8e-28
Identities = 55/317 (17%), Positives = 107/317 (33%), Gaps = 51/317 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL-- 149
+G G F V+ +D VA+K + R + E+ L V +
Sbjct: 20 KLGWGHFSTVWLA-----KDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 150 ---------VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 200
+KL+ + G+ ++V+E + + + I +I++
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYVKQISK 132
Query: 201 DAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVV 259
GL Y+H II D K N+L++ L +A LG + + T +
Sbjct: 133 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 260 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNR----------------- 302
T Y +PE + +D+WS ++ELITG + +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 303 ----PRSEQKLLQWVKPYLSDAKQFRQIVDPRL---------EGKYSLRLVSKLSHVANL 349
P + ++ + + + R I + + K+S ++S +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 350 CLVKNARTRPKMSEVLE 366
L + R R ++
Sbjct: 311 MLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 1e-17
Identities = 30/210 (14%), Positives = 60/210 (28%), Gaps = 36/210 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK----------QLGRRGVQGHKEWMTEVNFL 141
++GEG V+ + E VK ++ + G +
Sbjct: 7 LMGEGKESAVFNCYSEKFG------ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 142 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 201
E + L KL G Y + N + + + K + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKV---------YAWEGNAVLMELIDAKELYRVRVENPDEVLDM 111
Query: 202 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVG 260
+A + I+ D N+L+ E + DF + +G + V
Sbjct: 112 ILEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRN 167
Query: 261 TMGYAAPEYVQTGRLAARSDVWSYGVFLYE 290
+ Y + Y D+ S + +
Sbjct: 168 IITYFSRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 428 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.38 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.93 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.66 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 82.75 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=424.08 Aligned_cols=262 Identities=29% Similarity=0.471 Sum_probs=205.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC--cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.+.||+|+||+||+|.+.+ .||||++.... ....+.|.+|+.+|++++|||||+++|++.+..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~- 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ- 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccE-
Confidence 3679999999999999999997542 59999987543 334578999999999999999999999986532
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
++||||||++|+|.+++.... ..+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||
T Consensus 78 ----~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 78 ----LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp ----CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred ----EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence 489999999999999986433 4599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc---CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
+|+...............||+.|||||++.+ +.|+.++|||||||++|||+||+.||............ +..
T Consensus 150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~--- 224 (276)
T d1uwha_ 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGR--- 224 (276)
T ss_dssp CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHH---
T ss_pred ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--Hhc---
Confidence 9987654433334456789999999999864 35899999999999999999999999875543221111 100
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
....+.+ ......+++++.+|+.+||+.||++|||+++|+++|+.+.++
T Consensus 225 ------~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 225 ------GYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ------TSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0011111 122334567899999999999999999999999999988754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-58 Score=424.27 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=206.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++++.||+|+||+||+|.+..++ ..||||++..... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-- 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-- 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--
Confidence 357999999999999999999987654 3899999976533 23456889999999999999999999998876
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..|||||||++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 77 --~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 77 --IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp --EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred --eeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence 459999999999999999653 4599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
|+..............+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......... ..
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~---------- 218 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD---------- 218 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HH----------
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HH----------
Confidence 987654443444556789999999999988776 578999999999999999999997654322111 11
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.............+++++.+|+.+||+.||++|||++|++++
T Consensus 219 ----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 219 ----WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ----HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111223456788999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-57 Score=421.63 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=209.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||+||+|....++ ..||||++........+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---- 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD---- 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred cccEEEEEEecCcCcEEEEEEECCCC-----CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC----
Confidence 47999999999999999999876543 389999997665556678999999999999999999999998876
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.+|||||||+||+|.+++.. ..+++..++.|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 45999999999999998754 3499999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
...... ......+||+.|||||++.+..|+.++|||||||++|+|++|..||............ ..
T Consensus 165 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~~---------- 230 (293)
T d1yhwa1 165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--AT---------- 230 (293)
T ss_dssp ECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH----------
T ss_pred eecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH--Hh----------
Confidence 764332 2234568999999999999999999999999999999999999999765432211110 00
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
........+..+++++.+|+.+||+.||++|||+.|+++|
T Consensus 231 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 231 ---NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011112234456789999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-57 Score=429.99 Aligned_cols=263 Identities=25% Similarity=0.438 Sum_probs=215.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.++||+|+||+||+|.+...........||+|.+..... .....+.+|+.+|.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 57889999999999999999988776666777899999865433 3456789999999998 899999999999887754
Q ss_pred CceEEEEEeecCCCCcccccCCCCc---------------------ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSE---------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRD 221 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD 221 (428)
+||||||++|+|.++|..+.. ..+++..++.|+.||+.||+|||++ +|||||
T Consensus 117 ----~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 117 ----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp ----EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred ----EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 999999999999999865421 3589999999999999999999998 999999
Q ss_pred CCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCC
Q 014245 222 FKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 300 (428)
Q Consensus 222 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~ 300 (428)
|||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |..||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654444444456789999999999999999999999999999999998 8999976
Q ss_pred CCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 301 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
...... +. .++........+..+++++.+||.+||+.||++|||++||+++|..
T Consensus 270 ~~~~~~--~~--------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 270 IPVDAN--FY--------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCCSHH--HH--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHH--HH--------------HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 543221 11 1111112222334456789999999999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-57 Score=416.31 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=206.4
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||+||+|....++ ..||+|++.+.. ....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT- 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCC-----cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-
Confidence 46999999999999999999987654 389999986432 234567889999999999999999999999866
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++|||||++|+|.+++... ..+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 80 ---~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 80 ---RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred ---EEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 459999999999999998643 3599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+|+...... .....||+.|||||++.+..|+.++|||||||++|||++|+.||..........
T Consensus 152 ~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------------- 214 (263)
T d2j4za1 152 WSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK------------- 214 (263)
T ss_dssp SCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------
T ss_pred eeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH-------------
Confidence 998654332 345689999999999999999999999999999999999999997654322111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.... ...+..+++++.+|+.+||+.||++|||++|++++
T Consensus 215 ---~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 215 ---RISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111111 11223356789999999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-56 Score=420.86 Aligned_cols=263 Identities=25% Similarity=0.463 Sum_probs=202.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.++||+|+||+||+|.+..++. ....||||.+..... ...+.|.+|+.+|++++|||||+++|+|.+.+..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~- 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGK--REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV- 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC-
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE-
Confidence 456778899999999999999865432 234689999876543 3456799999999999999999999999877654
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
++|||||++|+|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 103 ---~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 103 ---MIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp ---EEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred ---EEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccc
Confidence 9999999999999988753 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCcee---eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 244 RLGPSEGFTH---VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 244 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
+......... ......||+.|||||++.++.|+.++|||||||++|||+| |..||....... +...+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~----- 247 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIE----- 247 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH-----
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHH-----
Confidence 8654332211 1223568999999999999999999999999999999998 899998654322 111111
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.......+..+++++.+|+.+||+.||++|||+.+|++.|+++++.
T Consensus 248 ---------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 ---------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111223334667899999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=415.05 Aligned_cols=257 Identities=26% Similarity=0.480 Sum_probs=200.1
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||+||+|.+.++. .||||++.... ...++|.+|+.++++++|||||+++|+|.+.+..
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~------~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~-- 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKD------KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI-- 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTE------EEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCC------EEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCce--
Confidence 47888999999999999999986542 79999997643 3457899999999999999999999999887654
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
++||||+++|+|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 76 --~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 76 --CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp --EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred --EEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence 9999999999999988644 34589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhC-CCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
....... .......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||...... .+...+..
T Consensus 150 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~-------- 217 (263)
T d1sm2a_ 150 FVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIST-------- 217 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHH--------
T ss_pred eccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHh--------
Confidence 6644322 223346799999999999999999999999999999999995 5555543321 11111111
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
- .....+..+++++.+|+.+||+.||++|||+++|+++|+++.++
T Consensus 218 --~----~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 218 --G----FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --T----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --c----CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0 11112223456899999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-57 Score=421.30 Aligned_cols=259 Identities=24% Similarity=0.433 Sum_probs=213.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||+||+|.+..++ ..||||++.... ...++|.+|+.+|++++|||||+++|+|.+.+..
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~-- 88 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF-- 88 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGT-----EEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCC-----eEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee--
Confidence 47888999999999999999987543 479999987543 3467899999999999999999999999877654
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
++|||||++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+
T Consensus 89 --~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 --YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp --EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred --EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 9999999999999998766566799999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
....... .......||+.|||||++.++.|+.++|||||||++|||++|..||....... .+.
T Consensus 164 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~-------------- 226 (287)
T d1opja_ 164 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY-------------- 226 (287)
T ss_dssp TCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH--------------
T ss_pred ecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHH--------------
Confidence 7654332 23344678999999999999999999999999999999999776654332211 111
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
+.+........+..+++++.+|+.+||+.||++|||+++|++.|+.+..
T Consensus 227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111112223334466789999999999999999999999999988753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=416.45 Aligned_cols=258 Identities=27% Similarity=0.451 Sum_probs=209.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||+||+|.++++ ..||||++.... ...+.|.+|+.+|++++|||||+++|++.++.
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~---- 81 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---- 81 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred HHeEEeEEEecCCCcEEEEEEECCC------CEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCC----
Confidence 5788899999999999999997643 379999997543 34578999999999999999999999886532
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+
T Consensus 82 -~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp -CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred -eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceE
Confidence 38999999999999988765555699999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
...... ........||+.|||||++.++.++.++|||||||++|||+||..|+...... ..+...+.
T Consensus 158 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~---------- 224 (272)
T d1qpca_ 158 LIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLE---------- 224 (272)
T ss_dssp ECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----------
T ss_pred EccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----------
Confidence 765433 22334567999999999999999999999999999999999965554332221 11111111
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
. ......+..+++++.+|+.+||+.||++|||+++|++.|+.+..+
T Consensus 225 ~----~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 225 R----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h----cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1 111122234567899999999999999999999999999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=419.48 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=195.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|+||+||+|....++ ..||+|.+..... ...+.+.+|+.+|++++|||||++++++.+....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 57999999999999999999977654 3899999976543 2345688999999999999999999999765433
Q ss_pred CceEEEEEeecCCCCcccccCCC--CcccccHHHHHHHHHHHHHHHHHhhcCC--CCCeeeccCCCCceEECCCCCeEEe
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGM--DFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
.+|||||||++|+|.+++... ....+++..++.++.||+.||+|||++. ..+||||||||+||||+.++.+||+
T Consensus 79 --~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 79 --TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred --EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 458999999999999998642 2346999999999999999999999861 1249999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||....... +...+
T Consensus 157 DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i----- 226 (269)
T d2java1 157 DFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKI----- 226 (269)
T ss_dssp CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH-----
T ss_pred eccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHH-----
Confidence 999998764322 22345789999999999999999999999999999999999999998654322 11111
Q ss_pred hhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..... ...+..+++++.+|+.+||+.||++|||++|++++
T Consensus 227 --------~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 --------REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --------HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------HcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11111 11223456789999999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-56 Score=410.90 Aligned_cols=252 Identities=24% Similarity=0.414 Sum_probs=200.1
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCce
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 165 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~ 165 (428)
+..+.||+|+||+||+|.+..++ ..||+|.+..... ...+.+.+|+++|++++|||||++++++.+.......
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~-----~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC-----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 55678999999999999976553 3799999865432 3346789999999999999999999999765444446
Q ss_pred EEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC-CCCCeEEeeecccc
Q 014245 166 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLAR 244 (428)
Q Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~ 244 (428)
++|||||+++|+|.+++... ..+++..++.++.||+.||+|||++ ..+|+||||||+||||+ +++.+||+|||+|+
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 79999999999999999643 4589999999999999999999987 11299999999999996 57899999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
...... ....+||+.|||||++.+ .|+.++|||||||++|||++|+.||........ +..
T Consensus 164 ~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~------------- 223 (270)
T d1t4ha_ 164 LKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR------------- 223 (270)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH-------------
T ss_pred eccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH-------------
Confidence 644322 345789999999998865 699999999999999999999999975443211 111
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+.........+...++++.+|+.+||+.||++|||++|+++|
T Consensus 224 ~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 224 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111111111222345679999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=416.91 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=207.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
+.|++++.||+|+||+||+|.+..++ ..||+|++........+.+.+|+++|++++|||||++++++.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETS-----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN---- 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCC-----eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----
Confidence 46899999999999999999977654 389999998776666788999999999999999999999998876
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
..+||||||++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 459999999999999987543 24599999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhc-----cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
..... .......+||+.|||||++. +..|+.++|||||||++|||++|+.||...........+ .
T Consensus 159 ~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--~------ 228 (288)
T d2jfla1 159 KNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--A------ 228 (288)
T ss_dssp ECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--H------
T ss_pred ccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--H------
Confidence 54321 11223568999999999984 456899999999999999999999999865443221110 0
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ........+..+++++.+|+.+||+.||++|||++|++++
T Consensus 229 -----~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 229 -----K--SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----H--SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----c--CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0001112233466789999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=411.62 Aligned_cols=262 Identities=23% Similarity=0.422 Sum_probs=210.7
Q ss_pred cCCCCcee-ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVV-IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~-lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|.+.+. ||+|+||+||+|.++..+ ....||||++..... ...++|.+|+.+|++++|||||+++|++.++.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-- 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-- 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSS--
T ss_pred cCeEECCcEEecccCeEEEEEEEecCC---CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCe--
Confidence 35666664 999999999999876543 245799999976543 34567999999999999999999999997542
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
++||||||++|+|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 83 ---~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 83 ---LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp ---EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred ---EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchh
Confidence 48999999999999987543 24599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 243 ARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 243 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
++........ .......||+.|||||++.++.++.++|||||||++|||+| |..||...........+ .
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i---~------ 226 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---E------ 226 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---H------
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---H------
Confidence 9876543322 22334578999999999999999999999999999999998 99999876543211111 0
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
. ......+..+++++.+|+.+||+.||++|||+.+|++.|+......
T Consensus 227 -------~-~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 227 -------Q-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp -------T-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------c-CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0 1111233446678999999999999999999999999998776543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=417.64 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=204.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++++.||+|+||+||+|....++ ..||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATS-----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE- 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-
Confidence 46999999999999999999976554 389999986532 233467899999999999999999999998765
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..|||||||+||+|.+++... +.+++..++.++.|++.||+|||++ +||||||||+|||+++++.+||+|||
T Consensus 82 ---~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 82 ---KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp ---EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 459999999999999988643 4599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+|+..............+||+.|||||++.+..|+.++|||||||++|||++|..||......... .
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~---------- 220 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF---Q---------- 220 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----------
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH---H----------
Confidence 998765444344445678999999999999999999999999999999999999999865432211 1
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 368 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 368 (428)
.+..... .++..+++++.+|+.+||+.||++|||++|++++.
T Consensus 221 ---~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 221 ---KIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp ---HHHTTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred ---HHHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 1111111 12234567899999999999999999999986653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=410.85 Aligned_cols=265 Identities=25% Similarity=0.471 Sum_probs=204.6
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
+.|++.++||+|+||+||+|.++.++ ......||||.+...... ...+|.+|+.+|++++|||||+++|++.+...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~-- 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP-- 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCC-CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc--
Confidence 46888999999999999999987653 234567999999765433 34578999999999999999999999987664
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 84 --~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 84 --MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp --EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred --eEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence 49999999999998877543 34599999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCc-eeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+....... ........||+.|||||++.++.++.++|||||||++|||++|..|+...... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~---------- 225 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKA---------- 225 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH----------
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHH----------
Confidence 87543322 22233467899999999999999999999999999999999966655433221 111111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
+........+..++.++.+|+.+||+.||++|||+.+|++.|+++++.
T Consensus 226 ----i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 226 ----INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111122233344567899999999999999999999999999998865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=424.17 Aligned_cols=266 Identities=26% Similarity=0.357 Sum_probs=206.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.++|++++.||+|+||+||+|....+ +..||+|++..... .....+.+|+.+|+.++|||||+++++|.+..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPS-----GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTT-----TEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCC-----CcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 46899999999999999999997654 35899999976533 33467899999999999999999999999876
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
+++||||||+||+|.+++... +.+++..+..++.|++.||.|||+ + +|+||||||+||||+.+|.+||+|||
T Consensus 78 --~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 78 --EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp --EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred --EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence 459999999999999999643 359999999999999999999996 5 89999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh-Hhh-----
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW-VKP----- 315 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-~~~----- 315 (428)
+|+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||........+..... ...
T Consensus 151 la~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 151 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp CCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 99854321 23457899999999999999999999999999999999999999976543322111000 000
Q ss_pred --------------------hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 --------------------YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 --------------------~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..........+.............+.++.+|+.+||+.||++|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000111111111111112245689999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=408.05 Aligned_cols=253 Identities=24% Similarity=0.414 Sum_probs=202.7
Q ss_pred eeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEE
Q 014245 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
++||+|+||+||+|.+.... ..+.||||++..... ...++|.+|+.+|++++|||||+++|+|.++. .+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~-----~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-----WML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS---SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-----EEE
T ss_pred CCcccCCCeEEEEEEEccCC---cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC-----EEE
Confidence 47999999999999876532 356899999965432 23467999999999999999999999996542 489
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCC
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 248 (428)
|||||++|+|.+++... ..+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 85 vmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 99999999999998643 3499999999999999999999998 999999999999999999999999999987654
Q ss_pred CCce-eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 249 EGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 249 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|||||++.+..++.++|||||||++|||+| |..||........... +.
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~---i~------------ 224 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LE------------ 224 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HH------------
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH---HH------------
Confidence 3322 22345679999999999999999999999999999999998 8999986543221111 10
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
.......+..+++++.+|+.+||+.||++|||+++|++.|+....
T Consensus 225 --~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 225 --KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --cCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 111122333456789999999999999999999999998877643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=402.68 Aligned_cols=253 Identities=25% Similarity=0.455 Sum_probs=209.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.++||+|+||+||+|.++++ ..||||.+..... ..++|.+|+.++++++||||++++|+|.+...
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~--- 73 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--- 73 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTT------EEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS---
T ss_pred HHCEEeEEEecCCCeEEEEEEECCC------CEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc---
Confidence 5789999999999999999998643 3799999976543 45789999999999999999999999987654
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
+++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 74 -~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 74 -IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp -EEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred -eEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence 499999999999999876433 4588999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...........+
T Consensus 149 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i------------- 214 (258)
T d1k2pa_ 149 YVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------------- 214 (258)
T ss_dssp BCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------------
T ss_pred eccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-------------
Confidence 65443322 2334679999999999999999999999999999999998 89999876533221111
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 370 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 370 (428)
.. ......+...++++.+|+.+||+.||++|||+++|+++|.+
T Consensus 215 ---~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 215 ---AQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---HT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---Hh-CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01 11112233455789999999999999999999999999854
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=412.86 Aligned_cols=269 Identities=25% Similarity=0.375 Sum_probs=208.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.+.||+|+||.||+|.+........++.||||++..... ...+.+.+|..++.++ +|+||+.+++++...+.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~- 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG- 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS-
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC-
Confidence 57999999999999999999988776677788999999976433 3345678888888777 78999999999876543
Q ss_pred CceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 228 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NIL 228 (428)
.+++|||||++|+|.+++.... ...+++..++.++.||+.||+|||++ +||||||||+|||
T Consensus 92 --~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 92 --PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp --CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred --eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 2489999999999999986432 23489999999999999999999998 9999999999999
Q ss_pred ECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhC-CCCCCCCCchhhH
Q 014245 229 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRSEQ 307 (428)
Q Consensus 229 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~ 307 (428)
|++++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+|| ..||........
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~- 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 999999999999999866544433334557899999999999999999999999999999999996 567765433211
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
+...+ .. ......+..+++++.+++.+||+.||++|||+.||+++|+.++++.
T Consensus 246 -~~~~~----------~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 246 -FCRRL----------KE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp -HHHHH----------HH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHH----------hc----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 11111 01 1111222335578999999999999999999999999999988653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-55 Score=413.19 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=191.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.+.|++.+.||+|+||+||+|....++ ..||||.+...... ....+.+|+.+|+.++|||||++++++.+.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQ-----KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-- 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTC-----CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 457999999999999999999977554 38999999765432 3456789999999999999999999998766
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC---CCCCeEEee
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLSD 239 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~D 239 (428)
.+|||||||+||+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|
T Consensus 81 --~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 81 --HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp --EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred --EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence 459999999999999999654 4599999999999999999999998 999999999999994 578999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
||+|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|..||...........+. .
T Consensus 154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~- 223 (307)
T d1a06a_ 154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL------K- 223 (307)
T ss_dssp C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------T-
T ss_pred cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh------c-
Confidence 99998654322 2345689999999999999999999999999999999999999997654322111100 0
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............+++++.+|+.+||+.||++|||++|++++
T Consensus 224 -------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 224 -------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -------cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111222233466789999999999999999999999885
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-54 Score=415.98 Aligned_cols=254 Identities=21% Similarity=0.346 Sum_probs=210.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|++.+.||+|+||+||+|....+ +..||||++........+.+.+|+.+|++++|||||++++++.+.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--- 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERAT-----GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--- 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT-----TEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT---
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCC-----CCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 45899999999999999999997654 3489999998776666678899999999999999999999998866
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC--CCCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD--EQWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFG 241 (428)
.+|||||||+||+|.+++.... ..+++..++.|+.||+.||+|||++ +||||||||+|||++ .++.+||+|||
T Consensus 97 -~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 97 -EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp -EEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred -EEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence 4599999999999999886433 3599999999999999999999998 999999999999995 46789999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+|+...... ......||+.|||||++.+..|+.++|||||||++|+|++|..||...........+ ..
T Consensus 172 ~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i---~~------ 239 (350)
T d1koaa2 172 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV---KS------ 239 (350)
T ss_dssp TCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH------
T ss_pred hheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---Hh------
Confidence 998765432 234578999999999999999999999999999999999999999765432211111 00
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
............+++++.+|+.+||+.||++|||++|++++
T Consensus 240 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 240 -----CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----TCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111222223456789999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-55 Score=407.05 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=204.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||+||+|.++++. .||||++.... ...+.|.+|+.+|++++|||||+++|+|.+. .
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~------~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~--- 85 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-P--- 85 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTE------EEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S---
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCC------EEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecC-C---
Confidence 57999999999999999999986543 69999997553 3457899999999999999999999998653 2
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++||||+++|+|..++.......+++..++.|+.||+.||+|||++ +|+||||||+||||+.++++||+|||+++
T Consensus 86 -~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 86 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp -CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred -eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhh
Confidence 38999999999999988765555699999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 324 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (428)
...... ........||+.|+|||++.++.++.++|||||||++|||++|..|+...... ......+.
T Consensus 162 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~---------- 228 (285)
T d1fmka3 162 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE---------- 228 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----------
T ss_pred hccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH----------
Confidence 654332 22234467999999999999999999999999999999999976665443322 11111111
Q ss_pred hhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 325 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 325 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.......+..+++++.+++.+||+.||++||++++|++.|+.....
T Consensus 229 ----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 229 ----RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ----TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1111223344567899999999999999999999999998876643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.8e-54 Score=414.01 Aligned_cols=254 Identities=21% Similarity=0.316 Sum_probs=210.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|++++.||+|+||+||+|....++ ..||||++..........+.+|+.+|++|+|||||++++++.+..
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--- 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--- 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS---
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 357999999999999999999976543 389999998766556677889999999999999999999998766
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC--CCCCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD--EQWNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFG 241 (428)
.+|||||||+||+|.+++.... ..+++..++.|+.||+.||+|||++ +||||||||+||||+ .++.+||+|||
T Consensus 100 -~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 100 -EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp -EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred -EEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence 4599999999999988776443 3599999999999999999999998 999999999999997 67899999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+|+...... ......||+.|||||++.+..|+.++|||||||++|+|+||..||...........+. .
T Consensus 175 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~---~------ 242 (352)
T d1koba_ 175 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK---R------ 242 (352)
T ss_dssp TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---H------
T ss_pred cceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h------
Confidence 998765432 2345689999999999999999999999999999999999999998654322111110 0
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..........+++++.+|+.+||+.||.+|||+.|++++
T Consensus 243 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 243 -----CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -----CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112222333466789999999999999999999999885
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-54 Score=410.09 Aligned_cols=266 Identities=27% Similarity=0.427 Sum_probs=216.5
Q ss_pred HhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 83 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
..++|++.+.||+|+||+||+|.+.+......+..||||++...... ..++|.+|+.+|+.++||||++++++|.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 35689999999999999999999887666667779999999765433 35679999999999999999999999988765
Q ss_pred CCceEEEEEeecCCCCcccccCCCC----------------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKS----------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 219 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 219 (428)
. ++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||++ +|||
T Consensus 91 ~----~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 91 M----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp C----EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred e----EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 4 99999999999999885321 23488999999999999999999998 9999
Q ss_pred ccCCCCceEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCC-CCC
Q 014245 220 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR-RPI 298 (428)
Q Consensus 220 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~ 298 (428)
|||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. .||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998654443334445678999999999999999999999999999999999985 577
Q ss_pred CCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 014245 299 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 372 (428)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~ 372 (428)
....... +...+ .+.. ....+..+++++.+|+.+||+.||++|||+.||++.|+++.
T Consensus 244 ~~~~~~e---~~~~v-------------~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEE---VIYYV-------------RDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHH---HHHHH-------------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHH---HHHHH-------------HcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6554322 11111 1111 11223345578999999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=411.60 Aligned_cols=263 Identities=26% Similarity=0.437 Sum_probs=209.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC-cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.+|+++++||+|+||+||+|.+..++. .....||+|.+.... ....++|.+|+.+|++++|||||+++|+|.+..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCC-EEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 369999999999999999999876532 334569999986543 345678999999999999999999999998754
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
.+++|||+.+|+|.+++... ...+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|
T Consensus 85 --~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 85 --VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp --EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred --eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccc
Confidence 37899999999998887644 34599999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...............||+.|||||++.++.|+.++|||||||++|||+| |..||...........+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~----------- 227 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------- 227 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-----------
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----------
Confidence 97765444444455679999999999999999999999999999999999 899997654332221111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.......+..+++++.+|+.+||+.||++|||+.+|+++|..+...
T Consensus 228 ------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 228 ------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 0111122334567899999999999999999999999999887654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-55 Score=412.17 Aligned_cols=246 Identities=30% Similarity=0.407 Sum_probs=201.2
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
.|+.++.||+|+||+||+|....++ ..||||.+...... ..+.+.+|+.+|++++|||||++++++.+.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hcEeeEEEecCCCeEEEEEEECCCC-----cEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--
Confidence 5899999999999999999976543 48999999765432 3356889999999999999999999998866
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
..+||||||++|+|..++..+ ..+++..++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+
T Consensus 89 --~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 89 --TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp --EEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred --EEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccc
Confidence 459999999999997766433 4599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhcc---CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
|+.... .....||+.|||||++.+ +.|+.++|||||||++|||++|..||.........
T Consensus 162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------------ 223 (309)
T d1u5ra_ 162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------------ 223 (309)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------------
T ss_pred ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------------
Confidence 986532 234689999999999864 46899999999999999999999999765432111
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+............+++++.+|+.+||+.||++|||++|+++|
T Consensus 224 ----~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 224 ----YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ----HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11111111111222356789999999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=400.05 Aligned_cols=261 Identities=22% Similarity=0.377 Sum_probs=201.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|++.+.||+|+||.||+|.+...+ .....||||.+...... ..+.+.+|+.+|++++|||||+++|++.+.
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---- 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCC--ceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 57899999999999999999886543 23457999998654433 356789999999999999999999999643
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 81 -~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 81 -PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp -SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred -eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence 249999999999999887543 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 322 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (428)
+...... ........||+.|+|||++.++.|+.++|||||||++|||++ |.+||...........+
T Consensus 156 ~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i------------ 222 (273)
T d1mp8a_ 156 RYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI------------ 222 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH------------
T ss_pred eeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH------------
Confidence 8654322 222345678999999999999999999999999999999998 89999876543221111
Q ss_pred hhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 323 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 323 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
... .....+..+++++.+|+.+||+.||++|||+.+|+++|+.+++.
T Consensus 223 ----~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 223 ----ENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HcC-CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 110 11123344567899999999999999999999999999988765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-54 Score=396.98 Aligned_cols=252 Identities=27% Similarity=0.452 Sum_probs=201.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||.||+|.+++ ..||||.++... ..+.+.+|++++++++||||++++|+|.+...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~--- 74 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG--- 74 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----
T ss_pred HHeEEeEEEecCCCeEEEEEEECC-------eEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC---
Confidence 467888999999999999999753 279999997543 44779999999999999999999999976432
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.++|||||+++|+|.+++..+....+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccce
Confidence 248999999999999999765555689999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014245 245 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 323 (428)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (428)
..... .....+|+.|+|||++.++.++.++|||||||++|||+| |+.||......... ..
T Consensus 152 ~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---~~----------- 212 (262)
T d1byga_ 152 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PR----------- 212 (262)
T ss_dssp ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HH-----------
T ss_pred ecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH---HH-----------
Confidence 64322 233568999999999999999999999999999999998 78888765433211 11
Q ss_pred hhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 014245 324 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 373 (428)
Q Consensus 324 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~ 373 (428)
+........+..+++++.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 213 ---i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 213 ---VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ---HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11112223334456789999999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=408.29 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=207.7
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 160 (428)
.++|++++.||+|+||.||+|....++ ..||+|++.+.. ....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 357999999999999999999976654 389999997542 234567889999999999999999999999876
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
.+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+||
T Consensus 79 ----~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 79 ----RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ----ccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence 459999999999999998653 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........
T Consensus 150 G~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----------- 216 (337)
T d1o6la_ 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------- 216 (337)
T ss_dssp TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------
T ss_pred ccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH-----------
Confidence 9998654332 223457899999999999999999999999999999999999999987653221111
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
+.... ..++..+++++.+||.+||+.||.+||+ ++++++|
T Consensus 217 -----i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 217 -----ILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----HHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----HhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11111 1123345678999999999999999995 8888875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=402.16 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=206.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc------ccHHHHHHHHHHHhcCCCCCcccEeeEEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV------QGHKEWMTEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
.++|++++.||+|+||+||+|.+..++ ..||||++.+... ...+.+.+|+.+|++++|||||++++++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 357999999999999999999986554 3899999865422 23567899999999999999999999998
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC----
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---- 233 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---- 233 (428)
+.. .+|||||||++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 84 ~~~----~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 84 NKT----DVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp CSS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred ECC----EEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCccc
Confidence 876 459999999999999999643 3599999999999999999999998 999999999999998776
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 313 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 313 (428)
.+||+|||+|....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.
T Consensus 155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-- 229 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-- 229 (293)
T ss_dssp CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--
T ss_pred ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH--
Confidence 49999999998764332 2345689999999999999999999999999999999999999998654322111110
Q ss_pred hhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 314 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ............++.++.+|+.+||+.||++|||++|++++
T Consensus 230 -~-----------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 230 -A-----------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -T-----------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -h-----------cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011111122345689999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-53 Score=395.69 Aligned_cols=264 Identities=26% Similarity=0.353 Sum_probs=206.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---cHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||+||+|....+ ++.||||++...... ....+.+|+.+|+.++|||||++++++...+.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRL-----HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCC-----CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 5799999999999999999997654 348999999765432 34578899999999999999999999988766
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.....||||||++||+|.+++... +.+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.++|+|||
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred CCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence 555679999999999999888543 3599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCC-ceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEG-FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
.+....... ........+||+.|||||++.+..|+.++|||||||++|||+||+.||.......... ... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~--~~~----~~- 229 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHV----RE- 229 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHH----HC-
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH--HHH----hc-
Confidence 987543322 1223445789999999999999999999999999999999999999998654322111 100 00
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhh
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-KMSEVLEMVNKIV 372 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ell~~L~~~~ 372 (428)
++.........+++++.+++.+||+.||++|| |++++++.|.++.
T Consensus 230 -------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 230 -------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00111111223557899999999999999999 8999999888765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=397.46 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=201.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++.+.||+|+||+||+|.+.... .....||||++.+.. ....++|.+|+.+|++++|||||+++|+|.+..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~- 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCC--CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecc-
Confidence 46889999999999999999876532 245579999987643 233567999999999999999999999997542
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||
T Consensus 85 ----~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 85 ----MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp ----CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ----hheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccch
Confidence 38999999999999887643 34599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcee-eeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014245 242 LARLGPSEGFTH-VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 319 (428)
Q Consensus 242 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (428)
+++......... ......||..|+|||++.+..++.++|||||||++|||+| |..||....... ..
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~--------- 224 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL--------- 224 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---------
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HH---------
Confidence 999765443322 2334568889999999999999999999999999999998 899997654322 11
Q ss_pred hhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 014245 320 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 371 (428)
Q Consensus 320 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~ 371 (428)
..+.........+..++.++.+|+.+||+.||++|||+.+|++.|.+.
T Consensus 225 ----~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 ----HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112222222233344567899999999999999999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=402.22 Aligned_cols=267 Identities=26% Similarity=0.404 Sum_probs=218.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.++||+|+||.||+|.+....+...++.||||++..... .....+.+|+.+++.+ +|||||+++|+|.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57888999999999999999987655566788999999976543 3445788999999999 799999999999887654
Q ss_pred CceEEEEEeecCCCCcccccCCCC----------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKS----------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
+||||||++|+|.+++.... ...+++..++.++.||+.||+|||++ ++|||||||+|
T Consensus 103 ----~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 103 ----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp ----EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ----EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 99999999999999985432 23589999999999999999999998 99999999999
Q ss_pred eEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchh
Q 014245 227 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 305 (428)
Q Consensus 227 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 305 (428)
||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||.......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987665544455566789999999999999999999999999999999999 555565443321
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.. ..++........+...+.++.+||.+||+.||++|||+.+|++.|++++..
T Consensus 256 ~~----------------~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 KF----------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HH----------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----------------HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11 111111122223334567899999999999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-53 Score=402.29 Aligned_cols=246 Identities=24% Similarity=0.399 Sum_probs=205.0
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++++.||+|+||+||+|..+.++ ..||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+..
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNG-----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ- 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCC-----CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-
Confidence 57999999999999999999976543 389999986532 234567889999999999999999999998866
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
.+|+|||||+||+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||
T Consensus 78 ---~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 78 ---QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred ---eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 4599999999999999886543 478889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+|+..... ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||..........
T Consensus 150 ~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------------- 211 (316)
T d1fota_ 150 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------------- 211 (316)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------
T ss_pred cceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH-------------
Confidence 99876432 235789999999999999999999999999999999999999998654322111
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.+.... ..++..+++++.+++.+||+.||.+|+ +++++++|
T Consensus 212 ---~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 212 ---KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111111 112233557899999999999999996 89999885
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=400.46 Aligned_cols=266 Identities=26% Similarity=0.433 Sum_probs=211.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCC--CCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 160 (428)
++|.+.+.||+|+||.||+|....... ......||||++..... ....++.+|+..+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578889999999999999998766532 23456899999976544 3346788999999888 8999999999998866
Q ss_pred CCCceEEEEEeecCCCCcccccCCCC--------------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 226 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 226 (428)
. .++|||||++|+|.++|..+. ...+++..++.++.||+.||+|||++ +||||||||+|
T Consensus 93 ~----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 93 P----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp S----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred e----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 4 499999999999999996543 24589999999999999999999998 99999999999
Q ss_pred eEECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHh-CCCCCCCCCchh
Q 014245 227 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 305 (428)
Q Consensus 227 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~ 305 (428)
||++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |..||.......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999999986654443334455789999999999999999999999999999999998 788887654322
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 306 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
+...+ ........+..+++++.+|+.+||+.||++|||+.||++.|++++..
T Consensus 246 ---~~~~i--------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 ---LFKLL--------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ---HHHHH--------------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHH--------------HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 11111 11111222334567899999999999999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=402.69 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=203.9
Q ss_pred hcCCCCce-eecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhc-CCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGI-VEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~ 161 (428)
.++|.+.. +||+|+||+||+|....++ ..||||++.. ...+.+|+.++.+ ++|||||+++++|.+...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCC-----CEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 45788775 6999999999999976543 3899999854 2567789998765 489999999999976433
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC---CCCeEEe
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLS 238 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~ 238 (428)
....+|||||||+||+|.++|..+....+++..++.|+.||+.||+|||++ +|+||||||+|||++. ++.+||+
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 334679999999999999999876556799999999999999999999998 9999999999999975 5679999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014245 239 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 318 (428)
Q Consensus 239 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (428)
|||+|+...... .....+||+.|||||++.+..|+.++|||||||++|+|+||+.||...........+
T Consensus 157 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-------- 225 (335)
T d2ozaa1 157 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------- 225 (335)
T ss_dssp CCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------
T ss_pred ccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH--------
Confidence 999998754432 234568999999999999999999999999999999999999999754332111100
Q ss_pred hhhhhhhhcCC--cCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 DAKQFRQIVDP--RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ~~~~~~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...+... .........+++++.+|+.+||+.||++|||+.|++++
T Consensus 226 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 ----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0011111 11122234567889999999999999999999999885
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-52 Score=403.49 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=204.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
++|++++.||+|+||.||+|.++.++ ..||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g-----~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS- 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCC-----CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-
Confidence 47999999999999999999986554 389999986532 234567889999999999999999999998876
Q ss_pred CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeec
Q 014245 162 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 241 (428)
Q Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 241 (428)
..++||||+.+|+|.+++... +.+++..++.|+.||+.||.|||++ +||||||||+||||+.+|.+||+|||
T Consensus 115 ---~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 115 ---NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ---ccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 359999999999999988643 3599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+|+..... .....||+.|||||++.+..|+.++|||||||++|||+||..||......... .
T Consensus 187 ~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~---------- 248 (350)
T d1rdqe_ 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---E---------- 248 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----------
T ss_pred eeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH---H----------
Confidence 99876432 23468999999999999999999999999999999999999999765432211 1
Q ss_pred hhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 322 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
.+.... ...+..+++++.+++.+||+.||.+|+ ++++|++|
T Consensus 249 ---~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 249 ---KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---HHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111111 112234567899999999999999994 89999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=396.47 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=206.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcC-CCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 162 (428)
++|++.++||+|+||+||+|.+.+++ ....||||.+..... ...+.|.+|+++|+++ +|||||+++|+|.+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT---EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCC---eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--
Confidence 57888999999999999999987643 234688898865432 3456799999999999 7999999999998766
Q ss_pred CceEEEEEeecCCCCcccccCCC--------------CcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 228 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NIL 228 (428)
.+++||||+++|+|.++|... ....+++..++.++.||+.||.|||++ +|+||||||+|||
T Consensus 85 --~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL 159 (309)
T d1fvra_ 85 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 159 (309)
T ss_dssp --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred --eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEE
Confidence 459999999999999998643 224689999999999999999999998 9999999999999
Q ss_pred ECCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCC-CCCCCCCchhhH
Q 014245 229 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR-RPIDRNRPRSEQ 307 (428)
Q Consensus 229 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~ 307 (428)
++.++.+||+|||+++..... .......||+.|+|||.+.++.|+.++|||||||++|||++|. +||......
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--- 233 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--- 233 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred EcCCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---
Confidence 999999999999999754322 1223457999999999999999999999999999999999975 567554322
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.+...+ ........+..+++++.+||.+||+.||++|||+.+|+++|+++.+.
T Consensus 234 ~~~~~i--------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 ELYEKL--------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHG--------------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHH--------------HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111111 11111223344667899999999999999999999999999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-52 Score=402.61 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=201.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc---ccHHHHH---HHHHHHhcCCCCCcccEeeEEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV---QGHKEWM---TEVNFLGIVEHQNLVKLVGYCA 157 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~nIv~~~~~~~ 157 (428)
.++|++.++||+|+||.||+|....++ ..||||++.+... .....+. .|+.+++.++|||||++++++.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~-----~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCC-----CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence 368999999999999999999977654 3899999864321 1222333 4577788889999999999998
Q ss_pred cCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEE
Q 014245 158 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 237 (428)
Q Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 237 (428)
+.+ .+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++ +||||||||+||||+.+|.+||
T Consensus 78 ~~~----~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 78 TPD----KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp CSS----EEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEE
T ss_pred ECC----EEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEE
Confidence 876 459999999999999999643 4588999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 316 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 316 (428)
+|||+|+...... ....+||+.|||||++.+ ..|+.++|||||||++|||+||+.||..........+..
T Consensus 149 ~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----- 219 (364)
T d1omwa3 149 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----- 219 (364)
T ss_dssp CCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-----
T ss_pred eeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 9999998654332 234689999999999975 568999999999999999999999998755433222211
Q ss_pred hhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 014245 317 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ell~~ 367 (428)
..... ....+..+++++.+||.+||+.||++||| ++++++|
T Consensus 220 --------~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 220 --------MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --------HSSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --------hcccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11111 11122345678999999999999999999 6888875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=398.71 Aligned_cols=266 Identities=23% Similarity=0.428 Sum_probs=214.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
++|.+.+.||+|+||+||+|.+...........||||++..... .....|.+|+.++++++|||||+++|+|......
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~- 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT- 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC-
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce-
Confidence 57888999999999999999986544444556899999976533 3345689999999999999999999999876654
Q ss_pred ceEEEEEeecCCCCcccccCCCC--------cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCe
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 235 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 235 (428)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+||||++++++
T Consensus 99 ---~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 99 ---LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp ---EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred ---eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 99999999999999885321 13468899999999999999999998 99999999999999999999
Q ss_pred EEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhC-CCCCCCCCchhhHHHHHhHh
Q 014245 236 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 236 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~ 314 (428)
||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|| ..||.........
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------- 245 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------- 245 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence 99999999876544444444556899999999999999999999999999999999998 4777654332111
Q ss_pred hhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 315 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
..+.+... ...+..+++.+.+++.+||+.||++|||+.+|+++|++.++.
T Consensus 246 ---------~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 246 ---------RFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ---------HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ---------HHHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11111111 112234557899999999999999999999999999877543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=391.82 Aligned_cols=261 Identities=28% Similarity=0.474 Sum_probs=205.0
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC-CcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCceEEE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~~~~l 168 (428)
.++||+|+||+||+|.+..++ .....||||.+... .....++|.+|+++|++++|||||+++|++..... ..++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~~l 106 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLV 106 (311)
T ss_dssp EEEEEEETTEEEEEEEECC------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT---EEEE
T ss_pred ceEEeecCCeEEEEEEEECCC--CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC---ceEE
Confidence 468999999999999987543 23457999999754 33345789999999999999999999999876442 4589
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecccccCCC
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 248 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 248 (428)
|||||++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++....
T Consensus 107 v~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999999887543 4578888999999999999999998 999999999999999999999999999987543
Q ss_pred CCce--eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014245 249 EGFT--HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 326 (428)
Q Consensus 249 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (428)
.... .......||+.|+|||.+.++.++.++||||||+++|||+||..||....... .+...+
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i------------- 247 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL------------- 247 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH-------------
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH-------------
Confidence 3221 12234578999999999999999999999999999999999888876432111 111110
Q ss_pred cCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 327 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 327 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
... .....+..+++++.+|+.+||+.||++||++.||+++|+.+....
T Consensus 248 ~~g-~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 248 LQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HcC-CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 000 011122334578999999999999999999999999999997653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=394.84 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=206.1
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.++|.+++.||+|+||+||+|....++ ..||+|.+..... ....+.+|+.+|+.++|||||++++++.+..
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~-----~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--- 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSK-----KTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESME--- 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT---
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC---
Confidence 468999999999999999999976553 4899999976543 3456789999999999999999999998866
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCC--CCeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ--WNAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFG 241 (428)
.+|||||||+||+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 75 -~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 75 -ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp -EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred -EEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence 4599999999999999997543 3589999999999999999999998 99999999999999854 579999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 321 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (428)
+++...... ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||..........
T Consensus 150 ~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~------------- 213 (321)
T d1tkia_ 150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------------- 213 (321)
T ss_dssp TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------
T ss_pred hhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence 998764432 2345689999999999999999999999999999999999999998754322111
Q ss_pred hhhhhcCCcC--CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 322 QFRQIVDPRL--EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 322 ~~~~~~~~~l--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+..... .......+++++.+|+.+||+.||++|||++|++++
T Consensus 214 ---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 214 ---NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---HHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 111111345689999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.4e-52 Score=386.91 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=205.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc---------cHHHHHHHHHHHhcCC-CCCcccEe
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ---------GHKEWMTEVNFLGIVE-HQNLVKLV 153 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~nIv~~~ 153 (428)
.++|++.+.||+|+||+||+|....+ ++.||||++.+.... ..+.+.+|+.+|++++ |||||+++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~-----~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPT-----CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCC-----CCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 36899999999999999999987654 358999999765321 1235789999999996 99999999
Q ss_pred eEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC
Q 014245 154 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 233 (428)
Q Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~ 233 (428)
+++.+.+ ..|||||||++|+|.++|..+ ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 77 ~~~~~~~----~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 77 DTYETNT----FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 147 (277)
T ss_dssp EEEECSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred eecccCc----ceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCC
Confidence 9999866 459999999999999999643 4599999999999999999999998 999999999999999999
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhcc------CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhH
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 307 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~ 307 (428)
.+||+|||+++...... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.........
T Consensus 148 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~ 224 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224 (277)
T ss_dssp CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH
Confidence 99999999998765432 2345789999999999863 34688999999999999999999999876432211
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 308 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+. . . ...........+++++.+|+.+||+.||++|||++|++++
T Consensus 225 ~~i~------~------~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 RMIM------S------G--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHH------H------T--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHH------h------C--CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 0 0 1111222334567899999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=398.04 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=202.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCC---cccHHHHHHHHHHHh-cCCCCCcccEeeEEecCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---VQGHKEWMTEVNFLG-IVEHQNLVKLVGYCADDD 160 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~ 160 (428)
++|.+++.||+|+||+||+|.+..++ ..||||++.+.. ....+.+..|..++. .++|||||++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~-----~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCC-----CEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 57999999999999999999977553 489999996532 223456677777665 689999999999999876
Q ss_pred CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 161 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
..|||||||++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 77 ----~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 ----NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ----ceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 459999999999999999643 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
|+++...... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.
T Consensus 148 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--------- 216 (320)
T d1xjda_ 148 GMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--------- 216 (320)
T ss_dssp TTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------
T ss_pred chhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---------
Confidence 9998654332 22345689999999999999999999999999999999999999998654332111110
Q ss_pred hhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 014245 321 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS-EVLEM 367 (428)
Q Consensus 321 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ell~~ 367 (428)
...+ .++..+++++.+|+.+||+.||++||++. ++++|
T Consensus 217 -----~~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 217 -----MDNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp -----HCCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -----cCCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 0011 12234567899999999999999999995 78663
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-52 Score=390.10 Aligned_cols=276 Identities=24% Similarity=0.335 Sum_probs=203.7
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHH--HHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWM--TEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.|...+.||+|+||.||+|.+.+ ..||||++.... ...+. .|+..+.+++|||||++++++.+.+...
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g-------~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETT-------EEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred EEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 56777899999999999998743 379999986442 23343 4555566789999999999998877655
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeccCCCCceEECCCCCeEEe
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG-----MDFQIIVRDFKSSNILLDEQWNAKLS 238 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~ 238 (428)
..+++|||||++|+|.+++... .+++..++.++.|++.||+|||+. ...+||||||||+||||+.++.+||+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 6789999999999999999643 489999999999999999999962 13499999999999999999999999
Q ss_pred eecccccCCCCCcee--eeeeeecCcccCCcchhccCC------CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014245 239 DFGLARLGPSEGFTH--VSTAVVGTMGYAAPEYVQTGR------LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 310 (428)
Q Consensus 239 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~ 310 (428)
|||+++......... ......||+.|||||++.+.. ++.++|||||||+||||+||..||...........
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~- 229 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY- 229 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-
Confidence 999998654332221 234578999999999987643 56789999999999999999988754322111000
Q ss_pred HhHhhhhhhhhhhhhhcCCcC----CCCc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhh
Q 014245 311 QWVKPYLSDAKQFRQIVDPRL----EGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 375 (428)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l----~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~ 375 (428)
.................+..+ .... .......+.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 000000000000111122222 2211 2346678999999999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=385.01 Aligned_cols=263 Identities=25% Similarity=0.271 Sum_probs=195.7
Q ss_pred CceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc-----cHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCC
Q 014245 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 163 (428)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 163 (428)
.+++||+|+||+||+|....++ ..||||++...... ..+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCC-----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC-
T ss_pred cceEeccCcCeEEEEEEECCCC-----cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce-
Confidence 4678999999999999976543 38999998654322 134688999999999999999999999887754
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeeccc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 243 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 243 (428)
+|||||+.++++..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 76 ---~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 76 ---SLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp ---EEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ---eehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence 999999998887766643 34588899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-h----hh
Q 014245 244 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-P----YL 317 (428)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~----~~ 317 (428)
+....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|..||...........+.... . .+
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 86544321 23346899999999988754 57999999999999999999999998665433221111000 0 00
Q ss_pred hhhhhhhhhc-CCcCCCC----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 SDAKQFRQIV-DPRLEGK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~-~~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.......... ....... .....++++.+|+.+||+.||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000000 0000000 011245789999999999999999999999885
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=386.01 Aligned_cols=266 Identities=23% Similarity=0.327 Sum_probs=199.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++++.||+|+||+||+|.+..++ ..||||++..... ...+++.+|+++|++++|||||++++++.+..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-- 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-- 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred CCCEeccEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--
Confidence 57999999999999999999976543 3899999965432 23568899999999999999999999998876
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.+|+||||+.++ +.+++.......+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 75 --~~~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 75 --KLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp --EEEEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred --ceeEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 459999999664 44444434445699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh-hh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-DA 320 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~ 320 (428)
|+...... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.......... ........ ..
T Consensus 149 a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~ 224 (298)
T d1gz8a_ 149 ARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDE 224 (298)
T ss_dssp HHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCT
T ss_pred ceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--HHHHhcCCCch
Confidence 98654332 2233468999999999887666 4789999999999999999999998654332211 11100000 00
Q ss_pred ---hhhhhhcC------CcCCCC---ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 ---KQFRQIVD------PRLEGK---YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ---~~~~~~~~------~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.......+ ...... ....++.++.+|+.+||+.||++|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 000000 011345788999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=382.76 Aligned_cols=273 Identities=24% Similarity=0.285 Sum_probs=201.9
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcC---CCCCcccEeeEEec
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIV---EHQNLVKLVGYCAD 158 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~ 158 (428)
.++|++++.||+|+||+||+|.+..++ ++.||||++..... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNG----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT----TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCC----CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 468999999999999999999875432 34799999865322 2233566777777665 89999999999864
Q ss_pred CC-CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEE
Q 014245 159 DD-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 237 (428)
Q Consensus 159 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 237 (428)
.. ......+++|||++++++..... .....+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 32 22346799999998877654433 3334589999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh-
Q 014245 238 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY- 316 (428)
Q Consensus 238 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~- 316 (428)
+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+......
T Consensus 158 ~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 158 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 999998754322 2234578999999999999999999999999999999999999999876543322221111000
Q ss_pred ----hhhhhh-hhhhcC---CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 ----LSDAKQ-FRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ----~~~~~~-~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+..... ...... ..........+++.+.+|+.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000000 000011222355788999999999999999999999885
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=382.59 Aligned_cols=242 Identities=24% Similarity=0.443 Sum_probs=195.3
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc------cHHHHHHHHHHHhcCC--CCCcccEeeE
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ------GHKEWMTEVNFLGIVE--HQNLVKLVGY 155 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~~~~~ 155 (428)
.++|.+.++||+|+||+||+|....++ ..||||.+.+.... ...++.+|+.+|++++ |||||+++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~ 77 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDN-----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence 357999999999999999999976543 38999998654221 1234678999999986 8999999999
Q ss_pred EecCCCCCceEEEEEeecCC-CCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-CC
Q 014245 156 CADDDERGIQRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QW 233 (428)
Q Consensus 156 ~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~ 233 (428)
+.+.+ ..++||||+.+ +++.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++
T Consensus 78 ~~~~~----~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 78 FERPD----SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp EECSS----EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred EeeCC----eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCC
Confidence 98876 35999999976 5777777543 4599999999999999999999998 9999999999999985 47
Q ss_pred CeEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCC-CCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 234 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 234 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
.+||+|||+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ....
T Consensus 149 ~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~- 218 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR- 218 (273)
T ss_dssp EEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-
T ss_pred eEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhh-
Confidence 89999999998654332 345789999999999987765 567999999999999999999997421 0000
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ... ++..+++++.+|+.+||+.||++|||++|++++
T Consensus 219 ------------~--~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 ------------G--QVF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------------C--CCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------c--ccC----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 001 112345789999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.3e-50 Score=376.20 Aligned_cols=266 Identities=20% Similarity=0.268 Sum_probs=199.8
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|.++++||+|+||+||+|.+..+ ..||||++..... ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~- 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR- 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS------CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-
T ss_pred CCceeccEEecCCCcEEEEEEeCCC------CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-
Confidence 5899999999999999999987543 3899999976532 235789999999999999999999999998775
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.+++|||+.++.+..+.... ..+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 75 ---~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 75 ---LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp ---EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred ---eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence 49999999887777666533 4599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-----h
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-----Y 316 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----~ 316 (428)
+....... .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+..... .
T Consensus 147 a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 147 ARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence 98654332 123345799999999998754 568999999999999999999999986543322111111000 0
Q ss_pred hhhhhhhhhh---c---CCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 317 LSDAKQFRQI---V---DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 317 ~~~~~~~~~~---~---~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
+......... . .+..........++++.+|+.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000 0 0000011122345789999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=380.29 Aligned_cols=273 Identities=22% Similarity=0.284 Sum_probs=201.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc-ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV-QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
..+|++++.||+|+||+||+|....++ ..||||++.+... ...+.+.+|+.+|+.++||||+++++++......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNK-----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTC-----SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCC-----cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 357999999999999999999876543 3899999976543 3356788999999999999999999999776543
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
....+++++|+.+|+|.+++..+ .+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 32335556667799999998643 499999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc-eeeeeeeecCcccCCcchhc-cCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 243 ARLGPSEGF-THVSTAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 243 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
++....... .......+||+.|+|||++. +..++.++||||+||++|+|++|+.||......................
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 986543221 11234567999999999985 4567899999999999999999999998765433322221111000000
Q ss_pred --------hhhhhhc-CCcCCCC----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 --------KQFRQIV-DPRLEGK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 --------~~~~~~~-~~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....... .+..... .....+.++.+|+.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0110000 011234678999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=368.55 Aligned_cols=274 Identities=21% Similarity=0.286 Sum_probs=198.5
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|++++.||+|+||+||+|.+..++ ..||||++..... .....+.+|+.+|+.++||||+++++++.....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTG-----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 368999999999999999999976543 3899999865432 345678899999999999999999999866432
Q ss_pred C----CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEE
Q 014245 162 R----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 237 (428)
Q Consensus 162 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 237 (428)
. ....++||||++++.+..+.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred cccccCceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEe
Confidence 1 12469999999887776555433 3488899999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCce--eeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014245 238 SDFGLARLGPSEGFT--HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 314 (428)
Q Consensus 238 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 314 (428)
+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+....
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999765432211 122346799999999998765 68999999999999999999999998765433332222111
Q ss_pred hhhhhh--------hhhhhhcCCcCCC-CccH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 315 PYLSDA--------KQFRQIVDPRLEG-KYSL-----RLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 315 ~~~~~~--------~~~~~~~~~~l~~-~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
...... ............. .... ...+.+.+|+.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 0000000000000 0111 123567899999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=375.61 Aligned_cols=267 Identities=25% Similarity=0.310 Sum_probs=198.0
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|++++.||+|+||+||+|....++ ..||||++..... ...+.+.+|+.+|+.++|||||+++++|...+.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC-----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 468999999999999999999976543 3899999976432 234578899999999999999999999987553
Q ss_pred C--CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ...+|+||||+ +++|..++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 92 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccc
Confidence 1 23459999999 6677776643 3499999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh-
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL- 317 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~- 317 (428)
||+|+..... .+...||+.|+|||++.+. .++.++|||||||++|+|++|+.||...................
T Consensus 165 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 165 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 9999865432 2456899999999998764 56899999999999999999999998765433222111110000
Q ss_pred -------h--hhhhhhhhcCCcCC---CCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 318 -------S--DAKQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 318 -------~--~~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
. ........+..... .......++++.+|+.+||..||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00000011100000 01112345688999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-48 Score=365.32 Aligned_cols=267 Identities=15% Similarity=0.214 Sum_probs=208.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC-CCcccEeeEEecCCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH-QNLVKLVGYCADDDER 162 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~ 162 (428)
.++|+++++||+|+||+||+|.+..+ ++.||||++..... ...+.+|++++..|.| +||+.+++++....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-- 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLN-----NQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-- 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTT-----TEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred CCceEEEEEEecCCCeEEEEEEECCC-----CCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC--
Confidence 36899999999999999999997654 34899999865432 2457788999999965 89999999987765
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECC-----CCCeEE
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-----QWNAKL 237 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl 237 (428)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||
T Consensus 75 --~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl 147 (293)
T d1csna_ 75 --HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 147 (293)
T ss_dssp --EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred --ccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence 359999999 789998886433 4589999999999999999999998 9999999999999964 578999
Q ss_pred eeecccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014245 238 SDFGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 312 (428)
Q Consensus 238 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 312 (428)
+|||+|+........ ......+||+.|||||++.+..++.++|||||||++|||++|..||..............
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence 999999875432211 123456899999999999999999999999999999999999999986554433222221
Q ss_pred HhhhhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhhh
Q 014245 313 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 376 (428)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~~~ 376 (428)
+.... ......+ ....+++++.+++..|+..+|++||+++.+.+.|++++....
T Consensus 228 i~~~~-~~~~~~~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 228 IGEKK-QSTPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHH-HHSCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhcc-CCCChHH---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 11100 0000111 111234689999999999999999999999999998876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9e-48 Score=367.43 Aligned_cols=262 Identities=20% Similarity=0.262 Sum_probs=200.2
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERG 163 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~ 163 (428)
++|+++++||+|+||+||+|....+ +..||||++... ..+++.+|+.+|+.+. ||||+++++++......
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~- 105 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITN-----NEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR- 105 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC-
T ss_pred cCeEEEEEEecCcCeEEEEEEECCC-----CCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC-
Confidence 5799999999999999999997654 348999998754 3467889999999995 99999999999865443
Q ss_pred ceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-CeEEeeecc
Q 014245 164 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGL 242 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGl 242 (428)
.+++|||||++++|..+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 106 -~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 106 -TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp -SEEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred -ceeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence 4599999999999987653 389999999999999999999998 999999999999998655 589999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccC-CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHH--hHh-hhhh
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ--WVK-PYLS 318 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~--~~~-~~~~ 318 (428)
|+...... ......||+.|+|||.+.+. .++.++|||||||++++|++|..||........+.... ... +...
T Consensus 177 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 177 AEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp CEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred ceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 98654332 23456799999999998765 47999999999999999999999997665433221110 000 0000
Q ss_pred ---------hhhhhhhhcCCc--------CCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 ---------DAKQFRQIVDPR--------LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ---------~~~~~~~~~~~~--------l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
....+....... ........+++++.+||.+||+.||++|||++|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000111000 1111122355789999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-48 Score=367.37 Aligned_cols=264 Identities=19% Similarity=0.272 Sum_probs=198.5
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCCCc
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 164 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~~ 164 (428)
++|++.+.||+|+||+||+|.+..++ ..||||.+..... ..++..|+++++.++|+|++..++.+.....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~--- 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD--- 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETT---
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCC-----CEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCC---
Confidence 57999999999999999999876543 4899999865432 3467899999999988877666655544332
Q ss_pred eEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEEC---CCCCeEEeeec
Q 014245 165 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLSDFG 241 (428)
Q Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFG 241 (428)
..++||||+ +++|.+.+... ...+++..++.++.|++.||+|||++ +||||||||+|||++ .+..+||+|||
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence 458999999 55666655432 34599999999999999999999998 999999999999985 45579999999
Q ss_pred ccccCCCCCce-----eeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-h
Q 014245 242 LARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-P 315 (428)
Q Consensus 242 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~ 315 (428)
+|+........ .......||+.|||||++.+..++.++|||||||++|||++|..||................ .
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 99875432211 12345689999999999999999999999999999999999999997655433222111110 0
Q ss_pred hhhhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 014245 316 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 374 (428)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~~~~~ 374 (428)
.... ... .....+++++.+++.+||+.||++||++.++.+.|+.+...
T Consensus 232 ~~~~--~~~---------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 232 KMST--PIE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHS--CHH---------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCC--Chh---------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0000 000 01112446899999999999999999999999988887654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=376.02 Aligned_cols=266 Identities=24% Similarity=0.289 Sum_probs=195.9
Q ss_pred CCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC--CC
Q 014245 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--RG 163 (428)
Q Consensus 86 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--~~ 163 (428)
+|+..++||+|+||+||+|.+..++ ..||||++..... .+.+|+.+|++++||||++++++|..... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSG-----ELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCC-----CEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 5888899999999999999987654 3899999976432 23479999999999999999999865332 22
Q ss_pred ceEEEEEeecCCCCcccccCC-CCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCC-CeEEeeec
Q 014245 164 IQRLLVYEYMPNGSVDQYLSP-KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFG 241 (428)
Q Consensus 164 ~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG 241 (428)
..++||||||+++.+..+... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEeccc
Confidence 356899999977644433221 2234599999999999999999999998 999999999999999775 89999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCcchhcc-CCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014245 242 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 320 (428)
Q Consensus 242 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (428)
+++...... .....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...........+...... ...
T Consensus 169 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~-~~~ 244 (350)
T d1q5ka_ 169 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT-PTR 244 (350)
T ss_dssp TCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC-CCH
T ss_pred chhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC-ChH
Confidence 998654332 2234689999999998765 56899999999999999999999999866543222111110000 000
Q ss_pred hhhhhhc----C---CcC-----CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 321 KQFRQIV----D---PRL-----EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 321 ~~~~~~~----~---~~l-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
..+.... + +.. ........++++.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0 000 011122356789999999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=358.05 Aligned_cols=265 Identities=23% Similarity=0.294 Sum_probs=203.9
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCCC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 162 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 162 (428)
++|++++.||+|+||+||+|....++ ..||||++..... ....++.+|+.+|+.++||||+++++++.+...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~- 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK- 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCC-----cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc-
Confidence 57999999999999999999976554 3899999865432 345788999999999999999999999988774
Q ss_pred CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeeecc
Q 014245 163 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 242 (428)
Q Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 242 (428)
.++|+|++.+++|..++... +.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.
T Consensus 76 ---~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 76 ---LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp ---EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred ---eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 48999999999998877644 4588999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh--
Q 014245 243 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD-- 319 (428)
Q Consensus 243 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 319 (428)
++....... ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||......... ...+......
T Consensus 148 a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~ 223 (292)
T d1unla_ 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPT 223 (292)
T ss_dssp CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred hhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCC
Confidence 987654322 223456788999999887665 689999999999999999999997554332221 1111110000
Q ss_pred ---hhhhhhhcC---------CcCCCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 320 ---AKQFRQIVD---------PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 320 ---~~~~~~~~~---------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
........+ ..-........++.+.+|+.+||+.||.+|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 000111223455788999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=366.74 Aligned_cols=268 Identities=22% Similarity=0.250 Sum_probs=194.8
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|+++++||+|+||+||+|.+..+ +..||||++..... ....++.+|+.+|++++|||||+++++|.....
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVL-----DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTT-----TEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCC-----CCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 36899999999999999999997654 35899999976532 234568899999999999999999999976542
Q ss_pred --CCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 162 --RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 162 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
....+|+|||||.++.+..+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~d 162 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred cccCceeEEEEeccchHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeec
Confidence 234679999999776555442 2389999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHh-Hhh---
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW-VKP--- 315 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-~~~--- 315 (428)
||+++..... ......+||+.|+|||++.+..++.++||||+||++++|++|+.||...........+.. ...
T Consensus 163 f~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 163 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred hhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 9998764432 233456899999999999999999999999999999999999999976543322111100 000
Q ss_pred -hhh-hhhhh---------------hhhcCCcC---CCCccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 316 -YLS-DAKQF---------------RQIVDPRL---EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 316 -~~~-~~~~~---------------~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.+. ..... ........ ........+.++.+|+.+||..||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000 00110000 111233567889999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=367.99 Aligned_cols=257 Identities=26% Similarity=0.362 Sum_probs=201.7
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc----ccHHHHHHHHHHHhcCCC-CCcccEeeEEecC
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV----QGHKEWMTEVNFLGIVEH-QNLVKLVGYCADD 159 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~ 159 (428)
++|++++.||+|+||+||+|..... ..++..||||.+.+... ...+.+.+|+.+|++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred hceEEEEEEecCCCeEEEEEEECcc--CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 5699999999999999999986442 22455899999875422 234567899999999966 8999999999887
Q ss_pred CCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEee
Q 014245 160 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 239 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 239 (428)
. ..++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 102 ~----~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 102 T----KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp T----EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESC
T ss_pred C----ceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEee
Confidence 6 3599999999999999986543 478889999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCcchhccC--CCCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014245 240 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 317 (428)
Q Consensus 240 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 317 (428)
||+++....... .......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||...........+.
T Consensus 173 FG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~------ 245 (322)
T d1vzoa_ 173 FGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------ 245 (322)
T ss_dssp SSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH------
T ss_pred ccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------
Confidence 999986543322 223456899999999998764 46889999999999999999999997654332221111
Q ss_pred hhhhhhhhhcCCcCCCCccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014245 318 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 367 (428)
Q Consensus 318 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~ 367 (428)
...... ....+..+++++.+|+.+||+.||++|| +++|+++|
T Consensus 246 ------~~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 246 ------RRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------HhcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 000000 1112234567899999999999999999 47888874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=360.51 Aligned_cols=268 Identities=23% Similarity=0.312 Sum_probs=198.2
Q ss_pred hcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCc--ccHHHHHHHHHHHhcCCCCCcccEeeEEecCCC
Q 014245 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGV--QGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 161 (428)
Q Consensus 84 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 161 (428)
.++|+++++||+|+||+||+|....+ +..||||++..... ...+.+.+|+.+|+.++|||||++++++.....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKT-----GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTT-----TEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCC-----CCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 46899999999999999999987654 34899999976533 334578899999999999999999999865432
Q ss_pred C-CceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEECCCCCeEEeee
Q 014245 162 R-GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 240 (428)
Q Consensus 162 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 240 (428)
. ....++||+|+.+|+|.+++..+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++||
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred cccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence 1 11225667788899999998643 499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCcchhccCC-CCCchhhhhHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh-
Q 014245 241 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS- 318 (428)
Q Consensus 241 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 318 (428)
|++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+........
T Consensus 166 g~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 166 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp ----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred chhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99975432 233467999999999877654 68899999999999999999999987654333222211100000
Q ss_pred ------hhhhhhhhcC--CcCCCCc----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014245 319 ------DAKQFRQIVD--PRLEGKY----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 367 (428)
Q Consensus 319 ------~~~~~~~~~~--~~l~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 367 (428)
.......... ....... ....++++.+||.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000 0000000 11245678999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-42 Score=335.20 Aligned_cols=267 Identities=20% Similarity=0.256 Sum_probs=191.3
Q ss_pred cCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-----------CCCcccEe
Q 014245 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-----------HQNLVKLV 153 (428)
Q Consensus 85 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~~ 153 (428)
++|+++++||+|+||+||+|....+ +..||||++..... ..+.+.+|+.+++.++ |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~-----g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVN-----NTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCC-----CCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 3599999999999999999997654 34899999976532 3456778998888775 57899999
Q ss_pred eEEecCCCCCceEEEEEeecCCCCc-ccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECC
Q 014245 154 GYCADDDERGIQRLLVYEYMPNGSV-DQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDE 231 (428)
Q Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~ 231 (428)
+++...... ..+++|+++..+.. ...........+++..+..++.||+.||+|||+ . +|+||||||+||||+.
T Consensus 87 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 87 DHFNHKGPN--GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI 161 (362)
T ss_dssp EEEEEEETT--EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred EEeeecccc--ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence 998765543 33666666544332 222233344568899999999999999999997 5 8999999999999986
Q ss_pred CCC------eEEeeecccccCCCCCceeeeeeeecCcccCCcchhccCCCCCchhhhhHHHHHHHHHhCCCCCCCCCchh
Q 014245 232 QWN------AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 305 (428)
Q Consensus 232 ~~~------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~ 305 (428)
++. ++|+|||.+...... ....+||+.|+|||++.+..|+.++|||||||++++|++|+.||.......
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 654 999999999765332 234679999999999999999999999999999999999999997543221
Q ss_pred h----HHHHHhHhhh-------hhhhhhhhhhcCC-----c--------------CCCCccHHHHHHHHHHHHHhcccCC
Q 014245 306 E----QKLLQWVKPY-------LSDAKQFRQIVDP-----R--------------LEGKYSLRLVSKLSHVANLCLVKNA 355 (428)
Q Consensus 306 ~----~~~~~~~~~~-------~~~~~~~~~~~~~-----~--------------l~~~~~~~~~~~l~~li~~cl~~dp 355 (428)
. ..+...+... ...........+. . .........++++.+|+.+||..||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 1 1111111100 0000000000000 0 0112345678899999999999999
Q ss_pred CCCCCHHHHHHH
Q 014245 356 RTRPKMSEVLEM 367 (428)
Q Consensus 356 ~~RPs~~ell~~ 367 (428)
.+|||++|+++|
T Consensus 317 ~~Rpta~e~L~H 328 (362)
T d1q8ya_ 317 RKRADAGGLVNH 328 (362)
T ss_dssp TTCBCHHHHHTC
T ss_pred hHCcCHHHHhcC
Confidence 999999999885
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=6.7e-26 Score=197.95 Aligned_cols=163 Identities=15% Similarity=0.118 Sum_probs=117.8
Q ss_pred CCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcc------------------cHHHHHHHHHHHhcCCCCCc
Q 014245 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQ------------------GHKEWMTEVNFLGIVEHQNL 149 (428)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~nI 149 (428)
.+.++||+|+||+||+|...++ ..||||++...... .......|+..+.++.|.++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g------~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v 76 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKF------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 76 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTT------EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS
T ss_pred hhCCEeeeCcceEEEEEECCCC------CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc
Confidence 4678999999999999986543 37999987532110 11234568889999999999
Q ss_pred ccEeeEEecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEE
Q 014245 150 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 229 (428)
Q Consensus 150 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl 229 (428)
+..+++.. . +++|||++++.+.++ +......++.|++.+|.|||++ +|+||||||+|||+
T Consensus 77 ~~~~~~~~----~----~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv 136 (191)
T d1zara2 77 PKVYAWEG----N----AVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 136 (191)
T ss_dssp CCEEEEET----T----EEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred ceEEEecC----C----EEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheee
Confidence 99886532 1 799999988665443 2334567899999999999998 99999999999999
Q ss_pred CCCCCeEEeeecccccCCCCCceeeeeeeecCcccCCc------chhccCCCCCchhhhhHHHHH
Q 014245 230 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP------EYVQTGRLAARSDVWSYGVFL 288 (428)
Q Consensus 230 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslG~il 288 (428)
+++ .++|+|||+|......... .|... +.+ ...|+.++|+||+.--+
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 976 4899999999765433211 11111 111 35688899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=3.7e-08 Score=88.05 Aligned_cols=149 Identities=16% Similarity=0.105 Sum_probs=96.0
Q ss_pred HHHHHHhcCCCCceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEE
Q 014245 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYC 156 (428)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 156 (428)
.++......|...+..+-++.+.||+....+. .+++|............+.+|..++..+. +--+.+++.++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~-------~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~ 79 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENE-------NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSC-------EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCC-------eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence 35566667787766654444578998753322 57888876544334445678888887773 33367777777
Q ss_pred ecCCCCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcC------------------------
Q 014245 157 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG------------------------ 212 (428)
Q Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------ 212 (428)
.+.+ ..++||++++|.++.+...... . ...++.+++..|..||+.
T Consensus 80 ~~~~----~~~lv~~~l~G~~~~~~~~~~~----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 80 RHDG----WSNLLMSEADGVLCSEEYEDEQ----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp EETT----EEEEEEECCSSEEHHHHTTTCS----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred ecCC----ceEEEEEecccccccccccccc----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 6554 3489999999988765442111 1 122344444555555521
Q ss_pred --------------------------------CCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 213 --------------------------------MDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 213 --------------------------------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
....++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237999999999999987667799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=1.5e-05 Score=70.12 Aligned_cols=130 Identities=15% Similarity=0.082 Sum_probs=80.1
Q ss_pred eecccCc-eEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC--CCcccEeeEEecCCCCCceEEE
Q 014245 92 VIGEGGF-GCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGIQRLL 168 (428)
Q Consensus 92 ~lG~G~~-g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~~~~~l 168 (428)
.+..|.. +.||+....+.. .+++|....... ..+..|+..++.|.. -.+.+++++..+.+. .++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~------~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~----~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRP------VLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGR----DWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSC------CEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC----EEE
T ss_pred EcCCcccCCeEEEEEeCCCC------EEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccc----eEE
Confidence 3445553 678988754433 477787654432 346678887777633 336677777766543 489
Q ss_pred EEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhc-------------------------------------
Q 014245 169 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE------------------------------------- 211 (428)
Q Consensus 169 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~------------------------------------- 211 (428)
||++++|.++.+... ... .++.++...|.-||.
T Consensus 84 v~~~i~G~~~~~~~~-------~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSHL-------APA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp EEECCSSEETTTSCC-------CHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEeeeccccccccc-------cHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 999999877655321 101 112223333333331
Q ss_pred --------------C----CCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 212 --------------G----MDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 212 --------------~----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
. ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12248999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.87 E-value=2.4e-05 Score=73.65 Aligned_cols=78 Identities=15% Similarity=0.089 Sum_probs=47.4
Q ss_pred ceeecccCceEEEEEEEcCCCCCCcceEEEEEEccCC------C-cccHHHHHHHHHHHhcC-CC--CCcccEeeEEecC
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------G-VQGHKEWMTEVNFLGIV-EH--QNLVKLVGYCADD 159 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l-~h--~nIv~~~~~~~~~ 159 (428)
.+.||.|....||++....+ ++.+++|.-... . .....+...|...|..+ .+ ..+.+++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~-----~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEH-----DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--
T ss_pred EEEeCCCceEeEEEEEeCCC-----CeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--
Confidence 44789999999999875433 236888875421 1 11234556788888766 22 34666765543
Q ss_pred CCCCceEEEEEeecCCCCc
Q 014245 160 DERGIQRLLVYEYMPNGSV 178 (428)
Q Consensus 160 ~~~~~~~~lv~e~~~~g~L 178 (428)
... ++|||++++..+
T Consensus 104 ~~~----~lvmE~L~~~~~ 118 (392)
T d2pula1 104 EMA----VTVMEDLSHLKI 118 (392)
T ss_dssp TTT----EEEECCCTTSEE
T ss_pred CCC----EEEEeccCCccc
Confidence 222 899999976443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.38 E-value=0.00051 Score=64.30 Aligned_cols=80 Identities=14% Similarity=0.155 Sum_probs=51.2
Q ss_pred ceeecccCceEEEEEEEcCCCCC--CcceEEEEEEccCCCcccHHHHHHHHHHHhcCC-CCCcccEeeEEecCCCCCceE
Q 014245 90 SVVIGEGGFGCVYKGLIKNSEDP--SQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQR 166 (428)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~~~~ 166 (428)
++.|+-|-.=.+|++........ .....|.+++.... .......+|..+++.+. +.-..++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-------- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG-------- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------
Confidence 35677788889999887654221 11234666666532 23345568999988884 4444577777642
Q ss_pred EEEEeecCCCCcc
Q 014245 167 LLVYEYMPNGSVD 179 (428)
Q Consensus 167 ~lv~e~~~~g~L~ 179 (428)
.+|+||++|..|.
T Consensus 117 g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEECCCCEEECC
T ss_pred ceEEEEeccccCC
Confidence 6899999886554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.93 E-value=0.0024 Score=57.38 Aligned_cols=159 Identities=11% Similarity=0.023 Sum_probs=83.2
Q ss_pred cCHHHHHHHhcCCCCceee-----cccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCC---
Q 014245 75 FTIAELKSATKNFSRSVVI-----GEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEH--- 146 (428)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--- 146 (428)
.+.+++.....+|.++++. ..|---+.|+....++ .+++|+..... ..+++..|+.++..|..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-------~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~ 73 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-------PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGL 73 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-------CEEEEEECC-----CCHHHHHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-------cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccc
Confidence 4667888888889876544 3555577899876543 48999886532 22345556666666632
Q ss_pred --CCcccEe-eEEecCCCCCceEEEEEeecCCCCcccccCC----------------------CCccc------------
Q 014245 147 --QNLVKLV-GYCADDDERGIQRLLVYEYMPNGSVDQYLSP----------------------KSETI------------ 189 (428)
Q Consensus 147 --~nIv~~~-~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----------------------~~~~~------------ 189 (428)
|..+... |.... ........++.+..+......-.. .....
T Consensus 74 pvp~pi~~~~g~~~~--~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (316)
T d2ppqa1 74 SCPLPLPRKDGELLG--ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS 151 (316)
T ss_dssp CCCCBCCBTTCCSCE--EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred cccccceecCCCcce--eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHH
Confidence 2222211 00000 001123566777766444322100 00000
Q ss_pred -----ccHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEECCCCCeEEeeecccc
Q 014245 190 -----LTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 244 (428)
Q Consensus 190 -----l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 244 (428)
.........+..+...+.-.+. ....++||+|+.++||+++.+...-|.||+.+.
T Consensus 152 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 152 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0000111222223333333322 224589999999999999988777899999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.66 E-value=0.0042 Score=56.07 Aligned_cols=136 Identities=13% Similarity=0.087 Sum_probs=73.4
Q ss_pred eEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCc--ccEeeEEecCC---CCCceEEEEEeec
Q 014245 99 GCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNL--VKLVGYCADDD---ERGIQRLLVYEYM 173 (428)
Q Consensus 99 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~~~~~~~~~~---~~~~~~~lv~e~~ 173 (428)
-.||++...++. .+++|+.... ....+++..|...+..|...+| +..+. .... ......+.+++++
T Consensus 36 N~vy~v~~~dg~------~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~--~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 36 NRVYQFQDEDRR------RFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVA--FNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp SEEEEECCTTCC------CEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCC--BTTBSCEEETTEEEEEEECC
T ss_pred ceeEEEEcCCCC------EEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCcee--cCCCeeeeeeeEEEEEEeec
Confidence 479998765543 6889987543 2345677888888877743222 11111 0000 1122458899999
Q ss_pred CCCCccccc------------------CC---CCcccccHH----------------------HHHHHHHHHHHHHHHh-
Q 014245 174 PNGSVDQYL------------------SP---KSETILTWA----------------------MRLKIAQDAARGLAYL- 209 (428)
Q Consensus 174 ~~g~L~~~l------------------~~---~~~~~l~~~----------------------~~~~i~~~i~~~L~~L- 209 (428)
+|..+...- .. ......+.. .....+.++...+.-+
T Consensus 107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 186 (325)
T d1zyla1 107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 186 (325)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 875543210 00 000111111 1122233333333322
Q ss_pred hcCCCCCeeeccCCCCceEECCCCCeEEeeeccccc
Q 014245 210 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 245 (428)
Q Consensus 210 H~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 245 (428)
......++||+|+.+.|||++++ ..++||+-+..
T Consensus 187 ~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 187 REDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 22224579999999999999754 45899988754
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=82.75 E-value=2.4 Score=36.58 Aligned_cols=139 Identities=10% Similarity=0.031 Sum_probs=76.5
Q ss_pred ecccCceEEEEEEEcCCCCCCcceEEEEEEccCCCcccHHHHHHHHHHHhcCCCCCcccEeeEEec--------------
Q 014245 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGVQGHKEWMTEVNFLGIVEHQNLVKLVGYCAD-------------- 158 (428)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-------------- 158 (428)
+..+|.+-|+.+....+ .+++|.-. ....+.+-.|+...-.+.-|...-+. .+..
T Consensus 76 ~s~~Gs~Gv~FV~~e~g-------aiVlK~s~---tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e 144 (342)
T d1cjaa_ 76 RSEKGTEGLFFVETESG-------VFIVKRST---NIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDK 144 (342)
T ss_dssp ECCSTTSCEEEEEESSC-------EEEEECCT---THHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCS
T ss_pred EeecCCceEEEEEcCCc-------eEEEecCC---chHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCC
Confidence 34455555666655443 68888632 23345666777766677777754432 1110
Q ss_pred CC-----CCCceEEEEEeecCCCCcccccCCCCcccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC-CCCceEECCC
Q 014245 159 DD-----ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF-KSSNILLDEQ 232 (428)
Q Consensus 159 ~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~NILl~~~ 232 (428)
.+ ......+++|||.+|..|.+.-.......+.......+- .|+--=.+++.....++++|+- .++||+++.+
T Consensus 145 ~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LG-kIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n 223 (342)
T d1cjaa_ 145 SFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG-SLMALDVIVNNSDRLPIAWTNEGNLDNIMLSER 223 (342)
T ss_dssp SSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH-HHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESB
T ss_pred hhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhh-hHHHHHHHHcCCccccccccCCCCccceEEecC
Confidence 00 011134899999999888766533222223333322211 1222223567655556777732 7899999877
Q ss_pred C-CeEEeeeccc
Q 014245 233 W-NAKLSDFGLA 243 (428)
Q Consensus 233 ~-~~kl~DFGla 243 (428)
+ .+..+|=|+.
T Consensus 224 ~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 224 GATVVPIDSKII 235 (342)
T ss_dssp TTCEEECSCCCC
T ss_pred CcEEEEecCCcc
Confidence 7 5777775544
|